,Unnamed: 0,Primary Cell Line Name,Compound,Target,Doses (uM),Activity Data (median),Activity SD,Num Data,FitType,EC50 (uM),IC50 (uM),Amax,ActArea,CCLE_Name,cell_lines,DepMap_ID,primary_disease,Unnamed: 0.1,SMILES,Compound (brand name),Target(s),Mechanism of action,Class,Highest Phase,Organization,smiles,Label,y_pred
0,398,A172,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.75,3.15,9.45,7.81,1.15,4.57,-3.7,-2.1","6.44,3.36,2.34,1.18,1.86,3.21,4.71,6.22",8,Constant,,8.0,2.413093328,0.0,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3035385608673096
1,399,A-204,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.74,8.27,-2.4,-7.0,-2.6,-61,-68,-68","9.49,4.76,8.76,9.15,7.86,34.6,7.87,6.42",8,Sigmoid,0.724007547,1.081994414,-69.67256927,1.727,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,0.07880601774922563,2.8795814514160156
2,400,A2058,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.64,-1.9,2.59,.34,2.58,1.18,4.64,-12","5.59,.10,4.36,1.90,4.96,3.27,6.55,6.52",8,Constant,,8.0,-0.027685003,0.02046,A2058_SKIN,A2058,ACH-000788,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.1388609409332275
3,401,A-253,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.90,-6.1,7.33,3.60,-10,-.44,-1.8,-14","2.82,10.5,9.54,11.7,3.88,7.12,.62,6.87",8,Constant,,8.0,-1.752123356,0.2846,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0554370880126953
4,402,A2780,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.32,-1.6,7.05,3.04,8.70,-2.4,-12,-40","7.99,4.99,2.00,4.20,3.53,3.21,6.54,21.4",8,Sigmoid,8.225344173,6.804694176,-57.66464233,0.4157,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9176126940208085,2.8031516075134277
5,403,A-375,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.20,-2.4,-.065,-5.8,-4.7,-2.9,-17,-49","4.43,.47,.73,4.89,2.29,.57,1.53,1.88",8,Sigmoid,3.652579784,8.0,-48.63061905,0.521,A375_SKIN,A375,ACH-000219,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.9708595275878906
6,404,A549,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.72,1.11,-1.2,1.07,1.47,-5.7,-12,-75","4.85,6.89,3.85,19.5,5.70,8.01,2.31,19.5",8,Sigmoid,8.150643814,6.0388937,-70.8199234,0.6661,A549_LUNG,A549,ACH-000681,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.7982208329188143,3.3638384342193604
7,405,ALL-SIL,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-41,-84,-93,-92,-95,-96,-97,-99","1.40,11.5,1.16,.10,.33,.34,1.12,.14",8,Sigmoid,0.002542614,0.002952101,-96.07331848,7.0051,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,-5.825238158737059,2.8005316257476807
8,406,AMO-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.94,4.00,-3.9,.12,-.47,-14,-55,-83","11.5,3.36,20.5,14.1,5.73,9.08,0,0",8,Sigmoid,1.900959373,2.226455688,-82.69425964,1.5625,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,0.8004109434930912,3.0772297382354736
9,407,AsPC-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.77,6.33,-2.1,-12,-6.9,-2.0,-18,-34","5.45,5.62,36.4,4.69,6.62,5.25,15.2,15.4",8,Linear,,8.0,-48.63910675,0.2155,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4742753505706787
10,408,AU565,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-8.9,-9.2,-.35,-16,-8.4,19.1,-52","4.34,12.7,13.4,22.8,9.47,18.8,2.71,4.04",8,Sigmoid,8.138304193,7.879194736,-52.14413452,0.873,AU565_BREAST,AU565,ACH-000248,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0642257077850017,3.4585351943969727
11,409,B-CPAP,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.50,6.13,1.75,5.19,-1.7,-5.1,-3.7,-56","2.99,1.90,3.21,.98,2.25,5.08,1.39,3.57",8,Sigmoid,8.390072637,7.456087112,-55.99276352,0.7336,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0090307607914335,3.422640800476074
12,410,BDCM,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.96,21.5,-4.0,34.6,-14,19.9,8.21,-13","31.4,43.7,10.5,23.9,10.3,9.03,1.84,7.27",8,Constant,,8.0,4.974695206,0.0,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.844316244125366
13,411,BFTC-909,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,5.14,-2.1,9.49,2.37,2.00,1.28,-.99","11.2,3.57,6.54,.91,5.24,5.31,.38,1.13",8,Constant,,8.0,1.431144595,0.00241,BFTC909_KIDNEY,BFTC909,ACH-000792,Kidney Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2893667221069336
14,412,BL-41,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.56,4.92,5.61,2.05,.31,-6.0,-4.2,-7.5","2.85,10.1,6.62,.88,3.51,8.19,10.7,14.2",8,Constant,,8.0,1.332888007,0.0,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.8336524963378906
15,413,BL-70,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.76,.030,5.98,3.16,2.14,-9.1,1.98,-15","5.03,6.36,19.6,.59,16.9,6.90,1.48,3.53",8,Constant,,8.0,-0.302530825,0.1648,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.7876906394958496
16,414,BT-20,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,-22,-7.8,1.63,-5.7,.37,13.1,-13","8.33,21.8,7.96,16.9,26.3,26.6,16.7,18.8",8,Constant,,8.0,-5.42175293,0.3956,BT20_BREAST,BT20,ACH-000536,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.528024435043335
17,415,BT-474,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".75,13.1,-2.3,14.5,-4.7,2.28,-7.9,-63","2.65,4.71,4.82,12.2,18.2,2.01,24.3,12.1",8,Sigmoid,8.738396718,6.892540932,-62.47209167,0.5231,BT474_BREAST,BT474,ACH-000927,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9304398025271257,3.7087321281433105
18,416,BT-549,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,7.90,16.3,7.44,10.2,1.62,4.03,-42","59.7,17.3,6.55,21.4,20.4,1.79,33.7,9.29",8,Sigmoid,8.071275328,8.0,-41.76569366,0.641,BT549_BREAST,BT549,ACH-000288,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3360462188720703
19,417,C2BBe1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","12.0,4.83,37.3,.51,8.67,-16,-.78,-61",".40,13.8,16.1,10.5,4.57,5.01,10.3,2.01",8,Sigmoid,8.834738015,6.82102108,-59.16954422,0.7346,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9200091791237517,3.564455032348633
20,418,C32,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,2.95,-5.3,-4.6,-5.0,9.25,1.25,-25","11.6,13.9,6.57,.11,11.6,9.43,20.6,5.88",8,Sigmoid,7.24379921,8.0,-24.5538063,0.1393,C32_SKIN,C32,ACH-000580,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.195333480834961
21,419,CAL-85-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,9.55,7.19,4.79,3.46,5.20,2.87,-12","7.42,31.5,16.5,11.7,10.1,5.54,13.5,18.5",8,Constant,,8.0,-0.259259254,0.07419,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2496025562286377
22,420,Calu-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.05,8.55,2.94,1.67,-2.5,5.59,-6.3,-25","7.90,16.4,5.23,6.55,1.65,7.23,8.03,2.25",8,Sigmoid,2.97313714,8.0,-24.51846504,0.1917,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.744515895843506
23,421,Calu-3,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.22,12.2,1.13,4.15,5.94,4.07,-4.6,-46","16.5,25.1,13.5,21.4,25.3,7.48,21.2,24.7",8,Linear,,8.0,-46.01375961,0.4743,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5030436515808105
24,422,CAMA-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","16.4,-1.4,-3.4,8.61,-4.0,7.87,-5.1,-52",".31,.90,12.7,1.87,14.0,9.87,6.92,17.4",8,Sigmoid,3.461487055,6.332070827,-51.81809235,0.4371,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.84562732752159,3.2287683486938477
25,423,Capan-2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,10.8,-14,-2.1,-.92,12.0,-3.2,-79","12.0,23.8,6.98,14.9,9.11,19.8,46.5,67.4",8,Linear,,0.062944786,-126.6332626,0.7497,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,-2.765497349563164,3.649235248565674
26,424,CAS-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,13.7,-2.5,-2.2,6.17,-12,.34,-25","4.73,5.21,15.2,10.2,13.8,5.87,2.88,7.53",8,Constant,,8.0,-2.313755989,0.207,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4273905754089355
27,425,CI-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","15.8,10.9,9.49,-24,35.6,3.60,25.6,17.1","1.08,4.13,37.8,36.8,32.6,51.6,14.1,29.9",8,Constant,,8.0,14.42729759,0.2173,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.584329128265381
28,426,COLO-320,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.8,4.24,-2.1,-3.0,7.09,-6.5,-30,-58","3.90,3.65,8.38,.24,1.11,8.30,1.02,11.4",8,Sigmoid,2.641251087,4.991260529,-57.45098877,0.8088,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.6076884888846794,2.956047534942627
29,427,COLO-678,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.23,5.50,19.2,7.08,1.60,-3.8,8.57,-23","5.38,11.4,20.8,1.35,5.74,20.1,16.5,2.70",8,Constant,,8.0,5.360154152,0.2982,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.7832906246185303
30,428,COLO-679,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.6,-5.0,10.8,-6.1,5.12,-6.8,-14,-54",".067,11.7,6.65,7.91,7.87,11.6,4.32,11.6",8,Sigmoid,8.342865131,7.357892513,-53.87722397,0.5391,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.995773548394311,3.3178658485412598
31,429,COR-L23,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.89,-1.6,2.23,-1.1,5.34,1.22,-7.2,-19","2.98,3.70,2.54,.22,1.31,.97,3.65,3.83",8,Constant,,8.0,0.030184133,0.1142,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.188815116882324
32,430,COV318,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.69,-6.0,4.80,-8.7,4.60,3.83,3.83,-56","7.47,8.79,1.38,10.7,5.24,2.91,4.17,7.45",8,Sigmoid,7.938932896,7.686830521,-55.67036057,0.5619,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0395085426411823,3.453340530395508
33,431,COV504,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.2,-5.5,.10,14.9,24.3,11.4,19.8,-36","16.7,32.3,2.26,6.99,10.3,9.70,8.80,17.5",8,Sigmoid,8.011692339,8.0,-35.36859894,0.1649,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5114693641662598
34,432,Daoy,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,5.75,-8.7,1.39,-8.0,9.28,4.27,-30","9.33,12.9,2.14,2.09,2.49,9.77,11.3,18.1",8,Sigmoid,7.009179115,8.0,-29.72894096,0.2486,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0121195316314697
35,433,DBTRG-05MG,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.24,13.5,-6.2,2.29,-1.9,10.3,-13,-20","10.7,6.38,3.54,4.22,11.0,5.98,5.82,3.85",8,Sigmoid,2.124032021,8.0,-19.76345444,0.3488,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3052010536193848
36,434,Detroit 562,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,10.3,6.38,3.51,10.9,-5.2,-4.1,-40","1.92,22.5,12.7,3.80,16.2,5.86,9.18,11.4",8,Sigmoid,8.143018024,8.0,-40.00160217,0.5156,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4027771949768066
37,435,DK-MG,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.27,-.39,-.069,6.26,7.73,1.77,-1.9,-1.3","5.53,14.3,4.79,6.17,.95,5.54,3.48,12.5",8,Constant,,8.0,2.636674166,0.0,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.323951244354248
38,436,DMS 114,Nilotinib,ABL,".0080,.025,.080,.25,.80,2.53,8","27.9,-5.6,7.75,-13,4.75,-11,-70","9.03,29.9,9.40,16.7,5.59,11.7,20.4",7,Sigmoid,8.331872804,6.058652401,-69.76840973,0.8476,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.8014873992793907,3.682178258895874
39,437,DOHH-2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.42,66.7,26.3,-20,-9.1,-28,-47,-35","25.4,61.8,11.8,15.2,37.7,7.63,2.53,30.5",8,Linear,,8.0,-47.84657669,1.7965,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.062030792236328
40,438,EB1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","29.0,13.4,11.4,16.2,23.3,6.59,-5.3,-21","17.4,26.8,5.50,22.3,24.9,6.06,9.88,21.8",8,Linear,,8.0,-20.41915894,0.3182,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.610992670059204
41,439,EBC-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","20.9,13.6,8.81,2.89,9.46,6.08,-13,-28",".15,10.5,7.19,11.7,7.71,4.91,13.8,20.6",8,Sigmoid,8.336495536,8.0,-27.94343376,0.3761,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4117183685302734
42,440,EFE-184,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.6,-.24,10.0,-2.4,5.94,2.91,2.97,-26","12.8,6.91,10.3,17.0,4.76,12.1,3.97,1.53",8,Sigmoid,6.56737709,8.0,-26.16277695,0.2116,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.394932270050049
43,441,EFM-19,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.84,6.27,-3.7,15.7,-2.0,9.03,-17,-14","2.66,6.64,2.22,8.30,2.44,.51,14.6,11.5",8,Constant,,8.0,0.745572448,0.3452,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3822014331817627
44,442,EFO-21,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,-.60,-3.8,5.87,3.07,7.56,7.13,-14","13.8,12.4,2.82,11.9,5.31,11.1,2.91,11.4",8,Constant,,8.0,-0.164606914,0.08193,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4116358757019043
45,443,EFO-27,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,5.58,-10,7.79,-2.8,1.55,-6.4,-18","3.41,.14,10.8,3.48,8.46,7.59,4.18,4.18",8,Constant,,8.0,-3.399219036,0.09143,EFO27_OVARY,EFO27,ACH-000936,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.124812126159668
46,444,EM-2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,-52,-81,-89,-91,-93,-94,-96","1.61,.61,1.35,.23,.41,.31,.27,1.52",8,Sigmoid,0.004420172,0.007538102,-93.63391876,6.0634,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,-4.887784852788042,2.9351985454559326
47,445,EN,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.95,7.67,10.3,-.77,3.16,-3.7,6.76,-13","5.07,5.30,6.60,7.66,15.9,8.38,9.26,4.84",8,Constant,,8.0,4.238839149,0.1392,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.024214506149292
48,446,F-36P,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","30.8,1.91,41.7,26.7,1.33,-9.6,-22,-58","29.7,12.4,31.5,12.3,9.23,16.7,17.1,2.79",8,Sigmoid,8.093987239,6.25021553,-57.82687759,0.9395,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.8326159479537232,2.9146697521209717
49,447,FaDu,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,13.0,13.7,2.46,6.05,5.76,-4.6,-83","11.0,6.79,14.3,11.5,2.99,4.04,2.59,9.75",8,Sigmoid,6.701414585,5.612988949,-82.17654419,0.7939,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.7250833671357475,3.3246941566467285
50,448,FU-OV-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.08,-7.3,20.1,11.0,10.5,1.62,-3.4,-42","18.5,17.0,21.1,9.18,22.5,32.0,11.0,24.2",8,Linear,,8.0,-41.38858414,0.4601,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0733346939086914
51,449,G-361,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,11.5,-5.6,-2.0,-9.3,5.48,-7.4,-38","2.74,12.9,5.48,7.29,7.10,17.7,4.53,13.9",8,Sigmoid,4.008089542,8.0,-38.11253738,0.5674,G361_SKIN,G361,ACH-000572,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.154853105545044
52,450,G-401,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.4,6.13,-5.6,3.49,5.70,-7.6,-4.5,-42","5.97,.42,18.1,3.70,9.30,2.58,4.93,.24",8,Sigmoid,8.699294488,8.0,-41.21418762,0.6602,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.858386516571045
53,451,GB-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-8.7,-3.9,-2.3,1.36,-4.0,-4.5,-16","27.4,14.1,6.97,7.94,7.70,14.9,16.2,9.16",8,Constant,,8.0,-5.79782486,0.256,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.321676254272461
54,452,GCT,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.51,-9.7,7.45,-.98,7.05,-3.6,-3.6,-50","10.7,16.9,1.50,15.2,6.89,8.67,8.41,19.8",8,Sigmoid,8.100199047,8.0,-49.24378204,0.5817,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.300032138824463
55,453,GMS-10,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,6.62,-6.0,13.0,-5.7,2.40,-.30,-2.5","2.91,.76,10.5,2.98,8.01,3.23,11.6,15.9",8,Constant,,8.0,0.612546623,0.0,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.003767251968384
56,454,GRANTA-519,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.88,53.6,-16,45.2,-6.6,1.40,-63,-85","2.01,52.6,20.1,39.2,21.6,7.81,41.7,16.8",8,Linear,,0.379206822,-87.55726624,1.8129,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,-0.9696735182567684,2.9782276153564453
57,455,H4,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.47,.92,3.69,3.26,9.01,2.29,8.65,-57","3.55,5.12,8.83,.83,7.61,8.65,.60,6.84",8,Sigmoid,8.004673578,7.630359173,-57.33721924,0.5618,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.03213491797611,3.4479904174804688
58,456,HCC1187,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.71,-4.0,-.62,23.0,3.59,-.27,-7.6,-13","3.38,23.5,5.35,41.0,10.5,20.9,.71,11.2",8,Constant,,8.0,-3.813393116,0.1172,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.281247854232788
59,457,HCC-15,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".12,7.13,-7.6,2.91,-6.3,-1.1,-1.7,3.27","8.13,1.55,.98,4.03,5.64,1.73,.35,14.9",8,Constant,,8.0,-1.695663333,0.3714,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.486443519592285
60,458,HCC1569,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-4.4,5.12,2.89,2.27,9.44,3.58,-18","1.90,9.14,3.54,1.81,4.40,9.01,8.26,4.65",8,Sigmoid,8.060549212,8.0,-17.68243408,0.1617,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.394043207168579
61,459,HCC1806,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-6.1,15.4,-11,6.62,-8.0,-9.3,-53","6.31,17.6,4.12,8.29,.11,33.7,15.9,2.55",8,Sigmoid,8.003666774,7.519812584,-53.48749161,1.0867,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0175412153107564,3.329484224319458
62,460,HCC1954,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,27.5,-.66,13.5,8.79,7.89,-7.2,-57","9.88,5.24,6.53,12.0,3.35,3.32,6.63,2.64",8,Sigmoid,3.300563574,5.009234905,-56.9713974,0.5581,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.6112831898620141,3.4198756217956543
63,461,HCC2935,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","17.0,14.7,7.90,9.65,12.9,10.5,3.74,-39","16.8,5.69,22.4,30.8,1.20,20.0,15.2,1.22",8,Sigmoid,8.19167101,8.0,-38.75590515,0.3039,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3565902709960938
64,462,HCC4006,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.0,-2.2,2.62,.60,-14,-2.2,-1.1,-64","8.28,11.8,7.38,3.05,12.1,21.2,4.26,26.3",8,Sigmoid,8.33766156,7.44418478,-63.52691269,0.7678,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0074331611479073,3.3635807037353516
65,463,HCC-56,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.92,3.59,-.37,-4.7,22.1,-.66,1.98,-12","7.48,.37,6.23,1.48,14.4,1.95,9.74,6.45",8,Constant,,8.0,-0.664824128,0.09552,HCC56_LARGE_INTESTINE,HCC56,ACH-000467,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0471925735473633
66,464,HCC70,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,2.66,14.4,19.6,2.99,10.1,1.60,-12","10.2,1.89,19.3,6.10,12.1,18.8,10.7,7.88",8,Constant,,8.0,10.93593502,0.09364,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2016282081604004
67,465,HCC-78,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,-2.7,5.34,4.18,-.88,-5.9,-7.5,-2.7","12.7,13.5,4.51,4.23,5.49,8.44,12.7,6.02",8,Constant,,8.0,1.14628911,0.01119,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.412099838256836
68,466,HCT 116,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.3,14.6,6.33,19.5,-4.9,9.66,3.05,-25","4.55,17.5,1.58,5.57,6.36,2.72,3.25,6.48",8,Sigmoid,8.401109818,8.0,-24.68492699,0.2101,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.100572109222412
69,467,HCT-15,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","30.6,1.56,-5.0,-.23,-2.6,-9.3,-12,-62","3.42,.37,6.35,8.47,.39,4.78,2.25,1.60",8,Sigmoid,8.806065405,6.496217728,-60.56451797,0.6787,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.871220119539066,3.455843210220337
70,468,HDQ-P1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,-18,15.4,20.7,3.95,-10,-59,-98","28.7,2.90,3.06,20.5,27.9,49.9,51.0,.26",8,Linear,,0.125851952,-99.25421143,3.0468,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,-2.0726490469926926,3.2826383113861084
71,469,HEC-151,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.52,22.6,-10,10.3,-2.0,4.59,-.070,-60","3.47,14.6,14.9,38.8,12.1,22.9,4.88,5.30",8,Sigmoid,7.329790115,7.333292961,-60.17536545,0.6752,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.99242465935687,2.936979293823242
72,470,HEC-1-A,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.04,-12,-5.5,6.72,1.25,-.48,3.60,-70","9.80,18.8,32.8,5.48,5.84,4.37,1.33,8.28",8,Sigmoid,7.230309486,6.968556881,-70.32185364,0.7392,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.941408156132906,3.2050724029541016
73,471,HEC-1-B,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","23.1,-13,11.4,-20,47.6,-.67,-32,-57","29.1,6.04,13.4,20.7,15.5,21.4,14.2,48.0",8,Linear,,4.339510496,-57.00508881,1.4282,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.4677615528110706,3.225468158721924
74,472,HEC-251,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,3.56,-5.8,8.09,-11,17.1,10.9,-26","5.59,13.9,23.6,7.42,8.56,7.98,15.3,24.5",8,Constant,,8.0,-1.410305858,0.2585,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4047818183898926
75,473,HEC-265,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,8.31,-18,-3.8,-12,3.00,-2.0,-38","17.5,10.6,6.99,22.6,9.77,10.5,2.64,10.6",8,Linear,,8.0,-38.32134247,0.5323,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.1702308654785156
76,474,HEC-59,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,-2.2,2.56,-2.5,-5.3,-16,-16,-22","3.54,14.3,16.1,.23,3.80,1.45,11.1,10.6",8,Constant,,8.0,-8.019701958,0.1066,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.127830743789673
77,475,HEC-6,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","30.4,21.2,113,2.36,9.34,-29,-16,-67","18.5,6.86,32.8,32.1,20.2,4.82,22.6,4.01",8,Linear,,2.039887553,-65.19429779,1.4706,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,0.7128946852584711,3.4075214862823486
78,476,HEL 92.1.7,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","11.0,3.42,4.62,-1.7,3.67,-2.2,-5.1,-15","19.8,12.5,19.0,15.0,19.8,15.7,19.7,11.7",8,Constant,,8.0,-3.562633991,0.3645,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.676034688949585
79,477,Hep 3B2.1-7,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.86,9.89,8.66,12.7,-2.6,22.6,-8.1,-68","8.46,5.54,16.3,7.90,9.18,23.6,16.4,5.21",8,Sigmoid,3.336803436,4.14665699,-68.37870026,0.6464,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.4223024650389147,3.4012374877929688
80,478,Hep G2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,6.95,-1.4,5.21,-6.9,-6.7,-2.9,-28","6.90,2.19,28.3,5.02,.56,6.05,17.9,7.71",8,Constant,,8.0,-4.590772152,0.239,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5548930168151855
81,479,Hey-A8,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.06,3.38,8.03,5.97,-5.3,-7.6,-25,-38","2.92,7.61,4.63,3.45,4.35,7.85,4.80,2.68",8,Sigmoid,2.030411243,8.0,-38.01076508,0.403,HEYA8_OVARY,HEYA8,ACH-000542,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.288572311401367
82,480,HGC-27,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.32,3.30,-.23,-1.5,2.91,-6.6,-19,-69",".42,2.28,.29,.45,.066,.97,1.33,6.00",8,Sigmoid,8.920719027,5.899519444,-68.50126648,0.7505,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.774870897424937,3.0467116832733154
83,481,HH,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","18.9,-14,-3.8,35.8,-15,1.94,-4.0,12.6","4.45,.84,11.2,4.27,10.1,8.98,27.8,20.3",8,Constant,,8.0,1.404376388,0.8973,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.8416686058044434
84,482,HLF,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.05,4.27,9.68,-.34,15.5,3.09,8.21,-17",".77,11.4,12.4,9.44,11.9,1.13,5.52,29.0",8,Constant,,8.0,5.244944096,0.1366,HLF_LIVER,HLF,ACH-000393,Liver Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.1638970375061035
85,483,HMC-1-8,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.48,6.79,-3.9,.69,2.79,6.66,-8.1,-30","3.86,4.34,2.53,.69,2.70,.20,.61,.43",8,Sigmoid,2.920504093,8.0,-30.06512642,0.2208,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.014862060546875
86,484,HMCB,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.45,-2.5,1.32,.20,-3.4,-2.7,-15,-57","1.11,5.58,.63,3.93,5.09,4.80,3.76,12.7",8,Sigmoid,8.688573093,7.181233406,-56.49801254,0.5979,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9714711518724852,2.9809622764587402
87,485,HOS,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,-2.9,-5.2,4.91,5.30,-6.0,-18,.050","9.97,14.5,2.12,.61,25.4,13.9,5.28,22.7",8,Constant,,8.0,-5.177227974,0.4549,HOS_BONE,HOS,ACH-000613,Bone Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.116614580154419
88,486,HPAC,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,-12,-12,5.83,3.67,-7.4,-1.1,-72","2.39,3.27,10.3,1.62,11.1,3.49,23.0,5.79",8,Sigmoid,8.030153259,7.072412014,-71.83008575,0.9597,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9562015835364903,3.39119291305542
89,487,Hs 294T,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.39,5.21,6.69,8.56,1.05,7.60,-4.2,-19","9.76,16.4,3.12,2.29,6.16,5.23,11.1,6.87",8,Sigmoid,2.756451607,8.0,-19.34709167,0.1473,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.471186876296997
90,488,Hs 578T,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,.15,1.85,.99,1.62,2.06,-9.4,-23","2.40,6.71,4.21,5.42,8.17,2.85,3.57,13.4",8,Sigmoid,2.636601925,8.0,-21.89304924,0.2575,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.469810724258423
91,489,Hs 683,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.53,-.35,6.15,1.12,-3.8,-.54,-9.5,-20","7.83,12.8,14.8,8.76,4.31,10.8,15.2,5.76",8,Constant,,8.0,-5.716826439,0.2585,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0497512817382812
92,490,Hs 695T,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.43,10.8,2.92,-.091,-1.2,1.32,3.38,-21","13.4,3.86,0,11.7,7.73,8.07,1.81,5.65",8,Sigmoid,8.327775958,8.0,-21.42825508,0.1666,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5888962745666504
93,491,Hs 746T,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","12.2,4.94,17.3,14.9,5.72,1.68,-12,-71","10.9,26.5,14.5,14.3,23.1,18.2,5.48,21.1",8,Sigmoid,9.006840753,6.016578197,-71.11335754,0.8844,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.794518691902951,3.5017900466918945
94,492,Hs 766T,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","20.3,11.4,12.5,33.7,31.4,35.0,9.33,-20","5.12,.67,5.53,14.0,6.93,10.6,21.9,7.53",8,Sigmoid,2.93998909,8.0,-20.18796539,0.2082,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.229520797729492
95,493,Hs 852.T,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","15.2,2.28,11.3,9.12,11.9,1.56,1.13,-58","7.73,19.6,.92,2.87,.53,12.8,6.01,6.46",8,Sigmoid,8.214773011,7.286914825,-58.33191681,0.5659,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9860802499962564,3.4122204780578613
96,494,Hs 936.T,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.17,-1.5,3.03,-3.6,-.57,-.085,-9.3,-7.0","4.89,5.30,4.63,5.68,10.7,19.3,4.81,23.2",8,Constant,,8.0,-0.071452312,0.001392,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.4876108169555664
97,495,Hs 939.T,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.2,9.75,2.33,21.0,19.2,.90,2.41,-62","11.9,2.14,8.41,2.45,1.66,12.4,24.7,3.21",8,Sigmoid,8.340245751,7.080129623,-61.87065887,0.6022,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9572922158713664,3.4237220287323
98,496,Hs 944.T,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.39,7.24,8.09,7.25,2.09,-1.5,7.52,-26","9.62,12.0,5.73,7.93,11.5,13.0,7.51,9.12",8,Sigmoid,7.793718338,8.0,-25.60616112,0.2055,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.217616558074951
99,497,HSC-2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.49,3.41,-1.3,-1.8,2.16,-4.4,-6.9,-18","6.11,3.54,2.68,.040,2.99,.073,9.11,.88",8,Constant,,8.0,-1.671659231,0.2326,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2810535430908203
100,498,HT,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","20.8,21.3,20.4,19.8,16.5,5.01,6.32,11.5","6.94,15.9,39.5,27.4,6.54,18.0,7.24,26.0",8,Constant,,8.0,14.15216637,0.05258,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0265984535217285
101,499,HT-1197,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","19.6,10.9,11.4,3.13,8.38,6.63,13.5,-6.5","12.3,15.9,18.0,9.94,13.7,2.55,3.96,3.96",8,Constant,,8.0,9.048144341,0.06098,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5106122493743896
102,500,HT-144,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,-2.8,-2.9,5.76,-2.1,-4.6,-27,-65","5.25,4.74,8.14,9.56,6.31,4.40,1.72,6.50",8,Sigmoid,3.392899752,4.633401871,-64.84313965,0.8419,HT144_SKIN,HT144,ACH-000322,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.5332913436612896,3.3219854831695557
103,501,HuCCT1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.77,4.62,3.51,1.77,-.23,-5.0,-5.3,-28","4.90,5.88,8.72,.59,2.69,5.58,6.92,3.30",8,Sigmoid,8.643622381,8.0,-27.36325073,0.3396,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.259349822998047
104,502,huH-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.82,31.2,4.05,9.25,.31,3.22,16.9,-47","4.73,17.5,9.28,2.44,33.7,12.1,32.3,3.61",8,Sigmoid,8.2515737,8.0,-46.62519836,0.2987,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2260308265686035
105,503,HUP-T3,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.56,27.5,16.2,16.2,-1.3,-4.7,12.5,-21","9.28,.66,1.54,7.95,4.15,1.80,16.5,11.8",8,Sigmoid,0.176628724,8.0,-7.243167877,0.1507,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.7437915802001953
106,504,HuT 78,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","30.6,8.57,48.5,-5.7,55.0,-18,-23,-97","64.8,16.8,69.0,47.8,13.4,46.5,10.3,.76",8,Linear,,0.426970909,-94.08966064,1.4199,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,-0.8510393968800056,3.173487663269043
107,505,IA-LM,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-.54,32.6,11.0,-14,-19,5.38,-25","9.38,15.4,40.6,11.2,22.7,14.8,6.00,35.0",8,Constant,,8.0,1.30574894,0.5739,IALM_LUNG,IALM,ACH-000672,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.357776165008545
108,506,IGR-37,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,10.2,9.20,-1.5,-5.8,-9.1,-2.1,-42","14.8,6.84,3.01,5.98,16.0,8.75,3.39,3.05",8,Sigmoid,9.056224834,8.0,-41.71127701,0.8076,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.142760992050171
109,507,IGR-39,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,-8.7,7.11,-5.5,-3.3,-8.2,-3.5,-20","5.00,4.81,4.85,11.4,4.49,.75,7.37,20.2",8,Constant,,8.0,-6.481412888,0.1603,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3428359031677246
110,508,IGROV1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,4.29,-.58,8.43,-4.5,-4.6,-12,-41","1.97,1.12,.30,6.99,2.63,3.68,3.88,19.5",8,Sigmoid,8.934597249,8.0,-40.37040329,0.4447,IGROV1_OVARY,IGROV1,ACH-000966,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3495354652404785
111,509,IMR-32,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-3.0,5.68,52.6,-4.7,-19,-13,-67","9.33,25.9,28.9,87.9,15.8,5.46,9.34,12.7",8,Constant,,8.0,-12.92429066,0.933,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.052595376968384
112,510,IPC-298,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.56,-7.9,-9.3,.67,-4.0,2.05,-6.7,-30","2.46,6.67,1.07,1.99,7.13,4.21,13.7,1.63",8,Sigmoid,3.673153162,8.0,-30.1255455,0.2386,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4308600425720215
113,511,IST-MES2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.3,16.0,-6.4,-5.4,-1.3,-9.2,-4.2,-58","21.4,10.0,22.1,17.9,16.2,8.73,25.4,10.6",8,Linear,,3.565156339,-56.80332947,0.7994,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.2712079067616495,3.2489891052246094
114,512,JHH-4,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.67,-5.2,12.8,7.90,.79,-1.7,-20,-39","3.02,10.4,18.1,15.6,10.3,18.1,6.03,3.53",8,Sigmoid,2.580118895,8.0,-39.40438843,0.5288,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.267378568649292
115,513,JHOS-2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","22.2,15.8,-8.2,18.2,23.4,-15,17.6,-44","21.1,20.7,19.4,28.7,8.46,2.55,21.3,2.69",8,Constant,,8.0,4.058880806,0.5389,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.510830879211426
116,514,JM1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.97,7.24,-.42,-4.5,-3.0,-3.9,-23,-52",".83,13.5,.56,11.0,20.5,2.28,6.36,15.6",8,Sigmoid,9.127332962,7.700304031,-51.34240341,0.6152,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0412598126255985,2.9491817951202393
117,515,JMSU-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.31,-1.2,12.5,6.58,9.75,6.67,-11,-65","13.3,.49,3.87,3.12,4.53,4.07,5.73,8.60",8,Sigmoid,3.698751211,5.011620998,-65.35240173,0.6397,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.6117594152599626,3.452767848968506
118,516,JURKAT,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,7.29,8.31,17.7,5.80,.35,-18,-44","5.28,3.46,15.8,2.28,11.3,4.85,7.64,2.16",8,Sigmoid,3.388038397,8.0,-44.22171402,0.9375,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.810328483581543
119,517,JVM-3,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","25.9,27.4,46.5,48.6,-6.1,-8.7,-54,-62","19.3,3.16,10.6,11.6,31.9,23.5,34.2,27.2",8,Linear,,2.293517775,-63.94112778,1.8695,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,0.8300867851885629,3.1511268615722656
120,518,K029AX,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,-5.7,3.29,-15,-8.9,-5.8,-13,-45","8.07,14.7,2.16,1.84,18.4,8.05,9.46,5.37",8,Sigmoid,5.484663486,8.0,-44.60385132,0.6065,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2918384075164795
121,519,KALS-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.40,3.66,15.7,6.52,8.38,9.09,7.66,-23","20.8,6.52,20.2,11.9,13.2,6.47,6.25,12.7",8,Sigmoid,6.307493687,8.0,-22.55001259,0.2728,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.9878549575805664
122,520,KARPAS-422,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.25,24.8,15.4,2.67,1.46,6.81,19.3,8.72","11.1,3.45,.60,10.8,7.98,13.0,3.36,.90",8,Constant,,8.0,11.75966072,0.1021,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.9378035068511963
123,521,KASUMI-2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".52,4.38,15.3,27.9,-2.9,-17,-26,-52","8.92,12.0,10.1,5.90,16.8,1.99,.42,6.79",8,Sigmoid,3.082498312,7.463879585,-51.12798309,1.0794,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0100753306442756,2.8810906410217285
124,522,KCL-22,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.97,-26,-74,-88,-90,-92,-93,-96","12.7,10.2,13.0,.081,1.56,.61,.50,.018",8,Sigmoid,0.010807797,0.013746729,-92.97868347,5.6277,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,-4.286954374079178,2.9252676963806152
125,523,KG-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","11.9,-5.2,27.6,14.2,-8.5,25.6,2.48,-25","9.35,14.2,46.9,11.3,19.3,3.90,18.6,35.1",8,Constant,,8.0,5.041718006,0.6361,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.9024658203125
126,524,KHM-1B,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.23,-18,-13,6.78,-2.2,-5.3,-33,-59","33.7,12.1,.21,.49,20.1,12.4,36.3,47.8",8,Linear,,2.321830997,-59.88999176,1.8774,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,0.8423560972504617,3.119115114212036
127,525,KMBC-2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".60,6.94,3.67,3.94,-1.2,-.43,-3.3,-4.2","1.12,.72,4.36,2.88,2.04,.13,5.76,2.69",8,Constant,,8.0,0.347355723,0.01426,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.426492214202881
128,526,KMM-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.88,12.1,8.08,-9.7,-3.0,-25,-47,-75",".54,6.53,12.2,13.9,20.1,3.12,1.24,.12",8,Sigmoid,8.028491872,2.917067289,-75.12310028,1.5839,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.0705787584974817,3.2083969116210938
129,527,KMRC-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.98,10.6,11.4,17.7,9.19,5.33,-13,-11","2.68,4.92,8.32,14.2,4.67,.14,7.67,9.46",8,Sigmoid,1.114308,8.0,-12.65379047,0.1906,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.38181734085083
130,528,KMRC-2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","12.5,8.47,12.7,8.38,4.03,7.93,3.13,-22","3.25,0,1.95,0,2.94,.072,5.41,.50",8,Sigmoid,8.50136868,8.0,-21.49071693,0.1628,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.9547953605651855
131,529,KMS-11,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,6.33,14.4,.25,-23,-23,-35,-67","1.88,4.23,12.3,7.16,3.88,15.3,12.3,8.77",8,Sigmoid,8.375004936,4.221470356,-65.24971008,2.0814,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.4401834929542368,3.0352766513824463
132,530,KMS-12-BM,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","26.5,20.5,-24,-1.1,-.64,-6.9,-.15,-15","1.98,9.94,22.1,26.5,90.0,6.63,5.33,12.2",8,Constant,,8.0,-3.072375059,1.1375,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0683650970458984
133,531,KMS-34,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","12.5,-1.8,3.79,18.2,3.52,-16,-38,-77","8.55,3.87,22.1,3.20,16.2,11.8,5.79,10.3",8,Sigmoid,3.831058264,3.499485731,-76.03860474,1.4553,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.2526160236995103,2.991107940673828
134,532,KNS-60,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.35,11.0,22.1,10.3,21.1,8.26,2.51,-33","12.2,6.81,11.5,7.20,8.63,6.27,7.84,9.05",8,Sigmoid,8.296111221,8.0,-32.69221497,0.2903,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4026899337768555
135,533,KNS-81,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.90,13.2,-6.6,23.8,1.04,12.5,-9.2,-48","10.4,.15,16.4,4.10,8.41,10.3,1.43,5.87",8,Sigmoid,2.942981482,8.0,-48.49059296,0.5671,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3365421295166016
136,534,KO52,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.38,10.9,24.1,30.3,29.3,-4.8,-26,-47","3.38,15.0,4.49,11.3,9.47,17.3,.49,13.6",8,Sigmoid,1.562627792,8.0,-45.14951706,0.764,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0303077697753906
137,535,KP-N-SI9s,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.68,1.59,9.17,9.21,19.8,-4.3,-12,-88","3.69,3.90,12.4,18.0,7.92,18.9,5.95,8.55",8,Sigmoid,8.588520213,5.412808418,-87.5424118,1.1281,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.6887680742455806,3.2188501358032227
138,536,KU812,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.56,-3.1,-78,-51,-95,-96,-97,-98","11.6,6.78,.030,7.61,.45,1.01,.37,.25",8,Sigmoid,0.015693095,0.016822226,-96.38480377,5.016,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,-4.08505429074436,2.7994937896728516
139,537,KYSE-30,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.87,2.99,5.83,1.72,-.78,-3.6,-2.7,-50","6.72,4.15,2.83,2.78,3.12,6.26,3.93,2.64",8,Sigmoid,8.69731493,8.0,-49.98544312,0.4685,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5518877506256104
140,538,KYSE-520,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-4.8,6.52,-2.3,4.63,-7.6,-15,-64","4.31,.98,4.42,1.30,4.62,7.82,2.20,.57",8,Sigmoid,8.700853713,6.504006386,-64.09433746,0.6587,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.872418354102346,3.6310133934020996
141,539,L3.3,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.98,7.59,3.73,2.95,-6.8,-8.6,-2.5,-26","5.36,3.33,4.47,3.04,13.7,7.90,15.9,7.61",8,Constant,,8.0,-0.983010232,0.4161,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2500452995300293
142,540,L-363,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,21.6,-16,2.24,-2.8,-13,-37,-27",".49,21.8,8.26,17.0,10.3,.83,2.33,3.66",8,Sigmoid,8.078594601,8.0,-31.61336327,1.9171,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.9845662117004395
143,541,L-428,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.96,7.89,22.4,27.4,-7.5,-11,-20,-58","4.39,8.05,30.0,6.08,4.28,.097,4.55,2.24",8,Sigmoid,8.378164416,6.550229549,-56.95167923,1.1117,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.8795000946819311,3.210913896560669
144,542,LCLC-103H,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.2,-.85,-5.1,7.69,-9.4,5.78,-5.8,-5.3","14.2,3.85,1.78,5.49,3.58,1.31,6.51,1.10",8,Constant,,8.0,-3.664573908,0.1693,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.243328332901001
145,543,LN-229,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.7,3.24,4.82,11.3,8.44,1.77,-6.0,-72","3.75,16.4,5.69,8.10,5.48,.41,.078,.72",8,Sigmoid,8.694676116,6.401216984,-71.8019104,0.7352,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.8564881260386934,3.3783514499664307
146,544,LOU-NH91,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".85,9.55,13.7,-.19,-28,2.37,-12,-5.5","14.1,9.89,38.5,1.42,14.2,19.6,11.8,15.9",8,Constant,,8.0,-2.591321468,0.3538,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.403080701828003
147,545,LP-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","20.4,10.4,-2.9,17.4,7.30,-15,-40,-58","8.37,13.1,20.0,14.9,15.9,21.4,22.0,9.90",8,Sigmoid,1.275990963,4.030470371,-57.07263565,2.2922,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.3938830865173764,2.95662260055542
148,546,LS123,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.75,16.6,-15,4.93,12.0,13.7,-3.2,-46",".54,1.52,14.2,11.7,19.3,16.8,1.95,47.5",8,Sigmoid,8.54671183,8.0,-46.3462677,0.5402,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.305636405944824
149,547,LS513,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","14.0,3.03,18.5,-6.4,6.57,-19,-61,-39","2.23,11.5,14.7,10.5,17.6,14.9,4.99,4.43",8,Sigmoid,0.824943781,8.0,-49.98314285,1.4159,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4782514572143555
150,548,LU99,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,13.6,-.15,6.29,-6.2,6.98,-14,-45","3.79,.033,5.63,2.70,1.88,12.4,9.35,13.6",8,Sigmoid,2.869487524,8.0,-45.38352585,0.5356,LU99_LUNG,LU99,ACH-000444,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.045403242111206
151,549,LUDLU-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","16.7,25.3,-6.2,12.6,-2.1,14.5,-18,-56","15.5,17.3,4.67,14.7,16.2,12.0,2.50,22.3",8,Sigmoid,2.689198732,4.289455414,-55.52612305,0.8515,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.4561597817584222,3.415616512298584
152,550,Malme-3M,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.12,8.72,13.2,-26,2.43,2.07,-27,-72","6.27,12.3,14.5,71.3,8.91,2.51,1.89,5.07",8,Sigmoid,3.901403666,4.411684036,-72.50914001,1.1576,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.484256484139585,3.321112871170044
153,551,MCAS,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.99,6.08,2.48,2.14,3.60,-2.2,6.77,-22","1.66,.86,4.35,2.16,8.50,5.55,11.0,1.15",8,Sigmoid,9.580913285,8.0,-19.41866112,0.1668,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3522911071777344
154,552,MCF7,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","41.8,7.16,12.1,34.7,10.7,15.3,-23,-44","19.5,20.1,34.1,32.0,3.77,24.8,2.87,1.41",8,Linear,,8.0,-44.93592834,0.1241,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5555193424224854
155,553,MDA-MB-157,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.05,26.1,-6.7,10.1,-6.1,20.5,-9.1,-32","5.39,31.4,18.3,3.27,24.4,21.7,1.00,17.1",8,Constant,,8.0,5.329815865,0.6589,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.123671770095825
156,554,MDA-MB-175-VII,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,4.55,-17,1.10,10.8,11.1,6.20,-20","5.65,10.0,20.7,5.68,8.48,5.83,1.22,5.10",8,Linear,,8.0,-19.67239761,0.182,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.595409393310547
157,555,MDA-MB-415,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,19.8,9.74,10.8,6.45,-10,-30,-92","11.7,4.80,9.85,15.8,10.4,17.1,12.6,31.3",8,Sigmoid,8.210792629,3.974702597,-88.93553925,0.9927,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.3799499269424818,3.5235233306884766
158,556,MDA-MB-436,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.3,1.51,18.4,5.84,34.7,11.7,20.9,-31","1.45,2.86,2.93,4.82,8.09,12.0,19.8,5.24",8,Sigmoid,8.302404276,8.0,-31.31963539,0.2853,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.424173355102539
159,557,MDA-MB-453,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,-10,17.7,-1.5,-6.0,-17,-7.6,-41","6.95,5.54,12.9,9.79,5.61,3.86,5.70,5.89",8,Sigmoid,9.532789503,8.0,-39.4767952,0.3012,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.1857833862304688
160,558,MDA-MB-468,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","11.5,4.65,33.7,53.0,7.36,20.3,-5.7,-63","7.18,21.7,30.5,7.61,6.87,9.58,11.9,8.22",8,Sigmoid,3.195904255,4.322463036,-63.02706146,0.6117,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.4638253870060662,3.2069954872131348
161,559,MEG-01,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.05,-15,-14,-56,-90,-95,-96,-98","17.5,19.7,.12,.17,.83,.98,1.15,.11",8,Sigmoid,0.067006387,0.069269069,-96.8416748,4.4689,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,-2.6697568071996294,2.8446226119995117
162,560,MEL-HO,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","11.9,6.46,3.82,-1.8,11.6,.44,-9.3,-56","17.7,1.07,6.71,2.05,10.2,2.24,3.06,2.94",8,Sigmoid,8.412597259,7.266346931,-56.38873672,0.654,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9832536798377902,3.128911018371582
163,561,MES-SA,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.98,-1.1,1.29,2.33,-1.2,5.43,-13,-38","3.53,.32,1.92,3.31,3.18,4.46,6.96,31.7",8,Constant,,8.0,0.065704137,0.3623,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.261373519897461
164,562,MeWo,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.5,6.02,4.93,21.2,13.2,42.5,90.8,32.5","35.9,20.0,7.64,.70,28.8,7.01,21.7,26.7",8,Linear,,8.0,3.485078812,0.0,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.074018955230713
165,563,MG-63,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.94,-3.4,4.83,3.02,3.80,.71,3.18,-33","4.54,3.56,.61,1.36,1.31,7.51,1.93,2.48",8,Sigmoid,8.030547454,8.0,-32.54291916,0.29,MG63_BONE,MG63,ACH-000359,Bone Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.1816017627716064
166,564,Mino,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.50,14.2,2.53,10.7,-3.9,-8.1,4.22,-4.9","13.3,3.92,1.31,7.34,34.6,10.5,22.2,20.3",8,Constant,,8.0,4.617715359,0.0,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.091665744781494
167,565,MJ,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-22,-.19,-.76,27.5,-14,-27,10.1","24.9,.97,17.5,5.25,17.9,29.1,14.2,15.0",8,Constant,,8.0,-2.06360054,0.4704,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.717851400375366
168,566,MKN-45,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.63,1.73,12.8,-9.3,-1.1,-3.5,-7.7,-44","2.21,7.88,4.58,10.1,12.4,11.2,25.9,3.60",8,Sigmoid,9.249514698,8.0,-44.10825729,0.358,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.419064998626709
169,567,MKN7,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.47,12.1,-4.9,5.67,6.92,-7.1,15.0,-46","6.59,.77,11.4,56.8,29.7,17.2,5.22,4.83",8,Constant,,8.0,3.49082613,0.5522,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.415790557861328
170,568,MKN74,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-25,10.5,2.34,-.90,9.07,-13,-28","21.2,11.5,21.2,16.7,4.30,16.5,12.6,23.9",8,Constant,,8.0,-4.032675743,0.4273,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2554726600646973
171,569,MOLP-8,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.56,13.3,.56,20.1,35.3,19.4,-17,-46","24.5,25.9,29.8,10.3,22.4,7.42,25.8,2.34",8,Sigmoid,2.42606473,8.0,-46.27841568,0.838,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0591650009155273
172,570,MOLT-16,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","16.5,31.3,1.03,7.36,23.7,-23,-28,-65","10.0,2.44,10.9,23.3,5.47,8.70,12.5,7.15",8,Linear,,2.131068909,-63.26843643,1.8004,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,0.7566236890554231,2.436134099960327
173,571,MONO-MAC-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","15.9,12.7,-12,-2.9,5.92,-14,-37,-83","17.2,2.26,28.4,15.7,33.1,1.33,19.9,6.82",8,Sigmoid,8.953079835,3.887146473,-82.68412018,2.979,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.3576753339488907,2.9765539169311523
174,572,MSTO-211H,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.93,.72,10.3,-2.3,-12,5.78,-6.8,-55","2.96,9.94,27.2,3.27,10.4,13.2,17.7,2.23",8,Sigmoid,3.965860128,5.937797546,-54.8473587,0.5277,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.7813382811156708,3.353355884552002
175,573,NCI-H1048,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,8.84,9.59,4.64,.53,-2.1,-4.6,-46","32.5,12.7,17.8,12.4,2.33,23.8,17.8,4.70",8,Sigmoid,8.541516665,8.0,-45.82275772,0.4625,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2767839431762695
176,574,NCI-H1092,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,27.5,5.67,3.03,2.47,-4.5,-19,-16",".97,19.9,11.3,13.8,26.4,11.8,10.9,33.3",8,Constant,,8.0,-4.039637089,0.1775,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.434204578399658
177,575,NCI-H1184,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","63.6,181,101,28.1,5.80,9.23,.55,4.56","90.7,250,35.1,52.4,17.5,117,1.00,48.1",8,Constant,,8.0,16.26290894,0.0,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4757018089294434
178,576,NCI-H1341,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","90.9,14.0,-1.4,23.7,45.2,16.3,-9.9,28.3","67.7,29.4,21.4,74.5,93.1,1.88,4.82,6.16",8,Constant,,8.0,16.34705353,0.05606,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.104249954223633
179,577,NCI-H1373,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","25.7,-2.2,21.1,-2.9,10.6,-4.2,-2.5,-2.8","3.53,12.4,5.43,17.4,3.95,3.98,4.20,4.55",8,Constant,,8.0,3.168289423,0.0,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.729764938354492
180,578,NCI-H1568,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.03,1.34,5.82,24.3,6.81,34.1,-11,-48","5.80,4.73,12.6,.16,12.0,6.56,5.42,9.48",8,Sigmoid,2.79715991,8.0,-47.77973557,0.6011,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4254374504089355
181,579,NCI-H1648,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,.77,1.56,-8.8,-14,-12,-20,-72","21.0,11.6,11.9,21.0,21.0,15.0,14.4,5.29",8,Sigmoid,8.198090537,5.590958595,-71.44713593,1.4162,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.7211507563651456,3.2437877655029297
182,580,NCI-H1650,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.71,7.97,3.99,.44,13.1,-7.5,-6.3,-49",".86,.33,11.1,1.21,2.78,6.20,14.6,13.0",8,Sigmoid,8.345626676,8.0,-48.84057236,0.4834,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.496617555618286
183,581,NCI-H1651,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","16.7,13.6,5.16,11.0,4.53,2.59,6.36,-23","8.44,1.80,10.2,3.19,16.1,2.81,14.5,37.3",8,Constant,,8.0,9.952025414,0.2314,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.6178112030029297
184,582,NCI-H1792,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.99,5.39,10.4,10.3,5.13,3.11,-.76,-17","3.39,.035,8.72,3.33,.39,1.24,1.85,1.07",8,Sigmoid,8.699085142,8.0,-16.94510841,0.1523,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5162887573242188
185,583,NCI-H1793,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.69,1.63,4.89,-9.1,22.3,27.4,19.5,-30","13.7,6.70,12.6,3.50,39.8,31.5,13.2,36.4",8,Constant,,8.0,2.828771114,0.1586,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5424163341522217
186,584,NCI-H1915,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,23.6,4.41,18.7,2.95,15.5,-7.0,-14","9.84,17.6,18.2,10.1,1.99,28.7,11.3,3.66",8,Constant,,8.0,2.95316577,0.1953,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.450395107269287
187,585,NCI-H1944,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.3,-1.3,16.3,9.36,13.9,-.80,-1.1,6.74",".22,5.81,6.27,10.2,24.7,12.5,13.7,2.20",8,Constant,,8.0,7.774597645,0.0,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.354363441467285
188,586,NCI-H1975,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.45,7.53,-1.3,11.7,13.4,5.98,-7.2,-15","11.4,4.57,21.3,.59,2.65,9.25,.46,15.8",8,Constant,,8.0,6.780337334,0.07336,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5390806198120117
189,587,NCI-H2009,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.83,8.69,-1.2,1.46,9.05,-3.5,7.05,-20","1.95,11.5,2.22,10.8,12.9,5.60,2.64,1.80",8,Sigmoid,8.305358757,8.0,-20.00805855,0.237,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.421578884124756
190,588,NCI-H2023,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,11.3,8.27,2.05,19.3,15.5,-18,-58",".24,14.6,2.55,1.17,5.49,8.04,2.16,9.88",8,Sigmoid,2.748748779,4.014651299,-58.50542068,0.612,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.3899504940629486,3.4934535026550293
191,589,NCI-H2030,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.040,1.03,11.0,12.1,15.0,7.29,2.74,-35","3.03,.73,9.05,4.76,8.99,.42,1.84,.51",8,Sigmoid,4.508524418,8.0,-34.75722504,0.3102,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.47615385055542
192,590,NCI-H2052,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.19,8.36,-9.7,9.77,-3.3,.95,-8.9,-16","1.86,8.38,8.61,5.83,8.15,.99,13.7,22.2",8,Constant,,8.0,0.948245108,0.4418,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.689255475997925
193,591,NCI-H2085,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-6.2,6.42,14.4,-6.0,-2.4,-19,-42","20.6,21.8,18.6,16.4,7.54,1.93,5.44,16.3",8,Sigmoid,3.51935482,8.0,-41.99665833,0.6032,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5186519622802734
194,592,NCI-H2087,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.18,2.03,13.5,23.6,13.0,-9.0,-7.7,-70","15.8,9.63,14.0,9.87,5.78,3.01,18.2,4.34",8,Sigmoid,8.559747605,6.089197159,-69.56259155,0.8483,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.806516243639101,3.5823888778686523
195,593,NCI-H211,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.57,9.66,7.92,1.32,4.42,-15,-20,-64","6.92,15.5,8.35,6.84,5.14,5.59,8.48,.79",8,Sigmoid,9.392559458,6.046969891,-62.23643875,0.9206,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.7995573021154583,3.120957851409912
196,594,NCI-H2122,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.40,-3.0,10.7,18.5,-3.3,.34,-20,-54","11.8,18.3,7.03,25.9,6.83,8.73,43.5,2.49",8,Sigmoid,8.410592695,7.855627537,-54.13156891,0.5732,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0612301586502104,3.1275839805603027
197,595,NCI-H2170,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","11.6,1.34,22.9,-.57,-.37,8.81,-29,-64","28.0,4.26,7.76,18.1,8.10,15.3,16.7,2.56",8,Sigmoid,2.523588896,3.32824254,-64.01064301,0.9569,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.2024443989092148,3.407076120376587
198,596,NCI-H2172,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.2,9.64,2.37,22.9,-18,-3.3,12.5,-36","19.4,54.1,41.4,61.6,3.52,45.1,2.68,1.79",8,Constant,,8.0,-16.99010658,0.07936,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.537722587585449
199,597,NCI-H2228,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","17.2,9.55,6.66,21.8,17.1,13.7,2.56,-27",".39,7.49,2.51,8.33,5.75,12.9,3.19,10.4",8,Sigmoid,3.47710228,8.0,-26.67790222,0.2487,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3165688514709473
200,598,NCI-H2286,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".55,3.84,8.49,20.8,-5.6,-14,-52,-94","8.40,8.86,9.43,15.1,19.3,5.26,10.1,3.00",8,Sigmoid,2.694330215,2.386837244,-94.18314362,2.2442,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,0.8699691607002387,3.3427181243896484
201,599,NCI-H23,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","23.2,11.4,-5.7,8.21,13.3,-3.2,.37,-56","41.6,4.79,19.4,8.96,14.1,3.81,10.4,19.4",8,Sigmoid,8.016330921,7.43892622,-56.11838913,0.6261,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0067265131602894,3.348609685897827
202,600,NCI-H2444,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,.82,-3.6,6.40,-1.7,-.042,5.49,-1.2","13.1,38.5,9.40,.59,20.8,22.7,26.9,.48",8,Constant,,8.0,-1.235705256,0.1556,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3301801681518555
203,601,NCI-H2452,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,20.7,29.6,21.6,-3.7,-3.9,-10,-25","2.60,.96,8.07,11.9,14.3,15.2,7.89,16.4",8,Sigmoid,0.202767119,8.0,-11.62753868,0.2073,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4545493125915527
204,602,NCI-H28,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","14.1,9.40,2.13,-4.0,-1.8,.85,-8.9,-24","16.2,10.6,.48,9.53,12.8,8.06,6.56,12.3",8,Sigmoid,9.110539318,8.0,-20.94848633,0.2426,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.306013822555542
205,603,NCI-H322,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.36,6.96,2.10,4.03,3.04,-4.3,-13,-31","5.95,.90,.94,2.69,6.33,2.67,6.59,.35",8,Sigmoid,8.289563817,8.0,-30.90446281,0.1888,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.398313045501709
206,604,NCI-H3255,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.47,-.41,7.27,-1.7,1.84,-12,6.21,-74","4.22,.53,4.44,2.57,2.11,3.74,9.02,11.6",8,Sigmoid,8.123379347,7.134063244,-73.9552002,0.7838,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.964880952050194,3.438347339630127
207,605,NCI-H358,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","14.8,2.79,15.3,4.40,10.3,7.00,6.54,-49","3.88,4.29,8.81,.60,3.97,8.25,5.69,9.67",8,Sigmoid,7.010480881,8.0,-48.89810944,0.4732,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5714879035949707
208,606,NCI-H441,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.04,-1.7,2.22,-5.9,.47,-.29,-2.5,-18","7.49,9.50,11.8,.45,6.68,0,1.66,1.25",8,Constant,,8.0,-3.598492146,0.1257,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.326612949371338
209,607,NCI-H522,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","12.7,21.9,13.3,9.94,8.05,-4.5,-4.5,-31","2.47,2.57,24.1,5.74,9.02,.88,6.09,8.53",8,Sigmoid,8.384469166,8.0,-28.99860001,0.4237,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.524667501449585
210,608,NCI-H647,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","29.6,-23,33.3,-16,15.7,-16,27.3,-33","5.08,5.99,31.8,6.80,15.9,9.95,27.3,10.2",8,Constant,,8.0,-2.240668058,0.5991,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.319082260131836
211,609,NCI-H650,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","15.3,9.12,11.8,2.33,-.86,-4.1,-7.0,-21","6.18,1.64,.80,3.73,20.1,3.24,3.79,1.75",8,Sigmoid,8.804893862,8.0,-19.31016922,0.1037,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.286761999130249
212,610,NCI-H661,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.52,-9.2,1.42,4.76,-4.6,-12,-3.9,-38","8.71,10.1,10.3,7.01,7.72,12.7,6.01,46.9",8,Constant,,8.0,-2.353503704,0.5492,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.218503713607788
213,611,NCI-H727,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.62,4.93,-1.5,-.95,9.43,10.8,-20,-31","19.3,20.6,15.0,12.3,32.7,9.17,28.2,42.8",8,Constant,,8.0,4.449195862,0.5898,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.7088210582733154
214,612,NCI-H747,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.91,11.0,11.1,-2.4,-7.6,14.8,-18,-46","7.66,21.4,34.8,1.78,.36,2.75,20.3,2.27",8,Sigmoid,2.684751272,8.0,-46.30311584,0.6162,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4995107650756836
215,613,NCI-H810,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.60,-.87,2.35,-11,-4.8,-9.1,-8.3,-54","22.6,12.8,4.63,2.63,6.95,14.8,6.45,2.09",8,Sigmoid,3.878439665,5.777545452,-55.10595322,0.8719,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.7539789302059858,3.2923014163970947
216,614,NCI-N87,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,8.20,-9.7,4.71,-2.2,21.5,-17,-68","15.2,3.26,11.2,3.96,15.5,3.17,12.2,1.34",8,Sigmoid,3.029248476,3.743279696,-67.9882431,1.2436,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.3199621512173405,3.38569712638855
217,615,NCO2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-24,-86,-93,-95,-97,-97,-99","16.7,42.5,4.65,.23,.63,.33,.072,.39",8,Sigmoid,0.005450114,0.00760066,-96.92962646,5.944,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,-4.8795201933551455,2.7776670455932617
218,616,NIH:OVCAR-3,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.1,27.4,-.041,27.8,9.10,22.3,11.3,-6.1","35.7,35.3,17.1,33.8,31.8,12.1,10.6,19.7",8,Constant,,8.0,9.183729172,0.07783,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.253917694091797
219,617,NUGC-3,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-11,13.6,9.36,-11,-23,-13,-41","5.10,25.7,11.5,20.0,15.1,24.2,15.2,6.33",8,Sigmoid,8.308522738,8.0,-40.24261475,0.5547,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.327486515045166
220,618,NUGC-4,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.31,13.0,1.50,11.9,12.2,.20,-30,-62",".89,.66,5.94,9.06,5.00,12.3,3.35,3.85",8,Sigmoid,2.466419697,4.356728077,-61.49070358,0.8153,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.4717213345840559,3.7686607837677
221,619,OCI-AML2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,.44,2.18,1.86,-4.5,-10,-3.9,-76","7.25,1.53,1.48,.64,2.05,1.84,5.01,4.90",8,Sigmoid,8.1254617,6.798111916,-75.69709778,0.8493,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9166449142157849,2.6545674800872803
222,620,OCI-AML5,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.52,6.33,8.60,6.61,-2.3,-10,-35,-51",".78,8.63,8.75,10.8,10.1,8.23,2.31,2.09",8,Sigmoid,1.649887204,7.265676975,-50.73963165,1.1833,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.983161475750485,2.675264596939087
223,621,OCUM-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.1,-6.3,8.28,8.56,14.4,-15,-.13,-31","14.2,.83,13.8,7.50,5.37,.92,36.2,40.6",8,Constant,,8.0,-0.154497311,0.3957,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5077061653137207
224,622,OE21,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.52,.93,10.7,-2.6,15.9,14.5,-20,-79","24.1,30.6,25.8,26.9,8.82,16.2,11.7,4.08",8,Linear,,0.464579643,-78.76741791,0.8543,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,-0.7666222757917519,3.170645236968994
225,623,OE33,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.89,18.4,22.5,9.73,-7.8,-8.2,-4.5,-18","9.95,25.6,1.19,25.1,6.32,14.5,6.35,6.08",8,Sigmoid,0.115451172,8.0,-10.28017807,0.1666,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.655294418334961
226,624,ONCO-DG-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.31,.49,5.31,-.84,13.3,-12,-11,-29",".46,4.81,10.3,8.94,19.9,17.4,16.6,7.88",8,Sigmoid,8.149492306,8.0,-28.23373032,0.6137,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.33256196975708
227,625,ONS-76,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.19,1.52,7.31,5.17,5.17,.14,2.09,-19","4.59,1.78,.43,.16,.83,1.90,7.34,9.47",8,Sigmoid,6.594996929,8.0,-19.02279663,0.1742,ONS76_CENTRAL_NERVOUS_SYSTEM,ONS76,ACH-000776,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.462134599685669
228,626,OPM-2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","27.8,18.9,34.4,-6.5,-7.6,-21,9.41,-7.6","3.44,5.00,49.9,1.17,.40,1.55,3.42,12.3",8,Constant,,8.0,0.886128545,0.3997,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.9947290420532227
229,627,OV-90,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,5.36,23.5,5.54,6.17,-8.7,-13,-60","5.37,15.2,10.0,8.06,30.4,3.89,5.80,2.36",8,Sigmoid,9.142463603,6.70353508,-59.72651672,0.6314,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9026350111329795,3.2106988430023193
230,628,OVCAR-4,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,18.2,14.5,8.82,-3.4,1.12,-.61,-31","4.12,12.0,8.24,.81,4.42,1.68,11.8,5.80",8,Sigmoid,8.311750285,8.0,-31.10575104,0.2542,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.386883020401001
231,629,OVCAR-8,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","18.7,11.0,17.4,4.82,5.43,6.78,-17,-53","3.67,2.06,15.5,7.31,3.02,5.74,6.65,.98",8,Sigmoid,8.8888785,7.570580006,-52.53462982,0.6021,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.024269683536727,3.524606704711914
232,630,OVMANA,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.51,8.58,-.0048,9.71,2.00,.58,-3.7,-24","7.24,12.2,3.09,7.55,6.22,5.39,6.38,12.0",8,Sigmoid,8.528664312,8.0,-23.54007339,0.2676,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.8718509674072266
233,631,OVSAHO,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.26,-1.8,5.06,8.79,18.5,17.6,35.6,-10","6.91,.045,3.06,13.3,2.30,8.53,0,6.76",8,Linear,,8.0,-9.182085991,0.02441,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.469210147857666
234,632,OVTOKO,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.38,6.61,6.25,7.99,4.46,.93,-4.8,-15","2.32,0,1.37,9.34,.42,0,4.73,5.23",8,Constant,,8.0,2.344628811,0.1559,OVTOKO_OVARY,OVTOKO,ACH-000663,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.354395866394043
235,633,P12-ICHIKAWA,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.22,-3.4,8.52,11.9,-7.0,-7.7,-6.3,-46","7.39,13.3,6.01,15.1,14.6,3.93,4.72,5.10",8,Sigmoid,8.560446626,8.0,-45.94842529,0.8608,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.57961368560791
236,634,P31/FUJ,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.50,-.59,-5.8,12.7,-7.6,7.62,.47,-9.2","27.3,13.1,2.09,3.31,6.68,10.5,.47,2.62",8,Constant,,8.0,-1.490428209,0.4948,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0783534049987793
237,635,P3HR-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","16.7,8.47,-1.8,-6.0,10.5,4.84,-5.4,-19","7.34,3.35,12.0,5.83,20.7,11.3,13.1,11.5",8,Sigmoid,0.002542614,8.0,-9.508730888,0.12,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.1378448009490967
238,636,Panc 02.03,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.60,-8.5,.93,-2.0,13.2,-1.1,-.58,-33","12.0,10.4,14.8,16.6,15.1,17.2,13.9,7.47",8,Sigmoid,8.226230017,8.0,-33.41638184,0.3683,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5041332244873047
239,637,Panc 03.27,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,3.61,-1.0,9.33,11.3,-5.3,3.88,-6.7","2.57,22.1,24.6,9.49,9.53,5.80,17.8,5.06",8,Constant,,8.0,-0.800327718,0.01959,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.371788740158081
240,638,Panc 04.03,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.59,6.07,13.7,3.78,-1.2,-15,-14,-50","25.7,22.7,4.22,9.70,23.7,7.92,1.76,5.20",8,Sigmoid,8.387398494,8.0,-47.39357376,0.6639,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.777144193649292
241,639,Panc 10.05,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.18,-4.6,23.1,-.23,19.6,31.6,8.44,-29","15.7,11.1,13.0,.11,31.1,8.03,38.1,1.94",8,Constant,,8.0,1.299642444,0.2589,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5857858657836914
242,640,PC-3,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.48,-4.6,1.90,-5.4,-4.8,-.38,9.44,-21","11.9,3.41,3.60,.32,9.36,7.47,2.43,2.38",8,Sigmoid,8.081646999,8.0,-20.92627907,0.3649,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4682164192199707
243,641,Pfeiffer,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","42.8,25.8,-5.6,-2.7,-11,-24,-8.0,-12","27.1,13.9,5.01,4.35,24.0,25.9,18.7,20.0",8,Linear,,8.0,-18.99466515,0.5337,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.4649298191070557
244,642,PK-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.41,2.55,.68,-.56,-1.8,-4.0,3.97,-20",".89,1.62,.41,2.51,7.41,3.24,3.22,4.34",8,Sigmoid,8.087695179,8.0,-20.13869858,0.1723,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.639219284057617
245,643,PK-45H,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","12.3,22.0,-.85,19.8,6.06,19.0,-5.6,-20",".74,2.50,1.80,4.81,1.33,4.94,7.72,7.70",8,Sigmoid,2.390664101,8.0,-19.84389877,0.221,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5169243812561035
246,644,PK-59,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.37,4.52,2.39,1.39,2.37,3.73,-6.1,-40",".29,1.65,8.05,8.56,1.66,4.18,3.08,8.46",8,Sigmoid,3.320762873,8.0,-39.54069901,0.3275,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5812978744506836
247,645,PLC/PRF/5,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.73,-5.8,4.36,-14,.49,-15,12.0,-57","7.17,9.30,9.72,20.6,.23,9.24,8.41,6.94",8,Sigmoid,8.140598161,7.693918705,-56.91008377,0.8893,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.040430238248808,3.022230386734009
248,646,Raji,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","33.6,-22,-3.1,-6.0,2.59,6.20,-14,-13","3.98,4.32,11.1,29.4,.61,5.80,.87,2.99",8,Sigmoid,0.002542614,8.0,-7.227972031,0.3417,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.7892444133758545
249,647,Reh,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.71,7.97,.30,5.11,-3.4,3.82,-23,-49","4.22,3.85,2.47,5.78,.82,4.78,3.57,3.36",8,Sigmoid,2.563351631,8.0,-49.09311676,0.577,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.4932167530059814
250,648,RERF-GC-1B,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.62,4.23,-11,4.89,-.41,16.5,-7.3,2.44","20.4,21.6,13.9,3.71,6.59,16.5,1.33,1.95",8,Constant,,8.0,1.776579738,0.08913,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4770803451538086
251,649,RERF-LC-AI,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.49,7.09,2.04,5.03,15.8,13.0,3.25,-34","5.37,2.74,7.61,.28,1.45,1.90,.82,3.14",8,Sigmoid,3.859427452,8.0,-34.02895355,0.3106,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.35982608795166
252,650,RERF-LC-MS,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-6.6,5.22,-2.8,9.60,.82,7.56,-11","13.6,2.43,2.01,1.56,.56,9.11,5.84,10.3",8,Constant,,8.0,0.937503099,0.0,RERFLCMS_LUNG,RERFLCMS,ACH-000062,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0869181156158447
253,651,RKO,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.62,5.76,-2.2,-4.0,5.72,-5.6,-22,-40","18.2,6.99,6.34,6.15,3.80,4.26,7.87,5.02",8,Sigmoid,2.500087261,8.0,-39.81613922,0.5761,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2293832302093506
254,652,RL95-2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.57,-2.2,12.6,1.81,5.07,26.7,15.0,-50","14.2,9.29,13.3,20.5,3.62,4.63,11.6,32.8",8,Sigmoid,8.118472541,8.0,-27.57564735,0.479,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4863133430480957
255,653,RPMI-8402,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.19,5.87,23.3,11.8,4.09,1.29,-26,-59","2.52,1.91,13.6,7.62,4.68,3.92,8.21,30.9",8,Sigmoid,1.715039372,8.0,-38.58794022,1.0203,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.533085584640503
256,654,RT-112,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.20,1.97,-.25,4.28,-1.5,15.6,1.46,-30","7.04,12.1,5.01,12.8,1.06,8.58,4.65,26.7",8,Sigmoid,4.136828899,8.0,-28.98711777,0.2699,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2450501918792725
257,655,RT4,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,9.74,-12,36.5,4.81,8.79,-15,-24","7.63,17.0,7.97,.029,31.3,10.6,29.2,14.7",8,Constant,,8.0,0.051117245,0.7336,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2065987586975098
258,656,RVH-421,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","11.2,1.07,3.79,-3.2,-1.4,-2.7,5.02,-11","2.57,2.76,2.55,.14,9.72,1.31,.81,3.56",8,Constant,,8.0,0.660736382,0.2469,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3545961380004883
259,657,SBC-5,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,2.95,.75,1.82,-4.2,-8.2,-11,-44","14.3,.57,9.58,1.42,3.38,2.15,3.89,.32",8,Sigmoid,8.635073277,8.0,-43.91086578,0.5386,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.1315677165985107
260,658,SCaBER,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-1.2,14.6,9.08,5.92,-3.7,-4.4,-28","6.90,4.57,12.5,8.83,1.10,9.08,7.81,2.57",8,Sigmoid,8.065310905,8.0,-27.4666214,0.196,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.632497787475586
261,659,SF126,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.20,5.53,-10.0,3.00,4.21,.98,-21,-44","9.24,7.08,12.4,.25,11.2,2.81,6.26,1.99",8,Sigmoid,2.548211575,8.0,-43.54914474,0.5877,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2986531257629395
262,660,SF-295,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".83,1.06,-1.6,-.56,-7.4,-11,-14,-12",".48,4.89,.17,2.95,11.8,5.07,8.99,10.0",8,Constant,,8.0,-2.360579252,0.2989,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.1542534828186035
263,661,SH-10-TC,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","16.2,4.93,13.6,-1.8,7.87,2.21,-13,-50","2.11,6.05,4.15,1.57,2.61,5.69,5.32,1.76",8,Sigmoid,8.980959486,7.97711277,-50.14498138,0.4446,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0765765377226364,3.3673644065856934
264,662,SHP-77,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.47,51.0,-4.1,40.1,-13,6.39,-13,27.3","11.6,0,10.3,0,20.7,0,8.59,96.1",8,Constant,,8.0,0.510410607,0.2396,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2091379165649414
265,663,SIG-M5,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.05,10.4,21.1,1.54,.70,-43,-55,-88","3.69,12.5,42.6,34.4,33.3,10.4,.088,.70",8,Sigmoid,8.070861379,1.649600863,-86.99542236,2.294,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,0.5005333574375507,2.573943614959717
266,664,SIMA,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.83,-4.3,20.5,34.4,-11,20.2,-15,-38","11.2,10.3,49.0,29.4,13.6,4.34,33.6,3.82",8,Constant,,8.0,0.190985814,1.172,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0544798374176025
267,665,SK-BR-3,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","17.1,18.9,20.7,6.17,13.8,7.10,1.73,-38","18.4,3.86,39.1,4.82,25.2,6.72,27.5,.48",8,Sigmoid,8.348594511,8.0,-37.93336868,0.3601,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4667248725891113
268,666,SK-CO-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".0085,-3.1,8.68,9.91,8.31,-19,-6.6,-99","29.0,13.2,15.9,24.8,41.7,8.00,2.13,3.87",8,Linear,,0.15920667,-97.04240417,1.199,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,-1.837552109464584,3.4441659450531006
269,667,SK-ES-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,-2.2,-22,-8.1,-2.4,-11,-27,-40","4.36,31.6,4.59,11.1,15.3,19.7,10.0,6.61",8,Sigmoid,2.293938637,8.0,-39.98680878,0.6998,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.1412506103515625
270,668,SK-HEP-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.62,9.61,1.47,3.89,5.86,-10,-4.2,-26","6.48,7.75,6.14,.55,14.0,17.5,1.45,13.1",8,Sigmoid,9.326036056,8.0,-24.87979126,0.1774,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4736108779907227
271,669,SK-MEL-2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,-2.5,-1.9,-7.2,-10,-3.5,9.24,5.43","26.6,5.66,4.28,6.78,14.5,.85,15.6,6.33",8,Constant,,8.0,-1.925419927,0.7005,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4144625663757324
272,670,SK-MEL-24,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.09,-7.6,4.38,1.17,3.31,-7.7,-13,-59","4.64,13.8,2.92,10.1,22.6,4.38,6.25,11.5",8,Sigmoid,8.29878325,6.903137207,-58.11930466,0.5484,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9319759759543425,3.3409886360168457
273,671,SK-MEL-30,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.86,1.35,-1.5,-2.2,1.22,-5.5,-14,-33","9.70,2.63,10.1,3.95,2.16,2.16,6.41,4.08",8,Sigmoid,8.79499711,8.0,-32.65394592,0.2941,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0287225246429443
274,672,SK-MEL-31,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.0,4.75,2.75,-.92,-5.9,3.68,9.72,-60","31.8,15.1,16.2,2.14,15.7,4.97,7.08,1.43",8,Sigmoid,8.057313138,7.54642868,-59.74458694,0.5639,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.021074428833934,3.352325916290283
275,673,SK-MEL-5,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","11.1,10.6,3.24,1.19,6.69,5.20,-1.5,-47","20.5,18.0,6.30,2.02,1.54,7.24,9.78,5.28",8,Sigmoid,5.784722328,8.0,-46.62487411,0.4471,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4988694190979004
276,674,SK-MM-2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.84,10.1,.64,9.27,6.21,1.49,-13,-39","9.24,1.83,7.61,3.88,8.89,.36,4.72,.23",8,Sigmoid,4.023250103,8.0,-38.85299301,0.5101,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.8045458793640137
277,675,SK-N-BE(2),Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","18.0,22.3,18.2,-5.3,21.3,5.69,-1.5,-49","20.8,16.0,30.3,9.12,28.6,10.1,19.8,27.8",8,Linear,,8.0,-47.83959579,0.5456,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.225677490234375
278,676,SK-N-SH,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,5.03,4.75,.62,-3.2,-11,-18,-84","13.1,5.71,9.55,4.55,8.11,1.60,4.64,1.25",8,Sigmoid,8.483698154,5.205433846,-84.07558441,1.0504,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.6497030503705032,3.3023648262023926
279,677,SK-OV-3,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.46,18.2,-1.4,32.7,3.15,3.87,-7.7,-7.0","3.67,13.2,8.31,1.77,5.10,28.6,12.8,36.5",8,Linear,,8.0,-37.59794617,0.1564,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3666024208068848
280,678,SNG-M,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.24,3.55,7.20,2.64,4.14,-4.5,-5.9,-28","2.86,7.38,1.74,8.02,2.92,3.19,.47,2.83",8,Sigmoid,8.513591655,8.0,-27.62026024,0.3269,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2292585372924805
281,679,SNU-1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.96,15.7,-6.0,6.59,1.90,1.27,-18,-45","2.64,29.7,8.01,7.13,.18,1.60,5.33,5.67",8,Sigmoid,2.826813221,8.0,-44.54332352,0.566,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.861011505126953
282,680,SNU-182,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".98,-6.5,6.20,-1.1,3.27,-27,7.64,-4.5","3.07,9.34,6.07,22.9,9.86,8.01,7.27,1.05",8,Constant,,8.0,-0.647960663,0.2845,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2383933067321777
283,681,SNU-423,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,.39,1.70,2.41,5.09,-8.9,-.82,-16","28.6,12.5,8.15,2.62,8.09,6.79,6.02,6.87",8,Constant,,8.0,-2.016933203,0.08987,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2044997215270996
284,682,SNU-449,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.17,-4.5,-1.3,3.64,1.55,-7.4,-7.8,-35","9.16,3.76,17.2,1.21,12.9,12.1,11.4,3.38",8,Sigmoid,8.227484421,8.0,-34.43399811,0.278,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.688511848449707
285,683,SNU-C2A,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".98,13.9,-16,13.3,-4.3,21.4,15.5,-.76","2.57,.74,11.7,11.5,5.27,6.96,26.9,4.46",8,Constant,,8.0,2.450647593,0.1011,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.2916598320007324
286,684,SU-DHL-10,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.85,-7.9,22.6,-1.6,8.77,-23,-4.0,-18","12.3,25.7,2.25,4.09,25.5,6.28,37.3,13.7",8,Constant,,8.0,-3.841873884,0.3176,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0551934242248535
287,685,SU-DHL-4,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.20,19.6,22.3,17.2,-13,-10,-27,-67","1.86,18.6,25.5,3.22,.63,13.3,3.56,6.17",8,Sigmoid,8.652793069,5.041968346,-66.31307983,1.4978,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.6177965506817606,2.6337409019470215
288,686,SU-DHL-6,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,37.0,-8.8,2.05,45.5,28.4,79.3,-99","0,0,0,0,0,0,0,0",8,Linear,,0.099240054,-94.41659546,1.2999,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,-2.310213576023256,2.706292152404785
289,687,SU-DHL-8,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".089,8.07,1.74,7.46,-2.0,-8.3,-27,-62","16.8,7.28,4.25,43.9,13.0,5.24,17.6,.059",8,Sigmoid,8.288375457,5.790517807,-62.01280212,1.3969,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.7562217188469615,3.1093482971191406
290,688,SUIT-2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.57,5.73,5.15,-1.3,4.09,-5.1,-2.8,-7.9","3.92,5.75,4.72,8.76,9.49,1.35,1.32,4.46",8,Constant,,8.0,1.559181333,0.05218,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.1504900455474854
291,689,SUP-M2,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-1.2,10.8,.62,-3.6,-8.1,-.050,-28","8.20,23.3,9.63,28.0,19.5,8.98,14.8,5.90",8,Constant,,8.0,-8.512599945,0.1514,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.561917781829834
292,690,SUP-T1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,1.00,10.8,-4.2,3.09,-15,-12,-12","14.7,4.68,6.90,22.0,.96,3.77,1.44,12.2",8,Constant,,8.0,-3.20112586,0.6136,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.9288432598114014
293,691,SW 1088,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.41,-3.1,1.85,-1.8,.79,21.0,.77,-70","33.5,.19,33.0,3.76,47.5,10.1,29.6,12.7",8,Linear,,1.020972229,-70.26512909,0.6276,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,0.02075533900849357,3.406583547592163
294,692,SW 1271,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.67,-3.6,9.40,-1.3,11.3,-12,-15,-44","9.65,4.67,25.6,5.79,3.87,10.2,9.70,1.40",8,Sigmoid,8.082780261,8.0,-43.49624634,0.6314,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.321810722351074
295,693,SW 1353,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.61,15.7,-1.0,6.21,8.74,23.6,15.2,-12","6.81,1.56,12.1,17.4,4.45,5.13,2.21,5.19",8,Linear,,8.0,-12.1687479,0.149,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4120092391967773
296,694,SW 1990,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.40,8.18,-8.1,5.14,-16,-7.1,-.72,-54","1.48,14.7,9.56,14.7,4.66,5.50,12.1,13.8",8,Sigmoid,8.252157907,7.833574772,-53.7117424,0.7679,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0584189539644635,3.644622325897217
297,695,SW403,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,21.7,-12,24.3,36.4,47.2,18.6,-11","13.6,13.1,28.7,48.4,31.5,.22,25.7,8.15",8,Constant,,8.0,9.964643478,0.2939,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.690791130065918
298,696,SW48,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.19,4.68,-6.3,-7.5,6.28,8.99,6.15,-31","6.55,45.1,15.1,8.14,19.2,12.6,12.5,4.67",8,Constant,,8.0,-0.750831366,0.3872,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0913467407226562
299,697,SW480,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.41,15.6,3.46,12.2,7.60,1.79,-7.0,-8.7","7.64,1.18,20.8,15.0,19.8,6.47,9.91,10.2",8,Constant,,8.0,0.947888911,0.09498,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.595851421356201
300,698,SW579,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.30,4.09,4.57,8.97,-6.8,-24,-49,-55","1.91,1.30,.084,7.08,1.17,2.54,1.29,.66",8,Sigmoid,0.844504833,3.264090061,-55.3743782,1.0923,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.1829810289393397,3.426002025604248
301,699,SW620,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","14.8,-1.2,18.1,18.1,16.6,14.2,-.48,-24",".50,9.15,2.31,17.9,3.72,30.1,11.4,12.0",8,Sigmoid,2.807668686,8.0,-24.26585007,0.1627,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.221649646759033
302,700,SW 780,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.40,-9.8,5.53,3.07,.56,-1.9,-.80,-17","3.83,2.53,3.10,10.1,6.31,7.50,2.51,13.1",8,Constant,,8.0,-0.803987086,0.2467,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.516880989074707
303,701,SW 900,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".41,-2.5,10.9,-9.7,19.7,-6.9,10.3,-14","8.74,.92,15.4,2.33,20.6,3.58,6.70,15.3",8,Constant,,8.0,-2.547712564,0.3543,SW900_LUNG,SW900,ACH-000669,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.6005539894104004
304,702,T24,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","14.0,20.7,20.2,12.9,17.1,7.92,4.70,-11","3.89,2.73,6.81,14.3,8.86,1.89,13.2,10.6",8,Sigmoid,8.331194948,8.0,-10.61934662,0.1709,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3700695037841797
305,703,T3M-10,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.43,-18,18.0,13.4,-5.0,8.65,15.1,-4.1","31.8,5.34,4.70,8.75,2.89,1.15,23.8,9.31",8,Constant,,8.0,4.849438667,0.0999,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.488769054412842
306,704,T-47D,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,19.0,1.69,13.1,5.68,-8.4,5.64,-50","25.8,28.2,5.86,5.15,7.88,4.64,11.8,10.8",8,Sigmoid,8.230148804,8.0,-49.67881775,0.5094,T47D_BREAST,T47D,ACH-000147,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.5180037021636963
307,705,T84,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.7,79.8,30.0,-50,7.69,12.4,43.8,-18","18.8,82.4,23.9,14.9,27.1,16.6,101,7.99",8,Constant,,8.0,5.633076191,0.7187,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.4070398807525635
308,706,TCCSUP,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-1.7,-.79,.73,.21,-4.3,5.91,-42","5.47,9.53,.28,.16,3.71,4.89,8.64,6.20",8,Sigmoid,8.058427547,8.0,-41.67660522,0.3292,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.230509042739868
309,707,TE 617.T,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,-6.3,14.8,11.6,18.9,13.7,-57,-97","15.1,24.7,22.2,4.39,5.16,23.8,1.10,3.82",8,Sigmoid,2.187348843,2.358335733,-97.31585693,1.5507,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,0.8579561723871758,2.774822473526001
310,708,TE-9,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.21,16.7,-1.6,6.59,3.37,11.9,4.65,-62","2.01,7.48,1.64,10.2,16.2,.60,8.93,9.57",8,Sigmoid,4.781723022,6.083400249,-61.98797607,0.6286,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.8055637911355096,3.495753288269043
311,709,TEN,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,11.4,-17,15.4,-18,23.8,-28,-11","2.38,7.80,19.4,16.5,9.26,8.94,.97,4.81",8,Constant,,8.0,-9.503437996,0.8952,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.459677219390869
312,710,Toledo,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,15.4,-13,10.1,-13,17.4,2.57,-9.1","25.5,4.89,17.1,38.3,18.4,12.8,30.0,7.74",8,Constant,,8.0,-1.17787385,0.0,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.8867039680480957
313,711,TOV-112D,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.48,1.17,6.30,3.64,-.95,.65,-10,-48","6.94,4.95,13.1,2.83,4.32,3.61,6.38,5.79",8,Sigmoid,8.79866809,8.0,-48.3130188,0.4922,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.1141512393951416
314,712,TOV-21G,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,10.4,-2.0,10.7,-5.7,5.20,-13,-15","2.23,4.60,.52,.72,.97,2.93,1.24,10.9",8,Constant,,8.0,-3.709531546,0.1506,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,2.7388694286346436
315,713,TT2609-C02,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.53,15.7,-6.1,5.94,28.7,7.02,-11,-77","5.63,3.04,12.2,7.28,3.87,10.9,19.2,6.08",8,Sigmoid,4.49600029,4.903181076,-77.15048981,0.8678,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.5898841936616237,3.2190346717834473
316,714,TYK-nu,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.32,6.23,-11,1.00,1.86,-.51,-11,-23","15.1,3.75,.23,15.4,7.99,11.6,5.81,6.61",8,Sigmoid,2.592992067,8.0,-23.33183861,0.1484,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.369964599609375
317,715,U-118 MG,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.62,-3.9,3.39,3.83,-3.6,1.15,1.48,-15","3.70,17.1,17.4,4.61,4.07,2.56,10.8,.16",8,Constant,,8.0,-0.695588231,0.04546,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.3201370239257812
318,716,U-2 OS,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.76,8.24,17.3,9.59,25.8,12.2,23.8,-69","4.43,2.10,9.11,10.4,8.32,1.48,13.4,19.1",8,Sigmoid,8.163844693,7.420892239,-69.16178131,0.6846,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.004299297793762,3.271857976913452
319,717,U-87 MG,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,-3.3,3.80,4.58,4.01,-11,-4.0,-10","3.53,4.33,5.82,2.96,1.48,6.48,2.28,16.1",8,Constant,,8.0,-1.421543956,0.2714,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.407799243927002
320,718,U-937,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.01,10.2,4.47,10.7,-2.4,-4.6,-14,-38","11.0,7.44,2.33,12.9,5.07,10.3,21.4,38.2",8,Sigmoid,8.519376698,5.434136868,-62.82763672,0.5501,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.6927006980259371,2.6369826793670654
321,719,UACC-812,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","20.0,3.56,.30,-9.8,-1.7,-17,-27,-51","18.7,23.8,14.7,14.7,18.2,9.86,7.67,8.31",8,Linear,,8.0,-49.48458099,0.7207,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.6712584495544434
322,720,UM-UC-3,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.3,-.017,-10.0,-1.3,-7.9,-3.8,-7.5,-7.1","1.93,1.68,3.34,1.64,.44,.47,2.20,2.91",8,Constant,,8.0,-5.632931232,0.1194,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.0183610916137695
323,721,VMRC-RCW,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.20,-2.8,-3.7,7.74,1.00,-12,29.8,-75","7.00,4.31,13.0,5.36,.14,5.81,7.66,6.57",8,Sigmoid,8.114268689,7.079586029,-75.25524139,0.8637,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9572154355159372,3.227219581604004
324,722,VMRC-RCZ,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.25,19.6,9.25,1.65,.78,25.4,5.57,-9.8","16.3,.39,17.0,23.5,18.2,8.93,13.8,45.6",8,Constant,,8.0,13.85560417,0.0939,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.215212345123291
325,723,WM1799,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.79,-6.8,4.23,12.8,-17,-11,-.27,-77","1.53,9.04,14.9,3.50,1.78,13.1,2.13,5.10",8,Sigmoid,8.387841087,7.204105377,-76.88353729,0.9846,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9746510547747456,3.2691335678100586
326,724,WM-793,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","15.6,4.76,20.5,-4.2,30.7,-.38,2.86,-69","8.41,14.4,18.2,17.6,5.32,19.2,13.2,6.15",8,Sigmoid,8.837140243,6.826157093,-69.31829834,0.708,WM793_SKIN,WM793,ACH-000827,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9207618641370738,3.7000789642333984
327,725,WM-88,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,.49,13.4,22.0,-.73,-1.2,-1.4,-71","5.59,4.57,.47,11.5,5.93,5.91,13.7,.55",8,Sigmoid,8.779281271,6.776633263,-70.60153961,0.6898,WM88_SKIN,WM88,ACH-000899,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1.9134804097420923,3.445673704147339
328,726,WM-983B,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.34,-5.4,10.6,5.61,-11,-1.3,.68,-54","19.7,5.27,5.33,13.6,.93,17.4,24.1,2.97",8,Sigmoid,8.05186593,7.791449547,-53.91896439,1.9258,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.053026920492719,3.2729389667510986
329,727,YKG1,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,-7.8,4.20,2.98,-3.8,-7.8,-11,-53","5.62,2.60,14.9,3.45,12.1,5.49,1.09,16.2",8,Sigmoid,8.412155083,7.677743435,-52.50390244,0.4998,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0383256804172705,3.2104508876800537
330,728,ZR-75-30,Nilotinib,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","19.4,15.0,-7.9,19.8,-5.9,-.61,-22,-29","28.1,16.7,9.76,25.9,31.2,7.41,11.5,13.1",8,Constant,,8.0,-0.394994527,0.3953,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,6,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,1,Abl/Bcr-Abl,Abl Inhibitor,Kinase inhibitor,Launched-2007,Novartis,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2.0794415416798357,3.599834680557251
331,729,A172,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-3.6,-8.3,-13,-49,-67,-67,-71","2.33,.79,1.76,4.40,3.10,2.19,1.71,2.43",8,Sigmoid,0.179407626,0.267498583,-68.93263245,2.4662,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.3186410098563677,0.05726370960474014
332,730,A-204,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,-18,-57,-65,-78,-79,-80,-82","3.09,13.0,29.2,.95,1.03,.47,2.69,1.20",8,Sigmoid,0.01808529,0.029675882,-81.44564056,3.5747,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.5174206169398894,-0.19327810406684875
333,731,A2058,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-15,-29,-73,-83,-83,-80,-81","5.93,1.32,7.27,5.92,.24,.11,.44,1.69",8,Sigmoid,0.041432258,0.042496935,-81.66654205,4.747,A2058_SKIN,A2058,ACH-000788,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.1583233232994274,-0.6637856364250183
334,732,A-253,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-27,-8.8,-10,-43,-73,-85,-88","13.1,4.27,1.40,2.63,3.10,2.52,2.02,1.38",8,Sigmoid,0.343221009,0.339544863,-86.33873749,3.7077,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.0801491963837824,-0.46529048681259155
335,733,A2780,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-5.1,-27,-68,-88,-92,-92,-92","14.8,3.28,18.7,20.4,6.86,3.44,2.85,1.07",8,Sigmoid,0.030796837,0.031109899,-93.63037109,4.7559,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.470229214622381,0.27333885431289673
336,734,A-375,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-5.8,-9.8,-23,-64,-77,-85,-84","3.55,2.05,.89,8.58,1.52,2.09,.34,1.47",8,Sigmoid,0.150489956,0.169737235,-83.90649414,3.5625,A375_SKIN,A375,ACH-000219,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.7735037141927015,-1.0010929107666016
337,735,A549,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,-8.0,-24,-60,-105,-110,-110,-108","3.06,3.32,11.3,1.00,1.11,1.44,.54,.86",8,Sigmoid,0.077502377,0.06676174,-109.752121,2.9712,A549_LUNG,A549,ACH-000681,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.7066251170170657,0.04929223656654358
338,736,A-673,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-7.9,6.96,-28,-59,-77,-82,-83","27.4,3.25,3.68,14.5,.92,3.57,.023,.051",8,Sigmoid,0.164396465,0.198152512,-82.30304718,3.6758,A673_BONE,A673,ACH-000052,Bone Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.6187182821613504,0.5637957453727722
339,737,ACHN,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-6.3,-2.9,-2.4,-25,-53,-70,-74",".77,2.66,.72,10.2,.33,5.85,7.62,1.24",8,Sigmoid,0.472540706,0.678260922,-73.16583252,2.0636,ACHN_KIDNEY,ACHN,ACH-000046,Kidney Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.388223224365969,-0.07492808997631073
340,738,ALL-SIL,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-7.8,-3.4,-2.1,-20,-62,-94,-94","3.19,3.67,17.6,.67,23.9,2.23,.20,.20",8,Sigmoid,0.720209777,0.714353621,-93.95813751,3.2142,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.33637717174002196,0.7845836281776428
341,739,AMO-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","6.83,-5.8,-50,-86,-95,-95,-95,-95","12.4,4.86,6.11,.096,0,0,0,0",8,Sigmoid,0.022205526,0.025441425,-95.40047455,5.2887,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.671376527928006,1.0393275022506714
342,740,AsPC-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-19,-22,-45,-78,-73,-83,-83","11.6,10.6,6.33,14.8,7.11,14.4,4.03,10.0",8,Sigmoid,0.08627671,0.072310209,-88.25067139,3.4197,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.6267899564661663,-0.10595832020044327
343,741,AU565,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-13,-55,-72,-69,-72,-73,-71",".28,12.3,7.15,7.16,1.84,1.17,3.39,5.24",8,Sigmoid,0.021328464,0.0233486,-71.35012054,4.2668,AU565_BREAST,AU565,ACH-000248,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.7572182538381815,0.4230424761772156
344,742,B-CPAP,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,-8.6,-4.9,-7.3,-61,-66,-74,-75","1.96,1.53,3.77,.74,4.29,4.12,.74,6.83",8,Sigmoid,0.184246182,0.210629389,-71.80564117,3.4746,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.5576551401104228,-0.32248827815055847
345,743,BDCM,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,.22,-19,-.56,-64,-90,-96,-96","7.82,7.07,15.0,15.1,.33,2.56,.53,.88",8,Sigmoid,0.200280085,0.204344377,-94.83753967,3.8043,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.5879485858662188,0.9023536443710327
346,744,BFTC-909,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.4,-5.6,-11,-39,-69,-70,-71,-76","3.40,.082,8.51,17.8,5.27,8.42,8.98,6.70",8,Sigmoid,0.081238762,0.104652666,-72.31032562,3.6219,BFTC909_KIDNEY,BFTC909,ACH-000792,Kidney Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.2571083550204496,-0.21012766659259796
347,745,BL-41,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-16,-3.8,-13,11.6,-55,-92,-94","4.03,.026,16.7,2.28,17.0,11.0,.65,.18",8,Sigmoid,0.79903841,0.764389515,-93.49221039,2.9811,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.26867778335059544,0.98235684633255
348,746,BL-70,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,.027,7.17,-7.1,-42,-92,-94,-93","6.87,10.5,4.02,4.24,1.69,.91,.43,.22",8,Sigmoid,0.275329709,0.284389943,-94.26802826,3.5976,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.2574089438442708,1.1406726837158203
349,747,BT-20,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,21.2,-28,-14,-20,-24,-28,-39","1.15,5.07,11.4,1.79,21.1,8.50,1.83,8.98",8,Constant,,8.0,-19.38268089,1.0525,BT20_BREAST,BT20,ACH-000536,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,0.44754186272621155
350,748,BT-474,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","7.77,-14,-36,-79,-81,-86,-97,-95","9.85,5.55,.40,8.60,2.73,6.73,.21,3.48",8,Sigmoid,0.033079438,0.044726733,-96.64443207,3.7846,BT474_BREAST,BT474,ACH-000927,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.107183902434178,1.5745396614074707
351,749,BT-549,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-23,-59,-66,-76,-80,-79,-80","10.5,6.78,3.22,2.13,7.12,7.63,.78,2.75",8,Sigmoid,0.01780379,0.020397235,-77.85842896,4.799,BT549_BREAST,BT549,ACH-000288,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.8923559265339223,0.815159261226654
352,750,BxPC-3,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-6.2,17.7,3.78,-73,-91,-92,-91","24.0,12.5,1.22,17.2,8.61,.25,1.12,.37",8,Sigmoid,0.17851758,0.187336221,-91.50035095,3.4843,BXPC3_PANCREAS,BXPC3,ACH-000535,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.674850303284612,0.22795721888542175
353,751,C2BBe1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-2.2,16.6,-10,-20,-50,-71,-73","18.5,10.6,29.6,36.0,20.9,6.58,10.7,2.06",8,Sigmoid,0.549149871,0.777057707,-73.16810608,2.2767,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.25224066238902504,0.1674027442932129
354,752,C32,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-76,-97,-96,-97,-96,-95,-96","10.5,15.2,.45,.62,.54,.40,.92,.76",8,Sigmoid,0.007620106,0.006673547,-96.16029358,6.5863,C32_SKIN,C32,ACH-000580,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-5.0096037762937184,-0.4340997636318207
355,753,CAL-12T,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-24,-19,-34,-56,-84,-76,-88","13.1,15.2,6.92,.49,.88,9.31,3.54,5.22",8,Sigmoid,0.185387149,0.183841035,-84.20608521,3.5,CAL12T_LUNG,CAL12T,ACH-000826,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.6936838350019778,0.2540821135044098
356,754,CAL 27,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-20,-22,-16,-79,-84,-90,-89","4.50,3.23,7.66,5.22,2.01,.82,.18,3.24",8,Sigmoid,0.173958063,0.166818783,-87.6975174,4.0906,CAL27_UPPER_AERODIGESTIVE_TRACT,CAL27,ACH-000832,Head and Neck Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.7908471874836167,0.17005819082260132
357,755,CAL-85-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-10,-27,-30,-60,-63,-80,-81","4.74,7.58,3.40,7.17,1.83,5.74,5.80,1.05",8,Sigmoid,0.141157091,0.175339907,-81.52091217,3.6877,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.741028863219922,0.4991775155067444
358,756,Calu-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,6.11,-19,-35,-70,-65,-74,-71","4.52,3.28,2.87,6.14,.23,5.18,.25,8.54",8,Sigmoid,0.096476123,0.103493586,-70.29549408,3.3698,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.268245639211489,0.5715761184692383
359,757,Calu-3,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","22.4,1.28,3.29,-25,-38,-43,-51,-57","36.9,17.2,25.8,17.0,11.7,9.84,15.4,1.09",8,Sigmoid,0.041841503,1.688857436,-55.95833206,2.0534,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.5240522269215406,0.4903629422187805
360,758,Calu-6,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-7.9,-1.0,5.80,-70,-74,-79,-76","3.04,2.12,4.06,9.90,1.41,1.43,2.24,4.84",8,Sigmoid,0.165125921,0.183477089,-76.77734375,3.0328,CALU6_LUNG,CALU6,ACH-000264,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.6956654748684505,-0.14427050948143005
361,759,CAMA-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-35,-26,-56,-56,-53,-59,-72","15.2,15.9,9.19,8.73,.0094,1.51,7.68,2.69",8,Sigmoid,0.013019911,0.141045213,-66.17385101,3.1786,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.9586747804297944,0.7464038729667664
362,760,Capan-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","11.9,-16,-16,-71,-87,-87,-91,-91","15.5,7.96,22.3,5.79,3.93,2.17,1.25,4.17",8,Sigmoid,0.046799377,0.046125766,-91.8241806,3.905,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.0763835697132706,0.182428240776062
363,761,CAS-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-8.5,-1.00,-2.7,-37,-39,-68,-70","12.4,21.9,7.11,16.5,12.5,5.13,.76,8.02",8,Sigmoid,0.671148479,1.019528747,-71.53601837,2.1995,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.019340507790308933,0.6770341992378235
364,762,CCK-81,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,8.88,-36,-21,-48,-84,-80,-83","19.4,7.33,3.26,34.5,4.10,1.02,7.63,1.05",8,Sigmoid,0.316282302,0.263275087,-82.64190674,3.4189,CCK81_LARGE_INTESTINE,CCK81,ACH-000963,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.3345558352625824,0.5226988196372986
365,763,CHP-212,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,15.5,-36,-94,-98,-97,-98,-98","0,0,0,.14,1.10,.61,.54,.30",8,Sigmoid,0.026552394,0.029792815,-97.897789,5.2114,CHP212_AUTONOMIC_GANGLIA,CHP212,ACH-000120,Neuroblastoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.5134880219243865,-0.04245930165052414
366,764,CI-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-31,-25,18.5,-23,-37,-64,-88,-94","14.3,7.32,5.05,49.5,3.46,5.51,2.55,1.84",8,Sigmoid,0.706982791,0.479196012,-94.21889496,3.8812,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.7356455544192,0.5931947827339172
367,765,COLO-320,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-9.2,-19,-17,-12,-49,-65,-90","8.01,2.67,6.55,11.3,6.39,21.8,.51,.25",8,Sigmoid,1.897327304,1.569168806,-90.01780701,2.8034,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.4505460562364776,0.6598933339118958
368,766,COLO-678,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-27,-44,-56,-66,-64,-65,-68","15.9,13.0,2.77,1.78,2.10,4.96,3.63,2.85",8,Sigmoid,0.013500599,0.040361557,-66.7589798,4.2419,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.2098775064410314,0.0322563499212265
369,767,COLO-679,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,5.22,-23,-48,-73,-78,-76,-77","3.19,2.17,3.44,9.06,2.35,1.06,.37,.81",8,Sigmoid,0.031729337,0.062656693,-77.54040527,3.984,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.770084771741999,-0.2686235010623932
370,768,COLO 741,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.8,-3.2,-22,-18,-23,-44,-56,-64","4.48,5.93,10.5,2.71,3.96,5.33,2.06,3.98",8,Sigmoid,0.660736561,1.479850173,-64.61505127,3.2321,COLO741_SKIN,COLO741,ACH-000582,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.39194084819201047,-0.1431301236152649
371,769,COR-L105,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","14.3,.53,9.17,11.7,-22,-45,-78,-85","23.3,8.47,18.0,5.77,14.3,3.63,1.84,.0090",8,Sigmoid,0.728481233,0.887269139,-85.30766296,1.9816,CORL105_LUNG,CORL105,ACH-000161,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.11960691654138308,0.8141884207725525
372,770,COR-L23,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-8.0,-5.9,-1.6,-22,-67,-72,-72","2.02,.90,5.01,6.49,2.33,10.6,6.36,1.94",8,Sigmoid,0.479296297,0.608988762,-72.16020966,2.3346,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.495955464644473,0.515487551689148
373,771,COV318,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-14,-15,6.10,-15,-36,-49,-44","5.59,27.1,22.5,11.5,8.31,7.16,4.10,26.6",8,Sigmoid,0.557713151,8.0,-48.664505,1.9673,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,1.1060199737548828
374,772,COV504,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-12,-10,-22,-47,-59,-72,-71","5.70,17.0,.18,12.8,12.2,2.40,1.62,3.82",8,Sigmoid,0.261089951,0.347438395,-70.69543457,2.0498,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.0571679102688885,0.39374250173568726
375,773,Daoy,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,-30,3.54,-33,-16,-83,-84,-88","19.1,14.3,11.6,9.41,6.57,7.84,2.61,5.16",8,Sigmoid,0.485228688,0.477916837,-86.34555054,3.6005,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.7383185427987089,0.003862394019961357
376,774,DBTRG-05MG,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.4,-2.3,-2.6,1.21,-43,-69,-71,-78","1.52,2.20,11.4,8.08,7.70,2.90,2.15,.74",8,Sigmoid,0.238610581,0.276005715,-72.44678497,2.7457,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.287333706957625,0.046690016984939575
377,775,Detroit 562,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-3.8,-9.5,15.7,-53,-59,-68,-63","4.34,2.64,9.06,7.85,2.25,.96,1.45,1.71",8,Sigmoid,0.187755972,0.238989621,-63.67699051,2.8606,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.431335154771839,-0.07383709400892258
378,776,DK-MG,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8",".090,-1.8,-8.8,-35,-47,-57,-72,-74","2.12,1.62,6.39,8.05,.66,.45,1.2e-4,.42",8,Sigmoid,0.123933911,0.319927543,-74.13994598,2.603,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.139660736952083,0.10776674002408981
379,777,DMS 114,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","8.54,8.25,7.27,-6.2,-21,-52,-72,-78","3.29,8.72,1.16,3.36,10.3,3.13,.37,4.50",8,Sigmoid,0.38508141,0.695213139,-78.65285492,2.2019,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.36353680561231166,1.429366111755371
380,778,DOHH-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,3.32,-.087,-19,-39,-63,-79,-82","19.7,21.1,7.64,11.4,4.14,8.61,2.37,6.41",8,Sigmoid,0.33423841,0.409685045,-82.00114441,4.3378,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.8923665974143072,1.2130789756774902
381,779,DV-90,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-26,-13,-46,-67,-85,-91,-90","25.7,25.9,3.77,7.71,3.02,3.88,2.54,.15",8,Sigmoid,0.110455282,0.120939881,-90.60025024,4.6153,DV90_LUNG,DV90,ACH-000925,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.1124617080965424,0.2784930169582367
382,780,EB1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-14,-.19,-18,-3.9,-49,-65,-76","24.5,24.1,9.77,2.58,1.72,2.35,12.3,3.24",8,Sigmoid,0.709325135,0.812782228,-71.11301422,2.5251,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.20729206755444596,0.864632785320282
383,781,EBC-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,2.76,-66,-66,-71,-71,-77,-70","7.63,3.28,4.36,.052,.69,.36,.043,1.09",8,Sigmoid,0.015572329,0.018749278,-71.19284821,3.9338,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.9766000339737846,0.32855305075645447
384,782,EFE-184,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","2.10,-12,5.82,-.78,-26,-58,-55,-59","8.06,4.39,9.57,2.46,1.07,3.59,.85,1.72",8,Sigmoid,0.264932662,0.387381613,-57.2739296,1.8778,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.948344991706611,0.5813365578651428
385,783,EFM-19,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,3.03,-16,-60,-66,-69,-68,-75","4.23,6.61,3.70,.95,5.53,2.46,4.03,.10",8,Sigmoid,0.042367008,0.058103666,-69.85145569,3.5096,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.845526519008161,0.9729089140892029
386,784,EFO-21,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-8.2,-5.1,-20,-47,-64,-55,-70","12.9,2.53,17.8,8.74,7.3e-4,1.06,14.0,1.50",8,Sigmoid,0.180796623,0.288561821,-68.23006439,2.2269,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.2428459317607994,0.4799426794052124
387,785,EFO-27,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-2.7,-6.9,-13,-51,-74,-79,-87","1.38,1.38,6.27,12.8,25.3,3.76,.82,4.84",8,Sigmoid,0.317508072,0.366359919,-82.51599884,2.7526,EFO27_OVARY,EFO27,ACH-000936,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.0041390435413806,-0.08526891469955444
388,786,EM-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-8.8,-1.3,-25,-83,-94,-94,-94","12.2,.87,15.4,10.5,2.81,.33,.012,.36",8,Sigmoid,0.133837685,0.130336672,-94.45192719,4.667,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.0376343916246884,0.7507603168487549
389,787,EN,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-17,-14,-30,-46,-48,-46,-56","11.4,5.24,21.9,11.6,14.5,7.44,5.47,5.20",8,Sigmoid,0.104442269,8.0,-49.7822113,2.6637,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,0.7660126090049744
390,788,ES-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-5.4,-14,-3.1,-14,-58,-86,-86","3.92,7.20,5.83,7.06,14.5,7.17,.99,.44",8,Sigmoid,0.676031291,0.69963789,-86.44496155,3.0835,ES2_OVARY,ES2,ACH-000906,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.35719237778453833,0.00229005329310894
391,789,ESS-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,-1.1,-8.4,-27,-68,-76,-76,-78","4.97,1.02,4.57,26.8,.079,2.70,.68,.69",8,Sigmoid,0.088794842,0.11770121,-76.72341919,3.4977,ESS1_ENDOMETRIUM,ESS1,ACH-000913,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.139605984394917,0.028165509924292564
392,790,F-36P,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-24,-4.7,-21,-28,-70,-78,-79","8.08,19.1,14.0,24.5,14.4,9.01,.20,.56",8,Sigmoid,0.391811848,0.435421079,-78.7911377,3.7075,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.8314417183999534,0.8793929219245911
393,791,FaDu,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-24,-62,-83,-85,-82,-85,-85","5.27,2.85,16.7,2.66,1.20,.57,.93,1.31",8,Sigmoid,0.019789666,0.019284135,-84.39362335,5.1603,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.948472541840988,-0.2538900375366211
394,792,FU97,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-23,-10,-68,-76,-85,-83,-86","1.34,5.58,13.3,6.03,.17,.30,.48,.57",8,Sigmoid,0.062063873,0.062858187,-82.85019684,4.4951,FU97_STOMACH,FU97,ACH-000633,Gastric Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.7668740898994746,-0.1227017492055893
395,793,FU-OV-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-7.1,.43,-13,-42,-63,-80,-82","5.81,6.53,3.46,10.4,3.60,7.07,3.26,.15",8,Sigmoid,0.297369093,0.373221964,-81.47976685,1.7438,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.9855819585788841,0.32196518778800964
396,794,G-361,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,-14,-13,-44,-59,-64,-65,-72","11.3,.81,.46,.18,6.02,.11,5.99,1.71",8,Sigmoid,0.07529626,0.089309976,-65.57502747,3.2302,G361_SKIN,G361,ACH-000572,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.415642084013285,-0.6442689895629883
397,795,G-401,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","3.27,-21,-.27,-49,-74,-91,-92,-94","2.94,9.09,2.98,1.26,.65,.22,.19,.19",8,Sigmoid,0.070909321,0.085478991,-94.33609772,4.5407,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.459484652531601,-0.010913731530308723
398,796,G-402,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-13,-23,-55,-79,-88,-95,-95","2.34,1.38,.012,7.19,1.65,.27,1.45,1.04",8,Sigmoid,0.079352327,0.073431857,-93.81569672,4.4662,G402_SOFT_TISSUE,G402,ACH-000375,Kidney Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.6113974184471322,0.11129016429185867
399,797,GAMG,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,5.39,8.65,-38,-73,-88,-90,-85","2.34,22.9,5.38,7.15,4.06,1.87,.23,2.85",8,Sigmoid,0.08195965,0.109149978,-86.96504974,3.711,GAMG_CENTRAL_NERVOUS_SYSTEM,GAMG,ACH-000098,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.2150323975436943,0.5276690721511841
400,798,GB-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,10.1,-.41,-3.8,-3.8,-53,-92,-91","25.0,13.0,9.26,3.55,8.46,12.6,.15,.35",8,Sigmoid,0.726430118,0.768663943,-92.33756256,2.3449,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.26310141019265465,0.5865201354026794
401,799,GCT,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,-11,8.31,-3.6,-40,-75,-84,-86","6.80,8.38,9.68,12.9,5.97,6.99,.81,1.06",8,Sigmoid,0.294174373,0.330548614,-84.94069672,3.4082,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.1070015382229879,0.1585976779460907
402,800,GI-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,-12,-13,-24,-60,-70,-78,-84","2.81,7.29,8.04,8.65,4.31,1.52,2.11,.87",8,Sigmoid,0.15393959,0.198652357,-80.43789673,3.6972,GI1_CENTRAL_NERVOUS_SYSTEM,GI1,ACH-000756,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.6161989317025656,0.009413355961441994
403,801,GMS-10,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,-2.1,-5.4,-4.9,-52,-70,-78,-77",".15,5.39,9.36,12.6,11.3,.18,1.10,1.13",8,Sigmoid,0.208066851,0.245301753,-75.31314087,3.1344,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.405266181391822,0.06772695481777191
404,802,GRANTA-519,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-47,-6.4,-15,-1.8,-50,-45,-76,-74","0,19.5,19.0,5.38,2.90,.61,.96,2.47",8,Linear,,0.010983705,-75.22703552,2.8214,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-4.511342468124034,0.8902427554130554
405,803,H4,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.2,-7.5,3.25,-19,-76,-93,-94,-94","3.15,13.1,1.00,4.47,10.1,.20,.10,.84",8,Sigmoid,0.144919693,0.150771588,-94.23287964,4.1075,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.8919892496474537,0.2393563687801361
406,804,HARA,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-7.2,-6.0,-8.9,-61,-73,-83,-80","14.5,.43,8.79,4.14,1.75,3.61,.58,1.59",8,Sigmoid,0.192938626,0.212432846,-79.24515533,3.2458,HARA_LUNG,HARA,ACH-000843,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.5491293593856659,0.1692635864019394
407,805,HCC1187,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-2.7,6.47,26.0,16.6,-7.9,-59,-55","2.55,1.56,10.7,7.94,5.68,26.6,3.54,3.94",8,Sigmoid,1.017667413,1.531470418,-57.36456299,1.2846,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.4262283314005837,1.4400930404663086
408,806,HCC1395,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-15,-35,-39,-26,-38,-43,-49","2.20,6.99,8.02,2.28,22.3,2.87,4.10,2.78",8,Sigmoid,0.010956545,8.0,-42.42713165,2.6091,HCC1395_BREAST,HCC1395,ACH-000699,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,0.37860167026519775
409,807,HCC-15,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,.87,-18,-70,-68,-64,-69,-68","4.02,14.3,14.7,5.62,3.15,2.52,1.37,1.47",8,Sigmoid,0.03170532,0.038541321,-67.80645752,3.8606,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.256024340506525,0.4470919370651245
410,808,HCC1569,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,-.092,-5.9,-21,-58,-71,-77,-79","13.1,16.5,3.43,3.41,6.18,.41,4.00,4.80",8,Sigmoid,0.144838095,0.201155081,-77.08747101,2.8103,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.6036791211489614,1.0040006637573242
411,809,HCC1806,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-.97,7.30,2.79,-62,-86,-88,-92,-90","15.8,4.84,4.13,.30,1.21,.18,2.02,2.13",8,Sigmoid,0.059570543,0.06748455,-89.12297058,4.1444,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.6958565961916015,0.6384640336036682
412,810,HCC1954,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-32,-6.1,-34,-69,-84,-81,-84,-84","12.0,34.9,11.2,1.09,.36,3.76,.70,2.70",8,Sigmoid,0.053708408,0.048323501,-83.62531281,4.5797,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.0298372735100774,0.8535734415054321
413,811,HCC2935,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-40,-46,-76,-80,-80,-77,-82","2.53,11.7,14.8,1.14,1.42,6.42,2.33,2.38",8,Sigmoid,0.015474424,0.018270468,-80.63720703,4.7694,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-4.002469293156753,0.5243995785713196
414,812,HCC4006,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,-10,-25,-61,-56,-53,-61,-72","3.99,7.27,.58,8.42,11.9,10.7,.76,2.15",8,Sigmoid,0.032509625,0.044439085,-62.73595047,3.4326,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.1136359039816317,0.6441702246665955
415,813,HCC-44,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-.21,-11,-61,-88,-91,-91,-91","9.02,4.53,1.40,7.30,1.62,.23,.48,.60",8,Sigmoid,0.062767997,0.065585621,-90.60346985,4.7402,HCC44_LUNG,HCC44,ACH-000667,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.724398799131358,0.30265963077545166
416,814,HCC70,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,4.55,-32,-36,-64,-71,-69,-80","15.2,16.0,18.9,16.7,2.89,1.40,1.12,4.25",8,Sigmoid,7.088535118,0.065257996,-79.20053101,3.0273,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.729406696225942,0.8737772703170776
417,815,HCC-78,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,8.83,.43,4.97,-35,-45,-59,-61","13.1,3.97,10.8,30.3,6.46,12.3,11.3,6.57",8,Sigmoid,0.187795743,0.80337292,-59.97629166,1.8194,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.21893626437136843,0.7544126510620117
418,816,HCC827,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","11.8,6.02,9.40,-5.9,-58,-77,-82,-86","16.8,10.00,7.53,28.1,7.66,4.04,1.73,2.77",8,Sigmoid,0.12517111,0.18870239,-84.04538727,3.074,HCC827_LUNG,HCC827,ACH-000012,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.6675841610810573,0.4863539934158325
419,817,HCT 116,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","1.53,-3.3,-2.2,-4.1,-61,-80,-85,-87","7.04,.84,2.02,11.2,1.87,2.04,2.86,1.99",8,Sigmoid,0.178582862,0.202989653,-85.09122467,3.4601,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.5946002716827368,-0.27641600370407104
420,818,HCT-15,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.8,13.1,-9.2,-.88,-25,-64,-80,-79","7.37,2.72,.90,2.13,18.5,5.40,.84,.58",8,Sigmoid,0.515514553,0.592416525,-79.65554047,2.6346,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.5235453019741757,-0.07764031738042831
421,819,HD-MY-Z,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-12,-1.6,-13,-80,-84,-85,-86","5.86,9.27,4.28,5.93,.81,1.05,2.21,.34",8,Sigmoid,0.147855014,0.1518711,-85.22717285,3.7408,HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HDMYZ,ACH-000190,Unknown,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.8847231442293813,0.09059372544288635
422,820,HDQ-P1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,3.24,-.24,-30,-69,-73,-74,-69","5.37,13.5,53.2,29.8,3.56,12.5,13.8,17.1",8,Sigmoid,0.098501183,0.122433454,-72.57951355,4.9797,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.1001876292547323,0.7236190438270569
423,821,HEC-151,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-32,1.18,-18,-66,-80,-89,-90","6.64,10.0,2.64,8.89,3.04,1.43,3.25,.69",8,Sigmoid,0.173502579,0.182358727,-86.98732758,3.7984,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.701779504358783,-0.22673863172531128
424,822,HEC-1-A,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-31,-5.1,3.49,-18,-65,-56,-77,-71","7.97,3.05,6.54,.42,13.2,12.6,6.73,6.06",8,Sigmoid,0.1191165,0.155032128,-70.55566406,2.8197,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.864122906122532,0.01474776677787304
425,823,HEC-1-B,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,11.0,28.5,-60,-64,-57,-58,-63","40.7,9.24,19.5,6.31,4.65,13.8,7.70,.56",8,Sigmoid,0.042914387,0.061065979,-61.75510788,2.9013,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.795800376390652,0.04824499785900116
426,824,HEC-251,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,-6.0,-14,-24,-44,-44,-60,-83","9.22,7.08,.87,5.44,23.8,19.8,1.51,.18",8,Sigmoid,8.61799467,0.90558356,-80.7131958,2.5866,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.09917572540824655,0.6335143446922302
427,825,HEC-265,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.7,1.39,-2.6,-92,-94,-93,-93,-93","7.28,15.0,8.65,.24,.83,.22,1.99,.16",8,Sigmoid,0.043697171,0.044854023,-93.87295532,4.6862,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.104341995503391,-0.03822460025548935
428,826,HEC-59,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-3.2,-10,-18,-53,-83,-90,-94","9.72,11.6,9.54,6.27,6.32,2.77,.94,.083",8,Sigmoid,0.238041714,0.236760587,-92.9746933,3.2777,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.4407058298587498,0.2807959318161011
429,827,HEC-6,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","5.23,-4.6,16.7,7.37,-29,-56,-59,-68","33.1,11.7,21.4,45.0,8.37,15.0,10.4,6.08",8,Sigmoid,0.262559563,0.561491907,-64.44797516,2.4531,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.577157918086495,0.4828318953514099
430,828,HEL 92.1.7,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-16,-7.0,-8.2,-1.6,-2.0,-81,-82","4.14,4.33,.96,3.14,6.71,3.88,1.97,2.05",8,Sigmoid,1.560896754,1.616860271,-84.81639099,2.2799,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.4804861643689256,0.7583410143852234
431,829,Hep 3B2.1-7,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,3.06,-13,-2.4,-64,-85,-90,-88","24.6,7.64,10.8,10.6,.13,.29,1.14,1.81",8,Sigmoid,0.201482788,0.209670588,-87.65670013,3.5814,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.562217608421997,0.5272818803787231
432,830,Hep G2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-41,-50,-86,-95,-95,-96,-95","34.8,25.7,12.7,4.24,1.25,1.07,1.60,1.24",8,Sigmoid,0.026127659,0.022530433,-95.54827118,5.3606,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.792888305903311,0.0036043357104063034
433,831,Hey-A8,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-14,-15,-47,-78,-80,-77,-78","4.56,4.08,3.09,.74,1.24,2.39,.22,.20",8,Sigmoid,0.080627881,0.08386872,-78.0650177,3.8485,HEYA8_OVARY,HEYA8,ACH-000542,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.478502559816836,-0.3015097677707672
434,832,HGC-27,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-9.5,-14,-15,-65,-81,-83,-84","2.87,.46,3.49,.020,1.34,1.33,.41,1.85",8,Sigmoid,0.193859294,0.199818447,-82.8037796,3.6359,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.610346089702262,0.06738671660423279
435,833,HH,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","5.96,9.99,-18,23.1,-36,-52,-61,-71","16.0,10.7,8.96,11.7,11.2,4.77,6.43,3.57",8,Sigmoid,0.230489343,0.316189826,-61.75072861,2.1617,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.151412530562496,0.7106912732124329
436,834,HLF,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.3,-5.8,-4.9,-13,-54,-81,-82,-86","10.8,15.7,11.4,5.85,19.5,.15,1.83,1.43",8,Sigmoid,0.212694153,0.233836412,-83.93231201,3.5942,HLF_LIVER,HLF,ACH-000393,Liver Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.4531335021217018,-0.02642749436199665
437,835,HMC-1-8,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-10,-7.9,-46,-76,-85,-86,-87","5.70,3.35,2.89,8.09,.66,.13,2.51,.74",8,Sigmoid,0.09855096,0.105055355,-86.08422089,3.6072,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.2532678772645007,0.3451043367385864
438,836,HMCB,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-6.6,-38,-68,-79,-78,-79,-78","2.06,3.98,7.13,8.85,1.97,.19,.83,.79",8,Sigmoid,0.031231295,0.034340765,-78.47813416,4.5134,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.3714221465332184,-0.25349631905555725
439,837,HOS,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8",".10,4.99,9.79,-28,-70,-80,-85,-88","12.3,8.38,11.3,4.63,3.87,3.50,.89,4.45",8,Sigmoid,0.106993526,0.136840746,-84.88843536,3.4429,HOS_BONE,HOS,ACH-000613,Bone Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.9889374672652604,0.114271380007267
440,838,HPAC,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-16,-19,-41,-80,-76,-80,-72","14.7,.10,24.0,13.6,3.10,5.66,2.83,2.64",8,Sigmoid,0.087546386,0.090494916,-77.36972809,3.905,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.402461606649812,0.11568818241357803
441,839,HPAF-II,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-32,-33,-52,-51,-58,-71,-56","28.3,5.67,9.65,14.6,4.03,15.2,6.32,1.44",8,Sigmoid,0.108629867,0.151630998,-61.59915543,3.803,HPAFII_PANCREAS,HPAFII,ACH-000094,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.886305354379962,0.8951458930969238
442,840,Hs 294T,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","6.29,-6.6,3.70,-28,-56,-73,-81,-83","8.71,4.16,5.64,13.9,6.59,1.40,1.74,.74",8,Sigmoid,0.172179401,0.229678199,-81.49351501,2.7954,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.4710760845445514,-0.17892135679721832
443,841,Hs 578T,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-16,-11,-66,-74,-77,-79,-78",".79,9.40,9.76,2.78,4.12,3.74,1.54,5.93",8,Sigmoid,0.059520297,0.062882334,-76.93476868,3.8639,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.766490013229443,0.1567656695842743
444,842,Hs 683,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-6.9,-14,-41,-69,-88,-92,-92","8.72,6.44,2.82,16.6,3.66,1.69,.44,1.99",8,Sigmoid,0.153227687,0.143921196,-92.18196869,4.354,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.9384893792020708,0.02079303376376629
445,843,Hs 695T,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,3.84,-22,-29,-77,-85,-77,-74","2.09,4.52,32.8,14.2,3.50,5.12,.27,9.80",8,Sigmoid,0.081423536,0.095518604,-79.01912689,3.3577,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.34843424418501,0.15146924555301666
446,844,Hs 729,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,2.05,-24,-52,-58,-57,-56,-64","6.61,11.9,5.80,.024,8.67,5.88,.83,1.43",8,Sigmoid,0.030450042,0.066169545,-58.81827927,3.1048,HS729_SOFT_TISSUE,HS729,ACH-000133,Unknown,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.715534967209708,0.31037458777427673
447,845,Hs 746T,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,4.92,-14,-32,-62,-69,-77,-73","7.50,3.67,14.0,8.41,4.20,.63,4.29,1.59",8,Sigmoid,0.089458182,0.146164864,-73.38089752,3.5069,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.9230200888673101,0.3669963479042053
448,846,Hs 766T,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-13,-.98,-33,-52,-73,-74,-71",".31,2.52,2.10,6.09,2.85,1.04,1.46,4.43",8,Sigmoid,0.171976149,0.208693713,-73.87713623,3.2746,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.5668875899334742,-0.05191381275653839
449,847,Hs 852.T,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-15,-34,-70,-87,-90,-90,-89","2.67,6.35,4.05,4.58,1.86,.80,.65,1.20",8,Sigmoid,0.046268828,0.043077972,-89.8218689,4.9316,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.144743503010935,0.12461959570646286
450,848,Hs 936.T,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-25,-13,-62,-66,-70,-65,-74","17.2,3.92,8.73,1.88,1.71,1.49,.63,.56",8,Sigmoid,0.056238528,0.061651316,-68.81011963,3.9897,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.7862607032897997,-1.1169793605804443
451,849,Hs 939.T,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-23,-39,-72,-82,-89,-85,-88","6.25,4.00,19.7,4.24,1.74,2.75,.063,1.83",8,Sigmoid,0.028618159,0.030074231,-87.1053772,5.1729,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.504086586858106,-0.48050081729888916
452,850,Hs 944.T,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-3.3,-4.5,-29,-70,-75,-78,-77","1.17,2.39,8.29,2.60,5.01,2.62,.24,2.35",8,Sigmoid,0.106417872,0.128760532,-76.64881134,3.4641,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.04980094084214,-0.5407229065895081
453,851,HSC-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-12,-13,-13,-30,-66,-89,-92",".93,1.87,1.28,4.70,1.25,1.42,1.91,.66",8,Sigmoid,0.542286038,0.499589235,-92.59281158,3.1995,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.6939690482006496,0.14528237283229828
454,852,HT,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-6.7,-8.8,-23,-59,-75,-79,-85","12.6,19.6,14.6,9.45,6.73,11.1,.77,2.87",8,Sigmoid,0.179806605,0.200726017,-81.64007568,4.4626,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.605814400290771,1.1031380891799927
455,853,HT-1080,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-9.2,-28,-40,-68,-79,-86,-87","7.81,.35,4.12,3.12,1.26,1.94,.35,2.57",8,Sigmoid,0.103699848,0.113508768,-87.12612915,4.0847,HT1080_SOFT_TISSUE,HT1080,ACH-000054,Sarcoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.175875193943071,-0.49074387550354004
456,854,HT-1197,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-2.8,.37,-5.4,-36,-37,-50,-59","41.3,6.20,7.99,13.0,.91,6.15,17.7,5.26",8,Sigmoid,0.245931655,1.937179565,-57.47852325,1.8151,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.6612330827611729,0.4791406989097595
457,855,HT-144,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.3,-11,-16,-50,-83,-85,-88,-85","5.84,5.70,.55,.91,2.72,.71,.63,1.92",8,Sigmoid,0.076719917,0.07971938,-86.31567383,4.3186,HT144_SKIN,HT144,ACH-000322,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.529242560888057,-0.5306529998779297
458,856,HuCCT1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,-9.9,-4.9,-40,-67,-73,-70,-73","6.38,6.89,3.28,4.56,8.47,8.35,.37,1.44",8,Sigmoid,0.079780571,0.091983378,-70.87214661,3.6046,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.386147392169638,0.06608111411333084
459,857,huH-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-46,-42,-70,-75,-70,-74,-82","14.6,27.4,11.3,8.74,8.25,2.72,5.93,5.92",8,Sigmoid,0.033712391,0.033526562,-75.34752655,2.7021,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.3954172588043217,0.08130853623151779
460,858,HUP-T3,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,-7.3,4.96,-4.6,-42,-71,-73,-73","9.46,14.4,.66,4.12,5.75,7.44,2.87,5.64",8,Sigmoid,0.229888469,0.300195903,-73.04895782,2.5525,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.2033200074441923,0.5250101685523987
461,859,HuT 78,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","6.71,11.1,-14,9.08,-51,-90,-94,-94","7.72,29.3,24.7,15.9,11.5,3.05,1.73,.52",8,Sigmoid,0.241394043,0.250834763,-92.98352051,3.4997,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.382960871375685,0.6435694098472595
462,860,IA-LM,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","3.62,-1.3,12.4,11.7,-3.4,-29,-29,-51","19.8,6.39,.86,20.6,2.22,9.93,6.89,11.5",8,Sigmoid,0.936279118,8.0,-46.68705368,1.1265,IALM_LUNG,IALM,ACH-000672,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,0.1826109141111374
463,861,IGR-37,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-8.6,-37,-44,-51,-37,-49,-42","2.00,13.8,12.2,1.05,7.26,.84,1.55,3.45",8,Sigmoid,0.020577401,8.0,-44.33883667,3.0876,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,-0.44358402490615845
464,862,IGR-39,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-5.1,-49,-37,-50,-43,-42,-46","5.63,5.43,2.59,6.11,.034,5.65,4.09,1.01",8,Sigmoid,0.014463118,8.0,-44.94340134,2.3156,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,-0.3583472967147827
465,863,IGROV1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-5.6,-9.5,-6.5,-42,-63,-77,-81","4.32,6.70,1.45,.020,14.3,1.83,2.91,1.79",8,Sigmoid,0.409140021,0.491089851,-79.79278564,2.6076,IGROV1_OVARY,IGROV1,ACH-000966,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.7111281720026483,0.10437486320734024
466,864,IMR-32,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-4.9,-23,.51,-1.2,-24,-62,-78","7.95,5.44,3.16,3.56,6.57,13.8,3.37,3.21",8,Sigmoid,1.376783013,1.724061966,-77.77779388,1.7962,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.544683114751014,0.8992897868156433
467,865,IPC-298,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-17,-12,-49,-67,-68,-64,-64","1.19,5.36,5.19,3.86,2.98,3.46,.10,2.13",8,Sigmoid,0.069171287,0.08109536,-65.51959229,3.5373,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.5121295328144067,-0.41014406085014343
468,866,IST-MES2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","8.64,-16,-5.8,-43,-58,-76,-72,-80","1.73,8.95,4.56,8.20,5.94,.52,.66,4.28",8,Sigmoid,0.07066308,0.133910671,-77.29837036,3.4708,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.010582335659048,0.32051074504852295
469,867,J82,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-6.5,-16,-33,-48,-53,-60,-55","8.48,8.57,7.98,5.45,6.89,3.09,11.3,4.44",8,Sigmoid,0.085465223,0.286560714,-55.25733948,2.8006,J82_URINARY_TRACT,J82,ACH-000396,Bladder Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.249804849048049,0.19802990555763245
470,868,JHH-4,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","1.90,10.4,9.33,11.2,4.50,-21,-37,-38","8.48,2.39,21.9,12.8,7.79,5.82,2.12,.65",8,Sigmoid,0.652017474,8.0,-37.58717346,0.8741,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,0.15655067563056946
471,869,JHOS-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","4.62,-4.1,19.8,-13,-54,-57,-52,-58","27.8,8.85,12.2,3.77,11.0,8.26,1.93,3.28",8,Sigmoid,0.089294441,0.145015299,-55.42700195,1.9626,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.93091603178256,0.43975144624710083
472,870,JHUEM-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-2.9,-35,-64,-91,-90,-94,-94","5.45,17.0,6.94,6.83,2.50,1.00,.20,.99",8,Sigmoid,0.056507904,0.04826415,-93.43262482,4.8857,JHUEM2_ENDOMETRIUM,JHUEM2,ACH-000909,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.0310662299419917,-0.059587687253952026
473,871,JM1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.8,-13,-12,-11,19.6,-34,-83,-92","16.6,9.27,13.9,7.39,9.54,1.97,1.16,.73",8,Sigmoid,1.151369452,1.119323969,-91.83315277,2.0988,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.11272490396058266,0.9706894755363464
474,872,JMSU-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,-11,-18,-84,-94,-94,-94,-93","7.75,1.55,9.23,5.05,.73,.13,.86,.12",8,Sigmoid,0.046007138,0.044885039,-93.64517975,4.8463,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.1036507468867067,0.6215085387229919
475,873,JURKAT,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,-9.2,3.63,-2.6,-7.6,-47,-88,-89","5.31,9.31,10.6,6.70,13.0,14.5,.90,.31",8,Sigmoid,0.795484781,0.829291582,-89.33007813,3.0827,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.18718345830602895,0.8863548636436462
476,874,JVM-3,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-4.9,-14,-47,-86,-89,-93,-92","26.2,11.4,3.95,23.8,1.09,1.33,.33,.52",8,Sigmoid,0.073130772,0.076346688,-91.87243652,5.1094,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.572470627433252,1.1978833675384521
477,875,K029AX,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,-1.1,-8.4,-46,-53,-62,-60,-62","19.9,10.7,1.68,7.06,1.64,6.09,1.21,.38",8,Sigmoid,0.045011476,0.119215205,-60.1853714,2.73,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.1268249737609777,-0.5475048422813416
478,876,KALS-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,1.50,-8.3,-49,-60,-74,-76,-74","17.9,4.66,4.66,1.73,4.83,.77,1.21,1.12",8,Sigmoid,0.058672283,0.089755602,-73.72459412,3.853,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.4106648357343623,0.35225242376327515
479,877,KARPAS-422,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","25.7,7.17,5.66,-17,-60,-71,-78,-83","2.85,5.28,16.5,12.1,8.29,7.49,1.14,4.37",8,Sigmoid,0.102951385,0.204620793,-81.34395599,3.0913,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.5865968030623598,0.9759830832481384
480,878,KASUMI-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,-16,-48,-69,-75,-76,-74,-76","1.96,2.85,3.03,6.10,1.34,3.19,.059,1.04",8,Sigmoid,0.01727682,0.027120752,-75.48740387,4.3846,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.607456087680804,0.8232923150062561
481,879,KCL-22,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-15,-7.7,-37,-83,-91,-93,-93","1.86,10.5,24.1,6.16,.82,.49,.41,.36",8,Sigmoid,0.116775215,0.10770423,-92.41072083,4.7185,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.22836641982505,0.7778359651565552
482,880,KG-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-28,-15,-4.5,23.8,-9.0,-75,-84","5.42,30.6,18.7,20.1,15.5,12.0,.38,1.44",8,Linear,,0.047090092,-89.82595062,2.3487,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.0556926610229125,1.143190860748291
483,881,KHM-1B,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-.69,7.54,-5.3,-17,-65,-68,-76,-77","23.1,9.23,1.49,6.17,2.87,5.78,3.79,5.04",8,Sigmoid,0.120064072,0.167679474,-74.99288177,3.4416,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.7857010147818608,0.88362056016922
484,882,KMBC-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-12,-15,-68,-94,-94,-94,-94","3.24,2.74,5.09,1.15,.23,.39,1.30,.54",8,Sigmoid,0.063914657,0.061397079,-93.87311554,4.2994,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.7903930182505876,0.49254465103149414
485,883,KMM-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-3.9,18.3,-11,-66,-81,-83,-85","6.13,8.81,50.3,8.41,.60,1.95,2.50,2.58",8,Sigmoid,0.174300954,0.190332726,-83.13102722,3.5771,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.6589815488924973,0.999346911907196
486,884,KMRC-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-1.4,-8.9,2.90,-40,-47,-68,-64","7.34,7.13,8.71,10.2,12.7,.13,.046,7.51",8,Sigmoid,0.230306476,0.309771448,-60.01463318,2.7651,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.1719205179322136,0.4776979684829712
487,885,KMRC-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","11.5,-7.8,-1.2,-16,-14,-35,-52,-52","34.6,12.1,4.32,32.3,22.8,8.13,8.53,5.71",8,Sigmoid,0.584067166,2.275416613,-52.70366669,2.2171,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.8221631622306925,-0.13207074999809265
488,886,KMS-11,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,-4.1,-43,-75,-92,-91,-92,-91","5.88,3.41,8.79,.27,.53,1.04,.46,1.60",8,Sigmoid,0.031390667,0.033564694,-91.73921204,5.4708,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.3942805382723353,0.9255703091621399
489,887,KMS-12-BM,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","13.3,2.75,-12,-42,-63,-88,-91,-91","23.4,1.08,40.7,10.7,5.61,.97,.36,1.42",8,Sigmoid,0.101396866,0.124920338,-91.97840881,4.355,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.0800790408392515,0.9824722409248352
490,888,KMS-34,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,25.5,.84,-16,-69,-82,-90,-91","6.20,39.9,5.95,11.8,4.16,3.45,1.76,.35",8,Sigmoid,0.15605475,0.171445847,-88.56306458,3.5192,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.7634878231720672,1.1782782077789307
491,889,KNS-60,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-6.9,-10.0,-66,-73,-87,-87,-90","1.51,7.38,21.9,12.4,11.4,2.46,2.87,1.59",8,Sigmoid,0.052857235,0.055461988,-87.19047546,4.1338,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.8920573937824194,0.18416902422904968
492,890,KNS-62,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-50,-38,-16,3.59,-35,-66,-81,-87","31.3,14.3,37.6,7.43,15.4,4.28,.047,4.26",8,Sigmoid,0.711982965,0.576808989,-84.32296753,3.6717,KNS62_LUNG,KNS62,ACH-000858,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.550244108874856,-0.2635517418384552
493,891,KNS-81,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,6.24,6.10,-1.1,-51,-46,-54,-56","8.21,.86,22.3,4.99,4.40,2.73,5.85,.99",8,Sigmoid,0.141654119,0.257104039,-52.5506897,2.0891,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.3582744549931625,0.5227906703948975
494,892,KO52,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,-4.6,1.77,13.5,11.4,-66,-77,-77","15.8,2.14,16.2,.042,4.71,5.30,.29,3.86",8,Sigmoid,0.56580466,0.652886987,-77.08110809,2.6941,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.4263512320649103,1.0306854248046875
495,893,KP-N-SI9s,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-14,.34,-48,-90,-94,-94,-94","15.0,8.71,2.06,21.3,1.05,.59,.28,.24",8,Sigmoid,0.082486682,0.082642227,-93.05713654,4.6858,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.4932345063247507,0.43239253759384155
496,894,KU812,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-4.5,-8.7,-31,-77,-94,-94,-94","5.31,7.83,11.6,6.04,2.04,1.12,1.37,.14",8,Sigmoid,0.136492729,0.129609898,-94.11627197,3.8223,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.0432261245234766,1.0161268711090088
497,895,KYM-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-11,11.5,-40,-82,-86,-86,-87","26.3,7.34,11.8,1.67,1.49,.71,1.34,1.34",8,Sigmoid,0.083218895,0.088494658,-85.3950119,4.1346,KYM1_SOFT_TISSUE,KYM1,ACH-000607,Rhabdoid,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.4248130903720075,-0.30575141310691833
498,896,KYSE-140,17-AAG,HSP90,".025,.080,.25,.80,2.53,8","2.76,7.61,-3.3,-44,-70,-79","6.24,4.18,10.3,14.5,5.10,.27",6,Sigmoid,0.685912013,0.961978316,-77.78546143,1.6901,KYSE140_OESOPHAGUS,KYSE140,ACH-000823,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.038763369111012844,0.33523327112197876
499,897,KYSE-150,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,-7.4,.94,-51,-58,-75,-73,-79","1.13,6.48,.34,17.6,1.72,2.47,2.76,4.38",8,Sigmoid,0.070753358,0.080904983,-73.28972626,3.8432,KYSE150_OESOPHAGUS,KYSE150,ACH-000855,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.5144798622533715,0.535077691078186
500,898,KYSE-180,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-17,-10,-56,-86,-90,-92,-92","5.68,9.87,.39,17.4,.11,.31,.16,.54",8,Sigmoid,0.078485474,0.075374797,-89.97319794,4.5305,KYSE180_OESOPHAGUS,KYSE180,ACH-000693,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.5852823171390775,0.1623561680316925
501,899,KYSE-30,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,-2.4,-10,.59,-1.7,-49,-88,-92","7.91,9.46,4.15,4.56,6.41,2.55,2.28,.17",8,Sigmoid,0.78889209,0.811484754,-90.08290863,2.8684,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.2088896796346611,0.49061840772628784
502,900,KYSE-510,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,.92,-1.00,-2.2,-81,-89,-93,-93","4.21,8.15,3.77,6.06,.80,.066,.20,1.22",8,Sigmoid,0.170953944,0.175444975,-91.58558655,3.7623,KYSE510_OESOPHAGUS,KYSE510,ACH-000824,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.7404298180014224,0.17776086926460266
503,901,KYSE-520,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-13,-20,-49,-78,-81,-83,-81","19.1,4.10,1.71,4.04,2.31,3.47,.39,.22",8,Sigmoid,0.073731884,0.079899609,-82.28026581,4.248,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.526984319838903,0.27637556195259094
504,902,KYSE-70,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.6,-.90,-24,-60,-64,-80,-79,-81","2.13,.22,6.42,.55,3.71,.73,2.22,.081",8,Sigmoid,0.044722799,0.060356256,-78.51622009,4.2296,KYSE70_OESOPHAGUS,KYSE70,ACH-000784,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.8074906748392965,0.2665030360221863
505,903,L3.3,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.6,-6.0,-13,-34,-63,-57,-65,-61","9.13,10.0,7.49,23.6,7.06,1.97,3.93,1.56",8,Sigmoid,0.047479793,0.157320872,-59.69362259,3.2074,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.849467788591276,0.5333321690559387
506,904,L-363,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","6.86,11.2,-58,-87,-88,-92,-93,-92","20.6,4.87,5.32,1.50,1.08,.13,.20,.048",8,Sigmoid,0.021598894,0.023713689,-90.38772583,5.0957,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.7417028026480943,1.0186957120895386
507,905,L-428,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-9.9,-9.9,-9.1,-18,-32,-71,-77","5.70,7.56,5.68,2.84,13.6,2.32,.29,.58",8,Sigmoid,1.081503272,1.254022121,-77.25272369,2.9575,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.22635608240601698,0.8308956623077393
508,906,LCLC-103H,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-14,-17,-18,-19,-42,-39,-68",".21,5.95,12.4,13.0,17.3,4.05,8.58,8.06",8,Sigmoid,8.512794803,3.666449308,-66.96501923,2.8339,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,1.29922370273679,0.03198518604040146
509,907,LN-229,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,2.50,-19,-59,-75,-74,-76,-76","3.84,5.40,11.6,7.77,2.08,4.16,3.23,2.65",8,Sigmoid,0.046719469,0.061167378,-75.60999298,4.0027,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.7941412707954503,-0.34465718269348145
510,908,LOU-NH91,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,3.99,-42,-40,-39,-25,-54,-42","11.0,.050,9.49,.47,11.6,19.2,2.41,10.6",8,Sigmoid,0.015238421,8.0,-43.23075485,2.6406,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,-0.08978227525949478
511,909,LOX IMVI,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-6.1,-3.9,-3.3,-80,-95,-96,-95","3.02,1.30,2.97,2.87,1.83,.19,.072,.14",8,Sigmoid,0.186254472,0.18541798,-95.39637756,4.0766,LOXIMVI_SKIN,LOXIMVI,ACH-000750,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.6851426510488146,-0.3145277500152588
512,910,LP-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-.90,18.6,12.0,-8.4,-31,-54,-55,-65","26.0,58.7,34.9,46.1,11.7,12.9,8.01,3.27",8,Sigmoid,0.295196176,0.610796988,-61.16102982,3.2781,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.49299063688753925,1.321702480316162
513,911,LS123,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-10,11.4,7.14,-38,-47,-52,-65","17.0,10.5,13.1,10.6,26.6,11.1,6.03,.70",8,Sigmoid,0.220570996,0.349257827,-54.89951706,2.3211,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.0519448702157277,0.2461223006248474
514,912,LS411N,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-29,6.97,-48,-89,-91,-92,-93","7.29,30.3,5.42,18.6,2.54,.44,1.32,.0018",8,Sigmoid,0.078610569,0.081793495,-91.19625092,4.496,LS411N_LARGE_INTESTINE,LS411N,ACH-000985,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.503557561762959,0.16790147125720978
515,913,LS513,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.4,-3.6,-45,-55,-78,-91,-93,-93","20.0,23.8,5.40,24.0,21.1,1.63,1.13,.67",8,Sigmoid,0.019685648,0.029090017,-93.87889862,4.3214,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.537360222081935,0.2926326394081116
516,914,LU99,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-17,-16,-85,-94,-95,-96,-95","6.67,10.6,3.08,.98,.24,.39,1.32,.29",8,Sigmoid,0.056266502,0.052298609,-94.99398804,5.2031,LU99_LUNG,LU99,ACH-000444,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.950785504823272,-0.1621897667646408
517,915,LUDLU-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-.58,-15,-69,-61,-67,-69,-73","4.37,23.6,9.46,8.51,1.08,5.58,5.15,3.16",8,Sigmoid,0.042109817,0.048696097,-68.19195557,3.2861,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.02215639584244,0.6005449891090393
518,916,Malme-3M,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-8.1,-10,-38,-76,-78,-79,-78","25.4,23.4,7.74,9.15,1.97,.95,.35,1.40",8,Sigmoid,0.069563471,0.090723187,-78.71881866,3.6466,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.399942309549195,-0.3004024028778076
519,917,MCAS,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.8,-6.8,-8.4,-50,-71,-78,-78,-77","4.50,1.09,5.96,11.6,1.85,3.83,1.62,4.46",8,Sigmoid,0.10287384,0.072973058,-75.85829163,3.6897,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.617664974449435,0.2681959867477417
520,918,MCF7,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-41,-6.2,-33,-12,-89,-69,-99,-81","16.4,54.9,27.0,4.75,15.3,11.5,2.30,14.4",8,Linear,,0.01876104,-88.48046875,2.2316,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.9759728998404245,0.7692030072212219
521,919,MDA-MB-157,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,23.7,-6.9,-14,-24,-5.6,-33,11.6","7.18,13.7,28.5,5.76,6.83,.56,7.40,2.18",8,Constant,,8.0,-8.078001022,0.8792,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,0.3015519082546234
522,920,MDA-MB-175-VII,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","10.2,1.44,-42,-62,-61,-60,-69,-62","9.21,8.75,6.57,9.56,4.64,11.0,2.14,10.9",8,Sigmoid,0.017604515,0.032827336,-63.1816864,3.1627,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.416493696055032,0.9014464020729065
523,921,MDA-MB-415,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-8.5,-69,-77,-84,-85,-92,-85","23.8,39.1,3.00,1.70,.60,10.2,15.2,1.23",8,Sigmoid,0.0206032,0.018407384,-82.0868454,3.8425,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.9950033905204245,0.5335716009140015
524,922,MDA-MB-436,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,8.65,-14,-31,-45,-44,-47,-45","9.15,2.45,5.88,1.08,10.6,3.87,8.74,6.10",8,Sigmoid,0.041530512,8.0,-45.43484497,2.2556,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,0.24361711740493774
525,923,MDA-MB-453,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-32,-5.2,-80,-96,-98,-97,-96,-95","4.71,2.28,1.43,.91,1.19,.24,.26,.14",8,Sigmoid,0.01410364,0.015530476,-96.45956421,5.5367,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-4.164950991937101,1.2081332206726074
526,924,MDA-MB-468,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","1.27,8.78,-8.7,-8.3,-30,-60,-56,-59","27.3,14.5,8.03,.17,10.4,6.78,1.66,3.68",8,Sigmoid,0.265800059,0.367030263,-58.30907059,2.575,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.0023109738367828,0.9149979948997498
527,925,MEG-01,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-9.1,2.77,-14,-17,-41,-75,-89","17.9,8.93,4.11,29.8,8.65,2.84,3.41,1.94",8,Sigmoid,0.97806257,1.050176263,-89.50341797,2.6177,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.04895801960472968,0.9095685482025146
528,926,MEL-HO,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-7.7,-6.0,-12,-49,-44,-46,-52","17.4,4.44,8.30,2.83,8.89,3.76,8.93,1.74",8,Sigmoid,0.115499377,8.0,-48.0657692,2.0796,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,-0.8706898093223572
529,927,MES-SA,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,-2.6,-19,-90,-94,-94,-94,-93","5.88,6.47,4.08,.45,.71,.36,.26,.044",8,Sigmoid,0.037581444,0.037811786,-93.51750946,4.9795,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.2751344260139845,-0.0015769470483064651
530,928,MeWo,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-.30,-26,-8.8,-13,-26,-14,-39,-28","14.0,11.1,1.12,.55,16.8,20.5,4.79,12.4",8,Constant,,8.0,-16.81283951,2.3806,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,-0.23867757618427277
531,929,MFE-296,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-32,-11,8.50,-2.4,-43,-71,-86,-87","4.17,5.53,16.6,3.32,3.49,2.37,1.38,.98",8,Sigmoid,0.287810951,0.328074843,-85.42443848,2.9064,MFE296_ENDOMETRIUM,MFE296,ACH-000879,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.1145135167490134,0.01510387472808361
532,930,MG-63,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-12,-2.5,-2.2,-9.9,-49,-63,-65","2.64,1.23,1.44,1.17,2.36,2.30,4.13,4.71",8,Sigmoid,0.592983723,0.814632237,-64.45409393,1.3119,MG63_BONE,MG63,ACH-000359,Bone Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.205018510526795,-0.04675270617008209
533,931,Mino,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-40,-27,-56,-81,-95,-95,-95","14.3,24.3,10.8,17.4,3.91,.70,.012,.47",8,Sigmoid,0.122465871,0.081997298,-95.59487152,4.9855,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.5010689834802995,1.26776123046875
534,932,MJ,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,17.9,-13,-38,-88,-94,-96,-95","19.1,8.12,14.7,3.66,.97,.12,.055,1.71",8,Sigmoid,0.085055649,0.097161315,-95.92569733,4.5197,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.3313826405634677,0.742144763469696
535,933,MKN-45,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,.72,-77,-85,-88,-86,-86,-88","8.93,12.6,6.35,5.63,2.24,4.98,1.00,3.47",8,Sigmoid,0.017321344,0.017859768,-86.69085693,5.2123,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-4.0252046935397665,0.6752869486808777
536,934,MKN7,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","4.74,-17,-32,-31,-10,-40,-54,-62","27.4,11.8,54.5,14.4,17.2,3.07,15.9,5.72",8,Sigmoid,0.761752009,0.996641457,-59.11095428,2.6606,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.003364195565345895,0.4855523705482483
537,935,MKN74,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-9.5,-26,-32,-59,-57,-65,-70","1.33,6.04,2.48,16.3,3.35,17.7,6.76,8.34",8,Sigmoid,0.137193099,0.169060647,-65.80508423,3.2581,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.7774977704450254,0.08729325979948044
538,936,MOLP-8,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,2.38,.70,-6.3,-40,-78,-90,-88","13.3,5.54,15.6,21.6,1.14,13.7,.18,4.18",8,Sigmoid,0.295536757,0.323331714,-88.96504974,3.7225,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.1290765044127822,0.9815165400505066
539,937,MOLT-16,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","9.26,3.07,-3.8,-3.0,-41,-59,-88,-90","18.4,14.9,21.3,10.1,11.0,4.57,.91,1.08",8,Sigmoid,0.362071663,0.447354048,-91.90317535,3.3586,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.8044049441862849,0.6560669541358948
540,938,MONO-MAC-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-34,-66,-87,-92,-93,-93,-93","13.6,14.5,2.11,2.08,.12,.024,.56,.11",8,Sigmoid,0.015440387,0.014459794,-93.5515976,6.104,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-4.2363833085494,1.015810489654541
541,939,MOR/CPR,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,-34,-7.0,-23,-71,-83,-85,-85","18.6,3.19,2.35,47.1,9.00,.37,.72,5.21",8,Sigmoid,0.074916176,0.076338477,-81.71883392,3.875,MORCPR_LUNG,MORCPR,ACH-000851,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.5725781820867497,0.3759458065032959
542,940,MSTO-211H,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-5.0,-6.6,-28,-59,-81,-90,-93","13.5,5.38,8.14,7.65,3.65,.044,1.87,1.47",8,Sigmoid,0.186413318,0.190373659,-92.20284271,3.6676,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.658766511783741,0.23971709609031677
543,941,NCI-H1048,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.8,-25,-21,-74,-89,-88,-88,-89","7.52,15.1,9.59,7.61,.56,1.19,.069,.61",8,Sigmoid,0.048311025,0.048622094,-88.72504425,4.7653,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.0236772423255798,0.7784532904624939
544,942,NCI-H1092,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","4.17,-9.0,-9.9,13.1,4.50,-15,-38,-50","3.37,5.33,23.5,24.4,16.9,15.0,23.7,5.22",8,Sigmoid,1.29968071,8.0,-49.70415115,1.0754,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,1.7684962749481201
545,943,NCI-H1155,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-22,-3.4,-33,-77,-82,-85,-86","18.6,26.5,21.2,14.0,.39,4.44,.39,2.12",8,Sigmoid,0.111736611,0.117387019,-84.95707703,3.8781,NCIH1155_LUNG,NCIH1155,ACH-000980,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.142278948399998,0.9052065014839172
546,944,NCI-H1184,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","24.6,115,9.06,-23,-9.5,-68,-89,-90","20.2,108,18.7,.039,56.5,26.0,.57,.94",8,Sigmoid,0.103519626,0.230962545,-90.86921692,3.0332,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.4654997244640606,1.582730770111084
547,945,NCI-H1341,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-23,-66,-79,-81,-80,-86,-88",".24,21.6,3.76,4.20,13.2,2.90,5.22,.11",8,Sigmoid,0.014267176,0.01379581,-84.28817749,5.2972,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-4.283390356110236,0.6616729497909546
548,946,NCI-H1373,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-19,-19,-56,-63,-67,-67,-68","3.63,7.74,4.03,11.5,.13,1.79,5.71,1.61",8,Sigmoid,0.053046115,0.067688048,-66.29280853,3.7468,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.6928456582241527,0.19812189042568207
549,947,NCI-H1568,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","8.02,-2.0,-4.8,27.6,-30,-45,-43,-37","13.4,9.08,3.26,12.6,10.8,5.18,3.91,.043",8,Sigmoid,0.210890979,8.0,-41.82129288,1.527,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,0.6639240384101868
550,948,NCI-H1648,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-6.4,-3.6,-22,-41,-28,-45,-33","8.88,11.3,14.1,7.04,.34,.97,6.94,10.5",8,Sigmoid,0.085443236,8.0,-37.01711655,1.8947,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,0.4608135223388672
551,949,NCI-H1650,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.8,-5.0,-43,-73,-79,-78,-82,-82","9.94,.060,2.51,.81,1.66,2.37,.67,2.68",8,Sigmoid,0.02402693,0.030661542,-79.96678925,4.5681,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.4847461132610724,0.581189751625061
552,950,NCI-H1651,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,2.27,.28,-20,-36,-64,-64,-71","17.9,2.51,16.9,9.88,23.5,1.10,2.21,4.22",8,Sigmoid,0.129097909,0.243237942,-67.75559235,2.669,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.4137151295454977,0.5361056327819824
553,951,NCI-H1792,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-7.4,-24,-40,-80,-90,-91,-90","4.18,4.44,4.85,2.64,.74,.89,.22,1.11",8,Sigmoid,0.113282129,0.103014566,-90.76078796,4.2291,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.2728848832752817,0.4305182099342346
554,952,NCI-H1793,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,1.29,-12,-35,-47,-56,-55,-52","9.62,13.8,6.70,22.1,15.7,12.0,7.42,15.3",8,Sigmoid,0.071522288,0.238597125,-53.82111359,1.6359,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.4329788188460717,0.2186223566532135
555,953,NCI-H1915,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-5.3,-35,-83,-94,-94,-96,-95","3.20,6.97,5.12,.77,.50,.73,.20,.12",8,Sigmoid,0.036156192,0.035393722,-94.75389862,5.2552,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.3412208192025954,-0.12400320917367935
556,954,NCI-H1944,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-18,-49,-92,-111,-111,-111,-111","1.95,1.24,19.8,5.81,4.32,2.77,.17,3.97",8,Sigmoid,0.033754427,0.026266662,-111.3378601,4.244,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.6394547484514037,0.2664337456226349
557,955,NCI-H1975,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-2.4,-30,-57,-79,-79,-80,-78","5.72,4.87,9.40,10.4,2.10,1.28,1.34,.58",8,Sigmoid,0.053103231,0.055695072,-79.07965088,3.3781,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.887863609930635,0.08676134049892426
558,956,NCI-H2009,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,-15,-1.5,-30,-58,-77,-83,-84","6.19,5.65,7.15,4.35,4.84,6.90,2.06,3.09",8,Sigmoid,0.166794598,0.188103288,-83.57317352,3.6954,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.670764062764131,-0.016542481258511543
559,957,NCI-H2023,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,-15,-36,-69,-64,-68,-73,-72","19.8,6.43,28.5,4.08,.053,.96,2.67,1.68",8,Sigmoid,0.021053601,0.023395276,-69.2872467,3.4569,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.755221157340941,0.34091633558273315
560,958,NCI-H2030,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-47,-15,-21,-72,-83,-85,-85,-85","57.4,1.85,5.89,1.67,2.16,.81,.90,1.01",8,Sigmoid,0.047699604,0.04906629,-84.56704712,4.9167,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.0145830380153713,0.3333548307418823
561,959,NCI-H2052,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,-3.1,-8.6,-14,-53,-73,-77,-81","3.55,.41,.80,4.31,1.21,2.48,4.36,2.34",8,Sigmoid,0.193890542,0.238069907,-78.48151398,2.8877,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.435190921549204,0.36862465739250183
562,960,NCI-H2085,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.4,-3.6,-4.3,14.0,-27,-46,-73,-64","13.4,9.63,9.09,7.54,3.65,.73,1.60,1.49",8,Sigmoid,0.435018092,0.761869073,-68.18983459,2.2438,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.2719805582682479,0.9206957817077637
563,961,NCI-H2087,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-2.9,-26,-48,-52,-46,-55,-52",".55,1.11,8.97,6.05,6.14,1.91,1.81,4.56",8,Sigmoid,0.027897216,0.064093605,-50.61772919,3.0497,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.74741068602311,0.3563254773616791
564,962,NCI-H211,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","4.51,12.3,-18,-38,-70,-64,-68,-71","21.5,21.5,6.12,5.49,6.52,3.35,2.74,2.91",8,Sigmoid,0.021893905,0.125717342,-66.07949066,3.2255,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.073719209497078,1.4706306457519531
565,963,NCI-H2122,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-21,-47,-98,-100,-98,-100,-102","27.5,14.5,4.62,4.07,.40,1.99,.45,.90",8,Sigmoid,0.031530607,0.026409486,-99.93881226,4.996,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.634032015187367,-0.3038319945335388
566,964,NCI-H2170,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-24,-67,-73,-69,-70,-74,-68","11.9,6.84,.57,.41,2.89,4.39,.98,5.83",8,Sigmoid,0.013836415,0.015281511,-71.0229187,4.5194,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-4.181111612698248,0.6134792566299438
567,965,NCI-H2172,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-37,4.55,6.34,20.3,-117,-169,-239,-181","28.3,6.11,10.4,38.0,25.7,41.2,35.5,54.9",8,Linear,,0.005899465,-227.1256561,1.7525,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-5.13289361014806,0.5667331218719482
568,966,NCI-H2228,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,17.3,-8.9,-38,-68,-66,-76,-76","3.27,9.50,4.43,.97,2.34,.089,2.76,2.60",8,Sigmoid,0.07676471,0.113416389,-73.6834259,2.7224,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.176689374321521,0.21347105503082275
569,967,NCI-H2286,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,-6.7,-36,-80,-91,-91,-91,-91","6.35,.53,.82,2.28,.42,.51,.37,.47",8,Sigmoid,0.032796428,0.034514762,-91.39285278,5.2895,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.366368162403131,0.07451361417770386
570,968,NCI-H23,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,4.99,-28,-68,-84,-85,-84,-84","17.7,5.62,9.63,5.32,.88,.96,3.41,.90",8,Sigmoid,0.036011036,0.046550732,-84.58200836,4.2066,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.067212550355845,0.3937476575374603
571,969,NCI-H2444,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-1.0,6.73,-3.9,-49,-48,-65,-63","26.3,11.7,10.1,23.9,3.56,7.84,3.00,8.74",8,Sigmoid,0.155316696,0.268049806,-59.72573471,2.3125,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.3165824724544222,0.4816156029701233
572,970,NCI-H2452,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,6.09,-11,-25,-69,-82,-88,-84","3.15,5.48,10.5,7.35,.19,3.38,.28,2.24",8,Sigmoid,0.125031874,0.147931322,-85.44950867,3.558,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.9110071534586937,0.38954317569732666
573,971,NCI-H28,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,-18,-16,-42,-56,-61,-60,-67","8.58,5.64,7.16,8.57,.15,.75,1.01,5.10",8,Sigmoid,0.078077309,0.148407042,-61.61209488,3.0959,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.9077964965445182,0.15787938237190247
574,972,NCI-H322,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-16,-54,-75,-82,-82,-82,-84","4.69,.74,5.90,.61,3.04,.86,.11,.49",8,Sigmoid,0.023800675,0.024739213,-81.85693359,3.9905,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.69936572335643,0.8669722676277161
575,973,NCI-H3255,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-11,-8.2,-51,-54,-59,-53,-63","2.98,1.24,7.07,12.1,7.59,6.35,2.55,8.19",8,Sigmoid,0.055714834,0.078972206,-56.91324234,2.8736,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.5386593112040816,0.2740974426269531
576,974,NCI-H358,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,-6.3,-11,-51,-56,-54,-57,-60","1.73,3.82,7.77,1.45,2.13,3.03,5.76,6.50",8,Sigmoid,0.047353089,0.07596647,-56.561306,2.9418,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.5774632202567203,0.5790878534317017
577,975,NCI-H441,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-4.4,-15,-32,-53,-51,-54,-58","10.6,7.84,10.5,1.09,1.50,4.36,.26,2.76",8,Sigmoid,0.08181905,0.170633957,-54.96196365,2.8905,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.7682346191826444,0.0874318853020668
578,976,NCI-H460,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,2.80,-7.0,-65,-93,-94,-96,-95","4.09,1.04,6.55,3.05,1.04,1.24,2.03,1.27",8,Sigmoid,0.061524644,0.0637509,-94.74355316,4.2751,NCIH460_LUNG,NCIH460,ACH-000463,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.7527719773961956,0.10327465087175369
579,977,NCI-H522,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-10,-29,-34,-56,-57,-65,-61","17.9,33.0,3.39,24.9,9.41,.48,5.21,.85",8,Sigmoid,0.071027406,0.079639822,-60.44155502,3.5106,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.5302410348463993,0.6937986016273499
580,978,NCI-H647,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-18,1.98,-32,-67,-74,-77,-83","28.4,1.59,34.5,13.7,7.23,.55,4.54,4.47",8,Sigmoid,0.144128844,0.146558329,-78.72703552,3.1829,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.9203317795951134,0.13652260601520538
581,979,NCI-H650,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-7.7,2.96,-16,-44,-79,-96,-97",".26,2.77,9.41,1.09,4.65,4.64,.83,.35",8,Sigmoid,0.326179266,0.306331158,-97.09456635,3.3292,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.1830885465167265,0.1188136413693428
582,980,NCI-H661,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","1.05,.62,7.30,-7.3,-5.8,-25,-41,-46","2.46,4.87,1.31,13.8,4.56,15.9,23.2,8.34",8,Sigmoid,0.2876734,8.0,-40.23322678,1.1851,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,0.40766894817352295
583,981,NCI-H727,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-12,-2.6,-3.9,-41,-40,-49,-46","13.9,4.08,20.6,21.7,4.35,25.2,15.1,19.3",8,Sigmoid,0.186604857,0.347080976,-59.24023438,2.1313,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.0581971660289937,0.4530102610588074
584,982,NCI-H747,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-13,-18,-49,-73,-73,-80,-78","1.70,2.39,5.56,7.89,2.86,1.54,3.73,.0035",8,Sigmoid,0.076768719,0.084120333,-76.63079834,4.1782,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.4755069695249454,0.30098801851272583
585,983,NCI-H810,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-2.9,-3.3,5.66,-17,-32,-42,-43","10.7,4.01,5.36,5.15,4.94,1.22,1.47,5.83",8,Sigmoid,0.395941019,8.0,-43.36346436,1.5995,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,1.3952748775482178
586,984,NCI-N87,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,-54,-85,-87,-86,-86,-87,-89","20.6,9.38,3.71,2.84,.20,.74,.23,.44",8,Sigmoid,0.01171113,0.006280354,-87.03778839,6.109,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-5.070328930663974,0.19985859096050262
587,985,NCO2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,-11,15.8,-26,-85,-91,-93,-93","10.5,9.52,22.0,.58,.88,.16,1.84,1.30",8,Sigmoid,0.112682417,0.117010742,-92.43540192,4.4584,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.1454895364330295,0.8091452717781067
588,986,NIH:OVCAR-3,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,-14,21.3,5.23,-52,-53,-49,-65","9.99,11.7,8.48,12.6,3.26,3.68,10.9,3.63",8,Sigmoid,0.163058758,0.245931864,-56.42448425,2.8123,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.4027007570243588,0.4666226804256439
589,987,NUGC-3,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-13,-2.6,-60,-69,-79,-83,-81","14.5,31.6,25.6,5.97,1.34,.85,2.76,1.87",8,Sigmoid,0.040484954,0.061240714,-79.87059021,4.1622,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.7929430492142453,0.00325617752969265
590,988,NUGC-4,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-7.7,-66,-77,-78,-74,-78,-78","3.85,1.42,.64,.17,3.37,.69,.39,3.26",8,Sigmoid,0.018131483,0.019910261,-76.89723969,4.9358,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.916520052001497,0.6050329804420471
591,989,OCI-AML2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,-4.0,-5.5,-39,-96,-96,-95,-95",".52,1.76,5.46,6.31,.18,.020,.19,.013",8,Sigmoid,0.089344054,0.088610291,-95.66188812,4.2295,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.4235072768746,0.46049630641937256
592,990,OCI-AML5,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-12,-5.2,-4.9,-43,-79,-89,-89","3.76,6.69,.15,8.63,1.33,3.58,2.69,.093",8,Sigmoid,0.296931773,0.305264801,-88.54528046,3.5381,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.186575679042346,0.27454665303230286
593,991,OCUM-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,11.6,-19,-75,-90,-92,-93,-92","18.8,6.26,9.01,11.1,3.84,.016,.50,1.06",8,Sigmoid,0.040542003,0.046381559,-92.1137619,4.7362,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.0708533340931137,-0.18990591168403625
594,992,OE21,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","6.82,-30,-3.7,-38,-68,-71,-76,-73","22.3,31.1,11.7,2.55,2.05,1.65,5.32,2.01",8,Sigmoid,0.085482724,0.112160243,-72.73395538,3.2699,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.1878266891504152,-0.008320966735482216
595,993,OE33,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-9.8,-31,-58,-79,-80,-81,-81","8.77,5.88,16.3,12.0,1.59,.83,1.42,2.70",8,Sigmoid,0.056656875,0.058549874,-80.17546082,4.7147,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.837876340947558,0.3364827632904053
596,994,ONCO-DG-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-8.3,1.11,2.91,-69,-75,-78,-81","5.55,2.47,5.82,7.61,22.7,6.49,8.14,3.21",8,Sigmoid,0.190539032,0.212087214,-78.1412735,3.252,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.550757702114018,0.5365557670593262
597,995,ONS-76,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,-2.1,-1.3,11.5,-3.3,-25,-63,-75","12.0,.78,4.65,3.44,6.88,4.82,2.50,.18",8,Sigmoid,1.118956089,1.565893888,-74.45502472,1.904,ONS76_CENTRAL_NERVOUS_SYSTEM,ONS76,ACH-000776,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.4484568353749769,0.4013747572898865
598,996,OPM-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-30,-23,6.42,-15,-63,-82,-82","14.7,4.71,2.54,11.6,8.37,1.77,.72,1.00",8,Sigmoid,0.688126922,0.666394174,-82.38972473,3.1534,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.4058739306647188,1.2466750144958496
599,997,OV-90,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-.44,-3.6,-69,-75,-80,-80,-77,-85","1.05,2.38,3.36,4.10,.69,1.42,6.08,.18",8,Sigmoid,0.01654092,0.018589249,-79.92575836,4.5708,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.985171876128283,0.18779215216636658
600,998,OVCAR-4,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,-1.5,-1.9,-8.0,-33,-64,-73,-79","3.67,2.38,.029,2.20,5.62,1.91,4.71,.18",8,Sigmoid,0.333466411,0.459155321,-77.77867889,2.2591,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.7783667361843543,0.5928286910057068
601,999,OVCAR-8,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,3.66,-6.3,-2.2,-90,-93,-93,-93","11.3,2.40,6.64,.89,.19,.31,.037,.35",8,Sigmoid,0.140891612,0.146128953,-93.4610672,4.0967,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.9232658073744566,0.47105515003204346
602,1000,OVMANA,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","2.42,3.24,1.57,2.14,-18,-75,-74,-71","5.26,3.09,2.73,7.49,3.27,4.77,10.3,5.88",8,Sigmoid,0.31143108,0.364703447,-73.7845459,2.7475,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.0086707296081106,-0.03880952298641205
603,1001,OVSAHO,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.2,-4.2,-3.4,-8.6,-5.9,-6.8,-36,-61","3.33,5.15,2.75,11.5,12.6,13.6,5.02,5.90",8,Sigmoid,2.416357279,3.464982748,-61.44053268,1.3862,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,1.2427076536972927,0.987479031085968
604,1002,OVTOKO,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,1.10,-3.7,.53,-26,-48,-61,-65","1.61,.14,.77,3.76,3.32,5.19,2.16,3.89",8,Sigmoid,0.38511458,0.805820227,-64.09789276,2.0471,OVTOKO_OVARY,OVTOKO,ACH-000663,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.21589460477771025,-0.16991962492465973
605,1003,P12-ICHIKAWA,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-5.4,-3.3,.55,-24,-60,-84,-89","10.1,4.50,2.30,2.72,3.86,2.26,.048,1.26",8,Sigmoid,0.539912045,0.594166398,-88.35444641,2.6965,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.520595867535811,0.810579240322113
606,1004,P31/FUJ,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-.038,-8.1,-4.5,-12,-71,-92,-95","6.02,7.68,5.46,9.26,15.7,3.02,.096,.16",8,Sigmoid,0.540682316,0.549713969,-93.76567841,2.6454,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.5983571923954704,0.9128411412239075
607,1005,P3HR-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,2.79,-21,9.32,-14,-34,-80,-82",".34,2.11,6.87,17.5,19.3,7.83,1.25,.23",8,Sigmoid,0.977119565,1.020657063,-81.94581604,2.5398,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.020446599313448575,1.405738353729248
608,1006,Panc 02.03,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,5.63,2.91,-48,-77,-76,-75,-75","7.46,7.29,6.73,10.5,8.92,1.22,1.07,2.09",8,Sigmoid,0.071660705,0.082458355,-75.71987915,3.4803,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.495461900968582,-0.1418166160583496
609,1007,Panc 03.27,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-10,-2.9,-61,-83,-83,-85,-85","15.6,7.93,8.65,9.07,.0057,.81,1.33,.16",8,Sigmoid,0.062006198,0.068110488,-84.17266846,4.3483,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.686624068874237,0.13522419333457947
610,1008,Panc 04.03,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,-3.7,-14,-54,-71,-73,-73,-77","3.25,8.39,11.7,1.80,1.64,1.85,.16,6.55",8,Sigmoid,0.04895727,0.069349982,-73.78749084,2.6612,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.668589391774322,0.38735705614089966
611,1009,Panc 10.05,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-9.0,-8.2,-44,-73,-70,-71,-74","16.4,3.32,1.54,6.72,3.68,6.03,.56,1.17",8,Sigmoid,0.076651163,0.086982444,-72.34233093,3.2431,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.4420489737939692,0.41127490997314453
612,1010,PA-TU-8902,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-18,-2.9,-14,-19,-54,-55,-59","4.80,7.70,2.60,4.80,6.80,8.54,2.85,7.00",8,Sigmoid,0.379172623,0.660462797,-57.23008728,2.4817,PATU8902_PANCREAS,PATU8902,ACH-000599,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.4148144821170748,0.0873347818851471
613,1011,PC-3,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,.54,-1.4,.99,-37,-52,-57,-70","10.4,3.70,4.57,9.18,1.09,.64,3.51,.61",8,Sigmoid,0.224229589,0.388138115,-60.07659912,2.0787,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.9463940362050599,0.7452202439308167
614,1012,Pfeiffer,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,8.56,-13,6.27,-29,-74,-95,-95","17.5,22.7,15.7,3.80,11.0,1.15,1.12,.62",8,Sigmoid,0.440398842,0.449662149,-95.88446808,3.259,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.7992587581942194,0.5665888786315918
615,1013,PK-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-15,-19,-53,-74,-85,-84,-88","6.35,3.82,6.04,4.17,3.19,.24,.73,2.50",8,Sigmoid,0.077295512,0.078745671,-85.6215744,4.3709,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.5415319742159506,0.1590026319026947
616,1014,PK-45H,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,2.02,-16,-24,-81,-90,-90,-87",".45,16.8,2.24,5.75,3.56,.80,1.87,.91",8,Sigmoid,0.137126818,0.134196922,-89.11306,3.7247,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.0084469906241305,0.47192633152008057
617,1015,PK-59,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.4,-9.2,-3.6,-.49,-69,-81,-80,-80","11.8,1.64,3.00,.39,8.59,1.31,1.80,1.33",8,Sigmoid,0.184374303,0.199349344,-80.63398743,3.0683,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.6126964958549452,-0.03486659377813339
618,1016,PLC/PRF/5,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-12,-20,-37,-80,-86,-88,-84","2.61,9.76,2.36,13.9,2.62,1.98,.58,2.03",8,Sigmoid,0.113400035,0.105967887,-86.05831146,4.0595,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.2446191835997378,-0.384088933467865
619,1017,PSN1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-3.1,-5.3,-9.7,-83,-88,-89,-89","11.7,1.85,12.2,4.54,1.24,1.55,.30,1.99",8,Sigmoid,0.14699848,0.150998741,-88.68256378,3.4967,PSN1_PANCREAS,PSN1,ACH-000320,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.8904837799503165,0.11249049752950668
620,1018,QGP-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-36,-22,-14,-64,-64,-66,-70","34.7,35.5,31.1,6.52,2.30,3.06,2.34,.61",8,Sigmoid,0.115441084,0.141021386,-66.4623642,3.341,QGP1_PANCREAS,QGP1,ACH-000347,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.9588437263464051,1.400615930557251
621,1019,Raji,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-34,-13,42.5,-13,-.097,-47,-76","4.41,1.49,21.6,91.3,30.6,28.8,4.07,7.29",8,Sigmoid,2.734068394,2.661648512,-75.77412415,1.9767,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.9789456721866251,1.1320061683654785
622,1020,RD,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-13,-20,-32,-82,-87,-89,-86","8.15,7.68,.41,10.1,3.96,.19,1.30,.23",8,Sigmoid,0.123874798,0.117055684,-87.66610718,4.2745,RD_SOFT_TISSUE,RD,ACH-000169,Sarcoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.145105525779983,0.6149595379829407
623,1021,Reh,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-5.0,-3.3,-18,-30,-60,-77,-85","4.94,3.33,14.2,2.33,6.97,8.70,3.85,.63",8,Sigmoid,0.528056622,0.557084382,-84.9153595,3.0737,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.5850385568125298,0.5960623621940613
624,1022,RERF-GC-1B,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,-.31,-12,15.1,4.95,-18,-59,-76","15.9,9.66,3.07,5.13,17.2,6.06,5.84,3.73",8,Sigmoid,1.456382871,1.931385279,-75.36738586,1.4162,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.6582375065893562,0.8115001320838928
625,1023,RERF-LC-AI,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-14,-13,-37,-82,-84,-86,-86","6.50,5.38,.36,.26,.032,.49,1.17,.033",8,Sigmoid,0.101184793,0.101998895,-85.11112976,4.175,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.2827932990898803,0.38713324069976807
626,1024,RERF-LC-MS,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-27,2.37,-34,-62,-89,-86,-90","14.1,8.85,6.13,8.94,10.6,3.64,4.24,2.62",8,Sigmoid,0.177281737,0.161490873,-89.31702423,3.202,RERFLCMS_LUNG,RERFLCMS,ACH-000062,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.8233066518482868,-0.0028175432235002518
627,1025,RKO,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-11,-15,-53,-93,-96,-95,-95","4.78,14.1,8.20,5.35,.087,.33,.15,.15",8,Sigmoid,0.083263159,0.076428831,-95.36824036,4.4812,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.571395284885529,0.1721227765083313
628,1026,RL95-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-8.1,-25,-54,-51,-54,-59,-52","6.86,5.39,13.0,4.31,5.24,1.95,6.57,2.58",8,Sigmoid,0.02329641,0.037230793,-54.52938461,3.2136,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.290619091297494,0.38153892755508423
629,1027,RPMI-7951,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-22,-76,-90,-94,-94,-94,-94","3.33,4.91,12.9,1.18,.11,.46,.18,.52",8,Sigmoid,0.016853478,0.015701033,-93.55957031,5.8391,RPMI7951_SKIN,RPMI7951,ACH-000348,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-4.154028772614004,0.13662895560264587
630,1028,RPMI-8402,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-8.5,9.38,-1.9,-14,-56,-86,-90","8.48,10.6,13.9,5.07,4.58,4.90,2.91,.49",8,Sigmoid,0.649266601,0.701769114,-90.55194855,3.1359,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.35415082649084734,0.6214412450790405
631,1029,RT-112,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-3.6,-30,-56,-80,-81,-86,-85","4.61,6.78,7.09,.71,.57,.17,2.28,.40",8,Sigmoid,0.056900103,0.063486055,-84.64182281,4.3543,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.756935003499698,0.44463950395584106
632,1030,RT4,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","7.28,15.1,-16,-51,-77,-81,-85,-86","46.3,14.4,3.53,14.3,1.71,4.97,1.39,1.12",8,Sigmoid,0.028310904,0.058811292,-84.61968231,4.2034,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.8334214016987063,0.570780336856842
633,1031,RVH-421,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.3,-21,-3.2,-56,-59,-76,-80,-84","1.04,11.5,17.4,4.22,2.48,.017,.049,3.66",8,Sigmoid,0.069832161,0.074710794,-78.41842651,4.0161,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.594130699290227,-0.5366024374961853
634,1032,SBC-5,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-6.1,-11,-13,-86,-89,-90,-87","1.84,2.11,.99,3.42,1.05,1.33,.62,1.34",8,Sigmoid,0.139704272,0.141069055,-88.75357056,2.6699,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.9585057567201765,-0.09703140705823898
635,1033,SCaBER,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-14,-25,-35,-81,-87,-87,-86","13.6,21.6,1.50,16.9,2.10,.086,.98,1.27",8,Sigmoid,0.086353771,0.077901043,-86.8973465,3.4438,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.5523159372348605,0.2608770728111267
636,1034,SCC-9,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-7.2,-26,-74,-84,-90,-90,-92","2.74,9.27,13.4,5.89,.93,4.49,3.15,1.58",8,Sigmoid,0.046472292,0.046046477,-89.62221527,4.7346,SCC9_UPPER_AERODIGESTIVE_TRACT,SCC9,ACH-000181,Head and Neck Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.078104023007603,-0.02184966392815113
637,1035,SF126,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.9,-7.5,-4.9,5.23,4.73,-63,-93,-95","6.94,5.64,7.35,3.74,6.17,35.4,.70,.24",8,Sigmoid,1.208774686,1.220534086,-95.37657928,2.7719,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.19928853835930352,0.07962115854024887
638,1036,SF-295,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,-5.5,-9.8,-19,-68,-90,-91,-92","4.54,4.43,15.1,4.25,5.31,.72,.20,1.48",8,Sigmoid,0.168494225,0.171886235,-91.93041229,3.2674,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.760922445424921,0.010087912902235985
639,1037,SH-10-TC,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-3.0,-23,-13,-46,-65,-78,-84","1.20,9.02,4.55,4.63,10.5,2.96,2.77,.83",8,Sigmoid,0.406413794,0.42586872,-82.83068085,2.8494,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.8536241492206795,0.07585542649030685
640,1038,SHP-77,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,22.9,7.14,.15,-41,-79,-85,-86","17.8,25.4,4.72,17.1,17.4,3.61,3.72,3.59",8,Sigmoid,0.261356413,0.312299043,-85.40758514,3.0618,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.1637940790589905,0.8578934073448181
641,1039,SIG-M5,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","3.09,3.87,2.46,-5.0,-77,-93,-94,-93","1.23,16.8,24.6,6.52,2.43,.39,.46,.045",8,Sigmoid,0.16050905,0.170254305,-93.61808014,4.1762,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.7704620479285973,0.18707343935966492
642,1040,SIMA,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,-12,13.9,-3.7,3.59,-18,-59,-69","13.7,6.29,8.30,12.3,12.5,22.5,14.0,1.27",8,Sigmoid,1.253249645,1.778700352,-68.2434845,2.3687,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.5758829582966158,0.5170679092407227
643,1041,SJSA-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.3,-12,-10,-17,-44,-69,-74,-78","2.34,.32,13.8,32.1,7.40,2.94,.19,.43",8,Sigmoid,0.236706719,0.312380582,-77.25074005,3.2033,SJSA1_BONE,SJSA1,ACH-000748,Bone Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.1635330204388599,-0.18264487385749817
644,1042,SK-BR-3,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","10.2,-34,-43,-56,-48,-60,-50,-65","4.85,4.77,5.24,1.48,11.5,1.76,5.64,6.58",8,Sigmoid,0.002542614,0.036554132,-56.31596756,3.3439,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.3089610485604934,0.7220579981803894
645,1043,SK-CO-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,11.1,-15,-65,-74,-72,-73,-81","5.65,20.3,5.94,4.71,1.51,2.41,.023,.70",8,Sigmoid,0.048333567,0.055818412,-74.91209412,3.9465,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.8856514998633664,-0.03552086651325226
646,1044,SK-ES-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,-9.7,-12,2.51,-31,-57,-79,-77","10.4,11.8,7.24,15.7,9.29,4.05,2.33,2.19",8,Sigmoid,0.458095729,0.563193679,-79.31912231,2.7715,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.5741316975677643,1.1852667331695557
647,1045,SK-HEP-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,.23,-22,-3.2,-56,-69,-75,-70","1.70,.58,10.1,7.77,2.31,1.56,1.86,3.85",8,Sigmoid,0.19891876,0.230151474,-71.38426208,1.9799,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.4690176042206033,0.2150273323059082
648,1046,SK-MEL-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","44.0,-1.4,1.09,-15,-32,-43,-38,-38","33.5,3.65,13.5,6.37,.68,4.73,5.74,16.0",8,Sigmoid,0.080269165,8.0,-40.53546906,2.0922,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,-0.21656280755996704
649,1047,SK-MEL-24,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.9,-12,-12,-24,-65,-91,-100,-103","11.7,18.3,14.1,3.00,5.95,.82,3.98,4.11",8,Sigmoid,0.178840443,0.174343437,-102.1946259,3.5284,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.7467281492417648,-0.12392222136259079
650,1048,SK-MEL-30,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-22,-11,-24,-46,-45,-46,-54","2.49,6.69,3.17,4.33,9.13,4.46,5.66,4.26",8,Sigmoid,0.106271856,8.0,-47.96096039,1.6956,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,-0.6310538053512573
651,1049,SK-MEL-31,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,-7.7,-14,-13,-40,-32,-40,-38","16.6,16.4,2.13,1.10,7.32,7.94,2.77,5.77",8,Sigmoid,0.148360804,8.0,-38.40506363,2.3166,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,-0.5596306920051575
652,1050,SK-MEL-5,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,2.34,-20,-38,-53,-49,-56,-56","14.5,4.44,2.64,3.25,2.86,.73,.63,1.97",8,Sigmoid,0.033377439,0.210538805,-54.87563324,1.6628,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.558085296056134,-0.37402528524398804
653,1051,SK-MES-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,6.27,-47,-64,-71,-62,-67,-66","18.7,13.5,9.73,2.33,.17,.067,1.82,.17",8,Sigmoid,0.021727188,0.026852531,-66.08779144,4.0054,SKMES1_LUNG,SKMES1,ACH-000665,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.617395198037846,0.6465098261833191
654,1052,SK-MM-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.3,-3.1,-9.8,-32,-72,-78,-75,-77","6.69,3.87,10.9,5.57,1.25,3.44,3.04,1.65",8,Sigmoid,0.096447602,0.116272509,-76.57459259,3.3913,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.1518186274512767,0.9307255148887634
655,1053,SK-N-AS,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-.52,-7.5,-1.4,-14,-32,-68,-75,-71","5.32,1.20,4.13,11.0,5.25,4.26,.060,3.77",8,Sigmoid,0.294434249,0.385245234,-73.48193359,2.5368,SKNAS_AUTONOMIC_GANGLIA,SKNAS,ACH-000260,Neuroblastoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.9538751760459763,0.38907843828201294
656,1054,SK-N-BE(2),17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","2.37,-11,-21,-10,-17,-45,-54,-62","3.24,14.0,7.68,37.5,15.2,15.7,2.40,8.56",8,Sigmoid,0.546095788,1.170010686,-59.63009644,2.2439,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.15701288210128939,0.6711131930351257
657,1055,SK-N-DZ,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,-4.4,-6.1,-9.1,-26,-56,-76,-85","10.7,9.08,9.38,13.1,23.3,2.41,.87,.60",8,Sigmoid,0.526291549,0.637133241,-84.26248169,2.942,SKNDZ_AUTONOMIC_GANGLIA,SKNDZ,ACH-000366,Neuroblastoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.4507764757381319,0.25273117423057556
658,1056,SK-N-FI,17-AAG,HSP90,".0025,.025,.080,.25,.80,2.53,8","15.9,-6.5,-12,11.6,-32,-80,-82","22.6,10.7,4.86,54.0,13.7,.66,4.17",7,Sigmoid,0.942697227,0.993309379,-80.94787598,2.6195,SKNFI_AUTONOMIC_GANGLIA,SKNFI,ACH-000341,Neuroblastoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.0067131035422414165,0.6077004075050354
659,1057,SK-N-SH,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-2.2,-6.3,-24,-54,-77,-95,-95",".67,1.62,8.63,25.5,4.31,.90,.88,.42",8,Sigmoid,0.25051105,0.237033531,-95.79574585,3.3319,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.4395536668418423,0.3589608073234558
660,1058,SK-OV-3,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-7.5,-11,-25,-51,-51,-64,-54","23.0,2.71,1.41,4.04,11.7,7.84,3.26,5.01",8,Sigmoid,0.085083596,0.117106043,-58.21738434,2.3103,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.1446754042445675,-0.020237447693943977
661,1059,SNG-M,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-17,-14,-21,-55,-73,-75,-77","3.59,4.93,4.78,.63,29.6,6.12,10.9,4.13",8,Sigmoid,0.245337933,0.27879262,-76.69844055,3.6265,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.2772870710343558,-0.08657404780387878
662,1060,SNU-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,-12,-26,-74,-84,-84,-87,-86","18.3,3.65,9.30,10.7,.78,.76,.40,.26",8,Sigmoid,0.043934189,0.046669591,-85.99437714,4.5573,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.0646624827185525,0.7640567421913147
663,1061,SNU-182,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-18,-14,-4.7,3.42,-23,-70,-59","11.4,23.1,2.33,2.30,7.21,.19,1.88,4.45",8,Sigmoid,0.97193408,1.199916959,-65.01111603,2.0055,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.1822523535661332,0.3997015357017517
664,1062,SNU-387,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","5.85,8.14,19.6,10.2,-29,-86,-93,-91","27.2,6.61,11.6,15.2,6.83,.56,2.62,1.08",8,Sigmoid,0.29217872,0.340427518,-91.93766785,3.05,SNU387_LIVER,SNU387,ACH-000478,Liver Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.077553045362296,0.059174858033657074
665,1063,SNU-398,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,-12,9.30,4.07,-8.1,-72,-83,-83","6.51,5.27,2.58,7.98,13.1,2.31,.024,.045",8,Sigmoid,0.497993797,0.547320902,-83.1004715,2.5308,SNU398_LIVER,SNU398,ACH-000221,Liver Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.602719990441483,0.5107399821281433
666,1064,SNU-423,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,-7.5,-7.1,-.38,-9.1,-46,-85,-89","4.77,18.0,14.8,.94,6.61,.49,.52,1.19",8,Sigmoid,0.794813752,0.855389178,-89.06666565,2.0606,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.1561987346605203,0.6057628393173218
667,1065,SNU-449,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-4.5,-12,1.67,-4.7,-3.6,-64,-70","4.33,11.4,3.18,4.10,.61,7.04,1.44,7.41",8,Sigmoid,1.673974752,1.962941647,-70.41904449,1.5499,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.674444188413361,0.9595137238502502
668,1066,SNU-475,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,4.23,-57,-61,-63,-52,-65,-54","26.4,60.5,5.08,5.49,14.3,.66,13.3,5.19",8,Constant,,0.002542614,-53.47348404,3.9646,SNU475_LIVER,SNU475,ACH-000422,Liver Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-5.9745625932886295,0.34363803267478943
669,1067,SNU-C2A,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,7.36,-20,-25,-52,-54,-61,-52","1.12,14.2,7.70,10.6,16.3,5.02,1.75,6.02",8,Sigmoid,0.119735748,0.256480753,-56.24282837,2.7511,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.360701654223769,0.32838255167007446
670,1068,Sq-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-18,-19,-40,-63,-75,-78,-76","21.9,6.05,27.8,9.77,2.60,4.02,5.62,8.27",8,Sigmoid,0.108540684,0.123309262,-78.01563263,4.1275,SQ1_LUNG,SQ1,ACH-000553,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.0930597540336726,0.4812626242637634
671,1069,SU.86.86,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.7,-2.6,-6.1,-.66,-53,-57,-64,-68",".23,5.88,1.74,1.11,11.1,2.10,1.15,6.93",8,Sigmoid,0.187899411,0.243544534,-62.45162201,2.4711,SU8686_PANCREAS,SU8686,ACH-000114,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.4124554620116125,0.30554911494255066
672,1070,SU-DHL-10,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-23,.67,62.8,-62,-94,-92,-90","8.02,20.4,1.73,19.9,1.00,.54,1.02,.39",8,Sigmoid,0.223236114,0.225168079,-92.18444824,3.8928,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.490908137878843,1.1788185834884644
673,1071,SU-DHL-4,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-.28,.66,5.64,-56,-82,-89,-90","9.34,2.42,9.30,2.81,3.03,1.66,1.15,.90",8,Sigmoid,0.225681767,0.240270659,-86.83820343,3.7258,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.4259892452344556,0.7750745415687561
674,1072,SU-DHL-6,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","13.9,-.87,43.8,53.0,8.46,-42,-91,-91","22.0,13.5,9.28,24.0,10.7,26.3,.58,.22",8,Linear,,0.333022144,-97.60627747,2.238,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.0995462927141217,0.6497046947479248
675,1073,SU-DHL-8,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","1.95,.86,-13,-45,-64,-75,-78,-80","5.97,25.5,10.7,13.6,4.42,1.76,1.50,4.55",8,Sigmoid,0.072837174,0.117609031,-79.3927002,4.1173,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.1403894522484483,1.002394437789917
676,1074,SUIT-2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-4.6,-10,8.87,-18,-56,-79,-73","9.62,3.24,1.32,17.3,1.75,4.78,2.51,1.55",8,Sigmoid,0.586290956,0.652435839,-84.62996674,2.3478,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.4270424756545844,-0.3689253628253937
677,1075,SUP-M2,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","8.49,-13,21.6,-31,-95,-95,-95,-95","24.9,6.84,30.1,18.1,.46,.038,.089,.19",8,Sigmoid,0.09751115,0.097292751,-95.03438568,4.1261,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.3300307941071794,0.4728739857673645
678,1076,SUP-T1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-.19,8.29,16.4,-23,-71,-83,-83","3.52,5.05,1.42,27.3,7.03,5.43,.74,2.99",8,Sigmoid,0.382690609,0.454656243,-83.42649841,2.5547,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.7882136554627222,1.2649827003479004
679,1077,SW 1088,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-4.1,-31,-43,-66,-68,-67,-65",".52,18.5,5.79,15.0,1.66,12.9,4.66,9.35",8,Sigmoid,0.038097113,0.062667288,-67.24526978,2.8038,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.7699156899758326,0.4777296185493469
680,1078,SW 1271,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","4.86,-3.7,2.59,24.1,-38,-65,-72,-70","2.16,.079,5.36,8.51,6.78,.026,4.54,.76",8,Sigmoid,0.239901453,0.293411762,-69.01069641,2.6201,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.2261783254605592,0.1431582272052765
681,1079,SW 1353,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-4.8,-14,-24,-66,-68,-70,-70","10.7,3.47,4.72,4.98,3.70,6.44,4.07,6.04",8,Sigmoid,0.110867716,0.140588775,-69.70623779,3.1215,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.9619161392080315,0.14019523561000824
682,1080,SW1417,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,-28,-5.5,-61,-70,-78,-81,-79","24.4,15.8,2.91,16.0,8.20,3.04,8.31,8.78",8,Sigmoid,0.066786624,0.068497665,-77.10978699,4.141,SW1417_LARGE_INTESTINE,SW1417,ACH-000236,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.6809556218861936,0.4034826159477234
683,1081,SW 1573,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-15,-7.1,-16,-41,-48,-53,-44","2.11,12.9,3.50,11.2,2.52,3.16,.31,4.62",8,Sigmoid,0.165745407,8.0,-48.2461319,2.0416,SW1573_LUNG,SW1573,ACH-000677,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,-0.21605098247528076
684,1082,SW 1990,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.6,1.40,-8.4,-65,-82,-81,-82,-81",".59,1.49,14.1,5.05,.51,3.55,3.23,1.16",8,Sigmoid,0.046923675,0.055297799,-81.90934753,3.9558,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.895022172330923,0.040649957954883575
685,1083,SW403,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-11,-43,-62,-77,-78,-81,-81","4.15,14.5,16.8,5.71,.44,.58,2.07,2.50",8,Sigmoid,0.047540449,0.050812941,-80.08496094,4.3652,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.97960421274498,0.28429388999938965
686,1084,SW48,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-15,-78,-95,-95,-95,-95,-95",".43,10.9,.28,.22,1.25,.71,.11,.70",8,Sigmoid,0.015682427,0.014938917,-95.0752182,5.8824,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-4.203785591864829,-0.286011666059494
687,1085,SW480,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-2.1,-1.4,-29,-66,-68,-67,-68","5.63,2.65,3.86,13.3,2.59,2.12,5.00,4.82",8,Sigmoid,0.087802775,0.106521167,-67.35800171,2.2298,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.239411562407346,0.3948332369327545
688,1086,SW579,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-10,-33,-50,-89,-90,-92,-92","1.62,3.59,6.02,3.70,1.76,1.71,1.15,.63",8,Sigmoid,0.095205031,0.080146693,-91.55223846,4.6507,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.5238966609150406,0.28388798236846924
689,1087,SW620,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-12,-38,-78,-88,-88,-89,-87","5.09,.57,12.9,.71,.36,.76,1.09,1.03",8,Sigmoid,0.038064361,0.03864982,-88.05181122,4.962,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.2532131611393695,-0.26294711232185364
690,1088,SW 780,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,.84,-27,-51,-74,-71,-78,-79","3.90,13.6,1.66,12.9,1.16,.19,2.56,.15",8,Sigmoid,0.041886806,0.055612143,-76.54248047,2.995,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.8893537022906757,0.15874016284942627
691,1089,SW 900,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-9.6,7.61,1.24,-32,-71,-75,-71","3.35,4.91,22.3,10.7,14.3,6.85,2.15,4.85",8,Sigmoid,0.285464168,0.320660651,-72.31522369,2.5565,SW900_LUNG,SW900,ACH-000669,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.1373718770357688,0.4795348048210144
692,1090,T24,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-4.7,-3.3,-35,-57,-78,-79,-84","3.89,15.7,.11,19.1,3.51,4.98,1.02,3.99",8,Sigmoid,0.159281328,0.199150398,-81.74423218,3.6966,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.613694970862883,-0.08107336610555649
693,1091,T3M-10,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-25,-29,-80,-82,-90,-90,-92","3.02,20.3,14.3,4.44,9.15,2.58,2.12,1.72",8,Sigmoid,0.045473676,0.040968742,-89.36954498,4.9033,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.1949458932889683,0.030846523120999336
694,1092,T-47D,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","8.23,-.69,1.93,7.79,-6.2,-22,-59,-65","8.49,1.04,14.7,28.5,5.24,11.2,3.16,6.98",8,Sigmoid,1.037528276,1.789526105,-66.33282471,1.4674,T47D_BREAST,T47D,ACH-000147,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.5819508389912492,1.3838629722595215
695,1093,T84,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,75.5,.099,4.46,-9.6,-52,-76,-75","12.5,65.1,43.9,84.7,7.76,31.3,3.79,4.23",8,Linear,,0.53340598,-81.54312134,2.5327,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.6284724561984545,0.5307497382164001
696,1094,TCCSUP,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,7.95,-15,-76,-86,-89,-89,-90","12.1,3.14,16.9,3.54,2.38,1.49,.17,.76",8,Sigmoid,0.041227795,0.04668178,-88.56083679,4.4105,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.06440134032849,0.1874571442604065
697,1095,TE-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-4.8,-9.9,-55,-76,-81,-80,-80","5.27,6.74,.038,1.01,1.19,1.83,.88,.081",8,Sigmoid,0.068732113,0.074513651,-79.52107239,3.9523,TE1_OESOPHAGUS,TE1,ACH-000647,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.596772935482758,-0.2486724853515625
698,1096,TE-11,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-32,-18,-5.1,-27,-63,-71,-75,-75",".26,3.81,.34,16.0,3.65,4.24,3.14,6.40",8,Sigmoid,0.15447855,0.172436342,-73.86631012,3.3987,TE11_OESOPHAGUS,TE11,ACH-000488,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.757727142503803,0.0606626495718956
699,1097,TE-15,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,6.36,-23,-58,-56,-80,-83,-88","19.1,29.4,9.36,9.69,.67,.91,6.23,4.32",8,Sigmoid,0.04338365,0.103201464,-88.72467041,4.0282,TE15_OESOPHAGUS,TE15,ACH-000353,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.271072239988784,0.1418657898902893
700,1098,TE-5,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-7.5,-1.6,-12,-38,-76,-88,-89","6.80,.75,4.63,1.09,8.51,2.23,1.47,.83",8,Sigmoid,0.330358058,0.350542456,-88.81047821,3.0955,TE5_OESOPHAGUS,TE5,ACH-000408,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.0482734500285653,0.15249304473400116
701,1099,TE 617.T,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-11,-40,-78,-95,-95,-96,-96","1.18,8.31,2.12,7.82,.89,.32,.18,.22",8,Sigmoid,0.040166762,0.034616712,-95.85877991,5.1812,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.363418707747856,-0.44606292247772217
702,1100,TE-9,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-7.4,-23,-16,-77,-80,-87,-85","1.96,6.52,6.05,25.7,3.15,6.39,.17,1.94",8,Sigmoid,0.084427357,0.087467499,-85.80389404,4.2666,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.436487994619492,0.45630985498428345
703,1101,TEN,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,-2.1,-10,6.58,-24,-50,-68,-71","8.91,6.04,20.1,33.2,11.0,1.77,4.85,6.30",8,Sigmoid,0.465444475,0.809816062,-72.50281525,3.0622,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.21094814105373422,0.39405179023742676
704,1102,Toledo,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-15,-14,6.00,-1.6,3.85,-62,-65",".47,13.9,29.1,8.64,16.4,9.53,.49,11.9",8,Sigmoid,1.679776788,2.039073229,-66.47551727,1.2479,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,0.7124954051210342,0.8412269949913025
705,1103,TOV-112D,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,-2.3,-5.0,-9.8,-32,-72,-76,-77","3.20,5.24,2.31,4.26,2.78,3.83,4.04,.19",8,Sigmoid,0.305045217,0.383055866,-77.22284698,2.6725,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.9595744362088784,0.3053820729255676
706,1104,TOV-21G,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,3.67,-75,-84,-90,-88,-85,-85","3.89,3.78,11.2,3.43,.036,.71,1.67,.87",8,Sigmoid,0.018373549,0.019315857,-86.46894073,3.9631,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.9468289141873116,-0.6803879141807556
707,1105,TT2609-C02,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,6.21,1.30,-57,-77,-77,-79,-78","11.0,9.13,1.50,15.0,.19,.11,4.49,.91",8,Sigmoid,0.066065766,0.074787728,-77.57803345,3.9975,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.593101471632827,-0.08880381286144257
708,1106,TYK-nu,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-2.9,-12,-46,-75,-77,-76,-76","3.70,9.62,11.3,8.32,1.06,.067,2.06,.20",8,Sigmoid,0.076763563,0.085773639,-76.2318573,3.7232,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.456043557457649,0.3243875503540039
709,1107,U-118 MG,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,2.10,-20,-44,-70,-81,-85,-89","5.60,12.1,12.2,14.5,2.89,3.29,.64,.30",8,Sigmoid,0.118210398,0.131359786,-86.80393219,3.4405,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.029815262390186,0.2090456485748291
710,1108,U-2 OS,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,-13,-23,-39,-74,-91,-92,-92","16.2,7.93,.26,14.8,6.43,1.34,1.08,.64",8,Sigmoid,0.107041113,0.099057235,-93.58200836,4.6678,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.312057464587941,0.27070194482803345
711,1109,U-87 MG,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-1.1,-12,-39,-73,-81,-83,-78","12.9,16.7,3.68,5.12,1.49,1.25,3.15,3.87",8,Sigmoid,0.088260479,0.106696405,-80.94089508,3.4931,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.2377678138381016,0.262376993894577
712,1110,U-937,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,-3.8,-26,-46,-89,-91,-91,-90","11.6,.83,24.9,52.5,.97,1.35,.39,1.26",8,Sigmoid,0.131447598,0.132671893,-91.98108673,4.6603,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.019876168669389,0.3478451073169708
713,1111,UACC-257,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-.60,-4.9,-21,-52,-52,-51,-52","2.90,4.97,3.15,2.31,2.41,1.88,.34,6.76",8,Sigmoid,0.091536902,0.176819474,-51.65089798,2.2128,UACC257_SKIN,UACC257,ACH-000579,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.7326259877855124,-0.1294320970773697
714,1112,UACC-62,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-4.2,-26,-59,-73,-84,-86,-85","7.87,1.95,2.51,7.31,1.99,4.39,.58,1.16",8,Sigmoid,0.055714209,0.063543618,-84.39550018,4.5286,UACC62_SKIN,UACC62,ACH-000425,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.7560287112519015,-0.4178810119628906
715,1113,UACC-812,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-32,-24,-43,-66,-59,-74,-66","20.0,22.2,51.6,36.2,6.87,15.9,28.2,31.1",8,Sigmoid,0.192266747,0.200488731,-86.43447113,3.1346,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.6069972383038227,1.4881892204284668
716,1114,UM-UC-3,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,.76,-6.3,1.27,-42,-87,-96,-96","2.94,6.81,2.31,1.00,3.33,3.37,.24,.73",8,Sigmoid,0.288144439,0.293646216,-95.04688263,3.2913,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.225379583185516,-0.24720826745033264
717,1115,VMRC-RCW,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-4.2,-.58,-5.1,9.64,12.1,-3.5,-31","13.3,7.23,9.75,1.55,9.12,31.1,4.57,1.89",8,Sigmoid,6.185892582,8.0,-30.6334877,0.4375,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,2.0794415416798357,-0.10467006266117096
718,1116,VMRC-RCZ,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-10.0,8.75,-25,-25,-51,-46,-55,-48","17.4,26.0,6.77,11.2,4.31,9.32,3.73,12.5",8,Sigmoid,0.064701825,0.852490127,-52.10763168,2.3024,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-0.15959365112319968,0.10793600231409073
719,1117,WM-115,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-16,-24,-65,-71,-71,-68,-68","2.00,9.12,4.33,7.90,8.47,9.37,2.22,7.91",8,Sigmoid,0.039512355,0.047518171,-69.16239929,3.7538,WM115_SKIN,WM115,ACH-000304,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.0466430937257094,-0.1887325644493103
720,1118,WM1799,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-11,-21,-55,-62,-72,-71,-68","21.7,12.4,6.61,1.75,11.3,2.32,7.12,8.14",8,Sigmoid,0.044556081,0.06831377,-69.69178772,3.7607,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.683643922184339,-0.7667692303657532
721,1119,WM-266-4,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-26,-56,-94,-95,-95,-96,-95","11.9,1.38,10.6,1.37,.025,.15,.34,.35",8,Sigmoid,0.024863278,0.021235578,-95.67035675,5.5988,WM2664_SKIN,WM2664,ACH-001239,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.852077296373776,-0.5487046837806702
722,1120,WM-793,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-40,-31,-27,-76,-93,-92,-94,-94","8.86,10.8,20.7,2.86,.70,.34,.60,.66",8,Sigmoid,0.067191079,0.053718675,-93.08917236,5.6352,WM793_SKIN,WM793,ACH-000827,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.9239945725605474,0.0532689243555069
723,1121,WM-88,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-4.4,-37,-70,-83,-82,-83,-79","3.02,3.42,17.8,.42,.98,3.39,3.03,4.63",8,Sigmoid,0.037107021,0.041547392,-81.69818115,4.5972,WM88_SKIN,WM88,ACH-000899,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-3.1809205274003567,-0.19584256410598755
724,1122,WM-983B,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,-1.3,-26,-65,-74,-79,-80,-74","12.4,22.6,6.95,5.71,1.88,2.47,.24,1.01",8,Sigmoid,0.041969128,0.050495461,-77.34940338,3.9403,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.9858718279284977,-0.5875065326690674
725,1123,YKG1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-7.2,4.60,-1.6,-63,-67,-80,-85","4.44,.81,3.74,1.47,2.48,2.64,1.15,1.96",8,Sigmoid,0.194671407,0.214574531,-78.1256485,2.8308,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.5390981370961923,0.16109323501586914
726,1124,ZR-75-1,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","2.13,-14,-47,-61,-81,-86,-92,-84","43.2,21.2,25.0,13.9,12.6,2.49,13.3,8.20",8,Linear,,0.327225992,-91.02919769,4.4719,ZR751_BREAST,ZR751,ACH-000097,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-1.1171042397557365,0.7321553826332092
727,1125,ZR-75-30,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","9.03,-16,-8.5,-47,-61,-61,-46,-63","48.1,21.0,26.1,8.43,10.7,2.09,9.19,.92",8,Sigmoid,0.069838338,0.086871609,-59.09033203,2.3161,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.443324008952517,1.0108282566070557
728,1126,SCC-25,17-AAG,HSP90,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-36,-16,-47,-80,-91,-93,-93","10.9,12.5,10.4,4.90,6.35,1.96,1.62,.74",8,Sigmoid,0.115102671,0.091868989,-92.36445618,4.46,SCC25_UPPER_AERODIGESTIVE_TRACT,SCC25,ACH-000188,Head and Neck Cancer,18,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,Tanespimycin,HSP90,Heat Shock Protein 90 (hsp90) Inhibitor,Other targeted therapies,Phase III,Bristol-Myers Squibb,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,-2.387391749439841,-0.06336607038974762
729,1127,A172,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-.73,3.40,1.00,.26,5.42,7.48,10.4",".86,7.72,2.80,14.1,6.64,2.25,7.98,6.82",8,Linear,,8.0,-10.64412117,0.08666,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1487908363342285
730,1128,A-204,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-13,5.59,-1.2,32.7,-4.7,8.43,-34","4.44,17.8,7.12,13.7,18.2,5.78,6.25,8.77",8,Sigmoid,8.134110117,8.0,-33.48770523,0.6474,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.8408191204071045
731,1129,A2058,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,1.84,-.28,3.23,2.29,-.70,3.92,-26","3.66,6.10,8.73,1.28,3.02,2.17,1.64,3.94",8,Sigmoid,7.817465305,8.0,-28.69736671,0.2003,A2058_SKIN,A2058,ACH-000788,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9467806816101074
732,1130,A-253,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,-1.4,3.05,3.78,-1.1,-.49,-3.6,-27","5.33,3.74,2.36,3.13,1.94,6.41,19.7,39.6",8,Constant,,8.0,0.198224634,0.2471,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9288582801818848
733,1131,A2780,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.56,1.43,4.20,7.04,2.91,1.71,6.64,-11","6.95,5.25,5.91,5.64,4.39,8.92,9.74,9.16",8,Constant,,8.0,-0.197527334,0.03508,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.8646392822265625
734,1132,A-375,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-1.3,.57,5.99,4.47,3.32,-2.4,-47",".87,4.75,.83,3.97,8.23,3.39,2.05,3.34",8,Sigmoid,4.208201885,8.0,-47.43115616,0.4121,A375_SKIN,A375,ACH-000219,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.8148319721221924
735,1133,A549,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.13,6.19,2.88,8.17,.20,1.61,7.18,-.74","1.30,2.05,8.58,2.28,10.4,12.2,11.4,7.18",8,Constant,,8.0,4.431193829,0.08954,A549_LUNG,A549,ACH-000681,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1870880126953125
736,1134,A-673,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","14.0,-.26,13.7,16.0,5.61,8.07,-3.2,-14","13.5,4.82,3.12,5.29,2.69,1.93,10.3,20.2",8,Constant,,8.0,4.976217747,0.1048,A673_BONE,A673,ACH-000052,Bone Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1269426345825195
737,1135,ACHN,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-3.9,1.35,-2.6,6.50,-5.3,-6.1,-28","8.27,.87,2.05,5.21,3.69,.96,6.74,35.2",8,Constant,,8.0,-3.358840704,0.1702,ACHN_KIDNEY,ACHN,ACH-000046,Kidney Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.232318878173828
738,1136,ALL-SIL,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,8.03,22.6,-.11,-13,-29,-46,-78","5.84,12.8,16.7,6.18,18.7,51.7,48.0,17.5",8,Sigmoid,3.653612375,4.477983475,-66.81092834,1.7146,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.4991728279062435,2.968207597732544
739,1137,AMO-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.53,11.5,.37,-7.8,3.72,9.31,-3.8,-97","1.46,5.96,5.12,15.2,4.59,8.38,18.5,2.43",8,Sigmoid,4.153167725,4.206129074,-98.13126373,1.0553,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.4365427648743085,3.130703926086426
740,1138,AsPC-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.77,5.34,5.68,11.7,-1.7,-1.3,3.89,-41","5.07,6.17,18.3,10.3,14.6,11.3,10.0,2.33",8,Sigmoid,8.37231647,8.0,-42.75026703,0.2758,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3308205604553223
741,1139,AU565,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-1.5,-13,10.2,1.31,9.21,1.46,-7.9","7.10,4.65,3.87,13.2,16.5,22.9,14.6,7.33",8,Linear,,8.0,-11.33695698,0.3374,AU565_BREAST,AU565,ACH-000248,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.317025661468506
742,1140,B-CPAP,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,.79,2.47,4.54,-1.7,-3.3,-6.9,-44","7.74,3.81,6.08,1.79,3.10,11.9,4.67,53.8",8,Constant,,8.0,-1.758717418,0.8851,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2016305923461914
743,1141,BDCM,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,5.26,-1.3,-3.1,5.73,8.56,-9.1,-22","13.7,6.98,13.2,9.44,8.39,13.0,19.8,49.0",8,Constant,,8.0,5.138595104,0.03856,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.973285436630249
744,1142,BFTC-909,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,-1.6,-3.0,2.52,1.77,-2.9,-.093,-15","8.38,1.71,2.65,3.24,2.18,3.31,5.86,15.0",8,Constant,,8.0,-0.153866619,0.1644,BFTC909_KIDNEY,BFTC909,ACH-000792,Kidney Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0830578804016113
745,1143,BL-41,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,-.71,8.20,.97,2.50,2.91,5.98,9.66","5.51,4.13,9.33,4.92,1.56,5.92,5.77,6.35",8,Constant,,8.0,2.582644224,0.0,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.977916717529297
746,1144,BL-70,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,17.1,.47,9.04,-1.3,3.47,-8.3,-30","9.20,4.26,5.89,11.9,1.10,15.2,1.25,19.4",8,Sigmoid,3.342267036,6.465454578,-51.24952316,0.4072,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.8664733234410245,2.950486183166504
747,1145,BT-20,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-15,-18,-14,-16,-8.8,2.22,-24","9.10,10.7,12.7,17.1,12.4,5.94,51.3,22.3",8,Linear,,8.0,-20.66633415,0.4686,BT20_BREAST,BT20,ACH-000536,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.410816192626953
748,1146,BT-474,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,7.84,-8.2,-18,-1.2,-3.3,-13,-43","6.65,23.6,9.37,2.10,1.00,8.90,9.36,14.0",8,Sigmoid,6.58958292,6.84863472,-59.60608673,0.4139,BT474_BREAST,BT474,ACH-000927,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.924049321460162,3.6878480911254883
749,1147,BT-549,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.48,4.57,13.8,-7.1,24.0,9.39,3.70,-19","4.24,2.60,3.93,12.9,31.6,0,7.72,3.32",8,Constant,,8.0,2.980574608,0.1106,BT549_BREAST,BT549,ACH-000288,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2832512855529785
750,1148,BxPC-3,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,-1.1,-2.5,9.75,6.13,-18,-43,-44","19.4,13.3,20.8,17.1,16.1,27.0,51.4,62.3",8,Constant,,8.0,-0.802405357,0.8834,BXPC3_PANCREAS,BXPC3,ACH-000535,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.205261707305908
751,1149,C2BBe1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".094,-2.2,2.46,-8.0,17.0,5.48,17.5,3.17","16.7,27.2,31.4,6.87,12.4,20.3,29.1,22.8",8,Constant,,8.0,4.48514843,0.0,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.356363296508789
752,1150,C32,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-11,22.2,8.63,4.93,3.49,13.0,-9.3","25.7,21.5,12.2,15.5,25.2,10.0,14.5,3.27",8,Constant,,8.0,3.002574444,0.1914,C32_SKIN,C32,ACH-000580,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.001171350479126
753,1151,CAL-12T,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.5,-24,-2.3,-25,-25,-31,-45,-76","25.8,7.81,5.85,6.70,31.9,50.1,71.8,42.7",8,Linear,,8.0,-47.17254639,1.5377,CAL12T_LUNG,CAL12T,ACH-000826,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.216869831085205
754,1152,CAL 27,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,2.74,2.28,2.87,5.78,-1.0,-40,-52","6.25,12.0,3.62,6.20,4.20,4.02,67.3,60.9",8,Linear,,8.0,-17.22671509,0.7764,CAL27_UPPER_AERODIGESTIVE_TRACT,CAL27,ACH-000832,Head and Neck Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1902098655700684
755,1153,CAL-85-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","7.61,16.4,8.63,-11,17.4,-7.0,26.1,2.56","21.9,13.8,.091,32.7,22.1,17.6,9.02,5.49",8,Constant,,8.0,7.917528152,0.04997,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.199927568435669
756,1154,Calu-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-7.8,4.57,-1.3,-4.2,-10,1.56,-12","6.67,4.55,5.77,7.50,7.23,6.21,.65,2.29",8,Constant,,8.0,-5.561928749,0.195,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.5701353549957275
757,1155,Calu-3,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-.75,-.59,-1.6,-1.4,-2.4,.079,-24","11.9,7.31,14.1,18.0,17.0,6.84,.99,35.0",8,Constant,,8.0,-5.626743793,0.1975,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.4126527309417725
758,1156,Calu-6,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,14.5,6.32,16.2,-2.7,19.9,-2.1,-36","8.14,19.6,26.3,10.2,6.39,9.82,7.58,24.4",8,Constant,,8.0,-2.085486889,0.4372,CALU6_LUNG,CALU6,ACH-000264,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.121121883392334
759,1157,CAMA-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","12.2,-.74,-10.0,6.87,-1.3,2.18,-19,-39","19.1,1.18,5.79,4.14,6.64,6.82,36.5,28.4",8,Constant,,8.0,1.018740654,0.3651,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2053465843200684
760,1158,Capan-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.70,4.33,15.7,35.5,14.5,13.3,29.2,-26","51.9,22.2,24.6,27.6,27.4,21.1,47.3,22.3",8,Constant,,8.0,23.48796844,0.1632,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.4599123001098633
761,1159,CAS-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.61,9.64,-2.3,9.23,1.72,7.81,-2.6,.52","5.57,6.94,5.78,5.49,4.30,3.44,7.06,2.44",8,Constant,,8.0,0.251661241,0.0,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3193368911743164
762,1160,CCK-81,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.18,-.96,10.2,.88,-19,-7.2,-21,-24","18.1,13.8,24.5,20.1,16.5,19.3,23.2,23.1",8,Constant,,8.0,-6.241695404,0.7094,CCK81_LARGE_INTESTINE,CCK81,ACH-000963,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.26802396774292
763,1161,CHP-212,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-4.8,1.68,-7.7,5.50,4.93,-8.7,-38","24.6,12.8,14.1,15.5,9.05,12.4,16.8,50.0",8,Linear,,8.0,-35.25748444,0.86,CHP212_AUTONOMIC_GANGLIA,CHP212,ACH-000120,Neuroblastoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1885900497436523
764,1162,CI-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","12.8,9.34,-11,22.8,11.4,11.8,-8.3,-42","26.8,6.29,16.9,9.34,41.5,38.7,16.8,16.8",8,Constant,,8.0,3.367224932,0.8997,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.6788313388824463
765,1163,COLO-320,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.97,-3.1,-.11,.024,3.67,-2.2,-.78,-32","6.47,9.15,1.76,2.82,7.78,4.56,6.59,10.7",8,Linear,,8.0,-20.6668148,0.2699,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9681711196899414
766,1164,COLO-678,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","10.6,-.96,4.34,4.12,2.54,6.98,6.38,-18","10.9,6.36,1.29,20.7,11.8,7.25,13.1,11.2",8,Constant,,8.0,3.990395546,0.2274,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.574525833129883
767,1165,COLO-679,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.50,-16,15.5,-4.9,11.5,-5.8,11.4,-44","6.69,2.35,1.55,7.18,7.61,8.32,12.9,26.0",8,Sigmoid,8.054211392,7.286690712,-66.54251099,0.486,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.9860494939833468,3.131047487258911
768,1166,COLO 741,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,9.69,-9.5,-2.3,1.06,-5.9,-17,-36","28.4,10.1,26.0,25.7,8.94,10.1,7.93,57.0",8,Constant,,8.0,-10.93197918,0.7811,COLO741_SKIN,COLO741,ACH-000582,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1263225078582764
769,1167,COR-L105,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","8.16,2.10,-7.5,8.83,8.31,20.7,-9.9,-31","6.81,5.14,1.89,19.5,17.8,22.7,10.9,69.4",8,Constant,,8.0,8.891347885,0.225,CORL105_LUNG,CORL105,ACH-000161,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3246593475341797
770,1168,COR-L23,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.6,-.11,1.54,3.54,-1.2,1.76,1.73,-2.1","7.39,3.96,8.33,4.65,6.39,3.39,3.92,3.85",8,Constant,,8.0,-1.425967097,0.02301,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.192220687866211
771,1169,COV318,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,6.97,-3.7,6.69,.17,2.33,7.20,-.23","2.04,7.19,10.3,3.08,7.52,15.8,5.63,10.7",8,Constant,,8.0,0.544722259,0.04829,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.415172576904297
772,1170,COV504,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,5.48,-.11,13.3,-1.4,-.26,-5.6,1.11","13.3,7.26,2.90,6.91,19.9,8.47,31.9,43.7",8,Constant,,8.0,5.888234615,0.0,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.38454532623291
773,1171,Daoy,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,-2.9,5.16,-3.6,-4.4,-5.2,4.79,-4.1","5.44,16.1,11.3,4.93,11.7,7.78,15.0,3.01",8,Constant,,8.0,-2.562992811,0.02801,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9243931770324707
774,1172,DBTRG-05MG,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.19,-8.5,4.84,-5.9,-2.4,-18,7.10,-5.5","9.01,3.65,5.96,5.55,.74,8.64,10.8,.84",8,Constant,,8.0,-3.898821592,1.0773,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1620397567749023
775,1173,Detroit 562,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.2,2.63,-4.5,-4.1,-6.5,-1.1,-36,-46","4.10,8.59,4.71,8.95,7.22,3.25,44.5,69.8",8,Constant,,8.0,-3.594129562,0.8825,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.221289873123169
776,1174,DK-MG,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,2.87,2.01,9.88,3.28,3.05,-12,-38","7.63,7.02,11.6,1.62,9.07,7.37,22.2,12.7",8,Sigmoid,1.40881598,8.0,-26.60773659,0.3604,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.201225757598877
777,1175,DMS 114,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,-7.5,-18,-11,6.22,8.95,3.35,-43","11.9,2.63,3.95,2.76,11.0,10.3,18.8,33.8",8,Sigmoid,5.337802887,8.0,-42.408638,0.8946,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.6396889686584473
778,1176,DOHH-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","10.3,2.99,12.3,43.9,10.5,-18,-24,-68","16.7,4.64,24.8,15.2,21.4,19.7,30.3,41.2",8,Sigmoid,2.625776291,2.651649952,-95.72023773,1.3201,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,0.9751820696448283,3.1627728939056396
779,1177,DV-90,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,8.84,-19,-49,-58,-42,-47,-53","2.70,10.1,26.7,48.9,48.9,76.4,70.5,64.9",8,Constant,,8.0,-2.011014462,3.0544,DV90_LUNG,DV90,ACH-000925,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.112095832824707
780,1178,EB1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","13.3,4.72,-3.6,-.54,7.22,-25,1.05,-39","9.30,11.4,21.2,19.9,16.3,19.5,32.7,17.6",8,Constant,,8.0,4.870385647,0.7433,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.759772777557373
781,1179,EBC-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,4.60,.58,9.56,-27,-44,-56,-59","9.83,9.94,3.51,4.96,29.5,60.6,46.6,42.8",8,Sigmoid,0.238291606,0.27125594,-87.16655731,1.6816,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,-1.3046924757497276,3.2563977241516113
782,1180,EFE-184,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-2.1,-.72,2.36,-12,-18,15.5,4.76","19.4,.28,4.65,3.26,10.6,.68,10.6,2.51",8,Constant,,8.0,-0.854489982,0.333,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.319915294647217
783,1181,EFM-19,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,2.64,6.59,8.18,5.18,-10,5.19,-66","3.89,11.7,12.1,10.4,16.1,5.07,16.6,3.44",8,Sigmoid,8.275729266,7.446472168,-66.28803253,0.7263,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.007740385741957,3.3508758544921875
784,1182,EFO-21,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,.93,-5.2,2.43,-13,3.47,3.04,-.49",".61,4.78,8.15,14.3,2.70,8.91,7.34,8.20",8,Constant,,8.0,-2.369434118,0.2856,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3013219833374023
785,1183,EFO-27,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.085,7.44,2.06,11.0,-.57,9.91,4.09,4.11","4.58,1.34,4.79,1.81,2.28,.43,8.86,.99",8,Constant,,8.0,5.01304245,0.0,EFO27_OVARY,EFO27,ACH-000936,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.017211675643921
786,1184,EM-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,-7.0,8.09,13.3,7.94,-6.6,-14,-40","6.71,2.38,15.0,4.44,8.67,20.0,8.61,14.2",8,Sigmoid,4.014349461,6.589995384,-52.75415421,0.9357,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.8855526480589353,3.1226630210876465
787,1185,EN,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.8,-7.7,1.86,1.83,1.85,-10,-.28,-4.5","7.82,7.05,3.21,6.26,6.66,14.4,6.55,2.51",8,Constant,,8.0,-0.443618417,0.08131,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.064265251159668
788,1186,ES-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.90,3.40,.030,.61,2.82,-.12,-4.5,-28","8.95,4.52,7.93,1.29,13.5,2.74,10.0,50.5",8,Constant,,8.0,2.26880908,0.2601,ES2_OVARY,ES2,ACH-000906,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.163020133972168
789,1187,ESS-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,.29,-5.1,-8.7,-40,-51,-56,-73","19.2,6.77,8.98,10.3,66.0,66.3,60.7,37.3",8,Sigmoid,6.282022953,8.0,-45.5270462,2.2772,ESS1_ENDOMETRIUM,ESS1,ACH-000913,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.998444080352783
790,1188,F-36P,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,1.79,15.4,26.2,-8.9,-3.5,-7.1,-45","6.55,12.2,15.8,25.9,5.64,17.1,20.9,13.0",8,Constant,,8.0,1.295301557,0.8031,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.068230628967285
791,1189,FaDu,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.26,3.38,.28,10.3,1.36,-5.9,-7.1,-25","8.13,11.6,7.10,17.9,3.43,13.5,17.9,44.5",8,Constant,,8.0,1.364941239,0.2629,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.176494598388672
792,1190,FU97,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.2,-18,5.46,3.66,7.65,-2.1,-23,-52","2.57,6.02,2.52,.45,5.13,3.30,48.6,54.4",8,Constant,,8.0,3.657366753,0.806,FU97_STOMACH,FU97,ACH-000633,Gastric Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.96759033203125
793,1191,FU-OV-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.45,-6.9,-.60,-4.5,11.4,-2.5,33.3,-4.1","10.1,17.1,13.5,34.9,3.16,2.66,5.35,38.5",8,Constant,,8.0,6.433806419,0.2678,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.029972553253174
794,1192,G-361,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,-.79,-6.5,2.19,-2.2,13.8,-8.6,-60","9.18,8.24,13.5,20.6,22.1,11.7,6.05,54.9",8,Sigmoid,6.553905964,5.691830158,-96.12545013,0.6601,G361_SKIN,G361,ACH-000572,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.7390318410614105,2.9707517623901367
795,1193,G-401,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,-4.4,-1.9,-2.7,-2.4,-2.0,2.52,-22","5.67,7.44,6.16,12.4,4.51,8.27,6.37,23.9",8,Sigmoid,8.036013554,8.0,-44.9728775,0.6015,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.8481249809265137
796,1194,G-402,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,2.98,-4.7,5.41,-2.0,7.4e-4,-43,-61","15.1,6.11,13.7,7.28,7.84,22.5,73.0,52.0",8,Linear,,8.0,-30.55787468,0.8114,G402_SOFT_TISSUE,G402,ACH-000375,Kidney Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.992229461669922
797,1195,GAMG,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,-2.6,.11,12.2,10.8,22.0,-14,-58","7.37,13.0,8.90,7.70,5.26,6.72,15.0,24.5",8,Constant,,8.0,-0.85119009,0.5998,GAMG_CENTRAL_NERVOUS_SYSTEM,GAMG,ACH-000098,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2759909629821777
798,1196,GB-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-1.8,-1.4,16.4,-2.8,5.34,-.83,-2.6","1.94,7.82,22.5,6.61,21.6,2.81,7.29,5.82",8,Constant,,8.0,3.148371458,0.0,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2279257774353027
799,1197,GCT,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.21,1.00,6.33,-14,-31,-32,-47,-52","8.05,10.5,1.40,28.0,54.2,68.8,63.7,57.6",8,Constant,,8.0,3.429410458,1.8311,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1479692459106445
800,1198,GI-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.01,3.47,.98,-7.4,1.50,-3.8,-2.3,-44","19.1,5.86,16.2,5.30,11.4,11.2,21.3,50.8",8,Constant,,8.0,-1.057271719,0.4336,GI1_CENTRAL_NERVOUS_SYSTEM,GI1,ACH-000756,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9512574672698975
801,1199,GMS-10,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,7.72,1.54,4.57,-6.4,-10,-32,-25","2.95,8.62,9.15,7.92,4.47,41.7,36.2,68.3",8,Constant,,8.0,2.471241713,0.4683,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.923668384552002
802,1200,GRANTA-519,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,13.8,11.0,5.81,5.28,-.31,-11,-29","16.6,6.87,14.0,17.0,9.39,18.4,12.7,5.26",8,Linear,,8.0,-26.70916557,0.4665,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0660619735717773
803,1201,H4,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.22,-.93,1.55,-2.0,4.51,-1.2,-7.7,-35","2.64,1.71,6.96,6.86,4.98,1.66,9.77,23.5",8,Constant,,8.0,-1.161686897,0.5117,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2777249813079834
804,1202,HARA,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,3.27,-3.8,5.39,-.14,-6.3,-5.4,-19","13.8,2.37,16.2,4.37,9.22,16.3,7.05,33.9",8,Constant,,8.0,-1.16616416,0.1362,HARA_LUNG,HARA,ACH-000843,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0536916255950928
805,1203,HCC1187,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-4.5,-2.7,8.42,6.41,8.77,-21,-30","8.49,4.49,1.82,9.55,3.77,16.1,7.32,49.9",8,Linear,,8.0,-17.37914467,0.4499,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3125083446502686
806,1204,HCC1395,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","9.62,5.29,5.08,-13,4.09,4.36,-5.7,-38","18.0,17.2,16.8,9.28,3.22,28.6,36.8,70.4",8,Linear,,8.0,-16.95356178,0.4523,HCC1395_BREAST,HCC1395,ACH-000699,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.098475933074951
807,1205,HCC-15,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.83,-4.3,-.68,-1.8,5.32,-4.0,-3.9,-60","10.1,6.55,2.83,7.93,13.4,2.59,7.72,51.7",8,Constant,,8.0,-3.996366739,1.0101,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3254432678222656
808,1206,HCC1569,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,-6.2,-8.1,7.96,.67,-8.6,-26,-38","17.8,7.21,5.17,7.00,7.18,8.71,28.7,62.7",8,Linear,,8.0,-22.41881561,0.3944,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.331216335296631
809,1207,HCC1806,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.26,16.5,-13,13.1,-6.2,6.25,-.65,-14","7.90,8.72,16.0,4.84,8.52,12.1,23.8,35.5",8,Constant,,8.0,7.366841793,0.1681,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2573962211608887
810,1208,HCC1954,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.05,-4.4,-4.7,-7.0,-1.1,-7.3,2.47,-22","1.25,6.66,7.06,1.97,4.95,17.4,5.98,49.9",8,Constant,,8.0,-0.06186438,0.2587,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3520867824554443
811,1209,HCC2935,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.51,-8.6,-4.5,13.8,4.37,7.21,13.7,-6.6","13.0,5.27,25.5,11.8,24.5,9.15,25.2,42.9",8,Constant,,8.0,15.45193863,0.1044,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.272462844848633
812,1210,HCC4006,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.80,5.55,-.74,1.88,7.58,-5.7,-8.3,-8.8","5.54,.26,4.02,10.5,9.11,10.8,2.10,3.50",8,Constant,,8.0,1.530913234,0.0,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3007147312164307
813,1211,HCC-44,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,.14,3.32,-7.6,-11,-28,-32,-48","5.62,1.87,6.96,9.29,19.7,40.5,65.5,71.2",8,Constant,,8.0,0.875980735,1.1856,HCC44_LUNG,HCC44,ACH-000667,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.250732898712158
814,1212,HCC-56,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,1.92,-6.3,-3.7,-12,.49,-3.0,-22","25.5,18.0,8.69,4.36,5.23,20.5,5.58,15.0",8,Constant,,8.0,-5.920182228,0.3011,HCC56_LARGE_INTESTINE,HCC56,ACH-000467,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.046812057495117
815,1213,HCC70,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,2.21,-1.7,2.42,-5.7,-5.6,-9.3,-18","6.55,4.99,14.2,15.6,18.7,25.1,23.4,40.4",8,Constant,,8.0,-3.123594761,0.1703,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2143774032592773
816,1214,HCC-78,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,-1.3,2.33,2.46,-4.6,-13,-34,-40","7.44,4.62,2.37,2.00,12.7,16.3,66.2,53.5",8,Constant,,8.0,-0.361786991,0.7086,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.336724042892456
817,1215,HCC827,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,-4.7,-1.6,-3.1,7.56,-5.9,-30,-38","40.9,10.2,6.90,7.47,20.7,20.0,25.1,78.4",8,Linear,,8.0,-36.04058075,0.4763,HCC827_LUNG,HCC827,ACH-000012,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2314963340759277
818,1216,HCT 116,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.36,-5.3,-1.3,-4.2,-6.5,-23,1.75,-9.8","5.47,8.87,4.41,4.72,11.9,3.32,8.08,13.6",8,Constant,,8.0,-2.327574015,0.6267,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.038439989089966
819,1217,HCT-15,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","8.23,.99,-8.6,5.16,2.12,-3.7,-8.0,-9.5","3.54,.70,8.67,8.71,6.40,11.5,17.2,14.4",8,Constant,,8.0,0.314082563,0.2077,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2591867446899414
820,1218,HD-MY-Z,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-8.5,-2.7,1.59,2.39,1.44,-12,-56","26.1,11.3,5.63,1.51,6.65,5.12,25.7,51.6",8,Constant,,8.0,-3.70621562,0.6999,HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HDMYZ,ACH-000190,Unknown,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9577457904815674
821,1219,HDQ-P1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-.13,10.4,-3.1,-8.3,-19,-42,-58","7.55,6.14,8.54,14.3,9.34,25.2,41.3,49.7",8,Constant,,8.0,-0.977406263,1.2229,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2462239265441895
822,1220,HEC-151,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","7.37,-2.0,-.25,.24,3.04,-36,-27,-36","8.35,8.41,12.3,11.0,20.6,45.1,59.4,43.6",8,Constant,,8.0,0.438065648,0.9897,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.8389103412628174
823,1221,HEC-1-A,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","7.38,-.86,8.33,10.6,.067,7.02,-.065,-2.1","24.2,10.5,19.0,13.2,6.10,25.2,5.71,20.5",8,Constant,,8.0,-0.064681083,0.0,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0881896018981934
824,1222,HEC-1-B,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","8.59,8.39,-7.2,6.78,2.24,10.5,23.5,15.0","9.66,8.83,16.9,14.1,29.4,14.4,23.0,15.5",8,Constant,,8.0,5.965909481,0.02138,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1275196075439453
825,1223,HEC-251,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,10.7,1.53,5.67,-11,-7.3,-8.6,-13","12.6,6.40,9.27,6.18,6.95,15.3,10.2,14.3",8,Constant,,8.0,2.165766478,0.1203,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.285320520401001
826,1224,HEC-265,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,-9.6,-.44,-4.9,-5.2,-13,-15,-27","4.57,6.70,9.75,3.41,5.17,17.0,29.2,43.4",8,Constant,,8.0,-1.027635217,0.5421,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0050079822540283
827,1225,HEC-59,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.2,.12,8.33,6.54,-1.2,-4.9,-13,-14","4.35,1.28,4.23,9.20,5.89,16.3,27.7,36.6",8,Constant,,8.0,5.304269314,0.03088,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0693020820617676
828,1226,HEC-6,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.41,-11,20.5,3.39,28.2,-18,-16,-65","20.2,13.3,15.7,20.4,45.9,39.5,39.5,24.2",8,Linear,,8.0,-40.64346313,1.6126,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.240215301513672
829,1227,HEL 92.1.7,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,6.11,-3.3,4.31,2.55,7.94,-5.5,-15","7.26,17.9,1.64,16.6,2.50,11.1,2.65,9.33",8,Constant,,8.0,-4.182910919,0.2805,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.86702036857605
830,1228,Hep 3B2.1-7,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,35.1,11.4,26.5,-14,29.8,-20,-24","12.3,7.56,3.55,18.6,10.2,3.76,9.56,26.6",8,Constant,,8.0,-7.707257748,0.4931,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.307403802871704
831,1229,Hep G2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.15,2.62,1.45,.21,10.4,12.0,.49,-29","8.25,3.57,3.36,3.93,10.3,10.4,18.7,38.8",8,Sigmoid,3.472042322,5.555599213,-55.03087997,0.2249,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.71480628640105,3.3158435821533203
832,1230,Hey-A8,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,2.33,6.27,3.75,-3.7,-1.9,9.97,-1.3","3.09,.50,2.42,.62,.87,3.33,3.11,4.63",8,Constant,,8.0,1.885689735,0.0,HEYA8_OVARY,HEYA8,ACH-000542,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.07165789604187
833,1231,HGC-27,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,-1.4,2.62,1.25,1.76,.13,-2.0,-13","3.75,1.14,4.21,1.11,4.28,4.75,1.58,6.73",8,Sigmoid,3.231816292,8.0,-19.53985214,0.05354,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9676313400268555
834,1232,HH,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,16.0,5.64,18.2,-13,11.4,22.8,7.73","6.72,8.94,28.5,32.0,14.4,10.0,25.2,9.82",8,Constant,,8.0,4.41689539,0.3423,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9139490127563477
835,1233,HLF,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,4.58,3.32,3.49,11.8,3.47,.096,-11","12.5,6.38,7.37,3.12,1.12,11.1,10.8,13.0",8,Sigmoid,7.182582378,8.0,-19.41041183,0.1807,HLF_LIVER,HLF,ACH-000393,Liver Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0476417541503906
836,1234,HMC-1-8,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.99,-5.1,-.15,3.08,7.54,-.82,-.66,-3.8","3.71,6.41,4.05,4.45,1.51,3.07,1.12,5.58",8,Constant,,8.0,1.288721681,0.0,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9890336990356445
837,1235,HMCB,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-3.6,-4.5,2.59,-4.0,-4.7,-4.4,-38","0,.0041,5.21,2.50,2.55,3.13,.79,4.74",8,Sigmoid,8.51023704,8.0,-37.87001801,0.5584,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.897183895111084
838,1236,HOS,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","19.5,2.85,-6.1,-6.3,-3.3,-2.2,-27,-71","8.56,6.68,7.29,21.1,14.8,48.1,43.2,26.7",8,Constant,,8.0,-0.860108733,1.1388,HOS_BONE,HOS,ACH-000613,Bone Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0502424240112305
839,1237,HPAC,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-8.2,-8.7,4.30,-9.2,-6.0,-33,-49","52.3,12.6,5.34,22.9,22.9,10.6,41.4,58.1",8,Linear,,0.054659581,-75.57476807,1.1633,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,-2.9066307640805675,3.2893707752227783
840,1238,HPAF-II,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-19,-1.3,-15,-6.3,-17,-51,-59","32.7,15.1,7.12,38.7,25.2,13.6,38.2,44.7",8,Constant,,8.0,-24.6514225,1.7663,HPAFII_PANCREAS,HPAFII,ACH-000094,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.5509324073791504
841,1239,Hs 294T,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,4.38,4.26,1.52,.26,-5.2,11.1,-11","3.23,4.98,3.31,3.94,5.56,5.27,17.9,30.7",8,Constant,,8.0,2.183810472,0.1508,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2695722579956055
842,1240,Hs 578T,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.27,3.12,-5.6,-2.7,1.22,8.23,-5.0,1.48","5.61,5.13,6.42,.43,4.12,9.07,7.17,20.3",8,Constant,,8.0,-1.371344924,0.0,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2606773376464844
843,1241,Hs 683,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.76,2.50,-.016,-.093,-1.0,3.02,-7.7,-10","9.63,10.5,8.73,11.7,11.7,6.74,8.16,16.2",8,Constant,,8.0,-6.109383583,0.05832,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9386584758758545
844,1242,Hs 695T,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-5.8,8.18,2.36,-5.5,-3.0,-3.0,8.88","8.62,19.1,4.74,2.55,6.68,3.57,4.71,2.84",8,Constant,,8.0,0.394015908,0.2251,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3863587379455566
845,1243,Hs 729,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,-2.8,-2.3,-4.2,1.05,-20,-23,-42","14.6,.73,18.7,12.2,9.32,3.42,50.7,55.5",8,Constant,,8.0,-4.644103527,0.9979,HS729_SOFT_TISSUE,HS729,ACH-000133,Unknown,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.15989351272583
846,1244,Hs 746T,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,6.87,.32,-2.2,-23,-22,-36,-44","5.41,8.02,11.4,29.3,40.5,36.9,21.1,1.87",8,Sigmoid,0.090939686,8.0,-48.38586426,1.221,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.29935622215271
847,1245,Hs 766T,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","12.4,-2.1,5.70,24.9,.66,5.95,9.48,30.1","11.8,11.8,3.64,16.0,0,2.85,9.48,0",8,Constant,,8.0,6.840079784,0.0,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.11281156539917
848,1246,Hs 852.T,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,.31,8.57,4.85,9.36,-3.5,-12,-22","11.4,9.36,5.83,12.2,14.8,14.0,25.1,13.0",8,Constant,,8.0,3.999722958,0.3071,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.221104621887207
849,1247,Hs 936.T,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-3.5,3.06,-8.7,3.87,-1.5,-6.4,-46","5.08,4.61,3.26,8.35,4.89,.40,4.89,55.0",8,Constant,,8.0,-3.827976465,0.4376,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.4271531105041504
850,1248,Hs 939.T,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,4.25,-12,-3.6,-6.2,-5.8,-31,-45","11.4,4.27,5.88,11.5,4.63,14.0,63.9,74.0",8,Linear,,8.0,-12.58722496,0.8439,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1511216163635254
851,1249,Hs 944.T,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".21,1.99,2.59,7.70,2.50,1.58,-5.9,-36","1.62,1.20,1.78,2.36,6.36,18.2,25.5,30.9",8,Constant,,8.0,2.809737921,0.3612,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0170741081237793
852,1250,HSC-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.67,-.89,4.16,2.21,.65,-.29,2.13,-17","6.69,1.24,1.94,5.74,6.07,5.14,1.69,26.7",8,Constant,,8.0,2.928710222,0.2599,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.146768569946289
853,1251,HT,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","11.1,3.62,12.5,4.54,-11,-7.8,-4.5,-13","14.3,18.3,27.8,20.0,22.7,10.9,17.7,43.5",8,Constant,,8.0,9.820447922,0.3471,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1095705032348633
854,1252,HT-1080,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,-1.1,-.68,.50,-1.5,-8.0,-21,-23","3.28,5.09,1.12,1.12,8.93,22.1,29.5,42.0",8,Constant,,8.0,2.573042631,0.2556,HT1080_SOFT_TISSUE,HT1080,ACH-000054,Sarcoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.7672512531280518
855,1253,HT-1197,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,14.1,-1.5,15.4,15.1,14.4,4.27,10.0","8.94,11.5,5.29,23.2,7.36,18.7,7.54,0",8,Constant,,8.0,6.409262657,0.008045,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3126044273376465
856,1254,HT-144,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-.80,-.0084,1.22,.096,.92,-4.4,-29","2.71,6.73,1.85,6.35,1.40,2.50,8.47,24.8",8,Sigmoid,7.703046322,8.0,-45.5134964,0.2313,HT144_SKIN,HT144,ACH-000322,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0746304988861084
857,1255,HuCCT1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.25,-.70,2.92,2.98,1.64,-11,-5.5,-13","3.54,3.85,1.53,2.20,1.52,2.29,16.0,13.6",8,Constant,,8.0,2.66068387,0.2262,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.169806718826294
858,1256,huH-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.25,-1.7,.76,9.33,5.70,.44,3.60,-21","19.1,13.8,25.8,9.54,9.82,12.9,8.70,3.64",8,Constant,,8.0,-0.387253851,0.1365,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.073848247528076
859,1257,HUP-T3,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.053,-2.3,.82,-4.0,2.27,-2.9,-8.0,-25","6.68,7.95,14.4,9.84,15.6,6.67,6.80,44.4",8,Constant,,8.0,-1.854240417,0.1855,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.566295623779297
860,1258,HuT 78,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","20.3,-1.6,12.6,-5.6,-5.6,-21,-24,-78","10.8,8.78,39.5,15.2,19.5,17.9,77.1,22.2",8,Constant,,8.0,11.85242367,1.2301,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.198092460632324
861,1259,IA-LM,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.3,.28,-15,-6.1,-18,5.37,-6.0,-16","18.2,13.0,12.7,25.2,15.6,13.4,23.2,8.34",8,Linear,,8.0,-24.52676964,0.6265,IALM_LUNG,IALM,ACH-000672,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1711151599884033
862,1260,IGR-37,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,9.20,3.65,10.6,-3.0,11.9,6.69,-.27","8.10,8.48,8.76,9.64,10.1,3.89,9.30,11.2",8,Constant,,8.0,7.753090382,0.03001,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.997994899749756
863,1261,IGR-39,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.6,-14,12.2,-1.3,15.3,-1.1,10.8,-3.1","5.75,9.73,16.5,6.04,16.2,5.20,2.05,3.51",8,Constant,,8.0,0.194842815,0.6169,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1078121662139893
864,1262,IGROV1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,-.91,-.20,-.57,-5.9,-4.5,.0033,.40",".40,3.01,.067,2.90,1.54,8.97,5.41,2.63",8,Constant,,8.0,-1.928274989,0.05415,IGROV1_OVARY,IGROV1,ACH-000966,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1893162727355957
865,1263,IMR-32,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,-8.5,14.9,-2.7,6.49,18.2,1.66,-44",".35,13.8,25.8,7.61,6.43,12.0,16.1,10.8",8,Sigmoid,8.140401546,8.0,-33.4431572,0.4065,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.147683620452881
866,1264,IPC-298,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-2.7,-5.4,7.15,-4.2,-11,.97,-4.8","4.83,7.32,7.59,6.54,2.97,1.26,5.54,3.07",8,Constant,,8.0,-4.457651615,0.1498,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2063262462615967
867,1265,IST-MES2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.4,8.74,-7.6,-6.5,-6.8,11.4,-1.3,-.91","19.9,7.98,27.0,14.1,24.4,8.08,6.56,11.0",8,Constant,,8.0,1.545389175,0.3662,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1447486877441406
868,1266,J82,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-4.1,-4.4,.76,-7.3,-2.9,-27,-33","2.38,4.13,12.4,2.22,.34,19.3,44.1,60.1",8,Constant,,8.0,-3.029208899,0.7733,J82_URINARY_TRACT,J82,ACH-000396,Bladder Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.284189224243164
869,1267,JHH-4,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.81,-2.2,1.81,-6.6,17.7,-2.0,-17,-51","10.5,4.39,8.16,3.84,4.05,3.24,40.6,56.8",8,Constant,,8.0,-1.183157325,0.6874,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.145308017730713
870,1268,JHOS-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,14.3,1.26,-.19,1.49,-1.5,-19,-19","7.57,22.7,5.82,21.2,18.9,8.29,7.40,13.0",8,Constant,,8.0,4.097470284,0.5548,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3415913581848145
871,1269,JHUEM-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,1.81,.87,-3.5,-2.0,-1.8,-7.1,-50","3.44,11.1,9.65,9.09,11.3,4.61,33.8,67.5",8,Constant,,8.0,-3.585984707,0.4778,JHUEM2_ENDOMETRIUM,JHUEM2,ACH-000909,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.001924514770508
872,1270,JM1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,8.62,-5.4,2.59,1.12,7.68,6.36,27.9","37.9,27.0,16.6,10.3,9.05,9.58,10.6,21.1",8,Linear,,8.0,-40.26737976,0.04249,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.02447509765625
873,1271,JMSU-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-4.6,6.72,14.8,2.04,-7.2,-25,-55","10.8,3.87,6.00,3.01,6.96,9.36,62.3,54.9",8,Constant,,8.0,5.957809448,0.7479,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3533499240875244
874,1272,JURKAT,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,11.2,4.03,8.19,-1.9,-9.5,-16,-40","4.77,6.36,3.73,3.74,6.76,2.96,21.7,41.1",8,Sigmoid,3.065923214,4.221210957,-67.34200287,1.009,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.4401220435188111,2.9760162830352783
875,1273,JVM-3,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,8.89,17.2,18.6,-2.7,-14,6.04,-22","1.27,22.8,32.4,25.2,45.7,18.9,72.8,37.1",8,Constant,,8.0,23.72425652,0.8275,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.178882360458374
876,1274,K029AX,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,3.60,10.3,8.89,-5.0,-5.1,17.2,-53","16.6,12.8,3.80,3.23,3.05,1.57,2.46,5.19",8,Sigmoid,8.130042375,7.850198746,-53.25404358,0.6852,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0605388494356065,3.043919563293457
877,1275,KALS-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.34,7.58,.19,13.6,2.47,1.86,-10,-21","1.91,10.1,9.05,3.89,10.8,12.7,33.2,38.6",8,Constant,,8.0,8.538855553,0.2795,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0123720169067383
878,1276,KARPAS-422,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","7.20,-1.9,-6.8,4.03,22.9,-10,-13,-82","6.62,9.98,8.49,9.17,18.2,14.6,30.8,23.8",8,Sigmoid,6.384061813,5.938162327,-97.8730545,1.0764,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.7813997129500685,3.067375659942627
879,1277,KASUMI-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,-.0030,9.66,-2.6,3.43,-7.1,-13,-43","11.2,7.84,10.8,6.97,5.04,.95,7.46,5.71",8,Sigmoid,8.792463671,8.0,-46.04041672,1.0151,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.00431227684021
880,1278,KCL-22,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.03,3.67,-1.7,.015,-4.3,-49,-60,-71","16.2,10.7,2.72,10.6,6.86,38.0,46.5,33.6",8,Sigmoid,2.790223837,8.0,-40.20283508,1.9724,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0247011184692383
881,1279,KG-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.57,-4.4,-5.8,13.2,12.0,7.56,1.58,-61","20.9,23.6,30.1,15.8,25.7,11.4,36.2,8.01",8,Constant,,8.0,-0.215956584,0.6818,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.074321746826172
882,1280,KHM-1B,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.40,11.6,-5.3,11.2,-13,6.17,-20,-78","12.2,4.49,8.54,6.69,4.96,8.22,2.78,26.2",8,Sigmoid,3.325286388,3.339766264,-95.13924408,1.1948,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.2059008237015125,3.1428236961364746
883,1281,KMBC-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".25,-3.0,.81,1.39,-8.9,-27,-20,-48","2.29,1.83,1.57,4.77,10.2,43.4,34.2,66.3",8,Constant,,8.0,-0.85994637,0.8383,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.314380168914795
884,1282,KMM-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.66,.18,13.7,-2.3,-2.1,-25,-40,-87","11.2,13.2,7.65,6.84,23.2,45.3,50.7,6.39",8,Linear,,0.720862557,-69.34064484,1.5408,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,-0.32730678816310665,3.2255594730377197
885,1283,KMRC-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-11,-4.4,.71,-1.4,-5.7,-4.3,-29","10.8,.79,3.56,4.03,7.89,14.8,3.71,.67",8,Sigmoid,7.998670101,8.0,-29.40368843,0.3043,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.222480297088623
886,1284,KMRC-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","27.0,-8.1,12.2,-9.5,26.5,-6.3,22.0,-19","4.54,12.1,10.2,21.6,4.95,7.46,24.0,29.0",8,Constant,,8.0,2.471864462,0.05675,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.8831911087036133
887,1285,KMS-11,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.24,-9.6,14.5,7.43,-8.7,2.75,-18,-44","11.1,2.42,16.5,11.6,9.50,1.48,13.1,19.7",8,Sigmoid,2.473711967,8.0,-31.14797783,1.3851,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0866260528564453
888,1286,KMS-12-BM,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","20.2,-7.7,-1.2,3.47,5.20,22.8,8.38,-24","21.3,22.2,10.5,35.1,20.7,25.1,35.9,48.6",8,Constant,,8.0,3.271294355,0.4828,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.127077579498291
889,1287,KMS-34,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".93,-2.6,2.43,3.97,-.0044,-4.3,-4.0,-17","6.62,7.54,3.75,21.9,30.3,2.31,29.7,27.6",8,Sigmoid,2.231092691,8.0,-35.71008682,0.7987,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0931143760681152
890,1288,KNS-60,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.88,-.36,1.93,-6.4,-8.3,-23,-33,-53","10.5,10.3,3.36,4.21,23.9,46.6,59.1,49.6",8,Linear,,8.0,-14.20052814,0.9126,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.256432056427002
891,1289,KNS-62,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,1.46,2.69,-7.2,-8.0,-19,-30,-44","6.68,1.46,8.10,25.0,2.41,18.5,39.3,44.5",8,Constant,,8.0,-7.528455257,0.8163,KNS62_LUNG,KNS62,ACH-000858,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1140081882476807
892,1290,KNS-81,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,6.69,5.25,9.85,-2.5,.053,-7.9,-25","6.87,7.62,11.7,8.00,9.18,6.92,7.25,34.1",8,Constant,,8.0,-0.315755427,0.5666,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.237969398498535
893,1291,KO52,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-2.3,7.40,8.71,-12,-5.0,-10,-32","20.3,7.80,10.8,13.4,13.0,8.79,19.2,8.28",8,Constant,,8.0,-7.01295948,1.2709,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.196537971496582
894,1292,KP-N-SI9s,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,.39,12.2,15.3,1.06,-13,-25,-42","8.85,5.46,9.20,24.5,11.8,1.57,15.6,11.5",8,Sigmoid,0.917449415,8.0,-35.82545471,1.1746,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.162696361541748
895,1293,KU812,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,-4.1,6.75,8.58,1.67,1.96,2.02,-31","7.54,10.8,4.59,3.45,12.9,15.9,22.7,47.6",8,Constant,,8.0,-0.484898776,0.3105,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9996073246002197
896,1294,KYM-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,-14,-4.0,-24,-13,-46,-53,-69","4.10,4.66,26.7,31.2,46.8,73.8,59.2,41.4",8,Linear,,8.0,-28.21921349,2.4325,KYM1_SOFT_TISSUE,KYM1,ACH-000607,Rhabdoid,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.788113594055176
897,1295,KYSE-140,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.88,3.04,-8.5,-1.9,1.27,-38,-61,-54","17.0,10.5,17.2,8.35,25.5,54.8,42.1,57.2",8,Constant,,8.0,-4.577453613,1.2101,KYSE140_OESOPHAGUS,KYSE140,ACH-000823,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.059443473815918
898,1296,KYSE-150,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,.34,8.47,3.19,9.67,-5.2,.57,-9.2e-4","3.93,10.7,8.40,5.00,5.85,3.17,7.28,4.65",8,Constant,,8.0,0.754086375,0.0,KYSE150_OESOPHAGUS,KYSE150,ACH-000855,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3128838539123535
899,1297,KYSE-180,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.95,.95,-9.9,-1.5,-3.2,-3.7,-11,-50","22.3,.79,8.44,7.78,6.29,15.9,24.2,56.3",8,Constant,,8.0,0.505656064,0.4611,KYSE180_OESOPHAGUS,KYSE180,ACH-000693,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.070998191833496
900,1298,KYSE-30,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.23,2.16,2.35,-2.2,2.58,.63,-.92,-8.0","6.17,2.02,3.27,.44,1.15,2.48,1.38,11.2",8,Constant,,8.0,-1.665513635,0.139,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3728933334350586
901,1299,KYSE-510,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","7.01,12.9,-1.4,.22,-6.1,.045,-7.5,-48","4.21,11.4,3.35,6.83,4.13,8.87,12.1,64.1",8,Constant,,8.0,-2.674756765,0.6993,KYSE510_OESOPHAGUS,KYSE510,ACH-000824,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.245175361633301
902,1300,KYSE-520,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-2.9,-6.5,-.74,5.46,1.86,4.95,-8.3","9.17,9.12,6.57,5.04,2.08,3.29,2.09,9.34",8,Constant,,8.0,-0.106352754,0.01816,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.4441747665405273
903,1301,KYSE-70,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.69,7.00,-12,1.91,5.14,7.36,-15,-59","12.0,4.73,10.8,9.22,8.63,7.55,22.1,23.8",8,Linear,,8.0,-32.21973419,0.7026,KYSE70_OESOPHAGUS,KYSE70,ACH-000784,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9857029914855957
904,1302,L3.3,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".37,-2.4,8.79,.34,7.07,-.37,13.4,-11","13.4,5.56,11.6,18.8,7.74,3.33,6.49,17.9",8,Constant,,8.0,2.688089609,0.04629,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.206223487854004
905,1303,L-363,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","17.6,6.31,3.57,6.49,-42,-31,-45,-81","7.26,6.70,11.9,19.1,28.6,52.7,31.3,15.9",8,Sigmoid,9.138195133,4.469186783,-91.3430481,2.1395,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.4972064643341265,3.0629162788391113
906,1304,L-428,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,.75,9.04,11.3,-10,-13,-19,-36","8.44,.59,6.59,4.15,5.95,9.13,25.2,38.5",8,Constant,,8.0,-5.199213982,0.9671,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2056002616882324
907,1305,LCLC-103H,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.37,-3.8,-2.0,-.18,-2.1,-4.0,-16,-53","3.20,12.9,3.97,10.6,2.81,3.70,16.2,46.6",8,Constant,,8.0,-4.948693275,0.8282,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1045944690704346
908,1306,LN-229,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,-4.3,-2.2,2.40,.59,3.27,-8.8,-3.8","14.0,7.52,21.3,2.50,5.33,.94,5.86,20.2",8,Constant,,8.0,-3.629781246,0.161,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1749918460845947
909,1307,LOU-NH91,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","10.1,1.36,3.62,-4.1,-5.8,24.2,.64,-4.4","1.50,11.2,9.86,2.88,5.45,8.23,3.09,5.36",8,Constant,,8.0,-0.169696361,0.04844,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1908204555511475
910,1308,LOX IMVI,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,.31,4.27,3.95,2.18,1.78,-3.7,-41","3.86,3.60,.94,5.45,6.81,2.02,11.3,58.4",8,Constant,,8.0,0.313664794,0.469,LOXIMVI_SKIN,LOXIMVI,ACH-000750,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9682273864746094
911,1309,LP-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","34.2,10.9,16.7,48.5,36.5,-7.0,48.0,-30","64.5,52.5,10.8,33.2,28.6,11.2,39.2,23.5",8,Constant,,8.0,15.32743645,0.6193,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0932016372680664
912,1310,LS123,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-2.9,.11,-2.3,2.63,5.44,6.74,-10","4.93,11.4,6.56,13.2,2.46,8.44,8.80,30.3",8,Constant,,8.0,0.176865906,0.2806,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.221710681915283
913,1311,LS411N,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,-19,-2.4,2.79,3.95,2.29,-20,-40","5.13,16.0,14.2,14.6,9.65,6.01,10.6,35.1",8,Constant,,8.0,-8.312530518,0.8759,LS411N_LARGE_INTESTINE,LS411N,ACH-000985,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.10730242729187
914,1312,LS513,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","51.3,-17,26.2,-17,20.7,-8.5,-12,-79","21.5,16.9,26.4,25.7,34.7,24.0,81.2,17.6",8,Constant,,8.0,20.62142754,1.4464,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3835244178771973
915,1313,LU99,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-1.1,7.63,9.97,-.33,-.92,3.96,-15","15.3,1.92,7.13,5.13,4.82,11.4,3.40,11.3",8,Linear,,8.0,-20.8693943,0.1787,LU99_LUNG,LU99,ACH-000444,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9436287879943848
916,1314,LUDLU-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.18,15.1,-14,15.7,10.1,8.15,6.20,-8.1","9.45,7.62,7.62,5.68,14.3,2.82,10.6,16.6",8,Constant,,8.0,11.67856121,0.1069,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3032517433166504
917,1315,Malme-3M,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,6.18,-1.5,-.84,2.82,-10,1.43,-12","4.15,3.11,1.01,.61,5.20,3.10,6.71,11.8",8,Constant,,8.0,-1.705107331,0.269,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1579084396362305
918,1316,MCAS,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-.38,-1.4,5.63,.41,6.48,-1.3,-16","15.6,4.70,2.82,2.30,2.19,1.55,2.34,5.92",8,Constant,,8.0,-0.864280462,0.02942,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.252768039703369
919,1317,MCF7,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".19,35.7,-6.7,47.5,10.2,5.19,4.31,-14","28.7,18.7,2.92,6.04,4.02,9.37,33.2,34.7",8,Constant,,8.0,1.057473421,0.0,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.4383726119995117
920,1318,MDA-MB-157,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".26,-3.9,20.6,4.27,8.36,-2.7,27.1,-4.2","16.2,15.8,13.1,14.9,3.72,13.1,44.2,22.7",8,Constant,,8.0,6.951115608,0.01494,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0469255447387695
921,1319,MDA-MB-175-VII,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.14,5.79,-6.6,3.15,-1.1,11.5,-1.6,-19","15.4,6.96,17.1,3.08,17.0,6.88,7.61,13.3",8,Constant,,8.0,-0.375861466,0.1795,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.488003730773926
922,1320,MDA-MB-415,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.3,-1.7,-6.1,11.3,11.1,14.2,8.94,-7.9","24.5,3.22,26.8,21.9,3.17,15.8,1.54,10.6",8,Constant,,8.0,0.583533347,0.0,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3450417518615723
923,1321,MDA-MB-436,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,8.47,-9.9,1.85,-6.0,4.82,2.35,15.9","10.3,1.66,7.57,11.2,5.25,10.2,3.73,14.7",8,Constant,,8.0,-1.573630214,0.2029,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.258072853088379
924,1322,MDA-MB-453,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.15,2.08,9.37,2.12,4.31,-5.3,15.1,-20","3.25,15.9,23.0,16.5,1.83,4.27,10.6,2.53",8,Constant,,8.0,1.536154032,0.04652,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2231783866882324
925,1323,MDA-MB-468,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","8.01,-31,6.53,-25,2.13,-9.1,1.60,-46","4.47,5.31,8.75,4.54,9.58,41.4,9.71,2.04",8,Linear,,5.090885788,-53.23396683,0.868,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.6274518405691596,3.191542625427246
926,1324,MEG-01,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,4.82,1.05,15.0,-2.0,9.69,-3.6,-20","6.02,7.13,5.68,13.8,5.61,6.23,20.7,9.19",8,Sigmoid,2.915791273,8.0,-20.33312988,0.2072,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9013495445251465
927,1325,MEL-HO,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.64,11.4,10.3,20.3,3.97,3.06,11.2,-14","7.13,4.12,6.04,9.71,10.0,13.3,19.7,13.6",8,Constant,,8.0,9.503417969,0.01668,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.903690814971924
928,1326,MES-SA,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.76,2.31,1.97,4.24,-3.0,-1.1,-4.1,-5.5","5.97,15.0,2.48,3.12,3.39,4.20,4.08,10.7",8,Constant,,8.0,1.644732475,0.0,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1137495040893555
929,1327,MeWo,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,12.5,5.52,21.4,-6.2,12.3,-7.0,-24","3.57,8.59,19.8,16.6,1.86,25.3,15.8,14.8",8,Constant,,8.0,4.328145504,0.4424,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9661471843719482
930,1328,MFE-296,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-4.1,-1.7,-3.0,-4.0,.26,-22,-37","21.1,8.35,12.6,3.63,8.56,14.1,13.6,29.1",8,Constant,,8.0,-10.46947575,0.453,MFE296_ENDOMETRIUM,MFE296,ACH-000879,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.034125804901123
931,1329,MG-63,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.27,-2.3,5.53,-3.1,7.10,-1.2,-6.7,-6.2","8.36,3.30,3.90,1.41,5.70,.45,5.65,6.86",8,Constant,,8.0,-2.254619837,0.02981,MG63_BONE,MG63,ACH-000359,Bone Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0395641326904297
932,1330,Mino,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,6.23,-3.2,15.8,7.01,7.64,-26,-23","31.8,6.71,14.3,5.85,13.2,6.04,.13,75.2",8,Linear,,8.0,-34.40093613,0.1203,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1884562969207764
933,1331,MJ,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","13.9,28.3,-2.2,16.7,20.2,16.5,10.9,-42","17.9,9.46,8.54,18.9,9.75,14.1,29.9,23.5",8,Constant,,8.0,12.61318588,0.3775,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.8418824672698975
934,1332,MKN-45,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,17.5,7.06,-6.5,-24,-41,-87,-67","15.1,11.2,8.61,7.08,33.8,68.4,4.04,33.9",8,Sigmoid,0.228800446,0.259098381,-89.79872894,2.14,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,-1.3505474399862774,3.3404178619384766
935,1333,MKN7,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","18.6,19.4,7.54,2.78,10.2,-.027,12.4,20.1","4.08,14.6,9.86,17.2,19.6,18.2,18.7,31.6",8,Constant,,8.0,18.61754227,0.0,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.270897388458252
936,1334,MKN74,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,-2.0,-6.9,4.67,-6.4,-12,-37,-71","13.9,22.2,20.2,9.37,8.76,15.6,48.4,27.1",8,Constant,,8.0,-7.853661537,0.9258,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.167501926422119
937,1335,MOLP-8,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.94,.66,-4.7,19.7,9.52,-40,-26,-70","46.4,20.5,20.9,22.1,48.2,10.8,38.4,20.6",8,Constant,,8.0,-6.145564079,1.5495,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.108565330505371
938,1336,MOLT-16,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","23.0,15.8,9.56,-18,13.8,-37,-68,-92","16.5,4.71,18.1,11.2,41.3,33.7,25.1,2.60",8,Sigmoid,4.469226837,2.653279781,-93.23731995,2.6088,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,0.9757965279443007,2.7006163597106934
939,1337,MONO-MAC-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","15.9,12.5,7.35,-9.4,-8.3,-33,-66,-76","2.55,6.53,5.14,16.2,16.3,11.6,4.46,4.16",8,Sigmoid,0.888773859,1.376474261,-75.67716217,2.4402,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,0.3195253465517432,3.1455817222595215
940,1338,MOR/CPR,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,-6.6,8.03,-7.9,-13,-39,-43,-54","17.6,19.4,5.49,3.54,15.9,53.5,58.7,65.5",8,Constant,,8.0,-2.932865381,1.1972,MORCPR_LUNG,MORCPR,ACH-000851,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1216821670532227
941,1339,MSTO-211H,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,1.34,-19,11.6,-.36,4.79,-5.9,-29","21.0,13.8,5.39,20.0,6.53,8.19,7.03,12.9",8,Sigmoid,8.23935923,8.0,-29.08018684,0.3346,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.171884059906006
942,1340,NCI-H1048,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,-9.8,1.61,5.13,15.7,12.8,-6.4,-26","17.0,4.14,9.31,12.0,2.89,27.7,30.2,29.5",8,Constant,,8.0,8.750020027,0.1776,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2700304985046387
943,1341,NCI-H1092,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","7.61,1.08,-6.5,15.4,4.29,15.2,-1.9,-5.9","16.1,4.76,6.54,14.8,21.8,9.70,12.1,10.6",8,Linear,,8.0,-10.55317307,0.0,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.4828238487243652
944,1342,NCI-H1155,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".80,1.52,2.55,7.77,9.91,1.39,-25,-39","8.08,1.31,4.93,24.0,22.3,4.77,40.2,69.2",8,Constant,,8.0,1.487944484,0.3567,NCIH1155_LUNG,NCIH1155,ACH-000980,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1154391765594482
945,1343,NCI-H1184,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,12.6,53.2,37.8,-12,70.6,14.2,10.9","21.8,2.43,64.3,21.9,20.6,81.6,60.6,56.7",8,Constant,,8.0,25.97299767,0.2403,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.5050647258758545
946,1344,NCI-H1341,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-13,9.80,4.83,18.6,-7.3,-4.0,-36","3.74,13.4,5.92,20.2,11.7,12.0,40.1,8.41",8,Constant,,8.0,-1.692621946,0.5645,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.086042881011963
947,1345,NCI-H1373,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.79,-7.0,-2.3,-8.2,-.11,-1.1,3.37,-26","9.23,3.21,12.4,3.04,4.30,7.14,10.00,34.2",8,Constant,,8.0,-3.403757572,0.2623,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.50628662109375
948,1346,NCI-H1568,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.56,.67,10.6,-7.2,7.04,3.59,4.53,-21","1.85,10.2,1.72,4.63,2.79,6.32,17.3,51.0",8,Constant,,8.0,6.750699997,0.2685,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.315117359161377
949,1347,NCI-H1648,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,9.66,-.63,10.7,5.57,1.30,.043,3.50","8.37,18.1,7.86,14.6,16.9,18.8,23.9,42.1",8,Linear,,8.0,-6.788494587,0.1418,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.185319423675537
950,1348,NCI-H1650,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".093,6.72,5.77,.58,8.22,3.86,-2.6,-14","5.04,10.7,6.37,11.9,8.36,7.18,5.81,24.2",8,Constant,,8.0,-0.124470331,0.03316,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3677115440368652
951,1349,NCI-H1651,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".93,-5.8,-6.7,-2.3,-.22,-6.8,-5.6,-20","13.4,13.8,17.4,8.58,2.49,13.4,3.77,14.8",8,Constant,,8.0,-8.650915146,0.2531,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.4373176097869873
952,1350,NCI-H1792,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,-.54,-.020,-.96,2.72,-1.5,4.25,-5.0","4.00,4.11,8.90,8.05,3.34,5.74,4.53,15.5",8,Constant,,8.0,1.850300789,0.0,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.364304780960083
953,1351,NCI-H1793,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","12.2,4.54,-7.9,-20,6.03,8.75,29.8,13.4","19.1,14.3,10.3,19.1,12.0,6.16,44.8,37.8",8,Linear,,8.0,-5.997144699,0.08983,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3801307678222656
954,1352,NCI-H1915,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,.53,13.6,-13,24.6,-3.8,-15,-26","8.64,1.53,9.32,10.0,7.44,.79,12.3,44.0",8,Constant,,8.0,-3.346441746,0.3796,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2387213706970215
955,1353,NCI-H1944,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,.083,3.77,11.7,3.20,4.87,-43,-47","3.29,9.33,17.5,21.7,13.9,23.8,76.2,92.8",8,Constant,,8.0,10.93409157,0.5487,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.206233501434326
956,1354,NCI-H1975,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.3,-19,-4.1,.76,1.02,-1.0,12.4,-4.4","9.41,11.6,1.47,19.1,11.9,1.55,10.5,3.44",8,Constant,,8.0,-2.574311256,0.1393,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3370890617370605
957,1355,NCI-H2009,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-1.4,-4.2,6.52,1.31,6.69,-28,-45","12.1,4.84,7.75,6.67,14.0,7.45,27.5,36.8",8,Constant,,8.0,-4.600592136,1.1969,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2492358684539795
958,1356,NCI-H2023,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,-3.5,8.11,3.04,-3.6,2.91,-29,-60","1.82,7.33,29.2,20.3,3.82,6.43,4.82,27.3",8,Sigmoid,2.303973913,8.0,-41.81402588,0.6195,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.340717315673828
959,1357,NCI-H2030,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.02,3.58,.37,4.79,-.29,1.99,3.64,-5.6","5.56,1.20,6.63,4.40,5.00,10.5,5.34,2.37",8,Constant,,8.0,2.315696478,0.0,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.305975914001465
960,1358,NCI-H2052,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-.15,-3.0,-6.4,-1.3,-11,-.56,-.43","2.93,8.54,10.7,3.86,7.52,3.55,7.31,4.95",8,Constant,,8.0,0.894958138,0.1986,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.50449275970459
961,1359,NCI-H2085,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,10.5,-3.9,1.49,-13,1.71,-2.1,-36","1.96,7.29,6.99,6.80,16.9,6.44,13.4,24.0",8,Constant,,8.0,-5.259599686,0.4189,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3956291675567627
962,1360,NCI-H2087,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".44,3.88,-.83,6.43,6.58,1.89,-3.2,-41","11.0,3.72,7.63,7.97,6.12,5.54,5.42,38.1",8,Constant,,8.0,-1.577658653,0.3437,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.4237213134765625
963,1361,NCI-H211,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.29,2.66,3.47,.89,5.24,.58,23.6,-38","16.5,9.97,13.2,5.69,12.5,11.7,26.2,58.6",8,Sigmoid,7.166388988,6.395418167,-90.82009125,0.3437,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.8555818225724312,3.2360644340515137
964,1362,NCI-H2122,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.34,-18,15.7,-7.6,-1.3,1.70,13.4,-32","4.53,2.23,9.29,5.45,4.45,12.9,21.3,29.4",8,Constant,,8.0,-2.823547602,0.7922,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.023106098175049
965,1363,NCI-H2170,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.84,-10,5.12,.87,12.2,1.76,6.86,-3.7","11.7,14.8,7.09,4.78,8.16,9.64,10.1,26.5",8,Constant,,8.0,9.047558784,0.118,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3205113410949707
966,1364,NCI-H2172,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,-2.9,11.7,3.09,17.4,-25,-23,-84","29.5,15.3,7.73,12.8,10.1,15.9,37.4,56.0",8,Constant,,8.0,-3.061804295,0.2135,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3785295486450195
967,1365,NCI-H2228,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.13,-6.3,10.8,1.20,3.93,-5.3,22.0,15.7","25.4,.88,8.56,6.74,20.9,11.0,12.1,17.1",8,Constant,,8.0,4.708330154,0.02345,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.196793794631958
968,1366,NCI-H2286,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.37,7.10,11.4,12.8,1.92,-1.3,-5.4,-17","17.9,12.3,12.3,5.00,8.72,8.98,26.1,30.2",8,Sigmoid,2.35163784,8.0,-37.52056503,0.9438,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.165384292602539
969,1367,NCI-H23,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-3.8,6.54,5.06,3.19,-3.6,3.44,-22","15.4,7.22,15.5,4.12,2.92,27.2,7.86,34.6",8,Constant,,8.0,0.662962198,0.3608,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.247436046600342
970,1368,NCI-H2444,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,4.83,-3.0,8.77,8.29,-11,-25,-21","16.2,8.67,7.10,3.61,3.46,11.7,29.0,43.3",8,Constant,,8.0,2.215818167,0.4396,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2159485816955566
971,1369,NCI-H2452,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.20,-20,-2.3,-4.4,-3.6,-6.9,4.70,-15","13.8,10.7,4.67,16.0,7.82,30.4,12.3,4.13",8,Linear,,8.0,-15.35308075,0.3236,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.279975414276123
972,1370,NCI-H28,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,.77,-.84,-4.0,-.98,-1.3,.011,-20","6.05,2.31,3.65,8.87,7.24,2.86,6.23,5.48",8,Constant,,8.0,-3.381513834,0.2016,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.16995906829834
973,1371,NCI-H322,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.61,2.00,-2.6,7.56,1.20,.79,6.17,.52","5.48,3.23,13.8,3.87,6.36,1.77,1.46,.51",8,Constant,,8.0,3.248240471,0.0,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3131771087646484
974,1372,NCI-H3255,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,1.15,6.43,4.30,8.58,4.57,2.61,-3.7","3.78,3.99,4.38,5.40,6.92,9.13,4.28,10.6",8,Constant,,8.0,4.254320145,0.115,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2982048988342285
975,1373,NCI-H358,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.14,3.96,6.89,2.39,7.11,.63,3.02,-17","8.51,4.05,2.11,5.61,2.68,.80,11.6,14.8",8,Constant,,8.0,0.534148872,0.1218,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.4305191040039062
976,1374,NCI-H441,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,4.63,4.07,7.56,2.55,-14,.81,6.33","4.57,6.34,12.7,7.48,13.5,12.3,12.4,11.2",8,Constant,,8.0,0.089910917,0.2391,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1521522998809814
977,1375,NCI-H460,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.51,-.10,5.75,3.07,1.18,5.45,-2.0,-25","9.02,2.89,5.27,5.24,5.56,3.19,22.2,30.2",8,Constant,,8.0,-0.013100332,0.1941,NCIH460_LUNG,NCIH460,ACH-000463,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.118666648864746
978,1376,NCI-H522,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.39,-13,-1.9,-3.7,3.43,4.27,21.6,-4.3","5.98,7.67,12.7,2.99,14.1,4.91,6.60,7.04",8,Constant,,8.0,3.003428698,0.1305,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.4328229427337646
979,1377,NCI-H647,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","8.30,1.76,-11,-14,.77,-13,-4.9,-51","19.7,3.36,11.6,14.2,9.66,16.4,3.61,44.5",8,Constant,,8.0,-7.260377407,0.5762,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2003207206726074
980,1378,NCI-H650,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.06,-.14,6.65,-3.3,-8.0,-9.5,-26,-41","5.88,6.50,7.66,8.64,7.88,11.5,47.7,74.3",8,Constant,,8.0,3.145570755,0.5756,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1520893573760986
981,1379,NCI-H661,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-2.4,7.12,.072,-2.3,-13,-14,-43","7.91,3.23,8.23,5.12,3.66,10.8,31.4,35.5",8,Constant,,8.0,1.84605813,0.6622,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1157331466674805
982,1380,NCI-H727,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.43,5.37,-.80,6.85,-7.3,13.0,-9.8,-9.0","16.8,16.8,24.8,26.4,15.7,23.1,17.2,53.0",8,Constant,,8.0,2.924649239,0.1742,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.571218729019165
983,1381,NCI-H747,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,27.2,3.27,6.14,15.1,2.09,-.23,-37","10.2,8.15,16.8,1.96,13.8,3.96,5.41,41.8",8,Constant,,8.0,0.440065593,0.4446,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.398103952407837
984,1382,NCI-H810,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.43,-3.6,-7.2,13.9,10.5,17.5,-4.3,-1.5","14.4,24.4,2.18,11.6,14.4,13.1,7.27,7.56",8,Constant,,8.0,3.356054068,0.2943,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.322688102722168
985,1383,NCI-N87,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","13.5,-6.2,-19,3.76,-2.4,2.68,16.7,-5.8","15.5,13.3,3.00,12.8,.43,32.3,42.8,4.05",8,Linear,,8.0,-16.42986107,0.4056,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3056535720825195
986,1384,NCO2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,19.8,3.53,-2.4,-12,-8.1,-39,-83","3.60,17.0,17.2,12.0,5.31,25.2,9.35,22.1",8,Sigmoid,2.525011301,2.515162706,-97.49664307,1.8126,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,0.9223374956937131,2.9357080459594727
987,1385,NIH:OVCAR-3,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,12.7,27.7,-13,30.8,.75,41.5,36.1","29.4,8.19,12.4,1.54,30.8,5.41,8.53,54.8",8,Constant,,8.0,13.41745853,0.2992,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.170274019241333
988,1386,NUGC-3,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.24,-.20,6.46,-6.1,-5.6,-3.0,.28,-5.1","24.5,7.41,13.0,11.5,26.6,7.68,17.6,20.4",8,Constant,,8.0,4.526775837,0.2236,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1720290184020996
989,1387,NUGC-4,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,5.58,-13,3.05,-21,-16,-43,-79","12.7,8.49,18.7,2.26,28.9,24.8,3.42,14.8",8,Sigmoid,6.853005886,3.009513855,-58.93414307,1.2881,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.1017785557498676,3.6355624198913574
990,1388,OCI-AML2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,3.05,3.97,10.3,-.67,-.75,-4.1,-15","1.09,2.25,2.58,3.47,4.11,3.43,5.06,4.93",8,Constant,,8.0,-3.104340792,0.07766,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.824488401412964
991,1389,OCI-AML5,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","11.9,-.66,6.80,5.84,-2.6,-5.9,-24,-28","17.5,8.41,2.91,3.06,3.70,1.45,10.2,12.6",8,Sigmoid,1.232947946,8.0,-37.61729813,1.707,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.802640914916992
992,1390,OCUM-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,5.15,13.6,3.41,-1.4,11.9,-8.5,-29","8.39,4.18,10.8,5.01,23.0,8.29,2.47,46.5",8,Constant,,8.0,2.870867014,0.2974,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.297663927078247
993,1391,OE21,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,2.83,5.90,-6.6,5.26,3.92,-7.4,-37","12.7,7.79,6.44,9.52,8.82,12.5,3.83,33.9",8,Sigmoid,2.264820814,8.0,-14.7461586,0.3258,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.032383918762207
994,1392,OE33,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.34,4.72,8.01,-7.0,7.23,-26,-20,-39","11.5,19.4,14.9,16.3,6.67,16.5,19.6,6.81",8,Sigmoid,0.403171003,8.0,-34.78709412,0.7694,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.501862049102783
995,1393,ONCO-DG-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.16,-4.2,-5.0,1.17,4.81,7.70,-3.6,-16","17.1,4.42,1.64,6.91,11.8,14.7,6.70,14.1",8,Constant,,8.0,-2.215890408,0.142,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2603659629821777
996,1394,ONS-76,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-.96,4.91,3.04,1.55,-1.5,1.52,.11","1.94,1.39,6.75,2.74,1.68,2.24,6.47,2.40",8,Constant,,8.0,1.273013353,0.01134,ONS76_CENTRAL_NERVOUS_SYSTEM,ONS76,ACH-000776,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3639109134674072
997,1395,OPM-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,29.5,-3.3,40.2,12.8,-11,-14,-44","34.4,12.0,22.8,36.2,10.2,31.7,57.2,41.7",8,Constant,,8.0,-6.746687889,0.6293,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0913944244384766
998,1396,OV-90,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.36,1.17,11.6,10.8,11.6,-1.8,5.03,-6.1","2.53,13.4,.26,6.83,11.5,3.69,1.15,6.96",8,Constant,,8.0,5.237266064,0.07258,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1115834712982178
999,1397,OVCAR-4,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".71,-6.4,-4.4,-9.5,-11,-11,3.68,-3.7",".42,13.2,4.64,8.31,16.4,.61,2.39,7.27",8,Constant,,8.0,-2.639470816,0.01486,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.290076494216919
1000,1398,OVCAR-8,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-3.5,9.43,-1.3,4.03,1.22,4.66,-47","4.47,10.1,9.33,12.4,4.55,8.42,.48,20.5",8,Sigmoid,8.022311906,8.0,-44.01670074,0.4074,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3639469146728516
1001,1399,OVMANA,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.58,5.41,1.25,-.93,-2.9,1.39,6.94,2.25","5.92,1.44,8.63,1.81,8.86,8.12,16.6,19.9",8,Constant,,8.0,5.435899734,0.1321,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.8757638931274414
1002,1400,OVSAHO,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.48,-.20,21.1,2.05,13.2,11.6,34.6,-2.0","6.83,10.0,2.69,11.8,6.48,7.50,9.39,.17",8,Constant,,8.0,9.385293007,0.0,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3939380645751953
1003,1401,OVTOKO,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,1.42,.93,2.84,-3.6,-5.5,1.39,-7.1","2.84,.15,4.58,7.50,7.63,7.72,5.71,6.15",8,Constant,,8.0,-2.13732338,0.2041,OVTOKO_OVARY,OVTOKO,ACH-000663,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.151169776916504
1004,1402,P12-ICHIKAWA,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.54,1.70,10.4,9.05,-3.2,-18,-24,-49","8.25,10.8,4.80,6.68,13.8,13.9,23.4,23.4",8,Sigmoid,2.036108971,8.0,-19.8465786,0.7028,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.8135221004486084
1005,1403,P31/FUJ,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,1.96,-1.3,-7.1,2.49,-37,-17,-69","3.91,7.74,3.52,9.36,28.3,67.1,51.5,33.4",8,Sigmoid,8.134393084,8.0,-28.1795063,1.3855,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.153000593185425
1006,1404,P3HR-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-3.9,-1.2,13.8,10.8,-5.5,-18,-41","13.4,6.17,5.89,22.9,11.0,7.34,2.65,50.5",8,Constant,,8.0,-0.012675148,0.5316,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.207432746887207
1007,1405,Panc 02.03,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-7.2,-.53,3.41,-12,-14,-.84,-9.0","5.53,8.00,7.46,13.8,16.7,3.25,.45,6.55",8,Constant,,8.0,-4.698207855,0.3393,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.306556224822998
1008,1406,Panc 03.27,PHA-665752,c-MET,".0080,.025,.080,.25,.80,2.53,8","-24,-11,2.64,-7.9,26.6,39.3,24.1","12.0,11.4,5.14,5.48,0,13.4,.078",7,Linear,,8.0,-23.87863731,0.2903,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.320227861404419
1009,1407,Panc 04.03,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,-16,6.39,7.15,-4.0,-12,-2.1,-23","3.77,10.4,5.57,9.39,16.7,7.19,31.3,15.6",8,Constant,,8.0,-8.042016983,0.09142,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.5946578979492188
1010,1408,Panc 10.05,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.03,-12,4.01,8.04,-16,4.62,32.6,7.99","47.1,9.34,.58,3.31,31.1,15.3,13.6,18.2",8,Constant,,8.0,4.522503376,0.2858,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.442038059234619
1011,1409,PA-TU-8902,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".32,-3.0,4.12,1.55,2.94,2.14,-27,-47","1.26,7.91,2.16,2.57,3.48,3.42,39.5,56.9",8,Constant,,8.0,0.677066743,0.6979,PATU8902_PANCREAS,PATU8902,ACH-000599,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.127791166305542
1012,1410,PC-3,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.3,1.00,1.39,3.05,.69,2.19,8.24,-1.5",".068,14.6,3.65,12.6,11.7,7.11,5.62,6.58",8,Constant,,8.0,6.952019215,0.01305,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.369020938873291
1013,1411,Pfeiffer,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","9.96,14.2,9.81,-.22,16.4,-9.0,-31,-59","26.4,14.7,13.1,15.9,12.6,15.2,35.6,51.3",8,Constant,,8.0,-4.823456287,0.8396,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.587172746658325
1014,1412,PK-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,.073,4.30,3.73,3.44,1.05,2.47,-2.7","1.68,6.85,2.98,5.63,3.42,3.94,4.23,4.49",8,Constant,,8.0,2.876432657,0.0112,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.4562838077545166
1015,1413,PK-45H,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,19.5,-8.8,19.3,-1.2,23.2,-11,4.30","2.92,9.98,5.94,14.2,8.99,16.9,5.79,24.9",8,Constant,,8.0,-2.556892633,0.3306,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3726024627685547
1016,1414,PK-59,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.13,.22,-.27,2.03,3.34,-.73,-5.3,-6.9","2.09,.70,1.87,.89,5.47,7.29,7.10,11.0",8,Constant,,8.0,0.181552365,0.0,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.4330806732177734
1017,1415,PLC/PRF/5,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-1.2,-16,3.88,-2.5,20.5,-5.9,-13","11.5,3.08,12.2,.72,12.0,3.67,3.59,17.7",8,Constant,,8.0,-4.395969391,0.1747,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9175286293029785
1018,1416,PSN1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.38,1.36,5.61,6.02,.13,5.84,-40,-45","3.72,4.19,5.81,4.35,9.34,10.8,61.6,68.8",8,Constant,,8.0,2.020934582,0.7477,PSN1_PANCREAS,PSN1,ACH-000320,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1578004360198975
1019,1417,QGP-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-13,1.00,-5.8,-1.7,-.78,-25,-50","24.9,3.47,3.89,6.49,15.3,12.9,16.8,43.7",8,Linear,,8.0,-37.92529297,0.9048,QGP1_PANCREAS,QGP1,ACH-000347,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.373368740081787
1020,1418,Raji,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-7.1,6.30,8.00,-13,-5.4,-6.6,-18","5.78,16.5,33.7,6.11,7.04,6.87,1.43,42.1",8,Constant,,8.0,-7.297501564,0.4254,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.93464994430542
1021,1419,RD,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".53,-8.4,2.30,-1.7,-1.9,-7.1,-14,-36","4.34,7.74,5.34,14.3,5.69,3.29,7.00,31.6",8,Constant,,8.0,-8.041443825,0.635,RD_SOFT_TISSUE,RD,ACH-000169,Sarcoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3657212257385254
1022,1420,Reh,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.80,-2.0,.26,-1.7,-.091,3.83,-6.7,-50","11.9,10.8,6.01,10.4,6.18,9.09,7.39,3.59",8,Sigmoid,3.466953754,8.0,-47.9125061,0.4732,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.7068376541137695
1023,1421,RERF-GC-1B,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-7.7,6.03,5.96,.081,8.34,-1.1,-18","11.8,4.95,10.9,7.67,5.01,4.32,8.93,35.6",8,Linear,,8.0,-8.999637604,0.3157,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.387367010116577
1024,1422,RERF-LC-AI,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,-2.8,.64,.59,8.10,1.44,3.06,-5.0","2.79,1.20,6.16,4.15,1.05,1.14,.89,1.43",8,Constant,,8.0,-2.010349512,0.002634,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.237794876098633
1025,1423,RKO,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-3.0,-.59,-3.9,1.37,-8.9,-11,-28","16.6,1.84,8.03,7.94,2.85,4.56,6.81,4.61",8,Constant,,8.0,-10.37917519,0.47,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0889980792999268
1026,1424,RL95-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-3.6,.77,12.7,-1.9,17.9,18.6,12.9","45.4,5.82,10.7,14.4,7.51,15.8,20.0,10.5",8,Linear,,8.0,-36.19473267,0.0,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3188657760620117
1027,1425,RPMI-7951,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,-11,-6.3,.65,-10,-15,-25,-26","19.4,9.04,2.13,13.6,7.13,16.8,19.7,18.5",8,Constant,,8.0,-7.470881462,0.7986,RPMI7951_SKIN,RPMI7951,ACH-000348,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3557181358337402
1028,1426,RPMI-8402,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.67,1.92,7.68,8.72,.86,-.85,-16,-37","3.99,6.63,6.14,8.55,1.96,1.04,1.84,9.06",8,Sigmoid,8.310730346,5.857888222,-73.89639282,0.5896,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.7677891669670907,2.7398877143859863
1029,1427,RT-112,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,5.78,-3.1,10.4,-2.9,-4.0,-5.7,-22","7.27,1.56,8.47,2.67,9.79,1.83,12.8,8.31",8,Sigmoid,9.177484114,8.0,-21.47139359,0.1706,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1504855155944824
1030,1428,RT4,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-33,19.9,-9.9,-2.2,-21,7.33,-24","15.8,22.0,21.0,6.99,14.9,6.18,5.93,17.1",8,Constant,,8.0,-15.05836773,1.0759,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1826672554016113
1031,1429,RVH-421,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,4.46,1.68,7.34,-4.1,6.39,-7.0,-22","8.53,11.5,4.73,2.98,5.49,9.82,4.47,22.8",8,Constant,,8.0,1.333927989,0.2618,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.151068687438965
1032,1430,SBC-5,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-.87,3.30,4.92,.17,-7.2,-19,-22","2.78,.87,4.15,1.33,6.82,7.32,18.1,31.2",8,Sigmoid,1.64845717,8.0,-45.3801918,0.2232,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.996542453765869
1033,1431,SCaBER,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.35,13.1,9.51,1.97,-12,6.76,2.87,-17","1.47,.071,8.50,11.6,7.60,8.09,7.07,1.01",8,Constant,,8.0,0.996594667,0.1211,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.408808708190918
1034,1432,SCC-9,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,-14,.92,-8.5,-6.6,-44,-44,-42","21.2,2.16,17.9,7.55,32.3,17.8,65.0,79.7",8,Constant,,8.0,-6.310967922,1.1941,SCC9_UPPER_AERODIGESTIVE_TRACT,SCC9,ACH-000181,Head and Neck Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.994838237762451
1035,1433,SF126,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.71,-1.7,4.90,-2.0,11.8,3.46,7.78,.099","6.72,.79,3.16,1.59,5.41,4.98,1.94,10.2",8,Constant,,8.0,3.305734396,0.0,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1608660221099854
1036,1434,SF-295,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-13,-1.1,-7.7,-1.5,-13,-7.6,-25","8.06,5.12,8.25,6.54,4.66,3.43,15.1,11.6",8,Sigmoid,2.685572386,8.0,-32.64720154,0.4697,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.055842876434326
1037,1435,SH-10-TC,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.31,1.22,-12,-9.1,-3.5,1.72,-2.8,-3.3","6.27,2.91,4.98,1.73,5.61,5.56,1.47,9.61",8,Constant,,8.0,-3.029616117,0.0805,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.189810276031494
1038,1436,SHP-77,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-6.8,1.17,20.6,-.79,14.9,-3.9,2.00","13.8,21.7,9.66,10.6,5.66,5.93,5.38,4.85",8,Constant,,8.0,-1.90098381,0.0,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.168839454650879
1039,1437,SIG-M5,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.36,12.0,-3.3,12.3,-1.4,-17,-35,-63","12.3,4.12,22.3,8.86,2.49,18.1,23.9,25.1",8,Linear,,0.449669963,-80.17800903,1.5314,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,-0.7992413808540891,2.7064340114593506
1040,1438,SIMA,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","24.0,7.52,8.84,-.079,13.5,-10,10.4,-41","4.69,21.7,6.65,12.7,13.5,31.0,10.3,14.3",8,Constant,,8.0,8.726161957,0.4474,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0106186866760254
1041,1439,SJSA-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-6.9,-3.8,3.29,-6.3,15.5,-7.6,-24","4.13,5.88,21.0,5.47,2.56,7.07,12.3,5.09",8,Constant,,8.0,-6.200252533,0.5401,SJSA1_BONE,SJSA1,ACH-000748,Bone Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1089680194854736
1042,1440,SK-BR-3,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".20,-18,18.1,-1.9,29.0,-5.7,19.0,-23","1.18,3.77,18.3,12.8,20.7,4.05,15.9,14.4",8,Constant,,8.0,0.202983677,0.2668,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.359369993209839
1043,1441,SK-CO-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,3.34,-3.1,7.23,-2.0,2.61,-5.2,-18","4.68,9.27,9.81,9.27,14.2,6.25,17.3,45.1",8,Constant,,8.0,1.7164464,0.2464,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2692582607269287
1044,1442,SK-ES-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".69,1.76,.77,7.18,.94,15.4,-3.3,-21","10.5,3.62,6.81,9.93,10.7,11.6,11.5,41.3",8,Sigmoid,3.841619492,8.0,-48.52488327,0.1814,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.229447841644287
1045,1443,SK-HEP-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","28.7,10.1,22.4,-3.5,16.3,-1.4,24.8,-5.6","10.5,5.72,8.98,7.46,14.6,3.21,2.28,3.39",8,Constant,,8.0,13.61033249,0.005834,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3043570518493652
1046,1444,SK-MEL-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-6.8,.94,7.13,-7.7,-2.6,-17,-1.2","7.13,6.73,6.80,12.0,11.3,17.2,9.86,16.1",8,Constant,,8.0,-2.414996862,0.5486,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1996757984161377
1047,1445,SK-MEL-24,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,15.2,5.47,4.26,2.68,8.98,.39,-22","1.36,4.71,8.49,20.1,5.20,21.1,12.9,23.8",8,Sigmoid,8.070814571,8.0,-37.66615295,0.2063,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.167548179626465
1048,1446,SK-MEL-30,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".46,2.71,5.70,12.2,4.15,8.45,17.8,-.36",".95,4.52,19.7,21.4,10.8,6.72,13.8,13.6",8,Constant,,8.0,4.848295212,0.23,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9251551628112793
1049,1447,SK-MEL-31,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.6,4.49,13.1,-10,-2.0,8.89,-1.9,-35","7.46,10.7,12.7,19.8,5.27,12.3,2.40,27.3",8,Sigmoid,3.9356668,6.313907146,-53.12837219,0.3766,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.8427546839776174,3.1059207916259766
1050,1448,SK-MEL-5,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,11.8,-9.8,9.65,2.05,6.80,-15,-31","13.4,10.8,20.2,1.49,22.8,8.37,21.9,19.0",8,Constant,,8.0,-2.586798668,0.2392,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2281253337860107
1051,1449,SK-MES-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","10.2,-3.5,-7.2,-10,-1.5,-37,-67,-96","18.9,10.4,12.6,2.52,12.7,41.2,39.0,4.94",8,Linear,,1.323563607,-64.13309479,1.9638,SKMES1_LUNG,SKMES1,ACH-000665,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,0.2803278012204044,3.5596792697906494
1052,1450,SK-MM-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.71,-2.7,-.36,-3.7,6.15,-4.6,-20,-39","3.33,11.2,4.83,6.70,4.44,9.72,19.7,21.6",8,Sigmoid,5.240545273,8.0,-24.95109177,0.6933,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9221315383911133
1053,1451,SK-N-AS,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.60,7.30,3.39,4.39,3.09,-3.0,-6.3,-15","10.5,9.61,4.68,8.03,5.58,10.6,10.1,28.5",8,Constant,,8.0,1.962526083,0.09334,SKNAS_AUTONOMIC_GANGLIA,SKNAS,ACH-000260,Neuroblastoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3225440979003906
1054,1452,SK-N-BE(2),PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.30,1.07,12.0,-.095,9.08,25.5,1.99,-22","33.3,6.16,20.6,13.5,17.4,27.2,25.0,11.9",8,Linear,,8.0,-28.87884331,0.1546,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1999471187591553
1055,1453,SK-N-DZ,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,-6.4,3.72,5.43,5.08,-5.5,-.64,-37","4.94,3.00,3.49,12.2,4.46,11.8,13.6,24.7",8,Constant,,8.0,-2.717042923,0.4223,SKNDZ_AUTONOMIC_GANGLIA,SKNDZ,ACH-000366,Neuroblastoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0485949516296387
1056,1454,SK-N-FI,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.10,21.7,-21,37.6,-12,31.4,-23,7.17","23.3,8.69,7.53,42.6,4.93,49.0,14.2,65.2",8,Constant,,8.0,1.095631599,0.7685,SKNFI_AUTONOMIC_GANGLIA,SKNFI,ACH-000341,Neuroblastoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.196859121322632
1057,1455,SK-N-SH,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,5.42,-3.7,1.35,-2.5,-.14,-4.0,-33","27.6,7.28,7.34,6.57,4.04,21.0,2.70,20.7",8,Constant,,8.0,-3.801179409,0.5025,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2223105430603027
1058,1456,SK-OV-3,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.9,-14,4.52,3.92,3.34,-.27,4.29,-13","31.2,5.56,8.94,14.9,10.0,11.2,33.2,30.0",8,Constant,,8.0,-0.166753605,0.1467,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2258780002593994
1059,1457,SNG-M,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.59,1.23,3.60,-4.3,-1.1,-.61,-15,-51","5.88,6.10,.66,6.40,1.72,3.22,21.9,61.1",8,Constant,,8.0,-1.535426497,0.6993,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0608925819396973
1060,1458,SNU-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,3.35,-1.5,5.66,.84,-.23,4.09,-12","2.78,4.62,4.21,1.27,2.13,6.02,3.05,8.58",8,Constant,,8.0,4.21501112,0.0,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.950709342956543
1061,1459,SNU-182,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.56,-19,.91,-12,8.14,-8.0,-6.1,-54","7.67,4.44,16.6,6.47,9.43,15.5,14.1,62.0",8,Constant,,8.0,-6.419090748,1.2067,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1530942916870117
1062,1460,SNU-387,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-.18,-5.0,-.079,-2.8,-17,-40,-53","6.07,8.19,1.89,7.94,17.8,14.5,54.2,61.1",8,Constant,,8.0,1.770556927,1.5203,SNU387_LIVER,SNU387,ACH-000478,Liver Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.141829252243042
1063,1461,SNU-398,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-7.6,2.80,.52,3.88,-11,-6.6,-23","9.55,1.62,21.7,12.9,14.6,12.4,19.8,34.8",8,Constant,,8.0,-8.928504944,0.5687,SNU398_LIVER,SNU398,ACH-000221,Liver Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.071713447570801
1064,1462,SNU-423,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,-.18,-1.0,3.38,-6.8,-9.3,-40,-51","13.0,4.65,3.87,4.17,2.08,28.1,55.1,57.1",8,Linear,,8.0,-23.62347984,0.8206,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.134437084197998
1065,1463,SNU-449,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.68,5.93,6.58,6.78,7.88,-4.2,-1.1,-13","13.5,5.30,3.23,7.64,5.48,12.9,17.0,17.3",8,Constant,,8.0,3.767104626,0.05912,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.546898603439331
1066,1464,SNU-475,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,36.7,21.0,11.3,69.5,-14,-5.1,-57","9.85,24.0,44.4,34.8,57.1,23.5,24.0,25.3",8,Constant,,8.0,4.916855335,1.0051,SNU475_LIVER,SNU475,ACH-000422,Liver Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2586753368377686
1067,1465,SNU-C2A,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,-5.7,3.20,-9.4,7.08,3.92,-8.3,-8.8","14.1,12.9,16.0,13.3,6.00,21.3,14.9,7.28",8,Constant,,8.0,-4.77752924,0.3268,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2061007022857666
1068,1466,Sq-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.84,8.38,-12,-7.6,-3.8,-34,-42,-46","4.16,2.67,1.06,13.6,16.0,58.9,66.6,65.4",8,Constant,,8.0,3.699370146,1.4825,SQ1_LUNG,SQ1,ACH-000553,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.321988582611084
1069,1467,SU.86.86,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-2.5,2.94,-.79,-.042,-3.2,-11,-20","6.57,3.34,.43,4.80,1.53,5.16,4.12,26.4",8,Constant,,8.0,-1.818407178,0.2854,SU8686_PANCREAS,SU8686,ACH-000114,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.207733392715454
1070,1468,SU-DHL-10,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.11,-8.3,16.4,5.53,17.0,24.6,54.9,77.4","14.8,6.21,.26,12.1,15.0,12.2,35.8,70.1",8,Linear,,8.0,-6.031882286,0.06698,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.111725330352783
1071,1469,SU-DHL-4,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,8.37,6.02,7.21,-19,-32,-55,-95","1.22,8.42,7.61,16.3,23.6,21.3,10.7,4.17",8,Sigmoid,3.407557487,2.310960531,-97.71294403,2.5702,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,0.8376632523926139,2.784893751144409
1072,1470,SU-DHL-6,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-8.0,1.62,14.0,2.10,-27,-18,-95","16.9,25.9,6.47,65.8,35.5,42.4,24.5,3.52",8,Constant,,8.0,4.485460281,2.0272,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.7888870239257812
1073,1471,SU-DHL-8,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.73,.36,14.8,-2.3,6.75,-4.3,-5.3,-55","4.44,2.78,13.4,7.41,6.12,11.9,7.30,22.2",8,Sigmoid,8.083123838,7.086876392,-69.86495209,1.3604,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.958244678163385,3.1761178970336914
1074,1472,SUIT-2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-9.3,4.11,-3.0,-2.2,-11,-4.3,-39","6.13,12.6,10.5,3.16,5.24,8.66,11.3,20.1",8,Sigmoid,7.965821743,7.365355968,-55.70095444,0.2108,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.9967873811295136,3.0519936084747314
1075,1473,SUP-M2,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,5.13,14.9,10.8,-12,-2.6,-34,-39","13.0,9.46,2.64,3.63,7.89,26.4,78.3,83.2",8,Linear,,8.0,-2.316575289,0.5715,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.6480650901794434
1076,1474,SUP-T1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.96,4.30,13.4,1.53,3.58,.66,4.47,-18","8.27,4.93,15.6,8.23,13.7,4.42,24.8,9.34",8,Sigmoid,8.430596652,8.0,-24.16787148,0.1771,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.083515167236328
1077,1475,SW 1088,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-13,-8.3,-4.5,-4.9,-4.6,-19,-11","17.6,35.7,3.66,23.8,5.01,23.4,14.5,22.7",8,Constant,,8.0,-6.662718296,0.03335,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.266791820526123
1078,1476,SW 1271,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,21.0,10.2,5.46,7.11,-27,-33,-33","7.38,2.78,12.3,.61,8.72,36.8,62.7,73.1",8,Constant,,8.0,7.771904469,0.8502,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2211151123046875
1079,1477,SW 1353,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,-2.6,-2.0,3.27,-6.2,5.24,-2.6,4.86","6.83,5.07,11.5,3.18,2.43,7.50,3.61,3.09",8,Constant,,8.0,4.170669079,0.2262,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.272709608078003
1080,1478,SW1417,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-14,-5.4,10.9,-9.7,-19,-28,-46","19.7,8.88,25.3,14.9,9.88,17.8,7.85,43.5",8,Constant,,8.0,-11.1709137,0.7279,SW1417_LARGE_INTESTINE,SW1417,ACH-000236,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.5577409267425537
1081,1479,SW 1573,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-.80,-.91,1.50,-1.1,2.64,-18,-34","16.6,2.13,2.76,1.38,2.90,6.54,27.6,62.1",8,Linear,,8.0,-25.18657112,0.4133,SW1573_LUNG,SW1573,ACH-000677,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2358322143554688
1082,1480,SW 1990,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.43,5.70,-.32,6.92,-6.2,4.63,1.86,-5.6","13.8,5.55,17.7,6.86,3.80,17.6,6.10,17.9",8,Constant,,8.0,1.93905735,0.06233,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.464114189147949
1083,1481,SW403,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.27,2.36,11.3,30.3,5.33,1.31,23.1,-23","8.77,13.6,15.8,12.1,31.8,12.9,22.0,16.1",8,Constant,,8.0,9.752846718,0.2497,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.5240468978881836
1084,1482,SW48,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".53,20.2,11.6,19.3,-13,.86,1.85,18.0","5.92,34.0,17.1,12.5,20.0,10.6,19.7,21.4",8,Constant,,8.0,21.13356018,0.131,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0228962898254395
1085,1483,SW480,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,1.89,7.96,.94,12.8,5.33,11.7,11.9","8.25,8.60,4.96,8.77,9.85,6.50,17.6,6.26",8,Constant,,8.0,6.525783062,0.0,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.4344253540039062
1086,1484,SW579,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.12,-2.2,4.09,-2.7,10.6,-2.2,9.62,-12",".77,2.66,1.40,10.7,1.99,8.82,1.92,5.46",8,Constant,,8.0,2.391074896,0.1384,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.243129253387451
1087,1485,SW620,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.93,-1.6,9.51,-.063,11.9,-9.3,16.5,-11","2.35,7.65,14.0,11.1,.14,10.9,14.5,28.8",8,Constant,,8.0,3.484919071,0.0,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.0872230529785156
1088,1486,SW 780,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.3,-2.6,-2.1,-7.9,-3.7,-5.7,-4.3,-25","20.2,4.30,2.11,5.20,4.28,2.71,11.2,29.4",8,Constant,,8.0,-4.766456604,0.3776,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.311689853668213
1089,1487,SW 900,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.08,-5.8,5.57,2.53,-6.1,1.76,-13,-9.9","4.83,3.18,3.53,9.60,11.8,2.26,27.3,42.6",8,Constant,,8.0,3.78092885,0.09265,SW900_LUNG,SW900,ACH-000669,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.456888437271118
1090,1488,T24,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-.40,-8.9,7.54,-5.8,-1.1,-10,-13","3.89,7.30,6.16,12.0,4.06,4.25,6.39,5.11",8,Constant,,8.0,-7.415384293,0.4776,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1529433727264404
1091,1489,T3M-10,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,-12,11.5,4.80,-5.8,-2.2,-16,-37","8.37,7.09,5.13,5.01,10.2,14.3,32.6,67.6",8,Constant,,8.0,-1.418947101,0.3635,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2913851737976074
1092,1490,T-47D,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","9.86,-14,-2.2,1.91,11.6,1.84,6.72,-20","17.5,5.00,11.5,8.47,6.39,3.37,15.7,28.2",8,Sigmoid,0.002682441,8.0,-2.122644186,0.3123,T47D_BREAST,T47D,ACH-000147,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.481362819671631
1093,1491,T84,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.73,-11,-9.0,10.7,-24,-12,8.63,-12","38.3,39.7,66.3,33.7,30.5,10.8,65.4,27.8",8,Constant,,8.0,14.60095024,0.4742,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.315153121948242
1094,1492,TCCSUP,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-.13,5.21,-.80,2.04,9.13,-18,-50","5.14,2.63,1.61,2.33,.29,2.19,43.2,54.5",8,Constant,,8.0,0.647593141,0.5486,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.102151870727539
1095,1493,TE-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,-1.5,-2.0,1.24,2.71,-1.1,-20,-43","14.5,4.09,5.34,2.23,5.89,2.68,16.4,51.2",8,Linear,,8.0,-18.87400055,0.6178,TE1_OESOPHAGUS,TE1,ACH-000647,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3147201538085938
1096,1494,TE-11,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-74,-10,-12,-3.6,3.83,14.7,12.1,2.26","1.00,2.14,2.71,7.85,7.21,3.60,.17,3.83",8,Linear,,0.031037039,-73.44934082,0.7925,TE11_OESOPHAGUS,TE11,ACH-000488,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,-3.4725739812585616,3.2320549488067627
1097,1495,TE-15,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.30,7.56,-36,-13,-5.0,-40,-51,-54","15.9,22.4,10.6,14.4,34.6,35.9,56.0,69.5",8,Constant,,8.0,-8.106201172,1.7902,TE15_OESOPHAGUS,TE15,ACH-000353,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2631783485412598
1098,1496,TE-5,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,1.05,3.48,-2.5,.93,2.43,-11,-35","6.45,3.18,1.65,4.47,5.67,8.66,17.9,55.6",8,Linear,,8.0,-12.95890427,0.3795,TE5_OESOPHAGUS,TE5,ACH-000408,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.177626132965088
1099,1497,TE 617.T,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.87,-9.0,-5.5,-6.7,9.52,-2.1,-23,-59","3.60,30.5,3.43,5.72,10.6,17.7,17.0,28.8",8,Sigmoid,3.451572895,8.0,-39.46285629,0.9109,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.709885597229004
1100,1498,TE-9,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,7.17,.69,6.03,-5.1,12.3,-2.2,7.27","4.58,12.2,4.59,.95,13.1,10.5,12.4,5.30",8,Constant,,8.0,3.174531221,0.1003,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.327969551086426
1101,1499,TEN,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.06,23.6,-5.2,-3.9,-15,18.7,-8.7,-.63","14.2,16.7,14.6,10.5,8.21,14.1,19.6,12.2",8,Constant,,8.0,2.037520647,0.5715,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.3075661659240723
1102,1500,Toledo,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","11.1,-5.1,24.9,-1.1,1.11,-3.6,1.30,-18","11.7,14.5,7.76,20.5,14.5,14.5,15.6,12.4",8,Constant,,8.0,-1.598980784,0.01955,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9736223220825195
1103,1501,TOV-112D,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.70,-2.3,1.22,-4.4,-5.9,-19,1.16,-13","8.94,3.47,11.6,1.06,10.4,1.42,11.2,7.08",8,Constant,,8.0,-4.893734455,0.3554,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.045572519302368
1104,1502,TOV-21G,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.90,-2.5,1.25,-6.6,-5.1,-11,.66,-48","10.2,1.47,5.41,9.43,2.69,15.1,3.07,12.8",8,Sigmoid,7.904887199,8.0,-47.66407394,0.3605,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.684211254119873
1105,1503,TT2609-C02,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,25.2,2.03,21.8,-18,1.26,-22,-2.4","22.7,14.4,8.15,8.02,8.98,2.06,21.8,27.4",8,Constant,,8.0,4.399387836,0.1429,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.084440231323242
1106,1504,TYK-nu,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,-8.2,9.69,-5.9,-1.1,-10,9.70,-16","10.0,11.0,.25,12.1,7.92,14.6,14.9,6.64",8,Constant,,8.0,-0.661195159,0.08034,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2271015644073486
1107,1505,U-118 MG,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","7.74,-2.8,3.01,10.6,3.37,3.16,4.69,-.73","2.60,8.68,.95,17.1,3.92,5.75,11.7,19.0",8,Constant,,8.0,4.554672241,0.0,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1867504119873047
1108,1506,U-2 OS,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.90,-6.1,2.23,-5.5,8.93,1.12,4.61,-15","6.89,2.47,2.56,20.0,11.3,6.51,8.30,9.55",8,Constant,,8.0,-0.862761915,0.2498,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1403772830963135
1109,1507,U-87 MG,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-11,4.81,13.1,-.49,-6.5,-9.4,-8.8","7.84,2.16,18.0,7.65,.20,14.9,10.9,1.28",8,Constant,,8.0,-4.532872677,0.443,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.2623839378356934
1110,1508,U-937,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-5.3,6.28,16.7,1.40,-6.1,-6.4,-52","8.83,8.04,9.68,8.02,9.98,9.10,12.7,46.5",8,Sigmoid,8.316470464,8.0,-38.21406937,0.7796,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.777377128601074
1111,1509,UACC-257,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,-4.0,.55,-.62,-.32,-5.8,-2.3,-30","8.33,3.65,2.54,.71,8.04,2.02,9.87,41.8",8,Constant,,8.0,-2.006096601,0.2647,UACC257_SKIN,UACC257,ACH-000579,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.107279062271118
1112,1510,UACC-62,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,-8.6,-12,-13,-2.2,-6.7,-13,-53","5.64,4.36,20.9,12.9,3.53,11.6,23.2,55.8",8,Constant,,8.0,-13.67689705,0.8429,UACC62_SKIN,UACC62,ACH-000425,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1114821434020996
1113,1511,UACC-812,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-1.8,7.82,15.4,-9.4,15.5,-23,-4.1","8.99,16.5,25.3,14.0,21.6,31.1,34.8,43.1",8,Constant,,8.0,9.880545616,0.1242,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.640456199645996
1114,1512,UM-UC-3,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,.13,2.66,5.83,.32,-.72,-11,-12","2.19,6.53,1.67,9.19,5.53,1.43,12.2,14.7",8,Constant,,8.0,-1.154456139,0.1439,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.8883135318756104
1115,1513,VMRC-RCW,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".078,-14,11.3,-2.5,5.23,-11,-34,-56","8.41,8.29,10.4,13.5,3.72,7.96,50.3,61.1",8,Sigmoid,1.917450428,1.936048985,-96.29273987,0.8209,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,0.6606492907037123,3.0757579803466797
1116,1514,VMRC-RCZ,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.08,-7.9,-3.3,3.08,20.4,4.93,7.17,-12","3.16,11.1,15.6,1.42,4.35,5.28,4.66,7.34",8,Constant,,8.0,4.954898357,0.1233,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.102419137954712
1117,1515,WM-115,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.5,-1.6,15.3,-2.1,-4.8,-7.4,-7.6,-37","11.5,3.43,6.88,14.0,11.1,4.94,16.1,63.9",8,Constant,,8.0,1.330205798,0.3838,WM115_SKIN,WM115,ACH-000304,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.1745238304138184
1118,1516,WM1799,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,.36,-1.8,16.3,-2.6,-3.2,-5.3,-31","4.33,4.71,10.2,14.4,7.56,9.48,9.56,10.3",8,Sigmoid,3.401581526,8.0,-28.98385429,0.6148,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.022951126098633
1119,1517,WM-266-4,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.0,7.22,.58,7.85,-7.6,4.88,1.30,4.06","13.4,6.98,4.27,2.40,10.4,.66,9.70,2.19",8,Constant,,8.0,1.931524396,0.1215,WM2664_SKIN,WM2664,ACH-001239,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9807798862457275
1120,1518,WM-793,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,3.96,5.08,6.76,-1.8,-6.4,-21,-52","17.0,9.11,5.65,9.03,9.98,11.8,42.3,52.2",8,Constant,,8.0,-2.112353325,0.8487,WM793_SKIN,WM793,ACH-000827,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.4435501098632812
1121,1519,WM-88,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".36,.69,11.4,9.64,-2.6,1.13,-3.0,-25","4.77,1.40,11.8,8.75,2.25,2.87,5.23,16.0",8,Constant,,8.0,-0.273324162,0.1746,WM88_SKIN,WM88,ACH-000899,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.232666492462158
1122,1520,WM-983B,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.83,9.29,1.50,9.15,-.71,-2.0,-20,-58","10.1,.87,8.11,2.19,5.97,12.4,8.63,9.02",8,Sigmoid,8.129403743,5.509027004,-70.35297394,1.3292,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,1.706388020275625,3.0862512588500977
1123,1521,YKG1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,1.21,-1.5,3.23,-.33,1.27,1.24,-4.5","14.3,11.3,.43,5.21,.19,.37,4.29,4.86",8,Linear,,8.0,-17.83234024,0.0179,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.132713794708252
1124,1522,ZR-75-1,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","21.1,-29,29.8,-4.2,-8.6,-23,-11,-59","10.6,24.8,16.4,4.88,6.08,31.8,25.5,47.0",8,Constant,,8.0,-3.619128942,1.1176,ZR751_BREAST,ZR751,ACH-000097,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,3.204540729522705
1125,1523,ZR-75-30,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,-8.6,-13,6.27,1.95,2.52,1.78,-37","4.46,10.0,5.10,11.1,2.52,22.8,7.18,38.2",8,Linear,,1.324181464,-61.74968338,0.2342,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,0.2807945055251216,3.538022994995117
1126,1524,SCC-25,PHA-665752,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-2.9,-6.0,-15,-5.1,-30,-33,-44","17.1,21.6,7.32,2.84,23.7,36.0,61.5,68.7",8,Constant,,8.0,-5.789671421,0.7471,SCC25_UPPER_AERODIGESTIVE_TRACT,SCC25,ACH-000188,Head and Neck Cancer,2,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,,c-MET,c-MET Inhibitor,Kinase inhibitor,Preclinical,Pfizer ,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2.0794415416798357,2.9953184127807617
1127,1525,A172,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.48,1.18,.20,2.58,-4.6,-2.1,-8.0,-4.2",".91,.27,3.61,4.82,4.66,6.00,3.26,8.81",8,Constant,,8.0,0.184026733,0.0,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.545670509338379
1128,1526,A-204,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.1,-1.0,6.49,2.79,-4.6,.39,-3.2,-56","4.84,2.66,2.13,4.96,12.1,7.84,16.3,20.9",8,Sigmoid,8.038060305,7.399832726,-55.6202507,0.3485,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.001457395360042,2.359410524368286
1129,1527,A2058,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".40,5.55,3.90,2.40,-5.5,-2.7,-5.5,-21","7.54,2.61,3.06,1.56,.60,.086,1.59,10.3",8,Sigmoid,8.785079022,8.0,-20.20003128,0.1202,A2058_SKIN,A2058,ACH-000788,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.264923572540283
1130,1528,A-253,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.45,2.10,7.02,4.67,-.89,-30,-21,-34","9.15,3.36,.25,5.67,4.16,6.41,5.63,.76",8,Sigmoid,0.343154937,8.0,-28.99416542,0.8241,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.3330986499786377
1131,1529,A2780,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.43,-4.0,4.48,5.25,-1.9,-5.4,-19,-54","12.6,13.6,6.92,1.77,7.64,1.21,1.14,3.86",8,Sigmoid,8.644919667,7.146677494,-55.1265831,0.6209,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.9666475625520006,2.494370222091675
1132,1530,A-375,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,.65,-.39,-1.0,-2.2,-.38,-6.3,-23","1.76,1.09,1.73,.45,.65,1.89,2.21,6.62",8,Sigmoid,3.254554749,8.0,-22.49501038,0.1527,A375_SKIN,A375,ACH-000219,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.1561460494995117
1133,1531,A549,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.41,-.17,-9.7,-12,-5.8,-25,-29,-77","11.7,7.54,13.8,5.52,20.7,2.17,8.75,6.10",8,Sigmoid,8.692716262,4.227246284,-75.15564728,0.6707,A549_LUNG,A549,ACH-000681,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.4415507843775255,2.5625877380371094
1134,1532,A-673,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,14.3,6.31,23.9,3.35,.38,-3.7,7.11","8.36,9.47,11.8,18.8,10.9,12.9,3.18,9.43",8,Constant,,8.0,4.408538342,0.005817,A673_BONE,A673,ACH-000052,Bone Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.721832752227783
1135,1533,ACHN,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.4,5.71,4.87,3.28,-3.9,-25,-32,-45",".27,4.69,3.43,2.42,.77,7.33,.24,1.07",8,Sigmoid,1.667333007,8.0,-45.20761108,0.8437,ACHN_KIDNEY,ACHN,ACH-000046,Kidney Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.565220355987549
1136,1534,ALL-SIL,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.97,.96,-1.2,7.74,-1.8,-6.2,-4.9,-59","14.0,9.86,5.35,5.01,18.6,9.20,21.9,10.5",8,Sigmoid,8.910315347,7.289489746,-59.28141785,1.1767,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.9864335498809078,2.726940393447876
1137,1535,AMO-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.01,30.1,-9.2,6.18,-12,28.8,-11,-91","20.2,.88,6.92,7.40,18.3,3.24,0,0",8,Linear,,0.256446651,-92.51835632,1.233,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-1.3608346243079732,2.8395156860351562
1138,1536,AsPC-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,12.8,-5.6,-9.1,5.01,1.64,-12,-55","9.11,12.3,21.2,11.5,15.2,1.97,5.37,10.5",8,Linear,,2.785627519,-59.5316391,0.411,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.0244731690036681,2.631369113922119
1139,1537,AU565,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-9.0,-15,-33,-55,-79,-90,-96","4.76,.47,5.16,.91,11.9,1.25,.62,.46",8,Sigmoid,0.204432026,0.183209524,-95.35471344,3.5677,AU565_BREAST,AU565,ACH-000248,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-1.6971248411938158,2.7351016998291016
1140,1538,B-CPAP,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.43,2.96,2.73,-.96,.029,-3.6,-3.3,-18","2.87,6.33,.84,1.01,2.69,.72,2.36,.66",8,Constant,,8.0,-1.448807597,0.3482,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.519733190536499
1141,1539,BDCM,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.7,22.2,-15,14.0,-6.7,16.6,-3.6,6.46","9.42,6.38,8.75,7.08,.35,8.44,12.3,14.9",8,Constant,,8.0,8.862740517,0.0,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8094770908355713
1142,1540,BFTC-909,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.65,-1.7,2.41,8.12,3.86,-.082,-9.5,-13","4.44,5.62,7.07,8.69,2.53,10.9,3.82,7.46",8,Constant,,8.0,2.13131547,0.1757,BFTC909_KIDNEY,BFTC909,ACH-000792,Kidney Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.450806140899658
1143,1541,BL-41,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,-2.7,.33,-1.3,-1.3,-4.4,-7.4,-69","2.58,4.77,2.38,5.21,5.13,2.44,7.13,6.31",8,Sigmoid,5.392519474,5.89598608,-68.45102692,0.6501,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.774271793961589,2.788379192352295
1144,1542,BL-70,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","22.3,6.77,8.81,2.14,12.3,5.08,17.5,-39",".60,6.39,10.3,17.3,2.39,11.5,5.48,15.9",8,Sigmoid,8.000893639,8.0,-38.82792282,0.3646,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8365302085876465
1145,1543,BT-20,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.77,-7.9,-1.2,8.03,-8.3,6.52,-15,-48","28.0,16.1,34.7,39.0,19.7,36.3,18.8,7.09",8,Constant,,8.0,-14.30575657,0.6681,BT20_BREAST,BT20,ACH-000536,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8748185634613037
1146,1544,BT-474,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.41,-17,-31,-43,-59,-83,-96,-120","28.5,21.1,13.7,15.8,16.8,.15,1.00,.41",8,Sigmoid,8.020292071,0.116183236,-118.4226532,3.3811,BT474_BREAST,BT474,ACH-000927,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-2.1525867134746095,3.2559661865234375
1147,1545,BT-549,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.96,2.36,-32,7.56,5.21,-12,-32,-48","11.2,16.4,63.7,7.34,4.25,14.1,65.8,3.51",8,Constant,,8.0,-0.168496042,1.0001,BT549_BREAST,BT549,ACH-000288,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.781960964202881
1148,1546,BxPC-3,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","28.7,-12,1.76,-6.2,-5.2,-34,-31,-61","21.2,3.22,8.68,12.7,12.3,6.72,15.5,2.84",8,Sigmoid,4.018966198,4.599786282,-59.76509476,1.2981,BXPC3_PANCREAS,BXPC3,ACH-000535,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.5260098419809474,2.660064935684204
1149,1547,C2BBe1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.96,16.9,10.6,.83,-29,-27,-36,-61","4.93,5.07,20.8,1.83,1.21,16.3,11.9,8.58",8,Sigmoid,1.169876575,4.09934473,-57.35443878,1.4312,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.4108271389861538,2.703279733657837
1150,1548,C32,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.28,-4.2,-2.6,-.24,.011,.74,5.93,3.52","21.6,2.31,8.35,10.8,10.5,3.53,1.46,8.18",8,Constant,,8.0,0.688936293,0.0,C32_SKIN,C32,ACH-000580,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.3322417736053467
1151,1549,CAL-12T,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.4,8.87,4.44,-7.4,2.87,-23,-59,-92","8.77,6.81,5.40,11.3,7.89,7.31,6.76,3.38",8,Sigmoid,2.0953269,1.951666355,-92.39616394,1.4973,CAL12T_LUNG,CAL12T,ACH-000826,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.6686835486889877,2.660792589187622
1152,1550,CAL 27,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.91,4.66,-1.3,-.14,-23,-56,-67,-80",".93,2.00,2.60,2.16,7.07,6.71,6.77,2.95",8,Sigmoid,0.433088809,0.688771248,-77.97801971,1.8794,CAL27_UPPER_AERODIGESTIVE_TRACT,CAL27,ACH-000832,Head and Neck Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-0.37284606890012295,2.6339752674102783
1153,1551,CAL-85-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.82,-10.0,16.2,-18,-11,-51,-55,-78","31.1,9.12,6.19,.053,4.20,33.0,11.0,.16",8,Sigmoid,2.043146133,1.899548173,-77.30729675,1.9052,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.6416160542084046,2.7233331203460693
1154,1552,Calu-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.88,7.35,4.41,-3.7,5.43,-2.6,-7.6,-39","1.04,11.0,9.21,11.1,3.00,10.5,2.72,2.49",8,Sigmoid,9.080534174,8.0,-39.04533386,0.3518,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.905066967010498
1155,1553,Calu-3,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","25.8,11.8,10.5,-24,-43,-52,-69,-83","25.3,20.6,3.56,11.9,5.25,3.65,6.68,6.02",8,Sigmoid,0.119516589,0.4945876,-79.91364288,2.6066,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-0.704030994973352,2.8932108879089355
1156,1554,Calu-6,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-2.6,8.33,-19,5.39,-2.4,-10,-20","27.9,5.25,9.48,17.0,6.09,2.24,6.38,6.08",8,Constant,,8.0,-4.835510254,0.1923,CALU6_LUNG,CALU6,ACH-000264,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4773855209350586
1157,1555,CAMA-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.74,9.93,3.30,3.84,6.52,16.1,-9.8,-22","1.63,.74,9.36,14.3,11.2,6.63,2.55,17.7",8,Sigmoid,2.360326529,8.0,-22.14266014,0.146,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8015341758728027
1158,1556,Capan-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.98,26.1,-7.4,6.32,1.48,-15,.61,-43","25.3,15.9,22.1,19.4,23.6,9.73,28.5,24.1",8,Constant,,8.0,-10.00565052,0.6047,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.812954902648926
1159,1557,CAS-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,3.63,-4.4,-.47,3.80,4.07,-8.3,-11","20.4,4.55,2.19,2.64,6.34,3.38,13.6,8.51",8,Constant,,8.0,0.082455963,0.02975,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.776575803756714
1160,1558,CCK-81,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,17.0,2.35,6.74,-8.6,-47,-66,-73","2.09,5.10,46.2,23.6,17.9,14.4,2.61,.45",8,Linear,,0.240194838,-74.57330322,2.3087,CCK81_LARGE_INTESTINE,CCK81,ACH-000963,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-1.4263048599918224,2.768063545227051
1161,1559,CHP-212,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.66,36.6,.21,13.8,20.0,13.8,-23,-24","2.44,23.5,21.4,28.4,9.95,2.73,23.2,8.61",8,Constant,,8.0,10.10571289,0.4609,CHP212_AUTONOMIC_GANGLIA,CHP212,ACH-000120,Neuroblastoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5207509994506836
1162,1560,CI-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","28.9,-6.6,-.31,-8.4,28.7,29.1,48.1,-9.2","19.5,25.4,66.9,9.88,18.1,7.52,75.5,2.40",8,Constant,,8.0,13.11286163,0.07477,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5662944316864014
1163,1561,COLO-320,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,.41,1.74,-3.6,-.85,2.14,-7.3,-52","11.6,16.0,12.6,7.34,6.97,1.09,15.6,2.00",8,Sigmoid,3.687685966,6.295311928,-52.34455109,0.5138,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.8398052179763698,2.612675905227661
1164,1562,COLO-678,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.4,-8.3,3.64,4.22,-15,-26,-27,-41","6.33,3.12,20.9,12.5,4.80,2.61,16.9,2.84",8,Sigmoid,3.175720453,8.0,-39.9418869,1.1779,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8292994499206543
1165,1563,COLO-679,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.91,1.60,17.5,7.69,12.2,8.27,-6.5,-3.5","10.2,9.26,5.66,.94,9.80,1.29,5.95,2.92",8,Constant,,8.0,7.234394073,0.0,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4254841804504395
1166,1564,COLO 741,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","21.4,17.4,2.26,15.2,3.10,8.83,-7.7,-23","10.8,13.9,9.11,6.46,19.1,11.8,9.00,11.9",8,Sigmoid,8.290110951,8.0,-22.24547768,0.3423,COLO741_SKIN,COLO741,ACH-000582,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.477944850921631
1167,1565,COR-L105,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,-12,7.34,-3.5,-.19,-.49,-27,-30","22.6,5.54,9.47,21.2,3.34,6.02,16.5,13.0",8,Constant,,8.0,-6.28453064,0.549,CORL105_LUNG,CORL105,ACH-000161,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.834458351135254
1168,1566,COR-L23,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.08,-1.4,2.06,3.69,5.84,-1.2,-2.0,-17","10.3,1.96,2.08,5.86,4.37,1.84,4.03,17.1",8,Constant,,8.0,2.245106936,0.1227,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7741189002990723
1169,1567,COV318,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.53,13.4,-.63,10.00,.74,5.54,7.88,-2.7","34.2,14.0,.66,36.1,13.0,4.65,8.79,22.7",8,Constant,,8.0,3.250419855,0.0,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.962878942489624
1170,1568,COV504,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,1.81,-2.6,11.7,9.94,-.28,20.5,-11","8.37,3.89,6.85,1.41,8.34,24.0,1.93,3.12",8,Constant,,8.0,3.181141376,0.0,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7731528282165527
1171,1569,Daoy,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.7,-10,-6.4,-12,-4.3,-6.0,-7.8,-9.4","12.5,19.3,8.66,25.1,16.5,7.58,12.5,4.51",8,Constant,,8.0,-8.668775558,0.05,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.450587272644043
1172,1570,DBTRG-05MG,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.21,3.04,-3.1,-2.7,3.37,-6.7,-8.8,-17","5.60,6.88,6.85,4.59,2.73,3.85,8.78,2.91",8,Constant,,8.0,-2.252633572,0.2992,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.632815361022949
1173,1571,Detroit 562,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.3,-1.4,1.04,-2.9,9.57,-2.2,-12,-40","7.91,6.06,3.21,7.44,20.0,4.81,6.99,1.67",8,Sigmoid,8.568179915,8.0,-39.84303665,0.432,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5767717361450195
1174,1572,DK-MG,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,9.00,-6.1,6.35,-3.8,-7.9,-12,-23","3.16,3.67,.25,3.30,9.39,5.85,11.0,1.55",8,Sigmoid,5.96993494,8.0,-23.17247963,0.2054,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6339330673217773
1175,1573,DMS 114,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.76,21.6,22.6,5.34,12.3,-12,-.38,-16","3.21,13.1,10.9,14.8,1.42,5.16,1.94,4.37",8,Sigmoid,0.385773063,8.0,-9.814640999,0.2177,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,3.200963258743286
1176,1574,DOHH-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.0,50.5,25.7,77.7,-17,22.2,-13,-63","5.79,12.4,6.56,12.7,7.04,26.2,22.1,20.5",8,Linear,,1.706622675,-66.03034973,1.1878,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.5345163736839029,2.958261013031006
1177,1575,DV-90,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","51.7,-3.4,2.28,3.27,-9.2,-24,19.6,-52","26.5,7.69,30.7,10.7,6.14,25.7,22.1,3.53",8,Linear,,8.0,-49.78066635,0.9329,DV90_LUNG,DV90,ACH-000925,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6266732215881348
1178,1576,EB1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","18.1,9.01,-3.3,-11,29.6,-5.1,33.9,-4.8","14.8,1.70,.59,23.0,5.35,19.7,21.7,11.4",8,Constant,,8.0,7.96852684,0.2499,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.701378107070923
1179,1577,EBC-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.6,18.5,13.1,13.0,-6.9,7.01,2.36,-70","12.8,14.1,10.9,5.29,11.1,4.95,8.01,6.68",8,Sigmoid,6.687931061,6.37237215,-69.61994934,0.6902,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.8519717942971599,2.6825389862060547
1180,1578,EFE-184,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.21,3.69,-8.2,-5.8,-18,-25,-33,-47","4.59,19.3,7.71,1.36,4.32,6.06,3.06,11.3",8,Sigmoid,8.204432079,8.0,-45.80168152,1.0358,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7982406616210938
1181,1579,EFM-19,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.4,-4.1,10.1,-7.1,-5.3,-15,-6.4,-47","10.2,12.6,17.5,5.83,4.63,5.18,5.85,3.24",8,Sigmoid,8.867133701,8.0,-45.59579086,0.7549,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.93799090385437
1182,1580,EFO-21,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.1,-2.0,19.0,4.28,-7.7,-18,-15,-45","21.8,5.51,20.2,21.4,5.87,17.8,15.5,2.60",8,Sigmoid,8.3594774,8.0,-42.97647095,0.5927,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.762636661529541
1183,1581,EFO-27,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,.60,-3.4,-4.8,-17,-23,-42,-49","3.49,3.82,1.40,9.60,7.29,5.61,1.63,5.15",8,Sigmoid,0.959794521,8.0,-49.54315186,0.9129,EFO27_OVARY,EFO27,ACH-000936,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4623310565948486
1184,1582,EM-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.9,22.0,9.49,5.95,-9.7,3.84,6.69,-8.2","2.45,19.4,16.6,19.2,2.04,2.73,10.1,26.7",8,Constant,,8.0,7.3659091,0.3354,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.869734764099121
1185,1583,EN,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.3,-8.6,13.5,-9.9,6.58,-14,3.63,-18","7.82,16.5,4.57,11.1,4.89,5.15,7.34,12.3",8,Constant,,8.0,0.537071645,0.4058,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.738192558288574
1186,1584,ES-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,2.52,-3.6,1.97,-1.6,-.29,-11,-2.0","10.00,.63,13.9,4.49,3.38,2.45,9.77,3.54",8,Constant,,8.0,-0.312586874,0.05121,ES2_OVARY,ES2,ACH-000906,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5221657752990723
1187,1585,ESS-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.33,3.81,.75,-1.8,-5.3,-14,-27,-84","6.86,4.00,8.07,5.55,1.98,8.73,10.1,4.09",8,Sigmoid,8.647834009,4.373962402,-83.22802734,1.2909,ESS1_ENDOMETRIUM,ESS1,ACH-000913,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.475669326424308,2.5110297203063965
1188,1586,F-36P,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.4,-2.0,42.8,21.1,-2.9,-15,4.11,-39","13.6,11.3,8.90,18.4,13.1,19.5,10.7,3.06",8,Linear,,8.0,-37.91736221,0.6322,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.770407199859619
1189,1587,FaDu,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,4.71,-9.1,2.35,-21,-50,-66,-74","7.92,6.78,2.96,10.2,.50,7.50,4.36,.58",8,Sigmoid,0.50554961,0.823072731,-72.8217926,1.9562,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-0.19471070918421662,2.569352149963379
1190,1588,FU97,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","18.2,16.3,9.19,12.4,10.9,.89,-18,-37","4.04,40.1,7.11,9.60,1.00,1.33,14.5,7.28",8,Sigmoid,2.635005236,8.0,-37.15691376,0.3622,FU97_STOMACH,FU97,ACH-000633,Gastric Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4213905334472656
1191,1589,FU-OV-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".40,.31,-5.4,-5.0,-.73,-25,-21,-37","7.22,7.50,7.94,5.87,.79,18.5,5.07,10.1",8,Sigmoid,0.57660687,8.0,-27.21039009,0.6817,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5645580291748047
1192,1590,G-361,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.6,15.7,-3.8,15.1,-7.8,5.04,-28,-97","9.14,.020,2.63,7.25,10.5,.31,11.4,.019",8,Sigmoid,2.981796265,3.047757149,-97.01760101,1.2718,G361_SKIN,G361,ACH-000572,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.1144059591252022,2.270705223083496
1193,1591,G-401,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.92,8.65,10.4,6.09,2.84,.87,-5.0,-37","17.8,1.62,11.9,12.0,21.7,1.03,23.1,15.0",8,Sigmoid,8.274941514,8.0,-36.16051865,0.4741,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.371156692504883
1194,1592,G-402,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,8.37,5.01,13.6,-1.3,-3.4,-5.5,-27","2.45,21.5,8.20,17.2,12.9,19.6,1.29,20.1",8,Sigmoid,9.087363641,8.0,-26.72159958,0.2117,G402_SOFT_TISSUE,G402,ACH-000375,Kidney Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5090909004211426
1195,1593,GAMG,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.07,.38,-5.1,7.95,14.9,7.44,-4.1,1.81","9.94,1.62,22.7,5.61,4.43,11.2,12.3,7.62",8,Constant,,8.0,4.159112453,0.0,GAMG_CENTRAL_NERVOUS_SYSTEM,GAMG,ACH-000098,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7456626892089844
1196,1594,GB-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.73,-12,-13,-3.2,-3.6,-3.1,-23,6.57",".93,18.1,9.93,4.13,6.00,8.59,14.2,.066",8,Constant,,8.0,-3.215782166,0.2394,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7363758087158203
1197,1595,GCT,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.64,3.56,2.00,4.58,.54,4.45,-9.4,-69",".86,3.21,7.89,4.22,.14,2.53,1.12,4.41",8,Sigmoid,3.483610868,4.213954926,-69.33984375,0.756,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.4384016190741988,2.5526037216186523
1198,1596,GI-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.0,-1.9,10.5,1.86,5.36,.63,-9.4,-18","4.86,1.10,10.5,2.20,7.47,9.00,3.64,7.73",8,Sigmoid,2.119527817,8.0,-17.52121544,0.216,GI1_CENTRAL_NERVOUS_SYSTEM,GI1,ACH-000756,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4497170448303223
1199,1597,GMS-10,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,1.96,-5.0,3.89,-1.9,5.59,-8.9,2.15",".19,4.01,10.3,9.27,22.1,10.3,3.19,5.91",8,Constant,,8.0,-1.11636126,0.004152,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5077297687530518
1200,1598,GRANTA-519,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,35.1,2.34,35.6,1.50,53.0,-.42,34.6","27.7,13.2,4.17,.73,6.80,23.4,4.69,15.5",8,Constant,,8.0,15.50423241,0.2367,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7866997718811035
1201,1599,H4,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-.84,-4.3,1.83,1.61,-2.7,1.44,8.12","2.59,.88,1.99,6.41,1.07,5.62,5.81,5.19",8,Constant,,8.0,-0.836039007,0.05188,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7129006385803223
1202,1600,HARA,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.54,3.77,5.40,-3.6,-5.6,-7.5,-27,-56","24.1,9.97,8.00,3.19,4.96,4.41,.95,2.06",8,Sigmoid,8.861800421,6.656740665,-56.2591362,0.7284,HARA_LUNG,HARA,ACH-000843,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.8956299751224641,2.5248398780822754
1203,1601,HCC1187,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".80,3.58,-.69,11.2,6.63,5.02,.91,-1.9","19.0,15.6,10.8,17.3,.10,6.57,1.03,7.56",8,Constant,,8.0,2.377377748,0.0,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.9882712364196777
1204,1602,HCC1395,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","19.0,20.2,22.9,.76,20.3,-8.0,-29,-22","24.2,35.0,7.22,2.65,5.90,3.37,17.2,14.6",8,Sigmoid,0.753262937,8.0,-25.6764946,0.3471,HCC1395_BREAST,HCC1395,ACH-000699,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.623870849609375
1205,1603,HCC-15,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-2.8,-7.8,6.21,-9.0,-4.3,-11,-8.1","24.5,8.60,14.8,8.00,14.0,13.3,22.0,3.79",8,Constant,,8.0,-2.61006999,0.6883,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7442383766174316
1206,1604,HCC1569,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.77,4.13,-.19,-2.6,-4.5,-1.9,-7.3,-37","7.35,41.3,5.26,16.1,8.58,9.89,22.7,2.59",8,Constant,,8.0,-4.682286263,0.3181,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.911860942840576
1207,1605,HCC1806,Lapatinib,EGFR,".0080,.025,.080,.25,.80,2.53,8","-12,3.81,-11,11.1,-18,-40,-54","17.6,11.1,13.1,20.6,36.5,9.01,18.6",7,Linear,,4.378564953,-54.0857811,1.4366,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.4767210344024855,2.7864298820495605
1208,1606,HCC1954,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,8.72,-1.1,-14,-20,-49,-54,-93","16.1,18.9,19.3,3.20,5.61,4.41,3.56,1.73",8,Sigmoid,8.357420767,1.457828045,-91.33030701,2.0762,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.3769476876736447,2.923924207687378
1209,1607,HCC2935,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.95,8.39,-3.2,-3.8,-31,-46,-64,-87",".63,20.6,41.4,3.77,16.3,14.3,.68,4.08",8,Sigmoid,1.39151454,1.239923596,-86.67224884,1.9085,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.21504976158956152,2.7922377586364746
1210,1608,HCC4006,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.94,7.09,-.0076,1.30,-5.6,-22,-62,-97","7.23,6.36,6.46,3.05,.95,1.92,4.08,2.45",8,Sigmoid,2.355744839,1.854881167,-97.5633316,1.8224,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.6178206330909684,2.823390007019043
1211,1609,HCC-44,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.12,3.54,3.57,8.29,-3.7,-.88,-6.8,-16","2.27,.23,3.59,4.97,2.36,.57,1.27,1.40",8,Constant,,8.0,-0.445093423,0.1527,HCC44_LUNG,HCC44,ACH-000667,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7121694087982178
1212,1610,HCC-56,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.43,-13,10.1,-5.1,-4.3,-4.5,-11,-31","18.7,7.36,6.51,2.78,5.46,2.69,11.2,7.75",8,Sigmoid,8.624270169,8.0,-30.20306778,0.4479,HCC56_LARGE_INTESTINE,HCC56,ACH-000467,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.513998508453369
1213,1611,HCC70,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,-.49,11.8,4.17,6.59,-11,-6.9,-47","7.87,6.51,24.7,17.9,21.4,10.3,26.2,27.2",8,Sigmoid,8.132246633,7.363319874,-65.43390656,0.6068,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.9965109008763242,2.87699556350708
1214,1612,HCC-78,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.65,3.73,7.32,9.96,8.33,-1.1,-5.4,-13","9.53,6.80,2.60,1.11,3.07,1.36,7.79,.12",8,Sigmoid,0.926578164,8.0,-12.93127155,0.07474,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.845874547958374
1215,1613,HCC827,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,23.7,-12,23.9,-4.4,.62,-19,-81","12.3,5.57,9.59,9.98,17.1,8.29,29.2,2.66",8,Linear,,0.372133989,-81.47216797,0.956,HCC827_LUNG,HCC827,ACH-000012,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-0.9885013040763391,2.6903786659240723
1216,1614,HCT 116,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.60,3.96,6.43,6.09,4.69,-12,8.96,-33","4.84,16.5,5.23,1.57,.91,16.4,5.40,26.4",8,Constant,,8.0,4.567094803,0.3587,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4831457138061523
1217,1615,HCT-15,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.4,18.7,-7.0,14.1,8.32,-9.1,-19,-89","5.44,1.07,12.3,1.00,16.2,7.08,14.3,.90",8,Sigmoid,8.597037519,4.666832924,-88.11208344,1.0195,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.5404806668839663,2.6462769508361816
1218,1616,HD-MY-Z,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.98,.39,7.41,6.58,3.81,-3.7,.44,-69","2.95,4.26,3.79,2.44,3.93,6.12,3.60,8.48",8,Sigmoid,8.411270266,7.012477875,-69.18188477,0.6625,HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HDMYZ,ACH-000190,Unknown,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.9476911157636236,2.4741649627685547
1219,1617,HDQ-P1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.50,-.82,8.37,18.5,-8.1,-39,-40,-60","25.4,5.35,12.1,1.82,29.2,8.06,12.4,16.5",8,Sigmoid,0.445293456,3.104604244,-50.69605255,2.4691,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.1328862496130723,2.8175432682037354
1220,1618,HEC-151,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,14.3,-24,-2.1,-31,-19,-36,-47","9.62,5.81,14.1,.90,10.2,8.12,6.51,1.23",8,Sigmoid,8.186836041,8.0,-47.04390717,1.59,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.3455867767333984
1221,1619,HEC-1-A,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","17.8,10.6,14.2,12.4,25.6,1.60,29.1,-14","21.8,21.7,20.5,9.53,.60,9.04,21.8,7.47",8,Constant,,8.0,11.12691116,0.1152,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5487899780273438
1222,1620,HEC-1-B,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".44,4.90,-14,7.74,-11,-7.5,-9.9,11.7","13.0,3.12,11.7,1.66,26.1,8.08,26.3,49.0",8,Constant,,8.0,0.350010276,0.6192,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.545851230621338
1223,1621,HEC-251,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.18,9.11,5.79,3.98,-23,-10,-37,-23","7.38,3.40,21.3,.21,31.6,18.2,29.2,.29",8,Sigmoid,0.270502985,8.0,-22.13840103,0.7347,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.787222385406494
1224,1622,HEC-265,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.75,18.6,-11,15.8,-3.1,10.4,-9.8,-39","15.9,3.50,25.7,4.03,13.6,1.65,6.08,7.79",8,Sigmoid,2.715893984,8.0,-38.64659119,0.4616,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4838099479675293
1225,1623,HEC-59,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.71,-1.9,11.3,6.71,3.08,-1.6,.82,-4.6","6.29,16.3,2.16,.18,4.15,9.65,3.09,6.53",8,Constant,,8.0,3.185275555,0.0,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.599306583404541
1226,1624,HEC-6,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,46.1,34.9,-1.2,-3.2,-9.8,32.5,-49","60.0,7.53,16.9,31.6,13.6,31.3,26.7,6.01",8,Linear,,8.0,-46.97991943,1.1782,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.734381675720215
1227,1625,HEL 92.1.7,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.2,14.0,2.12,8.53,.76,6.99,-1.4,-2.3","21.4,26.8,21.9,22.8,15.0,25.1,17.5,26.3",8,Constant,,8.0,3.208813906,0.1414,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.676830291748047
1228,1626,Hep 3B2.1-7,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.18,15.4,-12,-.13,-5.8,-4.2,10.1,-16","3.45,29.3,13.7,8.05,.069,2.10,1.57,20.4",8,Constant,,8.0,-2.694322109,0.1116,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.745861530303955
1229,1627,Hep G2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.4,7.85,-9.7,-12,-3.7,4.68,-6.6,-20","25.6,17.5,3.15,9.20,1.19,15.2,13.9,9.17",8,Constant,,8.0,-5.53278017,0.2365,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.620065927505493
1230,1628,Hey-A8,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,3.10,-.68,5.49,1.10,-.40,-12,-19","9.30,5.30,8.17,1.37,3.74,3.63,11.2,.68",8,Sigmoid,2.017758608,8.0,-19.51042557,0.0632,HEYA8_OVARY,HEYA8,ACH-000542,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4387025833129883
1231,1629,HGC-27,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.91,2.73,-.11,-2.3,.65,1.39,-7.0,-40","2.47,3.34,5.86,1.07,1.03,3.49,.88,6.23",8,Sigmoid,3.381972075,8.0,-39.49782944,0.3305,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.504260301589966
1232,1630,HH,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,1.46,-2.8,53.5,14.4,-3.3,2.81,15.1","26.1,22.1,36.2,4.97,26.8,.20,4.94,16.6",8,Constant,,8.0,3.282447815,0.7705,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6526122093200684
1233,1631,HLF,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.4,14.5,3.74,-2.5,3.87,-12,-11,-23","11.2,8.21,5.44,2.55,8.75,.079,1.31,7.98",8,Sigmoid,8.114125709,8.0,-20.63152695,0.3719,HLF_LIVER,HLF,ACH-000393,Liver Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.491999626159668
1234,1632,HMC-1-8,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.67,6.62,.62,2.04,5.24,8.33,-2.5,-34","7.01,.17,.79,4.74,4.79,9.40,.81,1.00",8,Sigmoid,3.51103878,8.0,-34.49472046,0.3697,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5820889472961426
1235,1633,HMCB,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".16,1.84,4.13,1.35,-12,-23,-38,-59","4.33,3.96,.038,.11,2.77,1.17,1.65,3.99",8,Sigmoid,2.660292149,4.767848015,-57.81430435,1.053,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.561895053206339,2.3930978775024414
1236,1634,HOS,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","27.8,-7.6,25.4,22.6,11.5,-16,3.94,-51","10.8,14.4,18.3,11.4,20.9,11.2,34.4,2.48",8,Linear,,8.0,-48.94153595,0.7597,HOS_BONE,HOS,ACH-000613,Bone Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5584096908569336
1237,1635,HPAC,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.48,1.04,13.3,7.60,5.28,.13,-16,-38","3.03,23.7,9.79,.64,9.60,21.4,2.37,20.3",8,Sigmoid,3.950451612,8.0,-37.05279922,0.5041,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.712905168533325
1238,1636,HPAF-II,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.05,35.7,-4.5,12.7,10.3,-8.4,-40,-57","5.22,4.35,24.3,43.9,11.8,4.98,14.1,2.47",8,Sigmoid,1.367424011,4.22283268,-57.06295776,1.3411,HPAFII_PANCREAS,HPAFII,ACH-000094,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.4405061540444442,3.0742106437683105
1239,1637,Hs 294T,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.68,6.15,4.40,8.47,-1.6,-1.8,-15,-23",".47,3.87,.042,15.2,3.41,4.75,2.91,15.2",8,Sigmoid,8.063289627,8.0,-22.81321335,0.3933,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5801734924316406
1240,1638,Hs 578T,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-3.2,-4.2,-2.8,-1.4,6.55,-9.4,-18","9.81,9.03,2.43,3.57,2.61,6.37,9.34,2.07",8,Constant,,8.0,-3.173414469,0.2025,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.638885498046875
1241,1639,Hs 683,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.40,-2.3,-.25,2.95,3.18,5.22,-5.8,1.81","5.55,5.69,1.22,2.68,5.27,3.29,1.57,17.1",8,Sigmoid,7.284635544,8.0,-21.92444801,0.03881,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4649534225463867
1242,1640,Hs 695T,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.19,-24,2.63,7.21,-4.9,-4.7,-1.1,-17","8.82,25.2,1.94,9.55,2.68,11.1,2.47,6.63",8,Constant,,8.0,-1.222524643,0.3009,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6857943534851074
1243,1641,Hs 729,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.9,-8.3,14.7,-4.6,12.0,-6.9,-9.6,-13","3.26,.53,9.44,8.24,1.81,5.86,13.6,2.97",8,Constant,,8.0,-1.733566523,0.4988,HS729_SOFT_TISSUE,HS729,ACH-000133,Unknown,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.599498748779297
1244,1642,Hs 746T,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,-.74,10.3,7.79,-11,-.53,1.90,-31","6.24,3.51,.18,9.73,6.80,26.7,8.53,2.55",8,Sigmoid,8.455546682,8.0,-26.75945663,0.5103,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6736464500427246
1245,1643,Hs 766T,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.93,7.44,11.9,2.27,.14,-8.5,-13,-14","0,29.0,5.18,8.86,4.40,29.4,5.27,5.19",8,Constant,,8.0,-2.79126358,0.3614,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.535250186920166
1246,1644,Hs 852.T,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.04,-1.9,-5.5,-3.4,-5.9,-12,1.52,-15","1.76,11.7,8.13,3.38,5.06,7.62,.26,11.4",8,Constant,,8.0,-4.074016571,0.1743,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5935065746307373
1247,1645,Hs 936.T,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,4.07,3.38,2.79,-4.6,6.24,-4.1,-4.0","8.17,5.26,.76,4.33,.16,5.84,7.59,2.95",8,Constant,,8.0,0.76260829,0.0,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,1.8566746711730957
1248,1646,Hs 939.T,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.90,5.03,18.3,.71,3.41,-6.5,2.80,-18","28.2,1.91,12.0,11.2,9.19,9.24,.53,17.1",8,Constant,,8.0,2.801398516,0.1568,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4192490577697754
1249,1647,Hs 944.T,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.6,7.24,5.72,-2.3,4.21,-6.2,7.77,-31","4.55,8.58,1.52,.52,3.31,5.42,13.0,2.13",8,Sigmoid,8.393867884,8.0,-31.11623955,0.2636,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.333199977874756
1250,1648,HSC-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,-.0050,.74,4.15,-7.2,5.39,-18,-34",".58,.43,1.49,4.69,2.67,1.05,2.05,3.50",8,Sigmoid,2.446460962,8.0,-34.02999496,0.5269,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5942490100860596
1251,1649,HT,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.4,3.78,35.6,33.7,39.3,8.13,30.8,-54","12.0,3.38,13.8,32.9,76.5,16.2,18.9,8.76",8,Linear,,6.772954499,-51.31420135,0.5864,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.9129374022122678,2.8826088905334473
1252,1650,HT-1080,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,6.24,-.86,1.35,1.23,-6.1,-6.7,-28",".15,6.08,2.75,1.77,4.18,2.06,4.19,1.30",8,Sigmoid,8.60871664,8.0,-27.29872704,0.2133,HT1080_SOFT_TISSUE,HT1080,ACH-000054,Sarcoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.2428183555603027
1253,1651,HT-1197,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","17.7,10.5,-9.1,20.0,7.50,-7.4,1.15,-31","12.9,13.5,0,18.2,14.0,2.47,8.18,8.10",8,Sigmoid,8.528633061,8.0,-28.9674778,0.3532,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7438323497772217
1254,1652,HT-144,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,4.14,-4.9,6.60,-5.6,-.82,-16,-48","6.71,10.0,9.28,9.68,4.43,6.82,7.52,24.7",8,Sigmoid,2.528650999,8.0,-31.45009804,0.5575,HT144_SKIN,HT144,ACH-000322,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.383594512939453
1255,1653,HuCCT1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.52,-.52,-1.6,.41,-2.8,-10,-14,-50","6.65,.39,5.28,4.51,2.51,2.11,8.62,7.89",8,Sigmoid,8.63322561,8.0,-49.52314377,0.7029,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6598315238952637
1256,1654,huH-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.2,23.6,-29,9.27,4.52,10.7,-23,-48","3.20,.45,12.9,16.0,15.7,.24,15.0,7.05",8,Linear,,8.0,-48.64342117,0.3326,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.526740074157715
1257,1655,HUP-T3,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.9,8.69,2.51,17.2,-8.2,-.98,-5.6,-21","3.90,5.96,25.5,9.58,8.43,.32,2.36,6.37",8,Sigmoid,0.161639333,8.0,-8.731599808,0.1481,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.9123036861419678
1258,1656,HuT 78,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","51.3,-15,20.0,18.0,30.7,-18,26.8,-44","45.8,11.7,10.4,26.8,18.4,4.58,15.4,11.6",8,Constant,,8.0,14.77444077,0.7425,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.807563066482544
1259,1657,IA-LM,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.33,-14,20.7,-19,1.44,-18,-5.0,-33","12.1,38.8,1.16,5.86,12.1,14.4,12.3,.037",8,Constant,,8.0,-7.671590805,0.8124,IALM_LUNG,IALM,ACH-000672,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6157875061035156
1260,1658,IGR-37,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.5,-5.5,22.9,1.25,-5.1,-8.4,11.7,-13","32.2,10.4,4.11,9.97,5.66,3.64,8.39,7.75",8,Constant,,8.0,-3.381108999,0.4278,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.3719828128814697
1261,1659,IGR-39,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.05,-17,1.76,-4.4,15.4,-9.8,-1.9,-13","1.43,13.2,5.47,14.4,11.8,8.29,6.17,17.4",8,Constant,,8.0,-1.409987688,0.08543,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4459571838378906
1262,1660,IGROV1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,.57,-.41,2.21,-12,-24,-30,-39","5.16,6.33,2.75,6.66,11.4,3.53,5.15,6.12",8,Sigmoid,0.575531602,8.0,-37.02425385,0.8646,IGROV1_OVARY,IGROV1,ACH-000966,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6009740829467773
1263,1661,IMR-32,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".28,11.2,-.75,-.56,-2.6,-.43,-4.9,-26","7.51,1.95,7.58,.031,5.54,37.5,18.3,18.9",8,Constant,,8.0,-0.562876165,0.2626,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.816845417022705
1264,1662,IPC-298,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.7,-.76,.67,5.41,-5.1,.56,-5.0,-34","4.38,2.67,7.71,2.02,2.01,9.74,4.81,16.4",8,Sigmoid,4.237603664,8.0,-33.39060593,0.2847,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4542951583862305
1265,1663,IST-MES2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.3,-4.8,.71,-15,4.09,-8.1,5.31,-52","17.5,20.5,4.13,3.88,3.54,6.80,1.66,5.91",8,Sigmoid,8.12534362,7.889610767,-52.1686554,0.7325,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0655468011947633,2.6192150115966797
1266,1664,J82,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".11,5.97,10.1,-5.7,-4.4,-6.0,-8.3,-5.6","4.75,6.44,.57,4.97,3.33,1.56,5.10,9.64",8,Constant,,8.0,-2.736862659,0.07309,J82_URINARY_TRACT,J82,ACH-000396,Bladder Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.686269760131836
1267,1665,JHH-4,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,-5.9,2.52,10.8,.30,-32,-27,-44","10.4,5.67,21.3,7.20,5.18,9.41,2.33,11.8",8,Sigmoid,0.48136571,8.0,-33.92828369,0.9322,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5583622455596924
1268,1666,JHOS-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","20.8,-17,-19,8.56,-8.2,-12,7.93,-15","4.71,1.77,9.87,26.0,8.39,6.14,3.33,31.1",8,Constant,,8.0,-8.130103111,0.5668,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7736856937408447
1269,1667,JHUEM-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,8.52,9.09,10.5,14.8,3.15,.68,-16","22.9,8.76,23.8,23.9,4.31,5.55,11.3,3.74",8,Constant,,8.0,4.766273022,0.1097,JHUEM2_ENDOMETRIUM,JHUEM2,ACH-000909,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.484931468963623
1270,1668,JM1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.3,27.1,-2.1,-22,-1.7,8.08,-6.8,5.59","14.7,17.9,5.60,.71,17.1,5.41,10.2,4.48",8,Constant,,8.0,3.538670063,0.143,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.841625213623047
1271,1669,JMSU-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-7.7,6.79,3.13,9.21,11.2,2.20,-20","9.71,5.58,2.78,3.05,8.45,6.37,.54,9.26",8,Linear,,8.0,-20.05674553,0.1266,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8010034561157227
1272,1670,JURKAT,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.3,10.9,14.1,9.97,6.95,-8.7,-12,-59","5.02,2.92,9.50,13.0,1.93,6.36,1.65,2.34",8,Sigmoid,8.672696986,6.770286083,-58.13252258,0.9963,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.912543343490742,2.817009449005127
1273,1671,JVM-3,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","21.5,18.5,-.39,20.4,-1.7,-9.1,14.8,-49","36.5,11.4,2.60,20.2,33.5,5.57,8.55,.75",8,Linear,,8.0,-47.34321213,1.2129,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.9273719787597656
1274,1672,K029AX,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".60,14.6,1.49,12.6,-2.9,2.37,-1.5,-69","12.7,12.8,14.3,14.0,6.36,5.52,23.4,5.92",8,Sigmoid,6.970349312,6.444432735,-68.58829498,0.6687,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.8632166162257906,2.349175453186035
1275,1673,KALS-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.5,-5.5,11.6,-3.8,4.26,-5.9,7.34,-14","22.7,11.9,5.95,1.52,5.11,3.91,18.0,8.21",8,Constant,,8.0,-3.070402622,0.5346,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5958681106567383
1276,1674,KARPAS-422,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,-2.8,14.1,4.12,-1.4,14.8,10.8,-7.2","5.01,4.58,35.7,4.33,1.52,13.6,14.3,15.9",8,Constant,,8.0,0.715876281,0.454,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.881437301635742
1277,1675,KASUMI-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.92,18.0,13.0,3.25,1.65,-8.3,7.61,15.6",".26,6.11,3.13,7.65,5.49,3.67,1.61,19.9",8,Constant,,8.0,5.921405792,0.1136,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.750786542892456
1278,1676,KCL-22,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.9,-1.6,6.33,-1.5,1.10,-4.1,-19,-51","14.2,14.7,4.37,7.29,3.04,14.5,6.27,9.55",8,Sigmoid,8.497634687,7.807744503,-50.91650772,0.9807,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0551161261112605,2.7129602432250977
1279,1677,KG-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","39.0,-7.9,8.58,27.2,20.1,5.93,14.4,-27","15.4,28.6,23.6,25.5,6.06,48.9,16.6,6.22",8,Constant,,8.0,13.67084408,0.5561,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8779678344726562
1280,1678,KHM-1B,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".21,7.01,9.30,33.6,-16,1.80,-23,-29","19.7,5.11,2.48,.14,.36,22.6,3.27,10.6",8,Sigmoid,0.19440411,8.0,-23.15319633,1.1746,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.825460910797119
1281,1679,KMBC-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,.36,-.56,3.83,-1.3,.083,-1.7,-46","8.59,.82,.34,.48,5.24,.55,3.04,4.91",8,Sigmoid,5.630817413,8.0,-46.02177048,0.4407,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7976202964782715
1282,1680,KMM-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".66,31.0,-11,.82,-3.2,17.7,-29,-74","6.15,1.03,5.77,3.41,6.87,4.05,6.53,4.40",8,Sigmoid,2.791263103,3.216899633,-73.734375,1.158,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.1684180488270774,2.891207218170166
1283,1681,KMRC-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,3.43,14.9,10.5,.55,.11,-28,-22",".060,4.63,8.17,6.40,6.54,.44,7.68,.21",8,Sigmoid,1.16283381,8.0,-24.13056374,0.4486,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6496236324310303
1284,1682,KMRC-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,6.29,-11,13.5,-17,-14,-27,-33","11.0,17.7,6.58,4.64,1.05,5.63,3.32,5.71",8,Sigmoid,3.698777676,8.0,-33.49433136,0.7808,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.3578243255615234
1285,1683,KMS-11,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.04,11.8,18.6,29.6,1.57,3.38,-2.7,-52",".048,5.97,3.67,1.49,.16,3.95,7.10,4.27",8,Sigmoid,8.57778128,7.795879364,-51.6269722,1.0317,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.053595307436313,2.788733959197998
1286,1684,KMS-12-BM,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".51,13.6,-5.6,-1.4,-1.1,-3.7,.77,8.13","17.4,7.55,4.10,12.5,2.76,51.9,1.33,20.4",8,Constant,,8.0,0.317328304,0.7467,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8205790519714355
1287,1685,KMS-34,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.93,-7.0,7.24,7.13,2.84,-9.4,-17,-85","5.92,.31,8.25,.50,9.67,6.06,4.37,2.70",8,Sigmoid,8.424238161,5.140589714,-85.15724182,1.361,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.637167803236245,2.9352831840515137
1288,1686,KNS-60,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.25,15.5,.88,12.8,1.88,8.43,.49,-2.2","10.5,8.23,8.49,10.5,5.91,3.32,4.03,2.09",8,Constant,,8.0,5.801792622,0.0,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.678895950317383
1289,1687,KNS-62,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.89,12.2,13.3,8.62,22.9,1.10,-7.1,-31","19.6,19.8,1.31,18.3,15.3,11.9,14.6,23.4",8,Sigmoid,3.775160074,8.0,-30.05010223,0.2334,KNS62_LUNG,KNS62,ACH-000858,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4718708992004395
1290,1688,KNS-81,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.92,-4.1,3.21,3.12,5.53,.90,-28,-23","6.22,12.2,8.82,11.0,2.53,3.53,12.3,5.40",8,Sigmoid,1.231710911,8.0,-25.18921089,0.484,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7098512649536133
1291,1689,KO52,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.44,3.21,34.9,40.5,-6.5,16.6,4.18,-2.7","3.34,1.24,2.46,9.14,2.25,1.60,11.7,13.5",8,Constant,,8.0,8.474616051,0.06963,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.927966594696045
1292,1690,KP-N-SI9s,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,1.96,4.12,3.34,-3.5,-24,-16,-44","19.4,14.1,1.26,1.24,6.07,17.7,10.7,4.92",8,Sigmoid,8.672548396,8.0,-42.33583069,1.0477,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6341028213500977
1293,1691,KU812,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","30.3,2.79,-11,8.64,14.9,-2.4,-17,-45","12.7,14.4,16.5,10.0,4.01,15.0,4.98,8.90",8,Sigmoid,8.165737698,8.0,-45.18922043,0.5306,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.770932197570801
1294,1692,KYM-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","18.3,-18,17.0,-.86,32.2,-10,15.1,7.10",".85,8.32,27.1,19.9,11.3,3.35,3.37,14.9",8,Constant,,8.0,12.63935375,0.2819,KYM1_SOFT_TISSUE,KYM1,ACH-000607,Rhabdoid,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.2746708393096924
1295,1693,KYSE-140,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.76,3.44,24.0,1.49,-17,-58,-70,-91","10.3,11.5,10.4,23.0,.16,.34,6.34,.90",8,Sigmoid,0.500889182,0.688929975,-86.44928741,2.2679,KYSE140_OESOPHAGUS,KYSE140,ACH-000823,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-0.3726156459346027,2.620704412460327
1296,1694,KYSE-150,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.9,5.70,2.61,6.00,-.93,4.23,-26,-38","10.7,5.25,8.91,10.6,2.05,2.09,3.88,10.6",8,Sigmoid,2.096794605,8.0,-38.10844803,0.5937,KYSE150_OESOPHAGUS,KYSE150,ACH-000855,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7606754302978516
1297,1695,KYSE-180,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.39,5.72,.99,-5.6,-16,-53,-52,-75",".51,.84,3.86,2.97,.70,3.17,7.48,1.75",8,Sigmoid,0.482794255,0.876243353,-72.25092316,1.7008,KYSE180_OESOPHAGUS,KYSE180,ACH-000693,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-0.13211142639677378,2.593285083770752
1298,1696,KYSE-30,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.59,4.74,2.73,3.63,-2.9,-4.5,-8.8,-51","9.97,4.57,3.22,8.80,4.63,1.09,.52,5.58",8,Sigmoid,8.599172857,7.858886242,-51.04441833,0.521,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0616448969096997,2.7739624977111816
1299,1697,KYSE-510,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.96,2.39,3.21,15.6,2.05,-.098,-5.6,-26","7.42,.071,2.74,3.41,7.65,1.53,6.36,8.00",8,Sigmoid,8.404596466,8.0,-26.17785072,0.311,KYSE510_OESOPHAGUS,KYSE510,ACH-000824,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6526966094970703
1300,1698,KYSE-520,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.61,-2.1,5.54,2.44,-.71,-12,-38,-74","3.82,6.25,5.37,13.2,15.1,.24,4.74,.75",8,Sigmoid,4.532172203,3.773011446,-73.67060089,1.037,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.3278734746377892,2.782839775085449
1301,1699,KYSE-70,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.82,13.2,3.76,-2.3,-7.8,-29,-39,-74","7.21,4.78,5.60,8.06,.085,6.48,9.75,39.6",8,Sigmoid,0.558346987,8.0,-47.36591339,1.3543,KYSE70_OESOPHAGUS,KYSE70,ACH-000784,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.569948196411133
1302,1700,L3.3,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.22,-4.5,-.18,-11,-18,-37,-51,-63",".84,4.02,2.36,1.08,3.08,.75,5.96,4.11",8,Sigmoid,1.7726886,2.124577284,-59.5263443,1.7718,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.7535728574116723,2.72519850730896
1303,1701,L-363,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.21,18.9,-.48,5.03,.92,8.84,9.19,-39","23.6,4.13,18.3,3.35,13.6,11.1,1.37,2.33",8,Sigmoid,8.125175171,8.0,-39.42722321,1.3522,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.829968214035034
1304,1702,L-428,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.06,4.12,25.6,19.6,-5.1,3.28,.80,-49","18.1,8.25,20.7,.97,8.13,20.8,8.24,2.05",8,Sigmoid,8.028615297,8.0,-49.26595688,0.6883,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8471834659576416
1305,1703,LCLC-103H,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".84,4.48,.80,1.30,-.87,-2.8,3.90,-12","17.5,3.10,1.19,1.22,15.7,8.88,1.05,1.26",8,Constant,,8.0,1.856094003,0.1241,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.519634962081909
1306,1704,LN-229,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.5,6.62,2.62,6.63,4.98,-1.4,-16,-26","2.44,2.81,9.63,7.64,2.59,3.23,6.99,2.12",8,Sigmoid,2.283804893,8.0,-26.7319088,0.3739,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5068607330322266
1307,1705,LOU-NH91,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,14.0,14.1,36.0,4.03,1.57,1.89,-9.8","6.16,6.86,47.2,1.77,10.6,2.27,0,1.11",8,Constant,,8.0,1.887332678,0.1664,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.528855323791504
1308,1706,LOX IMVI,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.89,.0024,3.24,-.073,-.10,-3.9,-2.4,-8.8","1.40,.85,2.84,6.00,3.82,8.49,.46,5.07",8,Constant,,8.0,0.002366346,0.0391,LOXIMVI_SKIN,LOXIMVI,ACH-000750,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.3617894649505615
1309,1707,LP-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","56.8,1.37,15.3,17.6,10.5,-1.9,1.38,-75","10.3,18.4,51.5,12.4,14.2,3.61,42.7,4.83",8,Linear,,1.779385119,-74.32923126,1.8908,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.5762678658622353,2.9319753646850586
1310,1708,LS123,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.9,37.0,-16,4.42,4.08,-1.6,.36,-36","21.2,2.72,8.32,4.63,26.4,11.7,14.4,3.95",8,Linear,,8.0,-35.21405411,0.4413,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.731205940246582
1311,1709,LS411N,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.04,-3.3,7.49,8.14,.18,-7.6,-11,-3.5","20.5,10.7,5.76,4.94,2.32,23.6,1.65,.91",8,Constant,,8.0,0.175440416,0.04328,LS411N_LARGE_INTESTINE,LS411N,ACH-000985,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.628720283508301
1312,1710,LS513,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.72,16.0,-19,-15,-7.2,-29,-46,-76","6.55,25.4,59.9,9.68,7.99,4.89,13.9,.32",8,Sigmoid,8.966962096,2.88055253,-74.96882629,2.1057,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.057982126441308,2.816830635070801
1313,1711,LU99,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,1.44,-13,10.9,-14,10.1,-15,-71",".66,6.75,10.6,8.71,3.03,4.70,.12,1.97",8,Sigmoid,3.347718954,3.926637173,-71.2853775,0.9483,LU99_LUNG,LU99,ACH-000444,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.3677833784065792,2.3848071098327637
1314,1712,LUDLU-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.8,12.6,-17,-8.8,-30,-34,-40,-61","6.41,17.3,22.2,12.0,16.2,23.5,26.6,16.1",8,Linear,,2.3196421,-61.47478485,1.8359,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.8414129065364244,2.848526954650879
1315,1713,Malme-3M,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.96,11.9,11.6,8.49,-.55,.44,-1.4,-57","16.4,4.71,12.0,17.6,8.66,3.08,13.9,2.64",8,Sigmoid,8.10332394,7.32541132,-56.82709122,0.5408,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.9913493062276397,2.438809394836426
1316,1714,MCAS,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.42,3.38,-.88,.12,2.51,-2.4,-10,-68","4.72,6.85,2.99,5.51,.11,.94,2.81,3.17",8,Sigmoid,8.033557123,6.324099541,-67.64493561,0.6464,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.8443676594194285,2.677626371383667
1317,1715,MCF7,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","30.5,28.8,-6.0,6.21,-28,-17,-30,-86","12.4,24.4,9.07,5.39,15.1,5.34,24.3,17.2",8,Sigmoid,8.974668059,2.845193863,-75.66042328,0.4242,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.0456312069087785,2.9136548042297363
1318,1716,MDA-MB-157,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.99,12.0,-7.1,13.6,10.4,9.26,2.44,5.91","1.40,10.8,3.19,9.25,5.52,3.64,.11,25.0",8,Constant,,8.0,7.157626152,0.1138,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.564586639404297
1319,1717,MDA-MB-175-VII,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.6,9.86,-4.4,-7.8,-35,-62,-87,-95","10.9,8.07,5.64,9.44,6.27,5.50,5.50,.87",8,Sigmoid,0.402319819,0.46874091,-95.93920898,2.3603,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-0.7577050938855437,2.95281982421875
1320,1718,MDA-MB-415,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,34.2,3.80,3.62,-13,9.84,-23,-23","12.2,10.9,28.9,14.9,5.39,4.75,34.9,37.9",8,Constant,,8.0,0.260646343,0.4949,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.768683671951294
1321,1719,MDA-MB-436,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","19.0,.31,13.7,-5.6,10.1,-9.8,-6.4,-15","2.41,12.2,3.08,12.8,7.93,3.75,3.01,12.8",8,Sigmoid,4.344305515,8.0,-13.39495945,0.2457,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6665778160095215
1322,1720,MDA-MB-453,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.3,-5.7,-9.2,-6.0,-29,-42,-58,-76","3.67,3.97,3.82,8.09,9.41,4.54,1.07,4.25",8,Sigmoid,1.272974253,1.437899709,-74.98283386,1.582,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.3631835134730692,2.972093105316162
1323,1721,MDA-MB-468,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","21.4,12.2,19.1,25.7,4.61,-14,-53,-88","7.15,4.97,13.2,3.27,2.18,4.23,7.69,1.62",8,Sigmoid,2.07880187,2.312558651,-87.66216278,1.4168,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.8383545526774125,2.8599743843078613
1324,1722,MEG-01,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.38,-5.4,6.41,10.3,3.38,-.42,21.6,-43","2.15,11.1,9.56,21.0,7.22,6.70,17.3,1.76",8,Sigmoid,8.851577971,8.0,-43.24430466,0.4225,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6572957038879395
1325,1723,MEL-HO,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","27.1,27.4,18.4,26.4,21.6,23.5,11.4,-71","8.74,4.81,2.68,10.9,1.57,4.84,8.91,10.8",8,Sigmoid,7.494398594,6.552443981,-70.51544952,0.6978,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.87983810692287,2.1863927841186523
1326,1724,MES-SA,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.95,12.6,-4.9,-.35,2.12,-6.0,-.24,-1.2","8.04,9.49,2.12,3.32,1.09,1.09,3.67,1.84",8,Constant,,8.0,0.701453984,0.0,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5518765449523926
1327,1725,MeWo,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,10.1,-5.0,1.27,1.15,19.9,44.4,-4.4","2.22,19.6,19.6,7.21,12.6,11.0,44.1,13.1",8,Constant,,8.0,5.2180686,0.0,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.3769102096557617
1328,1726,MFE-296,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.46,2.08,6.81,10.4,-3.1,-9.1,-18,-43","17.2,9.19,4.60,7.41,4.03,20.6,8.19,5.55",8,Sigmoid,8.206088575,8.0,-42.60711288,0.4447,MFE296_ENDOMETRIUM,MFE296,ACH-000879,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.51267147064209
1329,1727,MG-63,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.49,-.97,.98,2.81,1.61,3.43,-2.9,-23","8.97,3.78,2.79,4.33,8.50,.32,9.43,9.56",8,Sigmoid,3.383454323,8.0,-22.77168274,0.1513,MG63_BONE,MG63,ACH-000359,Bone Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4929277896881104
1330,1728,Mino,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,8.43,-2.7,-.41,6.82,1.65,-15,-85","26.1,24.1,16.7,5.70,14.9,12.8,1.72,.78",8,Sigmoid,3.468369246,3.686045647,-85.1723938,0.8071,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.304554243055922,2.976867198944092
1331,1729,MJ,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.72,-26,9.57,24.2,35.1,-3.0,4.97,-11","20.6,22.4,38.0,18.4,7.04,7.67,50.1,1.68",8,Constant,,8.0,-2.982520819,0.2492,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6685123443603516
1332,1730,MKN-45,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-2.0,16.7,4.59,-10,9.90,15.4,-31","2.88,23.7,12.8,6.94,16.5,7.94,10.0,17.7",8,Linear,,8.0,-31.28415489,0.2113,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8637049198150635
1333,1731,MKN7,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","17.3,-6.6,5.20,-3.8,-11,-19,-12,-41","42.6,5.08,17.8,16.5,15.4,7.84,14.5,9.00",8,Linear,,8.0,-40.76840591,0.8744,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.758293867111206
1334,1732,MKN74,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,15.3,6.82,33.5,1.31,-.39,-18,-52","1.43,8.48,43.7,17.8,9.30,3.64,7.17,17.4",8,Linear,,4.689732791,-52.74246216,0.6075,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.5453756066346702,2.621497631072998
1335,1733,MOLP-8,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,4.31,28.9,32.7,-22,23.6,-.87,-26","1.07,39.3,10.3,7.17,12.3,29.7,26.0,11.8",8,Constant,,8.0,0.020694505,0.8492,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.840364933013916
1336,1734,MOLT-16,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","26.9,8.20,15.4,-2.3,12.8,11.4,-2.2,-71","37.9,23.5,14.9,26.7,22.6,38.4,8.47,13.5",8,Linear,,1.46226204,-70.29083252,1.4487,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.3799845791932342,2.5720207691192627
1337,1735,MONO-MAC-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.1,8.70,12.8,2.11,-.0032,16.6,-13,-66","12.7,2.94,9.84,6.56,7.11,23.4,7.00,.90",8,Sigmoid,3.128163815,4.00608778,-65.56468964,2.3191,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.3878151491353614,2.8983263969421387
1338,1736,MOR/CPR,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.3,3.18,13.4,-.22,13.3,-5.9,-20,-26","5.66,1.54,7.53,2.11,14.8,3.87,13.9,.41",8,Sigmoid,1.098604321,8.0,-26.05660439,0.3634,MORCPR_LUNG,MORCPR,ACH-000851,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.656198024749756
1339,1737,MSTO-211H,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,4.09,2.57,7.29,3.80,8.54,3.23,-43","16.8,1.81,9.06,18.3,5.48,7.56,.28,7.94",8,Sigmoid,5.298338413,8.0,-43.0606041,0.3716,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5996716022491455
1340,1738,NCI-H1048,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,4.94,5.96,-3.7,-3.9,-2.3,-20,-40","9.94,7.19,14.9,5.42,5.10,6.25,14.6,10.4",8,Sigmoid,2.747856379,8.0,-40.39766312,0.5777,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8456368446350098
1341,1739,NCI-H1092,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-14,14.0,-.50,6.33,3.53,-2.7,-24",".31,29.2,36.6,9.62,20.1,17.8,11.2,6.36",8,Constant,,8.0,-7.720613956,0.2613,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,3.240788221359253
1342,1740,NCI-H1155,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.56,1.19,10.8,-11,2.25,-.62,-.40,-30","16.1,12.1,12.1,1.79,6.50,14.8,10.6,11.2",8,Sigmoid,9.143840949,8.0,-30.02987099,0.3304,NCIH1155_LUNG,NCIH1155,ACH-000980,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.793437957763672
1343,1741,NCI-H1184,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,97.5,-17,19.9,-2.0,14.4,22.4,33.6","28.3,87.2,6.15,57.0,38.0,71.1,1.65,49.3",8,Constant,,8.0,15.25763035,0.2531,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,3.1945600509643555
1344,1742,NCI-H1341,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","19.0,-18,20.4,13.3,45.4,10.1,-20,-41","9.43,22.8,10.6,43.1,36.0,28.3,38.4,17.9",8,Linear,,8.0,-39.97816849,0.6303,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.682882070541382
1345,1743,NCI-H1373,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.64,-5.8,15.9,-7.2,.95,-.23,15.2,-32","12.5,18.4,19.2,11.8,1.09,14.1,19.0,8.89",8,Constant,,8.0,1.173502564,0.2469,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8073983192443848
1346,1744,NCI-H1568,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,.45,-6.1,30.3,1.77,-1.8,-27,-42","1.00,27.0,2.76,2.07,20.4,11.6,1.17,1.13",8,Sigmoid,2.406738043,8.0,-41.61008453,0.918,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7934513092041016
1347,1745,NCI-H1648,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.47,-9.1,8.23,-15,-21,-40,-19,-84","7.29,27.4,4.30,12.7,10.3,8.11,14.9,7.92",8,Linear,,0.373408833,-82.67686462,1.8562,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-0.9850813925570893,2.719083309173584
1348,1746,NCI-H1650,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,20.8,-5.4,-2.8,-6.8,-25,-40,-55",".61,11.2,23.3,10.1,9.02,5.35,.22,6.47",8,Sigmoid,1.193770647,5.152448654,-54.07244873,1.0601,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.6394720684732407,2.8248720169067383
1349,1747,NCI-H1651,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.37,-3.7,13.6,.25,-4.4,-18,-8.0,-23","22.8,11.7,17.5,6.82,6.43,10.2,10.9,7.55",8,Constant,,8.0,-6.510961533,0.6165,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7745842933654785
1350,1748,NCI-H1792,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".35,6.58,-3.0,7.84,-5.6,-7.0,-8.1,-22","6.89,1.48,2.91,2.00,1.88,.78,1.95,3.72",8,Sigmoid,9.143822712,8.0,-21.47102928,0.3039,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7665019035339355
1351,1749,NCI-H1793,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.21,10.2,3.38,-19,-16,-14,-44,-36","17.3,4.46,2.57,3.55,9.73,15.9,8.79,11.4",8,Sigmoid,0.115966462,8.0,-39.55959702,0.6214,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7460007667541504
1352,1750,NCI-H1915,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","18.8,26.4,9.48,24.8,18.5,9.46,17.4,-16","3.51,20.0,2.15,3.45,19.0,9.91,10.6,8.66",8,Sigmoid,8.148781708,8.0,-15.52894497,0.1502,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5735678672790527
1353,1751,NCI-H1944,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.70,-3.8,6.55,6.76,-9.5,-19,-29,-38","8.42,7.08,1.34,8.60,.086,3.52,9.38,.23",8,Sigmoid,0.725090623,8.0,-37.43599319,0.2708,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.625868082046509
1354,1752,NCI-H1975,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.12,8.15,5.28,13.4,9.72,-6.3,-2.6,-30","9.45,4.39,.99,.32,1.36,10.0,7.66,5.53",8,Sigmoid,8.364759648,8.0,-30.31903839,0.3094,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.703862428665161
1355,1753,NCI-H2009,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.03,-1.4,8.18,3.56,-6.3,-.63,-7.1,-24","13.2,2.36,14.9,12.8,20.2,4.83,4.05,4.68",8,Sigmoid,5.461801052,8.0,-23.60258484,0.3635,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.636460304260254
1356,1754,NCI-H2023,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,23.4,5.59,3.25,-19,-18,-15,-17","0,3.69,6.51,7.26,10.2,2.54,4.14,5.93",8,Sigmoid,0.093200587,8.0,-17.2198143,0.3546,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.708055019378662
1357,1755,NCI-H2030,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.42,-3.7,-2.4,-1.8,-11,-24,-42,-64",".042,6.86,8.42,1.09,2.43,8.19,3.88,1.15",8,Sigmoid,2.875264645,3.724179983,-63.76958084,1.2422,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.314846688805476,2.6981348991394043
1358,1756,NCI-H2052,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.75,19.0,-7.6,6.64,-6.6,12.7,-11,-10","18.6,.46,1.14,1.22,10.7,6.70,21.5,7.45",8,Constant,,8.0,1.728281975,0.4151,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.86482834815979
1359,1757,NCI-H2085,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,7.95,11.1,-.17,-16,-26,-17,-38","14.1,17.3,7.77,23.8,3.76,3.20,20.1,9.37",8,Sigmoid,0.246645212,8.0,-33.45428085,0.8009,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.878979206085205
1360,1758,NCI-H2087,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.80,12.7,5.24,8.01,4.05,-4.2,-2.4,-34","10.2,6.97,14.8,7.71,12.0,8.60,10.4,4.09",8,Sigmoid,8.40302794,8.0,-34.02890015,0.3981,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7904887199401855
1361,1759,NCI-H211,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,-7.2,11.8,7.81,18.4,.30,-14,-44","25.3,8.91,12.5,13.5,8.27,5.16,7.23,5.08",8,Sigmoid,8.0,8.0,-39.63302231,0.6736,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.9968719482421875
1362,1760,NCI-H2122,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.95,19.4,9.02,25.0,-5.2,-5.5,-46,-84","5.86,13.3,14.9,16.3,6.21,23.0,9.55,15.1",8,Sigmoid,4.267987251,2.934415817,-83.82225037,1.0545,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.0765083932645,2.441368341445923
1363,1761,NCI-H2170,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".11,14.4,-15,-18,-43,-74,-83,-86","10.0,14.5,5.16,17.9,6.69,14.4,8.60,14.6",8,Sigmoid,0.22801438,0.300980896,-88.11788177,3.1451,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-1.200708484686006,2.8132731914520264
1364,1762,NCI-H2172,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-12,-1.4,5.69,12.9,1.65,12.2,-23","6.86,19.6,11.3,15.5,24.5,27.7,12.0,35.6",8,Constant,,8.0,0.990343332,0.03765,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7654287815093994
1365,1763,NCI-H2228,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.46,-6.3,6.76,-8.7,-7.1,-14,-1.1,-5.1","8.42,4.00,4.62,2.46,9.17,11.3,12.9,9.13",8,Constant,,8.0,-6.379756451,0.3527,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.617023229598999
1366,1764,NCI-H2286,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,-.40,8.34,10.2,-12,-8.0,-5.6,-56","4.80,.052,8.72,10.8,.60,.31,14.8,14.7",8,Sigmoid,7.924710751,7.359588146,-56.07967377,1.7222,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.9960039727511407,2.5509181022644043
1367,1765,NCI-H23,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.87,17.0,-.32,16.7,-.47,-3.2,8.20,-41","6.16,5.64,11.9,1.47,1.32,5.46,8.32,9.83",8,Sigmoid,8.230145348,8.0,-40.86384964,0.4302,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7212157249450684
1368,1766,NCI-H2444,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,5.59,13.7,14.5,-10,-18,-18,-57","7.85,8.12,.58,28.9,2.09,2.50,8.20,15.5",8,Linear,,1.746527776,-56.52373886,1.0206,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.5576296889459006,2.6991329193115234
1369,1767,NCI-H2452,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.3,27.2,31.0,26.4,10.7,-6.6,-11,-30","3.32,3.55,5.13,6.82,23.8,9.89,5.48,5.21",8,Sigmoid,0.925743043,8.0,-27.06485939,0.2728,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6864819526672363
1370,1768,NCI-H28,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.68,3.02,-3.8,3.32,-11,-34,-46,-58",".39,4.87,.55,7.70,.95,2.30,4.64,4.36",8,Sigmoid,0.683328748,2.911829233,-57.2147789,1.1902,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.068781486101164,2.599602222442627
1371,1769,NCI-H322,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.34,7.33,-3.3,.21,-14,-24,-76,-91","4.67,6.12,5.50,.51,11.6,1.02,1.01,1.91",8,Sigmoid,1.252795339,1.362128496,-91.16526794,1.3463,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.30904854688957667,2.863326072692871
1372,1770,NCI-H3255,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-16,-10,-17,-37,-85,-91,-98","8.84,2.91,9.63,12.4,6.60,.99,1.09,.44",8,Sigmoid,0.360085964,0.333763152,-95.24106598,3.3578,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-1.09732366330253,2.725482702255249
1373,1771,NCI-H358,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.60,19.3,1.75,.83,-9.3,-29,-48,-62","4.07,5.84,13.5,5.87,5.95,2.94,1.81,.52",8,Sigmoid,0.858836591,2.838340044,-61.42397308,1.4357,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.043219389742044,2.8796091079711914
1374,1772,NCI-H441,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".68,2.12,8.83,-2.4,1.78,-21,-3.3,-33","4.66,3.48,25.1,2.82,20.7,7.53,10.3,6.00",8,Sigmoid,8.568929619,8.0,-31.09734154,0.4346,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.585050344467163
1375,1773,NCI-H460,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.32,12.7,2.62,6.75,-6.1,-4.4,-2.3,-2.0","10.6,15.7,11.2,1.23,10.3,14.8,3.69,6.71",8,Constant,,8.0,1.473148942,0.1102,NCIH460_LUNG,NCIH460,ACH-000463,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5571184158325195
1376,1774,NCI-H522,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.28,26.2,-1.2,7.26,-13,-13,-22,-26","11.8,21.9,8.36,2.62,26.0,11.5,3.91,12.1",8,Sigmoid,0.555317342,8.0,-26.14527321,0.7621,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.9071507453918457
1377,1775,NCI-H647,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","32.0,-20,29.5,-12,36.8,2.05,37.5,-14","23.1,11.3,4.60,2.66,29.7,23.0,.39,6.96",8,Constant,,8.0,16.75373077,0.2396,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.648799419403076
1378,1776,NCI-H650,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.30,-2.1,7.32,-1.7,4.74,6.11,8.20,-28","6.00,17.2,.58,5.47,7.75,4.55,15.3,5.41",8,Sigmoid,6.759872437,8.0,-28.09431076,0.1778,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5809407234191895
1379,1777,NCI-H661,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.64,1.75,10.2,-2.7,4.34,-8.2,-7.7,-26","5.19,5.35,16.9,4.23,6.84,6.87,6.15,4.43",8,Sigmoid,9.318907213,8.0,-22.45742798,0.3394,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6263837814331055
1380,1778,NCI-H727,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.6,-7.0,-1.2,-3.8,3.64,24.6,-29,-15","50.2,17.1,15.7,7.12,13.7,11.9,25.0,13.5",8,Constant,,8.0,-1.595950723,0.5375,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.920107364654541
1381,1779,NCI-H747,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,15.6,5.12,-19,-7.9,-2.1,-13,-29","11.6,8.67,10.7,0,8.04,27.4,18.9,30.7",8,Constant,,8.0,-2.970324039,0.5944,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.846255302429199
1382,1780,NCI-H810,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,16.8,-12,15.0,.27,5.94,-1.0,-12","2.74,14.2,5.15,5.16,5.59,9.73,20.3,8.11",8,Sigmoid,2.519998074,8.0,-17.41378403,0.4256,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.982124090194702
1383,1781,NCI-N87,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","24.8,-2.2,-30,-60,-63,-92,-93,-99","28.9,6.94,9.44,10.7,7.31,1.60,.65,.79",8,Sigmoid,0.021223355,0.06610655,-98.94158936,4.381,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-2.716487444749395,2.7138164043426514
1384,1782,NCO2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,-.85,-5.3,7.35,-28,-30,-23,-57","7.36,11.7,2.29,1.76,9.58,5.84,16.5,11.5",8,Sigmoid,8.656271856,7.333292961,-51.15189743,1.6375,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.99242465935687,2.705355167388916
1385,1783,NIH:OVCAR-3,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.15,1.32,4.78,-5.3,-27,-10,-9.6,-53","5.41,10.4,23.5,23.1,5.96,11.2,21.3,3.27",8,Linear,,5.117734732,-52.91749573,1.0323,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.6327119059918542,2.661572217941284
1386,1784,NUGC-3,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-1.0,-4.0,6.36,-26,-40,-45,-69","14.0,12.7,14.2,20.3,2.78,1.22,3.08,2.00",8,Sigmoid,6.247581482,2.410752535,-67.71192932,1.5373,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.879938953947781,2.5943470001220703
1387,1785,NUGC-4,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.19,23.6,-3.9,-22,-62,-75,-78,-85","11.1,3.69,11.9,8.13,3.18,.76,2.90,.98",8,Sigmoid,0.098375209,0.171543315,-81.64607239,2.9416,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-1.762919478667796,2.9899215698242188
1388,1786,OCI-AML2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.88,-4.7,3.25,1.93,.28,.19,-5.6,-18","1.56,3.57,1.37,3.27,.93,.98,.069,2.28",8,Constant,,8.0,-0.401793808,0.1763,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5896072387695312
1389,1787,OCI-AML5,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".98,7.45,1.83,13.1,1.84,-4.7,-9.9,-9.2",".52,3.86,.96,2.58,6.65,4.64,4.81,4.15",8,Constant,,8.0,0.913438797,0.4723,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.518507719039917
1390,1788,OCUM-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,-10,13.2,3.74,9.41,-8.9,-7.8,-16","12.1,16.4,3.71,7.13,13.6,20.2,11.1,9.58",8,Constant,,8.0,-0.590841651,0.3383,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.579136371612549
1391,1789,OE21,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,13.1,1.81,3.48,-2.5,-26,-63,-86","4.09,22.1,12.2,13.8,22.4,6.32,1.10,2.06",8,Sigmoid,1.682511926,1.70167017,-85.79895782,1.5609,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.5316102217123158,2.5057146549224854
1392,1790,OE33,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.57,4.80,-1.3,6.31,-24,-26,-32,-76","3.45,15.9,18.2,22.6,7.91,7.85,1.05,3.16",8,Sigmoid,8.600961688,3.538352251,-72.9010849,1.3948,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.2636611529636321,2.852813243865967
1393,1791,ONCO-DG-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.34,3.77,4.46,-5.0,-2.1,-8.4,-22,-41","4.61,.91,20.1,9.86,7.73,5.59,13.5,8.37",8,Sigmoid,9.052602421,8.0,-40.97795868,0.8549,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.764688491821289
1394,1792,ONS-76,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.54,4.32,1.30,4.07,-.48,-3.9e-4,.52,-13","2.49,1.38,1.87,1.17,2.95,1.48,4.89,3.14",8,Constant,,8.0,1.23714757,0.1084,ONS76_CENTRAL_NERVOUS_SYSTEM,ONS76,ACH-000776,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7821617126464844
1395,1793,OPM-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.64,4.74,57.1,14.0,17.7,-5.1,7.33,-.37","3.97,35.8,34.9,9.96,7.78,5.80,15.8,12.1",8,Constant,,8.0,7.547005653,0.03488,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.912111759185791
1396,1794,OV-90,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","19.0,-7.4,12.4,10.4,7.22,34.6,-4.9,-44","3.76,7.37,19.6,14.8,5.70,12.2,.19,6.70",8,Sigmoid,3.002259254,8.0,-44.49710083,0.3964,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.54241681098938
1397,1795,OVCAR-4,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".14,8.59,-3.7,3.48,1.28,-2.8,-10,-46","6.35,8.30,12.0,.16,2.14,5.35,10.8,13.0",8,Sigmoid,8.21571943,8.0,-45.05362701,0.4367,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.784036159515381
1398,1796,OVCAR-8,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.57,-11,9.10,-11,5.48,-19,-22,-77","5.59,28.0,8.85,17.8,9.01,19.2,5.03,11.5",8,Sigmoid,9.168835508,5.095930576,-76.06649017,1.0963,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.628442294943156,2.7716922760009766
1399,1797,OVMANA,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.33,9.43,2.65,9.13,.86,-1.2,-22,-46","1.73,.051,3.37,14.5,4.21,9.94,.27,4.79",8,Sigmoid,3.405663729,8.0,-46.13118744,0.6579,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4144320487976074
1400,1798,OVSAHO,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,6.63,13.0,-1.1,-1.0,2.69,2.60,-39","13.7,2.39,11.9,9.47,13.3,4.81,3.89,6.35",8,Sigmoid,8.280971878,8.0,-39.08721161,0.3303,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.9520912170410156
1401,1799,OVTOKO,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.66,.75,-.68,1.78,-11,-21,-27,-40","4.57,7.29,.65,5.73,1.90,5.05,.72,8.52",8,Sigmoid,1.293386817,8.0,-37.79001236,0.8776,OVTOKO_OVARY,OVTOKO,ACH-000663,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5096726417541504
1402,1800,P12-ICHIKAWA,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.57,9.57,18.0,14.9,4.10,-1.1,.73,-61","11.0,9.76,25.3,11.5,7.94,6.61,3.69,11.1",8,Sigmoid,7.04285574,6.982272625,-60.69910049,0.7179,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.9433744547552543,2.6430234909057617
1403,1801,P31/FUJ,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,14.1,16.3,-5.6,14.2,8.31,19.0,-12","1.23,16.6,15.0,1.11,6.06,17.5,7.53,3.66",8,Constant,,8.0,4.707146168,0.3472,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.855165481567383
1404,1802,P3HR-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.7,8.89,7.95,11.3,-.78,-11,1.94,-4.5","11.6,6.73,.74,2.14,9.98,3.76,4.42,11.1",8,Constant,,8.0,4.650393963,0.005816,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,3.0154600143432617
1405,1803,Panc 02.03,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.2,9.66,3.37,-3.8,-.81,-16,-32,-63","2.91,2.88,17.0,.44,13.4,4.52,6.49,10.8",8,Sigmoid,8.967171102,5.197283745,-62.95778656,1.0355,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.6481361323808073,2.6147685050964355
1406,1804,Panc 03.27,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.3,6.25,4.32,-7.9,-11,.54,-23,-53","5.99,26.4,14.1,18.2,31.9,3.55,8.15,9.03",8,Sigmoid,3.738466978,6.904091835,-53.46982956,0.7534,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.932114255401814,2.787097454071045
1407,1805,Panc 04.03,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.39,-14,-4.7,-6.6,17.7,-11,-4.8,-52","49.3,5.29,29.9,42.7,32.8,31.8,35.3,14.2",8,Constant,,8.0,-13.98077965,0.6503,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.9289965629577637
1408,1806,Panc 10.05,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,10.3,-3.6,10.9,1.52,-9.7,-16,-50","5.85,15.5,12.3,28.0,12.4,26.9,3.76,3.97",8,Sigmoid,3.147685766,7.987658501,-50.00887299,0.6474,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0778976631374437,2.8544678688049316
1409,1807,PA-TU-8902,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.11,1.83,2.37,-.46,2.57,.057,-.60,-24","4.30,3.34,10.1,1.61,.018,3.20,3.10,5.71",8,Sigmoid,8.037856256,8.0,-23.52932549,0.2098,PATU8902_PANCREAS,PATU8902,ACH-000599,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.584235906600952
1410,1808,PC-3,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.99,9.48,12.8,14.0,.81,5.71,1.59,-25","11.3,7.78,13.2,1.67,3.39,7.12,8.42,2.58",8,Sigmoid,8.313116194,8.0,-24.57627869,0.3291,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8668699264526367
1411,1809,Pfeiffer,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","23.6,53.1,22.0,21.3,10.5,7.85,29.3,-34","14.4,29.8,4.76,5.31,16.5,8.19,8.33,3.57",8,Sigmoid,8.126005336,8.0,-32.74415207,0.35,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4458119869232178
1412,1810,PK-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.56,1.04,6.59,3.51,1.23,-8.8,-19,-54","1.15,5.91,4.22,9.13,1.45,1.21,2.42,2.14",8,Sigmoid,8.691275694,7.236270905,-54.08416367,0.7236,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.9791060053341802,2.7881789207458496
1413,1811,PK-45H,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.3,-1.6,2.44,-6.3,4.63,-7.9,-1.1,-39",".36,21.2,6.24,4.67,8.09,1.93,13.1,4.74",8,Sigmoid,8.033207459,8.0,-38.49197388,0.43,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.768068552017212
1414,1812,PK-59,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.60,6.27,3.19,3.53,-5.1,-5.9,-8.9,-58","2.89,.32,.78,3.03,2.52,1.67,5.44,.36",8,Sigmoid,4.19764328,6.190493584,-57.34639359,0.5183,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.8230148224512892,2.749699354171753
1415,1813,PLC/PRF/5,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.10,4.65,9.81,-13,-12,-12,-35,-54","6.56,1.60,14.6,5.59,3.65,4.72,5.23,5.46",8,Sigmoid,8.990505181,6.669433117,-53.73934937,1.2112,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.8975348663606588,2.321613073348999
1416,1814,PSN1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".92,2.60,1.46,1.16,1.02,5.08,-2.1,-13","2.23,3.32,.57,3.75,1.36,.37,2.96,3.92",8,Constant,,8.0,0.733748674,0.05786,PSN1_PANCREAS,PSN1,ACH-000320,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6054210662841797
1417,1815,QGP-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.14,1.23,34.8,12.8,2.74,-3.5,-30,-13","0,0,0,0,0,0,0,0",8,Sigmoid,0.903995156,8.0,-21.32652473,0.4053,QGP1_PANCREAS,QGP1,ACH-000347,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,3.0590734481811523
1418,1816,Raji,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","20.6,3.63,19.1,6.24,-20,-27,.92,2.79","20.8,17.3,3.94,2.08,9.71,2.28,2.82,1.24",8,Sigmoid,0.091195174,8.0,-10.66947174,0.3515,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.832488536834717
1419,1817,RD,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.92,1.51,6.94,3.32,6.71,-8.7,-16,-9.7","1.57,.76,10.2,5.72,5.67,4.87,3.53,9.84",8,Constant,,8.0,0.565336108,0.195,RD_SOFT_TISSUE,RD,ACH-000169,Sarcoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8080387115478516
1420,1818,Reh,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.39,3.16,3.38,-4.1,9.76,-7.7,6.97,-54","11.2,.87,3.18,3.47,10.7,4.02,15.8,7.02",8,Sigmoid,8.154154887,7.811583519,-54.12004852,0.4909,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.055607698613214,2.6024370193481445
1421,1819,RERF-GC-1B,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.71,-4.2,-.33,1.95,-15,-22,-32,-23","3.56,10.3,5.03,5.16,10.0,6.67,8.64,1.53",8,Sigmoid,0.21069175,8.0,-24.91658783,0.717,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8622288703918457
1422,1820,RERF-LC-AI,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,-2.6,-5.4,-2.3,-3.1,-4.2,-12,-25","4.57,5.48,4.03,4.92,5.02,2.21,1.62,.43",8,Sigmoid,3.192855358,8.0,-25.10490417,0.306,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.673828601837158
1423,1821,RERF-LC-MS,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,6.23,-4.6,-4.6,18.3,.24,11.6,-19","7.33,2.02,19.0,12.2,6.03,18.6,7.24,21.2",8,Constant,,8.0,4.211279869,0.03182,RERFLCMS_LUNG,RERFLCMS,ACH-000062,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.41754412651062
1424,1822,RKO,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.78,.96,4.94,2.34,12.7,10.1,-.074,-33","4.29,1.36,10.6,1.69,3.20,2.51,3.23,9.66",8,Sigmoid,3.70991087,8.0,-32.45015717,0.302,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5621514320373535
1425,1823,RL95-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.29,4.39,-.54,-2.4,-25,-28,-34,-63","29.5,1.60,18.8,16.5,2.64,9.18,6.08,6.43",8,Sigmoid,8.069838066,3.012983322,-63.56348801,1.3016,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.1029307247860138,2.7212753295898438
1426,1824,RPMI-7951,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.7,5.44,6.67,1.80,-7.3,11.7,-2.7,-8.7","10.2,9.90,4.37,2.97,1.28,7.29,15.2,6.40",8,Constant,,8.0,3.766339064,0.212,RPMI7951_SKIN,RPMI7951,ACH-000348,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6862850189208984
1427,1825,RPMI-8402,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.08,5.30,15.9,-5.0,-.36,-3.2,-7.2,-79","17.0,3.06,1.57,4.11,2.49,1.74,11.7,6.39",8,Sigmoid,8.235867727,5.996370792,-78.50969696,1.2147,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.791154418221606,2.620584726333618
1428,1826,RT-112,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.32,-2.5,8.27,-5.1,4.06,-6.3,-19,-61","13.2,5.65,4.03,29.6,10.6,11.6,.11,24.9",8,Sigmoid,8.139969116,6.525924206,-59.00575256,0.7505,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.8757825839449345,2.659050941467285
1429,1827,RT4,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.77,17.0,10.8,-11,-42,-26,-33,-58","9.04,12.2,30.4,11.2,5.24,23.6,12.8,11.9",8,Sigmoid,0.083713084,8.0,-42.12934494,1.889,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7812466621398926
1430,1828,RVH-421,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.0,10.2,14.5,5.83,8.64,-6.7,8.20,-4.7","8.63,9.84,.73,5.53,.51,5.48,1.67,13.4",8,Constant,,8.0,7.756498337,0.1602,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.412076950073242
1431,1829,SBC-5,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,5.49,-.67,3.94,-5.4,-2.4,-4.2,-30","7.57,11.5,8.69,13.8,5.38,9.44,3.98,16.7",8,Sigmoid,8.360128823,8.0,-29.21069717,0.2793,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4373085498809814
1432,1830,SCaBER,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.0,-1.0,.73,-10,-19,-37,-61,-73","10.4,5.47,16.9,10.4,.067,15.3,7.09,1.61",8,Sigmoid,1.038746715,1.511765718,-73.9677124,1.7113,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.4132783173388973,2.7609941959381104
1433,1831,SCC-9,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","35.3,.61,12.3,14.1,.79,-15,-24,-79","14.9,1.80,7.70,30.4,14.3,6.09,3.59,2.76",8,Sigmoid,8.656470017,4.28721571,-76.69525909,1.1401,SCC9_UPPER_AERODIGESTIVE_TRACT,SCC9,ACH-000181,Head and Neck Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.4556375035881322,2.4939393997192383
1434,1832,SF126,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.08,2.74,.60,-4.6,3.53,-.98,-2.2,-39","3.63,4.92,.37,7.95,10.2,8.48,9.86,4.28",8,Sigmoid,6.425824642,8.0,-38.66160202,0.3474,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6000919342041016
1435,1833,SF-295,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.29,.35,2.32,3.27,.20,-7.4,-12,-38","1.89,2.72,.94,3.12,1.71,2.17,1.03,15.7",8,Sigmoid,8.18345881,8.0,-27.44148636,0.4123,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.530113458633423
1436,1834,SH-10-TC,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","20.7,8.51,12.1,4.36,5.47,4.80,-11,-34","2.39,4.65,2.59,.079,6.19,2.74,2.81,1.48",8,Sigmoid,8.585089612,8.0,-33.53926468,0.2517,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5795302391052246
1437,1835,SHP-77,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.81,-5.4,-19,22.1,7.76,8.22,16.3,7.88","24.0,0,12.9,0,1.58,0,27.6,13.2",8,Constant,,8.0,6.703983784,0.2586,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.795346260070801
1438,1836,SIG-M5,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.82,-3.6,20.4,10.1,-4.6,-8.8,7.49,-55","5.85,1.61,26.7,10.3,12.9,9.38,6.60,4.37",8,Sigmoid,8.720544094,7.851887226,-54.80404663,1.3094,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.060753913855648,2.472932815551758
1439,1837,SIMA,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","21.4,18.4,.79,7.99,4.30,15.8,-5.7,-10","8.84,31.4,27.9,6.44,33.4,3.16,1.59,40.0",8,Constant,,8.0,12.97405243,0.5922,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.573000431060791
1440,1838,SJSA-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","16.3,35.5,21.8,14.4,14.7,3.55,-13,-17","6.73,23.9,33.2,6.76,15.5,5.04,11.2,15.7",8,Sigmoid,1.034476042,8.0,-17.43052864,0.3625,SJSA1_BONE,SJSA1,ACH-000748,Bone Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.49841570854187
1441,1839,SK-BR-3,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","19.7,-15,-10,-37,-42,-71,-71,-75","27.3,17.5,13.4,5.45,9.30,5.55,.47,4.39",8,Sigmoid,0.075882129,0.196391836,-75.49897766,2.9047,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-1.6276434521538603,2.8608579635620117
1442,1840,SK-CO-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,27.5,-15,12.3,7.57,-15,-13,-72","6.55,15.7,9.20,22.6,2.79,.66,3.94,35.7",8,Linear,,0.715620146,-70.82302094,1.0674,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-0.33460577514463247,2.6399216651916504
1443,1841,SK-ES-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".73,9.87,1.98,6.32,8.40,-3.9,-.96,-39","8.70,8.21,10.6,.096,.53,8.27,4.68,10.5",8,Sigmoid,8.114975729,8.0,-39.22535324,0.3363,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.970919132232666
1444,1842,SK-HEP-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.96,5.61,-12,-2.9,.28,-12,.65,-5.1","6.45,5.16,.074,.55,1.98,2.64,.15,2.83",8,Constant,,8.0,-1.763334632,0.1027,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.717224597930908
1445,1843,SK-MEL-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-17,1.66,5.85,-20,-16,-1.1,23.3","2.69,13.7,6.40,5.18,17.5,10.0,8.06,8.27",8,Linear,,8.0,-20.36111259,0.9673,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5177507400512695
1446,1844,SK-MEL-24,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.9,2.86,2.58,7.08,7.47,1.77,2.51,-43","7.30,14.3,2.12,18.0,14.7,2.41,4.23,7.27",8,Sigmoid,8.306881082,8.0,-42.97650528,0.3248,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5166425704956055
1447,1845,SK-MEL-30,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.90,-7.8,4.52,-2.2,3.08,-4.6,2.41,-15","7.71,1.91,5.33,.077,.62,.76,2.92,6.40",8,Constant,,8.0,-2.203866959,0.027,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.2562832832336426
1448,1846,SK-MEL-31,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.47,-6.4,7.77,7.61,-10,-16,-13,-43","23.0,10.7,6.66,12.8,5.94,9.92,15.2,9.80",8,Sigmoid,8.423722603,8.0,-40.8812294,0.5777,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.3842039108276367
1449,1847,SK-MEL-5,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.3,13.7,15.3,10.7,8.62,14.2,12.0,-13","14.4,3.63,7.05,4.73,7.50,.60,12.1,11.3",8,Sigmoid,6.618503094,8.0,-13.1427269,0.03464,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4959750175476074
1450,1848,SK-MES-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","22.4,13.9,27.1,9.43,-11,-37,-61,-92",".99,10.8,11.2,11.1,1.28,10.8,6.88,2.16",8,Sigmoid,1.548179388,1.476444125,-90.78666687,2.0259,SKMES1_LUNG,SKMES1,ACH-000665,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.3896365786141248,2.902038097381592
1451,1849,SK-MM-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.87,11.2,-12,6.28,-2.4,-10.0,-52,-57","1.14,6.05,3.67,.81,3.63,.23,2.48,13.8",8,Sigmoid,1.2403965,2.369957447,-57.96674728,1.2505,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.8628720001335288,2.7378292083740234
1452,1850,SK-N-AS,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.79,8.04,-1.8,-1.0,-.71,-12,7.29,-11","2.59,6.63,3.30,16.0,5.28,11.3,10.8,1.28",8,Constant,,8.0,0.205863178,0.08355,SKNAS_AUTONOMIC_GANGLIA,SKNAS,ACH-000260,Neuroblastoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7075700759887695
1453,1851,SK-N-BE(2),Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.0063,20.1,7.81,5.42,20.2,-7.2,16.0,-1.8","13.3,36.5,9.77,17.0,9.76,13.3,16.9,42.4",8,Constant,,8.0,6.780239582,0.1607,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6882166862487793
1454,1852,SK-N-DZ,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.5,-5.3,11.5,.98,14.0,-1.8,4.71,-19","2.87,11.2,12.9,4.95,3.61,12.4,2.90,.89",8,Sigmoid,8.408488578,8.0,-18.64640999,0.1598,SKNDZ_AUTONOMIC_GANGLIA,SKNDZ,ACH-000366,Neuroblastoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.560527801513672
1455,1853,SK-N-FI,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,56.8,40.4,30.5,15.9,-16,-17,21.2","21.9,77.0,67.0,30.2,41.4,29.5,1.97,21.0",8,Constant,,8.0,6.256745338,0.3646,SKNFI_AUTONOMIC_GANGLIA,SKNFI,ACH-000341,Neuroblastoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6836652755737305
1456,1854,SK-N-SH,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","16.1,-11,15.9,-10,15.8,-8.4,15.0,-40","1.73,4.73,17.4,8.90,8.37,7.84,11.5,12.9",8,Constant,,8.0,0.542642236,0.5023,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.637826919555664
1457,1855,SK-OV-3,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","21.0,22.0,14.0,20.2,-23,-18,-42,-38",".77,23.3,4.74,9.22,1.99,16.5,11.6,29.5",8,Sigmoid,0.252784073,0.983712375,-56.92263031,0.8272,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-0.016421726487658262,2.589845657348633
1458,1856,SNG-M,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.088,2.74,-1.2,4.16,-13,-8.8,-12,-30","4.89,3.88,.69,.98,.71,2.81,2.86,8.38",8,Sigmoid,8.61040593,8.0,-28.78151512,0.5455,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.497206687927246
1459,1857,SNU-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,3.84,-9.9,6.04,2.03,4.45,-12,-38","8.22,8.09,2.86,11.0,13.1,6.01,1.20,5.81",8,Sigmoid,2.923507452,8.0,-38.49322891,0.4886,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6744585037231445
1460,1858,SNU-182,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","20.2,7.21,14.5,-9.7,8.56,-3.0,10.6,-8.8","9.45,1.76,1.89,18.2,.95,21.9,6.80,8.41",8,Constant,,8.0,8.157282829,0.1451,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6098973751068115
1461,1859,SNU-387,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.17,-17,-.17,-16,2.99,-18,11.4,-4.0","17.8,13.7,9.41,3.33,18.0,22.1,14.6,4.00",8,Constant,,8.0,-5.585865974,0.8222,SNU387_LIVER,SNU387,ACH-000478,Liver Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5649051666259766
1462,1860,SNU-398,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-9.3,.53,-12,20.6,-16,-3.4,-11","22.3,4.54,3.87,14.1,13.2,9.36,11.4,4.29",8,Constant,,8.0,-7.238404274,0.2801,SNU398_LIVER,SNU398,ACH-000221,Liver Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6346378326416016
1463,1861,SNU-423,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-1.8,3.54,2.20,3.49,1.58,-15,-22","10.5,9.27,9.71,2.77,11.4,4.77,30.3,18.4",8,Constant,,8.0,-0.623290062,0.2067,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6362500190734863
1464,1862,SNU-449,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.84,-3.8,-6.7,2.55,-2.6,-9.9,-13,-19","5.12,12.0,2.82,1.34,13.7,6.51,2.46,.25",8,Sigmoid,8.885575308,8.0,-19.24770737,0.1797,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.975152015686035
1465,1863,SNU-475,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","64.4,17.8,64.8,-6.5,11.3,-29,-28,-27","37.3,18.6,39.4,49.0,15.7,30.0,26.7,9.78",8,Linear,,8.0,-35.66307449,0.8682,SNU475_LIVER,SNU475,ACH-000422,Liver Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.674053192138672
1466,1864,SNU-C2A,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,-3.1,6.29,13.9,-6.5,1.36,-17,-22","1.14,3.67,2.27,19.1,.60,19.1,24.6,8.29",8,Constant,,8.0,-3.422872066,0.2618,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6983766555786133
1467,1865,Sq-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.25,.51,-4.5,-7.3,-9.6,-11,-29,-39","5.79,9.38,3.69,8.69,2.26,13.3,10.4,1.44",8,Sigmoid,8.554424443,8.0,-39.85964584,0.6781,SQ1_LUNG,SQ1,ACH-000553,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7748568058013916
1468,1866,SU.86.86,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.26,-3.0,1.70,6.00,-7.9,-7.3,-5.3,-12","4.32,2.50,5.81,.31,8.50,1.81,2.35,1.08",8,Constant,,8.0,-2.95947814,0.09048,SU8686_PANCREAS,SU8686,ACH-000114,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.662386417388916
1469,1867,SU-DHL-10,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","26.8,-1.8,11.4,5.78,6.34,-.58,57.3,-82","16.4,3.68,17.1,5.66,5.48,10.0,8.30,18.8",8,Linear,,0.89234285,-78.42938995,0.7992,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-0.11390485926334236,2.8821942806243896
1470,1868,SU-DHL-4,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.1,12.9,20.9,31.5,5.18,-7.6,-10.0,-86","9.82,.0016,34.8,20.9,8.55,.86,12.7,.69",8,Sigmoid,8.633841916,5.036627293,-84.97476196,1.2882,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.6167366701802908,2.6704068183898926
1471,1869,SU-DHL-6,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","31.0,22.5,3.02,46.8,-37,65.6,5.35,-96","0,0,0,0,0,0,0,0",8,Linear,,0.386255655,-100.431488,1.4096,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-0.951255810100658,2.634119987487793
1472,1870,SU-DHL-8,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.70,12.0,21.1,11.3,6.37,6.18,20.8,-89","24.0,23.2,13.8,9.54,7.30,5.15,10.1,2.48",8,Sigmoid,8.016220157,6.819135189,-89.26989746,0.9553,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.9197326586829555,2.9495606422424316
1473,1871,SUIT-2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.28,4.36,8.32,7.08,10.2,-.86,-1.9,-31","12.3,2.74,5.23,5.44,5.18,4.78,5.82,8.42",8,Sigmoid,8.495548723,8.0,-24.11276817,0.1841,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4424266815185547
1474,1872,SUP-M2,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".46,-9.2,-12,6.73,-15,18.1,-.28,12.2","22.6,1.32,5.54,16.1,28.9,1.55,13.3,8.07",8,Constant,,8.0,0.051330704,0.0,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4758858680725098
1475,1873,SUP-T1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.56,-4.9,11.7,12.1,2.45,7.62,-13,15.6","9.69,1.14,.40,2.45,15.6,3.95,.97,3.05",8,Constant,,8.0,10.37762165,0.2321,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.9517340660095215
1476,1874,SW 1088,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,-18,-20,-18,-6.6,-9.2,-6.2,-76","45.6,2.71,25.3,4.44,15.7,3.45,8.36,13.5",8,Sigmoid,8.020390033,6.737086296,-75.70566559,0.7047,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.9076275311587678,2.730350971221924
1477,1875,SW 1271,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".99,-2.3,.81,.20,-1.4,10.1,-4.7,-11","23.6,2.31,12.1,10.7,5.94,19.5,11.7,6.73",8,Constant,,8.0,-3.339017868,0.1266,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.681830883026123
1478,1876,SW 1353,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.4,14.5,4.19,10.6,-.38,-3.0,-6.7,-20","5.36,8.22,8.14,11.8,8.35,2.26,4.57,.45",8,Sigmoid,8.298324195,8.0,-18.24295044,0.3409,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.638491630554199
1479,1877,SW1417,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","17.9,-16,23.4,-31,16.5,-20,-12,-33","11.1,29.9,19.4,27.9,2.03,39.0,2.51,20.4",8,Constant,,8.0,-3.086969137,0.9209,SW1417_LARGE_INTESTINE,SW1417,ACH-000236,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8658132553100586
1480,1878,SW 1573,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.90,6.05,2.24,-3.3,-6.0,-17,-10,-18","3.04,.55,3.76,1.28,5.51,.038,2.81,2.38",8,Sigmoid,0.159284785,8.0,-16.01420403,0.3101,SW1573_LUNG,SW1573,ACH-000677,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.55206298828125
1481,1879,SW 1990,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-.64,-4.7,-9.1,-7.3,-6.7,-13,-39","3.71,17.8,8.79,10.4,12.7,19.9,8.81,10.7",8,Sigmoid,3.700218201,8.0,-38.88829041,0.8197,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.754775047302246
1482,1880,SW403,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.72,27.8,-8.5,-20,-39,-28,-43,-59","17.6,30.4,18.7,25.6,.96,18.5,14.1,9.73",8,Linear,,2.379554535,-59.54841614,1.8469,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.8669132999967942,2.872082471847534
1483,1881,SW48,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,-19,-41,-43,-43,-35,-44,-65","10.7,4.50,1.43,10.2,4.55,9.12,.50,4.45",8,Sigmoid,0.002542614,8.0,-49.01160049,2.7696,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4184346199035645
1484,1882,SW480,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","16.0,-.98,9.94,-11,2.62,4.88,-4.4,-18",".82,8.71,1.75,11.7,.66,4.95,13.5,4.02",8,Sigmoid,8.219619415,8.0,-17.45058441,0.2645,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7909188270568848
1485,1883,SW579,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.63,-3.9,3.47,.75,-2.6,-.43,-2.0,-29","1.10,12.5,3.38,.31,5.89,.88,1.20,2.87",8,Sigmoid,8.065442431,8.0,-28.6566124,0.219,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6505231857299805
1486,1884,SW620,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","16.9,1.87,3.57,13.9,5.15,20.4,.56,-3.9","6.06,14.2,.12,6.52,3.81,8.86,5.12,12.8",8,Constant,,8.0,6.182596207,0.0,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.490166664123535
1487,1885,SW 780,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,5.22,2.71,3.38,-15,-9.7,-20,-37","11.3,5.63,8.46,3.25,8.38,8.88,24.5,17.9",8,Sigmoid,8.10353659,8.0,-36.69424057,0.6584,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.712317705154419
1488,1886,SW 900,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".75,-4.5,12.8,-5.9,.19,13.2,3.85,-30","21.4,9.25,1.08,24.0,6.48,5.05,29.0,18.8",8,Constant,,8.0,3.08762145,0.4217,SW900_LUNG,SW900,ACH-000669,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.849730968475342
1489,1887,T24,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.93,16.4,9.97,14.2,.82,6.00,-4.0,-26","2.86,2.40,14.6,9.11,4.49,8.62,1.28,1.88",8,Sigmoid,8.256046581,8.0,-25.23657417,0.416,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.519570827484131
1490,1888,T3M-10,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.24,-3.2,22.2,.58,11.3,5.41,-14,-51","12.9,5.22,.14,14.0,8.67,16.6,1.23,12.6",8,Sigmoid,3.119650126,7.170650959,-51.04762268,0.54,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.9699964397512424,2.6485445499420166
1491,1889,T-47D,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.32,14.0,1.09,9.52,-1.4,-16,-30,-20","23.5,9.30,23.1,10.4,16.8,8.80,3.94,7.00",8,Sigmoid,0.429147363,8.0,-25.04823685,0.5727,T47D_BREAST,T47D,ACH-000147,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,3.1103625297546387
1492,1890,T84,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.43,102,59.7,14.1,76.6,-19,32.1,-7.5","10.1,77.6,115,.92,32.7,21.1,36.6,34.4",8,Constant,,8.0,14.07734585,0.2998,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.8086349964141846
1493,1891,TCCSUP,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,-3.3,-2.7,-.36,6.64,.39,.24,-12","8.53,3.94,4.50,1.69,4.16,2.73,4.75,3.18",8,Constant,,8.0,-1.041813612,0.0,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5641980171203613
1494,1892,TE-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.60,6.74,4.89,-.11,2.73,-13,-20,-48","4.74,4.48,.53,6.02,8.08,3.69,.098,7.74",8,Sigmoid,8.879128393,8.0,-47.83055878,0.7076,TE1_OESOPHAGUS,TE1,ACH-000647,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5674498081207275
1495,1893,TE-11,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.57,1.86,-1.2,-7.6,-32,-54,-73,-85","5.22,8.30,9.18,2.18,1.32,4.27,7.17,2.80",8,Sigmoid,0.461431116,0.637750149,-83.88265991,2.2305,TE11_OESOPHAGUS,TE11,ACH-000488,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-0.44980868832637444,2.628679037094116
1496,1894,TE-15,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","16.5,22.6,-1.4,17.5,-5.1,-32,-69,-74",".99,1.48,17.1,13.8,10.3,2.98,.35,3.51",8,Sigmoid,0.707083583,1.285878181,-76.4571228,1.4963,TE15_OESOPHAGUS,TE15,ACH-000353,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.25144189426788305,2.6759822368621826
1497,1895,TE-5,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,2.36,3.95,-4.8,-3.2,-4.4,-20,-25","4.21,.94,.89,7.62,2.14,1.32,8.57,4.16",8,Sigmoid,1.643375516,8.0,-25.10857582,0.486,TE5_OESOPHAGUS,TE5,ACH-000408,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6519994735717773
1498,1896,TE 617.T,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.72,10.8,-32,-25,-49,-73,-84,-93","6.34,1.08,7.48,15.5,27.7,8.60,2.47,2.63",8,Sigmoid,0.225932196,0.242927998,-91.34347534,3.4461,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-1.4149901840751973,2.1972460746765137
1499,1897,TE-9,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.28,-8.8,.20,-8.0,-7.4,-12,-28,-62","14.2,5.32,2.14,15.5,1.90,6.83,1.25,.86",8,Sigmoid,8.881306257,5.855278969,-61.89756775,1.265,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.7673436421998587,2.7454538345336914
1500,1898,TEN,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,22.6,-6.1,21.4,-11,.75,-27,2.45","19.3,11.3,14.1,2.71,26.2,5.36,9.14,12.5",8,Constant,,8.0,0.257976443,0.6323,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.748570680618286
1501,1899,Toledo,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.1,22.7,.72,9.40,-21,6.75,14.3,-1.4","10.4,19.8,25.5,13.4,8.53,24.8,7.28,.20",8,Constant,,8.0,7.800075531,0.02839,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7729272842407227
1502,1900,TOV-112D,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.73,-.95,2.86,-2.4,1.60,-4.3,-16,-41","5.69,6.46,1.55,2.51,.072,4.69,1.83,6.49",8,Sigmoid,8.070217591,8.0,-41.46539307,0.4868,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.583019256591797
1503,1901,TOV-21G,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.38,-1.5,-7.7,3.60,-.48,-16,-15,-51","11.3,2.86,5.19,6.23,7.47,.16,8.86,13.1",8,Sigmoid,8.484685441,8.0,-49.79180145,0.5477,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.1231720447540283
1504,1902,TT2609-C02,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,12.5,-11,-.49,-2.3,3.39,-9.7,-33","18.7,.15,13.0,13.6,.73,10.3,14.3,22.6",8,Sigmoid,4.600250244,8.0,-33.2350502,0.4612,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5174543857574463
1505,1903,TYK-nu,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.16,2.17,-4.3,-3.1,1.98,4.98,-4.2,-62","2.98,11.0,13.4,8.63,1.21,16.2,3.09,18.8",8,Sigmoid,4.034721851,5.343410969,-60.61819077,0.5639,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.6758642072925916,2.7063376903533936
1506,1904,U-118 MG,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.25,-12,5.77,4.44,5.59,-3.5,4.01,.90","4.12,14.8,1.65,22.0,3.01,5.67,12.1,13.9",8,Constant,,8.0,2.539658546,0.04566,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6343038082122803
1507,1905,U-2 OS,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.47,7.06,6.19,-8.6,-4.3,-27,-17,-23","4.85,1.92,8.03,6.40,6.62,6.04,10.5,2.70",8,Sigmoid,0.190182284,8.0,-22.99322891,0.7341,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6079745292663574
1508,1906,U-87 MG,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,-1.5,1.08,-.51,.96,2.62,-1.6,-27",".51,1.20,6.78,11.2,5.59,7.82,10.3,5.55",8,Sigmoid,4.425104618,8.0,-26.78865051,0.5471,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.6527509689331055
1509,1907,U-937,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,11.2,19.6,8.32,-4.8,.57,2.33,-42","16.6,16.8,24.0,2.97,3.99,8.06,4.03,38.2",8,Sigmoid,8.15445946,6.971768856,-67.54827118,0.3857,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.9418689739240302,2.5276405811309814
1510,1908,UACC-257,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,-.59,5.50,1.13,-2.3,-.17,-1.4,-7.3","7.48,7.15,6.26,5.55,3.01,2.88,2.55,10.4",8,Constant,,8.0,-0.331190735,0.01452,UACC257_SKIN,UACC257,ACH-000579,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4034423828125
1511,1909,UACC-62,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.47,4.95,5.38,-.81,3.83,-7.1,-24,-36",".90,2.03,8.28,2.14,4.02,1.86,4.23,4.15",8,Sigmoid,1.865711331,8.0,-36.21395111,0.565,UACC62_SKIN,UACC62,ACH-000425,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.4159064292907715
1512,1910,UACC-812,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,34.9,-11,-.63,-24,-46,-60,-44","8.58,16.4,15.4,26.5,60.7,54.7,50.5,73.4",8,Constant,,8.0,14.09997559,1.3183,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,3.233299732208252
1513,1911,UM-UC-3,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.85,-2.9,3.00,4.37,3.58,2.28,-4.7,2.54","3.68,3.24,6.53,2.96,2.36,.69,.24,9.25",8,Constant,,8.0,2.200173616,0.0,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.3747806549072266
1514,1912,VMRC-RCW,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.1,-4.8,5.59,-.36,8.95,-17,-32,-90","5.70,9.16,2.42,12.1,3.90,1.03,13.0,.88",8,Sigmoid,8.518869297,3.89509654,-90.14572144,1.3765,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.3597184646381462,2.4693987369537354
1515,1913,VMRC-RCZ,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.45,13.0,3.35,10.5,-3.5,8.16,-7.6,-31","28.7,14.8,5.90,13.6,21.1,7.59,4.80,9.12",8,Sigmoid,2.745982885,8.0,-31.27448082,0.532,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5474743843078613
1516,1914,WM-115,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.3,-20,-4.5,-7.7,-4.7,-12,6.88,-20","12.5,6.97,17.5,23.4,7.48,7.77,5.53,7.66",8,Constant,,8.0,-8.176535606,0.1087,WM115_SKIN,WM115,ACH-000304,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.495084285736084
1517,1915,WM1799,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.18,12.4,10.3,5.60,-12,-4.7,5.20,-31","2.14,5.79,16.2,4.71,1.37,.74,8.92,2.41",8,Sigmoid,8.265155134,8.0,-31.36548996,0.394,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.284811019897461
1518,1916,WM-266-4,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,17.6,-2.7,14.4,-2.3,4.57,-5.0,-12","3.11,.40,3.38,8.48,8.04,5.15,6.05,8.12",8,Constant,,8.0,-0.275359511,0.1532,WM2664_SKIN,WM2664,ACH-001239,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.2763113975524902
1519,1917,WM-793,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","16.0,-1.3,12.5,1.35,8.93,11.6,-12,-56","11.7,.96,3.81,14.8,20.8,2.38,5.31,16.5",8,Sigmoid,2.951394558,4.641665936,-55.63446808,0.6875,WM793_SKIN,WM793,ACH-000827,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.5350733397305039,2.739814281463623
1520,1918,WM-88,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.7,10.6,14.5,12.6,-.15,-6.9,-.74,-11","4.54,18.5,.96,3.90,.53,2.88,14.0,4.53",8,Sigmoid,0.2028853,8.0,-8.386649132,0.1094,WM88_SKIN,WM88,ACH-000899,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.5084967613220215
1521,1919,WM-983B,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.14,-.27,3.74,-1.3,-.26,-6.7,-18,-71","1.62,5.59,19.4,1.31,8.69,15.5,1.20,10.9",8,Sigmoid,8.411429514,5.689120293,-71.13433075,2.28,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,1.7385556303858825,2.3681375980377197
1522,1920,YKG1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.38,-.20,9.49,-.97,3.07,1.23,-6.3,-3.8",".21,10.7,5.21,4.65,1.96,10.7,1.21,15.2",8,Constant,,8.0,1.639767408,0.0,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.616870880126953
1523,1921,ZR-75-1,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".93,6.61,12.4,37.9,14.8,.81,-18,-36","14.3,31.5,34.3,47.4,35.3,6.06,8.60,42.1",8,Constant,,8.0,-5.805284977,0.4156,ZR751_BREAST,ZR751,ACH-000097,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2.0794415416798357,2.7888741493225098
1524,1922,ZR-75-30,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,13.1,-23,-26,-74,-81,-95,-98","14.8,26.1,3.36,4.17,15.1,7.27,3.36,6.78",8,Sigmoid,0.196926519,0.166593418,-94.99932098,3.0902,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,-1.7921990578329698,3.0496129989624023
1525,1923,SCC-25,Lapatinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.63,9.21,26.5,2.98,-1.2,-17,-55,-56","8.39,10.7,6.33,23.3,10.4,3.96,.41,10.5",8,Sigmoid,0.910302222,2.398599148,-59.16038132,1.1151,SCC25_UPPER_AERODIGESTIVE_TRACT,SCC25,ACH-000188,Head and Neck Cancer,1,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Tykerb,"EGFR, HER2",EGFR and HER2 Inhibitor,Kinase inhibitor,Launched-2007,GlaxoSmithKline,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,0.8748848786082164,2.4419121742248535
1526,2323,A172,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".92,5.01,4.35,4.21,-5.9,-7.2,-12,-15","4.19,.58,1.55,.29,9.38,3.79,.98,3.20",8,Constant,,8.0,-0.760436237,0.2508,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.394710063934326
1527,2324,A-204,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.8,-14,16.4,9.84,13.4,-23,-23,-58","0,2.07,0,6.87,1.01,16.1,4.38,3.18",8,Sigmoid,4.898123264,6.074995518,-57.53110123,0.714,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.8041812514485622,2.1474549770355225
1528,2325,A2058,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.4,-7.6,-1.0,-12,-4.8,-7.5,-11,-13","3.27,3.43,.65,5.14,3.82,5.60,1.65,2.18",8,Constant,,8.0,-9.189489365,0.793,A2058_SKIN,A2058,ACH-000788,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2193477153778076
1529,2326,A-253,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-3.4,.96,3.35,.74,-3.9,-28,-39","6.07,8.57,5.77,4.42,6.51,2.94,1.30,5.82",8,Sigmoid,1.790827632,8.0,-39.14745331,1.3531,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.1897592544555664
1530,2327,A2780,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.06,-5.1,9.66,1.26,-5.6,-12,7.52,-.87","4.53,8.50,5.31,5.61,5.40,4.63,4.37,14.6",8,Constant,,8.0,-2.908685446,0.3709,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2014498710632324
1531,2328,A-375,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,-2.6,-2.6,-1.8,-12,-24,-17,-26","1.57,3.83,1.23,2.82,6.53,6.08,7.37,2.18",8,Sigmoid,0.269842952,8.0,-23.64470482,0.9057,A375_SKIN,A375,ACH-000219,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.0575695037841797
1532,2329,A549,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.95,-1.7,-1.9,-2.1,-5.1,-23,-13,-44","2.62,6.33,3.72,5.75,3.36,.50,.71,2.47",8,Sigmoid,8.28133539,8.0,-42.30753326,0.4962,A549_LUNG,A549,ACH-000681,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.440439462661743
1533,2330,A-673,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-5.0,-5.6,5.77,3.44,-5.2,-30,-33","39.0,12.9,10.6,.40,1.49,.95,8.96,8.57",8,Sigmoid,1.160511017,8.0,-33.10509491,0.9435,A673_BONE,A673,ACH-000052,Bone Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4636178016662598
1534,2331,ACHN,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.47,-9.8,4.98,-2.1,-12,-20,-45,-53","6.10,.14,1.61,.70,18.3,5.52,7.95,8.21",8,Sigmoid,1.12213552,4.372954369,-53.22465897,1.2189,ACHN_KIDNEY,ACHN,ACH-000046,Kidney Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.47543883766333,2.4558939933776855
1535,2332,ALL-SIL,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,-6.0,7.85,-11,-60,-90,-94,-95","14.4,7.47,5.45,8.97,1.39,.031,1.10,.053",8,Sigmoid,0.197714925,0.209438816,-94.67965698,4.0457,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-1.5633236300068856,2.3733315467834473
1536,2333,AMO-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".51,22.5,-5.6,6.13,9.06,13.1,-7.5,-22","0,0,0,0,0,0,0,0",8,Sigmoid,2.541367769,8.0,-22.12444115,0.3323,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.559180736541748
1537,2334,AsPC-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","18.1,13.0,5.77,8.75,14.4,-5.5,-24,-56","13.8,17.3,17.7,8.96,11.7,16.0,10.6,9.72",8,Sigmoid,4.551605,8.0,-46.68466568,0.6383,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5446133613586426
1538,2335,AU565,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,10.4,-12,-.22,13.3,7.72,-4.2,-15","7.69,3.51,16.2,6.19,29.4,6.78,6.40,18.8",8,Constant,,8.0,-2.102397203,0.2328,AU565_BREAST,AU565,ACH-000248,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5905561447143555
1539,2336,B-CPAP,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,-2.8,-.47,1.29,-5.5,-9.1,-27,-44","1.96,7.17,4.80,2.40,2.78,.98,.75,1.56",8,Sigmoid,2.507880688,8.0,-43.93824387,1.54,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3828775882720947
1540,2337,BDCM,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,5.34,-.39,-.76,-14,-59,-74,-75",".84,35.8,14.6,7.93,6.63,1.30,4.09,.15",8,Sigmoid,0.499204725,0.625976443,-74.93276215,1.9092,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.46844253958051735,2.4979381561279297
1541,2338,BFTC-909,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.40,5.38,5.58,10.8,3.94,10.6,.87,-31","1.15,.94,9.12,2.58,9.35,4.87,2.86,13.9",8,Sigmoid,3.534188747,8.0,-29.78089142,0.2464,BFTC909_KIDNEY,BFTC909,ACH-000792,Kidney Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.31646990776062
1542,2339,BL-41,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".068,-3.7,2.23,-2.0,2.45,7.13,-1.1,6.48","3.63,.21,7.12,1.48,1.29,12.1,6.51,7.31",8,Constant,,8.0,0.315587759,0.05539,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.427316188812256
1543,2340,BL-70,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,.099,-4.8,1.52,6.87,-20,-68,-89","2.37,11.3,4.32,10.9,17.2,10.6,2.40,.019",8,Sigmoid,1.610194564,1.689039111,-88.88272858,2.0535,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.5241597938630661,2.4545345306396484
1544,2341,BT-20,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,12.9,-11,19.9,-.11,-1.2,-44,-49",".37,21.4,37.2,21.4,17.7,40.0,19.6,2.10",8,Linear,,7.055198202,-50.48358536,1.181,BT20_BREAST,BT20,ACH-000536,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.953764678744313,2.6918859481811523
1545,2342,BT-474,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.060,3.97,-24,-6.0,-7.2,4.54,-34,-70","4.38,5.26,7.16,6.65,2.43,26.1,.94,3.78",8,Sigmoid,2.62784934,3.093749285,-69.81137085,0.8074,BT474_BREAST,BT474,ACH-000927,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.1293837162237255,3.073957681655884
1546,2343,BT-549,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.81,4.83,12.6,6.92,9.69,-10,-28,-49","3.55,9.09,5.30,6.95,.65,6.40,2.38,10.0",8,Sigmoid,2.042306185,8.0,-48.55896378,0.8363,BT549_BREAST,BT549,ACH-000288,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5759005546569824
1547,2344,BxPC-3,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-6.4,-10.0,-8.3,-5.7,5.08,-45,-64","8.16,15.6,11.5,10.5,16.4,7.18,2.17,5.09",8,Sigmoid,2.22893548,2.77215147,-64.03974152,1.5541,BXPC3_PANCREAS,BXPC3,ACH-000535,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.0196237226919331,2.5089967250823975
1548,2345,C2BBe1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,2.57,-2.2,-8.8,-18,-39,-64,-55","5.54,12.0,5.59,14.1,26.9,1.40,2.50,1.79",8,Sigmoid,0.712385118,0.985270083,-59.51253128,2.0615,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.01483947945579817,2.6045470237731934
1549,2346,C32,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.75,2.92,.66,8.93,-6.8,-3.1,-6.1,3.23","21.1,11.8,6.27,1.36,23.8,10.6,9.00,12.1",8,Constant,,8.0,1.94058907,0.0,C32_SKIN,C32,ACH-000580,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2658066749572754
1550,2347,CAL-12T,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,-10,-20,-8.9,-5.1,-20,-60,-65","14.6,12.4,24.3,5.12,17.0,10.9,7.94,7.29",8,Sigmoid,1.33098793,1.69527781,-64.58999634,1.8817,CAL12T_LUNG,CAL12T,ACH-000826,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.5278466271073392,2.5227138996124268
1551,2348,CAL 27,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-2.1,-.15,-6.5,-9.7,-30,-71,-72","7.24,.094,8.46,7.79,5.32,.11,1.56,.051",8,Sigmoid,0.949989021,1.180500031,-72.92740631,1.5346,CAL27_UPPER_AERODIGESTIVE_TRACT,CAL27,ACH-000832,Head and Neck Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.1659381038034895,2.4866085052490234
1552,2349,CAL-85-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.53,-1.6,-33,10.7,-3.4,-36,-57,-70","4.08,.93,49.1,21.3,6.56,4.17,.46,2.45",8,Sigmoid,0.876570761,1.580660701,-69.51208496,1.7728,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.45784292482205197,2.5411295890808105
1553,2350,Calu-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-2.4,-3.3,2.72,-1.4,-6.7,-8.4,-22","9.12,5.89,4.98,5.25,8.89,7.83,3.22,6.84",8,Constant,,8.0,-6.496945381,0.2008,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.757214069366455
1554,2351,Calu-3,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","14.5,6.13,-9.6,-8.3,-3.9,-40,-74,-92","29.5,23.1,.94,8.69,35.3,16.0,.90,3.77",8,Sigmoid,1.045679569,0.853420436,-92.05051422,2.3703,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.15850296194827748,2.7330422401428223
1555,2352,Calu-6,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,8.96,7.26,-12,-13,-25,-45,-51","7.18,23.8,4.04,.54,19.1,20.6,8.69,2.96",8,Sigmoid,1.156572461,4.705996513,-51.40734482,1.5736,CALU6_LUNG,CALU6,ACH-000264,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.5488375493359203,2.356595993041992
1556,2353,CAMA-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.30,-12,1.08,8.22,-4.7,2.49,14.8,-8.3","20.6,1.51,25.2,5.76,8.21,7.22,5.13,1.96",8,Constant,,8.0,-0.762968242,0.1606,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5920064449310303
1557,2354,Capan-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.1,-5.5,-2.9,-2.8,-31,-51,-67,-75","7.37,3.95,7.77,15.3,6.47,21.5,7.42,5.74",8,Sigmoid,0.21800824,1.103565097,-70.84308624,1.7225,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.09854593636575885,2.7247490882873535
1558,2355,CAS-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,5.53,5.64,-2.8,-6.0,-15,-43,-29","4.77,1.03,5.18,7.12,2.93,1.16,11.4,6.24",8,Sigmoid,0.854193985,8.0,-34.83454514,0.6927,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5766448974609375
1559,2356,CCK-81,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.7,10.0,-11,11.5,-11,-56,-66,-73","4.94,20.7,37.4,9.20,29.3,3.33,3.39,9.99",8,Sigmoid,0.46322754,0.676471174,-70.12673187,1.8014,CCK81_LARGE_INTESTINE,CCK81,ACH-000963,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.3908654427743431,2.659916400909424
1560,2357,CHP-212,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,16.3,-20,-30,-1.3,-19,-43,-58","1.51,7.91,8.59,5.68,.32,2.02,3.78,2.80",8,Sigmoid,2.065060854,3.336125612,-58.31125259,2.3748,CHP212_AUTONOMIC_GANGLIA,CHP212,ACH-000120,Neuroblastoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.204810137264844,2.356381893157959
1561,2358,CI-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,2.73,14.7,19.8,11.1,-13,-26,-34","16.0,4.47,6.35,8.19,23.4,4.78,1.99,1.33",8,Sigmoid,0.799247503,8.0,-32.47085571,0.6352,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2074215412139893
1562,2359,COLO-320,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-.40,3.14,-10,.80,-11,-13,-32","5.71,5.11,1.71,2.33,4.13,1.55,4.16,7.57",8,Sigmoid,8.29027709,8.0,-31.21095085,0.4243,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.368474006652832
1563,2360,COLO-678,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.78,15.1,-3.3,7.15,8.18,-23,-13,-31","14.8,2.00,5.87,1.56,.57,2.42,12.1,13.4",8,Sigmoid,0.47219193,8.0,-23.47384262,0.8386,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.7578353881835938
1564,2361,COLO-679,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.73,-10,13.9,-4.3,21.5,2.95,20.7,-22","17.7,.15,13.3,9.63,11.0,5.08,17.3,4.07",8,Constant,,8.0,3.564864159,0.1354,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3888602256774902
1565,2362,COLO 741,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.47,7.48,-18,-22,12.1,1.32,10.2,.57","6.36,8.66,6.85,.078,19.2,11.6,13.9,15.9",8,Constant,,8.0,1.101471066,0.4347,COLO741_SKIN,COLO741,ACH-000582,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.413320302963257
1566,2363,COR-L105,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.3,-22,9.49,-24,-8.4,-19,-7.3,-49","3.03,1.90,2.58,27.7,5.71,20.4,31.3,3.44",8,Constant,,8.0,-9.056195259,0.7688,CORL105_LUNG,CORL105,ACH-000161,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6760780811309814
1567,2364,COR-L23,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-6.7,-1.6,2.38,.91,-17,-2.3,-15","3.84,5.15,6.94,1.61,14.0,8.20,1.16,4.64",8,Constant,,8.0,-5.537099361,0.2272,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.575023889541626
1568,2365,COV318,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-3.3,-1.3,2.03,-.10,1.96,-21,-16","18.2,6.09,11.2,4.80,8.02,10.6,9.34,12.8",8,Constant,,8.0,-5.285148621,0.7234,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.7236170768737793
1569,2366,COV504,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.61,12.1,-9.1,18.1,-16,-17,-41,-31","13.0,13.6,5.68,7.51,13.5,9.97,5.23,22.4",8,Sigmoid,0.44123137,8.0,-36.48340225,0.6355,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.579477548599243
1570,2367,Daoy,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.9,3.18,-2.1,11.0,4.81,10.9,-13,-15","15.0,1.09,20.9,1.49,14.7,1.09,9.42,26.7",8,Constant,,8.0,2.784240484,0.2739,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2628417015075684
1571,2368,DBTRG-05MG,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.46,-7.4,10.3,-13,-12,-25,-25,-49",".11,4.98,2.63,4.14,5.63,4.87,6.42,5.52",8,Sigmoid,8.896761131,8.0,-47.18214798,1.475,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4440760612487793
1572,2369,Detroit 562,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-11,-6.3,6.54,-6.7,-9.2,-44,-58","1.24,1.86,7.97,3.20,4.17,4.04,2.19,4.03",8,Sigmoid,2.103766441,2.906109095,-58.08207321,1.1993,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.0668151057373092,2.4243078231811523
1573,2370,DK-MG,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,1.95,4.28,3.42,20.7,14.8,-25,-24","7.25,9.38,2.86,2.23,4.74,7.38,5.88,3.46",8,Sigmoid,1.590067983,8.0,-25.65447235,0.3462,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.45559024810791
1574,2371,DMS 114,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,-6.5,-6.4,-3.2,-17,-5.0,-15,-33","7.03,4.31,9.86,7.31,7.02,16.3,8.31,14.1",8,Sigmoid,8.138706107,8.0,-32.45454788,0.3061,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.9477615356445312
1575,2372,DOHH-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","39.5,17.9,59.4,59.9,4.83,-8.0,-4.9,-50","21.0,7.73,20.4,47.0,.27,51.0,29.5,19.5",8,Linear,,8.0,-49.51928329,1.4458,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.614145517349243
1576,2373,DV-90,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.7,-20,58.9,-4.9,26.3,34.0,6.58,-34","2.84,14.6,33.3,1.21,32.8,46.5,20.7,30.6",8,Constant,,8.0,-2.447325945,0.7536,DV90_LUNG,DV90,ACH-000925,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.489871025085449
1577,2374,EB1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-8.7,8.23,-4.6,8.91,-9.1,-40,-56","12.3,6.94,2.43,.40,42.7,8.86,.58,9.12",8,Sigmoid,1.898514509,3.892225504,-55.70349884,1.5087,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.3589811030358236,2.329860210418701
1578,2375,EBC-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.49,2.87,-2.4,-2.1,-5.4,3.55,-21,-53","12.0,4.95,4.40,12.2,17.8,14.6,1.19,2.30",8,Sigmoid,2.745554447,4.773197651,-52.94674301,0.64,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.5630164473905577,2.5413570404052734
1579,2376,EFE-184,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.72,-5.9,9.20,3.94,-9.2,-34,-44,-66","12.6,16.2,5.31,15.1,4.14,12.0,8.43,24.8",8,Sigmoid,0.771646023,2.867263794,-58.60836029,1.4942,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.0533581931324292,2.6235618591308594
1580,2377,EFM-19,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,4.11,-12,-2.1,-27,-34,-41,-55","11.1,10.6,7.39,15.0,.87,2.53,2.83,1.68",8,Sigmoid,8.105140426,5.352694511,-53.83574677,1.2611,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.6776000810362641,2.7341701984405518
1581,2378,EFO-21,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","14.3,4.24,16.6,1.02,-2.1,-3.9,-16,-36","13.5,15.1,9.22,14.3,5.68,0,19.9,13.1",8,Sigmoid,9.003418816,8.0,-35.34865189,0.6374,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.586273193359375
1582,2379,EFO-27,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,-2.3,3.35,-.63,-14,-31,-54,-58","5.14,6.06,5.63,9.11,1.74,12.5,5.37,.38",8,Sigmoid,0.565176964,1.616785765,-58.34381485,1.3038,EFO27_OVARY,EFO27,ACH-000936,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.4804400826400142,2.2809276580810547
1583,2380,EM-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-13,-11,-22,-58,-85,-91,-94","5.85,5.26,8.61,7.24,2.73,.98,.49,.69",8,Sigmoid,0.224727899,0.209947765,-92.6844635,4.2714,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-1.5608965173003573,2.4986116886138916
1584,2381,EN,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-6.4,-10,-6.0,-11,-13,-2.1,-8.6",".58,15.2,15.1,8.35,3.87,.53,7.52,5.02",8,Constant,,8.0,-11.76401711,0.6256,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.467863082885742
1585,2382,ES-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.048,1.29,2.16,1.84,5.19,6.17,9.07,11.9",".73,3.22,.39,5.80,1.45,2.38,2.84,.54",8,Constant,,8.0,4.398933887,0.05565,ES2_OVARY,ES2,ACH-000906,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4438085556030273
1586,2383,ESS-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,5.51,-16,-14,-7.1,-15,-31,-48","4.04,2.97,6.36,.28,20.6,8.54,18.9,1.33",8,Sigmoid,3.652647018,8.0,-48.52568436,1.8504,ESS1_ENDOMETRIUM,ESS1,ACH-000913,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.273912191390991
1587,2384,F-36P,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.95,-.45,15.9,4.85,-15,-1.7,9.05,28.3","4.73,3.50,10.8,1.71,5.85,25.0,7.11,18.2",8,Linear,,8.0,-10.77790451,0.2391,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.479332208633423
1588,2385,FaDu,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.24,-7.7,-9.2,-15,-12,-13,-54,-74","3.74,7.73,10.9,20.9,13.5,12.0,17.4,4.14",8,Sigmoid,1.825864911,2.281471968,-73.63304138,1.9008,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.8248208346563212,2.443470001220703
1589,2386,FU97,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".74,-14,6.45,14.9,-11,-21,-41,-56","11.6,8.60,15.8,5.64,2.26,.076,2.08,.99",8,Sigmoid,1.645186424,4.634256363,-55.83853149,1.3435,FU97_STOMACH,FU97,ACH-000633,Gastric Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.5334757466638274,2.305511951446533
1590,2387,FU-OV-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.89,-14,9.44,-25,-33,-51,-33,-44","13.1,7.00,10.7,6.02,6.84,1.50,12.2,4.55",8,Sigmoid,0.072883494,8.0,-40.53198624,1.7494,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.357100486755371
1591,2388,G-361,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.6,1.71,.62,8.35,5.02,-7.0,-21,-54",".86,9.12,20.5,1.14,8.40,4.54,5.22,2.38",8,Sigmoid,5.056686878,6.914599895,-54.05523682,0.7462,G361_SKIN,G361,ACH-000572,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.9336351029944405,2.234764337539673
1592,2389,G-401,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.3,13.3,11.4,9.76,10.1,-25,-22,-48","7.03,2.97,17.6,.38,18.1,8.02,21.3,2.21",8,Sigmoid,0.832176507,8.0,-47.78735733,0.983,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.154874801635742
1593,2390,G-402,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,15.2,-2.1,-4.6,-12,-39,-24,-62","8.42,11.2,13.9,1.69,7.26,16.8,24.3,12.5",8,Sigmoid,1.484662294,3.649983644,-59.04444504,1.4516,G402_SOFT_TISSUE,G402,ACH-000375,Kidney Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.2947226864884696,2.2914319038391113
1594,2391,GAMG,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,21.7,-2.3,12.5,10.8,-3.6,-12,-30","22.5,6.65,2.50,2.37,20.1,.22,17.3,32.2",8,Constant,,8.0,-1.647750616,0.2102,GAMG_CENTRAL_NERVOUS_SYSTEM,GAMG,ACH-000098,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5225625038146973
1595,2392,GB-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,-5.4,-11,3.84,-28,-16,-36,-48","17.5,10.4,25.4,10.9,6.71,22.1,18.9,12.9",8,Linear,,8.0,-49.3039856,1.0036,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.507728338241577
1596,2393,GCT,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.14,-2.3,14.4,7.08,-.0087,-18,-21,-51","13.6,4.46,.51,.86,7.72,4.31,17.6,3.79",8,Sigmoid,1.24093914,8.0,-49.61767197,1.1414,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4060521125793457
1597,2394,GI-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,-4.8,-11,-7.2,-5.1,7.72,-2.8,3.64","4.20,.77,.38,13.9,3.94,.70,9.64,1.26",8,Constant,,8.0,-3.376574516,0.5236,GI1_CENTRAL_NERVOUS_SYSTEM,GI1,ACH-000756,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2128701210021973
1598,2395,GMS-10,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.57,-4.3,3.41,8.31,-.75,.72,-37,-33",".13,7.75,4.61,5.10,5.93,13.5,2.21,2.99",8,Sigmoid,1.20294416,8.0,-35.42524338,0.7487,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.266228437423706
1599,2396,GRANTA-519,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".043,-.90,-26,19.2,-29,-30,-43,-40","36.1,6.64,8.21,11.2,7.03,9.49,2.17,6.09",8,Sigmoid,0.002542614,8.0,-42.84753418,2.0087,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.504091262817383
1600,2397,H4,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.4,-6.9,-4.2,-10,-1.8,-9.6,-16,-9.4","6.94,1.82,.41,2.99,5.39,4.54,.90,4.62",8,Constant,,8.0,-7.306735516,0.6725,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.527707099914551
1601,2398,HARA,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.77,-7.5,3.27,-8.2,3.31,-5.9,-24,-45","14.7,9.59,10.3,2.33,8.43,16.4,15.2,22.7",8,Sigmoid,2.579946041,8.0,-44.67996979,0.6418,HARA_LUNG,HARA,ACH-000843,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.37601900100708
1602,2399,HCC1187,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-1.1,-5.7,5.72,-5.0,-8.6,-11,-29","3.00,5.52,2.50,16.8,2.13,3.11,8.04,10.6",8,Sigmoid,8.486227374,8.0,-29.03898239,0.3754,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.760603427886963
1603,2400,HCC1395,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,19.8,-36,-18,-13,-1.7,-40,-31","9.17,8.12,8.21,22.2,19.1,.18,19.8,8.36",8,Constant,,8.0,-21.66063118,1.8946,HCC1395_BREAST,HCC1395,ACH-000699,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4332680702209473
1604,2401,HCC-15,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,-2.0,-3.4,.26,-6.4,2.59,-22,-28","2.95,6.14,2.96,7.62,2.71,6.41,14.8,14.4",8,Sigmoid,2.067428589,8.0,-28.16321564,0.9268,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.618544101715088
1605,2402,HCC1569,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,4.98,6.75,6.11,6.76,9.32,-19,-23","1.27,13.7,2.31,3.69,3.95,15.6,20.0,1.82",8,Sigmoid,1.95031023,8.0,-23.24701118,0.4595,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.702381134033203
1606,2403,HCC1806,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","17.8,-3.3,10.4,-2.9,-9.0,-51,-62,-72","13.6,15.5,5.37,26.2,9.44,.85,3.36,1.20",8,Sigmoid,0.431944311,0.794987917,-68.49586487,2.0485,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.22942836318544552,2.5772323608398438
1607,2404,HCC1954,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,-12,11.2,-2.9,-1.9,-35,-55,-80","18.6,12.9,10.1,6.12,2.63,8.69,1.31,3.36",8,Sigmoid,1.541207671,1.940425873,-79.07642365,1.6338,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.6629074711487204,2.7248733043670654
1608,2405,HCC2935,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,9.86,-14,-4.8,-26,-54,-59,-75","24.5,8.97,1.06,11.1,2.91,3.84,6.63,1.61",8,Sigmoid,0.605257571,1.065598249,-75.3217926,2.2272,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.06353637759693187,2.642427444458008
1609,2406,HCC4006,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-9.3,-6.4,-11,-4.6,-39,-78,-84","16.8,.12,.49,38.0,8.24,5.54,6.13,5.11",8,Sigmoid,0.886209369,0.974881709,-82.27723694,2.3879,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.0254391394472182,2.6203196048736572
1610,2407,HCC-44,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.2,-9.4,1.98,-9.3,1.09,-5.8,3.43,-19","5.68,.88,4.03,8.75,4.69,7.73,.85,.67",8,Constant,,8.0,-2.756709814,0.4591,HCC44_LUNG,HCC44,ACH-000667,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.536081552505493
1611,2408,HCC-56,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-5.7,2.84,5.44,-30,-23,-28,-32","4.37,5.74,7.87,6.89,2.34,11.5,4.70,5.34",8,Sigmoid,0.15779759,8.0,-29.42960167,1.1856,HCC56_LARGE_INTESTINE,HCC56,ACH-000467,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3631553649902344
1612,2409,HCC70,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,34.9,8.93,16.8,-6.9,-1.1,-19,-31","8.77,25.3,11.7,15.9,9.66,3.34,9.71,11.0",8,Linear,,8.0,-25.33459854,0.571,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6584067344665527
1613,2410,HCC-78,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-40,-1.1,15.2,12.8,21.3,7.77,5.93,1.21","65.5,1.06,3.16,5.14,.96,5.01,5.44,1.72",8,Constant,,8.0,6.898418427,0.3899,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6757895946502686
1614,2411,HCC827,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-3.9,4.17,29.2,-22,-81,-91,-90","7.95,2.51,33.0,43.8,19.4,1.53,.76,2.97",8,Sigmoid,0.403383762,0.423982233,-90.69728088,2.8997,HCC827_LUNG,HCC827,ACH-000012,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.858063727930034,2.542203426361084
1615,2412,HCT 116,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.81,1.23,7.11,1.26,-9.6,-10,1.79,-22","4.02,11.7,.92,7.82,7.24,6.36,8.51,18.8",8,Constant,,8.0,-3.917675972,0.2996,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3289670944213867
1616,2413,HCT-15,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".76,2.66,19.8,1.40,-.11,-11,-28,-67","20.4,14.5,3.15,4.81,.71,15.3,4.45,5.80",8,Sigmoid,8.447515814,5.243636608,-66.81352997,0.9084,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.6570152667802638,2.567082166671753
1617,2414,HD-MY-Z,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-11,13.0,5.98,1.03,-.63,2.95,-27","2.17,6.99,3.29,4.91,10.1,2.43,15.7,18.6",8,Sigmoid,8.032328649,8.0,-26.65455627,0.5385,HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HDMYZ,ACH-000190,Unknown,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2550947666168213
1618,2415,HDQ-P1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,4.01,1.48,-9.3,-24,-49,-57,-72","17.0,1.23,7.07,13.2,12.3,4.12,14.3,6.44",8,Sigmoid,0.42085582,0.906933963,-69.63291168,2.1889,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.09768563967640831,2.5809552669525146
1619,2416,HEC-151,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-6.1,8.58,-12,-13,-44,-53,-77","1.03,4.69,.60,21.4,17.7,9.47,18.2,1.39",8,Sigmoid,0.932121098,1.354741335,-74.21349335,1.6659,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.3036105394296072,2.170828342437744
1620,2417,HEC-1-A,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".30,-6.5,18.1,-19,-18,-18,-38,-52","1.97,4.23,15.1,19.9,19.2,13.3,30.4,7.30",8,Sigmoid,8.558108252,7.070782185,-52.15077972,1.6748,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.9559711081595306,2.3922204971313477
1621,2418,HEC-1-B,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","30.8,11.5,-.69,-30,-40,-65,-59,-58","15.4,10.5,7.66,12.4,14.3,9.41,2.70,6.45",8,Sigmoid,0.041293759,0.35326159,-61.59843063,2.6185,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-1.0405464483308127,2.39731502532959
1622,2419,HEC-251,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,4.46,11.5,-7.6,-10,-18,-35,-56","16.7,27.1,8.66,11.3,.027,13.0,5.67,2.69",8,Sigmoid,4.202255726,5.684926987,-56.08798599,1.5751,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.7378182840241598,2.602113723754883
1623,2420,HEC-265,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,10.6,-4.3,12.6,-4.6,18.0,9.48,-28","15.3,3.72,9.55,12.0,22.1,6.47,8.04,24.7",8,Constant,,8.0,4.360182762,0.1751,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3377866744995117
1624,2421,HEC-59,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-5.2,3.08,1.83,-3.5,-8.3,-5.3,-17","9.52,1.38,.86,2.24,1.62,2.83,2.59,5.97",8,Constant,,8.0,-4.448703289,0.04556,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.381533622741699
1625,2422,HEC-6,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","15.5,-3.1,51.8,-.58,21.3,-11,-12,-31","40.5,26.3,30.2,35.0,10.9,43.6,10.9,43.4",8,Constant,,8.0,5.898341179,0.7863,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.560584306716919
1626,2423,HEL 92.1.7,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,1.82,-13,9.57,-7.3,13.6,-15,6.87","4.15,1.87,.96,1.85,.41,1.93,1.64,2.45",8,Constant,,8.0,-3.222308397,0.5733,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3669486045837402
1627,2424,Hep 3B2.1-7,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.6,1.85,1.32,-1.2,-2.5,21.1,-18,-4.0",".014,13.9,3.44,.71,18.4,20.7,6.30,26.3",8,Constant,,8.0,-1.297008634,0.5329,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5889499187469482
1628,2425,Hep G2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,3.69,-.76,-2.1,-.16,-17,-19,-24","12.4,7.07,6.85,4.04,24.2,.96,5.62,9.36",8,Sigmoid,0.604638755,8.0,-21.14749527,0.3882,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5361876487731934
1629,2426,Hey-A8,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-1.9,-.11,3.82,2.25,-15,-19,-43","1.20,6.35,6.52,2.11,2.75,3.91,4.38,9.83",8,Sigmoid,7.59897089,8.0,-42.42467499,0.596,HEYA8_OVARY,HEYA8,ACH-000542,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2957074642181396
1630,2427,HGC-27,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,-.26,2.81,-3.3,-.022,-15,-23,-46","3.68,.79,4.00,.69,2.08,1.69,3.98,3.07",8,Sigmoid,5.936971664,8.0,-45.4347496,0.801,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2941339015960693
1631,2428,HH,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,23.1,5.70,-24,.59,-1.1,12.9,2.55","20.9,8.14,15.7,15.3,8.06,.97,33.4,15.8",8,Constant,,8.0,-1.134667993,0.8571,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.365650177001953
1632,2429,HLF,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,-3.8,6.60,-6.2,.017,-29,-18,-37","2.25,.96,4.34,3.96,8.87,4.25,16.8,10.4",8,Sigmoid,0.468688577,8.0,-30.13309669,1.5,HLF_LIVER,HLF,ACH-000393,Liver Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.29390287399292
1633,2430,HMC-1-8,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,.25,-.66,4.06,-1.0,9.37,15.0,13.4","3.22,2.92,3.40,5.11,4.58,1.52,8.48,2.14",8,Constant,,8.0,2.112740755,0.1051,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3440823554992676
1634,2431,HMCB,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,2.91,-3.2,-6.4,-19,-12,-25,-44","8.37,6.04,15.7,11.5,6.31,1.21,18.7,3.56",8,Sigmoid,8.819000408,8.0,-43.76298904,1.3243,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.242424726486206
1635,2432,HOS,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.97,16.6,17.0,-10,19.7,4.20,3.46,-17","19.9,17.1,10.2,11.0,35.1,14.8,8.96,13.2",8,Constant,,8.0,1.360745788,0.1945,HOS_BONE,HOS,ACH-000613,Bone Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.308377742767334
1636,2433,HPAC,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-11,-4.0,4.31,-21,-29,-43,-64","18.0,23.0,21.1,5.06,6.64,2.21,5.23,13.8",8,Sigmoid,2.107948542,3.235832453,-63.04671097,1.8324,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.1742862218978514,2.61083984375
1637,2434,HPAF-II,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-12,-11,13.4,38.1,-29,-36,-54","30.8,24.7,16.0,17.6,17.3,11.3,.63,3.60",8,Sigmoid,0.706596732,8.0,-44.77374649,1.8783,HPAFII_PANCREAS,HPAFII,ACH-000094,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.891251802444458
1638,2435,Hs 294T,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,-2.1,-.17,-5.5,-6.0,-19,-26,-42","3.97,11.6,3.01,.75,7.78,5.80,.69,5.33",8,Sigmoid,4.612277985,8.0,-41.73404312,0.6296,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4628803730010986
1639,2436,Hs 578T,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.42,4.66,-.20,.39,7.48,-.53,-3.4,-50","4.43,.90,5.62,13.0,3.99,8.49,.33,.84",8,Sigmoid,6.606109619,7.945315361,-50.35259247,0.4801,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.072582492215407,2.5196518898010254
1640,2437,Hs 683,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.99,3.19,-6.4,-8.8,-3.2,-20,-25,-38","4.33,11.8,1.79,6.17,5.74,3.01,6.22,8.86",8,Sigmoid,1.921799421,8.0,-37.64316559,1.2891,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2607927322387695
1641,2438,Hs 695T,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.01,-.50,8.32,-.79,-4.6,-8.7,-2.3,-11","4.91,10.5,.24,9.18,9.28,2.02,6.63,4.40",8,Constant,,8.0,-4.511499405,0.3278,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6031155586242676
1642,2439,Hs 729,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.6,-6.6,6.26,7.87,14.2,7.97,14.8,-21","22.2,10.2,.78,9.62,6.10,24.7,19.2,7.38",8,Sigmoid,7.572293758,8.0,-20.74751663,0.5674,HS729_SOFT_TISSUE,HS729,ACH-000133,Unknown,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4238064289093018
1643,2440,Hs 746T,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,3.45,2.26,-17,-7.7,-29,-42,-76","22.7,5.24,8.68,4.06,37.7,12.1,.26,3.47",8,Sigmoid,8.849842146,3.256877422,-75.64588928,1.7904,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.1807688903387128,2.558093309402466
1644,2441,Hs 766T,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,4.36,-.19,-17,-29,-37,-30,-39","1.82,32.3,25.1,7.79,11.1,1.39,4.65,5.08",8,Sigmoid,0.097341508,8.0,-35.22949219,1.7451,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.40185809135437
1645,2442,Hs 852.T,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,7.36,3.55,-.29,-9.1,-29,-38,-45","6.34,19.8,21.7,.59,20.5,9.47,6.44,6.16",8,Sigmoid,0.520623386,8.0,-43.85088348,1.0993,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4866323471069336
1646,2443,Hs 936.T,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-5.7,-.89,2.02,.68,2.32,2.62,-5.7","6.87,.34,7.98,.21,3.08,11.5,.41,2.23",8,Constant,,8.0,-2.795243979,0.1732,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,1.7521510124206543
1647,2444,Hs 939.T,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,4.82,8.18,10.9,-3.9,-14,-15,-8.7","2.97,7.48,2.93,34.3,10.4,4.34,5.91,23.7",8,Constant,,8.0,-11.1296854,0.5327,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3811299800872803
1648,2445,Hs 944.T,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,3.36,-.45,5.20,-11,-9.6,-28,-27","3.42,5.51,1.65,.49,.63,1.75,1.53,.39",8,Sigmoid,0.940276742,8.0,-28.74953079,0.7203,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.252331256866455
1649,2446,HSC-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,.30,2.58,-.77,.082,-2.5,-25,-51","8.72,4.66,3.99,2.82,12.0,24.7,32.6,18.4",8,Sigmoid,2.652791262,7.353033543,-50.59848404,0.7791,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.9951129550151856,2.430847644805908
1650,2447,HT,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,8.79,-7.5,10.3,14.9,-16,4.15,-27","36.0,18.5,2.23,12.9,17.8,39.1,43.3,19.8",8,Constant,,8.0,-0.924641013,0.7877,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5629849433898926
1651,2448,HT-1080,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-.27,-5.2,2.78,7.44,6.80,-5.3,-.79","13.3,1.48,2.48,.39,6.00,4.04,.027,1.75",8,Linear,,8.0,-13.86007023,0.1531,HT1080_SOFT_TISSUE,HT1080,ACH-000054,Sarcoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.061729669570923
1652,2449,HT-1197,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".52,-2.1,-17,12.1,-2.2,7.32,-20,-38","18.5,14.2,17.4,7.16,2.38,14.4,.79,8.23",8,Sigmoid,2.418441534,8.0,-38.07381439,0.7165,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.641232967376709
1653,2450,HT-144,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,-.062,-2.7,3.24,-7.5,2.52,-10,-1.3","11.4,2.46,6.11,9.20,14.9,5.36,6.63,10.8",8,Constant,,8.0,-1.381040096,0.3266,HT144_SKIN,HT144,ACH-000322,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.331780433654785
1654,2451,HuCCT1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.30,2.17,-.95,4.18,.085,1.29,-2.1,-16","4.87,3.54,1.81,2.31,4.49,.33,9.14,1.70",8,Constant,,8.0,0.659159124,0.08281,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5085268020629883
1655,2452,huH-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.16,-20,-21,3.52,7.97,-33,-33,-46","13.3,17.2,24.0,6.39,13.8,1.06,5.31,30.0",8,Sigmoid,0.506565392,8.0,-33.70567322,0.5394,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.402151584625244
1656,2453,HUP-T3,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-5.9,12.1,-1.7,-3.6,-19,-27,-51","19.1,6.69,1.89,3.30,14.7,19.9,2.58,3.03",8,Sigmoid,6.613750935,7.702197075,-50.79603577,0.7185,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0415056225751003,2.793393135070801
1657,2454,HuT 78,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.30,11.5,-5.6,-17,5.69,-24,-11,-53","47.2,28.0,29.2,14.1,40.9,5.17,53.5,11.6",8,Sigmoid,8.973648291,8.0,-48.51793289,1.2907,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5442934036254883
1658,2455,IA-LM,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.35,-9.9,22.7,-2.3,18.2,-6.1,-9.9,-24","8.49,9.45,7.50,3.94,29.1,5.18,9.91,.62",8,Constant,,8.0,-2.978734016,0.3366,IALM_LUNG,IALM,ACH-000672,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.461887836456299
1659,2456,IGR-37,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-.72,-7.4,10.8,-5.9,-1.1,-17,-16","13.0,9.51,12.5,11.7,13.0,24.3,3.57,27.7",8,Constant,,8.0,-7.647248745,0.6652,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.263735055923462
1660,2457,IGR-39,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.14,-7.2,13.9,1.08,-.60,-40,-47,-60","15.6,1.70,12.6,5.45,8.79,4.83,7.96,1.25",8,Sigmoid,0.592328668,1.195519567,-54.14462662,1.3605,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.17858087499267333,2.3728878498077393
1661,2458,IGROV1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.37,1.26,3.45,.53,-7.6,-53,-71,-74",".91,1.22,1.12,2.34,5.82,6.84,1.81,6.95",8,Sigmoid,0.542271137,0.761178851,-72.93480682,1.9254,IGROV1_OVARY,IGROV1,ACH-000966,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.27288692770859874,2.4350686073303223
1662,2459,IMR-32,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.17,-2.6,-2.6,-15,-17,-40,-38,-61","25.5,6.08,11.4,1.38,3.68,5.75,13.7,6.71",8,Sigmoid,0.826575875,2.62498188,-59.44128036,1.7157,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.9650739931626193,2.4997708797454834
1663,2460,IPC-298,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.16,2.80,5.64,9.54,-3.2,-8.3,3.04,4.01","8.04,2.31,.46,2.63,4.02,4.97,5.84,.057",8,Constant,,8.0,4.00579071,0.04946,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3987929821014404
1664,2461,IST-MES2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.50,13.4,13.7,7.87,16.3,-4.4,-27,-48","17.2,.43,20.5,13.4,34.5,10.4,9.14,2.34",8,Sigmoid,3.534788847,8.0,-47.7584877,0.734,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4412999153137207
1665,2462,J82,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,2.51,2.74,.17,-6.9,-.72,-14,-14","12.0,2.90,7.36,5.28,3.79,12.3,.053,16.7",8,Constant,,8.0,-2.991406202,0.321,J82_URINARY_TRACT,J82,ACH-000396,Bladder Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5464720726013184
1666,2463,JHH-4,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,7.25,2.78,3.92,-4.4,-12,-37,-48","4.26,5.59,11.1,.22,1.39,2.40,10.2,7.07",8,Sigmoid,1.492508292,8.0,-48.4641571,1.0493,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.415371894836426
1667,2464,JHOS-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,14.7,17.0,1.11,13.9,-2.2,-2.5,-6.9","18.1,21.9,28.5,8.61,28.0,15.9,31.9,28.2",8,Constant,,8.0,-0.950717747,0.4457,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6085238456726074
1668,2465,JHUEM-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".48,.027,6.19,1.60,-6.7,-14,-10,-36","12.3,13.4,6.20,19.1,8.18,6.72,.86,5.68",8,Sigmoid,8.668703671,8.0,-34.20933533,0.5545,JHUEM2_ENDOMETRIUM,JHUEM2,ACH-000909,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.272444725036621
1669,2466,JM1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-2.4,-7.2,9.37,3.52,40.5,34.2,54.9",".87,20.6,1.48,7.39,1.26,22.1,2.45,15.7",8,Linear,,8.0,-17.96143532,0.05758,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.456496477127075
1670,2467,JMSU-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-5.7,10.5,1.23,-.83,-11,-16,-49","13.4,12.0,6.41,7.76,8.92,2.24,3.49,3.48",8,Sigmoid,8.9465307,8.0,-48.79115677,0.6231,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.619002342224121
1671,2468,JURKAT,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,-.14,-6.8,-13,-32,-38,-43,-58",".94,4.91,3.72,7.78,2.58,1.90,5.51,6.23",8,Sigmoid,0.311872631,3.307549238,-54.53726196,2.5246,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.1962075036686535,2.446493148803711
1672,2469,JVM-3,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,-6.1,-1.5,-1.3,-18,-27,-20,-35","18.8,12.5,1.45,5.93,14.6,3.82,9.30,28.8",8,Sigmoid,0.208542764,8.0,-23.24621201,1.5103,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6752259731292725
1673,2470,K029AX,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,8.75,-2.8,-3.0,-2.3,-6.7,14.5,-7.5","3.38,3.86,6.26,5.30,.69,11.8,10.6,3.25",8,Constant,,8.0,-0.646054626,0.04896,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.341965675354004
1674,2471,KALS-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,5.59,22.4,2.35,-4.0,-16,-29,-44","2.19,8.36,2.72,9.81,5.28,6.21,10.2,1.23",8,Sigmoid,1.469589949,8.0,-43.56768417,1.1537,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3024988174438477
1675,2472,KARPAS-422,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","11.3,-.34,-1.9,7.84,-1.8,-19,-17,-27","12.2,1.43,15.2,17.8,.27,1.50,9.58,1.41",8,Sigmoid,0.431350231,8.0,-23.413517,0.5777,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5320792198181152
1676,2473,KASUMI-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","16.1,11.7,15.4,8.17,1.38,-37,-26,-51","14.1,12.9,1.06,14.4,7.78,3.50,7.66,5.07",8,Sigmoid,0.377973914,8.0,-41.13803101,1.2213,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4219064712524414
1677,2474,KCL-22,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".80,-7.8,2.13,3.99,-21,-67,-88,-94","20.8,8.80,13.3,10.3,13.6,1.56,.58,1.10",8,Sigmoid,0.520216286,0.551354647,-92.36167908,3.2752,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.5953770344099575,2.4585342407226562
1678,2475,KG-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","28.5,13.7,1.64,17.5,.054,9.27,41.7,38.6","12.0,14.4,5.99,8.57,49.0,47.7,26.1,18.8",8,Constant,,8.0,23.25084686,0.0,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5439014434814453
1679,2476,KHM-1B,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,8.89,29.2,1.84,-.78,2.46,4.83,-27","12.7,.74,22.0,4.72,21.3,11.6,9.58,.46",8,Sigmoid,8.428009117,8.0,-27.3719101,0.4197,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.61240291595459
1680,2477,KMBC-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-.19,-1.9,2.58,8.62,3.42,1.75,-2.9",".10,.32,3.30,.33,2.91,1.95,2.48,.12",8,Constant,,8.0,0.218383104,0.01229,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.668384552001953
1681,2478,KMM-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.76,10.7,-3.9,16.9,7.08,.14,-29,-25","1.49,13.5,9.03,9.07,2.43,6.31,9.85,25.3",8,Sigmoid,1.176314712,8.0,-34.83038712,0.7628,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.62206768989563
1682,2479,KMRC-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.4,-17,7.30,2.06,-.69,-20,-36,-68","1.49,4.77,6.00,7.14,1.52,8.76,4.40,9.59",8,Sigmoid,3.620013237,3.98032403,-67.75486755,1.6644,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.3813632305552241,2.516252279281616
1683,2480,KMRC-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,17.3,-28,-21,-39,-38,-51,-48","2.32,.33,5.25,4.87,1.33,13.5,3.80,8.82",8,Sigmoid,0.20754604,8.0,-48.01231384,2.8096,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.1709439754486084
1684,2481,KMS-11,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-1.6,14.1,5.69,-3.8,-4.5,-.21,-13","4.52,9.71,10.4,6.65,7.69,9.43,28.2,6.75",8,Constant,,8.0,-3.371965408,0.3816,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5010128021240234
1685,2482,KMS-12-BM,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","36.5,-.76,27.5,-6.3,.73,28.2,19.3,12.0","45.1,2.11,7.52,40.4,21.1,38.7,31.9,18.6",8,Constant,,8.0,10.61663628,0.2465,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5363259315490723
1686,2483,KMS-34,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","20.6,.16,65.1,-8.4,28.4,.29,-8.3,-5.3","27.0,2.98,73.4,10.8,49.8,22.5,20.6,1.97",8,Constant,,8.0,0.507288575,0.5543,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6084718704223633
1687,2484,KNS-60,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.74,-.79,2.29,14.2,26.5,10.2,23.5,-2.4","13.7,4.31,22.0,2.00,15.3,7.02,9.60,7.60",8,Constant,,8.0,13.84092331,0.0,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5067391395568848
1688,2485,KNS-62,AZD0530,ABL,".0080,.025,.080,.25,.80,2.53,8","26.0,3.16,9.67,7.18,-4.6,-6.5,3.51","5.65,10.2,13.8,26.8,3.03,21.1,7.42",7,Constant,,8.0,4.017105103,0.2138,KNS62_LUNG,KNS62,ACH-000858,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.368509531021118
1689,2486,KNS-81,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,.90,8.57,-3.9,-3.7,-8.8,-25,-20","10.9,1.71,3.14,2.68,4.54,9.92,7.14,11.4",8,Sigmoid,0.899059713,8.0,-23.31163979,1.0272,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4908037185668945
1690,2487,KO52,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.62,10.4,6.81,-.26,2.65,14.5,16.5,37.0","9.24,15.2,19.4,8.32,11.2,4.39,8.90,10.8",8,Linear,,8.0,-0.085383683,0.4784,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6224610805511475
1691,2488,KP-N-SI9s,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.19,1.59,7.48,-5.0,-14,-31,-29,-57",".73,9.25,11.7,9.31,2.24,2.79,1.95,3.58",8,Sigmoid,8.228010159,5.985694885,-54.95419693,1.095,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.789372436698075,2.4417929649353027
1692,2489,KU812,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-24,12.9,-6.2,-8.9,-89,-89,-96","27.5,5.68,8.04,17.1,6.00,1.37,7.80,.28",8,Sigmoid,0.472111225,0.471688002,-93.3496933,3.0717,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.7514375246736703,2.454556941986084
1693,2490,KYM-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","25.0,-25,2.40,.54,19.7,-24,12.5,-28","30.2,30.5,5.22,7.87,9.25,14.4,13.5,21.9",8,Constant,,8.0,1.175569654,0.9075,KYM1_SOFT_TISSUE,KYM1,ACH-000607,Rhabdoid,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.107267141342163
1694,2491,KYSE-140,AZD0530,ABL,".025,.080,.25,.80,2.53,8","-18,2.57,-24,-41,-57,-74","21.6,18.9,8.21,6.12,9.58,5.59",6,Sigmoid,1.175536394,1.507840991,-73.44699097,1.8523,KYSE140_OESOPHAGUS,KYSE140,ACH-000823,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.41067882039224124,2.4587044715881348
1695,2492,KYSE-150,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.12,.17,-8.5,-6.4,1.47,-9.2,-9.0,-34","9.57,13.9,7.33,11.9,.091,7.95,1.11,5.90",8,Sigmoid,8.429085041,8.0,-33.86745453,0.3552,KYSE150_OESOPHAGUS,KYSE150,ACH-000855,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5945005416870117
1696,2493,KYSE-180,AZD0530,ABL,".0080,.025,.080,.25,.80,2.53,8","-15,-7.2,-12,-31,-36,-50,-57","1.72,22.6,15.4,14.3,5.33,13.2,4.34",7,Sigmoid,1.242175221,2.983515978,-57.56348038,1.6671,KYSE180_OESOPHAGUS,KYSE180,ACH-000693,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.0931024634206616,2.384093761444092
1697,2494,KYSE-30,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.79,1.73,-1.9,-6.8,-8.6,-17,-28,-37","7.13,3.63,4.09,.14,1.98,4.46,2.32,3.42",8,Sigmoid,8.245557304,8.0,-37.68477631,1.2127,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6564981937408447
1698,2495,KYSE-510,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,-11,1.25,-1.7,7.81,5.50,.75,-17","9.69,9.31,19.6,1.20,9.40,3.96,.96,8.08",8,Linear,,8.0,-16.63479805,0.348,KYSE510_OESOPHAGUS,KYSE510,ACH-000824,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.542875051498413
1699,2496,KYSE-520,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,1.96,-4.1,-4.5,6.51,-7.2,-27,-65","6.76,8.49,5.41,7.26,1.84,4.96,4.40,.44",8,Sigmoid,3.816547394,4.866113186,-64.83454895,1.1904,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.5822955046744491,2.6634955406188965
1700,2497,KYSE-70,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.02,-.67,-12,-18,-3.8,-28,-34,-46","3.32,3.00,4.50,7.26,8.44,1.04,4.98,11.9",8,Sigmoid,8.692977263,8.0,-45.42017746,1.6009,KYSE70_OESOPHAGUS,KYSE70,ACH-000784,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3722774982452393
1701,2498,L3.3,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,3.18,2.21,1.35,3.16,3.73,-11,-36","8.26,13.2,7.82,6.58,3.73,6.52,8.61,14.3",8,Constant,,8.0,-1.297779679,0.3391,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5554299354553223
1702,2499,L-363,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,5.68,-.29,-5.7,8.88,-13,-15,-55","4.25,6.46,5.07,8.07,12.5,7.75,12.1,14.2",8,Sigmoid,8.457898903,7.322373867,-54.21300507,1.4398,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.9909345741702318,2.5294337272644043
1703,2500,L-428,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-8.3,.48,1.76,-.70,-.90,1.90,-6.3","15.0,4.18,7.49,13.9,.25,3.32,4.17,1.32",8,Constant,,8.0,-3.022116423,0.2569,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.567561149597168
1704,2501,LCLC-103H,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.18,-8.8,2.97,-5.4,-.92,-2.8,.52,-21","3.39,.49,3.05,2.20,4.59,.72,2.86,.51",8,Constant,,8.0,-2.846294641,0.2668,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3461947441101074
1705,2502,LN-229,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,1.45,-4.7,-5.9,-10,-24,-20,-35","8.89,4.96,9.47,.19,3.92,4.05,.91,1.12",8,Sigmoid,8.050437332,8.0,-33.61798096,0.9273,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3882477283477783
1706,2503,LOU-NH91,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,26.2,4.83,-9.7,-6.2,1.17,-25,-16","7.67,4.80,3.56,11.0,21.2,13.1,9.09,8.39",8,Sigmoid,0.32519415,8.0,-18.26032448,0.8153,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4293618202209473
1707,2504,LOX IMVI,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-5.8,-1.5,-1.5,1.01,-3.5,-52,-59","2.82,2.88,3.54,2.28,.37,3.26,.11,1.00",8,Sigmoid,1.690775633,2.388597727,-58.72532272,1.2245,LOXIMVI_SKIN,LOXIMVI,ACH-000750,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.870706468648287,2.2647695541381836
1708,2505,LP-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","73.6,49.1,12.0,37.6,4.85,12.7,12.4,.92","57.8,1.30,50.8,26.2,12.7,9.92,52.4,10.7",8,Constant,,8.0,19.73975372,0.4225,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5993149280548096
1709,2506,LS123,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,7.94,.57,3.15,-10,-14,-28,-44","16.3,5.93,10.8,5.09,15.2,4.40,9.03,13.9",8,Sigmoid,3.013163567,8.0,-42.97040558,0.9965,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.574995279312134
1710,2507,LS411N,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,-15,.31,8.73,11.1,-20,-7.4,6.87","2.03,23.6,19.8,1.85,17.8,34.2,16.1,20.7",8,Constant,,8.0,0.351398557,0.2772,LS411N_LARGE_INTESTINE,LS411N,ACH-000985,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.452951431274414
1711,2508,LS513,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","36.6,-18,43.2,-8.9,62.7,-27,7.53,-55","26.7,8.09,6.97,38.8,38.0,4.39,40.4,8.85",8,Constant,,8.0,2.397217035,0.9041,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.7538304328918457
1712,2509,LU99,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,-7.5,8.87,13.5,2.05,-3.2,-25,-42","10.2,.28,2.61,2.78,1.44,4.26,4.74,1.66",8,Sigmoid,2.088111877,8.0,-42.35057831,0.5512,LU99_LUNG,LU99,ACH-000444,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2313833236694336
1713,2510,LUDLU-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.8,3.48,9.38,-7.7,-4.1,-35,-31,-60","3.09,4.31,24.6,17.2,13.3,16.3,6.48,.16",8,Sigmoid,8.275049141,5.546560287,-59.50257492,1.1566,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.7131779675145906,2.6444387435913086
1714,2511,Malme-3M,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.15,9.53,1.54,-6.5,-3.3,-7.5,.072,-10","12.8,6.58,5.02,9.91,.74,7.41,5.65,8.53",8,Constant,,8.0,-2.170226336,0.1187,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3488411903381348
1715,2512,MCAS,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,1.18,-8.4,2.19,-6.5,-12,-31,-47","3.85,5.88,9.11,3.66,3.78,6.77,2.15,4.09",8,Sigmoid,1.546672344,8.0,-48.77988434,0.8336,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5637948513031006
1716,2513,MCF7,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","29.2,17.2,20.0,43.5,-.93,8.75,-20,-7.5","30.5,32.9,30.3,1.15,20.4,5.29,30.1,16.5",8,Constant,,8.0,7.028293133,0.03456,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.767271041870117
1717,2514,MDA-MB-157,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.33,15.1,9.57,21.3,-4.7,-3.1,-21,-3.9","4.10,6.42,3.11,18.4,8.34,8.02,.63,17.3",8,Sigmoid,0.212595552,8.0,-11.13424301,0.5788,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.331324577331543
1718,2515,MDA-MB-175-VII,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".34,20.2,-27,29.8,-14,10.2,-55,-85","4.72,11.6,1.99,20.2,11.5,7.02,4.48,.35",8,Sigmoid,2.217795849,2.408272505,-85.54084015,1.7853,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.8789096875719652,2.834613800048828
1719,2516,MDA-MB-415,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.2,17.2,-3.8,16.6,-18,13.6,-31,-48","22.3,53.5,16.9,22.2,18.7,26.9,8.36,6.22",8,Constant,,8.0,-10.07636166,0.699,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6874120235443115
1720,2517,MDA-MB-436,AZD0530,ABL,".0080,.025,.080,.25,.80,2.53,8","4.45,.42,-16,1.31,-18,-16,-16","7.41,17.1,6.08,.032,.42,8.62,6.83",7,Constant,,8.0,-11.30215836,0.6943,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5281691551208496
1721,2518,MDA-MB-453,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","11.6,10.4,7.96,23.7,4.72,19.8,2.31,-26","17.9,9.76,20.5,19.3,3.05,12.0,15.2,2.21",8,Sigmoid,3.103794813,8.0,-25.55487061,0.1335,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.7198612689971924
1722,2519,MDA-MB-468,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.52,-24,14.5,-25,-2.8,-.35,-21,-51","11.5,2.51,23.2,10.2,4.22,22.4,4.08,.85",8,Sigmoid,8.319108428,7.844894409,-50.88651276,1.016,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.059862926438582,2.6403462886810303
1723,2520,MEG-01,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-1.6,-15,-15,-9.7,-39,-77,-91","14.6,4.14,9.00,1.59,15.3,32.7,17.4,7.66",8,Sigmoid,1.194555521,1.165203691,-90.38591766,2.3393,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.15289591379465822,2.3656716346740723
1724,2521,MEL-HO,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".15,-4.4,-2.1,-2.0,-4.7,-8.8,-4.5,-43","3.59,7.45,4.16,1.89,3.88,2.62,7.51,16.5",8,Sigmoid,8.166262109,8.0,-39.73714828,0.9185,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.1880850791931152
1725,2522,MES-SA,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,9.58,-1.2,6.16,7.38,-6.2,-5.1,-.47","6.84,10.7,3.10,4.19,6.60,1.70,4.48,17.2",8,Constant,,8.0,0.91802448,0.02141,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.404484510421753
1726,2523,MeWo,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,-.32,.58,15.8,-.33,31.7,18.1,15.8","31.5,2.93,29.7,1.64,7.96,10.4,6.69,22.7",8,Constant,,8.0,12.38445187,0.08418,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.272242546081543
1727,2524,MFE-296,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,3.81,4.02,6.35,.51,-8.9,-32,-59","1.10,14.9,2.78,2.14,.23,6.03,3.54,.88",8,Sigmoid,3.063340902,5.239851952,-58.7897377,1.1319,MFE296_ENDOMETRIUM,MFE296,ACH-000879,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.6562932444987006,2.3329949378967285
1728,2525,MG-63,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,-4.3,7.93,2.69,-4.6,-12,-16,-32","12.0,.28,3.92,.30,1.50,5.02,4.99,1.59",8,Sigmoid,6.675624847,8.0,-31.53869438,0.5506,MG63_BONE,MG63,ACH-000359,Bone Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.290358543395996
1729,2526,Mino,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,-.55,1.38,-1.7,-2.0,-22,23.7,4.32","6.40,8.55,18.9,2.91,38.7,2.63,21.2,9.02",8,Constant,,8.0,-2.682932615,0.05838,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.629243850708008
1730,2527,MJ,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","22.8,5.71,8.83,19.4,-15,2.52,-2.9,-13","33.6,19.1,2.25,10.3,23.1,16.2,44.5,25.9",8,Constant,,8.0,5.782170296,0.3153,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.354701519012451
1731,2528,MKN-45,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-27,-3.6,-6.2,4.57,-11,-17,-37","11.4,2.74,9.60,20.2,8.55,.26,8.35,7.32",8,Constant,,8.0,-11.75539112,0.5686,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.688859462738037
1732,2529,MKN7,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.5,32.4,2.91,8.99,-6.1,7.93,24.6,.82","3.52,34.1,13.2,35.2,7.80,1.39,3.61,13.8",8,Constant,,8.0,9.827158928,0.2042,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5676565170288086
1733,2530,MKN74,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,-2.5,7.28,4.93,8.77,7.39,-21,-20","2.60,23.5,23.8,23.2,13.8,8.51,3.47,18.7",8,Constant,,8.0,-7.732811928,0.2625,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4556689262390137
1734,2531,MOLP-8,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,12.4,9.55,-.45,6.31,18.1,3.93,-12","36.8,21.0,9.91,5.39,7.31,37.0,2.42,.43",8,Constant,,8.0,1.873675108,0.4735,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5658087730407715
1735,2532,MOLT-16,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,-5.0,24.5,4.30,-3.9,-49,-23,-53","19.8,19.1,15.2,21.0,17.5,11.5,15.0,10.00",8,Linear,,7.28969499,-50.55561447,2.4599,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.9864617056390974,2.203500747680664
1736,2533,MONO-MAC-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,14.6,-18,-8.1,5.29,-18,-38,-73","9.88,2.22,5.22,7.17,5.84,5.64,2.19,1.42",8,Sigmoid,3.764480591,3.632587433,-72.82147217,2.5768,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.2899451858216335,2.577199697494507
1737,2534,MOR/CPR,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-7.9,10.6,-4.5,-6.7,-2.8,.57,-17","7.15,16.4,1.72,12.9,14.2,11.7,2.64,18.7",8,Constant,,8.0,-2.943063736,0.3816,MORCPR_LUNG,MORCPR,ACH-000851,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4941999912261963
1738,2535,MSTO-211H,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.96,4.20,-1.7,7.47,-3.6,-1.4,-43,-40","10.1,3.50,32.3,12.8,1.66,7.64,10.7,6.44",8,Sigmoid,1.181795835,8.0,-41.72012711,0.7174,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.435370683670044
1739,2536,NCI-H1048,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","20.7,16.5,24.7,-1.9,-8.3,-36,-45,-59","8.56,4.21,2.79,4.92,8.92,13.4,5.25,1.10",8,Sigmoid,0.443204492,3.120047092,-57.46012115,1.2751,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.1378480952972274,2.6255264282226562
1740,2537,NCI-H1092,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.86,2.37,3.76,9.61,-7.7,16.4,.38,3.35",".34,7.41,25.1,1.81,6.35,20.1,6.42,56.1",8,Constant,,8.0,2.537663221,0.0,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.9570674896240234
1741,2538,NCI-H1155,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-31,8.16,-16,-13,-36,-12,-13","8.03,9.42,3.07,19.1,15.3,.37,9.58,8.37",8,Constant,,8.0,-18.85766029,1.4315,NCIH1155_LUNG,NCIH1155,ACH-000980,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.509984016418457
1742,2539,NCI-H1184,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","45.8,57.3,23.9,48.7,57.2,41.9,67.3,190","80.6,108,68.4,101,46.2,20.5,94.9,228",8,Constant,,8.0,46.79595947,0.0,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.912107229232788
1743,2540,NCI-H1341,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","14.6,-18,44.6,-2.5,-.55,-30,-31,-54","16.6,39.0,17.7,31.7,16.5,13.0,20.5,15.3",8,Linear,,5.702689319,-52.67787552,1.1726,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.7409378739238748,2.4299683570861816
1744,2541,NCI-H1373,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,11.0,3.41,2.97,-4.4,-9.9,-16,-31","23.6,18.9,1.20,31.3,13.5,22.4,14.1,11.4",8,Constant,,8.0,-3.970962524,0.4326,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.725292682647705
1745,2542,NCI-H1568,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,-10,.20,-12,-6.4,-20,-23,-49","5.61,14.0,13.7,3.05,1.88,33.3,11.9,15.9",8,Sigmoid,8.47669597,8.0,-45.60332108,1.5767,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.644871473312378
1746,2543,NCI-H1648,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".11,9.64,1.22,22.3,29.4,42.9,15.6,-30","9.16,5.98,32.3,18.0,9.26,5.43,14.8,.063",8,Linear,,8.0,-30.91810799,0.2443,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5412347316741943
1747,2544,NCI-H1650,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,-.31,10.9,-23,-42,-47,-56,-62","1.06,12.7,6.12,10.5,3.58,1.00,5.04,3.04",8,Sigmoid,0.130263925,0.494352132,-57.17457581,1.9891,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.7045071979144019,2.6481032371520996
1748,2545,NCI-H1651,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.73,.67,2.87,-.90,2.94,-15,-18,-21","2.68,.21,4.06,12.2,4.22,5.75,6.53,11.7",8,Sigmoid,0.590774059,8.0,-18.82393646,0.5989,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6536524295806885
1749,2546,NCI-H1792,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,6.22,-5.0,-4.7,7.43,12.8,-21,-26","3.51,3.88,14.9,2.54,4.81,4.65,6.97,7.63",8,Sigmoid,1.942630053,8.0,-26.3799839,0.3243,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.58856463432312
1750,2547,NCI-H1793,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.55,2.41,18.5,-17,5.84,-24,-49,-60","12.6,8.72,5.22,6.67,5.32,42.7,.31,14.6",8,Sigmoid,1.83464849,2.583734751,-59.75666809,0.8634,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.9492359301096324,2.613626003265381
1751,2548,NCI-H1915,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,7.50,-.70,-.17,4.84,-9.2,-21,-40","9.85,.27,.71,21.4,20.0,6.07,19.2,3.56",8,Sigmoid,4.043407917,8.0,-40.08113098,1.1919,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4685096740722656
1752,2549,NCI-H1944,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,3.30,10.1,3.47,-9.4,-5.3,-42,-46","1.82,23.9,5.27,13.5,12.5,24.5,3.67,10.1",8,Sigmoid,1.310901165,8.0,-46.34920883,0.4428,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4952588081359863
1753,2550,NCI-H1975,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,-22,6.07,-16,-1.1,-7.7,-16,-48","4.77,3.70,1.17,4.51,5.51,3.40,.16,1.51",8,Sigmoid,5.654486656,8.0,-47.43016052,0.5187,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6101608276367188
1754,2551,NCI-H2009,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,-14,3.96,-3.0,-1.3,-14,-32,-45","14.1,3.23,2.57,5.99,4.18,1.80,5.81,5.40",8,Sigmoid,1.656336308,8.0,-44.34925842,1.094,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4798479080200195
1755,2552,NCI-H2023,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-5.3,10.5,-2.7,7.75,-20,-11,-49","13.3,13.5,7.33,3.04,6.12,15.8,2.91,14.9",8,Sigmoid,9.249932719,8.0,-47.78128433,0.4832,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5821304321289062
1756,2553,NCI-H2030,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.17,6.77,-1.3,-.20,-18,-39,-57,-69",".43,6.43,3.33,4.80,18.4,22.9,2.51,2.23",8,Sigmoid,1.101509809,1.831240416,-69.52604675,1.8416,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.6049935601859274,2.5420398712158203
1757,2554,NCI-H2052,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-4.1,-12,-24,-21,-21,-36,-41",".48,6.87,8.05,7.54,10.4,6.50,3.76,7.79",8,Sigmoid,8.077209659,8.0,-42.00416565,1.8074,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.69394588470459
1758,2555,NCI-H2085,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.0,7.51,16.5,14.7,-20,-.61,-23,-34","4.82,1.39,4.87,16.0,13.7,13.1,9.59,8.90",8,Sigmoid,0.166036025,8.0,-23.60252571,0.6582,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6994733810424805
1759,2556,NCI-H2087,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-3.0,-6.4,-4.9,7.15,13.4,-12,-32","7.02,8.65,10.2,11.8,12.0,.52,12.3,7.41",8,Sigmoid,2.783833504,8.0,-32.48584747,0.7401,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6921350955963135
1760,2557,NCI-H211,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.44,5.82,-4.6,-2.5,-4.5,-9.3,-5.8,-14","9.44,6.23,6.14,1.93,12.1,8.24,11.5,11.4",8,Constant,,8.0,-7.89563179,0.61,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.68930983543396
1761,2558,NCI-H2122,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","15.9,-7.2,8.63,-4.5,25.7,-16,-2.6,-69","8.40,25.0,13.9,10.7,.44,17.8,51.2,6.00",8,Sigmoid,2.13380003,3.376755238,-68.86206818,0.8178,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.2169152596532096,2.340440034866333
1762,2559,NCI-H2170,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-13,-4.7,17.5,-1.5,-26,-49,-81","7.73,17.1,8.06,25.0,3.73,3.17,11.1,6.03",8,Sigmoid,2.381195545,2.416388035,-80.14260864,1.7978,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.882273877689326,2.6631436347961426
1763,2560,NCI-H2172,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.53,-40,-8.2,-27,5.15,3.51,13.6,1.94","48.8,64.9,41.8,6.36,33.9,10.3,14.3,80.9",8,Constant,,8.0,-0.153632596,0.1918,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6443257331848145
1764,2561,NCI-H2228,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,4.75,7.61,-1.3,-3.8,-19,-20,-51",".51,2.48,3.32,4.80,4.57,9.40,2.09,2.06",8,Sigmoid,8.832124634,8.0,-49.64001846,0.9192,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.48925518989563
1765,2562,NCI-H2286,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.90,-1.1,1.12,10.0,-12,-25,-45,-56","4.14,6.59,8.77,.29,.12,8.91,7.76,2.44",8,Sigmoid,0.912032068,3.633536339,-55.94872665,2.0052,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.2902063721254098,2.3922204971313477
1766,2563,NCI-H23,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.2,8.40,-11,-16,21.3,6.92,-2.3,1.58","0,16.1,5.20,1.46,8.09,11.8,16.2,9.25",8,Constant,,8.0,-2.309051275,0.7626,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.510420322418213
1767,2564,NCI-H2444,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.16,-5.1,1.72,-7.0,-5.9,-17,-5.8,-46","7.13,14.9,22.2,8.11,16.5,21.1,15.8,7.64",8,Sigmoid,6.173307419,8.0,-45.49550247,0.528,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5514039993286133
1768,2565,NCI-H2452,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.45,-24,11.0,4.31,-7.8,-8.2,-19,-49","3.49,3.66,10.2,.71,10.8,11.1,3.70,8.38",8,Sigmoid,8.9033232,8.0,-48.53636932,1.0389,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5529162883758545
1769,2566,NCI-H28,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,8.49,-2.8,-2.0,4.49,-21,-69,-73",".29,15.8,8.69,12.4,8.49,14.2,3.66,2.81",8,Sigmoid,1.079372644,1.326548219,-72.39966583,1.327,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.28258024448154323,2.4358649253845215
1770,2567,NCI-H322,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.23,-4.8,1.35,1.71,-6.7,-43,-73,-79","1.44,.099,.75,.33,3.33,2.33,3.39,.86",8,Sigmoid,0.747733653,0.965358913,-78.69812775,1.5032,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.03525531622223216,2.681236982345581
1771,2568,NCI-H3255,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".11,-8.7,-7.2,-34,-79,-89,-95,-95","4.92,2.50,2.07,6.08,3.77,.025,.91,1.31",8,Sigmoid,0.114181615,0.117367186,-94.11991882,3.9472,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-2.142447916619734,2.5973575115203857
1772,2569,NCI-H358,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.17,-.36,5.76,3.49,6.48,-8.4,-30,-52",".26,.29,.35,11.2,1.23,.32,4.16,4.61",8,Sigmoid,2.199442148,6.738224983,-51.84972763,0.7506,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.9077965346020478,2.7197866439819336
1773,2570,NCI-H441,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,4.55,4.66,8.34,-3.7,-11,-4.5,-41","1.90,1.13,9.45,3.87,2.09,3.85,2.14,1.29",8,Sigmoid,8.279486272,8.0,-40.50992966,0.7499,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.48048734664917
1774,2571,NCI-H460,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".55,-3.4,1.72,-.55,-5.3,-1.3,-1.9,-20","12.3,22.0,2.75,12.8,6.37,5.87,1.67,5.09",8,Constant,,8.0,-2.068294048,0.1118,NCIH460_LUNG,NCIH460,ACH-000463,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.404167413711548
1775,2572,NCI-H522,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.38,9.99,13.2,-8.6,4.89,-27,-24,-26","27.9,13.9,7.45,5.58,6.15,.39,4.60,5.69",8,Sigmoid,0.317755431,8.0,-27.64705849,0.8378,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.696748733520508
1776,2573,NCI-H647,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,-30,24.7,-6.5,1.73,-16,-44,-61","8.90,8.24,3.89,13.1,21.6,11.5,12.7,.22",8,Sigmoid,1.78829968,3.184889317,-60.59897995,1.452,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.1584175370859051,2.4630751609802246
1777,2574,NCI-H650,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-2.9,3.18,5.62,-2.3,7.22,.75,-7.0","8.11,11.6,10.9,8.65,1.29,4.22,1.97,15.2",8,Constant,,8.0,0.955363154,0.0,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4165873527526855
1778,2575,NCI-H661,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.7,-1.5,3.34,-3.7,-4.5,-6.5,-22,-41","7.63,2.48,15.5,11.5,15.4,12.9,17.7,40.6",8,Constant,,8.0,-0.50817579,0.5857,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4154086112976074
1779,2576,NCI-H727,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,-2.8,-7.9,25.6,8.47,-8.7,-38,-31","21.7,12.5,15.8,7.97,18.7,15.3,18.7,1.69",8,Linear,,8.0,-34.35335541,1.0985,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.8076889514923096
1780,2577,NCI-H747,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-21,.48,-1.8,-22,-14,-19,-48","10.5,5.12,24.1,4.90,4.09,8.71,.74,7.48",8,Sigmoid,8.551506757,8.0,-48.28766632,1.2293,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.7226223945617676
1781,2578,NCI-H810,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,-3.5,3.09,4.75,-.47,-5.0,-9.6,11.4","7.69,6.74,7.20,2.58,19.9,4.31,13.8,13.9",8,Constant,,8.0,-3.812523365,0.2285,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.746675491333008
1782,2579,NCI-N87,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,16.3,7.83,-24,28.6,-13,-36,-79","1.14,34.4,19.7,3.53,7.64,33.3,33.5,1.10",8,Linear,,0.14846965,-77.36632538,2.0389,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-1.9073747187316061,2.581005334854126
1783,2580,NCO2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.99,6.32,-5.1,-31,-72,-93,-96,-97","2.39,3.40,49.0,13.6,7.37,1.38,.51,.087",8,Sigmoid,0.121123224,0.13301678,-97.27367401,4.2576,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-2.017279993305036,2.3970088958740234
1784,2581,NIH:OVCAR-3,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,.89,22.2,-11,-35,-39,-55,-68","13.3,24.1,33.1,7.66,7.52,8.80,8.37,.71",8,Sigmoid,0.531636059,1.363028646,-66.57531738,2.2222,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.3097091693680856,2.4745047092437744
1785,2582,NUGC-3,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","12.4,11.0,10.7,14.5,22.0,.23,-38,-61","7.74,1.58,10.5,14.6,13.3,7.81,18.1,.47",8,Sigmoid,1.824598432,3.666167736,-61.15366364,0.9751,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.2991469028716263,2.4649157524108887
1786,2583,NUGC-4,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,11.5,-5.6,-19,-30,-72,-81,-85","3.93,9.45,.38,7.49,8.97,7.28,.34,2.57",8,Sigmoid,0.338411957,0.400758862,-84.94493866,2.712,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.9143953741998575,2.9113173484802246
1787,2584,OCI-AML2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".33,-.013,4.06,3.84,-.11,-10,-.68,-21","7.59,.70,2.53,3.80,.67,6.84,7.47,5.02",8,Sigmoid,8.936905147,8.0,-20.42869949,0.2234,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2463905811309814
1788,2585,OCI-AML5,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-5.0,5.88,3.60,-.87,-26,-19,-41","34.7,11.8,6.53,4.37,3.96,1.18,.40,2.36",8,Sigmoid,0.535531044,8.0,-36.81332016,1.1565,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2176764011383057
1789,2586,OCUM-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,22.4,6.06,20.4,2.13,2.72,-2.6,9.09","9.85,24.3,22.2,11.1,15.7,23.4,3.21,6.98",8,Constant,,8.0,5.294035435,0.3956,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5355300903320312
1790,2587,OE21,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,14.3,-2.8,6.21,-7.5,-23,-62,-76","1.98,1.42,.18,21.2,15.6,1.41,4.32,.94",8,Sigmoid,1.210280657,1.721045375,-76.25189209,1.4609,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.5429318823670222,2.339898109436035
1791,2588,OE33,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-15,-14,3.61,-2.1,-19,-47,-65","9.23,17.0,2.37,28.2,10.9,7.58,5.79,8.46",8,Sigmoid,1.900690079,2.744313717,-65.28842163,1.5313,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.0095310316814203,2.718236207962036
1792,2589,ONCO-DG-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,.73,9.07,-1.0,-14,-24,-54,-73","6.03,7.60,16.8,13.2,1.54,7.65,1.16,4.88",8,Sigmoid,1.748194933,2.222901344,-73.430336,1.508,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.7988132543301364,2.5608158111572266
1793,2590,ONS-76,AZD0530,ABL,".0080,.025,.080,.25,.80,2.53,8","-.37,-1.2,.38,-6.5,-14,-17,-25","0,0,0,0,0,0,0",7,Sigmoid,1.156494617,8.0,-23.9006691,0.6145,ONS76_CENTRAL_NERVOUS_SYSTEM,ONS76,ACH-000776,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6043190956115723
1794,2591,OPM-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,9.17,2.38,2.37,8.46,-23,-11,-25","34.1,7.70,10.2,22.7,10.4,21.8,10.4,10.7",8,Constant,,8.0,-4.106649876,0.6917,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.605149269104004
1795,2592,OV-90,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","12.8,-8.2,-7.0,-2.0,9.18,-11,5.53,-24","2.91,10.4,1.61,8.40,3.32,2.22,13.3,27.1",8,Constant,,8.0,-4.399020195,0.2935,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.442187786102295
1796,2593,OVCAR-4,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.3,-4.0,-11,-8.5,-7.1,-16,-15,-25","5.67,4.98,4.76,1.05,6.68,2.51,1.72,2.15",8,Constant,,8.0,-12.34514904,0.4466,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.586216926574707
1797,2594,OVCAR-8,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,.46,-1.3,5.05,-9.3,-21,-28,-55","16.1,7.91,14.6,9.17,22.2,3.05,26.0,8.66",8,Sigmoid,1.069754362,3.547168732,-54.09415054,1.0565,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.2661497450011854,2.584486246109009
1798,2595,OVMANA,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.97,8.63,-.84,5.60,-.98,1.64,-36,-64","20.2,10.4,30.4,21.0,4.24,2.69,8.18,1.88",8,Sigmoid,2.30688715,3.485108137,-64.49333191,1.6191,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.2484990729993821,2.2049999237060547
1799,2596,OVSAHO,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,8.90,3.56,-9.6,-24,-4.1,-19,-3.2","16.0,5.50,19.8,8.64,3.69,2.42,12.9,6.64",8,Constant,,8.0,-6.641101837,0.8493,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.7402052879333496
1800,2597,OVTOKO,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,-8.5,7.13,-7.8,-44,-44,-50,-74","4.53,1.41,4.88,1.07,61.2,1.97,.55,18.0",8,Sigmoid,0.633831441,1.413676023,-62.77876282,1.9162,OVTOKO_OVARY,OVTOKO,ACH-000663,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.346193420288648,2.383112907409668
1801,2598,P12-ICHIKAWA,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,.56,-.070,-5.8,7.93,-11,-6.9,-18","5.02,.87,5.37,14.5,1.68,13.0,9.17,5.50",8,Constant,,8.0,-1.341610551,0.3353,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.280743360519409
1802,2599,P31/FUJ,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.83,-4.9,7.89,21.1,-.15,-5.4,16.5,15.5","1.59,2.06,15.5,19.9,1.01,1.57,3.11,24.7",8,Constant,,8.0,4.204292297,0.07896,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6007883548736572
1803,2600,P3HR-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,-8.8,2.98,3.50,28.1,10.7,-4.2,-29","6.47,9.23,1.22,10.4,2.42,16.9,6.37,9.84",8,Sigmoid,3.839285374,8.0,-28.60700035,0.3172,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6784467697143555
1804,2601,Panc 02.03,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.61,-2.8,.20,-2.1,-8.9,-42,-49,-81","3.82,8.72,9.38,17.2,9.53,19.5,7.74,7.10",8,Sigmoid,8.009187908,2.565029144,-81.32982635,1.669,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.9419698407414195,2.5215859413146973
1805,2602,Panc 03.27,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.69,-12,22.2,14.4,15.5,-15,-22,-49","4.83,10.0,3.88,4.88,11.1,6.71,2.84,11.3",8,Sigmoid,2.366593361,8.0,-47.29162216,0.9077,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5992870330810547
1806,2603,Panc 04.03,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,7.18,20.4,16.7,-8.8,-7.5,-48,-48","1.70,28.9,2.59,12.4,4.29,12.2,1.14,14.5",8,Sigmoid,1.11146009,8.0,-49.41849518,0.7926,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.850660800933838
1807,2604,Panc 10.05,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,9.58,-20,8.18,-20,-17,-46,-64","19.5,19.9,.65,26.5,10.9,6.32,9.53,12.8",8,Sigmoid,2.281346798,2.757964373,-63.89100647,1.4284,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.0144928615936948,2.6876282691955566
1808,2605,PA-TU-8902,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.27,.12,.093,-8.0,-5.5,-12,-29,-35",".35,5.71,1.40,10.2,4.48,4.00,3.71,6.56",8,Sigmoid,1.284914374,8.0,-35.59489441,0.9396,PATU8902_PANCREAS,PATU8902,ACH-000599,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.438060760498047
1809,2606,PC-3,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-1.3,-5.4,-14,-26,-41,-50,-50","6.67,6.01,14.5,9.03,16.6,2.52,8.66,7.33",8,Sigmoid,0.29809913,3.725782156,-50.94590378,1.6719,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.315276804555008,2.682302474975586
1810,2607,Pfeiffer,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,3.41,10.0,8.83,1.69,-36,-63,-78","10.4,6.46,50.5,8.55,6.51,3.19,1.32,1.12",8,Sigmoid,0.847417533,1.235854149,-75.02332306,1.7467,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.21176234964548032,2.096693515777588
1811,2608,PK-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,-7.5,-8.2,-5.1,-1.9,-11,-19,-48","2.56,3.11,1.30,4.85,4.30,2.44,1.23,2.21",8,Sigmoid,8.168487552,8.0,-48.360569,1.1932,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6503801345825195
1812,2609,PK-45H,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,3.67,.16,6.26,-11,-18,-38,-49","7.32,7.69,3.02,14.0,.63,7.67,8.52,3.63",8,Sigmoid,1.510641217,8.0,-48.76797867,1.4521,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6139774322509766
1813,2610,PK-59,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","2.09,-1.4,.29,-.064,1.39,-11,-28,-50",".25,1.15,2.55,1.24,.79,2.48,4.75,.39",8,Sigmoid,2.789659262,8.0,-49.41280365,0.8084,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6235055923461914
1814,2611,PLC/PRF/5,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".80,11.9,-.100,13.7,-11,.85,-29,-52","5.03,9.42,5.59,7.94,5.60,6.90,6.46,4.01",8,Sigmoid,2.273244858,6.426341534,-51.71364975,0.8137,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.86040540805194,2.1786739826202393
1815,2612,PSN1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,.53,-3.3,1.05,-4.1,-1.4,-7.7,-12","5.93,7.33,8.15,12.6,8.81,6.87,6.09,6.21",8,Constant,,8.0,-5.185963154,0.1458,PSN1_PANCREAS,PSN1,ACH-000320,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.452240228652954
1816,2613,QGP-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,-12,1.47,-2.4,-12,-18,-3.6,-9.2","10.7,25.0,38.8,30.5,12.5,.78,4.40,3.17",8,Constant,,8.0,-9.168526649,0.6628,QGP1_PANCREAS,QGP1,ACH-000347,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.8315072059631348
1817,2614,Raji,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","32.5,6.64,17.8,20.9,31.6,38.5,-4.5,7.81","2.72,9.04,4.00,16.6,13.4,23.4,34.3,17.3",8,Constant,,8.0,19.94038963,0.0146,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4557290077209473
1818,2615,RD,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".055,-8.6,-1.0,-11,-13,-27,-20,-35","23.1,16.2,2.47,18.8,15.0,4.46,2.68,6.50",8,Sigmoid,8.128570442,8.0,-33.45333481,0.8706,RD_SOFT_TISSUE,RD,ACH-000169,Sarcoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.591395378112793
1819,2616,Reh,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,-2.6,-.13,-3.2,8.29,6.01,14.3,-2.9","7.67,2.43,7.84,10.2,13.8,5.93,1.16,7.85",8,Constant,,8.0,2.188279867,0.00713,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.214768648147583
1820,2617,RERF-GC-1B,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,.023,.89,-7.1,-12,-34,-60,-73","1.09,24.7,20.3,11.7,17.0,1.92,3.80,5.86",8,Sigmoid,1.242251992,1.569265246,-72.88024139,2.1467,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.4506075136374824,2.6971945762634277
1821,2618,RERF-LC-AI,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.51,-2.9,8.61,.68,5.68,-.18,-4.5,-11",".55,.75,.67,6.33,1.52,3.21,4.90,4.34",8,Constant,,8.0,0.342069954,0.0,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4834907054901123
1822,2619,RERF-LC-MS,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.85,7.29,7.27,4.27,7.62,7.01,.47,-9.2","13.5,7.27,11.5,19.0,.93,6.62,14.8,3.08",8,Constant,,8.0,4.795918941,0.06091,RERFLCMS_LUNG,RERFLCMS,ACH-000062,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.267949342727661
1823,2620,RKO,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.3,-.39,6.35,-6.4,-3.7,-19,-9.7,-36","5.59,1.52,6.97,2.91,6.37,5.16,8.81,1.40",8,Sigmoid,8.695924958,8.0,-34.43815613,0.6394,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4108026027679443
1824,2621,RL95-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-2.6,.37,12.1,-22,-37,-41,-58","3.58,18.9,13.4,10.4,12.9,3.79,15.9,2.08",8,Sigmoid,0.50171876,2.097080231,-58.02454376,1.6957,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.74054601108298,2.5770559310913086
1825,2622,RPMI-7951,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.84,-5.3,.21,-1.5,-2.8,-8.5,-37,-33","16.6,9.69,10.3,15.4,8.58,9.48,22.5,4.96",8,Sigmoid,1.056271672,8.0,-34.41036987,0.8065,RPMI7951_SKIN,RPMI7951,ACH-000348,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.536749839782715
1826,2623,RPMI-8402,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.40,4.29,-.29,5.89,-8.0,-16,-26,-51","13.0,13.8,4.00,5.18,10.3,3.47,6.18,5.10",8,Sigmoid,8.32564188,7.867946148,-50.38681412,1.0333,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0627970560702424,2.2316250801086426
1827,2624,RT-112,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,5.40,-.53,-13,-8.7,-13,-12,-51","11.2,9.21,1.74,6.97,8.89,2.30,5.73,8.86",8,Sigmoid,8.33047445,7.906232357,-50.63967133,1.0985,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.067651354399612,2.490361213684082
1828,2625,RT4,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","15.0,-27,27.8,-30,-33,-81,-83,-94","7.86,32.3,30.7,23.1,6.54,8.03,1.70,2.55",8,Sigmoid,0.28609255,0.3537938,-91.92793274,3.5666,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-1.0390410214348724,2.5784738063812256
1829,2626,RVH-421,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,.81,-3.0,.26,3.04,4.20,-10,-7.9","9.89,2.99,5.75,6.29,11.5,6.12,8.98,4.92",8,Constant,,8.0,-2.556907892,0.0,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3672356605529785
1830,2627,SBC-5,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,-7.0,4.87,-4.8,2.38,-5.7,8.43,-7.8","4.16,1.38,1.77,.37,4.75,2.68,3.50,1.31",8,Constant,,8.0,-4.194680691,0.04244,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2986838817596436
1831,2628,SCaBER,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-2.3,-10,-2.6,-29,-41,-61,-71",".35,20.1,7.96,11.6,11.5,8.72,2.57,.97",8,Sigmoid,0.851977646,1.242898583,-70.79481506,1.6172,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.21744621869304923,2.6170806884765625
1832,2629,SCC-9,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-7.1,1.45,-12,19.4,-38,-24,-62","10.5,5.89,13.8,16.3,33.7,7.07,11.9,5.78",8,Sigmoid,0.626673281,8.0,-47.57872009,1.3741,SCC9_UPPER_AERODIGESTIVE_TRACT,SCC9,ACH-000181,Head and Neck Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.311497688293457
1833,2630,SF126,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.10,-10,2.98,-5.2,6.71,-8.7,-22,-45","2.18,4.55,2.11,1.39,6.34,3.09,12.0,2.31",8,Sigmoid,3.558599472,8.0,-45.10947418,0.5959,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3837497234344482
1834,2631,SF-295,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.17,-4.6,2.11,-6.4,-7.2,-13,-24,-39",".71,7.67,.82,11.0,6.74,1.59,.70,1.41",8,Sigmoid,9.041300834,8.0,-38.23951721,0.4257,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3366098403930664
1835,2632,SH-10-TC,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,.87,-19,-15,-6.2,-13,-29,-30","3.93,.25,10.9,2.83,1.68,2.55,9.03,1.55",8,Constant,,8.0,-12.33464718,0.4559,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4513607025146484
1836,2633,SHP-77,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,5.74,5.14,-2.7,1.82,-3.1,1.58,15.5","4.03,13.7,9.20,9.78,8.24,44.6,5.89,6.44",8,Constant,,8.0,1.431115985,0.2412,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.564728260040283
1837,2634,SIG-M5,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-8.1,-17,-10,-23,-38,-12,-65","9.70,14.5,11.4,11.6,20.0,3.18,49.2,10.5",8,Constant,,8.0,-18.8219471,3.1197,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.1777849197387695
1838,2635,SIMA,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","18.9,16.7,21.6,16.9,-21,-27,-29,-31","30.1,1.29,51.6,31.0,48.0,3.19,32.7,5.76",8,Linear,,8.0,-31.55862808,1.0497,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3703413009643555
1839,2636,SJSA-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,-6.9,1.79,-20,14.6,-30,-4.9,-38","16.7,15.1,27.9,4.70,12.5,9.91,5.39,3.46",8,Constant,,8.0,-15.50167751,1.3996,SJSA1_BONE,SJSA1,ACH-000748,Bone Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3160200119018555
1840,2637,SK-BR-3,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","16.8,-19,8.48,2.89,6.96,1.29,12.8,-39","15.7,4.52,39.6,3.96,7.24,8.21,.25,7.37",8,Linear,,8.0,-37.49472809,0.4847,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.700066566467285
1841,2638,SK-CO-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.4,-2.7,10.7,-21,7.51,-23,-43,-61","15.9,6.90,6.61,1.76,7.99,12.6,6.51,.68",8,Sigmoid,1.539928675,3.300038099,-60.00517273,1.7353,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.1939340135573049,2.5740556716918945
1842,2639,SK-ES-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".28,6.61,-9.1,-11,-17,-15,-13,-19",".14,11.8,11.0,13.0,10.7,5.06,6.98,26.1",8,Constant,,8.0,-9.097847939,1.0395,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.623178243637085
1843,2640,SK-HEP-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","25.3,-1.6,30.2,-10,15.6,-13,8.11,-18","11.8,19.4,5.06,3.45,3.19,.85,3.09,.84",8,Constant,,8.0,8.109059334,0.0,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.565232753753662
1844,2641,SK-MEL-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","8.06,11.1,-3.6,9.28,-.36,20.6,-2.7,2.92","3.01,29.1,2.18,5.42,6.82,1.05,3.66,8.07",8,Constant,,8.0,4.927656651,0.1274,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4791204929351807
1845,2642,SK-MEL-24,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.4,5.39,-13,-10,-5.7,-9.4,-1.1,-23","14.7,5.34,14.5,16.6,.35,20.3,.87,6.33",8,Constant,,8.0,-4.225236893,0.514,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.412088394165039
1846,2643,SK-MEL-30,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,1.56,.75,3.50,-5.0,-1.1,-6.8,-1.9","12.8,10.7,5.55,.053,9.61,8.92,4.73,10.6",8,Constant,,8.0,-0.749953806,0.0,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.177271604537964
1847,2644,SK-MEL-31,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,-2.3,.77,-10,-9.0,-12,.84,-16","5.36,12.4,8.39,4.69,14.7,4.77,1.31,7.70",8,Constant,,8.0,-7.867698669,0.3513,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3577215671539307
1848,2645,SK-MEL-5,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","11.6,.62,6.98,-.30,1.71,10.2,-.38,-27","11.2,15.4,19.5,5.30,.45,14.4,2.21,2.78",8,Sigmoid,5.167908192,8.0,-26.8904705,0.2502,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.457746744155884
1849,2646,SK-MES-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.3,-3.9,-5.4,-20,.61,-42,-63,-84",".46,10.2,16.7,10.0,11.7,3.33,2.00,4.88",8,Sigmoid,1.589475632,1.335319281,-83.89438629,2.5709,SKMES1_LUNG,SKMES1,ACH-000665,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.289170425055342,2.7865042686462402
1850,2647,SK-MM-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".52,-7.6,.14,-13,-8.6,-28,-34,-72","2.37,.57,2.12,3.95,3.44,10.7,2.07,4.92",8,Sigmoid,8.235575287,4.408838749,-72.20734406,1.6679,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.4836113325611486,2.4496564865112305
1851,2648,SK-N-AS,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,4.69,16.2,3.22,-1.1,-6.6,-22,-24",".12,5.25,5.93,1.78,4.78,4.26,2.48,4.29",8,Sigmoid,1.063935399,8.0,-24.61741447,0.3985,SKNAS_AUTONOMIC_GANGLIA,SKNAS,ACH-000260,Neuroblastoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5351791381835938
1852,2649,SK-N-BE(2),AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","9.02,21.5,38.7,1.56,-5.1,-11,-11,-26","23.3,10.3,48.8,15.9,18.7,6.52,29.1,11.8",8,Sigmoid,0.599606872,8.0,-24.46876335,0.4317,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5054593086242676
1853,2650,SK-N-DZ,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,-2.5,.55,-9.2,-11,-21,-31,-47","5.71,1.72,.088,1.27,2.79,7.17,2.69,3.48",8,Sigmoid,8.025906853,8.0,-47.03858185,1.5357,SKNDZ_AUTONOMIC_GANGLIA,SKNDZ,ACH-000366,Neuroblastoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3575239181518555
1854,2651,SK-N-FI,AZD0530,ABL,".0025,.025,.080,.25,.80,2.53,8","-28,-14,55.8,-20,37.2,-46,13.5","5.54,19.9,18.9,23.4,50.0,18.1,24.3",7,Constant,,8.0,-3.523523808,1.3394,SKNFI_AUTONOMIC_GANGLIA,SKNFI,ACH-000341,Neuroblastoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.537494659423828
1855,2652,SK-N-SH,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.57,-8.1,-5.0,-.85,-19,-35,-40,-46","7.93,1.89,.99,4.88,7.64,13.6,14.5,15.5",8,Sigmoid,0.362696737,8.0,-43.25873184,1.0388,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4329962730407715
1856,2653,SK-OV-3,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.69,-12,12.4,-11,3.04,-23,-44,-57","8.22,2.75,18.1,4.78,9.97,4.96,7.90,3.07",8,Sigmoid,0.922942817,2.545481205,-59.0692215,1.1181,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.934319710714845,2.4326725006103516
1857,2654,SNG-M,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.4,-9.7,-3.5,.77,-6.2,-15,-15,-54","3.92,11.2,1.54,18.6,2.13,3.85,5.42,4.90",8,Sigmoid,8.486290833,7.457118034,-53.7259407,1.0556,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.009169017053793,2.3800482749938965
1858,2655,SNU-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,-1.9,-.58,-5.2,6.09,9.74,-4.1,-39","1.16,16.9,10.3,11.2,2.24,15.0,12.1,10.7",8,Sigmoid,3.900854826,8.0,-38.83221817,0.6094,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4072461128234863
1859,2656,SNU-182,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,-7.3,9.44,-1.6,9.08,-20,-21,-53","8.83,18.1,7.87,16.6,9.04,17.2,10.1,3.89",8,Sigmoid,6.866363049,7.239161491,-52.86737823,0.943,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.9795053835301946,2.468055248260498
1860,2657,SNU-387,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","14.8,-6.4,.72,5.19,11.7,-15,1.23,-17","2.59,3.86,20.0,21.5,17.2,14.8,8.80,12.8",8,Constant,,8.0,-4.253164768,1.0306,SNU387_LIVER,SNU387,ACH-000478,Liver Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4307169914245605
1861,2658,SNU-398,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","13.5,-2.7,2.69,-2.9,-6.1,-12,7.29,-31","21.7,3.83,10.2,10.8,12.6,10.9,14.5,1.31",8,Sigmoid,8.723953265,8.0,-30.74238777,0.6213,SNU398_LIVER,SNU398,ACH-000221,Liver Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4425649642944336
1862,2659,SNU-423,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,-9.9,-2.8,-4.7,4.83,-6.1,1.53,-11","9.28,4.34,3.20,7.62,14.0,11.7,13.2,9.85",8,Constant,,8.0,-4.688166142,0.04521,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4127182960510254
1863,2660,SNU-449,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,-1.1,5.09,-1.6,-.39,-5.6,-12,-52","6.61,1.52,12.0,3.98,10.5,4.02,12.1,9.06",8,Sigmoid,8.134364564,7.714274883,-51.7829895,0.6314,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.04307249345242,2.797488212585449
1864,2661,SNU-475,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","20.1,56.7,15.0,-27,32.1,-3.8,-20,-2.1","25.6,61.2,52.2,15.4,35.4,10.4,5.12,69.9",8,Constant,,8.0,3.06193471,0.6638,SNU475_LIVER,SNU475,ACH-000422,Liver Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.535388708114624
1865,2662,SNU-C2A,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,-18,1.82,-17,-6.0,4.54,-32,-45","1.34,3.86,.94,17.0,10.5,4.34,2.88,2.47",8,Sigmoid,2.203264475,8.0,-44.991642,1.326,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5282771587371826
1866,2663,Sq-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","6.24,1.32,-20,-11,2.21,-6.6,-40,-74","3.57,18.8,14.7,11.4,6.97,6.90,2.19,1.20",8,Sigmoid,2.502472639,3.167957306,-73.72931671,1.9154,SQ1_LUNG,SQ1,ACH-000553,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.1530869972199544,2.5981979370117188
1867,2664,SU.86.86,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,-8.6,3.54,5.22,1.75,-.88,-5.6,-15","2.35,2.32,1.46,6.27,9.97,4.82,11.8,1.76",8,Constant,,8.0,-3.213159084,0.3333,SU8686_PANCREAS,SU8686,ACH-000114,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5245001316070557
1868,2665,SU-DHL-10,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-11,-8.7,-5.0,-8.3,21.0,48.3,63.3",".76,34.5,2.93,.84,17.5,11.5,57.1,10.4",8,Linear,,8.0,-22.05212593,0.4912,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5713822841644287
1869,2666,SU-DHL-4,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.64,-.58,2.81,-12,-32,-58,-73,-92","19.4,3.89,3.69,9.30,3.36,5.32,1.19,1.54",8,Sigmoid,0.540213943,0.620767057,-89.72570801,3.6068,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.4767993769206307,2.280472993850708
1870,2667,SU-DHL-6,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","39.5,16.5,71.6,47.3,-19,-17,-59,-94","27.3,37.7,43.8,11.7,11.9,41.0,12.6,2.04",8,Linear,,0.510724029,-95.43675232,1.7767,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.6719258953290828,2.2730393409729004
1871,2668,SU-DHL-8,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","10.6,-.15,8.18,-10,-7.6,-13,15.9,-8.6","2.59,.49,11.1,23.3,3.54,.53,25.2,10.3",8,Constant,,8.0,-0.703409851,1.196,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6003193855285645
1872,2669,SUIT-2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-7.3,2.60,-2.4,-5.4,-11,-22,-70","4.06,7.33,2.19,6.15,4.04,11.4,7.16,3.45",8,Sigmoid,8.788603556,4.957104683,-68.58563232,1.011,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.6008218370321137,2.309042453765869
1873,2670,SUP-M2,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","5.19,23.6,14.9,11.3,7.09,8.37,4.49,6.52","20.4,5.44,11.3,17.8,24.5,2.94,7.89,3.62",8,Constant,,8.0,9.341162682,0.0,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.178602695465088
1874,2671,SUP-T1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.02,-18,21.6,6.89,4.04,-1.9,-12,-27","10.0,12.5,3.27,8.79,13.3,21.7,1.13,8.89",8,Constant,,8.0,-2.234802485,0.5452,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5966105461120605
1875,2672,SW 1088,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-5.5,-9.4,-6.3,-16,-11,-14,-36","9.02,.86,6.04,8.07,18.4,26.1,12.0,2.86",8,Constant,,8.0,-9.32410717,0.2863,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5504226684570312
1876,2673,SW 1271,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,-1.2,-6.6,-8.4,-15,-15,-25,-44","23.0,19.3,10.8,1.23,3.12,12.8,8.12,3.07",8,Sigmoid,8.312214567,8.0,-43.56542587,1.3076,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.483621120452881
1877,2674,SW 1353,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.45,8.41,4.66,-.68,2.99,-5.1,-9.1,-32","12.5,9.28,2.70,.085,8.86,1.29,8.59,1.52",8,Sigmoid,8.592127735,8.0,-31.95262527,0.5077,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5045223236083984
1878,2675,SW1417,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","7.09,-34,-9.6,-14,-8.2,-36,-39,-50","8.43,7.93,1.54,3.72,8.62,31.8,5.33,15.9",8,Linear,,8.0,-49.33457184,2.5102,SW1417_LARGE_INTESTINE,SW1417,ACH-000236,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.804945707321167
1879,2676,SW 1573,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-2.8,3.44,-1.2,-9.6,-10,-20,-23","3.28,.10,3.25,2.17,13.3,6.66,10.5,12.7",8,Constant,,8.0,-9.613012314,0.6893,SW1573_LUNG,SW1573,ACH-000677,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4179999828338623
1880,2677,SW 1990,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,4.56,-2.3,-3.4,-16,-14,-37,-50","9.77,28.1,19.7,3.90,7.62,6.19,.20,11.6",8,Sigmoid,2.830564022,7.550835133,-50.70840454,1.3081,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0216581707860795,2.6397149562835693
1881,2678,SW403,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,12.3,-6.5,13.6,1.39,-26,-40,-28","7.83,19.1,10.5,14.5,4.32,11.5,7.06,18.3",8,Sigmoid,0.697270691,8.0,-39.40284729,1.1138,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.809896945953369
1882,2679,SW48,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","12.4,-9.7,-6.4,17.8,-31,-27,-38,-41","38.0,11.4,37.3,12.3,8.48,3.79,7.60,6.37",8,Sigmoid,0.178927898,8.0,-36.01488495,1.6492,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2977209091186523
1883,2680,SW480,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","3.90,-.47,-.90,-9.1,-14,-17,-7.1,-18","2.85,15.8,7.86,13.0,7.62,2.24,15.8,9.90",8,Constant,,8.0,-10.19511318,0.1153,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6788649559020996
1884,2681,SW579,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,-6.7,-4.6,-6.1,-9.7,-17,-36,-73",".16,13.0,.81,1.05,8.77,2.95,4.02,.66",8,Sigmoid,8.135232989,4.161397457,-73.14900208,1.5267,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.4258509450257368,2.506758213043213
1885,2682,SW620,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,-1.4,-3.5,-7.2,-8.5,-13,-9.1,-12","8.38,7.15,5.98,.46,8.39,.66,3.65,13.1",8,Constant,,8.0,-7.190340519,0.09312,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3698947429656982
1886,2683,SW 780,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.6,8.07,-5.3,-8.0,-5.5,13.6,-8.5,-31","10.1,9.44,2.09,12.2,5.37,8.99,4.10,1.35",8,Sigmoid,3.234086275,8.0,-31.30290222,0.23,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.573350429534912
1887,2684,SW 900,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.87,8.50,-9.1,.96,-14,-2.9,-16,-28","25.4,30.8,5.24,23.5,.036,4.68,12.8,17.5",8,Constant,,8.0,-12.2955246,0.3648,SW900_LUNG,SW900,ACH-000669,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.689190149307251
1888,2685,T24,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,3.18,-1.8,-1.9,-13,-10,-42,-57","2.58,16.6,6.39,12.8,1.35,29.5,3.70,4.72",8,Sigmoid,1.632467866,4.298030376,-56.44519043,1.5531,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.4581568656685875,2.400890350341797
1889,2686,T3M-10,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,3.91,-8.1,7.07,-9.5,9.71,-11,-21","5.06,2.73,15.6,8.20,2.79,4.13,3.28,3.64",8,Constant,,8.0,-2.541286707,0.03668,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.531444787979126
1890,2687,T-47D,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,-.94,13.6,-3.5,27.5,-3.7,-13,-46","30.2,6.15,27.4,13.6,8.43,15.2,3.18,3.25",8,Sigmoid,4.739023685,8.0,-45.5904808,0.5592,T47D_BREAST,T47D,ACH-000147,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.9081835746765137
1891,2688,T84,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,23.6,27.1,10.4,4.71,15.8,-51,-51","26.2,32.3,81.4,33.0,11.8,9.83,31.5,24.6",8,Constant,,8.0,-0.56773597,1.0293,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.691253662109375
1892,2689,TCCSUP,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,1.82,1.82,8.62,15.9,7.44,-5.4,-22","7.69,4.52,7.49,4.78,1.54,1.78,9.01,.55",8,Sigmoid,2.769994974,8.0,-21.86743164,0.08578,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.38084077835083
1893,2690,TE-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-7.2,.70,-8.5,-1.0,-12,-24,-53","4.12,4.18,1.80,13.9,3.97,1.44,4.68,3.38",8,Sigmoid,6.227421761,7.190616608,-52.80522537,1.0441,TE1_OESOPHAGUS,TE1,ACH-000647,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.9727769271657278,2.5012729167938232
1894,2691,TE-11,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-14,-4.1,-5.6,-12,-38,-56,-71","20.4,2.35,.46,5.62,.89,5.72,.82,5.59",8,Sigmoid,0.980407357,1.533730626,-68.63570404,1.9288,TE11_OESOPHAGUS,TE11,ACH-000488,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.4277030851783615,2.475677013397217
1895,2692,TE-15,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,10.00,-26,-16,-9.7,-22,-59,-70","12.2,26.2,18.6,.19,3.90,10.3,7.55,4.58",8,Sigmoid,1.574772477,1.926496029,-70.40041351,2.4415,TE15_OESOPHAGUS,TE15,ACH-000353,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.6557028238309776,2.514427423477173
1896,2693,TE-5,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.0,-1.0,-3.5,.73,-2.6,4.20,-10,-24","11.4,.18,10.9,4.02,9.01,6.43,8.17,14.5",8,Sigmoid,2.733612061,8.0,-23.64344788,0.5912,TE5_OESOPHAGUS,TE5,ACH-000408,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.507302761077881
1897,2694,TE 617.T,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.34,5.61,-7.4,.87,-32,-77,-76,-87",".57,23.8,.059,14.9,3.46,6.26,13.5,.95",8,Sigmoid,0.337273419,0.373187572,-85.32919312,2.941,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,-0.9856741117424374,2.034716844558716
1898,2695,TE-9,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-13,-5.1,-12,.50,-31,-32,-59","14.3,2.24,4.56,13.1,23.0,7.82,3.00,5.81",8,Sigmoid,8.205579858,5.475279808,-57.75083923,1.9496,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.700243380880691,2.608640193939209
1899,2696,TEN,AZD0530,ABL,".0080,.025,.080,.25,.80,2.53,8","4.18,-4.2,-5.0,-2.6,-15,-34,-12","8.79,9.10,7.41,8.58,8.11,4.37,4.55",7,Sigmoid,0.725003898,8.0,-22.83348465,1.3929,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5957212448120117
1900,2697,Toledo,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","16.2,-12,14.0,19.7,-4.2,29.9,-18,-16","17.4,18.0,24.0,26.0,16.6,24.3,3.73,12.8",8,Constant,,8.0,1.121925712,0.002277,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4200453758239746
1901,2698,TOV-112D,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-2.2,-3.2,-20,-19,-45,-26,-36","4.29,3.61,2.64,.88,5.08,8.71,4.08,4.19",8,Sigmoid,0.09762267,8.0,-33.08301544,1.8421,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3448338508605957
1902,2699,TOV-21G,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,-1.7,4.79,.46,-18,-34,-57,-62","1.31,10.1,9.29,10.8,22.6,3.05,8.15,5.63",8,Sigmoid,0.7473827,1.316256523,-61.09542084,1.6485,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,0.2747917401992577,1.930132508277893
1903,2700,TT2609-C02,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.71,-60,7.32,24.5,-2.6,-.63,-31,-48","4.31,24.5,5.29,34.4,9.80,5.79,12.2,16.6",8,Linear,,8.0,-52.53331375,1.3733,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3579235076904297
1904,2701,TYK-nu,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-.37,-15,.34,-6.1,1.73,-3.2,-63","10.2,6.37,4.20,1.29,1.96,3.35,14.1,3.98",8,Sigmoid,7.428279877,7.217175961,-62.68817139,0.8178,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.9764637352533538,2.5221736431121826
1905,2702,U-118 MG,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","4.16,15.6,3.42,-.70,4.34,-.30,-1.6,.61","14.5,20.6,7.37,22.9,22.0,6.02,18.1,15.4",8,Constant,,8.0,2.79758811,0.1566,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4592814445495605
1906,2703,U-2 OS,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,3.02,-.14,-3.8,-3.3,-23,-30,-41","7.72,14.6,15.9,.24,.33,5.58,5.49,14.1",8,Sigmoid,0.766910076,8.0,-37.88898468,1.3457,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.45518159866333
1907,2704,U-87 MG,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","1.24,2.46,-1.2,4.87,-8.8,-8.8,1.78,8.93","7.34,4.75,1.00,4.22,9.12,12.9,8.41,4.95",8,Constant,,8.0,-0.34473002,0.03487,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.5023326873779297
1908,2705,U-937,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,5.72,9.03,-1.3,-10,-2.3,7.64,-4.5","12.5,2.32,11.8,3.55,10.4,18.5,16.9,22.6",8,Linear,,8.0,-22.12746239,0.5793,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.232647180557251
1909,2706,UACC-257,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.2,1.81,-.038,.24,-.89,-.39,-8.2,-11","11.3,9.07,11.6,5.99,2.32,1.77,4.31,10.5",8,Constant,,8.0,-3.094419956,0.3102,UACC257_SKIN,UACC257,ACH-000579,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3705053329467773
1910,2707,UACC-62,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-5.0,-18,-25,-6.6,-7.8,-4.8,-19","5.97,2.32,5.06,5.30,6.72,13.7,21.3,7.31",8,Constant,,8.0,-12.71294117,1.0493,UACC62_SKIN,UACC62,ACH-000425,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.387713670730591
1911,2708,UACC-812,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.024,-8.9,12.1,7.30,9.09,-7.5,-13,-58","11.8,14.0,2.38,20.2,11.0,16.2,31.6,39.3",8,Sigmoid,8.25090714,3.755201817,-84.01983643,0.6199,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.3231420299768826,3.019690990447998
1912,2709,UM-UC-3,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8",".48,-.31,1.48,-.83,2.72,3.26,-36,-51",".93,5.46,5.91,5.76,.23,4.34,2.32,1.92",8,Sigmoid,2.127776861,4.390860081,-51.29933548,0.706,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.4795251261208457,2.1919195652008057
1913,2710,VMRC-RCW,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,-12,2.24,-8.5,.096,-24,-33,-80","5.10,5.11,7.39,.36,2.53,1.74,5.93,9.96",8,Sigmoid,8.420669397,4.103376865,-80.0610199,1.4463,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.4118102603265688,2.329871654510498
1914,2711,VMRC-RCZ,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,8.17,-17,-14,-39,-10.0,-37,-43","1.48,19.3,10.1,4.20,7.37,19.2,3.03,23.3",8,Sigmoid,0.101575986,8.0,-34.41145706,1.8178,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3834657669067383
1915,2712,WM-115,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-3.9,7.95,9.58,1.02,-6.9,7.58,8.62","3.29,2.34,4.23,27.1,32.6,5.59,7.38,14.1",8,Constant,,8.0,-1.530041933,0.04944,WM115_SKIN,WM115,ACH-000304,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3676230907440186
1916,2713,WM1799,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-8.0,13.5,-3.3,1.85,-11,-18,-24","7.99,12.0,14.2,24.1,5.35,13.5,1.26,4.67",8,Constant,,8.0,-13.50043201,1.2506,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.239473342895508
1917,2714,WM-266-4,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,4.78,-3.5,-1.5,-1.7,12.8,-5.4,6.82","12.0,1.76,16.3,4.75,.52,4.26,.35,1.37",8,Constant,,8.0,2.650427341,0.0,WM2664_SKIN,WM2664,ACH-001239,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.2059736251831055
1918,2715,WM-793,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-48,-1.6,7.39,4.00,-9.2,-21,-25","17.9,26.8,11.7,5.89,16.9,29.9,19.7,4.39",8,Constant,,8.0,-8.887606621,0.8811,WM793_SKIN,WM793,ACH-000827,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.618760585784912
1919,2716,WM-88,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-4.4,-9.4,5.56,-.79,-6.0,-5.6,-9.3","14.9,5.09,3.45,8.51,6.55,5.15,13.1,1.45",8,Constant,,8.0,-6.146098137,0.5142,WM88_SKIN,WM88,ACH-000899,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.4554855823516846
1920,2717,WM-983B,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,2.53,6.53,-5.1,-15,-28,-45,-59","11.4,17.1,23.3,1.32,16.4,23.6,18.1,14.2",8,Sigmoid,1.095963001,3.326862335,-58.39653778,2.4621,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.2020296180618166,2.284496307373047
1921,2718,YKG1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-11,-8.3,-17,-31,-38,-38,-35","4.36,5.68,14.8,7.69,4.74,2.16,3.68,5.85",8,Sigmoid,0.163291186,8.0,-36.92588806,1.6499,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.3927550315856934
1922,2719,ZR-75-1,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","59.9,-30,3.29,-24,18.0,-10,11.3,-39","14.4,11.3,11.6,24.8,28.2,2.07,16.8,2.62",8,Linear,,8.0,-36.41096878,1.1688,ZR751_BREAST,ZR751,ACH-000097,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.6189584732055664
1923,2720,ZR-75-30,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-.76,19.7,7.49,14.2,19.8,28.2,-2.8,-6.2","19.3,24.5,9.11,9.15,13.3,19.5,.26,50.8",8,Constant,,8.0,11.53612137,0.0,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,2.0794415416798357,2.88114070892334
1924,2721,SCC-25,AZD0530,ABL,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,-12,8.54,7.60,13.5,5.29,-41,-59","4.15,3.86,15.1,6.20,.26,21.7,26.1,1.68",8,Sigmoid,2.103100061,3.025877953,-58.5957756,1.1035,SCC25_UPPER_AERODIGESTIVE_TRACT,SCC25,ACH-000188,Head and Neck Cancer,7,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,Saracatinib,"Src, Abl/Bcr-Abl, EGFR",Src and Abl inhibitor,Kinase inhibitor,Phase II,AstraZeneca,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,1.1072012817702244,2.2611637115478516
1925,2722,A172,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,1.43,5.99,2.26,-.94,-12,-21,-40","4.11,5.65,1.58,4.12,3.69,14.0,11.6,5.92",8,Sigmoid,3.016013384,8.0,-39.52769089,0.4959,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9975414276123047
1926,2723,A-204,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,18.8,-24,-2.7,5.17,1.56,-25,-59","11.2,19.7,10.8,11.5,0,1.02,16.1,1.44",8,Sigmoid,2.789777994,3.820780754,-59.38309097,0.5515,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.340454787598413,2.6238667964935303
1927,2724,A2058,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.3,-2.8,-11,-1.4,1.59,1.09,-2.1,-48",".68,6.66,8.49,1.92,3.17,4.19,.37,4.62",8,Sigmoid,8.005800769,8.0,-47.57242584,0.5221,A2058_SKIN,A2058,ACH-000788,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.792433977127075
1928,2725,A-253,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-3.2,-4.1,1.82,11.9,12.8,-2.5,-27","1.95,8.84,4.34,.70,.54,1.74,14.8,4.98",8,Sigmoid,3.45032382,8.0,-27.31258965,0.3606,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.7210140228271484
1929,2726,A2780,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.5,-4.5,.21,5.32,7.58,-.39,-43,-86","8.13,10.2,17.2,3.67,2.78,4.00,15.2,.95",8,Sigmoid,2.13275,3.04247117,-83.16724396,1.3639,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.1126700700745842,2.572577476501465
1930,2727,A-375,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,-3.0,-1.0,.31,5.53,-2.7,-7.7,-72","1.30,5.11,1.70,4.33,.44,3.51,1.97,.40",8,Sigmoid,5.987625122,5.895261765,-72.24956512,0.7175,A375_SKIN,A375,ACH-000219,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.7741489375836328,2.648721694946289
1931,2728,A549,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,-2.7,-1.3,1.03,.21,-3.0,-9.2,-87","3.18,5.37,.082,4.32,1.87,4.70,1.53,8.85",8,Sigmoid,8.102258869,5.782162189,-86.73342896,0.4691,A549_LUNG,A549,ACH-000681,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.7547776938752486,3.0562758445739746
1932,2729,A-673,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-15,9.72,-11,1.55,10.3,-57,-72","3.06,19.9,8.30,1.64,17.4,24.1,.33,.59",8,Sigmoid,1.995349169,2.269307852,-72.30183411,1.6086,A673_BONE,A673,ACH-000052,Bone Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.819474873985281,2.862936019897461
1933,2730,ACHN,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,-4.8,-2.3,-1.0,5.23,14.2,-20,-39","1.13,.18,3.62,2.74,2.01,.51,3.15,6.99",8,Sigmoid,2.541533709,8.0,-39.19466019,0.4836,ACHN_KIDNEY,ACHN,ACH-000046,Kidney Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1063232421875
1934,2731,ALL-SIL,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.4,-6.5,-9.5,4.97,-4.5,-50,-92,-94","5.36,16.0,3.45,1.21,.44,6.44,.93,.19",8,Sigmoid,0.79295373,0.800736248,-93.34855652,3.0952,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-0.2222236645398119,2.5802507400512695
1935,2732,AMO-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","10.5,2.75,14.9,-13,11.0,-4.8,-20,-92","25.2,4.52,2.13,23.2,4.85,24.9,7.52,2.35",8,Sigmoid,8.786033476,4.841135502,-92.17236328,1.3265,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.5771493010636617,2.87252140045166
1936,2733,AsPC-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.05,-12,-.48,.17,7.87,-5.9,-18,-76","9.20,7.55,3.67,11.4,.90,7.63,10.8,6.61",8,Sigmoid,3.4122646,5.588983536,-66.06144714,0.6001,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.7207974344968562,3.134531021118164
1937,2734,AU565,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-10,-8.6,-20,11.7,4.29,6.62,-34","3.50,9.80,12.0,3.12,3.10,6.14,21.9,19.0",8,Sigmoid,7.183713436,8.0,-33.47408676,0.7979,AU565_BREAST,AU565,ACH-000248,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1302809715270996
1938,2735,B-CPAP,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,-8.3,4.94,-1.1,6.31,-2.1,-2.8,-43","3.75,3.46,1.22,2.64,6.50,.55,.70,1.68",8,Sigmoid,6.728606701,8.0,-42.6247406,0.6353,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0238380432128906
1939,2736,BDCM,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,8.75,9.10,10.8,14.7,23.8,7.76,3.29","2.06,12.2,11.5,5.93,5.67,2.87,5.95,.28",8,Constant,,8.0,8.856801033,0.0,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.688051700592041
1940,2737,BFTC-909,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,1.54,-6.2,-2.9,-4.7,7.12,6.19,-42","5.58,10.6,1.53,19.5,9.95,11.1,8.20,11.4",8,Sigmoid,6.747807026,8.0,-41.24777222,0.4398,BFTC909_KIDNEY,BFTC909,ACH-000792,Kidney Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9553756713867188
1941,2738,BL-41,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,-5.5,-7.5,-6.2,-4.6,-.89,1.44,-83","1.80,6.53,1.73,10.7,6.41,9.44,9.49,3.02",8,Sigmoid,8.108772013,6.840538502,-82.45742035,0.8768,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.9228664568981173,2.6516456604003906
1942,2739,BL-70,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.13,.64,2.98,6.25,5.93,12.2,-5.8,-93","4.97,3.64,21.9,7.56,17.2,14.8,14.4,.53",8,Sigmoid,3.913347483,4.058927536,-92.50401306,0.9159,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.4009187850243277,2.6529440879821777
1943,2740,BT-20,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,14.4,-9.7,17.3,-38,34.1,2.38,-16","15.1,14.7,3.74,9.04,11.7,24.3,11.4,25.2",8,Constant,,8.0,2.514498949,0.5166,BT20_BREAST,BT20,ACH-000536,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.2376325130462646
1944,2741,BT-474,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,1.41,-9.2,2.49,-.23,5.94,3.58,-19","10.2,2.48,21.6,.19,24.7,5.78,21.1,3.77",8,Constant,,8.0,0.928014755,0.2296,BT474_BREAST,BT474,ACH-000927,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.4737391471862793
1945,2742,BT-549,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","9.98,-2.0,6.81,-5.0,9.29,-6.4,7.66,-58","17.0,24.6,3.12,5.03,17.5,6.20,18.1,16.8",8,Sigmoid,7.813856125,7.568719387,-57.92537689,0.533,BT549_BREAST,BT549,ACH-000288,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.024023883653778,3.091127872467041
1946,2743,BxPC-3,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-5.2,.87,1.28,18.6,12.3,-7.5,-20","17.3,30.8,28.7,26.2,14.2,1.22,9.21,3.53",8,Constant,,8.0,-2.98536396,0.5536,BXPC3_PANCREAS,BXPC3,ACH-000535,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0147039890289307
1947,2744,C2BBe1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.54,-17,18.1,-14,29.1,-3.8,19.7,-51","3.24,5.42,3.64,19.2,9.65,4.17,29.2,2.57",8,Linear,,8.0,-47.84600067,0.7279,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.2083234786987305
1948,2745,C32,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.05,-8.5,15.7,6.52,-3.4,-12,7.19,-36","35.3,3.79,19.6,24.6,23.3,11.6,4.37,6.94",8,Constant,,8.0,-5.05491066,0.261,C32_SKIN,C32,ACH-000580,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.852069854736328
1949,2746,CAL-12T,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-5.2,-12,-.054,16.8,11.2,-18,-84","6.79,7.03,.95,5.22,2.88,5.93,2.81,3.46",8,Sigmoid,3.288858891,3.533518076,-84.1787262,1.1889,CAL12T_LUNG,CAL12T,ACH-000826,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.2622939967434417,3.0716707706451416
1950,2747,CAL 27,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-12,-2.0,1.15,3.07,4.98,-5.4,-64","12.2,9.01,3.83,.30,.72,10.4,2.81,3.17",8,Sigmoid,4.046081066,5.077645302,-64.07157898,0.5558,CAL27_UPPER_AERODIGESTIVE_TRACT,CAL27,ACH-000832,Head and Neck Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.6248476309019442,2.9501285552978516
1951,2748,CAL-85-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,20.3,-2.0,16.0,11.6,20.2,-3.5,-37",".41,20.1,7.97,.018,16.0,18.6,20.5,2.03",8,Sigmoid,3.091454029,8.0,-37.43328094,0.2923,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.962498664855957
1952,2749,Calu-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.30,11.0,8.05,-2.2,5.51,19.5,9.27,-15","0,9.09,5.41,12.5,5.50,10.3,9.74,9.18",8,Sigmoid,8.979390777,8.0,-14.82332611,0.08662,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.373065710067749
1953,2750,Calu-3,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.73,1.73,5.73,-8.0,11.2,8.40,1.03,-42","7.87,9.98,33.3,7.29,25.7,15.0,11.3,14.1",8,Sigmoid,6.664190769,8.0,-41.74385834,0.4668,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.2120397090911865
1954,2751,Calu-6,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,5.68,-12,9.64,5.41,7.70,-20,-61","7.66,11.2,23.5,6.34,15.4,4.50,17.7,12.9",8,Sigmoid,2.921099663,3.92736125,-61.23783112,0.7092,CALU6_LUNG,CALU6,ACH-000264,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.36796776270692,2.9308362007141113
1955,2752,CAMA-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","8.44,-9.9,.058,-2.3,14.3,-1.1,.54,-24","23.6,3.92,2.40,3.79,4.63,6.66,5.91,9.31",8,Constant,,8.0,-2.473095179,0.1829,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9605495929718018
1956,2753,Capan-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-3.2,-4.5,9.44,8.68,14.1,-20,-86","17.6,11.7,28.1,5.06,21.3,17.7,29.4,7.83",8,Linear,,0.214682548,-81.04138184,1.1095,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-1.5385948629159198,3.2953109741210938
1957,2754,CAS-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,8.76,-12,-11,-.25,-4.2,.031,-44","3.56,16.2,18.6,2.65,2.90,7.79,.98,3.21",8,Sigmoid,6.968060493,8.0,-43.54838181,0.6175,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1511175632476807
1958,2755,CCK-81,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.04,36.4,27.8,1.14,3.14,-.34,20.3,-18","27.4,46.3,22.5,34.2,24.5,36.0,18.8,33.3",8,Constant,,8.0,10.2729187,0.3273,CCK81_LARGE_INTESTINE,CCK81,ACH-000963,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0445446968078613
1959,2756,CHP-212,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.51,13.1,-22,-.35,39.5,13.9,-24,-64","16.1,13.7,16.9,2.27,20.5,16.6,4.24,.32",8,Sigmoid,2.660742998,3.521866798,-63.87480927,1.0766,CHP212_AUTONOMIC_GANGLIA,CHP212,ACH-000120,Neuroblastoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.2589911893701777,2.9404592514038086
1960,2757,CI-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","29.8,-27,73.3,10.4,-6.4,-8.6,32.9,-64","13.0,13.9,14.1,43.2,.58,12.8,36.6,3.51",8,Constant,,8.0,-2.998246431,0.8737,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.41241192817688
1961,2758,COLO-320,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.98,-3.6,-.31,-11,-4.7,-9.9,-8.0,-72","6.76,2.57,.46,3.26,5.65,5.55,9.86,1.28",8,Sigmoid,8.444743951,6.692833424,-72.18118286,0.7197,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.901037315716755,2.6995348930358887
1962,2759,COLO-678,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,-1.5,8.11,8.59,12.7,3.80,1.75,-33",".12,14.0,11.2,10.9,19.3,27.7,6.07,16.8",8,Sigmoid,5.25410223,8.0,-33.06335068,0.4238,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.3750052452087402
1963,2760,COLO-679,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,-2.2,-3.3,9.50,8.43,-6.6,3.08,-40","6.06,10.5,30.0,7.66,1.77,8.67,4.21,3.99",8,Sigmoid,8.221240947,8.0,-39.61114883,0.4152,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.949068069458008
1964,2761,COLO 741,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,7.24,-14,-13,13.0,8.02,-8.7,-11","12.1,5.77,1.97,9.66,9.31,1.10,3.95,.32",8,Constant,,8.0,-6.519843578,0.5903,COLO741_SKIN,COLO741,ACH-000582,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9458093643188477
1965,2762,COR-L105,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,3.99,-9.0,8.68,-11,19.7,11.6,5.96","18.4,12.2,26.4,8.80,8.25,38.3,11.6,22.5",8,Constant,,8.0,3.342544079,0.2549,CORL105_LUNG,CORL105,ACH-000161,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1513681411743164
1966,2763,COR-L23,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.3,2.84,-.67,3.15,.70,.22,-1.9,-43","2.66,4.91,3.08,1.82,5.07,2.69,3.80,28.3",8,Sigmoid,7.093375,8.0,-23.5051403,0.3596,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9262378215789795
1967,2764,COV318,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,.53,-4.0,-3.6,.28,8.79,-7.6,-25","3.68,6.56,11.2,1.87,.30,5.79,3.85,11.7",8,Sigmoid,3.182703733,8.0,-24.82761574,0.4279,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.193024158477783
1968,2765,COV504,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.73,4.68,-6.9,13.7,11.6,10.7,-3.1,-46","8.37,10.1,23.5,.10,2.98,28.8,5.74,4.32",8,Sigmoid,3.283787727,8.0,-45.77088928,0.2841,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1826651096343994
1969,2766,Daoy,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-9.4,-3.2,-4.3,6.21,1.46,-1.4,-33","15.6,21.5,14.2,20.6,12.3,18.5,29.7,8.42",8,Constant,,8.0,-6.416000843,0.2733,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.7444286346435547
1970,2767,DBTRG-05MG,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,2.35,-11,.045,.013,1.37,-3.1,-39","1.65,6.47,12.0,7.22,21.0,6.61,8.60,6.69",8,Sigmoid,4.480661869,8.0,-38.71605301,0.468,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0066699981689453
1971,2768,Detroit 562,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,3.99,2.11,-3.8,18.0,.93,3.23,-12","9.76,3.35,11.1,5.04,1.00,2.46,23.5,27.8",8,Constant,,8.0,2.162948847,0.1087,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.018810749053955
1972,2769,DK-MG,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,4.02,4.45,6.55,-7.1,-20,-32,-38","5.56,9.23,6.40,4.81,.036,5.83,11.6,1.55",8,Sigmoid,0.664803326,8.0,-37.8029747,0.7844,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0028340816497803
1973,2770,DMS 114,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-19,-20,-23,-16,-33,-25,-60","5.58,0,9.94,0,8.79,0,24.6,18.9",8,Sigmoid,5.794850826,6.143882275,-59.36783218,2.1489,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.8154568346917452,3.4595861434936523
1974,2771,DOHH-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,-32,26.7,3.11,-11,53.2,-23,-63","5.90,13.2,13.9,49.7,36.2,61.1,27.9,6.08",8,Constant,,8.0,-6.025298119,1.8184,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8977510929107666
1975,2772,DV-90,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","28.5,-5.6,14.5,34.6,19.1,-1.5,-5.0,2.74","11.1,19.9,1.88,5.96,30.2,30.6,8.43,32.0",8,Constant,,8.0,14.50169373,0.1697,DV90_LUNG,DV90,ACH-000925,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8914027214050293
1976,2773,EB1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-1.7,13.8,-20,37.6,4.43,21.9,-17","1.88,2.94,44.8,12.7,36.2,14.7,32.4,14.1",8,Constant,,8.0,-3.043238878,0.3304,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.467576503753662
1977,2774,EBC-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-9.8,-38,-77,-86,-85,-90,-92","9.65,24.0,4.19,10.6,.16,2.95,1.44,1.60",8,Sigmoid,0.045940842,0.039122928,-90.11182404,4.497,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-3.2410465899906225,3.099240779876709
1978,2775,EFE-184,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","19.0,-.72,11.6,-4.5,16.3,11.4,23.6,-30","2.65,7.50,3.72,10.5,3.43,14.3,14.3,22.9",8,Sigmoid,7.064960003,8.0,-29.19213104,0.2181,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1406893730163574
1979,2776,EFM-19,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","11.3,-6.1,-2.2,6.08,2.12,-11,-6.8,-53","3.21,4.38,6.99,2.28,14.3,5.50,2.45,2.25",8,Sigmoid,8.332003744,7.653485775,-52.97006226,0.6233,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0351612009211255,3.167888879776001
1980,2777,EFO-21,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,10.9,-8.4,4.40,1.44,16.7,1.40,-29","2.06,1.23,5.02,4.83,3.36,6.78,5.54,8.20",8,Sigmoid,5.451784134,8.0,-28.70408058,0.3743,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.104127883911133
1981,2778,EFO-27,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.29,-1.1,1.10,-1.2,7.37,5.73,6.35,-29",".24,1.07,3.39,9.16,.32,1.36,4.77,7.65",8,Sigmoid,8.024758138,8.0,-28.89403343,0.1799,EFO27_OVARY,EFO27,ACH-000936,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.846011161804199
1982,2779,EM-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-9.0,-2.3,-4.6,-12,-52,-87,-95","3.65,1.46,2.57,3.27,.85,4.37,.23,.015",8,Sigmoid,0.77206701,0.769372761,-94.54164886,3.0185,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-0.2621796922019997,2.6925950050354004
1983,2780,EN,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.96,-6.7,12.1,4.28,1.42,1.68,-6.3,-45","5.60,4.31,12.3,13.4,13.5,16.1,5.22,3.48",8,Sigmoid,8.423842674,8.0,-45.08930206,0.4521,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.827857255935669
1984,2781,ES-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,-3.4,-5.5,1.22,.94,7.36,-1.5,-28","7.38,6.53,6.47,3.24,2.86,3.15,2.42,10.3",8,Sigmoid,5.398576736,8.0,-27.6743927,0.3971,ES2_OVARY,ES2,ACH-000906,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0267200469970703
1985,2782,ESS-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,-7.2,-23,-19,10.3,-1.9,-8.9,-44","8.48,2.45,.47,22.1,4.20,7.07,2.29,20.0",8,Sigmoid,7.870743752,8.0,-44.19592285,1.3171,ESS1_ENDOMETRIUM,ESS1,ACH-000913,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8401286602020264
1986,2783,F-36P,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,.059,9.85,-1.6,15.0,6.26,-24,-92","14.1,11.5,2.01,6.76,12.1,1.70,.27,1.55",8,Sigmoid,2.99402523,3.150969982,-92.1806488,1.3331,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.147710336230236,2.674088954925537
1987,2784,FaDu,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-9.9,2.23,3.59,12.5,12.9,11.2,-34","9.09,13.5,13.9,7.41,9.40,13.8,17.1,.46",8,Sigmoid,6.833144665,8.0,-33.49047089,0.4794,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.979626178741455
1988,2785,FU97,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-2.1,-15,1.47,21.9,13.2,5.06,-26","1.04,1.50,15.1,7.52,3.80,8.41,1.14,7.75",8,Linear,,8.0,-25.2825985,0.2194,FU97_STOMACH,FU97,ACH-000633,Gastric Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.781747817993164
1989,2786,FU-OV-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.16,-18,2.27,4.07,19.9,3.87,17.0,-50","2.26,19.7,1.66,4.11,2.03,7.57,20.3,1.16",8,Sigmoid,7.542516708,8.0,-49.55350113,0.2888,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.824599266052246
1990,2787,G-361,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.7,7.00,8.40,.24,11.3,4.63,1.24,-78","5.60,7.92,13.5,7.17,11.9,1.58,18.9,4.38",8,Sigmoid,3.751197577,4.238430023,-77.89280701,0.7552,G361_SKIN,G361,ACH-000572,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.4441929230798514,2.8139376640319824
1991,2788,G-401,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,-7.2,-8.3,-4.3,4.86,-9.5,-3.5,-71","8.76,8.17,1.12,1.91,.76,6.81,2.24,3.82",8,Sigmoid,8.332430113,7.282438755,-71.18704987,1.1658,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.9854657999293746,2.6279284954071045
1992,2789,G-402,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-11,-4.0,.60,12.8,8.54,2.83,-61","10.4,11.9,16.5,.59,15.5,12.2,1.53,1.90",8,Sigmoid,6.327002525,7.053857803,-60.54808426,0.6586,G402_SOFT_TISSUE,G402,ACH-000375,Kidney Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.9535746732608055,2.808363437652588
1993,2790,GAMG,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-1.8,2.82,.15,-6.6,9.59,-7.3,7.20","8.32,15.3,11.8,22.6,14.5,23.4,21.2,11.4",8,Constant,,8.0,-2.714423895,0.07498,GAMG_CENTRAL_NERVOUS_SYSTEM,GAMG,ACH-000098,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0920119285583496
1994,2791,GB-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,16.1,-1.7,-1.3,17.2,26.2,-.84,-71","23.4,16.7,11.9,20.0,15.0,11.0,1.25,11.7",8,Sigmoid,3.723583698,4.514036179,-71.02153015,0.7245,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.5071916932059368,3.049098491668701
1995,2792,GCT,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,-3.9,-.75,9.77,-5.3,-6.7,-28,-70","3.90,10.2,6.84,11.7,6.51,15.4,13.5,5.07",8,Sigmoid,4.695664406,4.691992283,-69.83203888,1.1702,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.5458572860754691,2.9899940490722656
1996,2793,GI-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,-3.6,-19,-17,6.33,-.50,-24,-30","8.15,6.79,10.0,6.58,11.2,9.23,1.69,.77",8,Sigmoid,2.141913652,8.0,-30.25037193,1.0878,GI1_CENTRAL_NERVOUS_SYSTEM,GI1,ACH-000756,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.713912010192871
1997,2794,GMS-10,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.3,-5.0,5.14,-1.2,5.23,9.42,-9.8,-28","9.47,8.56,20.7,4.98,12.9,2.64,21.2,5.55",8,Sigmoid,2.858497143,8.0,-28.25354576,0.2727,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.7535603046417236
1998,2795,GRANTA-519,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.52,26.0,-.90,49.2,.87,15.4,-20,-54","17.3,8.69,10.5,33.8,13.0,10.7,14.7,12.9",8,Sigmoid,2.573021412,4.31927681,-54.40834808,0.9777,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.4630879831496297,2.7451486587524414
1999,2796,H4,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,-.91,-11,-3.0,3.99,-11,-31,-87","3.78,1.28,3.92,.97,7.29,3.98,2.71,1.71",8,Sigmoid,8.00827674,4.049647808,-87.25021362,1.5929,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.3986299163494675,3.1497721672058105
2000,2797,HARA,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-2.4,-7.6,-2.7,14.1,6.61,.13,-21","4.47,29.4,7.50,19.4,6.16,5.78,.034,6.90",8,Constant,,8.0,0.131114855,0.1488,HARA_LUNG,HARA,ACH-000843,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8988847732543945
2001,2798,HCC1187,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,-3.2,7.20,-1.1,9.04,16.0,6.11,-2.9","15.0,10.5,20.2,27.6,3.77,24.5,15.0,7.40",8,Constant,,8.0,2.024313927,0.05411,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0904150009155273
2002,2799,HCC1395,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","12.8,9.97,-14,-21,11.6,13.1,6.26,-12","7.42,7.51,2.15,16.5,21.0,11.6,8.95,1.53",8,Constant,,8.0,2.633744001,0.2731,HCC1395_BREAST,HCC1395,ACH-000699,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.931748151779175
2003,2800,HCC-15,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,4.68,5.08,15.5,11.1,14.0,-4.2,-48",".041,7.24,11.2,8.96,1.67,6.31,2.93,5.57",8,Sigmoid,3.256439209,8.0,-47.91797638,0.6549,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.191701889038086
2004,2801,HCC1569,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.0,4.07,-1.1,-2.0,16.4,2.58,11.2,-14","13.8,3.32,6.60,3.32,4.58,10.9,4.88,7.46",8,Constant,,8.0,1.054563522,0.03085,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1395297050476074
2005,2802,HCC1806,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-12,-.82,5.13,-5.7,1.83,-13,-57","10.7,17.8,6.93,6.36,6.96,16.0,11.1,2.51",8,Sigmoid,3.431067467,4.892572403,-57.15589523,1.0815,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.5877182189522265,3.0561232566833496
2006,2803,HCC1954,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-9.8,-6.9,-3.1,10.0,11.5,9.55,-48","20.8,.79,8.78,3.02,24.7,17.8,3.69,1.08",8,Sigmoid,8.072483433,8.0,-47.67789459,0.493,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1514315605163574
2007,2804,HCC2935,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.0,-8.9,-4.8,10.2,-13,-4.8,4.64,-13","7.92,13.9,6.65,27.3,12.8,19.2,3.63,9.06",8,Constant,,8.0,-5.850376129,0.01164,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1201751232147217
2008,2805,HCC4006,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,1.13,-8.2,-11,6.11,-6.8,-9.6,-33","11.8,10.1,5.44,6.04,1.95,15.9,4.85,11.4",8,Sigmoid,6.305928707,8.0,-32.69241333,0.531,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.125762462615967
2009,2806,HCC-44,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,-3.2,-5.2,-3.9,12.6,13.1,16.2,-6.3","5.10,4.89,6.93,8.10,8.33,2.43,5.60,.45",8,Linear,,8.0,-6.003590107,0.2043,HCC44_LUNG,HCC44,ACH-000667,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0903615951538086
2010,2807,HCC-56,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-3.3,-2.0,-5.5,-12,4.70,12.7,.95","15.3,.45,1.10,3.83,15.7,6.03,.83,8.98",8,Linear,,8.0,-12.80161285,0.2215,HCC56_LARGE_INTESTINE,HCC56,ACH-000467,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.753401279449463
2011,2808,HCC70,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,-6.6,2.04,-7.6,-.40,14.4,8.73,-38","4.87,7.77,12.5,4.90,11.8,11.8,8.62,7.41",8,Sigmoid,7.041330814,8.0,-42.2978363,0.2158,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9825146198272705
2012,2809,HCC-78,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.37,-5.7,1.33,-9.4,9.07,-14,-18,-38","1.04,9.16,14.2,4.59,8.19,.42,.41,3.47",8,Sigmoid,8.544915984,8.0,-38.29430389,0.5792,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1602721214294434
2013,2810,HCC827,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,13.8,-9.4,-19,5.05,7.58,6.41,8.47","42.3,8.55,17.0,5.66,3.68,60.0,11.3,20.9",8,Constant,,8.0,2.278413057,0.3058,HCC827_LUNG,HCC827,ACH-000012,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.083299160003662
2014,2811,HCT 116,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,.49,-2.4,4.66,2.75,2.66,4.61,-62","15.7,5.62,4.97,11.5,12.9,9.35,25.2,15.6",8,Sigmoid,6.490972996,7.049741268,-61.73587418,0.678,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.9529909165762633,2.7823150157928467
2015,2812,HCT-15,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.48,.15,-1.5,7.74,7.44,9.83,19.1,-38","1.58,4.50,7.07,2.21,8.06,.87,7.53,7.54",8,Sigmoid,7.953935146,8.0,-37.53209686,0.3213,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.063570976257324
2016,2813,HD-MY-Z,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,-17,1.73,-1.1,10.8,1.74,-12,-65","6.36,10.5,10.2,8.08,3.28,1.78,2.60,9.99",8,Sigmoid,3.424543858,4.283397675,-65.21063995,0.8361,HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HDMYZ,ACH-000190,Unknown,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.4547465439610772,2.7426772117614746
2017,2814,HDQ-P1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","19.0,17.5,5.30,10.2,.088,13.7,-2.2,-42","43.4,5.51,6.48,18.1,4.48,12.4,46.6,26.0",8,Linear,,8.0,-42.92635345,1.0024,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0027503967285156
2018,2815,HEC-151,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-3.4,-9.1,16.1,-6.1,2.81,-4.3,-34",".97,11.8,11.3,6.70,1.59,7.90,10.2,12.3",8,Linear,,8.0,-34.26011658,0.5081,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.6426079273223877
2019,2816,HEC-1-A,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.6,3.38,7.03,7.25,15.8,1.96,-6.0,-29","7.93,9.71,32.1,13.8,20.5,23.1,5.18,12.6",8,Sigmoid,3.50427556,8.0,-29.09866333,0.2774,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.903449535369873
2020,2817,HEC-1-B,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","25.4,-.73,22.3,11.8,33.4,-1.9,.013,-73",".34,38.5,7.97,18.3,43.4,35.7,6.36,5.61",8,Sigmoid,3.861989975,5.00846529,-72.82436371,0.7286,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.6111295388270395,2.891572952270508
2021,2818,HEC-251,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,-3.2,5.41,10.7,-2.4,16.2,14.0,-14","11.8,2.50,20.1,7.84,8.64,.49,10.2,16.0",8,Constant,,8.0,1.876295686,0.03693,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.083050489425659
2022,2819,HEC-265,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-17,-9.6,-8.2,-7.2,-7.7,-8.8,-24","8.65,2.72,18.5,2.86,17.8,3.07,17.6,12.1",8,Constant,,8.0,-12.60801029,0.7284,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.883514642715454
2023,2820,HEC-59,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.0,-8.0,2.54,2.78,1.18,-6.1,-21,-60","1.53,4.99,2.32,11.7,8.24,3.63,15.0,.92",8,Sigmoid,4.639713764,5.813066483,-60.48382568,0.6056,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.760108225605472,2.8469061851501465
2024,2821,HEC-6,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.61,-2.3,50.7,-15,29.8,37.4,32.1,-28","60.4,15.8,2.68,7.22,22.0,35.9,11.2,2.36",8,Constant,,8.0,14.29713917,0.7721,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0849475860595703
2025,2822,HEL 92.1.7,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,3.68,-1.6,8.18,6.39,16.1,-1.4,2.52",".58,5.83,.77,7.81,1.56,12.9,.68,4.19",8,Constant,,8.0,1.385745883,0.1365,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.523428440093994
2026,2823,Hep 3B2.1-7,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,25.2,-14,1.43,15.1,-2.3,-12,-52","19.9,23.3,14.8,.87,5.65,12.9,1.94,3.80",8,Sigmoid,5.654317379,7.646904469,-51.61151886,0.6479,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.034300921372573,3.117003917694092
2027,2824,Hep G2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,14.5,-9.3,-5.1,2.73,8.58,-22,-42","15.2,5.64,12.3,2.77,10.6,5.51,.045,4.72",8,Sigmoid,2.482724905,8.0,-42.36892319,0.744,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.159865140914917
2028,2825,Hey-A8,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,.30,4.18,1.46,4.70,-7.9,-24,-67","4.28,6.74,.12,9.65,2.39,3.29,1.00,8.74",8,Sigmoid,7.476478577,5.352530003,-66.51213074,0.7314,HEYA8_OVARY,HEYA8,ACH-000542,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.6775693468840194,2.9302093982696533
2029,2826,HGC-27,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,-1.8,-5.4,-.99,4.10,5.67,-25,-78","2.26,3.23,2.96,1.79,1.70,.76,1.39,1.41",8,Sigmoid,2.975087881,3.306939602,-78.34346008,1.0484,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.196023170149776,2.760984182357788
2030,2827,HH,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,33.5,11.2,28.6,-1.6,62.6,30.7,-45","16.8,21.9,5.94,5.25,26.1,12.0,20.4,9.50",8,Linear,,8.0,-47.19251633,0.8985,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.6111912727355957
2031,2828,HLF,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,13.3,-2.8,.90,13.8,3.88,3.30,-44","2.30,3.08,2.56,8.92,2.79,2.77,8.87,3.05",8,Sigmoid,8.039900682,8.0,-44.36872482,0.4126,HLF_LIVER,HLF,ACH-000393,Liver Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8733720779418945
2032,2829,HMC-1-8,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,-1.1,-7.8,-3.1,6.16,-2.7,-5.9,-58","1.54,6.26,.31,11.1,4.05,1.06,3.97,5.27",8,Sigmoid,4.688372135,6.201820374,-57.74960709,0.5299,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.8248428576661213,2.752223014831543
2033,2830,HMCB,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.65,-1.0,5.83,-2.8,8.29,-2.9,-4.1,-50","2.06,9.27,8.77,3.62,1.75,5.14,4.38,9.72",8,Sigmoid,7.446203709,7.987290382,-50.09194183,0.4672,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.077851576104207,2.680788993835449
2034,2831,HOS,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.69,-18,7.72,-.84,2.40,-11,-2.8,-35","22.3,29.5,19.8,8.56,4.05,14.3,13.1,15.0",8,Constant,,8.0,-3.535703897,0.7702,HOS_BONE,HOS,ACH-000613,Bone Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8516581058502197
2035,2832,HPAC,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-8.1,4.62,-.51,-19,-14,-40,-89","15.7,13.7,21.7,32.4,24.8,8.13,12.4,.90",8,Sigmoid,3.982466698,3.218382359,-89.19903564,1.77,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.1688788603433655,3.0978035926818848
2036,2833,HPAF-II,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.22,-9.4,-18,-3.9,-13,3.33,-14,-47","17.3,60.9,15.4,11.8,33.6,31.6,19.0,6.80",8,Constant,,8.0,-11.07758999,1.0399,HPAFII_PANCREAS,HPAFII,ACH-000094,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.333160877227783
2037,2834,Hs 294T,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,2.68,1.93,11.0,-4.7,1.57,-29,-48","9.32,10.4,3.77,8.16,18.9,8.50,4.41,2.30",8,Sigmoid,2.314946651,8.0,-48.25266266,0.5367,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.154083728790283
2038,2835,Hs 578T,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.60,-7.7,2.23,-.84,13.3,6.64,-3.3,-37","1.61,4.06,8.32,14.0,5.62,3.88,2.03,2.84",8,Sigmoid,3.193168879,8.0,-36.873909,0.4021,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1579842567443848
2039,2836,Hs 683,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,1.78,1.05,-8.0,-.10,-13,-15,-64","2.94,.83,2.51,1.85,11.7,9.08,3.49,9.15",8,Sigmoid,9.19212729,6.06753397,-69.91603088,1.0135,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.8029522572844467,2.8035104274749756
2040,2837,Hs 695T,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,-2.2,8.68,4.09,19.9,.57,3.22,-36","7.58,2.50,6.96,6.85,2.92,10.6,6.24,4.34",8,Sigmoid,8.035823047,8.0,-36.30971909,0.4068,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.243006944656372
2041,2838,Hs 729,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,-5.0,9.60,2.63,10.9,3.41,-7.8,-35","4.27,.030,8.19,7.87,3.33,15.0,14.3,15.0",8,Sigmoid,3.080497026,8.0,-35.19602203,0.7401,HS729_SOFT_TISSUE,HS729,ACH-000133,Unknown,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.997650623321533
2042,2839,Hs 746T,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.45,-25,-38,-54,-50,-52,-50,-72","6.59,4.04,6.79,9.80,1.01,.16,2.90,.36",8,Sigmoid,0.002542614,0.102542482,-58.98493576,3.4785,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-2.277478107731304,3.1561942100524902
2043,2840,Hs 766T,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-12,6.69,-2.3,6.01,-13,11.5,-48","14.6,14.1,9.78,18.7,7.93,.43,22.2,6.83",8,Sigmoid,8.156571552,8.0,-47.94231033,0.846,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.923612117767334
2044,2841,Hs 852.T,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-5.6,4.58,-2.0,-4.9,-3.9,-22,-72","2.47,5.00,17.2,6.65,17.4,7.92,4.16,3.18",8,Sigmoid,3.197003365,3.662902594,-71.71567535,0.9536,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.2982558915785156,3.04004168510437
2045,2842,Hs 936.T,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-12,-.33,-1.4,11.0,4.27,7.22,-23","7.35,9.00,4.01,.83,14.5,9.42,4.22,12.2",8,Sigmoid,7.194019794,8.0,-22.2961216,0.2561,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.221041202545166
2046,2843,Hs 939.T,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-9.5,-5.7,11.3,1.30,3.47,-4.5,-11","9.78,1.36,22.9,22.9,.80,21.5,16.9,11.2",8,Constant,,8.0,-3.878570318,0.1208,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0389063358306885
2047,2844,Hs 944.T,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.2,-9.1,2.49,-4.3,13.3,2.74,-13,-54","6.60,2.18,15.1,4.99,3.63,2.18,2.61,.64",8,Sigmoid,3.289626837,5.190103054,-54.39297485,0.71,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.6467535532427067,2.8683905601501465
2048,2845,HSC-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-1.3,2.23,-.67,.95,-2.0,-3.6,1.31","2.20,2.87,1.74,.76,1.69,5.86,1.36,3.85",8,Constant,,8.0,-0.679305255,0.03532,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.995588779449463
2049,2846,HT,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","10.4,6.72,-10,-16,9.00,-3.4,-32,-65","45.9,15.5,2.62,16.1,21.3,8.07,24.0,6.17",8,Sigmoid,2.655036926,3.295681238,-64.55118561,1.4918,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.1926128955984956,2.8268043994903564
2050,2847,HT-1080,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-3.7,-4.8,-3.5,1.81,-.56,-20,-73","8.45,4.60,9.12,1.19,7.78,.23,7.66,.45",8,Sigmoid,3.162342548,3.643709183,-72.7780838,0.8244,HT1080_SOFT_TISSUE,HT1080,ACH-000054,Sarcoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.2930021691328257,2.612779378890991
2051,2848,HT-1197,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.3,2.88,-2.6,-3.8,-6.2,9.00,6.95,-34","4.30,14.1,13.1,16.3,17.2,10.1,10.6,7.54",8,Sigmoid,6.850502491,8.0,-33.68331528,0.2529,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1902642250061035
2052,2849,HT-144,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,1.55,-.98,8.64,-.76,6.74,-1.4,-46",".74,2.81,6.99,13.5,7.86,3.54,11.3,3.12",8,Sigmoid,4.756692886,8.0,-46.18562698,0.6186,HT144_SKIN,HT144,ACH-000322,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9874019622802734
2053,2850,HuCCT1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,-2.5,-3.4,1.02,.71,-3.1,-6.3,-38","5.65,5.76,2.28,4.24,2.90,8.34,12.7,10.9",8,Sigmoid,8.201625337,8.0,-37.34894943,0.544,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.993757963180542
2054,2851,huH-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","25.4,9.19,6.66,-11,4.97,7.03,-15,-58","14.9,1.94,29.3,.71,15.8,17.7,19.6,5.73",8,Linear,,3.696080329,-57.91281509,0.4129,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.3072728875800534,2.9384818077087402
2055,2852,HUP-T3,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-20,6.71,-6.1,5.96,2.31,-2.4,-30","6.45,2.98,.84,.064,15.1,11.7,11.2,1.28",8,Sigmoid,8.176331446,8.0,-30.30729675,0.391,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.3500003814697266
2056,2853,HuT 78,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-37,8.49,-18,7.75,7.95,-10,-44,-89","13.3,.86,4.46,31.8,22.0,48.4,28.5,.074",8,Linear,,0.022862312,-89.20127106,1.9154,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-3.77826548837168,2.875028133392334
2057,2854,IA-LM,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,13.1,-18,11.8,-5.0,23.4,-4.2,7.06","4.78,12.2,8.24,1.63,9.72,.27,23.0,25.0",8,Constant,,8.0,3.236784697,0.5516,IALM_LUNG,IALM,ACH-000672,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0470499992370605
2058,2855,IGR-37,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-3.3,-8.2,4.28,8.27,19.0,-14,-43",".54,3.76,17.3,25.5,4.08,28.0,1.65,4.85",8,Sigmoid,3.10767889,8.0,-43.24489594,1.0685,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.824995517730713
2059,2856,IGR-39,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-41,18.0,1.76,-41,2.16,4.15,-20,-53","54.9,16.7,14.5,62.6,1.54,.0037,3.92,4.92",8,Constant,,8.0,-1.747066975,0.6601,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.993865966796875
2060,2857,IGROV1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,-5.5,-.40,1.50,-1.4,-.69,-.11,-11",".36,5.47,7.32,4.48,3.01,1.82,3.48,.49",8,Constant,,8.0,-2.164679766,0.1002,IGROV1_OVARY,IGROV1,ACH-000966,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0338010787963867
2061,2858,IMR-32,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,-21,-7.2,3.24,4.20,6.63,-40,-79","15.8,2.19,2.45,23.3,6.40,31.8,10.3,2.51",8,Sigmoid,2.617765665,2.821169615,-78.9778595,1.4072,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.0371515560542732,2.831834554672241
2062,2859,IPC-298,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.26,7.07,-1.9,5.56,-.88,-.72,6.78,-20",".35,3.22,7.14,12.5,1.60,4.21,7.24,4.13",8,Sigmoid,8.361158585,8.0,-19.84279633,0.1298,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.037238597869873
2063,2860,IST-MES2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.3,-3.6,-17,9.33,-6.1,19.1,-18,-60","14.8,1.43,15.7,2.42,13.7,11.5,16.8,1.42",8,Sigmoid,3.065595865,4.166898727,-60.0294342,0.8679,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.4271720485692658,2.9466614723205566
2064,2861,J82,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.3,-10,1.71,-2.5,7.80,5.27,-3.2,-23","3.72,4.61,9.57,12.0,6.87,5.55,17.0,8.72",8,Sigmoid,3.820840597,8.0,-23.43244934,0.2938,J82_URINARY_TRACT,J82,ACH-000396,Bladder Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1774299144744873
2065,2862,JHH-4,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.53,-11,.32,-13,20.8,-4.1,-7.0,-26","3.65,12.4,12.4,26.5,5.33,6.37,3.78,12.1",8,Constant,,8.0,-3.702389002,0.4427,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9583921432495117
2066,2863,JHOS-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.67,-2.5,-6.9,-7.4,14.2,32.5,-1.9,-25","4.75,11.1,18.0,6.16,5.60,43.6,13.5,14.8",8,Constant,,8.0,1.453456521,0.3298,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1918044090270996
2067,2864,JHUEM-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-6.6,-9.8,-18,2.51,9.99,-8.1,-80","21.6,11.1,8.50,12.3,8.24,15.6,.73,.038",8,Sigmoid,5.011953831,5.191458702,-80.12369537,1.1936,JHUEM2_ENDOMETRIUM,JHUEM2,ACH-000909,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.6470147178034091,2.776301622390747
2068,2865,JM1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","7.55,4.08,8.03,-12,5.88,10.1,-1.9,11.9","16.8,42.8,6.16,5.70,13.2,6.86,4.72,1.54",8,Constant,,8.0,4.700473785,0.0,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.7215232849121094
2069,2866,JMSU-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.73,-.58,6.04,.41,4.95,-5.0,-8.4,-76","10.9,1.66,4.06,3.73,2.18,2.16,4.82,3.56",8,Sigmoid,8.183458091,6.045948505,-76.2970047,0.7331,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.7993883791195393,3.1750707626342773
2070,2867,JURKAT,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.65,-7.2,11.0,15.0,-3.5,-19,-65,-80","8.16,9.34,14.0,5.21,3.70,1.54,5.22,4.27",8,Sigmoid,1.302514911,1.686938763,-79.93680573,2.0558,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.522915503557039,2.6330413818359375
2071,2868,JVM-3,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.53,-5.9,15.0,-9.5,9.39,8.15,-4.0,-74",".71,3.90,35.5,9.27,17.4,1.64,36.2,2.83",8,Sigmoid,4.426972389,4.957866192,-74.41036987,1.5846,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.6009754449470734,2.9534807205200195
2072,2869,K029AX,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".22,-5.5,.35,21.2,-1.4,4.09,2.91,-56","3.04,7.42,5.69,33.6,4.62,12.3,3.13,2.77",8,Sigmoid,7.823853016,7.655366898,-55.78430939,0.5345,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0354069571576834,2.918668746948242
2073,2870,KALS-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".17,-4.9,-13,9.63,-7.0,2.11,-.21,-40","24.6,.56,21.0,12.6,8.81,19.6,24.0,4.83",8,Constant,,8.0,-4.899491787,0.7377,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.7706432342529297
2074,2871,KARPAS-422,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","11.0,2.82,11.5,-8.0,10.9,11.9,-5.4,-45","8.31,19.7,10.3,2.41,12.2,5.72,4.51,4.19",8,Sigmoid,3.177840948,8.0,-45.05065918,0.719,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.755453109741211
2075,2872,KASUMI-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","15.6,13.4,15.4,4.29,6.40,14.4,-1.8,-71","2.96,.96,5.29,8.24,7.00,28.5,16.5,3.26",8,Sigmoid,3.540664196,4.335896492,-70.75379944,0.7177,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.466928392081192,2.6837430000305176
2076,2873,KCL-22,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.42,-16,-7.3,-2.0,-2.7,-37,-77,-94","11.2,.55,2.92,1.74,2.34,13.0,8.39,.57",8,Sigmoid,1.266806006,1.260782599,-93.80944061,2.7737,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.2317326384716667,2.7011189460754395
2077,2874,KG-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,8.59,-5.7,-17,19.3,18.7,-18,-61","22.9,22.5,13.2,15.8,7.26,16.6,.29,7.9e-4",8,Linear,,1.797705996,-60.86458969,1.0949,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.5865114054376475,2.70290470123291
2078,2875,KHM-1B,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","11.0,-5.1,-5.9,2.21,11.6,-8.2,-38,-92","12.4,.084,22.0,13.2,17.9,6.07,3.55,1.91",8,Sigmoid,4.224811077,3.265845537,-92.166008,1.9573,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.1835186991861422,2.861342430114746
2079,2876,KMBC-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,-.19,-.23,.86,2.59,3.35,-3.8,-12",".49,1.61,5.73,1.75,4.39,3.84,1.36,1.70",8,Constant,,8.0,-0.802696288,0.113,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1236624717712402
2080,2877,KMM-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","10.8,-6.7,11.8,-5.8,-6.2,-1.8,-23,-64","32.6,1.18,7.44,10.8,14.1,7.08,3.56,6.92",8,Sigmoid,2.93935442,3.714695215,-64.00512695,0.9584,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.3122966330813706,2.9715681076049805
2081,2878,KMRC-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-4.5,-4.0,4.78,9.79,6.71,3.45,-34","5.82,8.81,11.9,2.72,2.89,7.67,3.22,16.2",8,Sigmoid,8.01599692,8.0,-33.7388649,0.4754,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1216044425964355
2082,2879,KMRC-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,15.2,-29,3.00,10.2,18.1,-7.7,-43","2.59,14.5,9.13,5.63,11.6,7.55,3.42,8.53",8,Linear,,8.0,-43.89352036,0.9416,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.685159683227539
2083,2880,KMS-11,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,-.067,10.9,-.93,3.38,-.73,-15,-64","3.11,5.42,6.03,.11,8.94,6.22,11.3,20.5",8,Sigmoid,5.526027203,5.972376823,-63.33618927,1.1346,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.78714497597836,2.803675413131714
2084,2881,KMS-12-BM,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","14.6,-.022,30.9,25.0,25.8,28.5,-.21,-40","17.1,53.7,12.8,36.7,6.03,15.0,10.9,13.6",8,Sigmoid,2.749000788,8.0,-40.14466858,0.4616,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8450064659118652
2085,2882,KMS-34,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","10.2,-5.9,.86,12.5,-1.4,-19,-20,-79","15.0,.80,8.40,5.32,.41,4.22,4.69,2.78",8,Sigmoid,8.646239895,4.839499474,-77.4152832,1.6563,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.5768113009180862,2.7933335304260254
2086,2883,KNS-60,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.78,-6.5,4.24,3.80,15.6,14.6,9.33,-38",".57,0,13.1,3.01,7.03,1.76,16.1,.23",8,Sigmoid,7.315686703,8.0,-37.9018631,0.3137,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.069556474685669
2087,2884,KNS-62,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-17,2.79,11.0,-4.1,8.62,22.0,11.5","14.6,17.1,14.5,8.35,2.97,9.32,11.0,8.22",8,Linear,,8.0,-23.91731834,0.208,KNS62_LUNG,KNS62,ACH-000858,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.92205810546875
2088,2885,KNS-81,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.68,7.58,-3.1,11.3,-6.9,10.9,-.37,-38","1.91,3.94,1.26,1.75,18.5,2.46,2.81,3.79",8,Sigmoid,3.645155668,8.0,-38.20725632,0.3542,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0477590560913086
2089,2886,KO52,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.8,4.31,-6.6,-.35,-9.5,4.55,-54,-72","1.92,7.67,5.13,16.1,1.39,10.3,1.27,1.02",8,Sigmoid,2.062067747,2.383868933,-71.61036682,1.7782,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.868724769923314,2.8070905208587646
2090,2887,KP-N-SI9s,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,-1.3,20.4,7.38,-5.6,-31,-44,-82",".72,17.6,9.58,.19,.032,5.11,5.50,1.28",8,Sigmoid,3.268068552,2.556257248,-80.53712463,1.823,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.938544176208378,2.949481248855591
2091,2888,KU812,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-5.3,-7.2,23.5,-12,-15,-66,-97","17.1,7.75,13.3,9.65,14.8,15.1,5.68,.091",8,Sigmoid,2.000086546,1.890639901,-96.88757324,1.7159,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.6369153437266714,2.615400791168213
2092,2889,KYM-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,12.4,4.21,1.51,17.2,6.84,-18,-24","8.97,23.8,2.95,12.9,25.6,2.26,8.24,30.8",8,Constant,,8.0,-1.55258739,0.6022,KYM1_SOFT_TISSUE,KYM1,ACH-000607,Rhabdoid,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.6300179958343506
2093,2890,KYSE-140,PF2341066,c-MET,".025,.080,.25,.80,2.53,8","-12,3.25,15.6,.27,-5.1,-38","24.5,15.3,19.0,13.5,17.7,8.59",6,Linear,,8.0,-38.26655197,0.385,KYSE140_OESOPHAGUS,KYSE140,ACH-000823,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8877763748168945
2094,2891,KYSE-150,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.6,-3.9,-.99,-7.5,6.41,4.06,-4.8,-20","5.62,4.22,2.29,6.36,.042,5.31,2.20,.53",8,Constant,,8.0,-2.908234358,0.267,KYSE150_OESOPHAGUS,KYSE150,ACH-000855,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.155694007873535
2095,2892,KYSE-180,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-20,-57,-7.0,5.79,13.5,-9.0,-35","9.92,3.61,2.90,.28,13.9,1.05,17.6,9.06",8,Linear,,8.0,-38.2904129,1.0874,KYSE180_OESOPHAGUS,KYSE180,ACH-000693,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8799774646759033
2096,2893,KYSE-30,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-2.1,-1.5,-2.0,1.91,3.40,-9.0,-40","4.19,3.58,5.01,1.96,.028,4.83,4.37,8.70",8,Sigmoid,3.313858032,8.0,-39.89841843,0.5526,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.219635486602783
2097,2894,KYSE-510,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,-1.7,.87,-4.5,12.4,-1.5,2.09,-.20","4.91,.23,1.67,7.89,2.75,1.37,11.2,.90",8,Constant,,8.0,-0.437380135,0.1044,KYSE510_OESOPHAGUS,KYSE510,ACH-000824,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.086668014526367
2098,2895,KYSE-520,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","9.51,-3.3,3.64,-5.5,10.5,9.90,3.94,-27","4.65,3.33,18.6,9.59,1.58,7.47,1.69,3.79",8,Sigmoid,5.05964613,8.0,-27.20397568,0.2385,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.2992136478424072
2099,2896,KYSE-70,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.90,-2.4,-24,-7.4,7.02,5.75,-3.1,-41","4.78,8.09,2.91,16.3,8.08,8.23,3.08,6.41",8,Linear,,8.0,-40.3553772,0.6366,KYSE70_OESOPHAGUS,KYSE70,ACH-000784,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.817656993865967
2100,2897,L3.3,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".62,-2.6,.22,-.53,7.85,7.80,-3.4,-40","8.95,6.87,1.90,7.74,9.29,6.07,2.08,10.1",8,Sigmoid,3.4024868,8.0,-33.54974747,0.4875,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9777069091796875
2101,2898,L-363,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","17.7,7.15,3.90,7.71,-15,-38,-60,-92","3.22,2.63,7.77,4.67,5.97,.31,3.24,1.27",8,Sigmoid,3.185992956,1.53984499,-91.61986542,2.4015,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.43168175551524246,2.7774980068206787
2102,2899,L-428,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,-9.0,3.23,.28,-3.6,.46,-8.1,-37","0,12.3,5.11,7.79,2.55,11.0,7.93,2.63",8,Sigmoid,3.45660758,8.0,-36.80265045,0.7745,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.930402994155884
2103,2900,LCLC-103H,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,11.2,-.42,7.65,6.70,3.76,.44,-11","1.85,2.91,1.34,2.15,10.2,2.23,10.9,12.1",8,Constant,,8.0,1.372845411,0.06502,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.943545341491699
2104,2901,LN-229,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-3.3,-3.6,-11,1.11,-10,-3.2,-54","5.86,2.20,.66,6.55,7.29,.040,12.3,.31",8,Sigmoid,8.104030865,7.791688919,-53.75711823,0.8152,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0530576424170013,3.012798309326172
2105,2902,LOU-NH91,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,12.0,6.15,-9.6,7.97,10.2,-9.3,-34","12.4,6.85,5.51,6.46,7.20,18.3,8.82,9.25",8,Sigmoid,2.914171457,8.0,-34.45108795,0.6149,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0630674362182617
2106,2903,LOX IMVI,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,-2.9,.28,1.15,2.16,2.44,-10,-55","3.59,9.65,1.22,2.26,3.23,4.08,3.94,.22",8,Sigmoid,3.357966661,5.29121542,-54.51300049,0.6165,LOXIMVI_SKIN,LOXIMVI,ACH-000750,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.6660479775138997,2.898381233215332
2107,2904,LP-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,17.5,-28,-7.8,9.25,-20,-43,-72","18.2,32.2,19.9,26.2,1.25,7.91,32.8,4.46",8,Linear,,0.414755989,-71.64431,2.432,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-0.8800649099917285,2.800135612487793
2108,2905,LS123,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-2.7,-6.2,-2.8,-9.4,13.6,-.50,-37",".27,4.77,9.55,33.0,5.61,7.50,7.82,14.6",8,Sigmoid,7.708224773,8.0,-37.22569656,0.7037,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0116519927978516
2109,2906,LS411N,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,10.5,3.58,9.73,8.26,11.8,1.74,-28","8.78,13.6,14.1,5.72,19.1,9.75,8.63,4.97",8,Sigmoid,3.496265888,8.0,-27.50885773,0.3309,LS411N_LARGE_INTESTINE,LS411N,ACH-000985,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8365638256073
2110,2907,LS513,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","13.4,-6.8,-5.2,4.78,40.6,7.97,28.5,-72","4.16,8.60,32.1,7.48,14.4,5.99,7.59,2.84",8,Sigmoid,8.061217995,7.25318718,-71.83094025,0.6926,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.9814409833004454,3.145972728729248
2111,2908,LU99,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-1.6,8.08,16.2,-5.0,-13,-44,-81","4.93,1.53,6.43,2.64,16.7,1.70,10.2,4.22",8,Sigmoid,2.919942617,2.936535358,-81.16553497,1.2301,LU99_LUNG,LU99,ACH-000444,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.0772304367729217,2.7599267959594727
2112,2909,LUDLU-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","16.0,-.14,-15,3.90,-6.5,14.2,-9.2,-33","9.17,30.2,13.7,9.04,10.5,3.08,0,2.30",8,Sigmoid,8.745860557,8.0,-33.1395874,0.5817,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1478185653686523
2113,2910,Malme-3M,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,-.80,6.56,4.04,5.87,6.23,-5.4,-53","5.04,12.5,7.64,.79,1.15,.44,9.45,9.31",8,Sigmoid,3.564263582,5.954421997,-53.11109543,0.5432,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.784134136299653,2.9540514945983887
2114,2911,MCAS,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,3.04,2.95,3.32,-.45,5.56,-5.6,-65","2.44,2.47,3.91,5.04,2.78,1.42,3.84,8.82",8,Sigmoid,4.2533455,5.293410778,-57.55689621,0.612,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.6664627976483877,3.0702085494995117
2115,2912,MCF7,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,-12,10.0,-30,13.9,8.87,-13,-99","21.2,10.6,38.9,12.4,43.1,3.13,26.4,2.94",8,Linear,,0.122591665,-98.15213776,0.502,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-2.09889624310924,3.2621021270751953
2116,2913,MDA-MB-157,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,1.18,-12,3.95,4.29,3.31,-24,-22","7.93,8.60,15.0,1.05,.43,2.32,3.28,5.04",8,Sigmoid,1.41736269,8.0,-23.83189201,1.1257,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.85052490234375
2117,2914,MDA-MB-175-VII,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-.48,-17,-8.7,-8.7,-.49,-21,-23","9.20,2.05,13.0,12.8,.54,.89,2.71,2.10",8,Constant,,8.0,-12.66830826,0.6365,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.317760944366455
2118,2915,MDA-MB-415,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-8.3,-17,-8.8,4.99,22.8,5.21,-27","40.1,20.0,.58,13.5,9.80,22.3,15.3,1.24",8,Linear,,8.0,-27.44254684,0.652,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.209880828857422
2119,2916,MDA-MB-436,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,1.48,-4.9,-.93,3.77,4.19,10.8,-52","9.18,1.78,.22,1.63,13.5,3.50,11.2,1.74",8,Sigmoid,8.220542818,7.912307262,-51.96082306,0.8252,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0684194285006314,3.095766067504883
2120,2917,MDA-MB-453,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,10.2,11.5,5.04,22.2,6.12,-9.9,-43","14.6,2.01,7.74,1.70,19.2,10.5,10.7,.92",8,Sigmoid,3.406751156,8.0,-42.57759094,0.2967,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9808969497680664
2121,2918,MDA-MB-468,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-.55,-4.4,-23,13.9,6.11,-12,-54","6.54,10.4,5.98,8.11,11.2,1.81,5.97,3.54",8,Sigmoid,3.498851776,5.620063782,-53.52113342,1.0025,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.7263430129515194,2.9874560832977295
2122,2919,MEG-01,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,.57,-8.9,28.2,13.7,-13,-49,-96","7.59,3.41,12.1,2.49,17.3,9.63,3.37,.76",8,Sigmoid,3.063280582,2.577986002,-96.29101563,1.5732,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.9470084747117189,2.6293206214904785
2123,2920,MEL-HO,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,2.54,3.70,4.05,2.52,-3.9,5.00,-83","3.44,3.45,9.52,2.89,.54,.55,1.35,4.65",8,Sigmoid,8.502733815,7.153927326,-83.42351532,0.868,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.9676614822725078,2.790579080581665
2124,2921,MES-SA,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.17,.69,-2.4,2.66,.18,1.12,-23,-55",".59,5.03,2.99,.55,4.30,4.27,1.42,.26",8,Sigmoid,2.697656631,4.234330177,-55.10362244,0.6468,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.4432251519584671,2.9403908252716064
2125,2922,MeWo,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","12.1,-17,12.5,-3.1,16.8,21.6,9.81,-29","4.26,15.2,48.9,7.22,30.9,29.7,11.1,12.3",8,Constant,,8.0,1.750622153,0.3369,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.7658700942993164
2126,2923,MFE-296,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-20,-6.3,-9.9,16.2,9.58,5.31,-41","12.0,1.73,.96,2.97,3.93,8.52,5.40,2.12",8,Sigmoid,8.063348654,8.0,-41.31294632,0.5073,MFE296_ENDOMETRIUM,MFE296,ACH-000879,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8686089515686035
2127,2924,MG-63,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-8.7,4.65,-1.6,4.45,-5.0,-8.9,-75","5.58,2.25,2.03,.79,3.65,3.75,1.08,1.51",8,Sigmoid,5.794953346,5.650014877,-74.57769775,0.4803,MG63_BONE,MG63,ACH-000359,Bone Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.7316581782522282,2.8803176879882812
2128,2925,Mino,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,1.98,12.1,-14,12.2,-29,-2.5,-94","10.3,5.44,12.6,25.7,17.6,7.71,4.99,1.48",8,Linear,,0.041038326,-91.18928528,1.1621,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-3.1932488684252203,2.8785274028778076
2129,2926,MJ,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,20.5,-2.7,-12,20.9,27.6,-18,-75","7.83,22.0,26.0,14.2,7.32,35.4,5.05,11.4",8,Sigmoid,3.064124107,3.5432477,-75.39510345,0.9347,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.2650437359430977,2.572518825531006
2130,2927,MKN-45,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".79,-7.5,-24,-22,-87,-87,-89,-91","2.48,5.48,9.43,15.4,3.72,2.95,.35,.56",8,Sigmoid,0.110653877,0.113733932,-88.99807739,3.6422,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-2.173893488271664,3.1356818675994873
2131,2928,MKN7,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,19.2,-19,-4.4,21.5,14.8,21.5,12.5","38.7,22.3,38.9,.025,44.3,4.34,41.9,7.88",8,Constant,,8.0,7.199196815,0.5643,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1234591007232666
2132,2929,MKN74,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,10.8,-13,7.85,17.5,13.5,-.79,-2.5","1.57,7.58,8.77,.79,15.8,10.8,22.3,6.16",8,Constant,,8.0,5.982923031,0.0,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.932826519012451
2133,2930,MOLP-8,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","16.1,17.4,6.47,7.18,10.2,-2.1,-45,-60","16.0,14.1,17.0,35.3,10.5,40.7,5.03,3.77",8,Sigmoid,1.020376801,2.97330308,-59.14450836,1.1504,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.0896734829841515,2.8310155868530273
2134,2931,MOLT-16,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.31,5.20,14.2,.96,11.5,-17,-16,-80","6.11,29.2,10.5,6.31,1.84,24.3,9.83,2.56",8,Sigmoid,8.555460709,5.079283714,-79.21022034,1.8084,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.625170250467687,2.3146886825561523
2135,2932,MONO-MAC-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","12.6,6.11,3.66,7.52,2.61,-12,-47,-93","14.5,20.6,22.6,21.2,33.2,17.6,10.0,.57",8,Linear,,0.304343224,-92.87674713,2.741,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-1.189599188131019,2.7546780109405518
2136,2933,MOR/CPR,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.25,-13,10.5,-8.2,18.8,-4.5,-12,-19","15.6,25.9,21.9,2.36,1.13,19.4,4.19,16.9",8,Constant,,8.0,-6.866481781,0.1384,MORCPR_LUNG,MORCPR,ACH-000851,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9069061279296875
2137,2934,MSTO-211H,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-.58,-12,-.95,-6.5,8.52,-16,-62","10.1,6.30,4.77,3.21,11.2,12.1,15.9,6.79",8,Sigmoid,3.277687311,4.273801327,-61.8866272,0.8487,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.4525036717266915,3.0176711082458496
2138,2935,NCI-H1048,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,10.5,4.08,12.0,-1.6,8.76,-9.7,-69","8.50,19.0,47.5,13.4,.98,7.74,19.2,2.59",8,Sigmoid,3.371703386,4.13476181,-68.70104218,0.7133,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.4194297234307842,3.017449378967285
2139,2936,NCI-H1092,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".091,-2.9,11.5,-16,20.0,-7.6,-3.5,-43","7.77,.42,5.91,3.00,.59,2.77,14.7,3.76",8,Sigmoid,8.997163292,8.0,-42.76324463,0.286,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.2588846683502197
2140,2937,NCI-H1155,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,-12,4.33,.85,7.33,5.82,-49,-61","23.8,2.62,3.07,24.1,9.81,33.8,5.32,18.0",8,Sigmoid,1.92050457,2.580640793,-61.40977478,1.1355,NCIH1155_LUNG,NCIH1155,ACH-000980,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.9480377374748028,2.883786678314209
2141,2938,NCI-H1184,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","41.4,-19,-15,16.8,45.5,17.5,69.8,-3.0","70.8,2.04,34.1,61.8,33.7,61.8,40.6,35.0",8,Constant,,8.0,14.04006767,0.3619,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.26225209236145
2142,2939,NCI-H1341,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","21.5,-42,12.3,-15,27.2,-11,-32,-72","30.5,11.4,9.66,15.3,19.7,7.30,35.2,6.81",8,Linear,,1.201020106,-70.98342896,1.3442,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.1831712840068425,2.826447010040283
2143,2940,NCI-H1373,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-3.3,1.61,6.49,.59,10.0,-9.0,-37","2.96,10.7,5.43,6.13,8.87,5.06,11.3,11.5",8,Sigmoid,3.106575251,8.0,-36.83575439,0.3264,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.361743211746216
2144,2941,NCI-H1568,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,3.68,-8.2,-4.9,9.15,8.99,-9.0,-47","7.03,3.29,1.35,.026,1.56,.23,6.31,5.49",8,Sigmoid,3.410626411,8.0,-46.64033127,1.035,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.168701648712158
2145,2942,NCI-H1648,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,-12,9.43,-13,27.0,29.6,-3.1,-16",".21,20.7,42.9,7.98,16.1,4.45,5.17,11.2",8,Constant,,8.0,-4.360602379,0.673,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.97145938873291
2146,2943,NCI-H1650,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,-3.3,-4.8,-4.8,10.1,2.67,1.79,-31","1.14,13.6,5.18,4.93,6.76,4.05,8.59,2.57",8,Sigmoid,7.789039135,8.0,-30.55078125,0.4561,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.220829963684082
2147,2944,NCI-H1651,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,.018,-16,3.47,1.03,11.2,-11,-26","15.7,2.60,1.57,9.97,8.24,9.03,10.4,15.4",8,Sigmoid,2.796470404,8.0,-25.56374359,0.7751,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.305418014526367
2148,2945,NCI-H1792,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,-4.8,.19,-.13,11.1,8.43,-4.7,-60","4.14,1.07,5.95,.76,7.78,2.56,.37,5.44",8,Sigmoid,4.05943203,5.448011875,-59.62341309,0.7983,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.6952507485438078,3.180633544921875
2149,2946,NCI-H1793,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,2.28,-16,2.86,7.13,18.3,20.9,7.90",".42,16.8,13.4,6.02,10.8,33.9,2.53,35.4",8,Constant,,8.0,-0.610506773,0.04633,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.220046043395996
2150,2947,NCI-H1915,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,.80,10.0,22.3,20.5,10.5,10.7,-34","14.8,12.5,16.6,21.3,6.81,22.0,16.7,8.19",8,Sigmoid,6.740181446,8.0,-34.22609329,0.2831,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.088916301727295
2151,2948,NCI-H1944,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,-7.6,-3.8,-3.7,4.79,.50,12.2,-5.4","5.49,40.3,6.82,23.5,21.7,1.23,.080,4.06",8,Constant,,8.0,0.206219435,0.0,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0621697902679443
2152,2949,NCI-H1975,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,-9.0,4.38,-5.7,8.98,8.21,1.43,-30","7.58,4.95,9.27,.55,4.58,2.16,5.22,4.07",8,Sigmoid,7.211946964,8.0,-29.9696846,0.2606,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.223564624786377
2153,2950,NCI-H2009,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,-.99,2.41,-4.9,6.85,-1.9,-4.3,-45","8.45,3.50,8.13,4.33,3.95,.081,26.4,3.75",8,Sigmoid,7.201756954,8.0,-44.68572235,0.5123,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0799312591552734
2154,2951,NCI-H2023,PF2341066,c-MET,".0080,.025,.080,.25,.80,2.53,8","-25,.99,-6.9,-12,-21,-33,-79",".60,29.3,9.52,31.5,13.3,12.9,3.22",7,Sigmoid,8.21310934,4.380047321,-79.02116394,1.1931,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.4770595282112717,3.2021350860595703
2155,2952,NCI-H2030,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".49,1.97,-2.0,-1.8,.41,-5.5,-.97,-44","5.41,12.3,1.96,4.85,1.87,2.87,.039,6.65",8,Sigmoid,8.16472145,8.0,-43.43138504,0.4445,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.142350673675537
2156,2953,NCI-H2052,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,8.46,-4.7,-4.1,-6.7,-8.8,-12,-54","3.00,21.9,12.7,11.9,1.43,10.8,7.49,17.3",8,Sigmoid,8.436960985,7.581053734,-54.03620911,1.2299,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.025652205032163,3.3508386611938477
2157,2954,NCI-H2085,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".61,10.6,3.06,-6.9,-12,17.1,-18,-54","7.91,3.94,5.81,12.7,10.8,20.4,10.2,5.26",8,Sigmoid,2.905940771,4.665399551,-54.43396759,0.7718,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.540173479291906,3.2552599906921387
2158,2955,NCI-H2087,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,-7.3,-6.6,.060,11.2,14.2,5.81,-23","9.78,5.06,11.3,2.43,2.94,9.05,10.7,1.82",8,Sigmoid,6.681921005,8.0,-22.88606834,0.423,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.278294086456299
2159,2956,NCI-H211,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.04,10.8,.19,-3.2,1.55,19.5,8.46,-56","2.13,2.50,6.48,6.76,11.9,15.0,24.7,3.13",8,Sigmoid,3.09671855,4.108612537,-62.64735794,0.6209,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.4130853892759894,2.9121952056884766
2160,2957,NCI-H2122,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","8.36,1.32,16.6,-.34,-3.2,17.4,-8.9,-74","10.0,13.2,11.6,16.0,2.31,8.30,9.23,14.9",8,Sigmoid,3.372685909,3.988648415,-73.49909973,0.618,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.3834524304075964,2.838959217071533
2161,2958,NCI-H2170,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-3.6,5.14,6.23,-7.5,28.5,-11,-36","11.5,10.4,.78,14.3,21.3,18.5,4.23,8.84",8,Sigmoid,2.893176794,8.0,-36.30861282,0.5128,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.129761219024658
2162,2959,NCI-H2172,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-48,31.6,-28,18.1,-20,-4.2,-61","11.2,29.1,1.70,5.60,22.1,8.95,16.1,6.35",8,Constant,,8.0,-22.93396568,0.4162,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.2229347229003906
2163,2960,NCI-H2228,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.68,-.81,2.91,-6.6,-26,-50,-55,-82","1.78,1.03,6.26,11.0,.88,11.0,.74,.78",8,Sigmoid,6.795890808,1.600181341,-80.70623016,1.8879,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.47011696094845556,2.991338014602661
2164,2961,NCI-H2286,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-8.3,.56,-11,-17,-20,-26,-68","7.28,.092,5.52,.76,4.63,5.34,18.9,4.44",8,Sigmoid,8.747717451,5.16068697,-66.60840607,2.2926,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.6410697043528943,3.013058662414551
2165,2962,NCI-H23,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,-18,-16,-15,7.04,-5.4,-8.8,-32","2.91,8.08,4.11,24.0,2.27,25.0,4.34,7.26",8,Linear,,8.0,-31.63952446,1.136,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.040891170501709
2166,2963,NCI-H2444,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.09,-15,5.66,-8.2,19.1,13.4,1.54,-14","3.05,3.02,3.57,22.2,1.09,3.58,6.65,4.13",8,Linear,,8.0,-13.65617466,0.2978,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.072274684906006
2167,2964,NCI-H2452,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,1.79,14.0,-6.0,25.5,12.3,.16,-40","8.27,25.5,19.2,8.57,23.5,2.53,1.93,4.55",8,Sigmoid,3.874549389,8.0,-40.16337967,0.4166,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.156546115875244
2168,2965,NCI-H28,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-8.9,2.91,-8.1,2.10,5.02,-4.6,-44","4.17,2.85,20.2,12.9,.92,12.6,2.09,6.51",8,Sigmoid,6.657987595,8.0,-43.53467941,0.5851,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.012514352798462
2169,2966,NCI-H322,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,2.77,-9.0,-6.8,4.07,6.42,3.79,-29","7.69,9.84,3.70,7.82,3.10,5.22,9.01,8.29",8,Sigmoid,6.651379585,8.0,-28.55127716,0.1449,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1388278007507324
2170,2967,NCI-H3255,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,4.87,1.58,-.15,5.79,4.98,-29,-93",".98,9.26,9.36,5.18,1.19,.40,3.63,.81",8,Sigmoid,2.930515051,3.03383708,-93.23575592,1.2008,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.1098281813962143,3.147554874420166
2171,2968,NCI-H358,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.7,-2.7,-2.6,.99,6.49,-.41,-12,-45","5.87,4.92,5.03,2.02,9.54,3.60,2.53,1.08",8,Sigmoid,3.178440571,8.0,-45.45305252,0.8719,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.258028507232666
2172,2969,NCI-H441,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,12.9,-8.4,11.7,.89,4.48,-10,-38","5.36,5.43,1.96,5.96,1.85,5.72,8.25,2.61",8,Sigmoid,2.980494976,8.0,-38.18614197,0.455,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.016195058822632
2173,2970,NCI-H460,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.93,-.82,1.26,1.27,7.48,4.59,-3.8,-30","3.99,8.58,8.19,.77,13.1,6.05,5.30,1.84",8,Sigmoid,3.580091476,8.0,-29.77647209,0.3076,NCIH460_LUNG,NCIH460,ACH-000463,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.944538116455078
2174,2971,NCI-H522,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,-12,-15,4.13,1.55,.33,-.066,-9.1","5.35,5.97,2.61,17.2,27.2,24.7,5.73,9.01",8,Constant,,8.0,-7.526723862,0.5612,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.2082674503326416
2175,2972,NCI-H647,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,-.11,2.78,8.41,30.7,21.4,13.6,-10","8.16,2.57,29.1,13.7,41.5,.029,39.8,2.27",8,Constant,,8.0,1.56761384,0.0,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0042848587036133
2176,2973,NCI-H650,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,-8.6,2.04,3.95,2.25,5.36,2.99,-47","4.40,3.94,2.28,6.90,3.82,12.2,6.90,2.44",8,Sigmoid,6.352861881,8.0,-47.19881058,0.389,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9810214042663574
2177,2974,NCI-H661,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.79,4.65,2.29,2.15,7.82,-5.7,-20,-50","7.24,7.28,3.37,8.55,1.46,13.6,39.5,68.3",8,Constant,,8.0,4.319573402,0.7048,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.958514451980591
2178,2975,NCI-H727,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,-21,10.1,6.06,25.6,12.5,-24,-61","23.4,9.62,41.8,20.2,22.5,13.4,35.3,56.5",8,Linear,,8.0,-25.56332016,1.1206,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.3958115577697754
2179,2976,NCI-H747,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-10.0,10.0,-6.8,3.35,12.9,-9.7,-53","15.8,2.47,14.9,5.07,8.56,16.7,12.8,3.02",8,Sigmoid,3.680954933,6.117981911,-52.6845932,0.7988,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.8112322890391495,3.18505859375
2180,2977,NCI-H810,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,1.48,-7.7,-2.6,19.3,14.9,-21,-41","5.74,22.4,10.9,13.3,14.8,7.48,2.23,2.74",8,Sigmoid,2.328727484,8.0,-40.40819168,0.7947,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0724456310272217
2181,2978,NCI-N87,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,.84,-11,1.73,11.3,39.5,10.0,44.0","15.2,12.4,10.7,.81,1.89,3.14,8.22,34.1",8,Linear,,8.0,-13.49652004,0.5961,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0257515907287598
2182,2979,NCO2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".11,-3.1,3.92,-9.4,-18,-60,-90,-95","8.23,9.53,14.2,15.0,6.79,1.12,3.21,.35",8,Sigmoid,0.605434954,0.624113679,-95.46297455,2.9461,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-0.4714227493204696,2.573916435241699
2183,2980,NIH:OVCAR-3,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,2.05,-8.3,36.2,32.0,26.1,14.9,-40","6.13,44.7,14.5,24.3,25.9,15.5,31.7,16.0",8,Linear,,8.0,-39.24805069,0.5743,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9569356441497803
2184,2981,NUGC-3,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-19,-9.6,2.42,12.9,24.5,12.8,-46","8.52,8.90,5.67,7.53,21.9,16.9,28.9,14.4",8,Sigmoid,8.049669563,8.0,-45.67330551,0.4736,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.005162477493286
2185,2982,NUGC-4,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.17,-5.3,-35,-49,-42,-29,-20,-37","5.64,16.2,11.0,3.53,12.4,5.40,1.15,8.35",8,Sigmoid,0.009952967,8.0,-35.11814117,1.7116,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.4104981422424316
2186,2983,OCI-AML2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,-2.8,-.90,.11,-1.1,1.29,-11,-91",".27,.90,4.36,3.12,3.42,7.71,2.20,1.02",8,Sigmoid,3.926297426,4.002520084,-91.21260834,1.0041,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.3869241837399784,2.4417829513549805
2187,2984,OCI-AML5,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-4.8,2.51,8.76,2.73,-.30,-18,-88","3.59,7.23,8.59,4.12,3.20,12.4,15.1,1.13",8,Sigmoid,3.921534777,4.026138783,-87.63771057,1.3689,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.3928077983075187,2.460205078125
2188,2985,OCUM-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,-3.5,10.4,19.1,-8.9,2.51,-20,-61",".57,14.4,11.2,41.1,8.31,3.95,1.62,5.02",8,Sigmoid,3.03826642,4.016563416,-61.25592041,0.9729,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.3904266653779949,3.1249547004699707
2189,2986,OE21,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-4.8,-27,.64,29.9,-9.1,-17,-77","8.07,9.00,13.1,26.4,24.0,3.25,1.63,4.19",8,Sigmoid,8.003170222,5.682656765,-77.00423431,1.1686,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.7374188636935584,2.882711410522461
2190,2987,OE33,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".22,6.57,-31,-41,-45,-40,-41,-77","10.7,.15,17.1,4.31,10.7,3.50,1.87,.67",8,Sigmoid,0.002542614,0.894824922,-63.32264709,2.6605,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-0.11112719772004917,3.284485340118408
2191,2988,ONCO-DG-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-9.4,.94,-14,14.8,11.0,11.9,-18","20.5,5.98,16.9,12.7,7.13,13.2,.54,2.35",8,Constant,,8.0,-1.56811583,0.4426,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.045358657836914
2192,2989,ONS-76,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.82,1.87,10.5,9.26,1.14,-1.3,-6.8,-25","2.24,1.22,.35,.17,2.59,.15,3.00,2.42",8,Sigmoid,8.278985246,8.0,-24.71254158,0.2558,ONS76_CENTRAL_NERVOUS_SYSTEM,ONS76,ACH-000776,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.133246898651123
2193,2990,OPM-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,16.8,10.7,4.00,4.08,8.81,-9.1,-28",".93,10.9,17.0,37.4,.64,.41,5.29,17.0",8,Sigmoid,2.658649206,8.0,-28.45093155,0.2972,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.805662155151367
2194,2991,OV-90,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-.19,16.1,4.63,7.96,4.58,-14,-42","10.7,8.03,8.43,11.7,30.7,.047,31.6,.34",8,Sigmoid,2.82113862,8.0,-41.93790817,0.5705,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9345974922180176
2195,2992,OVCAR-4,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,5.32,-9.3,6.64,4.66,9.62,8.30,-15","5.74,7.73,3.26,8.21,5.26,16.0,8.87,12.7",8,Constant,,8.0,0.660795569,0.1563,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1027307510375977
2196,2993,OVCAR-8,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-4.4,-7.3,-7.0,5.89,-10,5.51,-58","2.81,1.08,8.34,8.02,14.0,10.2,2.90,6.52",8,Sigmoid,8.123874048,7.620050907,-57.53038406,1.0091,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0307830503849007,3.216442108154297
2197,2994,OVMANA,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","10.1,-8.2,-8.5,-17,21.4,.84,-6.2,-40","6.88,9.42,7.27,13.8,4.35,2.72,2.01,12.2",8,Sigmoid,8.517121472,8.0,-39.44495392,0.8049,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.638057231903076
2198,2995,OVSAHO,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,1.47,1.96,5.23,3.92,20.6,22.8,-8.3","2.42,2.09,21.7,15.8,5.51,10.5,0,4.63",8,Constant,,8.0,0.245752648,0.0,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.229489326477051
2199,2996,OVTOKO,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,3.76,1.90,8.32,3.11,7.33,12.2,-34","5.20,6.63,0,3.39,6.82,5.33,.76,2.53",8,Sigmoid,8.454329931,8.0,-34.09719849,0.3415,OVTOKO_OVARY,OVTOKO,ACH-000663,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.014050245285034
2200,2997,P12-ICHIKAWA,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","7.25,-4.0,6.09,17.5,8.25,-.26,.069,-93","7.34,2.57,1.45,16.4,2.54,.64,2.22,.24",8,Sigmoid,8.339177821,6.147752762,-92.68525696,1.0946,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.8160866104890698,2.4326412677764893
2201,2998,P31/FUJ,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.72,-8.4,-12,1.98,5.48,-10,-45,-45","12.9,23.2,16.8,10.5,.066,15.1,17.8,1.60",8,Sigmoid,1.043500543,8.0,-45.16644287,1.3834,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8526196479797363
2202,2999,P3HR-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.3,8.13,-1.9,18.1,7.49,2.41,-17,-4.3","2.39,5.02,20.5,2.04,1.11,23.0,11.3,7.56",8,Constant,,8.0,2.774287939,0.05595,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.940584659576416
2203,3000,Panc 02.03,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,1.47,-6.0,.85,-1.4,-5.0,-19,-72","15.9,6.19,4.88,2.19,13.9,2.11,23.4,3.10",8,Sigmoid,8.114266616,5.510635376,-72.14713287,0.8964,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.7066799297654003,3.085297107696533
2204,3001,Panc 03.27,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","11.9,-2.8,33.0,16.0,.75,-3.7,-21,-71","30.6,20.8,0,22.6,7.92,29.1,13.1,7.03",8,Linear,,1.011073122,-71.0120697,0.8512,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.011012263832401257,3.08205509185791
2205,3002,Panc 04.03,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.93,-10.0,-6.2,.27,17.1,-14,-13,-78","5.41,3.47,2.63,11.3,13.6,24.5,22.0,2.70",8,Sigmoid,5.114589214,5.029359341,-77.73828888,0.5411,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.6152926084052737,3.410719394683838
2206,3003,Panc 10.05,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,14.5,-31,-.31,-12,6.46,-4.1,-53","5.00,3.57,4.25,3.38,8.14,4.31,5.83,4.53",8,Linear,,3.306294305,-53.25232697,0.975,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.1958280169127602,3.240762948989868
2207,3004,PA-TU-8902,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,-3.1,-1.6,-5.7,4.62,4.47,-3.9,-25","7.66,7.19,7.32,8.06,1.88,.22,5.02,9.00",8,Sigmoid,3.76573348,8.0,-25.03500366,0.4002,PATU8902_PANCREAS,PATU8902,ACH-000599,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9206185340881348
2208,3005,PC-3,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-5.0,2.56,-6.6,17.0,10.9,-9.9,-43","2.28,5.52,3.91,7.19,12.1,9.77,2.62,9.30",8,Sigmoid,3.233734369,8.0,-43.46360397,0.1819,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.2154505252838135
2209,3006,Pfeiffer,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.30,19.1,36.1,34.8,1.19,-21,-24,-82","18.5,23.1,5.63,22.7,2.92,.95,17.5,2.57",8,Linear,,0.359736037,-81.11950684,1.1214,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-1.0223847470325345,2.308887481689453
2210,3007,PK-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".99,-9.0,-1.1,-1.5,7.49,5.71,3.74,-28","11.2,4.90,10.6,2.70,3.36,.063,3.96,.87",8,Sigmoid,6.662193298,8.0,-27.78801727,0.4587,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.290435791015625
2211,3008,PK-45H,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.77,-1.3,2.04,-8.5,5.53,3.99,-9.3,-47","9.89,10.7,5.74,1.86,8.07,11.0,10.7,8.35",8,Sigmoid,3.481613636,8.0,-47.44083786,0.5456,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.2148165702819824
2212,3009,PK-59,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.40,-2.1,-.63,-2.2,3.51,-2.6,-8.9,-56","1.77,3.97,.30,2.69,4.61,1.08,1.77,3.68",8,Sigmoid,4.270066261,6.398169518,-55.92527771,0.494,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.856011936643661,3.208893060684204
2213,3010,PLC/PRF/5,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,11.0,13.8,3.31,4.83,14.7,-19,-61","9.61,9.04,15.3,2.50,12.1,22.1,19.9,2.30",8,Sigmoid,2.834149361,3.865649462,-61.41925049,0.9598,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.3521297046627678,2.76204776763916
2214,3011,PSN1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,1.24,-.16,5.73,7.14,11.1,-1.4,-13","3.04,9.33,2.55,4.91,3.21,4.21,.91,10.2",8,Constant,,8.0,0.398864329,0.04047,PSN1_PANCREAS,PSN1,ACH-000320,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9443821907043457
2215,3012,QGP-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.72,-12,9.12,.90,21.5,40.8,-23,-10","0,0,0,0,0,0,0,0",8,Constant,,8.0,0.089034237,0.3333,QGP1_PANCREAS,QGP1,ACH-000347,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.129868507385254
2216,3013,Raji,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-2.0,-4.6,-10,15.0,7.43,10.0,.81","34.5,19.0,13.9,5.50,10.0,17.9,9.98,25.4",8,Constant,,8.0,4.035437107,0.02249,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.6767444610595703
2217,3014,RD,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".82,4.60,-9.5,6.38,1.43,7.32,-4.7,-70","9.04,7.66,14.2,8.83,1.70,11.8,2.65,3.79",8,Sigmoid,3.931115866,4.678461552,-70.02484131,0.7359,RD_SOFT_TISSUE,RD,ACH-000169,Sarcoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.5429693276814667,3.1367759704589844
2218,3015,Reh,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.27,-4.5,-3.2,-5.2,-.27,6.67,7.17,-90",".89,8.54,.47,2.22,2.95,.90,.16,.94",8,Sigmoid,8.034313393,6.671482563,-90.13220978,0.8942,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.8978421085418227,2.3229730129241943
2219,3016,RERF-GC-1B,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.6,.98,10.2,-11,21.3,9.12,15.9,-19","10.4,4.87,12.0,12.9,17.4,6.02,20.3,17.0",8,Constant,,8.0,2.305997133,0.3046,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.230800151824951
2220,3017,RERF-LC-AI,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.92,5.19,-13,.75,8.10,9.27,5.31,-40","3.41,6.07,5.78,2.39,5.08,5.93,.14,1.27",8,Sigmoid,7.651296139,8.0,-39.7565918,0.498,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0737123489379883
2221,3018,RERF-LC-MS,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-15,-.23,.038,-16,2.03,-13,-7.5","5.91,5.54,4.64,23.0,10.5,9.14,8.32,10.2",8,Constant,,8.0,-7.997804642,0.005164,RERFLCMS_LUNG,RERFLCMS,ACH-000062,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8502447605133057
2222,3019,RKO,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,-8.5,2.25,-1.1,3.43,-7.1,-17,-72","1.46,13.7,1.64,2.04,.56,3.52,10.8,1.81",8,Sigmoid,7.265216351,5.508096218,-72.2121048,0.9374,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.7062190494865255,2.925199270248413
2223,3020,RL95-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-4.3,-.63,4.59,2.34,20.1,-25,-47","1.91,3.55,22.4,7.20,18.6,4.75,7.18,8.39",8,Sigmoid,2.433660269,4.404100418,-52.34443665,0.8308,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.482536020144533,3.150639533996582
2224,3021,RPMI-7951,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,-14,7.47,15.2,24.6,20.2,-17,-56","28.9,12.3,7.46,4.50,8.42,4.32,10.6,5.58",8,Sigmoid,2.637480736,4.252909184,-55.65018845,0.9346,RPMI7951_SKIN,RPMI7951,ACH-000348,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.4476032626459077,3.1537208557128906
2225,3022,RPMI-8402,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","13.9,.23,3.39,15.2,9.10,.070,-15,-86","1.73,6.43,1.18,8.99,3.74,.87,3.94,.96",8,Sigmoid,8.55267863,5.304725647,-85.52311707,1.1405,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.6685980548002621,2.3865365982055664
2226,3023,RT-112,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,-6.3,-5.3,-22,12.3,-9.7,-8.3,-88","1.44,9.46,8.04,5.64,9.45,18.3,3.50,8.31",8,Sigmoid,6.196685314,5.654008865,-88.17384338,1.2498,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.7323648271866887,2.9586193561553955
2227,3024,RT4,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","22.2,24.9,6.71,-6.2,6.48,12.4,-11,-58","6.80,16.8,46.3,13.6,31.0,17.3,29.1,14.5",8,Linear,,3.469062955,-58.36126709,0.8884,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.2438845157041756,2.997096061706543
2228,3025,RVH-421,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-4.0,1.92,-4.8,5.04,-3.8,1.20,-14","10.1,10.5,4.10,4.13,.58,.15,3.33,11.7",8,Constant,,8.0,-1.55593133,0.3367,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0057716369628906
2229,3026,SBC-5,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-6.7,-9.3,-6.0,-25,-24,-67,-78","9.40,8.15,12.6,11.6,7.53,8.66,10.3,1.99",8,Sigmoid,1.421183348,1.574698687,-78.98426056,0.8519,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.45406394413426454,2.8223958015441895
2230,3027,SCaBER,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-44,-4.5,3.11,5.68,9.35,9.31,-14,-56","72.0,11.6,.40,7.05,5.84,7.38,16.0,1.95",8,Sigmoid,2.947669744,4.556394577,-55.89589691,0.3951,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.5165316478488988,3.2546491622924805
2231,3028,SCC-9,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,-6.7,1.12,19.7,25.8,13.4,21.8,-48",".71,2.39,32.8,12.0,6.39,10.2,3.16,16.8",8,Linear,,8.0,-46.79970169,0.4683,SCC9_UPPER_AERODIGESTIVE_TRACT,SCC9,ACH-000181,Head and Neck Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8029346466064453
2232,3029,SF126,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.55,-4.6,5.14,-3.6,7.55,1.73,1.19,-48","6.33,5.06,15.3,2.92,3.58,.51,4.56,1.09",8,Sigmoid,7.557165146,8.0,-48.33667374,0.4382,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.976592540740967
2233,3030,SF-295,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-8.6,-13,-5.9,4.37,-17,-33,-65","11.5,.11,9.29,9.27,4.09,9.61,.66,2.93",8,Sigmoid,3.636106253,4.456161499,-65.05189514,0.8342,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.4942877450113077,2.8757143020629883
2234,3031,SH-10-TC,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,6.70,-18,6.80,2.89,10.4,.29,-18","6.66,7.51,11.2,4.09,5.01,5.94,9.91,3.02",8,Constant,,8.0,0.619700074,0.2376,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.036255359649658
2235,3032,SHP-77,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,21.4,18.0,-10,-2.1,-9.5,-6.0,47.9","12.6,0,27.7,0,7.92,0,19.3,0",8,Linear,,8.0,-20.15229607,0.604,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.950869083404541
2236,3033,SIG-M5,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","17.9,-4.8,21.1,14.4,7.35,-22,-45,-94","2.75,33.1,21.7,17.4,5.34,31.1,.63,1.09",8,Sigmoid,3.501132965,2.855001211,-94.06009674,1.9859,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.0490722672760096,2.3570876121520996
2237,3034,SIMA,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","36.3,8.74,-16,-9.9,1.01,25.3,22.8,-41","4.61,1.24,13.5,6.68,3.34,3.34,78.2,8.18",8,Sigmoid,0.002542614,8.0,-5.53873682,1.0319,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8062703609466553
2238,3035,SJSA-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","16.7,-5.8,-4.6,4.88,12.2,12.3,1.75,-58","10.7,8.53,2.08,15.3,7.57,.55,4.78,4.46",8,Sigmoid,4.256304264,5.97356987,-57.62752151,0.6386,SJSA1_BONE,SJSA1,ACH-000748,Bone Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.7873447168669856,2.910304069519043
2239,3036,SK-BR-3,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,32.4,17.0,37.1,22.8,46.2,40.3,44.0","8.33,16.0,11.0,10.4,22.4,2.73,23.2,1.32",8,Linear,,8.0,-0.386610061,0.0,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1726906299591064
2240,3037,SK-CO-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,-3.5,8.37,-3.4,5.99,-7.1,-21,-49","34.5,2.81,13.0,10.8,3.53,10.3,13.2,5.35",8,Sigmoid,4.108197212,8.0,-48.43865585,0.8491,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0916872024536133
2241,3038,SK-ES-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,-3.8,-16,-2.8,9.84,10.2,-21,-84","19.8,10.2,3.17,6.51,15.3,12.5,12.9,2.30",8,Sigmoid,3.223680258,3.436305523,-83.80406189,1.0904,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.2343969183878776,2.9432592391967773
2242,3039,SK-HEP-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.62,-4.0,2.64,-20,8.82,-15,-4.0,-62","9.90,11.5,5.55,.38,9.13,1.23,2.01,11.8",8,Sigmoid,8.250660941,7.517156124,-62.05686569,0.3791,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0171878914355497,3.2084858417510986
2243,3040,SK-MEL-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,10.5,-12,8.22,2.94,20.5,17.9,6.60","22.0,17.5,8.77,4.40,4.49,.21,1.39,35.8",8,Constant,,8.0,8.541829109,0.4815,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0423383712768555
2244,3041,SK-MEL-24,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".95,-1.5,13.2,3.23,20.3,23.9,.95,-39","6.38,.35,18.0,11.1,2.94,5.52,9.71,13.7",8,Sigmoid,3.445289135,8.0,-39.23323441,0.3011,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.995006561279297
2245,3042,SK-MEL-30,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,10.1,2.83,9.45,6.71,5.78,15.9,-23","5.64,3.24,3.01,9.81,.66,7.12,.86,4.19",8,Sigmoid,8.126336676,8.0,-22.74980164,0.1049,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.7136037349700928
2246,3043,SK-MEL-31,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,1.85,-7.6,-14,5.20,6.01,8.23,-57","1.81,1.30,10.1,5.40,19.5,4.57,.048,1.02",8,Sigmoid,7.008276463,7.456315994,-57.08379745,0.8366,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0090614576547616,2.963869094848633
2247,3044,SK-MEL-5,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.69,-1.6,9.52,-8.6,5.51,3.67,6.73,-39","3.49,5.00,12.8,2.30,11.5,17.1,7.44,5.37",8,Sigmoid,6.746832371,8.0,-38.80753708,0.273,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.118245840072632
2248,3045,SK-MES-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","10.9,16.6,-6.1,3.41,16.1,-4.0,-21,-81","6.40,1.48,1.04,8.08,6.06,.020,9.36,9.89",8,Sigmoid,8.21994599,4.934690952,-80.74368286,1.3051,SKMES1_LUNG,SKMES1,ACH-000665,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.596290047216292,3.405026912689209
2249,3046,SK-MM-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-4.4,.044,-5.6,4.33,.90,-10,-48","8.27,1.83,7.20,.93,4.13,1.32,5.36,.69",8,Sigmoid,4.127548695,8.0,-48.28104401,0.6414,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.620051383972168
2250,3047,SK-N-AS,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,-4.4,1.81,-3.5,9.06,4.12,-39,-69","8.28,.28,1.24,8.83,9.03,3.66,2.94,.14",8,Sigmoid,2.417956114,2.933739901,-68.81239319,1.1172,SKNAS_AUTONOMIC_GANGLIA,SKNAS,ACH-000260,Neuroblastoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.0762780258252327,3.0221080780029297
2251,3048,SK-N-BE(2),PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","11.5,-5.1,11.0,24.5,16.6,10.8,-41,-64","20.3,21.3,27.1,5.10,44.5,19.7,9.00,6.45",8,Linear,,1.582723663,-65.44514465,0.9918,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.4591472002783796,2.9276726245880127
2252,3049,SK-N-DZ,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","2.73,-1.4,9.55,1.23,3.05,-3.6,-43,-83",".68,5.91,1.32,4.96,8.50,.84,7.57,.28",8,Sigmoid,2.569749594,2.908520937,-83.37030029,1.2322,SKNDZ_AUTONOMIC_GANGLIA,SKNDZ,ACH-000366,Neuroblastoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.0676446828987263,2.840080499649048
2253,3050,SK-N-FI,PF2341066,c-MET,".0025,.025,.080,.25,.80,2.53,8","15.8,-9.1,2.71,-7.9,28.0,15.4,-28","1.98,15.2,10.6,41.0,3.45,.088,19.1",7,Linear,,8.0,-29.13676262,0.4837,SKNFI_AUTONOMIC_GANGLIA,SKNFI,ACH-000341,Neuroblastoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0466511249542236
2254,3051,SK-N-SH,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.3,-12,.40,.64,2.55,-26,-59,-92","11.6,12.7,3.84,5.84,4.93,.45,2.66,.74",8,Sigmoid,2.062292099,1.902731538,-91.50746918,1.827,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.6432905053197104,3.0010409355163574
2255,3052,SK-OV-3,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,4.55,-3.2,3.06,27.7,10.1,-1.6,9.57","16.1,8.35,8.59,26.2,11.2,7.84,7.13,29.9",8,Constant,,8.0,1.166269541,0.02451,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0109376907348633
2256,3053,SNG-M,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".36,5.09,-5.5,2.60,2.19,-1.5,1.37,-27","1.66,4.62,4.00,4.88,3.83,2.46,2.99,19.1",8,Sigmoid,8.204803226,8.0,-25.18918228,0.2154,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9273386001586914
2257,3054,SNU-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,7.15,-3.2,-5.9,2.04,12.1,-13,-61","7.02,11.6,21.8,.23,10.3,8.49,11.4,2.29",8,Sigmoid,3.245627165,4.377726555,-60.63267136,0.826,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.476529538264698,2.676482677459717
2258,3055,SNU-182,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,-3.2,-4.3,-10,5.26,4.07,-12,-17","6.00,18.0,6.05,10.4,4.68,1.84,11.7,7.35",8,Constant,,8.0,-3.809909582,0.2485,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9905242919921875
2259,3056,SNU-387,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-10.0,-3.4,-8.7,10.8,-8.2,43.3,-1.7,-16","27.2,5.97,3.51,21.2,1.11,10.5,5.37,4.42",8,Constant,,8.0,-5.853300571,0.8758,SNU387_LIVER,SNU387,ACH-000478,Liver Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.031120538711548
2260,3057,SNU-398,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.28,3.22,-11,10.2,8.43,6.02,-1.1,-87","11.3,9.83,2.48,2.38,13.5,.99,7.90,.49",8,Sigmoid,4.62282896,4.82124567,-87.47426605,0.9383,SNU398_LIVER,SNU398,ACH-000221,Liver Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.57303233243256,2.932490348815918
2261,3058,SNU-423,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-9.6,-8.5,.62,4.27,3.99,-17,1.75","3.93,9.46,8.65,13.9,6.34,9.18,12.4,5.65",8,Constant,,8.0,-3.036067247,0.4193,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9579238891601562
2262,3059,SNU-449,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.29,-3.6,-5.1,.20,-4.0,11.7,3.18,-34","4.88,5.01,6.34,6.41,2.72,4.63,3.02,3.29",8,Sigmoid,6.587816715,8.0,-34.2869873,0.2711,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.3926870822906494
2263,3060,SNU-475,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","12.2,-20,-16,-9.8,53.4,-28,12.6,-10","20.4,28.3,44.6,30.1,56.2,18.3,36.3,24.9",8,Constant,,8.0,-1.326282859,0.7115,SNU475_LIVER,SNU475,ACH-000422,Liver Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1321516036987305
2264,3061,SNU-C2A,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,17.4,-1.6,-9.8,11.9,18.8,-27,-16","5.18,4.35,35.6,13.8,1.84,8.19,.54,14.6",8,Constant,,8.0,-0.597214282,0.5398,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.007277011871338
2265,3062,Sq-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","12.9,13.7,-8.7,-1.2,4.73,14.2,2.74,4.30","10.3,3.06,17.7,.83,5.81,15.4,5.11,2.71",8,Constant,,8.0,5.001246452,0.06157,SQ1_LUNG,SQ1,ACH-000553,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1227495670318604
2266,3063,SU.86.86,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,-9.2,-2.6,-2.6,8.46,4.50,-13,-17","17.7,7.63,9.30,8.19,2.03,.33,7.26,.013",8,Constant,,8.0,-6.084324837,0.2915,SU8686_PANCREAS,SU8686,ACH-000114,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0051450729370117
2267,3064,SU-DHL-10,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.8,.96,25.2,1.34,14.3,48.2,94.3,-90","5.03,2.60,35.9,10.0,22.9,48.9,36.8,1.77",8,Linear,,0.179609642,-87.24043274,0.8983,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-1.7169694385862582,2.83170223236084
2268,3065,SU-DHL-4,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","9.76,-9.3,-13,-6.2,3.11,-10,-32,-84","7.68,8.11,12.8,25.9,2.19,5.22,13.0,2.22",8,Sigmoid,4.93377924,3.873020172,-83.55539703,2.013,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.3540346088846598,2.4620656967163086
2269,3066,SU-DHL-6,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","61.8,-27,46.6,-8.0,48.3,77.9,4.45,-85","0,0,0,0,0,0,0,0",8,Linear,,1.01886914,-86.66342163,1.2027,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.018693325974403992,2.498901844024658
2270,3067,SU-DHL-8,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","24.5,22.3,20.0,26.3,37.9,3.91,-52,-78","44.5,7.13,23.6,6.83,27.4,16.7,8.63,3.40",8,Sigmoid,1.596907616,2.418319225,-77.74057007,1.3599,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.8830727637433742,2.871731758117676
2271,3068,SUIT-2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,1.36,-1.6,.71,1.25,2.36,-.61,-46","6.05,3.38,4.28,1.61,4.31,5.27,7.30,21.0",8,Sigmoid,8.0,8.0,-28.43558502,0.2423,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8333404064178467
2272,3069,SUP-M2,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".069,-7.8,-5.2,3.30,14.6,7.35,-83,-95","9.24,9.18,7.47,1.64,22.8,.39,12.6,.98",8,Sigmoid,1.791296005,1.823100448,-96.07801056,1.7536,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.600538594562538,2.377169609069824
2273,3070,SUP-T1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".48,-4.1,1.17,-2.4,15.4,13.3,8.10,1.73","18.6,5.41,2.24,9.70,4.49,9.37,4.81,9.79",8,Constant,,8.0,4.464664936,0.2455,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.779836654663086
2274,3071,SW 1088,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.29,3.22,19.8,14.7,45.5,30.3,16.1,-39","13.5,4.38,33.3,29.5,20.5,12.2,22.4,1.65",8,Linear,,8.0,-38.59604263,0.2437,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.106875419616699
2275,3072,SW 1271,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","14.6,-11,1.72,-18,6.69,-4.9,-2.0,-44","1.10,.90,.39,7.98,5.65,13.0,2.11,13.3",8,Sigmoid,8.400247992,8.0,-44.00506592,0.7189,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0191502571105957
2276,3073,SW 1353,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,2.88,4.22,-6.8,10.0,6.77,15.7,-48","1.28,4.30,2.52,.023,9.43,10.5,1.80,8.63",8,Sigmoid,8.091984361,8.0,-47.4229126,0.6467,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.118379592895508
2277,3074,SW1417,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","20.7,-.27,-2.4,.40,26.9,-14,-4.4,-45","23.0,4.99,22.3,9.48,13.8,21.2,18.3,18.4",8,Linear,,8.0,-43.17145157,0.5491,SW1417_LARGE_INTESTINE,SW1417,ACH-000236,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.398831844329834
2278,3075,SW 1573,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-8.4,-9.7,.48,4.24,10.0,-16,-41","2.67,4.78,5.18,8.18,2.40,4.94,1.81,1.88",8,Sigmoid,2.916736364,8.0,-41.37752533,0.6794,SW1573_LUNG,SW1573,ACH-000677,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0537376403808594
2279,3076,SW 1990,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,-11,-9.2,-14,-2.4,1.00,-11,-63",".72,3.31,.51,.83,7.39,12.3,7.68,9.25",8,Sigmoid,4.663060665,5.575777054,-63.39445496,1.0859,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.7184316895168383,3.3010644912719727
2280,3077,SW403,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,6.78,-11,19.0,6.60,31.0,21.3,-67","3.10,22.3,.070,26.7,1.21,28.8,31.9,8.71",8,Linear,,0.673564748,-67.27946472,0.9122,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,-0.39517115115269363,3.318272590637207
2281,3078,SW48,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","29.0,24.3,3.40,-4.8,36.3,11.2,20.1,-87","20.8,3.63,20.5,23.4,8.00,11.3,18.3,3.49",8,Sigmoid,8.121792309,7.052232742,-87.34707642,0.8926,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.9533442676779114,2.805513381958008
2282,3079,SW480,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.86,-6.9,2.99,3.19,8.78,-8.1,3.67,-52","4.52,9.98,3.32,1.09,19.1,6.07,1.29,7.48",8,Sigmoid,8.04322693,7.879920959,-52.17571259,0.3502,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0643178732357246,3.2515270709991455
2283,3080,SW579,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,3.09,-3.2,3.70,14.8,12.3,3.92,-40","6.66,0,2.15,2.69,24.8,8.80,19.8,6.84",8,Sigmoid,3.402526379,8.0,-39.81554031,0.4107,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.105685234069824
2284,3081,SW620,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,1.10,-4.5,4.98,6.16,-1.3,-29,-83","8.58,3.80,1.08,16.8,11.4,5.66,3.70,.78",8,Sigmoid,2.923780203,3.128878593,-83.02942657,1.122,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.1406746633587197,2.8852920532226562
2285,3082,SW 780,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-7.2,-1.7,-8.1,4.02,13.3,9.36,-41","8.71,7.20,.27,.81,.24,12.7,11.0,2.38",8,Sigmoid,7.964995861,8.0,-40.82357788,0.3069,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1713409423828125
2286,3083,SW 900,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-2.2,-13,-2.6,-3.1,2.08,-7.6,2.67","5.48,17.9,4.02,6.54,3.35,12.3,24.4,29.0",8,Constant,,8.0,-6.53124094,0.5228,SW900_LUNG,SW900,ACH-000669,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.310727119445801
2287,3084,T24,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.044,.22,3.63,-2.8,.36,8.99,-5.6,-57","8.41,9.86,1.19,7.97,.12,12.4,3.28,.86",8,Sigmoid,4.054718494,5.991122723,-56.62950897,0.9083,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.7902788274521557,3.0426149368286133
2288,3085,T3M-10,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-3.3,-9.0,8.19,-8.2,-.26,-3.4,-19","2.75,16.1,17.2,19.1,5.32,12.5,8.85,5.17",8,Constant,,8.0,-8.962043762,0.2702,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.122225284576416
2289,3086,T-47D,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8",".20,5.46,-12,-1.1,15.8,2.92,-5.3,-28","2.16,4.34,4.35,17.8,32.5,23.5,10.6,5.14",8,Constant,,8.0,-3.537573338,0.3487,T47D_BREAST,T47D,ACH-000147,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.322654962539673
2290,3087,T84,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,58.0,60.0,31.5,31.9,-20,4.13,-60","31.4,24.3,4.85,85.8,22.6,24.4,13.9,25.8",8,Linear,,2.514954444,-57.49612808,0.8613,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.9222546896699533,3.1173839569091797
2291,3088,TCCSUP,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,-4.9,-.040,5.30,4.47,1.66,6.36,-28",".16,1.74,.55,2.05,4.33,5.98,.78,.52",8,Sigmoid,7.120627403,8.0,-28.26646805,0.1913,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.927743434906006
2292,3089,TE-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,-9.1,-1.7,-6.0,4.59,.10,-3.4,-24","5.63,3.05,5.97,10.9,4.20,6.60,8.65,1.01",8,Sigmoid,5.048603058,8.0,-23.57889557,0.4085,TE1_OESOPHAGUS,TE1,ACH-000647,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.1850032806396484
2293,3090,TE-11,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-22,-8.3,-2.3,9.74,8.34,-.93,-62","3.28,6.61,5.65,5.27,3.42,1.52,8.46,3.64",8,Sigmoid,7.606641769,7.283445358,-61.63630676,0.9517,TE11_OESOPHAGUS,TE11,ACH-000488,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.985604013716302,3.063178777694702
2294,3091,TE-15,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","10.1,20.9,-38,-9.0,12.0,26.8,1.33,13.8","7.69,5.47,16.7,14.5,18.2,3.39,12.3,1.00",8,Constant,,8.0,11.30647659,0.429,TE15_OESOPHAGUS,TE15,ACH-000353,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0968918800354004
2295,3092,TE-5,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,-5.9,7.33,-1.1,7.95,6.80,-.67,-11","9.07,18.1,1.44,3.48,4.69,2.83,.020,3.04",8,Constant,,8.0,0.26147303,0.2186,TE5_OESOPHAGUS,TE5,ACH-000408,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.019869089126587
2296,3093,TE 617.T,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","11.1,-7.2,-3.4,-8.5,5.35,-22,-67,-86","25.3,21.0,11.6,2.27,2.85,9.29,7.39,3.55",8,Sigmoid,1.482220769,1.647043347,-85.64305878,1.7104,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.4989817696105551,2.531320095062256
2297,3094,TE-9,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","4.00,2.21,.73,4.49,11.4,11.3,-5.6,-24","1.20,18.8,20.4,6.37,4.46,7.96,1.20,9.96",8,Sigmoid,2.74007678,8.0,-23.86633492,0.3303,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.163902521133423
2298,3095,TEN,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,2.32,-16,21.6,-.55,40.1,-16,-14","10.7,12.0,15.2,12.7,28.0,10.1,12.3,9.20",8,Constant,,8.0,-5.572134972,0.6441,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.144986629486084
2299,3096,Toledo,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.00,-11,3.56,2.04,19.1,14.5,-4.0,-21","9.29,22.4,18.5,1.37,36.4,2.18,18.7,17.7",8,Constant,,8.0,2.044473171,0.03364,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.6660070419311523
2300,3097,TOV-112D,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","1.86,10.2,-8.9,8.71,-8.1,7.98,-26,-39","7.88,3.39,5.82,2.17,4.17,3.82,3.67,6.63",8,Sigmoid,2.169084311,8.0,-39.31116104,0.6993,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.855221748352051
2301,3098,TOV-21G,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.16,2.59,3.04,.20,3.87,-2.8,-50,-54","3.52,4.84,14.2,8.97,4.73,2.26,42.5,4.00",8,Sigmoid,3.545762539,6.567055225,-54.13008499,0.415,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.8820655166450766,2.444924831390381
2302,3099,TT2609-C02,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","19.0,7.42,3.12,11.9,23.0,5.43,10.7,-70","2.17,29.5,12.1,23.8,8.24,25.1,16.2,10.1",8,Linear,,1.465875295,-68.45198822,0.6655,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.38245253504406146,2.9349308013916016
2303,3100,TYK-nu,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.56,-2.8,2.61,-6.4,.23,-11,-18,-75","4.42,3.50,5.77,12.0,3.35,8.95,11.1,.41",8,Sigmoid,8.442826855,5.550395966,-74.65268707,0.7577,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.713869270438619,3.0537972450256348
2304,3101,U-118 MG,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.3,3.62,7.69,-4.2,.71,2.49,.53,-31","7.45,22.3,.93,1.03,2.76,1.77,7.69,2.31",8,Sigmoid,7.011594772,8.0,-31.41173172,0.4299,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0724692344665527
2305,3102,U-2 OS,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,-6.5,-15,-6.7,6.10,9.61,-4.7,-52","1.57,.43,2.80,2.27,7.16,7.31,4.00,3.63",8,Sigmoid,5.499295712,7.505040646,-52.32472992,1.0034,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0155748809268554,3.014044761657715
2306,3103,U-87 MG,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.71,11.0,2.26,9.64,6.47,-22,-19,-35","1.84,20.1,11.8,21.5,7.13,5.41,10.5,7.08",8,Sigmoid,0.614230752,8.0,-27.9662838,0.8907,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.0737969875335693
2307,3104,U-937,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.047,-1.7,3.26,-2.4,-3.1,-5.0,-28,-38","14.4,9.84,1.74,13.2,2.03,18.1,38.7,55.7",8,Sigmoid,1.6746521,2.278179884,-75.5561676,0.5069,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.8233768276667971,2.4081759452819824
2308,3105,UACC-257,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,-.18,-9.3,2.96,7.31,8.18,7.49,-14","3.79,2.63,1.64,3.95,11.1,5.56,3.81,10.00",8,Linear,,8.0,-13.59456825,0.1327,UACC257_SKIN,UACC257,ACH-000579,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.988926410675049
2309,3106,UACC-62,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","6.08,2.42,-14,-23,15.7,-8.7,-5.6,-31","7.69,.92,6.92,1.20,5.40,.12,2.22,5.12",8,Sigmoid,0.011233919,8.0,-15.01573753,0.7375,UACC62_SKIN,UACC62,ACH-000425,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.989748954772949
2310,3107,UACC-812,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","15.4,6.56,14.0,-5.6,20.3,-5.9,41.1,-9.4","8.79,7.74,36.1,12.1,35.9,18.4,34.1,13.5",8,Constant,,8.0,10.36696529,0.05788,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.448530912399292
2311,3108,UM-UC-3,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,-2.7,-2.0,5.47,.32,4.53,-9.6,-14","2.97,.80,1.79,8.30,1.49,13.4,3.99,4.78",8,Constant,,8.0,-2.994475365,0.1958,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.7398781776428223
2312,3109,VMRC-RCW,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-7.4,8.75,-5.0,14.3,-20,-55,-96","15.8,7.29,10.8,10.3,4.00,8.00,.82,.18",8,Sigmoid,2.604290247,2.230529308,-95.36723328,1.7715,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.8022389151546437,2.9064958095550537
2313,3110,VMRC-RCZ,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,-5.7,-11,4.85,-5.2,33.4,-3.8,-43","13.9,7.52,3.60,4.42,2.86,1.96,17.6,20.9",8,Sigmoid,4.386900902,8.0,-42.70872879,0.6149,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.909721851348877
2314,3111,WM-115,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","3.15,-1.3,11.2,-1.3,7.79,-7.1,-11,15.1","9.97,11.5,5.91,11.7,19.9,8.92,27.6,9.85",8,Constant,,8.0,6.422231197,0.0,WM115_SKIN,WM115,ACH-000304,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9690356254577637
2315,3112,WM1799,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,9.69,2.30,3.16,21.3,-.72,4.00,-33","3.03,7.15,2.33,13.6,3.59,23.8,10.7,1.61",8,Sigmoid,7.071075439,8.0,-32.65507126,0.3513,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8766353130340576
2316,3113,WM-266-4,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","5.50,-6.1,-5.4,-.98,9.06,17.2,-19,-39",".36,8.68,.89,3.93,.40,.81,5.06,8.60",8,Sigmoid,2.499312162,8.0,-39.02813721,0.6252,WM2664_SKIN,WM2664,ACH-001239,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.8230268955230713
2317,3114,WM-793,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,-5.9,2.32,5.42,13.3,-2.3,-4.3,-48","11.3,8.62,18.2,15.8,6.29,20.3,17.3,8.15",8,Sigmoid,5.809203625,8.0,-48.23401642,0.6696,WM793_SKIN,WM793,ACH-000827,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.337836742401123
2318,3115,WM-88,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,12.0,5.10,-3.5,-7.1,1.91,-5.1,-46","7.66,1.09,3.71,8.71,11.6,9.02,4.18,1.01",8,Sigmoid,5.152126789,8.0,-46.16932678,0.5136,WM88_SKIN,WM88,ACH-000899,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.079430103302002
2319,3116,WM-983B,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","15.7,4.71,5.81,-17,11.5,-1.7,-16,-65","4.64,3.98,3.80,20.4,9.34,13.9,4.24,5.19",8,Sigmoid,8.652264631,6.312064648,-65.26924896,1.5978,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,1.8424628255697038,2.8824222087860107
2320,3117,YKG1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-10,-4.0,-.17,-.71,.66,-19,-43","4.51,1.11,8.31,1.35,3.47,4.24,.10,3.98",8,Sigmoid,2.797755241,8.0,-43.16714096,0.5306,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9422082901000977
2321,3118,ZR-75-1,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,33.4,-5.4,18.4,16.9,73.7,-16,-27","19.9,14.7,1.88,32.0,17.8,40.0,20.0,1.00",8,Constant,,8.0,-2.729183435,0.5818,ZR751_BREAST,ZR751,ACH-000097,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.9804539680480957
2322,3119,ZR-75-30,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,4.60,-6.9,11.3,-5.9,18.4,13.4,.98","11.2,.63,26.9,7.28,30.1,41.3,20.3,8.60",8,Constant,,8.0,4.59804678,0.04209,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,3.3351688385009766
2323,3120,SCC-25,PF2341066,c-MET,".0025,.0080,.025,.080,.25,.80,2.53,8","-.95,-12,7.32,-2.2,3.41,16.4,7.97,-41","4.99,20.2,5.34,3.79,5.53,1.45,12.8,19.9",8,Sigmoid,7.923928738,8.0,-40.75316238,0.3788,SCC25_UPPER_AERODIGESTIVE_TRACT,SCC25,ACH-000188,Head and Neck Cancer,3,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,"c-MET, ALK",c-MET and ALK Inhibitor,Kinase inhibitor,Launched-2011,Pfizer ,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2.0794415416798357,2.7961132526397705
2324,4298,A172,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,-1.3,10.9,2.48,4.00,-3.1,7.48,-34","1.81,5.69,.98,3.17,3.51,6.29,4.54,6.37",8,Sigmoid,8.036559526,8.0,-33.81412888,0.2818,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.809206008911133
2325,4299,A-204,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,.39,-11,3.69,-24,-58,-61,-71","2.46,.24,1.57,4.23,4.89,2.79,1.43,2.95",8,Sigmoid,0.36103496,0.530858815,-65.97251129,2.0935,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,-0.6332591782163248,2.472721576690674
2326,4300,A2058,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-3.8,.96,3.43,6.63,.081,7.83,-2.9","1.19,1.27,2.89,.48,2.55,3.38,.80,1.54",8,Constant,,8.0,0.687094867,0.05127,A2058_SKIN,A2058,ACH-000788,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6046218872070312
2327,4301,A-253,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,6.45,1.79,3.20,14.3,9.23,25.3,-36",".70,7.92,7.18,1.55,9.61,.40,2.67,1.57",8,Sigmoid,8.098523288,8.0,-35.85645676,0.4373,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.5773391723632812
2328,4302,A2780,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,.10,13.5,1.13,13.8,6.30,-13,-80","15.5,8.80,4.26,8.21,1.79,14.7,1.91,4.51",8,Sigmoid,8.0,4.005534172,-77.12068939,0.9908,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.3876769479061477,2.4335641860961914
2329,4303,A-375,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,-3.4,4.21,.49,2.41,-1.6,3.88,-64","6.28,1.47,9.62,2.45,14.1,1.56,4.53,9.52",8,Sigmoid,8.013059141,7.351113796,-63.33012009,0.6118,A375_SKIN,A375,ACH-000219,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9948518386149419,2.4402098655700684
2330,4304,A549,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8",".15,-5.3,-7.4,-6.0,3.86,-9.8,3.57,-81","7.93,13.6,5.45,2.08,7.58,0,9.95,3.69",8,Sigmoid,8.012370158,6.775072098,-81.19078827,0.6549,A549_LUNG,A549,ACH-000681,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.913250008480359,2.8692002296447754
2331,4305,A-673,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-5.1,16.9,3.05,9.16,-1.9,-13,-8.3","8.71,12.2,32.5,18.1,9.29,18.1,7.32,.37",8,Constant,,8.0,-7.678833485,0.3025,A673_BONE,A673,ACH-000052,Bone Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.787262439727783
2332,4306,ACHN,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-12,-1.3,-8.1,10.1,-1.1,5.94,-24","4.27,3.48,2.77,11.7,1.98,4.19,6.16,4.78",8,Sigmoid,8.125815592,8.0,-23.56713867,0.6473,ACHN_KIDNEY,ACHN,ACH-000046,Kidney Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.903510093688965
2333,4307,ALL-SIL,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-9.8,3.12,-4.0,17.0,14.9,-44,-95",".48,12.5,8.85,15.9,15.3,6.97,14.3,.19",8,Sigmoid,2.614011049,2.664471388,-95.39081573,2.1035,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,0.980005684472237,2.547408103942871
2334,4308,AMO-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.88,4.62,-3.0,-9.5,.17,8.02,20.1,-92","3.24,14.3,4.91,.59,9.08,.044,4.52,.027",8,Sigmoid,8.238699151,6.908653736,-91.43753815,0.9786,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9327747904333783,2.8345789909362793
2335,4309,AsPC-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,-4.5,15.7,9.66,10.8,15.3,.86,-53","19.6,3.98,18.3,17.6,13.4,6.65,7.73,27.6",8,Linear,,8.0,-32.27458572,0.4228,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0025110244750977
2336,4310,AU565,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.35,1.88,-1.0,4.38,11.1,13.9,7.03,-49","7.05,6.25,1.48,.97,16.0,15.5,11.0,6.66",8,Sigmoid,7.585767269,8.0,-48.71353531,0.6273,AU565_BREAST,AU565,ACH-000248,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9907946586608887
2337,4311,B-CPAP,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,-3.4,.35,4.90,3.39,-4.2,-45,-78","2.35,1.92,1.17,1.83,.36,4.25,49.3,1.23",8,Sigmoid,1.827238917,2.139413357,-77.96238708,1.5503,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,0.7605316592096578,2.8171281814575195
2338,4312,BDCM,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-5.1,16.8,-5.2,-1.5,15.0,11.7,14.1","3.62,13.4,5.59,3.93,10.3,21.3,5.44,24.3",8,Linear,,8.0,-38.85283661,0.2804,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6781375408172607
2339,4313,BL-41,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.38,3.21,-1.1,4.63,1.92,5.50,28.7,6.45","10.2,2.74,11.6,4.56,1.34,5.46,13.7,.93",8,Constant,,8.0,5.432519913,0.0,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.612013101577759
2340,4314,BL-70,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.57,-.048,-1.3,9.15,7.73,15.1,-12,-2.5","11.2,20.3,3.66,17.6,5.19,29.2,4.55,20.4",8,Constant,,8.0,-0.708169818,0.1112,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6104302406311035
2341,4315,BT-20,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-14,-13,-18,-.088,22.1,17.1,-30","3.13,27.5,7.38,17.7,12.9,33.9,38.2,14.5",8,Linear,,8.0,-30.685709,0.4714,BT20_BREAST,BT20,ACH-000536,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.134462833404541
2342,4316,BT-474,Sorafenib,RTK,".0080,.025,.080,.25,.80,2.53,8","-4.7,10.7,-19,8.63,.41,6.93,-76","17.7,16.9,4.28,7.60,16.9,20.2,6.23",7,Sigmoid,6.539692402,6.462950706,-75.86407471,0.8083,BT474_BREAST,BT474,ACH-000927,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.8660859791435178,3.4548614025115967
2343,4317,BT-549,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,8.91,-10,1.84,-8.5,9.46,-6.1,-53","8.12,.77,4.93,14.7,13.3,7.64,5.01,7.59",8,Sigmoid,4.086617947,6.408694744,-53.30310822,0.5889,BT549_BREAST,BT549,ACH-000288,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.8576556221164429,2.9694249629974365
2344,4318,BxPC-3,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-25,1.86,.19,18.0,-2.4,34.2,9.68","35.3,8.58,28.4,13.7,11.9,.80,37.5,26.3",8,Constant,,8.0,3.657836676,0.3544,BXPC3_PANCREAS,BXPC3,ACH-000535,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9095499515533447
2345,4319,C2BBe1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","12.1,27.5,-5.2,-1.2,6.91,39.0,21.6,-24","4.38,29.7,2.70,47.8,3.49,10.7,37.0,2.63",8,Constant,,8.0,8.485733986,0.2239,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.057377338409424
2346,4320,C32,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-13,-.88,20.5,-13,6.49,-7.0,1.75","26.7,18.1,16.0,3.33,31.7,20.7,6.37,8.97",8,Constant,,8.0,-1.823769927,0.3158,C32_SKIN,C32,ACH-000580,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.688215970993042
2347,4321,CAL-12T,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10.0,-7.0,-.73,1.56,4.39,17.0,10.9,-56","2.25,2.74,12.9,12.9,11.4,3.85,11.3,3.76",8,Sigmoid,8.23739769,7.762419224,-56.24478912,0.6577,CAL12T_LUNG,CAL12T,ACH-000826,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0492940412795293,2.9399476051330566
2348,4322,CAL 27,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-40,-9.0,-5.9,5.86,5.43,10.9,16.8,11.5","47.0,1.88,7.76,4.27,8.11,.59,4.12,6.38",8,Linear,,8.0,-39.40666962,0.3294,CAL27_UPPER_AERODIGESTIVE_TRACT,CAL27,ACH-000832,Head and Neck Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8548784255981445
2349,4323,CAL-85-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.2,-10,1.59,6.34,25.2,3.95,34.2,2.67","3.43,10.4,9.59,3.14,39.2,13.3,22.2,5.63",8,Constant,,8.0,7.150664806,0.04859,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8855433464050293
2350,4324,Calu-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,6.12,6.20,-.87,6.35,3.77,13.9,-10","3.32,13.7,.52,8.02,17.1,3.07,7.28,1.38",8,Constant,,8.0,3.101964474,0.05791,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.2136435508728027
2351,4325,Calu-3,Sorafenib,RTK,".0080,.025,.080,.25,.80,2.53,8","-18,-9.2,-12,8.95,15.0,32.9,-9.1","2.53,6.43,18.5,1.83,4.25,10.5,3.51",7,Linear,,8.0,-17.68352318,0.5152,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.1351547241210938
2352,4326,Calu-6,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,-3.9,1.92,-15,-.56,-12,6.64,-24","15.3,8.36,11.5,5.05,9.09,26.8,21.2,26.5",8,Constant,,8.0,-6.615608215,0.8441,CALU6_LUNG,CALU6,ACH-000264,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.770662784576416
2353,4327,CAMA-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","21.3,.26,14.1,-8.0,23.4,24.8,41.9,-13","13.4,12.3,4.04,.17,16.0,10.4,12.8,9.85",8,Linear,,8.0,-11.27982712,0.1544,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.932722806930542
2354,4328,Capan-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,5.18,5.95,29.6,11.9,1.87,13.3,-3.1","27.3,8.93,24.7,17.7,18.1,17.8,21.7,52.6",8,Constant,,8.0,5.617125511,0.0,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.174436569213867
2355,4329,CAS-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.74,-8.2,13.4,-6.4,27.7,22.3,18.7,-11",".49,11.4,4.55,5.90,2.76,30.4,6.18,8.53",8,Constant,,8.0,2.084857225,0.06255,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9609014987945557
2356,4330,CCK-81,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.80,11.2,-19,-.17,-7.4,56.9,28.8,47.5","13.8,10.5,26.0,17.1,2.09,6.71,13.1,51.6",8,Linear,,8.0,-13.65083981,0.1157,CCK81_LARGE_INTESTINE,CCK81,ACH-000963,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0381617546081543
2357,4331,CHP-212,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,5.54,-1.1,-19,41.9,24.2,34.1,-6.7","15.6,4.68,4.39,16.1,30.1,38.7,23.0,7.84",8,Constant,,8.0,2.142471075,0.5689,CHP212_AUTONOMIC_GANGLIA,CHP212,ACH-000120,Neuroblastoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7382423877716064
2358,4332,CI-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-20,-6.5,-14,19.4,15.1,-6.8,55.1","10.9,47.8,82.7,14.0,40.9,16.5,32.2,62.4",8,Constant,,8.0,-0.060952377,0.3438,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.3536112308502197
2359,4333,COLO-320,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-3.5,-4.3,.14,.21,.38,-2.5,-71","5.30,7.52,1.99,3.27,.65,7.97,.47,3.96",8,Sigmoid,6.757509232,6.673327446,-71.37497711,0.7374,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.8981186030007935,2.6608173847198486
2360,4334,COLO-678,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-12,-.66,-4.8,6.58,9.54,13.5,-54","1.54,21.6,1.27,30.8,14.3,20.6,10.1,2.81",8,Sigmoid,8.035360726,7.80582571,-53.71868896,0.8591,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0548703408125126,3.2474541664123535
2361,4335,COLO-679,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-20,13.7,-12,15.5,-3.8,-4.0,-41","5.64,8.74,16.0,15.1,.49,7.87,15.0,7.98",8,Sigmoid,7.095861912,8.0,-41.32590103,0.4606,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.790339946746826
2362,4336,COLO 741,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.25,2.21,-12,-15,11.2,5.08,8.02,4.23",".54,4.03,12.2,7.36,5.59,.20,4.60,.51",8,Constant,,8.0,4.230924129,0.2976,COLO741_SKIN,COLO741,ACH-000582,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7923696041107178
2363,4337,COR-L105,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","12.6,8.15,26.0,8.21,22.6,18.3,34.7,10.9","37.3,18.0,18.5,42.6,30.4,2.87,3.87,32.7",8,Constant,,8.0,20.18308067,0.0,CORL105_LUNG,CORL105,ACH-000161,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.029656410217285
2364,4338,COR-L23,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,1.25,.91,3.08,4.90,5.24,-4.5,-82","7.83,3.16,8.49,3.43,3.02,4.64,1.42,11.5",8,Sigmoid,4.251617,4.65459013,-74.41914368,0.8032,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.5378538574432161,2.8834383487701416
2365,4339,COV318,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8",".10,5.65,12.0,-4.6,12.8,-2.8,14.8,-15","4.27,24.4,15.0,8.82,4.83,14.0,10.9,19.0",8,Constant,,8.0,2.46760869,0.2473,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.1004996299743652
2366,4340,COV504,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,-7.3,10.2,1.02,32.7,12.2,67.7,-15","21.1,4.70,6.50,12.2,10.3,8.17,18.1,3.70",8,Linear,,8.0,-11.59015942,0.09018,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9959468841552734
2367,4341,Daoy,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,6.89,-11,10.9,-21,16.4,-5.0,-8.2","5.19,3.66,12.6,3.24,13.5,3.39,15.6,.36",8,Constant,,8.0,-5.477086544,0.3994,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.552379846572876
2368,4342,DBTRG-05MG,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.16,1.59,-.61,2.38,-1.3,3.55,-1.5,-76","8.69,1.01,16.8,.19,7.05,8.41,19.2,10.4",8,Sigmoid,4.534245491,5.066503525,-75.54031372,0.7186,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.6226509396525637,2.821169853210449
2369,4343,Detroit 562,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.40,-14,2.03,-.29,25.0,-2.9,16.6,-2.2","7.11,2.65,7.22,.47,7.96,26.9,4.16,11.7",8,Constant,,8.0,4.641221046,0.08576,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8463826179504395
2370,4344,DK-MG,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-3.7,-8.9,2.55,9.61,14.0,5.68,1.85","1.01,1.09,2.03,.38,7.79,6.96,8.11,6.27",8,Constant,,8.0,1.279750228,0.04339,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8408660888671875
2371,4345,DMS 114,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,6.26,-.38,4.65,-.73,6.79,-3.6,-50","13.8,21.6,3.49,28.4,7.39,22.7,30.8,9.65",8,Sigmoid,4.73190546,7.832852364,-50.36483765,0.7432,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0583267302565,3.33090877532959
2372,4346,DOHH-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-32,24.4,-3.1,-13,11.9,-2.2,-21,-78","1.67,34.2,33.8,2.47,.95,24.4,9.34,2.91",8,Linear,,0.066550392,-77.00348663,2.8625,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,-2.7097958438503253,2.8505773544311523
2373,4347,DV-90,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.79,33.5,17.2,-13,-2.8,5.54,31.1,2.65","13.7,29.1,2.03,9.25,53.5,8.57,33.2,1.43",8,Constant,,8.0,8.653347969,0.04952,DV90_LUNG,DV90,ACH-000925,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8392090797424316
2374,4348,EB1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,15.4,23.6,-1.8,8.33,9.72,9.95,-13","2.38,49.4,37.8,2.62,26.3,46.0,29.1,14.5",8,Constant,,8.0,-3.375458002,0.2679,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.439742088317871
2375,4349,EBC-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-2.7,-3.8,-4.5,8.46,4.07,-3.2,-8.0","24.1,8.61,4.21,2.28,22.3,8.55,3.08,.79",8,Constant,,8.0,-5.671657085,0.3943,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9459609985351562
2376,4350,EFE-184,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-5.6,-4.0,2.20,6.05,4.31,8.79,-13","4.39,13.3,5.70,26.2,10.3,7.54,22.3,28.0",8,Constant,,8.0,-0.752831459,0.3326,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0228676795959473
2377,4351,EFM-19,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,14.6,-3.0,-6.5,1.18,-3.6,-7.1,-45","8.72,15.4,8.21,13.3,.021,4.42,10.6,5.08",8,Sigmoid,8.346948667,8.0,-44.88508606,0.3749,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.117798089981079
2378,4352,EFO-21,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-3.9,-6.0,1.52,-1.2,9.34,-9.6,-59","8.46,1.63,9.77,2.01,1.88,3.29,1.67,5.18",8,Sigmoid,3.570172071,4.917966366,-58.93230438,0.5223,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.5928951048116886,3.0112833976745605
2379,4353,EFO-27,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.10,2.47,6.33,5.86,2.20,13.3,15.1,-39","1.06,1.63,2.78,11.8,.30,.29,2.65,11.1",8,Sigmoid,8.096802133,8.0,-38.75762177,0.326,EFO27_OVARY,EFO27,ACH-000936,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.68422794342041
2380,4354,EM-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.8,-6.0,8.85,1.55,33.0,16.1,-33,-83","18.6,3.15,7.89,4.76,1.91,5.11,2.53,2.15",8,Sigmoid,2.654259682,2.948649883,-82.85455322,1.7046,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.0813473988106617,2.6757164001464844
2381,4355,EN,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-12,5.15,-9.4,9.10,-1.3,2.45,-37","4.54,14.7,3.48,4.80,.23,7.80,2.56,6.35",8,Sigmoid,8.046086544,8.0,-36.58108902,0.3369,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.758229970932007
2382,4356,ES-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.3,-8.2,3.78,-4.1,4.46,-3.1,1.88,-43",".83,9.47,7.45,9.33,.80,5.61,7.24,7.71",8,Sigmoid,7.79406929,8.0,-42.70350266,0.38,ES2_OVARY,ES2,ACH-000906,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.832655906677246
2383,4357,ESS-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,13.1,-5.9,3.28,23.1,29.2,17.1,-19","3.96,9.66,.24,2.34,4.63,2.93,3.76,9.49",8,Linear,,8.0,-19.12270355,0.4498,ESS1_ENDOMETRIUM,ESS1,ACH-000913,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6240603923797607
2384,4358,F-36P,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-6.5,-.22,22.6,31.3,104,108,-77",".66,7.14,6.84,2.27,27.2,5.76,19.7,1.72",8,Linear,,0.246048254,-77.38322449,1.2146,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,-1.4022276078140026,2.657879590988159
2385,4359,FaDu,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,9.96,25.6,1.89,14.4,15.4,37.2,4.35",".39,13.2,3.31,5.52,35.6,17.0,19.3,1.07",8,Constant,,8.0,5.311854362,0.05019,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8468222618103027
2386,4360,FU97,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-7.0,-.42,-3.3,-9.9,-10,-31,-48","4.68,2.36,7.95,6.26,15.2,3.35,.71,6.11",8,Sigmoid,2.26104188,8.0,-48.17205811,1.0666,FU97_STOMACH,FU97,ACH-000633,Gastric Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6610751152038574
2387,4361,FU-OV-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,10.5,5.75,9.83,22.0,12.7,-25,-51","17.2,12.5,6.89,5.84,16.6,2.37,12.6,12.2",8,Sigmoid,2.391615152,5.110904694,-51.1913147,0.6551,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.6313764323808193,2.6852030754089355
2388,4362,G-361,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,2.79,-3.4,16.0,-1.9,12.5,-.58,-64","13.1,1.48,12.2,3.57,18.9,7.25,7.53,3.42",8,Sigmoid,3.829979897,4.969456196,-63.87882233,0.8658,G361_SKIN,G361,ACH-000572,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.6033104168182046,2.623009443283081
2389,4363,G-401,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,3.78,-2.3,6.30,3.04,10.6,-14,-75","3.41,12.4,8.88,1.76,.50,6.41,3.11,4.68",8,Sigmoid,3.188667774,3.704551458,-75.300354,1.2294,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.3095621874516052,2.435368776321411
2390,4364,G-402,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-1.5,33.0,1.06,14.7,-21,-50,-56","2.53,.87,5.03,1.90,5.94,8.85,5.28,6.68",8,Sigmoid,0.868175209,1.491993666,-53.43358231,1.1492,G402_SOFT_TISSUE,G402,ACH-000375,Kidney Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,0.4001132564642467,2.628415584564209
2391,4365,GAMG,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,6.39,5.78,3.64,-9.9,7.53,17.3,5.73","2.65,18.5,13.4,16.2,4.04,12.1,31.3,9.11",8,Constant,,8.0,-1.83962357,0.1068,GAMG_CENTRAL_NERVOUS_SYSTEM,GAMG,ACH-000098,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.89730167388916
2392,4366,GB-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.5,-25,-21,-1.7,4.25,-6.2,-1.8,-77","19.5,2.25,2.70,12.0,.11,6.49,9.72,1.92",8,Sigmoid,7.668397427,6.686256886,-77.04446411,1.0509,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9000542087375354,2.8567566871643066
2393,4367,GCT,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,.032,11.0,6.13,7.26,5.59,.065,-37","19.5,4.20,9.42,6.05,20.1,.68,6.74,13.9",8,Sigmoid,4.183875561,8.0,-36.43082047,0.497,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7472927570343018
2394,4368,GI-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,1.62,-5.0,-17,3.61,-11,-1.5,-7.2","10.5,6.83,14.9,10.5,6.02,8.68,8.91,.095",8,Constant,,8.0,-6.275117397,0.4663,GI1_CENTRAL_NERVOUS_SYSTEM,GI1,ACH-000756,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.5375454425811768
2395,4369,GMS-10,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,.49,4.23,2.00,12.8,5.80,4.55,8.12","5.59,7.32,22.6,4.05,6.50,.51,21.1,6.34",8,Constant,,8.0,5.033106327,0.1598,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.574735164642334
2396,4370,GRANTA-519,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-.38,10.9,1.29,30.2,10.6,22.6,-19","3.72,17.1,18.3,10.3,5.16,4.49,.85,5.28",8,Linear,,8.0,-20.30295753,0.4338,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.726025104522705
2397,4371,H4,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-2.6,-.15,-3.7,2.51,5.40,-.81,4.68","6.92,2.21,4.60,.27,6.69,.29,.54,5.11",8,Constant,,8.0,-1.156847954,0.1642,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9335107803344727
2398,4372,HARA,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-5.4,-15,8.25,17.2,8.57,19.9,6.19","15.3,12.3,9.07,12.2,3.97,18.4,3.98,.65",8,Linear,,8.0,-13.76844883,0.3296,HARA_LUNG,HARA,ACH-000843,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.743588924407959
2399,4373,HCC1187,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,4.36,21.1,5.28,26.9,24.6,32.1,21.3","2.44,7.18,10.4,9.90,4.90,3.83,9.02,29.5",8,Linear,,8.0,-13.69319439,0.2117,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.036562919616699
2400,4374,HCC1395,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","17.3,8.17,-14,-22,14.5,6.46,18.2,.20","3.35,26.0,11.8,10.8,1.51,1.87,17.9,2.13",8,Constant,,8.0,5.753137112,0.3345,HCC1395_BREAST,HCC1395,ACH-000699,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7938997745513916
2401,4375,HCC-15,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.21,-8.7,10.4,-17,12.5,-1.2,1.64,-32","4.16,12.0,5.44,5.42,14.1,4.66,8.43,3.56",8,Constant,,8.0,-0.629345536,0.827,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0245814323425293
2402,4376,HCC1569,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-4.7,12.2,-14,9.19,-5.9,14.5,-2.8","3.41,9.23,13.5,15.6,19.7,19.0,1.78,10.6",8,Constant,,8.0,-1.223641276,0.2041,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.049781322479248
2403,4377,HCC1806,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.64,-5.5,-13,-.68,20.4,-.31,17.8,-34","18.3,18.1,18.4,3.74,10.1,8.20,19.2,4.30",8,Sigmoid,8.041353408,8.0,-34.04872894,0.8092,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9227330684661865
2404,4378,HCC1954,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,1.94,11.0,14.8,18.9,27.1,20.2,-38","3.20,1.90,9.75,2.01,25.8,14.4,19.2,15.1",8,Sigmoid,6.816840172,8.0,-38.02629089,0.4548,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.088289737701416
2405,4379,HCC2935,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","21.5,10.1,20.6,10.5,43.5,31.9,34.0,-7.9","21.4,21.6,2.62,20.2,40.3,11.8,6.80,1.77",8,Constant,,8.0,23.13110161,0.0,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.029379367828369
2406,4380,HCC4006,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,5.48,-5.0,-3.6,.71,-3.3,6.65,-33","5.23,12.2,4.31,1.02,2.06,8.62,3.64,.95",8,Sigmoid,8.138365076,8.0,-32.82162094,0.3675,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.014286518096924
2407,4381,HCC-44,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,.36,3.83,-7.1,5.95,8.37,21.2,-12","7.04,12.0,6.86,.11,.33,4.24,6.95,14.4",8,Linear,,8.0,-10.75930882,0.5025,HCC44_LUNG,HCC44,ACH-000667,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9227476119995117
2408,4382,HCC-56,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-1.5,6.18,2.88,14.5,7.46,18.8,26.2","21.1,5.40,15.6,15.8,13.8,4.36,9.82,5.20",8,Linear,,8.0,-14.33590508,0.08142,HCC56_LARGE_INTESTINE,HCC56,ACH-000467,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.699636459350586
2409,4383,HCC70,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,-12,1.47,-.067,19.5,4.68,50.8,-8.1","13.3,11.5,10.0,3.26,6.55,11.9,23.4,56.1",8,Constant,,8.0,15.84894657,0.5751,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9487502574920654
2410,4384,HCC-78,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,-.017,5.89,8.69,6.69,10.4,5.41,3.13",".14,13.3,5.60,1.48,.53,13.8,9.40,5.31",8,Constant,,8.0,6.502372742,0.0,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.075695037841797
2411,4385,HCC827,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,8.83,.64,-13,-9.8,22.1,50.3,26.1","39.1,70.0,60.7,41.8,8.09,21.9,25.3,21.6",8,Constant,,8.0,10.03282833,0.5981,HCC827_LUNG,HCC827,ACH-000012,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.961153984069824
2412,4386,HCT 116,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.59,-3.6,13.4,5.49,2.73,.045,13.9,-77","14.2,3.15,22.5,1.00,1.94,.17,22.7,2.14",8,Sigmoid,6.081815243,6.208874226,-76.03634644,0.8268,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.8259795954534754,2.6859774589538574
2413,4387,HCT-15,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.3,-13,6.19,-9.4,-1.8,-12,4.11,-82","13.3,2.30,13.2,6.01,.66,2.95,2.26,2.90",8,Sigmoid,8.629457783,7.161734104,-82.17159271,1.1377,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.968752144944582,2.98121976852417
2414,4388,HD-MY-Z,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-18,4.71,-.85,4.48,.76,8.42,-51","30.5,7.85,.074,6.55,.55,7.39,.081,.52",8,Sigmoid,8.065450755,7.934947491,-51.2086792,0.9484,HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HDMYZ,ACH-000190,Unknown,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.071276736565173,2.5775418281555176
2415,4389,HDQ-P1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,5.23,17.2,12.9,26.5,25.2,30.8,21.0","5.67,7.84,1.66,10.3,9.68,10.3,.54,8.54",8,Linear,,8.0,-9.38524437,0.1197,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9463019371032715
2416,4390,HEC-151,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,1.52,10.7,-2.3,-4.5,21.3,7.51,-63","5.19,18.6,11.4,1.19,12.1,8.50,8.10,.80",8,Sigmoid,7.913124084,7.363659382,-63.05106735,0.7036,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9965570078197996,2.502347469329834
2417,4391,HEC-1-A,Sorafenib,RTK,".0080,.025,.080,.25,.80,2.53,8","-15,6.30,-23,14.9,10.5,8.72,-45","8.19,.53,4.11,19.3,18.4,12.1,3.54",7,Sigmoid,6.771798611,8.0,-44.56217957,0.6987,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.777510166168213
2418,4392,HEC-1-B,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,23.2,20.0,23.6,43.6,25.4,3.33,-74","23.3,45.8,5.25,6.19,60.3,26.3,2.18,13.7",8,Linear,,0.30542944,-72.9151535,0.9618,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,-1.1860364926772704,2.740659713745117
2419,4393,HEC-251,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-2.0,-1.4,19.6,.94,7.47,22.0,-41","15.1,24.7,28.1,6.75,4.96,12.4,17.7,4.03",8,Sigmoid,8.186910633,8.0,-40.98997498,0.5294,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.996594190597534
2420,4394,HEC-265,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-6.6,-4.9,9.67,-14,12.3,3.76,-52","17.0,15.6,4.27,24.3,5.40,16.9,4.66,15.9",8,Sigmoid,7.020515919,7.848872185,-51.58017349,0.852,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0603698507720565,2.7282025814056396
2421,4395,HEC-59,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-5.2,.73,6.08,3.46,2.14,-6.5,-70","2.39,6.10,5.51,8.16,18.4,11.7,6.76,3.15",8,Sigmoid,4.202868462,4.897384644,-69.93553925,0.6413,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.5887013165009645,2.7226102352142334
2422,4396,HEC-6,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,4.48,21.6,13.3,45.4,-7.0,31.0,-66","45.6,11.2,10.9,36.3,92.2,28.4,52.1,6.76",8,Constant,,8.0,4.467668056,1.2738,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.933425188064575
2423,4397,HEL 92.1.7,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-3.1,-8.6,2.85,-1.4,7.54,-7.0,.16","6.64,3.18,4.48,1.39,5.37,1.70,.68,1.69",8,Constant,,8.0,-2.990036488,0.3034,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.5008983612060547
2424,4398,Hep 3B2.1-7,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.15,-8.7,16.8,-.53,14.7,2.75,-2.4,-34","17.6,3.22,12.5,9.26,23.9,12.8,19.1,14.4",8,Sigmoid,6.209504128,8.0,-34.31352615,0.6187,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9547128677368164
2425,4399,Hep G2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,9.19,17.6,-7.0,3.17,8.35,5.63,-36","26.9,.55,34.8,4.54,30.1,8.56,27.8,10.9",8,Constant,,8.0,-0.678127587,0.2541,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.981184959411621
2426,4400,Hey-A8,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-4.6,3.46,-1.2,1.83,-4.6,-23,-52","3.59,1.20,1.18,2.58,12.8,3.15,2.11,2.00",8,Sigmoid,3.530838966,7.243388653,-51.74032211,0.6201,HEYA8_OVARY,HEYA8,ACH-000542,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9800891428927396,2.7344448566436768
2427,4401,HGC-27,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-2.8,-.47,-3.4,-2.4,-4.0,-11,-44","3.99,.011,1.53,2.80,1.65,.54,2.42,.60",8,Sigmoid,8.392684168,8.0,-44.30849075,0.4772,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.595038652420044
2428,4402,HH,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.95,4.72,12.9,-23,-6.2,6.38,-17,-56","29.4,.50,8.32,18.6,33.5,19.7,1.50,13.6",8,Linear,,3.383168946,-56.40171432,1.3007,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.2188128282501187,2.555448293685913
2429,4403,HLF,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,2.51,1.52,.049,6.94,3.52,7.37,-24","5.59,12.1,2.96,4.46,5.92,6.67,17.7,14.0",8,Sigmoid,8.385945421,8.0,-23.87925148,0.5575,HLF_LIVER,HLF,ACH-000393,Liver Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.658900499343872
2430,4404,HMC-1-8,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.25,-4.4,9.73,5.77,12.4,11.1,-3.1,-54",".18,1.76,2.91,4.63,6.70,1.15,5.90,7.38",8,Sigmoid,3.643955708,6.195916176,-53.60719681,0.2971,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.8238903937348963,2.644266366958618
2431,4405,HMCB,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-6.9,-5.5,-4.9,7.72,.53,6.54,-64","47.6,.21,7.22,1.30,6.00,4.82,9.35,5.43",8,Sigmoid,7.922014236,7.296435833,-63.76731491,1.3145,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.987385986870589,2.5351173877716064
2432,4406,HOS,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","21.9,3.30,-1.9,33.8,1.17,24.3,29.4,6.90","18.6,20.4,2.21,7.86,3.61,3.99,13.7,12.5",8,Constant,,8.0,16.05424118,0.06738,HOS_BONE,HOS,ACH-000613,Bone Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.662790536880493
2433,4407,HPAC,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,-24,4.91,10.7,5.79,-14,4.48,-40","16.2,5.50,1.40,8.67,49.6,11.1,13.0,15.9",8,Constant,,8.0,-5.610108852,0.8845,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0383832454681396
2434,4408,HPAF-II,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-4.2,14.0,15.6,5.62,18.6,45.1,16.3","49.8,6.55,9.49,17.8,57.1,38.5,6.39,11.3",8,Constant,,8.0,13.52840137,0.4414,HPAFII_PANCREAS,HPAFII,ACH-000094,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.272104263305664
2435,4409,Hs 294T,Sorafenib,RTK,".0080,.025,.080,.25,.80,2.53,8","2.03,.24,2.03,6.93,9.78,10.0,11.4","7.08,9.47,2.33,5.63,2.92,4.48,5.23",7,Constant,,8.0,6.889853477,0.01333,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9255051612854004
2436,4410,Hs 578T,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,-3.4,-2.3,-9.9,6.62,13.0,6.98,10.1","2.15,9.03,2.36,7.45,17.6,2.90,4.06,2.60",8,Constant,,8.0,0.938483179,0.05614,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.960000514984131
2437,4411,Hs 683,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,-7.3,4.68,-1.7,4.82,9.39,2.21,1.43","16.3,6.37,5.84,2.82,5.76,2.17,9.12,6.92",8,Constant,,8.0,7.045977116,0.2025,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.5850517749786377
2438,4412,Hs 695T,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,.18,7.69,-.13,12.4,-10,5.38,8.96","4.04,4.09,7.10,9.97,1.57,2.55,4.33,12.1",8,Constant,,8.0,2.70225811,0.09031,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.056832790374756
2439,4413,Hs 729,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.36,4.33,6.20,-7.2,6.03,9.82,22.3,14.5","7.75,10.6,16.3,2.80,8.03,4.76,5.78,1.49",8,Linear,,8.0,-2.165975094,0.04854,HS729_SOFT_TISSUE,HS729,ACH-000133,Unknown,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8210697174072266
2440,4414,Hs 746T,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.2,-.14,19.8,2.11,19.1,24.0,-11,-12","13.7,20.1,28.7,1.00,10.4,15.6,5.30,13.4",8,Constant,,8.0,2.111765146,0.2575,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.988349437713623
2441,4415,Hs 766T,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,4.00,16.2,23.8,29.6,29.1,23.8,-25","2.52,15.2,16.0,18.4,12.5,19.4,22.1,1.10",8,Linear,,8.0,-24.35214233,0.2793,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.812340497970581
2442,4416,Hs 852.T,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.43,-5.2,1.72,14.5,12.5,18.5,21.6,-45","6.16,7.67,11.8,6.03,9.50,5.07,4.86,2.43",8,Sigmoid,7.145461082,8.0,-44.700737,0.4032,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.857999563217163
2443,4417,Hs 936.T,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,2.53,1.91,-2.0,6.23,9.98,10.5,5.37",".20,3.20,.95,2.05,5.46,4.46,3.97,5.75",8,Linear,,8.0,-12.6704092,0.1109,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.056321620941162
2444,4418,Hs 939.T,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.62,-8.1,7.77,21.7,12.0,-.74,24.8,9.47","10.0,6.50,6.01,3.24,3.98,.39,1.66,28.6",8,Constant,,8.0,10.54309273,0.08454,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.818572998046875
2445,4419,Hs 944.T,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-15,-8.3,4.45,3.79,2.29,.38,-39","11.7,7.52,15.6,1.13,20.5,3.21,20.2,8.19",8,Sigmoid,8.311541905,8.0,-38.65986633,0.6535,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6422572135925293
2446,4420,HSC-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8",".82,-3.5,-.59,-.52,-1.3,-1.4,-14,-91","4.27,8.12,5.88,5.58,5.37,4.10,9.30,1.98",8,Sigmoid,5.232250214,4.682631493,-91.19755554,1.0356,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.5438602367357337,2.8315281867980957
2447,4421,HT,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-8.2,-13,-32,4.55,8.94,9.98,-78","12.2,16.0,25.4,8.53,3.60,24.0,8.66,9.61",8,Sigmoid,8.071539734,6.917999744,-77.89025116,1.8156,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9341266735100615,2.795231580734253
2448,4422,HT-1080,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,-2.8,1.25,-9.9,-3.0,-3.8,2.68,-9.4","5.21,4.75,1.41,6.53,7.63,4.85,.95,2.77",8,Constant,,8.0,-3.029684067,0.1179,HT1080_SOFT_TISSUE,HT1080,ACH-000054,Sarcoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.390371561050415
2449,4423,HT-1197,Sorafenib,RTK,".0080,.025,.080,.25,.80,2.53,8","10.9,5.99,20.1,5.05,16.0,20.1,-21","0,2.42,24.5,22.9,10.7,19.7,6.95",7,Sigmoid,8.013929979,8.0,-20.79407501,0.1303,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.054736614227295
2450,4424,HT-144,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-2.7,-1.5,8.65,-.30,4.72,3.90,-47","9.96,6.63,4.96,10.3,24.6,3.48,8.98,11.9",8,Sigmoid,6.365860939,8.0,-46.28027725,0.6104,HT144_SKIN,HT144,ACH-000322,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7713911533355713
2451,4425,HuCCT1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,6.19,-5.3,4.25,-1.3,10.3,-5.2,-43",".71,1.68,3.57,1.06,2.32,.033,5.48,5.50",8,Sigmoid,3.524470806,8.0,-43.04095078,0.4565,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.875840187072754
2452,4426,huH-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-10,-9.5,-.0022,-.78,11.9,18.9,-43","4.99,15.0,2.98,43.3,2.77,8.66,19.5,2.80",8,Sigmoid,8.037207042,8.0,-42.51152039,0.1994,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.795074462890625
2453,4427,HUP-T3,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,8.24,-2.0,8.32,18.3,17.8,15.0,25.0","3.31,8.89,.16,24.9,3.22,12.6,7.06,1.02",8,Linear,,8.0,-20.48597527,0.1761,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.262746572494507
2454,4428,HuT 78,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","14.0,-16,44.5,-16,58.5,46.1,25.1,-13","26.2,4.24,22.1,50.1,35.7,13.6,8.05,31.2",8,Constant,,8.0,24.77173424,0.7262,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8056206703186035
2455,4429,IA-LM,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,2.34,-.41,-21,16.2,12.0,.52,-56","4.40,6.55,8.10,4.69,7.00,2.09,7.11,.90",8,Sigmoid,4.68627739,6.588274479,-55.64250946,0.8639,IALM_LUNG,IALM,ACH-000672,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.8852914749265481,2.8631818294525146
2456,4430,IGR-37,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-7.8,-8.7,3.65,-.84,13.6,-11,8.54","12.3,4.98,3.24,11.9,1.00,21.1,14.4,4.92",8,Constant,,8.0,-2.910304546,0.7135,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6382956504821777
2457,4431,IGR-39,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,-25,12.1,3.06,18.8,-4.2,20.7,-30","8.75,6.44,13.7,4.05,.20,.29,7.57,74.0",8,Constant,,8.0,2.776656151,0.2575,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7957587242126465
2458,4432,IGROV1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.37,-1.4,7.87,3.01,-6.0,-.50,3.94,-89","1.58,0,0,1.83,1.21,1.11,.80,8.32",8,Sigmoid,7.846647739,6.602256298,-88.88872528,0.8575,IGROV1_OVARY,IGROV1,ACH-000966,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.8874114539437583,2.839157819747925
2459,4433,IMR-32,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.53,.37,-7.4,7.82,3.11,14.7,33.5,6.74","14.2,11.3,18.2,18.0,30.0,22.4,8.48,9.35",8,Constant,,8.0,6.316829205,0.024,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.785226821899414
2460,4434,IPC-298,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.5,1.20,-5.4,8.59,-4.8,11.4,.079,-54","4.64,.95,5.51,3.88,5.34,4.05,2.78,3.18",8,Sigmoid,7.904875278,7.745028973,-54.25896454,0.6293,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0470512147269093,2.833193063735962
2461,4435,IST-MES2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,19.7,-1.4,18.8,3.12,16.3,-2.6,-59","3.88,22.7,24.6,26.5,.92,13.3,12.3,2.70",8,Sigmoid,3.710124254,5.200558186,-58.95345306,0.6781,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.6487659632880232,2.8184332847595215
2462,4436,J82,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,4.89,1.47,3.70,8.22,17.7,16.0,30.4",".81,17.6,8.84,6.59,1.35,8.85,12.2,12.6",8,Constant,,8.0,7.977095604,0.0,J82_URINARY_TRACT,J82,ACH-000396,Bladder Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.97792387008667
2463,4437,JHH-4,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-10,12.8,-.36,3.35,-7.8,20.6,-40","6.17,12.8,19.6,14.4,10.6,1.76,34.1,.87",8,Constant,,8.0,-5.17643261,0.7286,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.773958921432495
2464,4438,JHOS-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","28.1,13.7,31.5,25.6,27.2,48.4,24.9,26.2","35.0,15.9,22.6,2.51,14.2,5.06,4.60,4.51",8,Constant,,8.0,25.78813934,0.0,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.067964553833008
2465,4439,JHUEM-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-7.3,2.73,-1.3,-8.4,14.6,6.88,10.7","1.14,19.4,3.27,28.9,12.2,7.68,26.5,14.3",8,Constant,,8.0,0.845752776,0.4216,JHUEM2_ENDOMETRIUM,JHUEM2,ACH-000909,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.607455015182495
2466,4440,JM1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,4.41,-7.6,9.47,-1.6,21.6,-11,-28","10.1,14.6,3.54,22.4,16.9,18.0,1.76,7.83",8,Constant,,8.0,-5.392501354,0.2965,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6932201385498047
2467,4441,JMSU-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,-6.1,7.14,7.06,5.81,15.9,-12,-73","7.81,7.21,1.73,5.43,13.8,3.36,1.46,7.33",8,Sigmoid,3.281527758,3.876948833,-72.9318924,0.7113,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.3550484610262583,2.9749016761779785
2468,4442,JURKAT,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-5.9,16.2,2.14,19.6,11.0,-9.8,-76","7.72,18.3,19.4,8.89,18.4,4.32,5.86,2.16",8,Sigmoid,3.382384539,3.920067787,-75.6579361,1.4882,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.3661089462548965,2.5955557823181152
2469,4443,JVM-3,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","29.5,-12,13.0,-4.5,22.7,-2.8,30.9,-83","6.08,25.4,5.34,17.5,4.99,3.86,35.0,5.70",8,Sigmoid,8.069968231,6.987101078,-83.37021637,1.21,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9440657460464665,2.929649829864502
2470,4444,K029AX,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,6.85,-27,-.45,-8.4,12.7,.45,-28","7.59,17.3,57.7,3.89,21.0,1.64,10.8,16.4",8,Constant,,8.0,-3.875346661,0.5472,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7638838291168213
2471,4445,KALS-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,8.52,-3.9,8.53,7.78,26.5,5.52,-3.4","6.17,21.7,3.36,23.6,2.53,15.3,3.24,13.6",8,Constant,,8.0,4.513430119,0.1169,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6257495880126953
2472,4446,KARPAS-422,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,-9.4,17.1,-4.6,30.4,38.0,23.1,-24","4.11,.82,24.4,5.46,2.56,5.05,2.05,12.9",8,Linear,,8.0,-23.61689949,0.4391,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7214083671569824
2473,4447,KASUMI-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,1.00,2.86,2.91,17.2,-5.0,-4.4,-66","4.21,17.0,2.74,13.5,25.4,1.82,8.55,2.70",8,Sigmoid,8.657436333,6.908866405,-65.56326294,0.941,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9328055729468607,2.6139514446258545
2474,4448,KCL-22,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-8.1,-7.6,-.79,25.3,5.70,-18,-84","9.20,9.87,22.9,8.48,18.6,1.02,4.97,.40",8,Sigmoid,3.399511576,3.61183238,-84.29462433,1.6803,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.2842152280548933,2.6430160999298096
2475,4449,KG-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,11.6,11.5,-1.7,27.7,7.01,-34,-34","7.57,6.16,20.0,40.5,49.7,7.87,31.5,14.8",8,Constant,,8.0,-3.667685032,0.8453,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7122018337249756
2476,4450,KHM-1B,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.32,3.73,23.0,9.80,-.47,23.4,-13,-64","6.76,.66,15.4,13.1,8.50,14.4,.36,22.9",8,Sigmoid,3.038037062,4.015206337,-63.81002045,0.9919,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.3900887376099815,2.8296194076538086
2477,4451,KMBC-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,1.76,-.95,-1.2,.099,1.96,1.87,-.62","4.66,.63,1.08,1.60,6.11,.047,4.20,1.37",8,Constant,,8.0,-0.177624837,0.0,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.060142755508423
2478,4452,KMM-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-4.3,16.7,1.88,-4.7,6.10,-39,-87","12.0,1.23,23.2,10.3,2.67,7.11,9.41,8.95",8,Sigmoid,2.665688992,2.797390938,-87.47190094,1.6069,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.0286871749211999,2.893643379211426
2479,4453,KMRC-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,-12,2.22,-16,15.5,-15,10.5,-15","2.65,.057,2.86,1.52,2.20,2.41,7.57,8.20",8,Constant,,8.0,-6.841293812,0.337,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9435720443725586
2480,4454,KMRC-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,16.0,-15,17.6,-1.2,22.1,16.8,-8.2","14.9,20.8,11.9,5.61,2.04,8.60,24.3,14.6",8,Constant,,8.0,1.81833005,0.4541,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.501420497894287
2481,4455,KMS-11,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,-.70,-13,2.67,-16,-21,-22,-81","17.8,1.45,3.55,15.4,6.20,20.1,6.86,1.41",8,Sigmoid,8.574651958,4.98896122,-79.98226166,2.1886,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.6072277157478678,2.7393951416015625
2482,4456,KMS-12-BM,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","16.6,16.9,33.2,14.6,45.2,1.13,-2.7,-34","11.3,1.04,20.4,6.71,5.84,36.8,8.75,23.6",8,Linear,,8.0,-32.07065201,0.3402,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7878599166870117
2483,4457,KMS-34,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,-2.3,18.0,8.60,-12,8.71,-11,-92","0,0,0,0,0,0,0,0",8,Sigmoid,3.622434378,3.752606869,-92.44046021,1.2637,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.3224507635336733,2.7799086570739746
2484,4458,KNS-60,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,6.07,-16,-4.7,17.6,22.3,8.61,-25","5.66,1.74,24.6,7.43,14.4,12.4,8.75,5.39",8,Linear,,8.0,-24.66599464,0.4594,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.880988597869873
2485,4459,KNS-62,Sorafenib,RTK,".0080,.025,.080,.25,.80,2.53,8","6.55,9.89,-2.1,3.69,-2.5,13.6,14.5","8.43,30.3,2.33,29.6,11.1,6.24,4.47",7,Constant,,8.0,7.145657539,0.0401,KNS62_LUNG,KNS62,ACH-000858,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.762265920639038
2486,4460,KNS-81,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.83,-2.3,6.60,17.5,11.1,7.56,1.24,-26","21.3,9.52,4.72,5.37,.87,24.3,3.32,2.71",8,Sigmoid,3.193229914,8.0,-25.64178467,0.1781,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8800253868103027
2487,4461,KO52,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-2.1,22.8,45.4,41.7,.34,-51,-84",".021,3.26,16.2,41.3,2.99,10.7,5.04,2.94",8,Linear,,0.269100364,-83.75766754,1.6474,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,-1.312670868593187,2.8233911991119385
2488,4462,KP-N-SI9s,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.18,-6.6,11.0,-2.1,-.94,1.07,-8.0,-61","3.37,1.83,4.41,.61,1.23,9.96,8.66,5.56",8,Sigmoid,4.237562656,5.632163525,-61.35624313,0.7751,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.7284936534129276,2.7972311973571777
2489,4463,KU812,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,-13,1.84,21.1,-4.5,35.1,-6.1,19.4","28.1,10.6,.30,10.3,10.0,6.71,12.7,4.80",8,Constant,,8.0,2.261001587,0.0,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.603506088256836
2490,4464,KYM-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-20,17.8,-2.3,21.6,-5.3,7.40,-10","5.61,3.20,7.91,23.1,10.3,1.81,11.5,11.8",8,Constant,,8.0,-3.288496256,0.6532,KYM1_SOFT_TISSUE,KYM1,ACH-000607,Rhabdoid,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.4490160942077637
2491,4465,KYSE-140,Sorafenib,RTK,".025,.080,.25,.80,2.53,8","-3.3,19.6,7.78,24.5,30.7,-21","6.79,3.08,2.48,1.94,3.82,6.90",6,Sigmoid,7.414515018,8.0,-21.17023087,0.1106,KYSE140_OESOPHAGUS,KYSE140,ACH-000823,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.80856990814209
2492,4466,KYSE-150,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,-2.9,.97,4.26,-1.3,3.80,.64,.32","12.2,2.42,4.67,9.53,7.19,6.09,9.53,4.00",8,Constant,,8.0,-0.78710568,0.08508,KYSE150_OESOPHAGUS,KYSE150,ACH-000855,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9811878204345703
2493,4467,KYSE-180,Sorafenib,RTK,".0080,.025,.080,.25,.80,2.53,8","-6.9,-5.6,4.43,22.1,18.8,15.9,-43","14.6,16.7,6.14,.43,.79,4.34,4.70",7,Sigmoid,7.98085165,8.0,-42.48988342,0.3126,KYSE180_OESOPHAGUS,KYSE180,ACH-000693,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7500216960906982
2494,4468,KYSE-30,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,.49,3.75,2.08,6.53,10.3,6.61,-30","4.27,1.87,4.96,6.14,7.52,2.45,.57,6.96",8,Sigmoid,6.6256814,8.0,-29.86756325,0.466,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.092322826385498
2495,4469,KYSE-510,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.11,-4.6,-5.3,19.3,-1.2,.35,3.78,-34","10.1,5.02,13.7,9.28,4.77,1.66,3.18,32.7",8,Sigmoid,8.584219066,8.0,-33.86135101,0.6993,KYSE510_OESOPHAGUS,KYSE510,ACH-000824,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.958961009979248
2496,4470,KYSE-520,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.99,-2.1,2.16,2.47,13.3,13.7,19.0,-47","5.73,.60,2.47,14.7,6.61,6.51,22.1,7.33",8,Sigmoid,7.228210449,8.0,-46.74054718,0.4213,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.1085705757141113
2497,4471,KYSE-70,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-.16,-13,-4.7,15.9,20.8,18.7,-26","2.13,1.19,5.59,6.26,15.8,11.8,4.13,9.61",8,Sigmoid,7.539940834,8.0,-25.68491364,0.6312,KYSE70_OESOPHAGUS,KYSE70,ACH-000784,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7034192085266113
2498,4472,L3.3,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,8.93,-3.7,1.07,13.1,6.56,14.3,-43","9.71,4.15,6.71,4.20,2.61,8.53,10.1,5.42",8,Sigmoid,7.34512,8.0,-39.40600967,0.4845,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.917480945587158
2499,4473,L-363,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.6,-.019,8.36,-20,20.2,-6.8,-17,-88","17.3,7.16,9.65,16.6,7.37,12.4,11.7,1.97",8,Sigmoid,8.052586873,4.853794575,-87.69061279,1.6377,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.5797607856424825,2.7342708110809326
2500,4474,L-428,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,-2.6,1.92,6.69,-3.7,4.32,-3.1,-77","5.15,6.73,9.95,18.3,8.01,10.5,9.25,3.69",8,Sigmoid,5.621517658,5.844584942,-77.02428436,1.1127,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.7655155816242039,2.8473362922668457
2501,4475,LCLC-103H,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,2.78,-4.2,-2.9,-.28,2.01,-3.2,-35","10.8,17.6,7.73,8.24,10.3,3.53,10.7,9.19",8,Sigmoid,4.425852299,8.0,-34.54129791,0.4543,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7341785430908203
2502,4476,LN-229,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,-3.0,4.01,-2.1,1.23,15.7,11.1,-23","8.64,3.27,11.6,13.7,2.36,11.6,15.0,13.9",8,Sigmoid,8.102289522,8.0,-22.83851433,0.4278,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.793320655822754
2503,4477,LOU-NH91,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,4.44,.37,1.37,-15,5.55,-4.0,-36","3.39,18.2,2.64,16.5,1.85,1.25,28.0,38.9",8,Constant,,8.0,-8.652963638,1.0337,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8852834701538086
2504,4478,LOX IMVI,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,-.48,-2.5,-.84,3.04,7.55,-4.1,-41","1.00,.80,.36,1.11,4.57,1.97,9.62,1.78",8,Sigmoid,3.934700966,8.0,-41.2947464,0.524,LOXIMVI_SKIN,LOXIMVI,ACH-000750,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6822245121002197
2505,4479,LP-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,27.1,68.7,13.8,15.4,1.44,-22,-67","7.51,78.7,34.9,13.9,39.3,21.3,25.1,4.67",8,Linear,,0.774890772,-66.40545654,1.1561,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,-0.25503319891651294,2.788201093673706
2506,4480,LS123,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,-9.4,17.0,14.7,-2.0,6.52,3.30,-6.8","4.71,6.04,23.6,7.72,5.05,10.6,23.0,1.52",8,Constant,,8.0,-2.939512014,0.1955,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.983228921890259
2507,4481,LS411N,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-15,2.36,-7.7,16.0,-6.7,-3.4,-10","39.4,15.1,23.9,15.3,3.30,10.6,31.5,5.88",8,Constant,,8.0,-5.355067253,0.1615,LS411N_LARGE_INTESTINE,LS411N,ACH-000985,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.791269302368164
2508,4482,LS513,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","17.3,-6.8,46.4,-31,42.3,-42,11.7,-50","40.8,4.52,22.3,12.7,53.0,8.91,21.0,8.98",8,Constant,,8.0,-6.805297375,0.9539,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.147127866744995
2509,4483,LU99,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.50,-10,21.3,12.0,6.62,-.90,-24,-78",".23,10.3,.27,6.56,8.40,6.58,2.40,4.40",8,Sigmoid,5.272282124,4.511263371,-77.71759033,1.1541,LU99_LUNG,LU99,ACH-000444,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.5065772408939935,2.5941100120544434
2510,4484,LUDLU-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,25.8,-20,-.035,11.9,4.99,22.4,-43","8.20,20.3,5.88,11.4,25.9,16.3,16.2,2.71",8,Constant,,8.0,-5.610257626,0.6557,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.008302688598633
2511,4485,Malme-3M,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.46,-32,-9.2,6.19,-.87,9.62,4.64,-56","18.7,62.1,10.6,15.7,.81,15.3,10.3,7.53",8,Sigmoid,8.348484871,7.791688919,-55.78590012,0.8727,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0530576424170013,2.758669853210449
2512,4486,MCAS,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.5,-1.1,-1.1,3.24,.50,4.14,.56,-45","7.35,1.14,5.64,1.12,5.06,.86,8.17,38.4",8,Constant,,8.0,-2.341938496,0.4575,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0005109310150146
2513,4487,MCF7,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.18,1.91,9.99,41.9,17.4,17.2,26.8,-7.5","23.1,17.9,23.1,22.9,50.6,34.3,19.4,11.5",8,Constant,,8.0,13.85257816,0.0,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.1865577697753906
2514,4488,MDA-MB-157,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,1.77,17.2,10.8,-2.9,18.3,5.14,-38","2.62,6.85,6.37,3.10,5.34,8.05,.049,10.1",8,Sigmoid,5.865414143,8.0,-38.13471222,0.5498,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6836562156677246
2515,4489,MDA-MB-175-VII,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.84,16.7,-.021,16.7,1.75,37.3,18.2,-6.6","23.4,7.99,9.12,13.6,6.42,2.39,.76,3.25",8,Constant,,8.0,9.457919121,0.07455,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.2884066104888916
2516,4490,MDA-MB-415,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.59,-14,-12,-17,31.4,-9.2,-19,-18","15.7,4.48,4.93,11.2,25.7,16.0,14.6,.41",8,Constant,,8.0,-10.30340767,0.8087,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.1131043434143066
2517,4491,MDA-MB-436,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.08,10.4,7.21,-2.3,27.9,7.32,37.8,-19","26.3,24.9,25.9,5.58,23.5,2.30,2.46,20.8",8,Constant,,8.0,7.319075584,0.2087,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9169294834136963
2518,4492,MDA-MB-453,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,3.81,11.7,1.46,9.53,6.18,-3.5,-87","10.2,29.6,7.20,18.2,19.4,9.95,10.3,2.21",8,Sigmoid,3.994282246,4.255000591,-87.47189331,0.8147,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.4480949009207449,2.9627037048339844
2519,4493,MDA-MB-468,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","27.4,-17,16.9,-13,48.8,.055,41.6,-67","8.91,32.9,4.96,9.13,6.65,8.39,6.13,8.66",8,Linear,,2.424199783,-62.96039963,0.8336,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,0.8855014835402042,2.9415199756622314
2520,4494,MEG-01,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,.011,4.39,2.14,3.07,15.7,-8.5,-13","8.84,11.4,18.0,10.5,10.4,26.6,1.98,.93",8,Constant,,8.0,-6.028267384,0.1151,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.565498113632202
2521,4495,MEL-HO,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.2,5.47,-4.6,1.84,-8.0,7.65,-1.6,-65","5.66,2.91,6.12,1.78,3.83,1.06,14.8,.25",8,Sigmoid,5.597300529,6.380600452,-64.95639038,0.7755,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.8532622076617271,2.5908546447753906
2522,4496,MES-SA,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-3.6,5.35,2.10,10.6,6.55,1.69,-29",".27,.44,4.11,4.52,5.86,4.45,1.98,4.38",8,Sigmoid,5.371909142,8.0,-28.63566208,0.2463,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.776890516281128
2523,4497,MeWo,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,16.2,-6.8,-11,-4.5,-17,-16,27.7","7.37,18.2,24.1,2.84,2.29,6.66,7.64,25.2",8,Constant,,8.0,-8.261244774,0.4461,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6220896244049072
2524,4498,MFE-296,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-13,5.23,1.55,7.27,13.8,1.80,-17","13.4,2.91,2.04,7.81,.70,10.6,4.45,4.91",8,Sigmoid,3.78998971,8.0,-16.54487228,0.583,MFE296_ENDOMETRIUM,MFE296,ACH-000879,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6898441314697266
2525,4499,MG-63,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,2.86,-7.9,.65,-.38,6.06,-1.8,-9.4","12.0,5.24,2.03,1.75,9.08,8.32,1.64,2.87",8,Constant,,8.0,-1.828998566,0.3812,MG63_BONE,MG63,ACH-000359,Bone Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6832430362701416
2526,4500,Mino,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.3,5.37,6.45,1.70,-3.8,40.5,34.9,43.7","25.7,13.3,4.73,12.4,5.76,19.6,6.11,.75",8,Linear,,8.0,-5.264039516,0.002441,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8509039878845215
2527,4501,MJ,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.58,.066,20.7,26.9,2.46,20.0,24.3,11.2","1.74,6.52,27.0,30.3,5.64,.77,.36,3.67",8,Constant,,8.0,8.23287487,0.0,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.5038609504699707
2528,4502,MKN-45,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-31,-6.9,-.68,6.82,3.57,8.07,.90,-56","6.46,5.43,.68,12.2,9.57,2.37,.33,6.32",8,Sigmoid,7.774501801,7.639038086,-56.11927795,0.8244,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0332716902779104,3.0448718070983887
2529,4503,MKN7,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","34.3,32.2,-8.1,15.9,36.4,25.6,36.9,-5.9","22.6,8.11,18.9,26.7,36.3,12.3,11.9,18.8",8,Constant,,8.0,23.0379467,0.2289,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.980283260345459
2530,4504,MKN74,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-4.6,-3.8,17.9,-15,-5.7,-3.3,-27","6.03,8.52,18.9,11.4,1.83,6.13,.88,2.35",8,Constant,,8.0,-10.03342056,0.1997,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.819009304046631
2531,4505,MOLP-8,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.1,.25,32.9,18.2,-4.8,87.8,-10.0,-70","6.36,22.0,30.4,37.0,4.71,108,13.4,8.88",8,Constant,,8.0,3.901536703,0.9686,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7883193492889404
2532,4506,MOLT-16,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-4.4,-5.3,-18,7.18,-18,-28,-84","16.4,4.60,.87,9.12,8.23,1.88,21.1,5.65",8,Sigmoid,8.32191041,4.559615612,-84.18318176,2.8323,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.5172383243591847,2.274695873260498
2533,4507,MONO-MAC-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,-53,-68,-82,-79,-80,-75,-92","20.4,5.70,1.97,1.97,9.68,3.28,.83,.82",8,Sigmoid,0.002542614,0.007336914,-82.76668549,5.7935,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,-4.914836960730997,2.75288987159729
2534,4508,MOR/CPR,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-13,.91,20.9,4.13,27.4,13.0,2.12","5.33,12.0,.58,15.6,9.29,.87,27.4,8.90",8,Linear,,8.0,-17.78753471,0.1042,MORCPR_LUNG,MORCPR,ACH-000851,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8455700874328613
2535,4509,MSTO-211H,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.37,-21,21.4,-7.6,15.0,9.37,-8.7,-61","3.13,2.52,6.82,21.6,4.11,8.03,16.8,9.63",8,Sigmoid,8.382929648,6.981843472,-61.27042007,0.7464,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9433129896403623,2.8161721229553223
2536,4510,NCI-H1048,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.28,-1.6,14.4,-14,10.9,29.0,6.18,-56","6.83,28.0,21.7,.082,13.0,22.4,14.0,4.51",8,Sigmoid,5.90554142,7.31484127,-55.81800461,0.6078,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9899053349885352,2.9507572650909424
2537,4511,NCI-H1092,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-2.0,10.7,8.21,10.8,5.99,24.8,4.78","6.23,1.01,10.8,27.1,3.28,.95,25.4,16.6",8,Constant,,8.0,5.992979527,0.0,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.256274700164795
2538,4512,NCI-H1155,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-17,12.6,-3.6,18.4,29.4,15.5,-.82","13.3,4.32,10.4,1.23,45.2,14.2,14.3,27.4",8,Constant,,8.0,1.471071959,0.4457,NCIH1155_LUNG,NCIH1155,ACH-000980,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.794954299926758
2539,4513,NCI-H1184,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","60.5,.46,41.5,-31,2.06,24.1,12.8,-21","49.8,17.7,.30,38.9,37.2,33.1,26.0,10.5",8,Constant,,8.0,7.116984844,0.4186,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.217761754989624
2540,4514,NCI-H1341,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,-23,-25,30.3,27.6,-1.8,10.0,-4.7","62.4,34.0,2.43,9.16,36.7,12.3,28.3,27.9",8,Constant,,8.0,1.488507628,0.6177,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7561707496643066
2541,4515,NCI-H1373,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,11.1,12.5,9.97,-5.9,.71,1.13,-3.7","17.2,2.03,.21,33.6,21.0,7.21,9.86,.49",8,Constant,,8.0,1.741804481,0.1644,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.2300846576690674
2542,4516,NCI-H1568,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","21.7,-5.8,24.7,-4.4,24.4,4.08,18.2,-52","1.33,21.1,13.0,1.27,12.6,15.0,3.66,.62",8,Sigmoid,8.262275672,7.921915531,-52.48420334,0.7917,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0696330365576734,3.0344035625457764
2543,4517,NCI-H1648,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.87,-8.9,-11,-21,.61,20.9,1.43,2.37","20.0,4.33,18.6,8.74,11.9,6.97,11.0,1.99",8,Constant,,8.0,-2.425483942,0.5777,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9163949489593506
2544,4518,NCI-H1650,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,-7.7,-13,-4.9,13.2,14.0,20.6,-36","11.6,15.0,6.51,12.8,9.41,13.2,12.1,28.0",8,Linear,,8.0,-35.49110413,0.5556,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.078768730163574
2545,4519,NCI-H1651,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.08,19.4,-.85,3.67,11.8,12.3,-8.2,-27","3.73,5.38,16.9,.097,11.4,6.82,1.93,10.9",8,Sigmoid,2.568104506,8.0,-27.16765976,0.2962,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.113823890686035
2546,4520,NCI-H1792,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-.036,-9.2,-2.0,5.28,16.9,7.22,-14","8.24,2.59,11.3,14.4,16.2,1.35,9.13,5.74",8,Linear,,8.0,-14.27552605,0.3336,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.011573076248169
2547,4521,NCI-H1793,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","19.8,-13,7.13,-4.4,51.8,41.5,59.4,8.64","22.3,17.9,8.06,16.3,11.8,23.2,6.24,14.4",8,Linear,,8.0,-7.85561657,0.04823,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0682435035705566
2548,4522,NCI-H1915,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.47,-8.3,8.76,-6.6,16.4,28.4,5.50,-8.0","0,4.22,2.75,2.96,10.8,12.1,12.6,7.07",8,Linear,,8.0,-8.653709412,0.03571,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9045894145965576
2549,4523,NCI-H1944,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-3.5,10.6,3.16,7.66,33.1,53.1,22.7","21.1,2.09,6.45,7.40,5.63,7.01,10.5,3.37",8,Linear,,8.0,-13.5137558,0.04412,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.922663688659668
2550,4524,NCI-H1975,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.30,-9.0,-2.1,-8.8,23.7,10.3,17.7,-14","2.61,5.03,3.22,4.06,.10,4.19,13.4,4.74",8,Linear,,8.0,-12.49035454,0.1468,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0962352752685547
2551,4525,NCI-H2009,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.18,-1.1,3.61,17.0,10.5,10.9,-3.1,-2.4","5.30,19.3,8.72,4.15,9.48,23.1,5.49,22.8",8,Constant,,8.0,4.94149971,0.0,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9308218955993652
2552,4526,NCI-H2023,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.96,18.8,-2.5,3.67,35.0,1.17,27.2,8.63","9.94,8.38,1.06,.29,2.26,20.0,0,32.4",8,Constant,,8.0,13.2271862,0.006447,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.038372039794922
2553,4527,NCI-H2030,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.26,-.52,2.62,2.99,3.16,5.10,-5.5,-59","2.99,4.63,6.55,.95,0,22.2,10.1,2.24",8,Sigmoid,3.788349628,5.207033157,-59.09223557,0.5507,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.6500102419346379,2.956576108932495
2554,4528,NCI-H2052,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,2.78,4.36,1.81,-9.2,18.2,-2.5,-29","10.0,19.7,5.53,2.30,14.5,6.00,2.78,12.1",8,Sigmoid,3.923142672,8.0,-29.2733078,1.0207,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.1560633182525635
2555,4529,NCI-H2085,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-2.2,6.99,-11,5.49,1.14,17.7,-25","29.2,20.1,9.75,11.6,1.69,2.42,8.79,12.6",8,Constant,,8.0,1.621372581,0.5017,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.1230525970458984
2556,4530,NCI-H2087,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-7.4,-9.1,-4.7,12.2,13.3,-18,-58",".23,4.05,5.31,6.31,3.90,14.5,3.81,7.57",8,Sigmoid,3.202548027,4.511748314,-57.53520966,1.0198,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.5066847311682825,3.1543796062469482
2557,4531,NCI-H211,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,3.37,-7.7,-4.2,2.60,7.35,-3.4,-44","14.0,2.36,6.48,3.19,11.3,7.50,21.8,2.25",8,Sigmoid,2.187543392,8.0,-46.73141098,0.7736,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9470643997192383
2558,4532,NCI-H2122,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.01,4.97,11.1,20.6,14.7,.077,6.31,-57","10.6,31.2,4.47,2.28,22.2,13.6,24.3,4.98",8,Sigmoid,8.20650458,7.538781166,-56.8564415,0.4757,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0200605198816275,2.7373828887939453
2559,4533,NCI-H2170,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-10,3.55,11.4,3.43,10.8,1.11,-31","19.1,.26,2.06,11.6,2.24,8.24,7.29,9.14",8,Sigmoid,4.671964645,8.0,-30.66333771,0.1748,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0463783740997314
2560,4534,NCI-H2172,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-68,-77,-9.1,-27,27.8,8.32,-9.7,.19","15.6,16.4,29.1,24.0,41.0,2.91,6.65,67.4",8,Linear,,0.026705228,-72.72377014,0.3295,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,-3.6228959274998322,3.083928346633911
2561,4535,NCI-H2228,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-14,.63,-5.6,4.29,6.52,2.51,-41","4.80,11.5,1.18,5.61,2.99,7.26,6.37,7.61",8,Sigmoid,7.658344746,8.0,-40.52030182,0.5604,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9210290908813477
2562,4536,NCI-H2286,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,-8.1,6.18,3.31,11.2,12.4,8.73,-80","11.1,3.98,7.12,7.28,11.6,3.58,7.85,1.32",8,Sigmoid,8.07838632,7.001390934,-79.54859924,1.2132,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9461088341732609,2.8164730072021484
2563,4537,NCI-H23,Sorafenib,RTK,".0080,.025,.080,.25,.80,2.53,8","-.11,3.30,-8.7,6.59,18.6,10.9,-19","8.77,18.5,2.87,22.1,2.64,10.6,31.4",7,Constant,,8.0,2.888412952,0.3285,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8761181831359863
2564,4538,NCI-H2444,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8",".025,22.4,8.38,.94,-1.3,-12,-3.4,15.7","11.7,12.4,11.7,10.5,14.5,13.4,42.5,7.66",8,Constant,,8.0,7.877635956,0.1305,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9487857818603516
2565,4539,NCI-H2452,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","28.0,-6.2,9.40,.12,22.2,-16,15.0,-41","5.98,10.0,1.31,8.32,19.8,18.5,1.65,6.28",8,Sigmoid,8.397486084,8.0,-41.13433075,0.7511,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9671201705932617
2566,4540,NCI-H28,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,1.64,8.43,.25,11.9,20.3,24.4,-11","10.5,1.87,4.03,7.02,12.0,7.37,1.26,13.9",8,Constant,,8.0,4.442462921,0.1132,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8439888954162598
2567,4541,NCI-H322,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.6,-1.1,9.75,-.33,9.76,7.29,17.2,-7.7","5.56,8.96,.030,1.71,7.25,7.14,1.89,8.17",8,Constant,,8.0,5.910589218,0.0,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0529494285583496
2568,4542,NCI-H3255,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,4.77,5.02,-.64,13.5,2.30,-.24,-3.3","8.60,12.1,5.26,.27,21.0,13.3,10.2,3.24",8,Constant,,8.0,-0.673103869,0.1257,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.047727108001709
2569,4543,NCI-H358,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10.0,-5.7,3.06,1.16,-.89,11.3,-5.2,-47","7.66,5.20,5.78,5.95,5.81,.40,.25,5.94",8,Sigmoid,3.860264778,8.0,-47.15472412,0.4633,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.156855583190918
2570,4544,NCI-H441,Sorafenib,RTK,".0080,.025,.080,.25,.80,2.53,8","4.92,16.1,-4.8,8.10,7.16,11.3,-24",".73,6.07,2.66,3.67,4.34,.75,9.59",7,Sigmoid,8.927364658,8.0,-24.27414131,0.2335,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.910400867462158
2571,4545,NCI-H460,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,-11,-1.7,10.9,1.30,12.1,21.5,2.97","6.22,6.29,4.37,6.06,.54,2.78,7.67,6.88",8,Linear,,8.0,-12.19339943,0.1393,NCIH460_LUNG,NCIH460,ACH-000463,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7786569595336914
2572,4546,NCI-H522,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","27.7,4.67,-19,-13,6.84,10.4,13.0,-20","27.5,27.2,4.16,1.12,20.3,25.1,18.7,7.96",8,Linear,,8.0,-19.86928749,0.5832,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.072021007537842
2573,4547,NCI-H647,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.87,-28,13.6,-14,18.0,-16,-15,-12","4.09,1.36,15.4,14.7,9.10,2.70,1.03,9.99",8,Constant,,8.0,-9.770709038,0.8969,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8591060638427734
2574,4548,NCI-H650,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,9.18,4.95,6.03,-1.6,-.055,-7.5,-7.0","20.0,13.5,.50,4.78,3.68,8.26,1.63,13.9",8,Constant,,8.0,0.537539721,0.07339,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.797971725463867
2575,4549,NCI-H661,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,1.77,-1.2,.97,1.82,7.79,13.0,-9.8","2.02,6.69,1.79,3.73,1.91,6.02,3.79,28.0",8,Constant,,8.0,1.1876477,0.1372,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.786614179611206
2576,4550,NCI-H727,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","29.3,9.02,22.3,13.5,15.7,-3.4,-13,-12","6.30,29.9,12.1,6.00,23.4,9.96,24.1,60.6",8,Constant,,8.0,15.43999004,0.2139,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.285140037536621
2577,4551,NCI-H747,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,5.28,.018,12.0,23.2,30.9,-4.2,-29","3.48,1.49,15.5,21.6,11.7,8.30,30.7,5.16",8,Linear,,8.0,-30.13154221,0.5534,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.132629871368408
2578,4552,NCI-H810,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.072,2.05,1.53,-9.9,8.62,3.39,2.17,-35","8.25,3.04,3.99,4.56,11.3,5.66,5.35,21.6",8,Sigmoid,7.419494152,8.0,-49.56927872,0.5582,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0540878772735596
2579,4553,NCI-N87,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,20.9,17.6,-6.3,23.9,2.84,27.2,-32","36.1,14.2,43.3,26.9,21.0,20.0,24.6,17.5",8,Constant,,8.0,11.12274456,0.4951,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9935247898101807
2580,4554,NCO2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,-23,-8.2,-3.1,1.13,7.53,-41,-93","6.44,1.38,25.4,6.73,14.0,7.84,12.4,1.66",8,Sigmoid,2.706397533,2.736567497,-93.44422913,2.1583,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.0067043967462141,2.5570268630981445
2581,4555,NIH:OVCAR-3,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-13,.35,30.9,14.1,17.6,15.7,-55","4.02,9.66,20.6,28.4,3.24,30.1,32.6,2.49",8,Linear,,2.027971539,-55.02457428,1.3616,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,0.7070360516067903,2.84836483001709
2582,4556,NUGC-3,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-3.9,-11,-5.0,9.57,12.3,-2.9,-69",".65,1.02,12.5,10.6,2.47,4.84,18.1,1.72",8,Sigmoid,8.013911764,7.127600193,-68.66799927,1.0741,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9639745989489605,2.864377021789551
2583,4557,NUGC-4,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,4.61,-8.0,2.20,14.6,45.4,14.2,-23","4.51,2.94,1.50,10.7,6.19,2.95,5.67,3.20",8,Sigmoid,8.061151512,8.0,-23.15841484,0.3093,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.3491005897521973
2584,4558,OCI-AML2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.7,-5.6,4.85,2.61,-15,-5.2,-63,-95","4.66,.16,.0010,5.11,3.50,4.34,5.15,.26",8,Sigmoid,2.132151604,2.15498209,-95.06439972,1.7042,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,0.7677824126163029,2.399503231048584
2585,4559,OCI-AML5,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10.0,2.04,2.83,-13,-21,-46,-55,-77","6.51,6.35,10.9,7.44,10.3,6.22,2.63,.93",8,Sigmoid,0.948624849,1.325611115,-74.52951813,2.4072,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,0.28187357197738067,2.4036824703216553
2586,4560,OCUM-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.6,2.02,11.2,-3.1,5.33,7.36,11.3,-9.1","1.50,31.4,3.32,12.7,22.8,2.51,44.7,22.2",8,Constant,,8.0,7.383615971,0.1405,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0025904178619385
2587,4561,OE21,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.92,-15,10.7,-9.4,25.5,26.7,10.2,-37","1.30,10.3,.88,25.2,10.2,9.98,11.9,5.09",8,Linear,,8.0,-36.46738434,0.4841,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7151522636413574
2588,4562,OE33,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.30,-1.1,-14,9.44,3.83,17.2,18.5,-1.1","12.6,13.5,12.8,3.11,3.80,25.0,6.86,14.9",8,Constant,,8.0,6.868880272,0.2001,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.175802707672119
2589,4563,ONCO-DG-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.4,-14,-4.9,-16,11.1,2.28,1.20,-29",".54,6.80,12.4,3.53,6.03,.24,11.0,.10",8,Sigmoid,7.051833153,8.0,-29.19053459,0.4858,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.960496425628662
2590,4564,ONS-76,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,1.48,9.29,7.71,.14,3.96,-7.9,-96","1.51,2.98,.18,3.00,6.27,3.43,1.30,.19",8,Sigmoid,4.189873219,4.204772472,-96.1180191,0.9837,ONS76_CENTRAL_NERVOUS_SYSTEM,ONS76,ACH-000776,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.4362201830430164,2.954599618911743
2591,4565,OPM-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.016,-.15,-13,-17,9.08,31.3,41.8,-8.9","5.22,1.71,12.4,15.4,6.01,18.2,7.78,2.62",8,Linear,,8.0,-17.35274696,0.1978,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8025994300842285
2592,4566,OV-90,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,10.6,-6.5,-2.9,16.2,8.60,.34,-53","25.0,7.14,2.24,2.04,30.3,10.1,9.08,9.40",8,Sigmoid,6.050914764,7.591075897,-53.04799271,0.4936,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0269733332720943,2.813441514968872
2593,4567,OVCAR-4,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,5.89,-4.5,.87,-5.4,6.71,-5.8,-63","3.27,2.10,4.57,2.66,.50,4.23,3.09,3.18",8,Sigmoid,4.097584724,5.216080189,-62.63329697,0.6127,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.651746198164154,2.9808292388916016
2594,4568,OVCAR-8,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.8,4.18,4.36,-3.2,3.91,-.95,-3.9,-84","7.94,11.0,2.52,8.26,19.3,12.4,7.70,1.55",8,Sigmoid,7.824119568,6.164680958,-83.74859619,0.9127,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.8188363847500333,3.014477252960205
2595,4569,OVMANA,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-6.3,-6.3,-6.8,-2.1,-6.1,.65,-46","1.52,.052,7.98,5.16,3.13,6.06,1.22,15.8",8,Sigmoid,8.116646873,8.0,-42.487957,0.7517,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.551368236541748
2596,4570,OVSAHO,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,6.51,12.2,9.63,25.3,31.4,15.5,-41","2.34,18.2,2.91,5.87,6.02,26.4,4.52,.53",8,Sigmoid,6.48171854,8.0,-41.22256088,0.3679,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.1211743354797363
2597,4571,OVTOKO,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-48,7.39,-.64,7.79,-1.3,10.2,1.81,-32","55.7,9.09,1.90,10.4,1.77,.78,3.67,11.2",8,Sigmoid,4.839784145,8.0,-32.40842056,0.7373,OVTOKO_OVARY,OVTOKO,ACH-000663,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.811176061630249
2598,4572,P12-ICHIKAWA,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-5.6,10.5,.23,18.5,-1.4,-3.2,-88","14.8,3.32,13.5,.13,9.91,.87,8.55,4.76",8,Sigmoid,8.292140686,6.101369381,-87.94544983,1.325,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.808513234673975,2.3914976119995117
2599,4573,P31/FUJ,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8",".29,7.62,-16,18.9,20.3,7.23,-.79,-92","10.3,6.29,7.91,2.86,14.6,16.2,3.28,2.42",8,Sigmoid,4.058861256,4.265406132,-91.98712921,1.1751,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.4505374007946137,2.838683605194092
2600,4574,P3HR-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-3.4,2.96,11.7,1.45,7.76,-5.3,12.8","8.61,13.3,24.2,1.91,.74,5.75,4.04,19.4",8,Linear,,8.0,-29.13404465,0.2461,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9079830646514893
2601,4575,Panc 02.03,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.46,3.38,.11,9.98,6.92,19.4,-1.1,-57","4.76,1.50,1.23,17.0,7.69,19.5,1.68,7.03",8,Sigmoid,4.001616955,5.704259872,-57.37069321,0.5173,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.7412132416814805,2.9928972721099854
2602,4576,Panc 03.27,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,2.88,-5.9,-5.0,-12,-9.6,-4.3,-12","11.2,14.2,25.5,24.9,6.19,0,0,6.05",8,Constant,,8.0,-7.953798771,0.1145,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9834375381469727
2603,4577,Panc 04.03,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-.92,-19,8.09,-17,8.82,-1.1,-64","18.9,35.2,17.6,11.6,25.8,.85,15.8,28.8",8,Linear,,0.993234644,-64.34902954,0.4002,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,-0.006788344764353765,3.318293809890747
2604,4578,Panc 10.05,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-17,1.53,6.72,20.7,14.3,14.8,-56","10.7,10.4,17.6,5.48,19.3,.17,41.5,3.60",8,Linear,,2.948683799,-54.91900635,0.7027,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.0813589009578453,3.159543514251709
2605,4579,PA-TU-8902,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,-2.5,-8.8,1.37,3.05,16.9,3.22,-32",".97,3.15,9.86,7.51,4.52,.84,5.70,9.58",8,Sigmoid,7.863037586,8.0,-32.35398865,0.4794,PATU8902_PANCREAS,PATU8902,ACH-000599,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.835120439529419
2606,4580,PC-3,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-6.1,.97,-12,.65,7.51,9.75,-33","4.34,2.18,7.39,14.2,4.59,3.17,7.58,4.72",8,Sigmoid,8.460008431,8.0,-33.04758072,0.4568,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.119785785675049
2607,4581,Pfeiffer,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-.73,11.1,8.12,16.8,14.4,-3.8,-3.7","24.9,7.58,41.2,22.4,35.8,.62,.74,.80",8,Constant,,8.0,-3.276112556,0.06782,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.2247931957244873
2608,4582,PK-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,-3.9,-2.6,.88,3.98,.12,11.0,-40","4.18,2.32,1.08,.51,9.23,3.39,6.66,7.08",8,Sigmoid,8.040866064,8.0,-40.17140961,0.6839,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.1197056770324707
2609,4583,PK-45H,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,-6.5,3.60,8.55,17.5,15.0,28.2,8.93","2.43,8.31,3.24,12.5,7.66,10.1,14.9,15.5",8,Linear,,8.0,-6.219907761,0.06274,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.031097412109375
2610,4584,PK-59,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.00,-1.1,-2.2,5.58,7.20,10.5,5.11,-41","1.42,5.40,.88,4.54,2.27,1.70,4.05,10.8",8,Sigmoid,8.109154582,8.0,-40.61597443,0.3679,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.101759433746338
2611,4585,PLC/PRF/5,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,6.99,.79,8.15,-2.9,2.86,-4.7,-36","9.93,5.30,11.5,17.6,1.67,9.89,19.1,8.30",8,Sigmoid,3.704654217,8.0,-35.61009979,0.4683,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.5393738746643066
2612,4586,PSN1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-2.0,-8.1,4.02,-5.3,3.76,-.21,-3.2","15.2,16.7,1.17,21.5,2.18,6.02,8.11,7.99",8,Constant,,8.0,-6.193256378,0.2279,PSN1_PANCREAS,PSN1,ACH-000320,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8301069736480713
2613,4587,QGP-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-11,24.4,-1.4,31.2,23.1,22.4,-29","1.23,5.76,1.64,4.78,2.83,27.7,4.99,7.46",8,Linear,,8.0,-27.66061974,0.5314,QGP1_PANCREAS,QGP1,ACH-000347,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.1268982887268066
2614,4588,Raji,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.69,1.68,30.5,11.3,11.4,9.57,6.25,9.02","7.88,10.2,21.9,32.5,12.7,18.8,11.3,25.2",8,Constant,,8.0,10.69484997,0.03069,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6239171028137207
2615,4589,RD,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,-7.8,-7.3,.70,15.7,6.58,8.49,-21",".81,2.03,3.77,6.25,7.59,17.6,8.31,8.38",8,Sigmoid,8.165991314,8.0,-21.08664513,0.4051,RD_SOFT_TISSUE,RD,ACH-000169,Sarcoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.973278045654297
2616,4590,Reh,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,15.3,3.88,4.56,6.10,13.7,9.81,-42","1.12,9.80,.25,.44,10.8,.84,11.8,1.80",8,Sigmoid,7.533650875,8.0,-42.29810715,0.4783,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.315990924835205
2617,4591,RERF-GC-1B,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-13,19.0,2.48,40.7,33.2,46.8,1.85","14.4,6.29,14.8,7.47,16.9,11.6,9.81,18.4",8,Linear,,8.0,-8.653570175,0.1891,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.101778030395508
2618,4592,RERF-LC-AI,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-.71,2.29,2.32,10.5,13.8,5.80,-12","6.56,2.14,1.39,2.68,.22,3.97,7.26,4.74",8,Constant,,8.0,2.098568678,0.03211,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.902616500854492
2619,4593,RERF-LC-MS,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-.64,24.9,1.48,9.74,18.6,26.3,22.7","5.78,5.64,15.1,13.3,7.71,5.62,3.73,21.5",8,Linear,,8.0,-12.18904018,0.07522,RERFLCMS_LUNG,RERFLCMS,ACH-000062,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.650412082672119
2620,4594,RKO,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-9.4,-1.1,-3.0,3.11,-1.4,2.93,-49",".92,1.16,4.10,4.50,5.07,3.99,14.3,1.56",8,Sigmoid,7.86400795,8.0,-48.85411835,0.8653,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.780682325363159
2621,4595,RL95-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,6.13,2.60,10.2,36.3,46.2,38.8,25.7","4.04,20.0,17.0,5.86,16.4,8.32,21.7,11.5",8,Linear,,8.0,-19.19242096,0.1355,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.007932662963867
2622,4596,RPMI-7951,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,.98,14.1,13.3,14.2,5.08,6.73,-11","2.93,10.2,9.67,29.5,1.23,4.73,5.47,5.89",8,Constant,,8.0,5.353845596,0.1968,RPMI7951_SKIN,RPMI7951,ACH-000348,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9420623779296875
2623,4597,RPMI-8402,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8",".94,-15,-8.6,.25,6.52,2.31,-5.1,-63","0,17.3,9.52,3.11,2.89,20.3,.22,1.89",8,Sigmoid,4.306643486,5.420713425,-62.76327133,1.1083,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.690227435018102,2.3368844985961914
2624,4598,RT-112,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.34,4.70,3.19,2.27,22.1,17.3,-1.0,-67","12.3,3.63,8.95,4.06,14.0,1.74,5.01,2.07",8,Sigmoid,3.879951239,4.822282791,-67.25728607,0.6547,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.5732474240368814,2.848142623901367
2625,4599,RT4,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,11.7,16.5,17.8,6.17,40.4,-.31,-78","8.69,31.7,39.0,8.91,26.0,7.56,9.74,.30",8,Linear,,0.190259154,-79.2711792,0.9329,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,-1.6593681677605425,2.931593418121338
2626,4600,RVH-421,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.028,-6.3,6.49,3.12,.36,2.82,5.95,-6.2","5.23,5.86,6.90,11.0,2.69,.84,6.94,.54",8,Constant,,8.0,1.607612371,0.0,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7977724075317383
2627,4601,SBC-5,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,-4.2,-.15,-1.3,8.78,4.57,-8.9,-61","1.50,1.66,6.26,5.22,6.28,3.75,5.02,4.61",8,Sigmoid,3.811826944,5.130649567,-60.79331207,0.539,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.635232272414448,2.6446242332458496
2628,4602,SCaBER,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-16,-1.1,7.52,6.36,1.27,15.2,-31","8.23,14.6,19.5,5.68,15.8,1.19,20.0,1.58",8,Linear,,8.0,-30.41908646,0.6011,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.069275379180908
2629,4603,SCC-9,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8",".78,7.91,11.5,-20,8.83,.67,30.6,13.8","5.44,26.7,18.9,19.6,1.17,52.2,7.71,1.06",8,Constant,,8.0,8.826712608,0.2901,SCC9_UPPER_AERODIGESTIVE_TRACT,SCC9,ACH-000181,Head and Neck Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.653773784637451
2630,4604,SF126,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,.72,1.54,6.98,4.37,5.31,.74,-62","7.37,1.56,1.30,1.40,8.02,7.48,5.03,6.38",8,Sigmoid,5.087030411,6.239183426,-62.27645111,0.5917,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.8308493126003114,2.7808725833892822
2631,4605,SF-295,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.08,-.90,-7.8,-2.9,1.31,7.54,9.14,-37","9.95,6.36,13.3,3.36,.29,8.74,5.50,4.70",8,Sigmoid,8.013196391,8.0,-36.62017059,0.2399,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.674649715423584
2632,4606,SH-10-TC,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,-30,-5.6,-16,-5.3,-5.0,3.43,-39","1.07,3.20,1.50,5.14,2.13,.84,.70,.60",8,Linear,,8.0,-38.67735672,0.6857,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.857693910598755
2633,4607,SHP-77,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.57,-4.4,9.69,-5.6,12.8,-1.4,21.8,11.8","7.79,5.64,12.1,13.9,27.9,17.9,30.7,18.4",8,Constant,,8.0,1.463271141,0.04803,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8916289806365967
2634,4608,SIG-M5,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.35,-15,-13,4.21,19.5,-9.3,-13,-94","21.4,15.6,25.4,31.5,4.03,3.35,11.6,.48",8,Sigmoid,7.310781956,5.054609299,-93.47052765,2.421,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.6203005594755169,2.296374797821045
2635,4609,SIMA,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-31,-17,-6.9,28.1,9.68,25.7,-55","2.39,12.1,11.9,12.0,15.4,10.1,8.40,19.3",8,Linear,,4.717532419,-53.17310333,1.1921,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.5512858703090278,2.6986184120178223
2636,4610,SJSA-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-12,1.67,-4.6,-3.6,-12,7.25,-20","19.6,3.89,9.12,10.8,10.2,14.1,16.7,6.61",8,Constant,,8.0,-6.855554581,0.9267,SJSA1_BONE,SJSA1,ACH-000748,Bone Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.686473846435547
2637,4611,SK-BR-3,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,1.83,-14,-13,-7.2,-6.9,-.39,-47","21.7,7.91,.56,35.4,5.96,5.54,6.83,16.0",8,Sigmoid,8.042423912,8.0,-47.12971878,0.7789,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0993220806121826
2638,4612,SK-CO-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,6.31,-17,9.71,17.1,30.1,-4.0,16.2","3.16,8.77,3.59,5.92,28.7,11.4,12.5,2.34",8,Constant,,8.0,5.08052063,0.448,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.020916223526001
2639,4613,SK-ES-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,13.4,1.26,17.9,-1.3,28.3,4.02,-35","4.92,2.70,.98,13.2,5.55,36.5,5.56,29.8",8,Sigmoid,7.291844368,8.0,-34.28408432,0.5736,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8810269832611084
2640,4614,SK-HEP-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8",".74,-3.3,21.3,-11,16.9,8.83,18.0,-15","5.55,3.05,2.21,8.14,2.37,4.95,3.73,16.2",8,Constant,,8.0,4.982773304,0.3457,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.974785566329956
2641,4615,SK-MEL-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","25.1,-20,-4.9,-27,-5.5,5.13,1.95,5.48",".57,22.1,21.8,8.43,23.1,27.5,8.48,15.3",8,Constant,,8.0,-4.224470139,0.8119,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.835456609725952
2642,4616,SK-MEL-24,Sorafenib,RTK,".0080,.025,.080,.25,.80,2.53,8","3.66,12.4,-1.7,-11,19.7,7.37,14.1",".96,11.3,13.6,4.37,15.1,14.5,9.57",7,Constant,,8.0,6.072849274,0.06075,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8276560306549072
2643,4617,SK-MEL-30,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,-2.2,1.90,2.58,8.94,-3.6,-2.1,-57","3.70,3.04,9.52,1.29,4.03,4.88,9.36,2.60",8,Sigmoid,7.465999603,7.425682068,-56.73245621,0.4895,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0049445414799,2.537449836730957
2644,4618,SK-MEL-31,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.87,-2.0,-3.7,12.0,-5.7,13.4,2.37,-1.8","20.4,.75,20.3,3.24,2.58,9.59,.72,14.7",8,Constant,,8.0,2.370706558,0.09934,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7751882076263428
2645,4619,SK-MEL-5,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,-14,-7.6,-13,-1.9,-5.7,2.65,-65",".44,2.32,4.36,3.20,1.90,.47,5.89,18.0",8,Sigmoid,7.107354641,7.074476242,-63.14622879,0.9226,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9564934113896968,2.8983566761016846
2646,4620,SK-MES-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.9,-.21,-14,-12,14.8,-.35,.91,-4.3","12.4,36.5,3.37,7.68,13.0,12.0,1.12,10.4",8,Constant,,8.0,0.906897366,0.5808,SKMES1_LUNG,SKMES1,ACH-000665,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.2384603023529053
2647,4621,SK-MM-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-.041,-3.3,-.14,7.52,4.10,-4.4,-77",".18,1.69,3.67,.040,2.52,4.80,3.81,.52",8,Sigmoid,4.331678391,4.777966022,-77.46723938,0.9437,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.5640149375346737,2.638780355453491
2648,4622,SK-N-AS,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-5.5,7.58,6.56,6.99,15.1,3.08,-29","2.46,5.13,18.0,7.81,5.22,4.65,4.06,6.46",8,Sigmoid,6.264867306,8.0,-28.77734566,0.3163,SKNAS_AUTONOMIC_GANGLIA,SKNAS,ACH-000260,Neuroblastoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.881931781768799
2649,4623,SK-N-BE(2),Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.24,13.8,-3.1,15.1,36.7,-2.7,4.59,-40","17.3,32.3,19.6,20.3,24.1,32.2,3.27,4.46",8,Constant,,8.0,4.594604492,0.3857,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8478200435638428
2650,4624,SK-N-DZ,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,2.81,-.46,5.85,1.43,14.3,9.32,-6.1","1.41,2.86,5.01,12.3,3.27,14.6,7.78,15.4",8,Constant,,8.0,3.244979382,0.154,SKNDZ_AUTONOMIC_GANGLIA,SKNDZ,ACH-000366,Neuroblastoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6904397010803223
2651,4625,SK-N-FI,Sorafenib,RTK,".0025,.025,.080,.25,.80,2.53,8","-6.3,-13,19.9,-1.0,-4.1,4.09,50.3","31.3,17.8,37.2,68.7,23.2,28.6,40.0",7,Constant,,8.0,4.900914669,0.5742,SKNFI_AUTONOMIC_GANGLIA,SKNFI,ACH-000341,Neuroblastoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8917813301086426
2652,4626,SK-N-SH,Sorafenib,RTK,".0080,.025,.080,.25,.80,2.53,8","-24,4.07,-12,13.6,-10,-20,-40","16.4,9.61,20.5,7.17,7.60,16.6,3.24",7,Sigmoid,3.038823843,8.0,-39.83883286,1.011,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7824721336364746
2653,4627,SK-OV-3,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.5,-6.2,-6.5,-19,27.5,2.62,21.8,-2.1","11.3,10.8,9.47,4.45,.78,14.6,9.02,6.48",8,Constant,,8.0,-2.408923864,0.4214,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8294477462768555
2654,4628,SNG-M,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,4.22,2.16,-9.0,9.35,5.13,-3.4,-31","9.25,2.65,3.99,23.0,10.2,5.93,3.77,1.92",8,Sigmoid,3.344414473,8.0,-31.24862862,0.4755,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7788820266723633
2655,4629,SNU-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-3.2,.81,3.90,5.59,3.11,-18,-68",".29,14.7,4.72,16.8,.45,22.6,7.75,7.26",8,Sigmoid,3.151108027,3.844271421,-67.53705597,0.8939,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.3465840976163885,2.611668348312378
2656,4630,SNU-182,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,-2.4,7.76,4.27,4.05,11.4,1.01,1.85","8.65,8.04,6.30,.94,26.7,18.5,4.40,3.06",8,Constant,,8.0,3.23297596,0.04995,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8452043533325195
2657,4631,SNU-387,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.08,-6.4,-20,6.95,-17,23.8,.96,9.27","21.9,5.89,1.91,9.00,17.8,.21,21.0,3.45",8,Constant,,8.0,-0.780693889,0.7339,SNU387_LIVER,SNU387,ACH-000478,Liver Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8264594078063965
2658,4632,SNU-398,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-11,12.4,6.97,12.2,15.4,41.8,-27","26.5,1.13,15.1,22.9,8.73,5.23,52.2,7.94",8,Constant,,8.0,6.66699934,0.7151,SNU398_LIVER,SNU398,ACH-000221,Liver Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7816388607025146
2659,4633,SNU-423,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.88,-3.2,7.60,-7.7,20.5,3.87,25.9,11.8",".95,3.78,8.90,1.14,6.42,8.40,7.40,1.15",8,Constant,,8.0,6.492270947,0.06403,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7679314613342285
2660,4634,SNU-449,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-2.1,-.35,4.94,.87,5.12,-11,-33",".23,1.37,3.71,8.98,5.12,6.39,9.67,3.61",8,Sigmoid,2.90982914,8.0,-32.50292587,0.5036,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.1966798305511475
2661,4635,SNU-475,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","27.5,-28,-16,-3.8,-33,20.1,56.0,19.8","35.9,2.83,18.0,9.27,35.0,32.2,40.3,22.2",8,Linear,,8.0,-28.44329262,1.0406,SNU475_LIVER,SNU475,ACH-000422,Liver Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.932725191116333
2662,4636,SNU-C2A,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.3,-15,1.19,-25,26.7,7.02,17.3,-33","24.2,8.03,1.89,1.73,22.0,4.37,4.70,1.35",8,Linear,,8.0,-31.28945541,0.6656,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.889064311981201
2663,4637,Sq-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.71,-17,-15,-17,4.91,-.57,2.86,-12","5.85,29.7,6.51,9.90,9.35,25.4,9.76,13.3",8,Constant,,8.0,-3.362509251,0.6838,SQ1_LUNG,SQ1,ACH-000553,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.013176441192627
2664,4638,SU.86.86,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,-6.6,5.94,-2.1,5.18,-5.1,2.63,-11","2.93,2.48,3.73,5.42,2.47,15.2,7.70,3.60",8,Constant,,8.0,-3.182806015,0.2178,SU8686_PANCREAS,SU8686,ACH-000114,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9323642253875732
2665,4639,SU-DHL-10,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,10.6,-1.7,15.5,15.7,70.4,67.7,-1.4","3.50,7.19,5.61,24.5,8.26,12.6,5.31,33.2",8,Linear,,8.0,-15.57741356,0.01542,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8079419136047363
2666,4640,SU-DHL-4,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,5.65,-3.7,4.31,5.66,-2.2,-21,-82","4.45,.43,8.90,5.01,13.5,14.6,3.43,.50",8,Sigmoid,5.239301205,4.566555023,-82.01306915,1.8441,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.518759096348876,2.426429033279419
2667,4641,SU-DHL-6,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","16.6,23.0,-11,-2.1,6.15,20.4,96.3,-56","45.1,50.7,3.73,.50,20.9,15.7,58.7,29.2",8,Linear,,5.623217879,-53.10289383,0.8653,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.726904076380835,2.4398326873779297
2668,4642,SU-DHL-8,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.8,9.43,9.01,2.37,-21,-28,-22,-63","32.8,10.8,30.4,4.35,3.58,10.7,14.7,10.9",8,Linear,,2.223050764,-62.44350052,1.6194,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,0.7988804705287937,2.8221564292907715
2669,4643,SUIT-2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,-11,.91,-1.1,4.92,-2.6,2.15,-64","3.64,12.1,9.37,4.95,2.77,4.31,3.32,5.72",8,Sigmoid,7.970982075,7.185978889,-68.01499939,0.6344,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9721317508912979,2.7052860260009766
2670,4644,SUP-M2,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,2.88,-1.9,1.36,6.48,-.21,13.2,19.2","13.1,16.4,15.0,8.93,.063,12.1,1.76,15.4",8,Linear,,8.0,-14.4875412,0.04683,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.3389954566955566
2671,4645,SUP-T1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-8.4,9.01,2.46,10.4,2.56,2.93,-.81","9.82,20.7,18.6,10.2,41.4,20.3,12.1,31.6",8,Constant,,8.0,-3.790808678,0.05822,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.762706756591797
2672,4646,SW 1088,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,10.0,-6.8,-11,14.3,26.8,19.1,30.0","3.51,13.1,3.42,4.00,13.1,15.9,3.55,3.27",8,Linear,,8.0,-11.40643024,0.0797,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9260752201080322
2673,4647,SW 1271,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.92,7.66,-14,-3.7,6.88,1.45,23.1,-16","4.47,.26,14.0,3.46,3.49,.89,.35,10.0",8,Constant,,8.0,2.989052296,0.3072,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.859729290008545
2674,4648,SW 1353,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,2.14,-10,.96,4.91,31.9,21.6,7.76","4.33,12.7,2.84,5.31,6.14,10.3,2.11,8.31",8,Linear,,8.0,-19.03471947,0.3081,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.924476146697998
2675,4649,SW1417,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,-21,3.88,24.1,-28,12.9,16.0,-39","25.2,5.83,15.0,27.0,2.66,49.4,19.1,1.39",8,Constant,,8.0,-11.7135334,0.8551,SW1417_LARGE_INTESTINE,SW1417,ACH-000236,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.2881388664245605
2676,4650,SW 1573,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-12,5.22,6.54,12.8,18.6,18.8,-7.0","10.9,11.1,4.20,9.67,.024,8.71,1.39,1.97",8,Constant,,8.0,5.2192626,0.3386,SW1573_LUNG,SW1573,ACH-000677,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.9028160572052
2677,4651,SW 1990,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,2.21,5.10,-1.7,-2.9,8.08,5.06,-13","11.6,3.78,15.0,3.15,20.5,4.14,3.67,1.69",8,Constant,,8.0,1.500017643,0.06581,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.1435770988464355
2678,4652,SW403,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-6.8,20.3,21.3,13.3,18.0,24.3,5.09","18.1,28.2,22.9,5.55,15.8,67.9,31.9,5.61",8,Constant,,8.0,6.910450935,0.003239,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.2644968032836914
2679,4653,SW48,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-24,26.5,1.75,34.7,49.7,62.0,15.6","8.37,3.20,30.7,12.3,3.95,3.69,9.00,19.0",8,Linear,,8.0,-13.66520023,0.5355,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.699141025543213
2680,4654,SW480,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.19,7.39,9.81,-10,-2.2,-3.3,-5.3,-51","4.40,16.4,19.7,6.46,2.61,8.84,4.13,11.3",8,Sigmoid,8.402410752,7.946047783,-50.59065247,0.3728,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0726746708402213,3.122018575668335
2681,4655,SW579,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-10,.51,-24,-21,-50,-48,-51","1.11,5.68,1.78,1.87,.76,.52,1.76,.81",8,Sigmoid,0.309933871,8.0,-49.86283112,1.8088,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.913461208343506
2682,4656,SW620,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,6.77,-.28,15.1,20.4,42.7,18.2,-30","3.88,4.16,2.69,23.2,6.02,2.17,1.44,8.42",8,Linear,,8.0,-30.96914673,0.4125,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7849349975585938
2683,4657,SW 780,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","14.2,.33,-12,4.91,11.6,19.3,12.4,4.59","14.5,4.27,.58,13.6,9.23,.51,9.21,15.5",8,Constant,,8.0,5.866530418,0.1231,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0138039588928223
2684,4658,SW 900,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-15,-8.1,6.33,-14,1.41,-4.4,5.21","2.14,6.61,9.62,7.04,8.28,4.73,3.70,12.1",8,Linear,,8.0,-38.0104866,0.4596,SW900_LUNG,SW900,ACH-000669,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.170320987701416
2685,4659,T24,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,-.77,.22,3.53,13.6,18.9,14.8,-26","8.50,2.02,6.34,1.63,5.59,.67,2.70,4.32",8,Sigmoid,7.139532089,8.0,-26.05333328,0.5063,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.849167585372925
2686,4660,T3M-10,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","17.2,-2.8,1.77,-6.1,13.4,19.7,36.8,21.3","19.1,2.48,15.2,24.3,26.6,12.9,12.2,38.8",8,Constant,,8.0,10.58833599,0.0,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.97714900970459
2687,4661,T-47D,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,32.0,-4.6,3.15,10.6,6.00,-13,1.08","28.1,32.0,21.6,3.97,9.67,25.3,18.0,16.2",8,Constant,,8.0,2.313207865,0.427,T47D_BREAST,T47D,ACH-000147,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.2549538612365723
2688,4662,T84,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","79.1,16.4,36.5,2.18,-2.9,46.5,-27,142","37.5,17.8,89.0,3.74,95.3,58.2,11.3,219",8,Constant,,8.0,6.165392399,0.614,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0898611545562744
2689,4663,TCCSUP,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,.82,1.50,-1.7,-.95,-1.2,15.2,-12",".67,4.55,3.64,3.27,3.50,3.25,.15,2.42",8,Constant,,8.0,-1.5717026,0.01622,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.75404691696167
2690,4664,TE-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,1.07,-.47,-1.2,3.29,7.32,8.29,-12","6.12,1.46,6.94,6.15,8.96,5.77,1.29,3.75",8,Constant,,8.0,1.06524539,0.2454,TE1_OESOPHAGUS,TE1,ACH-000647,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0155506134033203
2691,4665,TE-11,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-31,-14,-1.1,.59,19.8,21.2,21.9,-12","33.0,2.85,16.3,4.41,17.3,1.79,9.56,.44",8,Linear,,8.0,-31.72718239,0.5301,TE11_OESOPHAGUS,TE11,ACH-000488,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8912384510040283
2692,4666,TE-15,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,14.5,-15,-25,20.1,23.0,15.1,7.57","20.5,45.5,12.9,17.4,22.4,24.6,1.61,9.89",8,Constant,,8.0,5.91636467,0.4139,TE15_OESOPHAGUS,TE15,ACH-000353,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.950198173522949
2693,4667,TE-5,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-7.0,3.28,-4.2,4.60,9.67,5.71,-1.9","3.10,1.01,10.7,2.56,5.29,1.78,3.49,4.30",8,Linear,,8.0,-14.96422195,0.2589,TE5_OESOPHAGUS,TE5,ACH-000408,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.876836061477661
2694,4668,TE 617.T,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,-5.1,21.5,-1.8,9.73,10.3,1.39,-79","13.6,12.8,19.9,9.24,14.4,24.2,17.0,1.89",8,Sigmoid,5.474927425,5.759644985,-79.04439545,0.9072,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.750875838259702,2.3442468643188477
2695,4669,TE-9,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,2.43,-.086,-3.0,5.58,11.2,7.15,-64","13.5,6.70,13.4,5.60,11.3,11.4,8.73,6.32",8,Sigmoid,7.49842453,7.270143032,-63.55709839,0.6806,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9837759656297462,3.0215888023376465
2696,4670,TEN,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","33.9,11.3,16.8,20.0,19.4,29.9,28.8,38.3","1.49,.17,16.3,36.7,16.0,17.9,1.67,12.0",8,Constant,,8.0,28.79145813,0.0,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.0076980590820312
2697,4671,Toledo,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","12.8,3.80,16.0,19.8,2.47,-5.0,-2.4,6.87","12.7,11.8,21.4,2.67,15.3,.49,.49,5.13",8,Constant,,8.0,3.92090106,0.02052,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6238412857055664
2698,4672,TOV-112D,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.84,-6.0,-2.7,-13,-5.0,-11,-13,-57","8.73,3.45,11.4,3.36,2.27,4.56,11.9,6.91",8,Sigmoid,8.179209829,7.147336483,-56.75350952,0.9695,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.966739767443017,2.6935312747955322
2699,4673,TOV-21G,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-4.2,-4.1,-.65,-3.9,2.44,.86,-66","18.1,2.61,8.02,3.27,6.84,9.23,2.60,15.1",8,Sigmoid,8.044984465,7.684823513,-55.81706619,1.0759,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.039247411599986,2.2622361183166504
2700,4674,TT2609-C02,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,27.7,31.6,30.4,14.6,42.7,-24,-25","3.62,22.0,50.2,50.0,18.3,14.3,15.4,29.8",8,Constant,,8.0,0.267928958,0.5484,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.749171733856201
2701,4675,TYK-nu,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.04,1.11,2.58,3.25,.53,-.075,13.2,-56","1.69,17.9,12.4,16.1,2.84,25.6,6.63,20.6",8,Sigmoid,8.046138967,7.718305111,-55.80105591,0.5322,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.043594794725854,2.8720831871032715
2702,4676,U-118 MG,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-6.1,8.24,4.03,-.29,13.4,11.0,17.5","15.1,13.1,7.64,22.7,1.23,20.6,10.1,18.3",8,Constant,,8.0,2.889857531,0.2384,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.840287923812866
2703,4677,U-2 OS,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,.42,-7.4,-6.4,10.5,9.42,12.2,-31","4.66,11.5,.57,2.77,2.44,8.19,3.34,2.67",8,Sigmoid,7.162780285,8.0,-30.47742844,0.5541,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.843897819519043
2704,4678,U-87 MG,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.5,4.51,9.53,5.69,6.04,15.6,.64,2.12","2.36,9.31,0,9.99,.013,6.83,6.71,11.5",8,Constant,,8.0,6.028011799,0.2031,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8928136825561523
2705,4679,U-937,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-4.0,-10,-1.8,-5.5,14.3,4.49,-36","7.92,6.43,4.13,10.8,5.79,8.62,6.47,67.0",8,Linear,,8.0,-18.65340614,0.7181,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.3842272758483887
2706,4680,UACC-257,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-32,-.65,-7.7,-.60,-2.6,8.38,-12,-.15",".74,9.22,7.50,9.97,.27,2.51,5.01,15.9",8,Linear,,8.0,-31.69347572,0.3558,UACC257_SKIN,UACC257,ACH-000579,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7748236656188965
2707,4681,UACC-62,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,10.6,-11,-.44,17.1,12.9,6.69,-17","1.28,8.70,16.7,1.84,7.13,11.2,1.60,2.05",8,Linear,,8.0,-16.74396515,0.398,UACC62_SKIN,UACC62,ACH-000425,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7987546920776367
2708,4682,UACC-812,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-3.6,8.77,.86,-1.8,20.1,21.3,-39","15.8,25.4,11.1,6.62,4.81,19.5,18.3,60.4",8,Constant,,8.0,1.448842406,0.2783,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.416001081466675
2709,4683,UM-UC-3,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,2.57,-6.3,-.43,-3.5,7.90,-11,3.69","3.43,2.48,7.28,1.02,1.94,3.32,1.18,1.92",8,Constant,,8.0,-1.299404025,0.2574,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.5481598377227783
2710,4684,VMRC-RCW,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-15,7.91,-23,4.64,-6.8,-.29,-67","11.8,19.0,.70,8.45,.81,24.9,9.46,21.4",8,Sigmoid,7.867411137,7.122237206,-67.04676819,0.9115,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9632218903947443,2.7312982082366943
2711,4685,VMRC-RCZ,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.12,-12,-11,-16,26.4,-7.7,.68,-23","11.8,6.09,2.21,9.06,.28,6.80,22.2,7.93",8,Constant,,8.0,-9.961586952,0.8126,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.757936477661133
2712,4686,WM-115,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-32,-5.2,9.85,11.4,14.8,6.66,1.75,12.9","5.81,24.9,6.42,13.4,15.4,19.0,.59,2.97",8,Linear,,8.0,-31.70710945,0.3239,WM115_SKIN,WM115,ACH-000304,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7678730487823486
2713,4687,WM1799,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-8.5,-18,-11,-11,-7.8,-.70,-17","3.83,3.31,9.34,.77,11.3,10.1,.76,10.9",8,Constant,,8.0,-10.97654057,1.0246,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.669579029083252
2714,4688,WM-266-4,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-4.4,-6.8,-.77,-7.0,6.22,-.37,-1.2","2.56,4.13,4.05,2.20,5.55,7.13,9.15,14.6",8,Constant,,8.0,-2.72540617,0.1223,WM2664_SKIN,WM2664,ACH-001239,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.629873275756836
2715,4689,WM-793,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-.31,5.99,9.08,-7.7,9.37,-9.9,-1.8",".58,8.37,4.74,12.4,10.9,12.2,17.7,2.46",8,Constant,,8.0,0.350965619,0.1739,WM793_SKIN,WM793,ACH-000827,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,3.1033854484558105
2716,4690,WM-88,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-4.3,2.32,3.46,4.82,6.65,-13,-44","1.97,5.72,4.26,1.60,5.92,1.23,11.1,6.39",8,Sigmoid,2.934004784,8.0,-43.69504547,0.7236,WM88_SKIN,WM88,ACH-000899,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.8827452659606934
2717,4691,WM-983B,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,12.2,14.4,1.30,27.1,-.42,2.68,-57","2.52,8.02,18.1,11.4,14.5,4.40,13.1,15.0",8,Sigmoid,7.042369843,7.312819004,-57.20359802,1.4692,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,1.9896288360850873,2.6919543743133545
2718,4692,YKG1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-7.7,-2.0,-2.6,5.29,6.18,7.52,4.95","2.57,8.54,.26,6.32,2.71,3.93,2.78,11.5",8,Linear,,8.0,-15.35629845,0.2007,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.7290897369384766
2719,4693,ZR-75-1,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-13,10.4,-6.9,34.0,22.5,13.2,-4.8","24.8,2.10,10.5,16.0,1.91,4.69,35.1,8.13",8,Constant,,8.0,2.004356861,0.8454,ZR751_BREAST,ZR751,ACH-000097,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.955630302429199
2720,4694,ZR-75-30,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,.42,-6.0,-9.9,8.75,-.17,15.9,-94","26.9,43.0,1.79,13.1,20.5,36.0,12.2,15.7",8,Linear,,0.17081114,-91.81031799,0.7984,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,-1.7671967772721255,3.3128509521484375
2721,4695,SCC-25,Sorafenib,RTK,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-13,-8.8,15.6,12.5,1.20,8.03,14.9","18.3,20.7,2.11,7.90,5.08,9.73,8.31,7.62",8,Linear,,8.0,-19.0757637,0.3316,SCC25_UPPER_AERODIGESTIVE_TRACT,SCC25,ACH-000188,Head and Neck Cancer,8,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Nexavar,"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4",Multi-kinase inhibitor,Kinase inhibitor,Launched-2005,Bayer,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2.0794415416798357,2.6172213554382324
2722,5747,A172,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,2.08,-3.6,-5.7,-9.2,-15,-22,-38","2.47,.86,.55,1.68,9.81,5.17,.30,5.57",8,Sigmoid,8.860050457,8.0,-37.31843948,0.5436,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4597359299659729
2723,5748,A-204,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","21.9,-13,34.3,-10,8.53,-28,-10.0,-56","2.59,6.18,4.14,.16,9.50,22.3,22.0,4.29",8,Linear,,5.23065485,-53.82843781,0.5889,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.6545364805637208,-0.634515643119812
2724,5749,A2058,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.90,-5.2,-21,-40,-53,-54,-57,-60","2.31,1.30,2.33,2.13,4.12,1.24,.38,2.01",8,Sigmoid,0.034894064,0.202899247,-57.81409073,2.4465,A2058_SKIN,A2058,ACH-000788,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.5950457433450316,-1.3600115776062012
2725,5750,A-253,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.42,.82,2.39,-4.2,-25,-33,-37,-44","6.48,2.36,5.24,1.19,4.28,.72,2.07,7.66",8,Sigmoid,0.18387711,8.0,-37.304142,1.3819,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.9960460066795349
2726,5751,A2780,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-12,-33,-51,-62,-68,-74,-80","3.82,1.93,18.7,4.76,2.41,4.06,1.68,2.32",8,Sigmoid,0.002542614,0.064197071,-78.49171448,3.6018,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.745797692379944,-0.161077618598938
2727,5752,A-375,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-52,-68,-75,-75,-78,-77,-76","1.14,2.55,2.94,.17,1.13,1.99,.62,1.38",8,Sigmoid,0.002542614,0.007476748,-76.84836578,4.8148,A375_SKIN,A375,ACH-000219,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.895957340889291,-1.6689667701721191
2728,5753,A549,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,-16,-20,-49,-56,-66,-90,-107","3.78,5.66,4.26,.91,.39,5.01,.28,.47",8,Sigmoid,8.272846487,0.171543315,-106.8563461,3.1106,A549_LUNG,A549,ACH-000681,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.762919478667796,-0.49978333711624146
2729,5754,A-673,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.63,-3.1,-17,-7.5,-28,-21,-18,-14","9.60,8.90,.69,2.11,8.09,3.13,11.8,19.8",8,Constant,,8.0,-13.18042564,0.6163,A673_BONE,A673,ACH-000052,Bone Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.18590521812438965
2730,5755,ACHN,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,-6.6,-13,-18,-30,-26,-35,-43","2.32,3.48,.0097,.67,3.72,1.17,5.76,6.95",8,Sigmoid,1.646963716,8.0,-41.65621948,1.2671,ACHN_KIDNEY,ACHN,ACH-000046,Kidney Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.5895680785179138
2731,5756,ALL-SIL,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","14.7,-2.3,-.60,-10,-28,-21,-29,-39","26.3,10.3,25.2,5.93,5.35,7.00,12.9,9.34",8,Sigmoid,0.01040253,8.0,-36.38437271,1.7295,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.2853536307811737
2732,5757,AMO-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-19,-22,-40,-42,-50,-54,-58","3.12,11.9,8.47,3.25,3.76,6.73,0,0",8,Sigmoid,0.052927416,0.739885271,-56.54475403,2.9921,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.3012601439929283,0.7118353247642517
2733,5758,AsPC-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,10.9,-36,-42,-58,-67,-84,-83","8.52,6.67,2.56,8.39,3.76,9.85,2.68,5.40",8,Sigmoid,0.002542614,0.138186365,-83.3290329,2.611,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.979152033876267,-0.6807489395141602
2734,5759,AU565,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,-5.5,-8.2,4.17,-3.0,2.21,5.88,9.99","5.90,.84,4.81,6.96,12.1,.58,14.4,19.8",8,Constant,,8.0,-1.823978543,0.04551,AU565_BREAST,AU565,ACH-000248,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.15570558607578278
2735,5760,B-CPAP,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,-19,-30,-39,-46,-46,-51,-54","10.4,2.72,4.54,3.23,5.45,3.98,4.28,.72",8,Sigmoid,0.002542614,1.604760051,-52.67718887,2.855,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.4729742444710211,-0.8915541768074036
2736,5761,BDCM,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-31,-38,-44,-47,-54,-57,-68","5.39,16.3,7.20,7.49,8.26,4.91,9.76,2.92",8,Sigmoid,0.05667638,0.324745417,-66.42063141,2.3201,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.1247137359251582,0.4869106411933899
2737,5762,BFTC-909,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".37,-9.7,-8.0,-10,-13,-20,-18,-25",".014,5.62,7.24,1.00,1.37,1.68,4.88,7.78",8,Sigmoid,0.140633196,8.0,-23.56767082,0.8653,BFTC909_KIDNEY,BFTC909,ACH-000792,Kidney Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.7542962431907654
2738,5763,BL-41,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.81,-.45,4.61,6.99,2.35,6.90,-4.5,-2.7","8.17,3.38,4.75,4.08,.71,8.98,.60,3.86",8,Constant,,8.0,1.62255156,0.0,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.5816192030906677
2739,5764,BL-70,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.7,14.8,-.37,15.9,-10,.89,-.12,6.70","9.56,17.4,8.92,.99,6.03,5.61,15.2,2.36",8,Constant,,8.0,4.879201889,0.06714,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.7785544991493225
2740,5765,BT-20,PD-0325901,MEK,".0080,.025,.080,.25,.80,2.53,8","7.02,.74,-5.6,-20,-7.4,-11,-15","30.7,6.75,3.04,13.0,23.9,12.7,12.9",7,Constant,,8.0,-7.232457638,0.4673,BT20_BREAST,BT20,ACH-000536,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.0014071110635995865
2741,5766,BT-474,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-15,5.28,-26,-11,-7.0,.15,-23","19.8,16.2,17.4,7.41,20.1,.24,11.9,7.38",8,Constant,,8.0,-7.477146149,0.5865,BT474_BREAST,BT474,ACH-000927,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,1.4379067420959473
2742,5767,BT-549,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.03,9.45,9.62,5.83,-11,13.4,-16,-8.4","8.50,2.19,7.18,3.95,13.2,2.42,.62,3.36",8,Constant,,8.0,4.01490736,0.1503,BT549_BREAST,BT549,ACH-000288,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.4539652466773987
2743,5768,BxPC-3,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.92,5.90,-32,-35,-49,-44,-64,-73","4.07,5.10,5.24,3.68,5.18,10.6,1.25,.15",8,Sigmoid,0.061868649,0.252431244,-68.52736664,2.8579,BXPC3_PANCREAS,BXPC3,ACH-000535,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.3766163683374677,-0.2861911356449127
2744,5769,C2BBe1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-26,-26,-43,-29,-46,-46,-45","0,2.49,36.1,7.42,3.71,6.22,8.67,4.60",8,Constant,,8.0,-40.32930374,2.6013,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.3941649794578552
2745,5770,C32,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.6,-17,-33,-43,-73,-72,-68,-71","16.9,5.21,7.71,.20,1.62,.62,.25,2.58",8,Sigmoid,0.082389861,0.089522883,-71.14279938,3.2117,C32_SKIN,C32,ACH-000580,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.4132610104032066,-1.1470706462860107
2746,5771,CAL-12T,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,-2.2,-6.9,-23,-49,-49,-68,-73","3.12,2.22,11.7,6.97,5.24,13.0,7.58,3.65",8,Sigmoid,0.148701027,0.309053719,-71.09223938,2.2204,CAL12T_LUNG,CAL12T,ACH-000826,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.1742401692977458,-0.26266443729400635
2747,5772,CAL 27,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,-17,-32,-45,-52,-61,-62,-68","4.27,1.04,2.15,1.20,5.99,2.41,1.29,1.00",8,Sigmoid,0.020673677,0.133890107,-65.32472229,2.6201,CAL27_UPPER_AERODIGESTIVE_TRACT,CAL27,ACH-000832,Head and Neck Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.0107359125096758,-0.3538174033164978
2748,5773,CAL-85-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.02,7.55,-19,-25,-47,-48,-58,-63","6.66,17.4,13.1,14.1,13.3,3.39,10.3,3.09",8,Sigmoid,0.06256634,0.679533243,-62.640728,2.3533,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.38634912385030995,0.01429070346057415
2749,5774,Calu-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.37,-20,-26,-42,-32,-47,-44,-53","1.82,1.47,3.31,4.74,1.91,2.86,5.63,5.02",8,Sigmoid,0.002542614,8.0,-48.03420639,2.1985,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.14066879451274872
2750,5775,Calu-3,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","11.7,-8.9,-16,.026,-15,-32,-44,-74","18.5,19.0,6.79,11.8,2.29,3.84,11.1,.72",8,Sigmoid,8.983236831,3.064517498,-73.36834717,1.8058,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.1198901338310843,0.02393682859838009
2751,5776,Calu-6,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","11.3,-12,-14,-43,-58,-73,-84,-93",".46,16.6,8.64,10.4,2.70,2.24,.46,3.19",8,Sigmoid,0.097801387,0.162139654,-90.50283051,3.2483,CALU6_LUNG,CALU6,ACH-000264,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.8192972533831606,-0.7089120149612427
2752,5777,CAMA-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.91,2.55,.87,-6.0,-11,-2.4,-15,-24","5.77,1.42,11.3,20.2,3.84,3.88,3.82,.14",8,Sigmoid,9.025460883,8.0,-22.43252754,0.238,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.47447752952575684
2753,5778,Capan-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-28,-36,-53,-54,-55,-67,-76","10.3,12.6,3.31,3.94,6.24,18.0,4.59,10.4",8,Sigmoid,2.174126148,0.077857971,-80.30715942,3.115,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.552868996733528,-0.3154461681842804
2754,5779,CAS-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,1.35,-1.1,-13,-8.1,4.03,-19,-48","13.1,7.57,6.80,4.36,3.44,8.79,.95,11.0",8,Sigmoid,2.86344099,8.0,-47.9660759,0.586,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.29045072197914124
2755,5780,CCK-81,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","24.0,-9.1,7.50,-13,-42,-46,-64,-64","11.5,9.69,8.01,20.8,13.6,.80,4.29,5.14",8,Sigmoid,0.116606072,0.719762087,-65.1452713,2.5956,CCK81_LARGE_INTESTINE,CCK81,ACH-000963,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.3288345562998405,0.005666440352797508
2756,5781,CHP-212,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-61,-75,-81,-84,-89,-93,-100","12.6,10.2,5.21,1.86,.28,.88,.53,.80",8,Sigmoid,0.002542614,0.005780043,-93.79586792,5.6249,CHP212_AUTONOMIC_GANGLIA,CHP212,ACH-000120,Neuroblastoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-5.1533441568791565,-0.6436752676963806
2757,5782,CI-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,7.96,-23,16.2,-41,15.4,-3.9,16.6","1.15,29.5,26.6,19.5,18.2,13.4,4.43,1.90",8,Constant,,8.0,-3.359089136,0.6039,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.14469175040721893
2758,5783,COLO-320,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".53,2.67,1.91,-2.0,7.19,.76,3.52,-6.0","12.1,.65,3.03,2.54,8.33,10.4,1.57,1.99",8,Constant,,8.0,1.938730717,0.01305,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.27824440598487854
2759,5784,COLO-678,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,-18,-35,-42,-49,-62,-52,-55",".87,8.12,1.25,1.48,2.38,5.48,2.27,3.49",8,Sigmoid,0.014698777,0.227784306,-55.59964371,3.1372,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.4793561241088016,-0.583437979221344
2760,5785,COLO-679,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.31,-46,-57,-73,-74,-81,-77,-90","1.81,16.6,.83,.27,.39,3.25,.92,2.71",8,Sigmoid,0.002542614,0.012509198,-82.38323975,4.7338,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.381291065271398,-1.0622823238372803
2761,5786,COLO 741,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","27.0,1.35,-7.2,-45,-48,-57,-56,-68","7.35,17.1,9.41,3.11,2.05,3.00,3.89,.73",8,Sigmoid,0.020953318,0.217735618,-62.3298111,2.757,COLO741_SKIN,COLO741,ACH-000582,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.524473713651241,-0.8798737525939941
2762,5787,COR-L105,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.56,1.31,5.54,-30,-23,-47,-58,-67","7.45,22.0,8.91,3.49,2.39,3.78,10.1,6.28",8,Sigmoid,0.395327657,1.19507885,-67.25302124,1.8902,CORL105_LUNG,CORL105,ACH-000161,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.17821216647027255,0.40132007002830505
2763,5788,COR-L23,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,1.35,-4.2,-.68,-3.6,-9.3,-23,-38","2.67,2.28,2.62,2.30,5.78,2.43,2.31,8.21",8,Sigmoid,2.2574444,8.0,-25.29614639,0.5205,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.04262978583574295
2764,5789,COV318,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,25.6,-.27,18.4,-3.2,-1.3,.11,-2.0","1.63,10.2,.72,19.3,8.82,6.06,.52,7.17",8,Constant,,8.0,0.332616538,0.02419,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.818120002746582
2765,5790,COV504,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-2.4,-16,-26,-35,-28,-47,-48","12.0,2.59,17.1,14.6,.94,6.10,3.25,2.16",8,Sigmoid,0.29375574,8.0,-48.50157166,0.9822,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.17546649277210236
2766,5791,Daoy,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,.77,.011,-3.7,-.84,-4.1,-1.6,-7.1","15.5,10.4,30.1,11.5,15.0,.37,23.0,11.2",8,Constant,,8.0,-4.11864233,0.01505,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.49656105041503906
2767,5792,DBTRG-05MG,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,-25,-42,-44,-46,-40,-46,-57","8.39,8.09,.14,2.95,8.24,15.3,3.67,7.43",8,Sigmoid,0.002542614,8.0,-49.30300522,2.9241,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4136941134929657
2768,5793,Detroit 562,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","11.0,-1.8,-14,-13,-29,-27,-38,-36","1.73,4.22,8.75,4.50,1.55,.034,2.03,2.82",8,Sigmoid,0.002542614,8.0,-37.57982635,1.2996,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.5863301753997803
2769,5794,DK-MG,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-1.8,-6.8,-24,-24,-31,-29,-50","4.49,2.84,1.62,1.05,.30,.75,6.13,3.80",8,Sigmoid,8.490422469,8.0,-45.70318604,1.3384,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.3420391082763672
2770,5795,DMS 114,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.80,6.41,6.93,-7.7,-11,-.86,-4.3,-34","17.6,18.3,10.5,30.8,8.08,26.4,.13,15.7",8,Constant,,8.0,-4.345439911,0.4387,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,1.1922708749771118
2771,5796,DOHH-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","26.8,22.2,-12,-.52,4.16,-14,30.0,4.26","22.0,24.9,40.9,18.2,20.4,5.03,52.4,2.51",8,Constant,,8.0,5.76189518,0.8781,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.9022449851036072
2772,5797,DV-90,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.43,.52,-44,-54,-69,-76,-78,-91","3.67,.64,11.4,7.16,5.63,6.62,5.70,1.90",8,Sigmoid,0.028613655,0.065534264,-84.52414703,4.1181,DV90_LUNG,DV90,ACH-000925,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.7251821586138085,-0.21704073250293732
2773,5798,EB1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.07,17.7,20.8,-13,-18,-21,-16,-14","24.4,15.1,50.5,17.9,23.4,15.7,13.2,6.73",8,Constant,,8.0,-10.02450943,0.9204,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.4333811402320862
2774,5799,EBC-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,2.68,-38,-61,-80,-87,-93,-94","8.47,4.56,4.67,2.07,1.80,3.12,1.76,1.41",8,Sigmoid,0.042187713,0.045943316,-93.6104126,4.3938,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.0803469032203252,-0.14831703901290894
2775,5800,EFE-184,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,-13,-13,-24,-24,-27,-36,-43","4.58,14.2,7.88,15.8,5.63,13.6,6.65,6.32",8,Sigmoid,4.492999554,8.0,-42.52119827,1.3875,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.20400023460388184
2776,5801,EFM-19,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.31,6.72,-3.6,4.29,8.02,6.04,1.28,-4.8",".87,1.73,.094,16.4,6.42,12.2,1.73,5.38",8,Constant,,8.0,2.086999178,0.09919,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.6338843703269958
2777,5802,EFO-21,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,23.8,-6.5,-10,-25,-27,-43,-35","9.92,0,10.2,35.5,2.13,5.46,3.42,6.23",8,Sigmoid,0.131599709,8.0,-38.1571312,1.0839,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.00516667403280735
2778,5803,EFO-27,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,.23,-11,-14,-28,-25,-37,-33","1.02,.53,2.40,.68,1.80,3.63,8.98,.77",8,Sigmoid,0.12823844,8.0,-30.40970612,0.9157,EFO27_OVARY,EFO27,ACH-000936,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.6044768691062927
2779,5804,EM-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.3,-25,-48,-62,-69,-72,-78,-85","12.9,10.7,9.40,1.83,2.28,.48,1.99,1.53",8,Sigmoid,0.002542614,0.034289107,-82.29035187,4.5392,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.372927555424433,0.23641598224639893
2780,5805,EN,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-1.6,-14,-6.9,-17,-11,-7.3,-10","3.90,5.52,.55,4.93,6.93,3.01,9.45,1.76",8,Constant,,8.0,-9.726068497,0.557,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.48188990354537964
2781,5806,ES-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.82,3.10,-19,-46,-54,-67,-67,-73","14.7,9.22,10.5,2.76,.24,2.31,.25,.15",8,Sigmoid,0.033823185,0.131824732,-70.33293152,3.051,ES2_OVARY,ES2,ACH-000906,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.0262820265659633,-0.6008704900741577
2782,5807,ESS-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.31,.90,-.75,-8.1,-3.0,-8.9,-27,-49","5.65,2.41,5.71,2.13,6.98,4.58,7.62,5.03",8,Sigmoid,9.111799583,8.0,-48.52753067,0.9489,ESS1_ENDOMETRIUM,ESS1,ACH-000913,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4516303539276123
2783,5808,F-36P,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-45,-36,-44,-59,-64,-54,-59","1.75,1.95,19.1,2.45,9.17,.50,3.10,3.91",8,Sigmoid,0.092979163,0.101642273,-59.15935516,3.7848,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.2862957575374097,0.4319869577884674
2784,5809,FaDu,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,-12,-25,-33,-42,-46,-50,-54",".022,7.69,4.71,.13,3.89,.53,5.01,1.41",8,Sigmoid,0.01276476,2.066126823,-53.60330582,2.2958,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.7256757545830206,-0.7402558922767639
2785,5810,FU97,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","11.4,-14,1.45,-2.5,-41,-53,-56,-68","2.05,7.48,14.9,5.78,9.63,1.62,6.40,2.74",8,Sigmoid,0.193015546,0.362124264,-59.59348297,1.9272,FU97_STOMACH,FU97,ACH-000633,Gastric Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.0157678553420475,-0.6932305097579956
2786,5811,FU-OV-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,-16,-21,-32,-35,-48,-43,-55",".031,7.19,3.29,15.5,7.35,2.60,10.4,10.3",8,Sigmoid,0.002542614,3.074702978,-54.15998077,2.2864,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.123208304072798,-0.11015381664037704
2787,5812,G-361,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,-8.5,-52,-72,-78,-81,-81,-85","1.87,10.4,6.27,.76,2.40,.83,2.11,2.25",8,Sigmoid,0.010502953,0.024077827,-82.17955017,4.4245,G361_SKIN,G361,ACH-000572,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.726463903477256,-1.405478596687317
2788,5813,G-401,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,.86,-25,-8.5,-24,-19,-47,-68","7.60,30.6,16.3,20.4,5.28,15.3,5.43,4.88",8,Sigmoid,2.484352112,2.883607388,-68.39903259,2.1278,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.0590420756201882,-0.4391375780105591
2789,5814,G-402,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.6,2.90,10.1,-16,-16,-19,-19,-45","5.71,12.7,.96,10.8,3.17,6.00,6.28,23.6",8,Sigmoid,8.172306175,8.0,-37.14874268,0.689,G402_SOFT_TISSUE,G402,ACH-000375,Kidney Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.30306828022003174
2790,5815,GAMG,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","11.0,4.79,-.14,-7.4,-.065,10.7,-15,-33","7.25,3.02,6.20,21.5,4.65,2.18,9.08,3.48",8,Sigmoid,2.469465971,8.0,-32.8453598,0.3018,GAMG_CENTRAL_NERVOUS_SYSTEM,GAMG,ACH-000098,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.13481417298316956
2791,5816,GB-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-10,-3.7,-31,-31,-39,-51,-81","13.4,6.11,17.0,1.77,3.64,1.48,1.07,2.67",8,Sigmoid,8.9177939,1.90375483,-79.49858856,2.272,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.6438281623218494,0.19493216276168823
2792,5817,GCT,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.51,-9.4,-14,-32,-38,-45,-39,-52","5.61,4.46,3.18,3.78,2.44,2.57,1.93,3.16",8,Sigmoid,0.004670071,8.0,-48.95529556,2.0909,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4574907720088959
2793,5818,GI-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.39,8.27,.69,-4.3,-3.9,-17,-27,-40","1.83,5.07,4.49,16.6,2.37,15.3,.53,13.9",8,Sigmoid,8.543831326,8.0,-40.06552124,0.7663,GI1_CENTRAL_NERVOUS_SYSTEM,GI1,ACH-000756,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.46268412470817566
2794,5819,GMS-10,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.38,5.44,-1.2,-7.3,-15,-13,-26,-33","8.73,14.8,5.47,8.33,9.76,2.80,.81,6.49",8,Sigmoid,3.883296251,8.0,-31.82688522,0.624,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.29517146944999695
2795,5820,GRANTA-519,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,5.60,-6.1,-.84,-20,-18,-21,-29","20.2,8.66,30.0,4.14,17.6,.87,10.6,4.98",8,Constant,,8.0,-15.68959713,1.2719,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.5417569279670715
2796,5821,H4,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.24,11.6,2.44,8.11,3.04,6.52,6.34,-3.5","8.21,3.15,2.85,.11,4.41,.95,8.26,5.28",8,Constant,,8.0,5.934113026,0.01881,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.25455448031425476
2797,5822,HARA,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,3.96,-2.9,-23,-21,-12,-40,-57","8.22,13.9,4.55,6.46,6.93,1.73,13.7,1.24",8,Sigmoid,8.475510472,5.792830944,-56.18247223,1.1893,HARA_LUNG,HARA,ACH-000843,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.7566211088818249,-0.3476811647415161
2798,5823,HCC1187,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.01,-4.1,-8.0,-9.1,-25,-21,-16,-15","8.42,5.78,10.3,2.46,1.16,2.51,3.67,2.61",8,Constant,,8.0,-13.62421036,0.5391,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,1.2432985305786133
2799,5824,HCC1395,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,4.09,.72,-1.5,-3.2,-20,-25,-38","6.87,4.12,.25,5.94,9.51,1.37,.49,8.35",8,Sigmoid,1.052071214,8.0,-35.76197433,0.56,HCC1395_BREAST,HCC1395,ACH-000699,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.05789927393198013
2800,5825,HCC-15,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","21.8,-4.7,-5.5,-30,-19,-39,-25,-38","5.53,23.3,4.94,19.0,4.77,9.71,5.67,18.5",8,Sigmoid,0.026453476,8.0,-29.36388016,1.8382,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.056159764528274536
2801,5826,HCC1569,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","27.4,.87,11.7,1.16,-9.4,-13,-4.7,-24","4.07,9.95,15.3,8.29,12.0,.49,6.39,22.0",8,Sigmoid,0.002542614,8.0,-17.40347862,0.2342,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.6587277054786682
2802,5827,HCC1806,PD-0325901,MEK,".0080,.025,.080,.25,.80,2.53,8","-7.2,-9.4,-38,-25,-40,-34,-53","2.41,4.92,8.77,6.23,13.4,.46,14.3",7,Sigmoid,0.038444895,8.0,-35.10932541,2.1571,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.202244371175766
2803,5828,HCC1954,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.8,.42,-5.9,-29,-27,-36,-43,-47","12.6,9.70,10.4,8.49,1.15,5.30,4.24,3.79",8,Sigmoid,0.004156668,8.0,-47.27595901,1.6269,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.49005126953125
2804,5829,HCC2935,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.47,-9.4,-3.2,-9.7,-20,-30,-25,-33","32.7,19.7,23.7,12.9,1.30,1.11,6.15,16.0",8,Constant,,8.0,-19.9040699,0.7479,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.0855586901307106
2805,5830,HCC4006,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","16.1,-1.5,8.67,-16,-22,-37,-41,-65","4.79,9.93,1.46,6.86,15.5,3.79,2.73,2.59",8,Sigmoid,8.499871275,3.165573597,-62.57227707,1.7547,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.1523342704553559,0.21809235215187073
2806,5831,HCC-44,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.17,-7.6,-1.3,-13,-13,-31,-45,-64","3.96,.30,3.69,2.23,7.12,7.05,2.54,9.87",8,Sigmoid,8.000812234,3.420663357,-64.49765015,1.5458,HCC44_LUNG,HCC44,ACH-000667,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.2298344963010102,-0.21183456480503082
2807,5832,HCC-56,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,-46,-61,-77,-82,-82,-85,-88","24.5,3.83,1.07,2.31,1.57,.89,2.37,.64",8,Sigmoid,0.005157314,0.010615913,-86.66324615,5.0257,HCC56_LARGE_INTESTINE,HCC56,ACH-000467,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.545401177162902,-0.6435350775718689
2808,5833,HCC70,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-4.8,-6.4,-15,-23,-35,-12,-31","8.70,18.6,34.9,34.8,31.3,26.1,47.4,37.4",8,Sigmoid,7.083399927,1.253405809,-53.56866837,2.1081,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.22586449339160292,0.5801954865455627
2809,5834,HCC-78,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-6.1,-3.9,-5.4,-19,-6.0,-14,-19","23.7,11.6,1.52,10.6,6.36,.89,15.0,6.25",8,Constant,,8.0,-9.539144516,0.3694,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.30189815163612366
2810,5835,HCC827,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.9,24.5,-4.5,32.7,-10,-11,-43,-32","26.2,12.2,6.96,18.2,10.6,3.30,10.5,.32",8,Linear,,8.0,-38.29376984,0.7286,HCC827_LUNG,HCC827,ACH-000012,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.012749755755066872
2811,5836,HCT 116,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-13,-18,-44,-59,-65,-77,-92","2.57,10.9,5.66,5.42,11.6,7.50,5.67,2.44",8,Sigmoid,0.277186483,0.202401146,-89.7215271,3.6651,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.5975036795295199,-0.8090727925300598
2812,5837,HCT-15,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.28,-3.0,-7.1,-22,-23,-29,-39,-51","9.35,1.74,1.07,6.75,1.89,6.55,.92,3.10",8,Sigmoid,8.364853844,8.0,-49.93529129,1.4088,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.6065460443496704
2813,5838,HD-MY-Z,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.2,-31,-51,-72,-77,-82,-87,-92","1.60,7.73,5.95,3.14,1.57,1.86,2.47,1.23",8,Sigmoid,0.00476073,0.022050716,-89.79743195,4.6897,HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HDMYZ,ACH-000190,Unknown,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.814410205961146,-0.3739335238933563
2814,5839,HDQ-P1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-22,-19,-28,-33,-37,-42,-54","21.3,31.4,15.6,5.13,3.95,1.16,1.21,23.4",8,Sigmoid,8.493745833,5.738184452,-52.39045334,3.6834,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.7471428627378753,0.3172141909599304
2815,5840,HEC-151,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-13,-40,-49,-61,-56,-76,-65","7.37,.88,6.83,.95,2.25,3.36,.27,6.46",8,Sigmoid,0.04823244,0.08198344,-66.40122223,3.6687,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.5012380033322894,-0.7647903561592102
2816,5841,HEC-1-A,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,.23,-29,-2.3,-30,-32,-44,-44","9.97,.87,16.7,25.2,21.0,5.99,22.5,12.2",8,Constant,,8.0,-24.16619492,1.652,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.5511249899864197
2817,5842,HEC-1-B,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.041,-20,-22,-43,-37,-26,-41,-51","8.37,5.55,13.7,.74,6.85,13.3,2.09,7.98",8,Sigmoid,0.002542614,8.0,-42.37294388,2.6065,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.557715117931366
2818,5843,HEC-251,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.46,12.1,-18,-12,-25,-22,-35,-36","1.30,6.48,1.09,14.6,1.81,5.91,4.54,21.7",8,Sigmoid,0.035637319,8.0,-34.70594406,1.1822,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.20052564144134521
2819,5844,HEC-265,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.96,6.59,10.3,1.83,.097,-5.7,6.17,-18","14.9,.12,1.40,8.29,7.74,11.2,3.96,18.2",8,Constant,,8.0,4.390866756,0.1312,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.5456231236457825
2820,5845,HEC-59,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.63,13.2,3.13,-.10,-11,-16,-18,-13","12.1,.12,4.98,3.45,9.53,5.29,4.63,10.8",8,Sigmoid,0.098127663,8.0,-16.77277565,0.05466,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.16618666052818298
2821,5846,HEC-6,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","79.1,-12,25.1,3.18,15.6,-32,-11,2.24","65.8,8.57,42.1,14.9,10.7,3.14,28.8,20.9",8,Linear,,8.0,-22.6084137,1.1049,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.01275644265115261
2822,5847,HEL 92.1.7,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.51,9.43,1.84,-1.7,-3.0,-8.9,-15,-15","13.5,3.18,12.9,1.24,8.73,.77,5.83,4.02",8,Sigmoid,0.014867549,8.0,-15.85270405,0.592,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.30699729919433594
2823,5848,Hep 3B2.1-7,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,11.2,-8.2,8.39,-35,-39,-89,-97","4.65,3.52,3.51,.25,9.82,.58,1.72,.86",8,Sigmoid,0.960415125,0.847085655,-99.33177948,2.6284,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.16595346193426969,-0.05382813513278961
2824,5849,Hep G2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".14,-25,-53,-60,-66,-72,-79,-69","3.66,8.28,.95,6.26,2.33,1.51,11.2,3.55",8,Sigmoid,0.00375666,0.022851815,-70.31735229,3.9209,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.778724733724194,-0.6581079363822937
2825,5850,Hey-A8,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,-15,-21,-33,-42,-52,-61,-69",".0052,2.25,.37,5.58,2.36,1.91,1.95,1.65",8,Sigmoid,0.139929116,0.636340976,-68.7664032,2.2657,HEYA8_OVARY,HEYA8,ACH-000542,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.45202073351993505,-0.8777428269386292
2826,5851,HGC-27,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".39,3.20,.59,-.91,1.96,3.89,-2.1,-2.0","2.38,1.56,3.04,.73,2.23,1.28,3.34,1.64",8,Constant,,8.0,0.288062811,0.0,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.37401384115219116
2827,5852,HH,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,28.3,7.04,1.62,-8.2,8.60,3.41,11.4","23.1,22.1,9.44,6.35,2.97,23.7,1.70,28.0",8,Constant,,8.0,3.412937403,0.7106,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.3108970522880554
2828,5853,HLF,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,13.4,-8.1,-14,-17,-16,-25,-23","7.66,3.23,.52,1.31,1.14,9.19,2.87,1.45",8,Sigmoid,0.057037335,8.0,-23.79829407,0.8906,HLF_LIVER,HLF,ACH-000393,Liver Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.49186116456985474
2829,5854,HMC-1-8,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-26,-44,-63,-67,-69,-73,-78","1.46,2.34,.82,3.06,1.66,1.32,3.41,.30",8,Sigmoid,0.022083836,0.036374319,-73.86588287,3.8973,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.3138922753152174,-0.10957589000463486
2830,5855,HMCB,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.30,-10.0,3.73,-23,-11,-32,-32,-59","3.01,4.80,7.64,6.61,.43,1.49,.26,4.15",8,Sigmoid,8.979474182,5.477803707,-55.87388611,1.327,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.7007042372306336,-0.7481070160865784
2831,5856,HOS,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.87,1.57,17.6,-25,-13,-24,-22,-23","26.4,13.9,7.93,15.2,.38,2.04,12.7,2.76",8,Sigmoid,0.047092516,8.0,-21.33578682,1.1514,HOS_BONE,HOS,ACH-000613,Bone Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.3178246021270752
2832,5857,HPAC,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-12,-31,-55,-50,-63,-70,-71","4.59,11.3,.91,29.7,7.43,7.72,4.63,6.51",8,Sigmoid,0.020677781,0.209011331,-72.46781158,3.3129,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.5653668131759182,-0.3881811201572418
2833,5858,HPAF-II,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.96,32.0,-20,-25,-41,-56,-67,-81","29.0,53.1,10.3,14.4,16.8,27.0,9.01,4.86",8,Sigmoid,1.08481288,0.566682398,-81.10289764,3.016,HPAFII_PANCREAS,HPAFII,ACH-000094,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.5679562768148031,0.492469847202301
2834,5859,Hs 294T,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-7.4,-18,-33,-39,-40,-43,-49",".95,2.93,.044,7.90,.021,6.68,4.36,3.06",8,Sigmoid,0.051911186,8.0,-45.81593704,2.213,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.860980749130249
2835,5860,Hs 578T,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".84,-15,-10,-20,-18,-18,-30,-40","1.78,1.03,3.29,1.83,1.33,2.84,4.49,3.71",8,Sigmoid,8.979272875,8.0,-38.08044434,1.2618,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.3884143829345703
2836,5861,Hs 683,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,4.25,3.25,-9.5,-13,-7.8,-2.8,-41","1.28,13.6,3.67,7.87,11.1,4.13,14.6,10.8",8,Sigmoid,8.34854788,8.0,-27.38531876,0.5807,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4851917028427124
2837,5862,Hs 695T,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.51,-5.8,-10,-41,-46,-50,-57,-60","4.37,7.07,.92,3.41,5.59,.82,4.08,2.81",8,Sigmoid,0.049212229,0.237993121,-55.68767166,2.3595,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.435513509089717,-0.4551241397857666
2838,5863,Hs 729,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".46,2.76,4.98,-3.4,5.12,-11,-.48,-21","6.89,3.31,2.08,7.79,3.66,3.61,3.85,3.53",8,Sigmoid,8.952503876,8.0,-20.43735695,0.44,HS729_SOFT_TISSUE,HS729,ACH-000133,Unknown,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.10590910166501999
2839,5864,Hs 746T,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-3.1,-25,-28,-32,-43,-53,-61","17.4,9.65,4.66,5.10,5.89,7.28,1.07,2.85",8,Sigmoid,8.087196551,2.000169039,-60.71192932,2.6193,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.6932316964883737,-0.196024090051651
2840,5865,Hs 766T,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-44,-50,-59,-52,-57,-58,-62",".93,12.5,.24,2.30,4.09,.68,.74,1.37",8,Sigmoid,0.002542614,0.01714126,-58.00505829,3.6998,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.066266856262355,-0.5591228604316711
2841,5866,Hs 852.T,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-5.7,-21,-31,-38,-43,-54,-70","7.50,.65,1.89,8.87,5.83,1.42,.83,2.26",8,Sigmoid,1.670592308,1.339613318,-68.07135773,2.3665,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.2923810036621572,-0.48981723189353943
2842,5867,Hs 936.T,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-8.6,-35,-66,-71,-78,-79,-78","16.8,.49,3.72,2.09,.60,.65,.17,.96",8,Sigmoid,0.031704303,0.042563576,-77.31542969,3.7454,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.1567564149220546,-1.7877869606018066
2843,5868,Hs 939.T,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".52,-10,-43,-53,-58,-58,-60,-64","1.32,3.37,7.57,.10,3.03,.68,4.69,4.60",8,Sigmoid,0.015624173,0.041808613,-59.41081619,3.25,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.174652908045775,-1.2576467990875244
2844,5869,Hs 944.T,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.2,-7.0,-23,-46,-56,-64,-67,-76","7.05,3.99,3.02,2.73,.16,.30,1.61,1.41",8,Sigmoid,0.014795478,0.143660545,-73.2800293,3.1033,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.9403020886631563,-1.2344160079956055
2845,5870,HSC-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.88,7.65,10.7,10.2,3.74,4.55,-9.9,-15","2.08,1.29,3.50,.38,5.38,5.40,.27,3.30",8,Sigmoid,1.620536923,8.0,-15.50141907,0.2316,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.35189589858055115
2846,5871,HT,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.12,-.38,20.3,-18,-8.5,-2.0,-5.3,-23","19.0,15.0,1.44,7.80,.095,14.6,18.6,16.8",8,Constant,,8.0,-9.481054306,0.9237,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.761141836643219
2847,5872,HT-1080,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.24,-14,-22,-38,-45,-52,-56,-61","1.60,16.1,1.68,.91,.23,2.06,3.75,1.30",8,Sigmoid,0.020372592,0.446043372,-59.56815338,2.4808,HT1080_SOFT_TISSUE,HT1080,ACH-000054,Sarcoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.8073390850534493,-1.0342507362365723
2848,5873,HT-1197,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,-9.4,-27,-35,-38,-40,-40,-51","9.86,7.91,7.36,.64,1.69,2.51,9.28,7.34",8,Sigmoid,0.002542614,8.0,-46.69897461,2.0249,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.015488388016819954
2849,5874,HT-144,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-39,-47,-70,-69,-78,-76,-81","1.72,10.1,8.93,4.02,3.39,3.78,2.76,1.63",8,Sigmoid,0.002542614,0.019130703,-79.67162323,4.4659,HT144_SKIN,HT144,ACH-000322,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.95646074764272,-1.2244112491607666
2850,5875,HuCCT1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".90,-12,-16,-32,-39,-44,-42,-56",".85,4.39,1.68,1.52,4.05,7.89,16.7,1.06",8,Sigmoid,0.016804576,1.695538163,-55.81387329,2.3323,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.5280001907348463,-0.40794631838798523
2851,5876,huH-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.49,-3.5,-6.9,-5.2,-10,-20,-48,-48","14.4,3.43,3.48,10.2,4.62,20.4,1.23,19.6",8,Sigmoid,1.045213103,2.671397686,-60.0185051,0.2633,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.98260181334802,-0.46622124314308167
2852,5877,HUP-T3,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.87,-6.5,-5.2,-33,-47,-54,-48,-70","7.68,11.7,3.57,7.25,14.5,.76,6.19,2.02",8,Sigmoid,0.077656463,0.355318874,-59.35465622,2.2718,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.0347396560601037,0.0011464189738035202
2853,5878,HuT 78,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.99,-30,-60,-78,-81,-83,-93,-93","25.1,6.44,4.76,3.56,5.67,3.53,7.51,5.55",8,Sigmoid,0.01134356,0.017062185,-89.18500519,5.1608,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.070890667745837,0.1666225790977478
2854,5879,IA-LM,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-20,6.70,-27,-13,-22,-4.6,-11","31.6,10.2,16.5,2.69,17.4,6.28,27.7,7.74",8,Constant,,8.0,-16.72260666,0.9959,IALM_LUNG,IALM,ACH-000672,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.3920515179634094
2855,5880,IGR-37,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-33,-53,-68,-76,-76,-74,-75","16.8,7.19,1.31,5.53,1.08,.30,5.83,2.38",8,Sigmoid,0.020583348,0.021839682,-75.80973053,4.6732,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.8240266886509975,-1.1310169696807861
2856,5881,IGR-39,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","20.0,4.36,19.6,-18,4.49,-41,2.13,-55","4.33,15.8,10.5,10.8,10.9,3.21,13.3,4.58",8,Linear,,6.818576091,-51.37903976,1.2794,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.919650665746042,-0.9634060859680176
2857,5882,IGROV1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-1.9,-50,-8.5,-31,-25,-49,-46","5.57,4.87,63.9,2.51,4.12,8.41,.61,.032",8,Constant,,8.0,-23.83785629,1.8264,IGROV1_OVARY,IGROV1,ACH-000966,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4460921287536621
2858,5883,IMR-32,PD-0325901,MEK,".0080,.025,.080,.25,.80,2.53,8","-17,-2.9,-20,6.43,-5.2,-13,-34","5.12,6.35,7.76,10.7,16.7,18.1,9.89",7,Constant,,8.0,-14.1147871,0.7572,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.6212477087974548
2859,5884,IPC-298,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-54,-73,-82,-83,-88,-90,-94","10.3,2.08,3.31,.77,2.13,.70,1.08,.59",8,Sigmoid,0.002542614,0.006270713,-91.78465271,5.61,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-5.071865214694041,-1.1385071277618408
2860,5885,IST-MES2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.93,.47,-11,-19,-12,-22,-28,-53","23.1,14.4,3.64,16.6,19.3,21.5,1.94,6.09",8,Sigmoid,9.041850591,8.0,-48.24528122,1.4177,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.10177413374185562
2861,5886,J82,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,-9.3,-11,-8.1,-16,-11,-24,-35","18.5,2.84,12.8,13.9,3.06,2.08,4.79,1.73",8,Sigmoid,2.473379135,8.0,-34.99827957,0.7796,J82_URINARY_TRACT,J82,ACH-000396,Bladder Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.2783137559890747
2862,5887,JHH-4,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.3,7.72,14.1,19.5,10.8,-1.7,-46,-83","6.40,7.81,13.6,1.03,18.5,17.5,4.54,1.96",8,Sigmoid,2.175676107,2.750053167,-82.61925507,1.2402,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.0116202449461364,-0.42526546120643616
2863,5888,JHOS-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,16.3,-12,-3.1,-31,-21,-27,-41","9.53,20.7,14.9,14.3,18.8,31.3,19.6,4.16",8,Sigmoid,0.178464696,8.0,-36.8667717,1.0772,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.0006651971489191055
2864,5889,JHUEM-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","16.3,-2.2,7.14,14.6,-3.2,-6.8,-35,-59","4.42,21.0,24.1,3.13,16.3,17.4,8.28,2.83",8,Sigmoid,2.198953152,5.034770489,-58.40958023,0.8896,JHUEM2_ENDOMETRIUM,JHUEM2,ACH-000909,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.616367942013411,-0.49459707736968994
2865,5890,JM1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".067,18.8,-17,-7.3,-13,7.67,-21,16.3","3.27,4.55,8.84,.70,13.1,8.58,10.7,1.45",8,Constant,,8.0,-3.159585476,0.2912,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.534584641456604
2866,5891,JMSU-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.11,-3.7,-5.7,-8.3,-25,-40,-59,-74","3.56,4.83,6.91,1.05,6.72,7.19,3.47,.087",8,Sigmoid,1.049455762,1.420838833,-73.92852783,1.7564,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.35124742466717196,0.15602032840251923
2867,5892,JURKAT,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","14.9,12.4,11.7,-18,-12,3.50,-1.6,-8.1","14.7,2.59,24.4,18.7,11.5,4.61,1.39,9.11",8,Constant,,8.0,-1.333934903,0.7167,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.47251957654953003
2868,5893,JVM-3,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-30,-15,-32,-46,-33,-60,-29","45.1,10.2,3.09,3.59,18.9,.37,7.97,8.79",8,Constant,,8.0,-33.36257553,3.4643,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.9099497199058533
2869,5894,K029AX,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-31,-38,-50,-59,-65,-64,-68","10.1,1.67,1.37,3.88,5.84,7.39,2.21,2.28",8,Sigmoid,0.015809378,0.080208279,-67.24105835,3.6445,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.523128540011025,-1.3568460941314697
2870,5895,KALS-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-3.6,-19,-15,-42,-33,-49,-59","9.28,11.5,4.96,1.10,3.14,3.67,4.70,16.7",8,Sigmoid,1.49147439,2.966596365,-58.0881424,2.4758,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.0874152905981904,-0.03356729447841644
2871,5896,KARPAS-422,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","12.7,-2.2,-7.7,-13,-4.3,7.35,-10,-4.2","15.5,22.6,1.59,16.8,2.22,5.91,.63,7.02",8,Constant,,8.0,-4.279325485,0.8127,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.5581663250923157
2872,5897,KASUMI-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.8,-22,-14,-31,-33,-29,-35,-31","10.7,10.1,8.11,1.75,1.11,7.47,2.05,.15",8,Sigmoid,0.003194017,8.0,-32.77322006,2.1986,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.4076455235481262
2873,5898,KCL-22,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".43,4.43,-28,-57,-64,-61,-69,-75","6.40,11.8,4.10,13.2,3.35,10.9,4.08,4.59",8,Sigmoid,0.029868389,0.054352019,-68.59266663,3.6923,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.9122735179908172,0.2787630558013916
2874,5899,KG-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,18.3,-37,-12,-43,-62,-66,-80","45.0,1.99,.32,45.2,22.3,24.1,12.6,2.84",8,Linear,,0.371464181,-79.62514496,3.2569,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.9903028367002191,0.7391527891159058
2875,5900,KHM-1B,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,-29,-30,-39,-33,-43,-43,-38","8.10,7.39,.35,5.50,5.00,15.2,6.74,14.8",8,Sigmoid,0.002542614,8.0,-39.34957886,3.0813,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.44288989901542664
2876,5901,KMBC-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".38,1.14,-2.3,-25,-28,-51,-63,-82","6.52,.28,1.15,17.1,2.07,22.2,16.3,13.1",8,Sigmoid,1.458437562,1.145538807,-81.35187531,2.3614,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.13587510012020182,0.07617288827896118
2877,5902,KMM-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.51,-9.1,-15,-19,-42,-45,-51,-59",".82,30.9,15.3,9.16,9.61,4.76,4.34,3.25",8,Sigmoid,0.102228098,1.129081249,-55.77945709,2.3543,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.1214042480342916,0.638136088848114
2878,5903,KMRC-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","21.4,-23,.82,-25,-18,-37,-30,-57","11.9,6.71,3.58,5.57,5.45,8.62,7.32,8.48",8,Sigmoid,0.003694395,8.0,-48.78098679,1.5562,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.003360440954566002
2879,5904,KMRC-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.00,27.1,-1.4,4.59,-28,-15,-36,-45","4.70,14.9,4.24,20.2,2.13,4.14,4.85,.79",8,Sigmoid,5.370524883,8.0,-45.23147583,1.0423,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.6281363368034363
2880,5905,KMS-11,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.4,-3.9,21.4,.78,.96,-7.7,-9.5,-27","1.68,11.4,5.67,1.14,8.04,7.07,3.20,20.7",8,Sigmoid,8.029185867,8.0,-13.42146683,1.1908,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.5552387833595276
2881,5906,KMS-12-BM,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.53,-45,-5.5,-13,-.66,-20,15.6,7.31","28.2,21.5,11.0,.081,57.2,12.5,35.6,22.4",8,Constant,,8.0,-11.09157467,1.3436,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.6398299336433411
2882,5907,KMS-34,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.7,-3.0,25.6,.59,7.14,-3.0,22.9,-9.6","1.43,7.40,5.80,2.77,20.9,18.8,7.48,5.36",8,Constant,,8.0,5.974149704,0.3285,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.8245543837547302
2883,5908,KNS-60,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.38,-22,1.78,-38,-26,-34,-33,-51","5.94,6.49,11.6,9.15,5.99,4.57,7.89,7.20",8,Sigmoid,0.048651855,8.0,-36.5868187,1.7332,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.273500919342041
2884,5909,KNS-62,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.88,-7.9,-15,-16,-49,-47,-55,-71","1.02,8.79,7.96,2.87,8.50,3.38,1.88,2.41",8,Sigmoid,8.021710697,1.194876909,-70.31511688,1.9951,KNS62_LUNG,KNS62,ACH-000858,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.178043175057172,-0.7992873787879944
2885,5910,KNS-81,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".94,-8.2,-13,-23,-36,-17,-28,-38","8.30,.73,31.1,.26,9.23,23.5,3.29,.14",8,Sigmoid,0.009502687,8.0,-34.40674973,1.4195,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.0922606959939003
2886,5911,KO52,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-42,-57,-63,-64,-72,-72,-71,-74","14.1,1.86,5.99,.21,1.22,1.00,1.29,1.35",8,Sigmoid,0.002542614,0.004738287,-72.93617249,5.0744,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-5.352079600998188,0.581070065498352
2887,5912,KP-N-SI9s,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,-27,-33,-45,-64,-65,-56,-77","17.7,2.08,5.81,5.34,4.31,.19,.26,7.67",8,Sigmoid,0.002542614,0.098736674,-70.9513855,3.7935,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.3152988311424925,-0.08428441733121872
2888,5913,KU812,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-27,-40,-65,-75,-86,-89,-91","30.6,15.0,3.28,.98,.73,.90,1.55,2.50",8,Sigmoid,0.053660139,0.042091515,-90.38087463,4.5708,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.167909102549504,0.5634462237358093
2889,5914,KYM-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","28.2,-5.0,10.6,8.00,-2.6,-32,-54,-70","13.6,4.24,6.10,31.8,19.9,1.74,2.40,7.39",8,Sigmoid,0.948015451,1.93816185,-69.72753143,1.6464,KYM1_SOFT_TISSUE,KYM1,ACH-000607,Rhabdoid,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.6617400239133687,-0.8680170178413391
2890,5915,KYSE-140,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.66,.73,-5.5,-27,-31,-31,-51,-68","14.0,17.9,4.39,7.16,4.59,22.5,1.69,3.98",8,Sigmoid,8.414278494,2.105214119,-65.26490784,1.9335,KYSE140_OESOPHAGUS,KYSE140,ACH-000823,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.7444171812011987,-0.0795392319560051
2891,5916,KYSE-150,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","12.0,-4.8,-.12,1.62,-3.9,-5.0,-33,-28","13.9,11.4,.81,8.33,9.08,.22,9.58,6.05",8,Sigmoid,1.096879005,8.0,-30.38050461,0.5862,KYSE150_OESOPHAGUS,KYSE150,ACH-000855,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.06986146420240402
2892,5917,KYSE-180,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.50,3.04,-1.2,-3.8,-16,-4.6,-25,-27","1.00,9.77,3.09,7.18,7.35,10.4,16.7,5.90",8,Sigmoid,8.013826364,8.0,-26.67659569,0.3991,KYSE180_OESOPHAGUS,KYSE180,ACH-000693,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.26161205768585205
2893,5918,KYSE-30,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-21,-37,-49,-61,-67,-73,-74","6.84,2.18,1.53,.93,.91,.74,5.13,1.93",8,Sigmoid,0.043559879,0.084109992,-73.43976593,3.742,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.4756299081213373,-0.0693807303905487
2894,5919,KYSE-510,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.2,12.9,16.7,12.7,14.1,4.51,12.8,-3.4","6.46,5.49,1.70,7.62,2.28,6.68,7.67,4.47",8,Constant,,8.0,11.71912956,0.04356,KYSE510_OESOPHAGUS,KYSE510,ACH-000824,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.3719348907470703
2895,5920,KYSE-520,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10.0,-14,-20,-23,-34,-37,-49,-60","1.60,5.29,2.70,2.17,7.21,.92,3.94,1.70",8,Sigmoid,8.573117326,2.899242401,-59.87744522,1.9066,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.0644494618285625,-0.32149538397789
2896,5921,KYSE-70,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-20,-30,-33,-46,-44,-62,-65","4.53,4.19,5.63,3.87,2.70,.93,7.53,22.9",8,Sigmoid,0.002542614,0.640863359,-64.51931,2.7093,KYSE70_OESOPHAGUS,KYSE70,ACH-000784,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.44493901327183766,-0.1816614270210266
2897,5922,L3.3,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.64,-4.7,-5.7,-21,-22,-34,-34,-46","5.19,2.32,10.9,4.69,5.12,5.28,3.51,5.12",8,Sigmoid,8.0,8.0,-41.64892197,1.5302,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.0842265710234642
2898,5923,L-363,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.1,4.06,.29,-17,-15,6.68,4.51,1.97","7.70,16.6,22.8,2.02,16.8,11.6,25.7,25.4",8,Constant,,8.0,-2.575538635,1.4584,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.6220923066139221
2899,5924,L-428,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","18.1,11.7,28.2,24.2,1.75,4.36,6.08,8.59","8.09,3.51,2.58,20.8,4.15,27.0,7.10,2.92",8,Constant,,8.0,10.67221451,0.01169,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.534745454788208
2900,5925,LCLC-103H,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.5,10.4,3.85,-1.1,.33,-1.7,-12,-6.4",".83,8.07,6.20,2.14,8.48,2.54,11.3,4.09",8,Sigmoid,0.002542614,8.0,-7.048756599,0.16,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.5115306973457336
2901,5926,LN-229,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.38,5.58,-9.7,-26,-23,-27,-39,-59","10.7,3.84,2.02,1.97,1.10,1.99,2.44,1.20",8,Sigmoid,8.633705513,4.980614185,-55.30191803,1.6776,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.605553213753288,-1.0083026885986328
2902,5927,LOU-NH91,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","18.5,8.06,7.58,-4.5,-1.3,12.0,-3.5,5.23","12.3,.22,15.1,9.61,19.8,2.06,35.9,10.3",8,Constant,,8.0,9.289196014,0.005301,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.6397429704666138
2903,5928,LOX IMVI,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-18,-31,-31,-37,-50,-46,-88","6.89,13.3,4.16,.74,.58,2.85,10.3,5.40",8,Sigmoid,8.923612147,1.002676487,-80.06711578,2.7549,LOXIMVI_SKIN,LOXIMVI,ACH-000750,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.002672911586946222,-0.8729383945465088
2904,5929,LP-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","42.9,-8.4,-3.4,-14,22.3,13.4,3.26,-24","6.21,22.9,30.2,6.67,4.08,43.1,56.2,2.27",8,Constant,,8.0,-1.245171785,1.7369,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.9934398531913757
2905,5930,LS123,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.05,17.5,-32,-6.6,-30,-31,-37,-39","4.92,8.51,22.4,6.65,18.1,3.93,17.8,23.6",8,Sigmoid,0.015350724,8.0,-29.50844574,1.5646,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.23263227939605713
2906,5931,LS411N,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-34,-68,-80,-80,-86,-88,-89","3.47,14.4,12.9,3.20,4.61,2.52,.63,.84",8,Sigmoid,0.005855605,0.013036346,-87.15453339,4.9922,LS411N_LARGE_INTESTINE,LS411N,ACH-000985,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.340013976475038,-0.3518015742301941
2907,5932,LS513,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","18.2,-34,-36,-63,-75,-90,-94,-96","31.1,4.08,36.9,16.6,5.44,.41,1.30,.064",8,Sigmoid,0.002542614,0.031874225,-97.33514404,4.8546,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.4459575895246206,-0.2882317900657654
2908,5933,LU99,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.90,.62,-10,-32,-54,-56,-63,-72","6.71,1.82,21.7,3.07,.015,4.83,3.25,1.78",8,Sigmoid,0.072833478,0.253714144,-68.09693909,2.6236,LU99_LUNG,LU99,ACH-000444,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.3715470630440496,-0.6484827399253845
2909,5934,LUDLU-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.91,-17,-11,-25,-21,-20,-31,-30","38.9,19.0,12.8,9.56,3.03,2.05,4.94,1.63",8,Constant,,8.0,-20.51251602,1.5501,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.18575596809387207
2910,5935,Malme-3M,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-66,-88,-93,-95,-95,-95,-96","5.77,2.60,1.76,.92,.65,.91,.56,.36",8,Sigmoid,0.006325447,0.004154827,-95.1467514,6.4385,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-5.483484488123983,-1.0708435773849487
2911,5936,MCAS,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.27,9.90,-12,-14,-37,-42,-63,-73","6.52,4.93,5.98,7.90,5.08,.50,3.56,.45",8,Sigmoid,2.0125227,0.94524008,-73.28076935,2.0873,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.056316330844317176,-0.26645416021347046
2912,5937,MCF7,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.20,-24,-45,-35,-33,-5.2,-18,-46","13.9,49.2,17.3,39.9,12.6,44.6,16.2,25.4",8,Constant,,8.0,-28.94855499,0.3616,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.3435305058956146
2913,5938,MDA-MB-157,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.0,2.32,-4.0,-10,-3.0,-12,.25,-5.4","9.48,1.81,10.1,16.2,26.2,.84,6.41,14.4",8,Constant,,8.0,-3.351212502,0.751,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.17198964953422546
2914,5939,MDA-MB-175-VII,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.60,28.1,-.78,6.12,-2.0,-11,-45,-52",".43,6.44,3.55,.42,9.80,3.76,8.30,8.83",8,Sigmoid,1.239876866,3.983871937,-52.76888275,0.8343,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.3822541948784026,0.5961347818374634
2915,5940,MDA-MB-415,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","16.6,28.7,1.99,-4.4,1.02,-13,-17,-1.7","1.27,37.9,4.32,29.0,37.7,9.57,10.4,19.9",8,Constant,,8.0,1.247571349,0.3595,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.01722010038793087
2916,5941,MDA-MB-436,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.22,-6.8,-6.1,-19,-12,-25,-20,-22",".50,1.21,20.1,5.33,10.1,5.85,4.22,4.98",8,Sigmoid,0.007445921,8.0,-20.60052681,0.8916,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.23452183604240417
2917,5942,MDA-MB-453,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.38,-1.3,1.96,24.0,2.36,-18,-48,-60","7.05,14.0,6.24,15.2,14.5,5.97,.13,.12",8,Sigmoid,1.178217411,2.751912594,-60.21360016,0.9213,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.0122961586655463,1.0109937191009521
2918,5943,MDA-MB-468,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","21.7,-22,28.9,-39,-7.5,-43,-24,-52","8.39,21.2,2.60,10.4,3.08,9.83,.033,16.8",8,Constant,,8.0,-23.60569191,1.5386,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.6020373106002808
2919,5944,MEG-01,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-16,1.28,-27,-53,-66,-87,-92","7.65,14.6,1.97,13.3,2.80,4.63,4.91,1.15",8,Sigmoid,0.275297195,0.276277214,-90.91310883,3.3323,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.2863505187849897,0.44891583919525146
2920,5945,MEL-HO,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-24,-77,-76,-85,-80,-84,-81","14.5,1.77,2.63,2.47,3.31,.15,.64,.62",8,Sigmoid,0.013719493,0.01382275,-81.58292389,5.1399,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.281439493462497,-1.6415843963623047
2921,5946,MES-SA,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.78,3.39,-3.7,-10,-12,-6.1,-3.5,-11","10.1,3.47,9.01,.011,1.65,3.38,.23,2.50",8,Constant,,8.0,-6.147462845,0.1012,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.5042299628257751
2922,5947,MeWo,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","32.7,22.8,3.41,-6.7,-16,-12,-48,-46","39.5,3.13,11.8,13.6,22.7,15.7,5.58,5.56",8,Sigmoid,0.627607584,8.0,-48.57889557,0.9748,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.8900880217552185
2923,5948,MFE-296,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.33,-9.5,5.11,-4.9,-11,-12,-26,-51","5.30,1.28,1.22,.83,18.0,3.84,.42,3.24",8,Sigmoid,8.905672049,7.721744537,-51.00691605,0.6229,MFE296_ENDOMETRIUM,MFE296,ACH-000879,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0440403148032242,-0.47658249735832214
2924,5949,MG-63,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,2.56,-1.2,2.24,-9.9,1.24,-15,-24","5.29,4.44,10.2,11.6,2.59,3.10,16.8,7.14",8,Sigmoid,2.300024986,8.0,-23.91699219,0.6005,MG63_BONE,MG63,ACH-000359,Bone Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.5282423496246338
2925,5950,Mino,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","11.2,-8.6,-11,-9.5,-30,-26,-21,-25","32.7,13.5,.20,10.3,10.5,2.22,.028,32.5",8,Constant,,8.0,-16.98526573,0.249,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.9583759307861328
2926,5951,MJ,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.5,19.1,5.87,-.91,-5.3,3.13,-2.9,-1.2","6.51,10.5,6.99,17.8,4.23,10.8,24.5,31.4",8,Constant,,8.0,10.41910744,0.0,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.30942416191101074
2927,5952,MKN-45,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.36,-2.1,-7.7,-25,-55,-59,-83,-86","11.8,13.9,19.5,14.5,4.34,2.43,1.01,4.28",8,Sigmoid,0.194990486,0.287491083,-86.09960175,2.7494,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.246563434877901,0.22031530737876892
2928,5953,MKN7,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,8.69,6.77,15.9,-14,-13,-28,-15","4.87,21.1,2.74,4.45,6.21,.40,11.3,7.09",8,Sigmoid,0.186072335,8.0,-17.55931664,0.777,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.029958268627524376
2929,5954,MKN74,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-7.3,-17,-1.9,-3.6,-28,-41,-26","6.03,14.6,14.5,.25,5.26,6.17,8.23,1.07",8,Sigmoid,0.61356467,8.0,-32.85472107,0.899,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.40435779094696045
2930,5955,MOLP-8,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-2.8,-9.1,-36,-48,-51,-37,-54","11.3,11.9,28.8,13.5,7.51,9.40,13.6,26.8",8,Sigmoid,0.068192415,8.0,-46.64195251,2.9593,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.5991366505622864
2931,5956,MOLT-16,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,13.3,-3.0,-16,-29,9.76,.21,-8.7","4.75,5.54,13.0,26.0,9.93,16.7,5.77,.28",8,Constant,,8.0,-2.696932316,1.74,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.18534821271896362
2932,5957,MONO-MAC-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","14.3,-12,-18,-39,-43,-28,-39,-48","16.5,14.5,12.5,8.06,9.94,2.21,11.5,6.58",8,Sigmoid,0.002542614,8.0,-41.77028275,3.6304,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.5935676693916321
2933,5958,MOR/CPR,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.67,8.05,-2.4,-5.4,-23,-15,-15,-25","2.43,10.9,.29,7.96,4.47,14.2,1.27,6.03",8,Sigmoid,0.095980637,8.0,-20.42215919,0.5833,MORCPR_LUNG,MORCPR,ACH-000851,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.028919996693730354
2934,5959,MSTO-211H,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.13,-13,-22,-29,-35,-33,-62,-88",".93,15.2,7.44,7.15,21.8,7.92,.51,.63",8,Sigmoid,9.078120689,1.102446795,-84.83261871,2.492,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.09753206867098368,-0.2600299119949341
2935,5960,NCI-H1048,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.4,-.12,4.56,-5.8,-4.6,4.93,-20,-49","11.1,10.6,.98,16.8,14.5,36.3,4.54,14.2",8,Sigmoid,2.703097582,8.0,-48.97356415,0.6409,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.4043417274951935
2936,5961,NCI-H1092,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.6,11.0,1.08,8.85,-1.0,-.90,9.39,2.25","14.7,18.4,32.8,5.06,24.4,8.61,8.77,18.6",8,Constant,,8.0,4.519159794,0.0,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,1.705890417098999
2937,5962,NCI-H1155,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","14.8,2.42,-15,2.31,-20,-13,-34,-21","13.0,1.45,11.9,8.78,5.58,13.3,4.43,16.4",8,Sigmoid,0.002542614,8.0,-25.60977554,0.8311,NCIH1155_LUNG,NCIH1155,ACH-000980,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.5787708163261414
2938,5963,NCI-H1184,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","55.7,-23,69.0,39.6,16.3,46.4,47.3,-12","97.2,18.7,12.2,39.7,70.8,46.6,135,34.2",8,Constant,,8.0,14.23855972,0.351,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,1.4160611629486084
2939,5964,NCI-H1341,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.2,30.5,29.4,-.10,2.90,-11,-9.1,-7.6","20.7,32.0,28.1,37.4,23.4,20.1,24.0,75.1",8,Constant,,8.0,7.989952087,0.1421,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.26176053285598755
2940,5965,NCI-H1373,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","11.5,-11,8.44,-12,-8.2,-23,-5.8,-26","15.1,2.13,20.8,10.1,1.67,.28,8.63,4.18",8,Constant,,8.0,-9.39729023,0.3876,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.3336956202983856
2941,5966,NCI-H1568,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,-3.2,-20,-17,-29,-12,-29,-25","5.17,7.93,8.69,10.9,5.51,5.84,9.68,3.95",8,Constant,,8.0,-19.02949905,1.5472,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.23580989241600037
2942,5967,NCI-H1648,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","27.5,-3.5,10.7,-14,18.0,1.56,-17,-48","1.30,17.1,17.8,20.7,9.49,4.41,7.54,.97",8,Sigmoid,4.250429153,8.0,-47.67159653,0.8604,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.04727093130350113
2943,5968,NCI-H1650,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,25.6,9.11,-5.8,-.37,2.09,-7.1,-10","1.79,19.4,5.18,7.02,10.1,12.2,15.8,6.37",8,Constant,,8.0,-0.979431331,0.0898,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.1958211064338684
2944,5969,NCI-H1651,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.4,9.38,14.9,-6.5,13.1,-13,-7.7,-10.0","3.41,.32,1.35,7.23,9.89,5.97,2.49,18.1",8,Constant,,8.0,4.292300224,0.4047,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.03829112648963928
2945,5970,NCI-H1792,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,-10,-19,-33,-44,-45,-52,-89","14.9,3.20,12.8,2.25,.82,.38,9.86,.97",8,Sigmoid,8.893997461,0.875140309,-82.07048798,2.7425,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.13337105233685653,-0.07847412675619125
2946,5971,NCI-H1793,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-7.1,-18,-35,-34,-40,-25,-53","2.99,7.65,5.37,31.2,14.7,17.8,21.0,20.2",8,Sigmoid,0.102811657,8.0,-46.30182648,1.1635,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.2720077931880951
2947,5972,NCI-H1915,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.26,-1.3,-36,-40,-58,-66,-78,-89","13.2,.33,7.05,4.31,.75,4.64,1.93,.24",8,Sigmoid,0.002542614,0.146351352,-87.87676239,3.546,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.9217450277591377,-0.686820924282074
2948,5973,NCI-H1944,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-21,-26,-31,-53,-47,-58,-58","1.98,7.62,4.09,2.62,1.06,13.9,.87,3.12",8,Sigmoid,0.033895552,0.416212499,-59.26710892,1.4783,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.8765593342385483,-0.3229290544986725
2949,5974,NCI-H1975,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,-16,-5.8,-22,-25,-40,-31,-60","2.24,3.26,3.48,4.70,6.65,1.69,10.8,2.04",8,Sigmoid,8.247708658,3.859478712,-57.63231277,1.2184,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.350532125652179,-0.41855359077453613
2950,5975,NCI-H2009,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-2.7,-13,-33,-36,-53,-58,-73","9.07,2.42,5.04,1.87,2.08,3.33,.37,3.66",8,Sigmoid,0.243129686,0.734539926,-71.33766174,2.6131,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.30851092677883923,-0.5685223937034607
2951,5976,NCI-H2023,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.47,8.91,-9.1,-17,-18,-24,-38,-50","28.2,13.9,23.1,2.84,27.3,3.58,2.57,18.2",8,Sigmoid,1.759874463,8.0,-46.83127975,1.0669,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.18012571334838867
2952,5977,NCI-H2030,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-19,-21,-29,-31,-32,-39,-50","2.61,2.10,1.42,1.95,.91,7.73,6.36,6.84",8,Sigmoid,8.692001976,8.0,-48.48736191,2.026,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.17691758275032043
2953,5978,NCI-H2052,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,16.5,-19,-12,-19,-13,-17,-21","11.2,6.54,4.34,11.7,20.9,.70,17.7,19.4",8,Constant,,8.0,-13.1333065,1.2644,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.1463015079498291
2954,5979,NCI-H2085,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.38,15.9,-27,-15,-18,-6.2,-21,-32","11.0,9.85,12.1,13.6,34.5,9.12,25.3,5.36",8,Constant,,8.0,-9.100054741,0.8872,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.5878053307533264
2955,5980,NCI-H2087,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-41,-47,-48,-59,-64,-71,-69","7.84,3.18,3.99,.86,6.27,1.03,.66,.30",8,Sigmoid,0.016308976,0.054371227,-70.62865448,4.1166,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.9119201804865296,-0.2658757269382477
2956,5981,NCI-H211,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.78,.33,-15,-10,-18,-20,-25,-15","7.79,14.3,3.44,16.6,10.1,5.35,2.72,4.98",8,Constant,,8.0,-11.30014133,0.9559,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,1.2135570049285889
2957,5982,NCI-H2122,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,-25,-46,-66,-71,-90,-99,-103","27.3,7.06,5.42,5.65,3.38,3.42,4.12,1.38",8,Sigmoid,0.03478035,0.035555024,-103.3224106,4.4466,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.3366738106363365,-0.7817496657371521
2958,5983,NCI-H2170,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.07,-30,19.2,15.9,2.33,-24,5.45,-15","1.03,3.70,10.1,5.06,33.4,6.84,38.6,5.90",8,Constant,,8.0,-1.365223289,0.684,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.0731019601225853
2959,5984,NCI-H2172,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.93,-19,7.58,-39,-29,-17,-33,-51","33.8,57.1,5.53,29.6,7.72,47.2,6.71,20.0",8,Constant,,8.0,-26.12156487,0.2755,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.11353830248117447
2960,5985,NCI-H2228,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-1.0,-16,-6.0,-26,-29,-36,-67","1.25,1.54,.99,.75,4.30,11.6,4.45,9.59",8,Sigmoid,8.868056036,3.938598871,-63.86376953,1.5899,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.3708250435658391,-0.25560012459754944
2961,5986,NCI-H2286,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,-16,-17,-24,-39,-40,-45,-70","7.12,3.22,2.16,8.67,8.15,3.04,8.76,2.59",8,Sigmoid,8.084680514,1.984133124,-67.39562225,3.2309,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.6851821054019804,-0.45130741596221924
2962,5987,NCI-H23,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.06,-18,-6.8,-14,-36,-46,-41,-58","13.0,4.06,14.6,3.85,5.39,2.67,7.03,4.66",8,Sigmoid,0.19455494,8.0,-49.47696686,2.1937,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.006598168984055519
2963,5988,NCI-H2444,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-17,-7.2,-31,-49,-42,-48,-62","7.19,9.28,5.85,28.7,6.72,.44,5.15,2.98",8,Sigmoid,0.084231026,0.267063349,-50.10744095,2.4795,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.3202693865518207,0.033563315868377686
2964,5989,NCI-H2452,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","20.4,-27,22.6,-19,-1.4,-45,-2.5,-54","13.8,22.3,12.6,15.8,1.34,16.9,3.66,8.25",8,Constant,,8.0,-6.633893967,1.184,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.13561934232711792
2965,5990,NCI-H28,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-2.4,-19,-34,-34,-41,-43,-56","10.9,1.58,.038,6.87,9.72,13.9,1.49,7.45",8,Sigmoid,0.110690311,4.119419098,-52.34674072,1.8972,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.4157121577895486,-0.3800017535686493
2966,5991,NCI-H322,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-47,-57,-71,-67,-77,-81,-90","5.95,10.0,7.35,8.18,1.82,1.15,.88,1.71",8,Sigmoid,0.00627533,0.015824527,-82.80467224,3.5462,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.146194200814076,0.49436134099960327
2967,5992,NCI-H3255,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-10,-3.9,-4.8,-26,-28,-32,-56","18.4,.24,3.83,13.9,8.14,2.31,12.5,1.79",8,Sigmoid,8.798857566,6.137561798,-54.73452759,1.436,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.814427561990518,-0.2130209505558014
2968,5993,NCI-H358,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-34,-40,-52,-56,-55,-60,-62","1.11,4.56,.11,1.41,3.93,.85,1.54,3.56",8,Sigmoid,0.002542614,0.084666125,-61.30785751,3.6668,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.4690396982899703,0.06206660717725754
2969,5994,NCI-H441,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.9,-13,-17,-28,-35,-33,-38,-43","13.1,9.04,1.51,.14,5.11,4.17,4.39,6.66",8,Sigmoid,0.041448683,8.0,-39.81105423,1.6923,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4759865999221802
2970,5995,NCI-H460,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,5.47,8.43,-9.2,-29,-32,-32,-46","3.25,8.16,17.8,9.08,5.94,18.3,3.33,2.66",8,Sigmoid,0.13540639,8.0,-37.82873917,1.3956,NCIH460_LUNG,NCIH460,ACH-000463,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.41640666127204895
2971,5996,NCI-H522,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,-.87,9.76,-.37,-14,-16,-17,-18","3.60,11.7,5.10,22.5,9.52,2.52,6.90,8.57",8,Constant,,8.0,-11.42617798,0.8364,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.2791307270526886
2972,5997,NCI-H647,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","22.6,1.38,-6.5,-13,-10,-30,-26,-35","29.0,13.7,1.79,4.20,10.2,1.32,7.54,12.6",8,Sigmoid,0.177699387,8.0,-33.89273834,0.8152,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.39188694953918457
2973,5998,NCI-H650,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,-7.4,.30,-6.9,-11,-23,-22,-38","1.02,4.50,11.6,2.79,7.48,3.46,5.15,2.13",8,Sigmoid,8.306769234,8.0,-36.84700394,0.5376,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4332997798919678
2974,5999,NCI-H661,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.10,5.44,-.30,-1.2,1.34,-13,12.7,-14",".57,9.54,1.21,4.01,5.05,12.8,15.5,15.9",8,Constant,,8.0,-0.964672744,0.2089,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.014996500685811043
2975,6000,NCI-H727,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.26,14.7,-39,-31,-64,-53,-61,-60","14.0,32.8,20.9,31.9,7.74,10.7,13.9,7.02",8,Sigmoid,0.013049815,0.020542197,-62.0029335,2.9449,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.885274118176438,-0.12115570157766342
2976,6001,NCI-H747,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.42,-20,-55,-72,-77,-82,-85,-87","3.42,.84,.91,8.09,3.40,.97,1.59,.039",8,Sigmoid,0.012374342,0.022053087,-83.97874451,4.5513,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.8143026868883676,-0.21438732743263245
2977,6002,NCI-H810,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.71,2.66,4.72,-7.5,3.15,-1.2,9.54,-.019","16.1,15.4,7.69,7.88,8.49,8.09,11.0,14.8",8,Constant,,8.0,4.223862171,0.1101,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,1.1719660758972168
2978,6003,NCI-N87,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","20.6,-22,6.26,-29,-8.4,-36,-42,-56","0,8.83,17.7,.062,5.62,3.04,3.36,.14",8,Sigmoid,8.313188381,5.074838161,-55.06758881,2.0757,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.6242946349612433,-0.3702945411205292
2979,6004,NCO2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","11.1,-1.2,-23,-44,-53,-78,-92,-96","12.4,12.3,17.0,.92,5.19,7.64,5.55,.46",8,Sigmoid,0.055469133,0.138409436,-97.61142731,3.9475,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.9775390589319117,0.3344361484050751
2980,6005,NIH:OVCAR-3,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,-17,-6.0,-15,-24,-18,-30,-32","11.1,16.5,7.32,6.47,3.32,23.0,14.7,25.3",8,Constant,,8.0,-17.15831184,1.3723,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.03250715881586075
2981,6006,NUGC-3,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,8.03,-18,-38,-44,-44,-58,-46","0,13.4,6.40,2.99,4.99,2.98,4.70,7.14",8,Sigmoid,0.037713241,8.0,-48.13257599,2.1154,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.5337897539138794
2982,6007,NUGC-4,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,-45,-62,-72,-78,-80,-86,-85","6.36,7.51,1.22,2.73,5.57,.14,2.42,1.58",8,Sigmoid,0.002542614,0.011152006,-84.33991241,4.7079,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.496135886944027,0.010706154629588127
2983,6008,OCI-AML2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-62,-93,-96,-96,-96,-96,-96,-97","3.20,.30,.25,.021,.10,.020,.018,.13",8,Sigmoid,0.003053141,0.0025,-96.38653564,7.2797,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-5.991464547107982,-0.13579118251800537
2984,6009,OCI-AML5,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,-12,-18,-36,-48,-60,-69,-70","6.86,.26,11.4,5.76,1.85,1.62,11.7,1.24",8,Sigmoid,0.108965613,0.274631172,-69.83348846,3.3518,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.2923262742467925,-0.21229229867458344
2985,6010,OCUM-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-30,-57,-79,-89,-91,-94,-94","7.77,3.43,.056,1.04,2.33,.80,.88,.43",8,Sigmoid,0.020937741,0.019374402,-93.49899292,5.29,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.9438025687351743,-0.8488250970840454
2986,6011,OE21,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.25,7.03,-13,-28,-43,-54,-67,-74","7.49,2.28,3.38,2.30,10.7,5.64,.47,4.32",8,Sigmoid,0.145240784,0.461666137,-73.82949829,2.3347,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.7729132963218849,-0.4740580916404724
2987,6012,OE33,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.62,.83,-7.5,11.7,-18,-32,-72,-83","3.27,9.30,19.3,7.13,11.9,11.8,8.88,.19",8,Sigmoid,0.934874833,1.207887888,-83.34214783,1.8762,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.18887328725867927,-0.25306200981140137
2988,6013,ONCO-DG-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-3.0,-6.6,-7.9,-9.3,-13,-17,-38","3.15,3.71,6.15,9.55,14.3,18.2,8.08,.95",8,Sigmoid,8.512905758,8.0,-37.30216599,1.0343,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.058905623853206635
2989,6014,ONS-76,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-29,-40,-58,-65,-70,-72,-78","2.37,1.35,.79,.38,1.25,.37,1.43,1.43",8,Sigmoid,0.006044883,0.045527395,-76.39682007,4.1038,ONS76_CENTRAL_NERVOUS_SYSTEM,ONS76,ACH-000776,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.08944104629535,-0.099415622651577
2990,6015,OPM-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","42.9,-4.1,-17,-23,-22,-27,-16,-34","10.0,22.3,14.4,21.1,9.71,34.6,13.2,4.78",8,Linear,,8.0,-33.12330246,1.3958,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.8971877694129944
2991,6016,OV-90,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,-27,-53,-62,-72,-70,-74,-79","1.12,13.3,.67,5.87,1.81,1.15,2.67,1.40",8,Sigmoid,0.002542614,0.022402048,-76.37239075,4.0762,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.798602895729051,-0.38663679361343384
2992,6017,OVCAR-4,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-19,-6.7,-18,-3.4,-32,-18,-31","2.36,1.26,2.03,3.08,2.26,.79,7.99,1.14",8,Constant,,8.0,-17.15257072,0.8609,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.18326407670974731
2993,6018,OVCAR-8,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","18.6,-1.8,5.72,-17,-11,-24,-25,-44","4.22,10.3,.82,12.6,2.07,7.27,9.46,12.2",8,Sigmoid,8.091759833,8.0,-39.12296677,1.0265,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.012214982882142067
2994,6019,OVMANA,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.53,20.9,4.77,-3.5,-11,-1.2,-13,-11","1.70,6.03,13.6,3.70,1.11,2.04,9.21,7.49",8,Sigmoid,0.045395065,8.0,-8.950539589,0.3681,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.49308064579963684
2995,6020,OVSAHO,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,-3.7,-6.6,-19,-26,-22,-28,-41","6.66,10.1,2.48,7.99,8.36,3.37,7.67,2.86",8,Sigmoid,8.524287696,8.0,-39.29212952,0.9977,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.7114824652671814
2996,6021,OVTOKO,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.8,-2.5,-4.5,-8.8,-11,-11,-17,-21","5.65,11.0,2.44,7.91,.63,10.2,4.21,13.7",8,Constant,,8.0,-10.41402626,0.5565,OVTOKO_OVARY,OVTOKO,ACH-000663,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.7316847443580627
2997,6022,P12-ICHIKAWA,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.07,-9.9,-29,-23,-46,-41,-41,-47",".11,14.7,6.36,6.34,3.09,1.17,3.22,1.17",8,Sigmoid,0.002542614,8.0,-45.40678406,2.4864,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.3292897641658783
2998,6023,P31/FUJ,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,-37,-47,-67,-69,-69,-75,-74","13.4,4.20,3.81,3.40,1.82,2.83,10.6,5.99",8,Sigmoid,0.002542614,0.020692002,-73.87633514,4.5666,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.8780080301851605,0.5262156128883362
2999,6024,P3HR-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.5,3.72,7.17,-6.5,-8.1,-5.5,-19,-25",".023,3.80,8.63,2.74,15.8,8.52,4.93,1.99",8,Sigmoid,1.690331101,8.0,-24.84225273,0.2984,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,1.0960469245910645
3000,6025,Panc 02.03,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-29,-62,-66,-81,-81,-89,-96","11.6,1.87,.48,1.76,5.30,.80,.048,4.05",8,Sigmoid,0.007314316,0.019754883,-92.91963196,4.8153,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.9243545776875743,-0.7015805840492249
3001,6026,Panc 03.27,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.77,-11,-20,-30,-38,-37,-54,-57","42.3,.67,23.7,16.0,22.5,7.28,4.11,12.7",8,Sigmoid,0.943632782,2.416165352,-57.92614365,2.1915,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.8821817181279824,-0.3302173316478729
3002,6027,Panc 04.03,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-17,-25,-39,-44,-54,-65,-76","13.2,2.62,33.2,10.9,15.9,5.81,2.26,7.25",8,Sigmoid,0.032858819,0.380417019,-74.20236206,2.8214,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.9664872095640603,-0.12359794229269028
3003,6028,Panc 10.05,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-9.5,-36,-43,-46,-50,-72,-73","4.49,12.4,1.32,2.32,13.2,4.14,10.9,9.66",8,Sigmoid,0.443341166,0.32165724,-73.64554596,3.0873,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.134268772440163,-0.13719063997268677
3004,6029,PA-TU-8902,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,-17,-19,-35,-39,-42,-45,-49","3.50,2.21,.40,3.95,.31,2.98,.29,1.00",8,Sigmoid,0.003170792,8.0,-48.19589615,2.216,PATU8902_PANCREAS,PATU8902,ACH-000599,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4402060806751251
3005,6030,PC-3,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.36,3.04,.025,.50,2.69,.44,2.31,-.79",".16,12.1,22.3,10.4,.28,5.70,.95,.72",8,Constant,,8.0,2.688619137,0.0,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.3338378071784973
3006,6031,Pfeiffer,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.4,2.90,-2.9,-9.4,-30,-18,-19,-13",".67,1.46,3.63,7.39,7.41,17.8,7.72,7.94",8,Sigmoid,0.013846423,8.0,-18.19900131,0.8899,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.1084318533539772
3007,6032,PK-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-9.3,-17,-32,-38,-48,-58,-71","3.03,2.68,4.29,4.46,2.30,4.74,.70,2.00",8,Sigmoid,8.0957742,0.952850282,-69.9625473,2.5158,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.04829748945355332,-0.41219326853752136
3008,6033,PK-45H,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-27,-48,-61,-74,-72,-81,-88",".52,3.43,2.69,6.41,9.13,1.96,4.65,4.44",8,Sigmoid,0.002542614,0.035253178,-85.76925659,4.299,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.345199597759301,-0.042805783450603485
3009,6034,PK-59,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,-4.5,-13,-25,-39,-59,-70,-81","5.45,4.37,3.64,15.8,5.24,7.57,.55,8.25",8,Sigmoid,0.340366036,0.490049899,-80.67507935,2.4655,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.7132480583683877,-0.5942416787147522
3010,6035,PLC/PRF/5,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,2.83,-15,-6.9,-10,-26,-34,-39","1.80,19.7,3.43,6.93,5.49,4.57,7.27,1.92",8,Sigmoid,0.691203952,8.0,-37.7467308,1.2975,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.9738585352897644
3011,6036,PSN1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.90,1.15,-10,-35,-45,-71,-82,-88","3.52,9.20,3.77,4.36,4.41,4.01,3.98,1.53",8,Sigmoid,0.140205115,0.246631786,-88.58157349,3.0172,PSN1_PANCREAS,PSN1,ACH-000320,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.3998587995592087,-0.42367181181907654
3012,6037,QGP-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-45,-26,-48,-67,-62,-70,-74","0,0,0,0,0,0,0,0",8,Sigmoid,0.06321346,0.085503943,-69.80844116,3.7813,QGP1_PANCREAS,QGP1,ACH-000347,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.4591927871437123,1.14482843875885
3013,6038,Raji,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,-11,7.73,11.2,-5.5,-16,4.76,-39","7.61,2.16,21.4,9.76,12.3,1.15,19.2,5.19",8,Constant,,8.0,-8.827418327,0.5314,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.794301450252533
3014,6039,RD,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.40,-7.5,-16,-38,-52,-55,-53,-68","4.25,9.35,5.71,13.8,5.19,8.72,5.82,5.16",8,Sigmoid,0.045832556,0.25415495,-61.65516663,2.6177,RD_SOFT_TISSUE,RD,ACH-000169,Sarcoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.369811158591898,0.18907353281974792
3015,6040,Reh,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.71,3.26,5.66,-.96,7.64,-3.3,2.14,2.48","5.24,8.59,15.1,6.33,4.08,16.5,3.81,5.68",8,Constant,,8.0,3.024997473,0.0,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.1073690727353096
3016,6041,RERF-GC-1B,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.15,-23,-9.7,-25,-28,-34,-29,-41","19.4,9.77,9.46,6.87,.21,5.85,5.88,8.08",8,Sigmoid,0.002542614,8.0,-36.80400467,1.5846,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.40576672554016113
3017,6042,RERF-LC-AI,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,-7.5,-16,-18,-15,-20,-28,-39","10.2,2.83,9.55,5.20,4.33,.36,6.38,.15",8,Sigmoid,8.87884429,8.0,-36.75541306,1.1637,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.12374141067266464
3018,6043,RERF-LC-MS,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","19.8,2.92,-8.3,-9.0,-7.1,-27,-29,-48","25.0,.44,1.03,15.0,18.0,16.3,2.11,14.1",8,Sigmoid,8.476032549,8.0,-44.72971344,0.6165,RERFLCMS_LUNG,RERFLCMS,ACH-000062,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4932137131690979
3019,6044,RKO,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.80,-15,-34,-51,-52,-63,-61,-76","8.73,.50,2.89,7.16,.98,.20,.042,4.65",8,Sigmoid,0.002542614,0.123916917,-70.93864441,3.2954,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.088143962137174,-0.4092884957790375
3020,6045,RL95-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-23,-43,-51,-62,-62,-70,-75","2.53,1.93,3.90,1.59,1.75,2.02,7.20,12.5",8,Sigmoid,0.002542614,0.063616872,-64.87282562,3.5574,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.7548765607985106,-0.1343078762292862
3021,6046,RPMI-7951,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.4,11.8,-14,-14,-29,-28,-40,-37","19.6,11.0,7.98,14.5,.046,.98,4.98,7.47",8,Sigmoid,0.002542614,8.0,-37.53565979,1.5961,RPMI7951_SKIN,RPMI7951,ACH-000348,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4708055853843689
3022,6047,RPMI-8402,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.93,3.64,15.3,30.7,-10,3.55,-11,-.087","17.5,5.11,9.66,7.21,20.2,9.14,2.91,6.11",8,Constant,,8.0,3.68194747,0.4658,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.1509399563074112
3023,6048,RT-112,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-20,-25,-38,-48,-50,-65,-71","10.7,13.1,3.36,1.87,7.79,6.96,5.93,3.34",8,Sigmoid,0.386481941,0.468805701,-71.01056671,3.0522,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.757566879957099,-0.00493229366838932
3024,6049,RT4,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-6.8,-19,2.36,-35,-38,-50,-51","24.8,17.8,3.22,11.9,30.4,29.5,2.24,15.3",8,Sigmoid,0.232941166,8.0,-48.56343079,2.4741,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.18306763470172882
3025,6050,RVH-421,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.9,-30,-56,-67,-73,-74,-73,-72","15.5,1.41,.23,3.72,1.35,2.31,.13,.71",8,Sigmoid,0.01116796,0.019136582,-72.79421234,4.4939,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.9561534877968096,-1.267744541168213
3026,6051,SBC-5,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.06,-10,-5.7,-21,-27,-49,-53,-61","1.06,2.07,.34,6.21,9.10,5.20,1.00,3.12",8,Sigmoid,0.247146919,1.338297009,-60.51768494,0.9161,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.2913979168927895,-0.5957488417625427
3027,6052,SCaBER,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-12,-15,-35,-38,-40,-48,-65","14.6,11.6,10.5,1.26,1.02,5.24,2.74,1.47",8,Sigmoid,7.320364952,1.84317863,-61.46682739,2.4202,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.6114915974852105,-0.28828325867652893
3028,6053,SCC-9,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.92,-4.9,-22,-29,-41,-57,-64,-69","14.1,4.45,7.13,4.72,8.86,6.98,.78,2.62",8,Sigmoid,0.016822303,0.489884287,-69.93051147,2.6857,SCC9_UPPER_AERODIGESTIVE_TRACT,SCC9,ACH-000181,Head and Neck Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.7135860647446174,-0.5062856078147888
3029,6054,SF126,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.90,1.82,-9.7,-11,-7.7,-18,-32,-54","1.65,.029,2.33,5.82,5.69,1.31,1.65,.90",8,Sigmoid,8.98370368,6.89561224,-53.54208755,1.0433,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.9308853020820673,-0.4100635051727295
3030,6055,SF-295,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.56,-15,3.61,-13,-5.3,-28,-6.3,-38","16.0,6.68,8.02,.90,2.09,6.94,4.96,14.0",8,Constant,,8.0,-10.16435909,0.6552,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4567357003688812
3031,6056,SH-10-TC,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,-21,-4.0,-6.9,-9.4,-.60,-18,-16","2.93,3.13,3.43,9.69,13.0,2.27,5.47,5.32",8,Constant,,8.0,-11.15591145,0.2473,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4772176742553711
3032,6057,SHP-77,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.49,3.81,4.29,-4.5,-21,-6.7,-24,-24","3.98,36.9,13.9,14.8,20.5,24.5,5.25,6.81",8,Constant,,8.0,-10.95015526,0.6498,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.42058324813842773
3033,6058,SIG-M5,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-81,-90,-92,-93,-94,-94,-94,-95","3.94,1.08,.93,1.12,.59,.48,.27,.14",8,Constant,,0.002542614,-93.40484619,7.3807,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-5.9745625932886295,-0.3812991976737976
3034,6059,SIMA,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-9.0,-18,-23,-43,-46,-52,-69","36.5,23.6,2.12,17.7,23.9,2.74,.70,1.54",8,Sigmoid,8.185358675,1.338009119,-67.89008331,3.3683,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.29118277707892565,0.049004726111888885
3035,6060,SJSA-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.30,2.42,-11,-22,-32,-25,-36,-43","7.65,1.03,15.7,1.86,11.2,6.94,11.7,14.1",8,Sigmoid,0.025817581,8.0,-37.16154861,1.746,SJSA1_BONE,SJSA1,ACH-000748,Bone Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.7188400626182556
3036,6061,SK-BR-3,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.5,5.36,14.6,8.09,-8.8,9.83,-5.2,8.06","10.6,11.8,20.1,16.4,.82,41.2,10.7,.15",8,Constant,,8.0,4.977493286,0.04932,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.28650254011154175
3037,6062,SK-CO-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-25,-21,-42,-59,-68,-68,-79","6.10,1.55,11.3,12.6,7.94,1.34,3.62,.60",8,Sigmoid,0.050274629,0.127512574,-77.19290161,3.5121,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.059540299638407,-0.6851375699043274
3038,6063,SK-ES-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.53,15.4,9.22,2.20,-2.7,3.66,-2.7,.063","12.6,11.2,10.2,.32,7.65,8.38,11.1,.33",8,Constant,,8.0,2.394669294,0.0,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.9847127795219421
3039,6064,SK-HEP-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","29.7,-7.1,-.34,-28,-20,-38,-24,-60","13.3,2.34,4.49,.0028,1.89,.13,.34,.28",8,Sigmoid,0.002542614,8.0,-45.72497177,1.683,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.21572484076023102
3040,6065,SK-MEL-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.2,8.99,-.41,-21,-53,-69,-78,-81","24.5,23.6,16.1,23.2,6.55,8.49,6.55,1.64",8,Sigmoid,0.129746348,0.233818457,-80.41552734,3.0417,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.453210289518558,-0.8807036876678467
3041,6066,SK-MEL-24,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,-19,-38,-53,-58,-58,-64,-72","14.9,.11,.38,.74,.90,7.04,11.3,1.07",8,Sigmoid,0.015250055,0.080252647,-70.43032837,2.8012,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.52257553309231,-0.8559447526931763
3042,6067,SK-MEL-30,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-41,-65,-74,-77,-78,-80,-80",".95,2.82,.27,.74,.78,1.14,1.27,.16",8,Sigmoid,0.010457134,0.012090529,-78.92946625,4.6005,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.415332860143104,-1.3659908771514893
3043,6068,SK-MEL-31,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.48,6.51,.95,-14,-18,-33,-4.0,-23","3.26,6.62,16.3,8.82,1.97,6.92,1.71,6.03",8,Sigmoid,0.042243443,8.0,-21.0033989,0.6448,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-1.232413649559021
3044,6069,SK-MEL-5,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,-38,-63,-70,-70,-72,-69,-73","26.6,6.89,8.70,1.66,3.19,3.58,6.62,2.75",8,Sigmoid,0.011963045,0.013439163,-70.86742401,4.2166,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.309582222612128,-1.1606405973434448
3045,6070,SK-MES-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.1,10.8,12.8,-18,-23,-45,-73,-67","27.6,26.9,16.5,6.87,6.72,1.21,2.13,18.6",8,Sigmoid,0.298549563,0.864690185,-73.20933533,2.3037,SKMES1_LUNG,SKMES1,ACH-000665,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.14538400383766106,0.120982326567173
3046,6071,SK-MM-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-14,-22,-33,-30,-32,-41,-45","3.95,.54,4.40,1.12,15.4,4.65,2.75,1.39",8,Sigmoid,0.046726715,8.0,-40.365448,2.1132,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.4957277178764343
3047,6072,SK-N-AS,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-16,-32,-56,-68,-69,-70,-71","6.03,2.90,2.93,5.05,2.57,1.71,.45,.60",8,Sigmoid,0.036439128,0.056742616,-70.71290588,3.5526,SKNAS_AUTONOMIC_GANGLIA,SKNAS,ACH-000260,Neuroblastoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.869229745623701,-0.1643512099981308
3048,6073,SK-N-BE(2),PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-22,-14,-35,-43,-42,-49,-59",".47,19.9,.33,13.5,14.3,1.34,4.00,11.7",8,Sigmoid,0.118057013,2.463804245,-55.78617096,2.5482,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.9017065964925436,0.2754284739494324
3049,6074,SK-N-DZ,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.28,-3.0,-1.1,-2.4,-3.6,-8.2,-7.3,-17","20.7,10.5,11.6,12.1,9.28,.88,5.63,3.88",8,Constant,,8.0,-8.19406414,0.2465,SKNDZ_AUTONOMIC_GANGLIA,SKNDZ,ACH-000366,Neuroblastoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.27754396200180054
3050,6075,SK-N-FI,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.65,-20,-19,-2.4,-19,-47,-39,-53","28.2,21.0,14.0,2.51,13.3,8.70,12.0,7.01",8,Sigmoid,0.327668309,8.0,-47.07352448,1.9218,SKNFI_AUTONOMIC_GANGLIA,SKNFI,ACH-000341,Neuroblastoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.12612424790859222
3051,6076,SK-N-SH,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.42,19.3,2.86,-27,-8.6,-22,-35,-41","17.8,1.18,28.2,13.2,18.0,14.1,8.00,7.88",8,Sigmoid,0.033668216,8.0,-28.55926323,1.1063,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.17271238565444946
3052,6077,SK-OV-3,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.27,-13,10.3,-19,8.79,-13,-14,-36","15.1,12.4,16.3,21.2,12.0,2.64,15.9,14.5",8,Constant,,8.0,-8.50215435,0.519,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.5043615698814392
3053,6078,SNG-M,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.99,-.86,-3.9,-14,-11,-30,-28,-43","2.10,1.88,2.27,2.42,.23,2.96,3.55,9.13",8,Sigmoid,8.324727999,8.0,-41.9461937,1.1151,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.5758599638938904
3054,6079,SNU-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-18,-38,-56,-61,-63,-73,-77","6.94,2.01,2.21,5.40,4.85,.79,.70,1.24",8,Sigmoid,0.028104199,0.07532502,-74.39038086,3.7711,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.58594292844971,0.40435847640037537
3055,6080,SNU-182,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.03,12.9,-6.8,-12,-24,-29,-40,-41","21.7,24.7,16.1,19.0,14.5,26.1,7.19,8.61",8,Sigmoid,0.135899186,8.0,-41.62247086,1.3371,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.0269616711884737
3056,6081,SNU-387,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.09,-2.3,.72,4.08,-.82,-8.2,-20,-24","8.12,17.7,.47,10.6,7.27,18.0,2.42,21.4",8,Sigmoid,1.032537103,8.0,-23.59988785,0.8845,SNU387_LIVER,SNU387,ACH-000478,Liver Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.48309603333473206
3057,6082,SNU-398,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,-11,-29,-32,-40,-40,-58,-62","17.3,12.1,7.73,14.9,5.62,15.2,.64,.28",8,Sigmoid,0.002542614,1.226284981,-61.63948822,2.4054,SNU398_LIVER,SNU398,ACH-000221,Liver Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.20398925829993234,0.1538684070110321
3058,6083,SNU-423,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.81,1.92,5.68,-3.3,-10,2.38,-5.1,-39","15.8,3.08,19.0,12.8,1.74,.25,3.57,5.02",8,Sigmoid,3.953911781,8.0,-39.48400879,0.3718,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.15692415833473206
3059,6084,SNU-449,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.10,6.16,4.57,-2.7,-11,-15,-27,-51","5.95,6.67,1.53,2.69,5.52,7.54,2.36,.094",8,Sigmoid,9.074303906,8.0,-49.25840759,0.7212,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.5559957027435303
3060,6085,SNU-475,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","41.9,-35,6.11,39.6,28.3,-11,-14,-33","21.6,13.4,15.1,9.35,71.8,3.96,33.2,23.8",8,Linear,,8.0,-32.03252411,0.9657,SNU475_LIVER,SNU475,ACH-000422,Liver Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.13866835832595825
3061,6086,SNU-C2A,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,-18,-9.7,-33,-19,-46,-41,-46","1.42,8.09,20.6,4.71,4.74,7.51,6.83,10.5",8,Sigmoid,0.002542614,8.0,-45.57045746,1.8779,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.2564530670642853
3062,6087,Sq-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".16,9.89,-2.9,-5.4,-8.8,-11,-48,-62","6.91,3.60,10.2,3.21,9.94,1.39,6.42,5.19",8,Sigmoid,1.610978842,2.799669504,-62.69810486,1.1333,SQ1_LUNG,SQ1,ACH-000553,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.0295013759288496,-0.02422455884516239
3063,6088,SU.86.86,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".40,-2.3,3.09,-3.8,-13,-24,-21,-36","1.07,4.70,7.53,2.17,3.30,1.60,6.61,8.59",8,Sigmoid,0.290863723,8.0,-29.07421684,0.7627,SU8686_PANCREAS,SU8686,ACH-000114,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.22028353810310364
3064,6089,SU-DHL-10,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-25,-12,-34,-36,-45,-20,-43","18.2,11.4,9.71,2.90,9.56,7.03,1.85,6.10",8,Constant,,8.0,-30.89922142,1.8426,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.8525925874710083
3065,6090,SU-DHL-4,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","18.2,2.93,17.1,-1.4,-15,-8.2,11.0,-8.1","4.74,7.99,5.43,1.61,7.77,14.2,2.92,26.4",8,Constant,,8.0,4.768203259,0.6981,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.3624092936515808
3066,6091,SU-DHL-6,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","59.4,-33,13.5,6.93,-15,33.2,-4.6,-9.2","0,0,0,0,0,0,0,0",8,Constant,,8.0,1.187728643,0.8526,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.2231980860233307
3067,6092,SU-DHL-8,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,-7.3,1.17,-16,-5.6,-19,-19,-27","13.4,4.15,21.5,5.94,.65,12.9,2.28,15.5",8,Constant,,8.0,-12.79710102,1.5111,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.6623639464378357
3068,6093,SUIT-2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.23,-20,.73,-47,-45,-71,-72,-86","2.84,11.5,1.66,9.34,2.84,2.46,3.47,2.68",8,Sigmoid,0.002542614,0.168788165,-84.4161377,3.014,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.7791108118375225,-0.8954479694366455
3069,6094,SUP-M2,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.0,13.6,13.0,-4.7,-24,-42,-64,-57","15.1,6.42,21.7,6.48,1.30,16.0,16.3,3.30",8,Sigmoid,0.284211665,1.158368349,-59.11429214,1.5185,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.14701241924426614,0.010529791936278343
3070,6095,SUP-T1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.27,-11,-.18,8.23,-17,-3.2,-2.4,.72","2.01,9.49,8.96,3.97,16.7,.29,16.4,7.41",8,Constant,,8.0,-3.177514315,0.4635,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.8967037200927734
3071,6096,SW 1088,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","17.7,10.6,6.00,9.34,-12,12.1,3.02,-20","12.1,13.1,11.3,10.1,18.4,2.16,13.1,1.17",8,Sigmoid,8.035635305,8.0,-19.88809967,0.03729,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.08619900792837143
3072,6097,SW 1271,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.3,-3.9,-7.1,-34,-40,-52,-56,-56","6.05,11.3,.69,10.9,1.65,.66,2.96,2.26",8,Sigmoid,0.055275537,0.665258825,-56.93872833,2.2362,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.4075791035227366,-0.3445039987564087
3073,6098,SW 1353,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.17,-9.8,-9.5,-20,-23,-19,-22,-34","9.61,4.46,15.4,4.26,9.01,1.93,8.27,14.3",8,Constant,,8.0,-17.35402679,1.3756,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.35799673199653625
3074,6099,SW1417,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-22,-41,-55,-67,-62,-60,-75",".025,31.7,12.4,24.1,8.98,5.87,3.40,2.04",8,Sigmoid,0.033015259,0.047472205,-66.37929535,3.5422,SW1417_LARGE_INTESTINE,SW1417,ACH-000236,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.0476108971079765,-0.2015729546546936
3075,6100,SW 1573,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,-7.0,-13,-28,-28,-30,-35,-41",".84,5.52,3.08,10.1,1.22,3.80,2.96,5.31",8,Sigmoid,0.028925991,8.0,-39.05793762,1.3967,SW1573_LUNG,SW1573,ACH-000677,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.8356147408485413
3076,6101,SW 1990,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,14.2,-25,-34,-54,-53,-69,-65","6.37,16.2,7.57,17.4,6.14,5.69,.40,.15",8,Sigmoid,0.063187137,0.225805432,-65.67758179,2.9671,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.488081570868599,-0.4817623198032379
3077,6102,SW403,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-43,-63,-77,-73,-77,-80,-78","24.8,12.1,5.29,.50,2.35,3.14,1.47,2.05",8,Sigmoid,0.017833482,0.015975719,-77.53831482,4.8714,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.136685271906634,-0.28809741139411926
3078,6103,SW48,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-42,-49,-70,-72,-79,-79,-79,-80",".95,4.48,.62,4.11,.57,1.66,1.23,1.74",8,Sigmoid,0.014210275,0.008396589,-78.52813721,5.322,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.77992972703077,-0.8621066808700562
3079,6104,SW480,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.22,-18,-36,-45,-49,-57,-61,-76",".73,2.70,7.86,5.04,3.38,.66,3.74,1.06",8,Sigmoid,0.002542614,0.186506376,-69.94618988,3.2477,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.6792898528150915,-0.11702937632799149
3080,6105,SW579,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.6,-11,-32,-17,-5.2,-22,-23,-68","2.89,4.21,55.4,1.38,1.04,8.03,.89,16.1",8,Sigmoid,9.325484447,5.793187141,-67.68275452,1.3252,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.756682596270762,-0.25418898463249207
3081,6106,SW620,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-50,-57,-69,-70,-77,-74,-79","5.79,.68,2.86,.85,5.38,1.62,8.34,1.21",8,Sigmoid,0.002542614,0.00991583,-77.58473969,4.7172,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.613622808965834,-0.8344759345054626
3082,6107,SW 780,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-7.6,-15,-36,-50,-58,-65,-75",".13,5.60,3.55,2.85,1.61,4.44,6.88,.64",8,Sigmoid,0.160302624,0.288278252,-71.82798767,2.6984,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.2438291124936072,-0.4315933883190155
3083,6108,SW 900,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","45.2,-5.9,3.94,-.57,17.8,-35,-11,-61","35.6,12.5,10.4,13.5,3.46,14.9,9.46,3.71",8,Linear,,4.372600087,-57.62756348,1.1128,SW900_LUNG,SW900,ACH-000669,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.475357817757279,-0.08392487466335297
3084,6109,T24,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,-9.9,-23,-29,-47,-43,-43,-39","3.44,6.01,8.62,.78,4.16,7.14,2.97,10.9",8,Sigmoid,0.062413141,8.0,-44.74831772,2.6029,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.6258322596549988
3085,6110,T3M-10,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,1.55,-16,-24,-47,-48,-54,-62","25.9,7.01,24.7,2.03,13.2,10.5,.27,5.87",8,Sigmoid,0.078056574,0.686679423,-58.91900635,2.1718,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.3758877288547078,-0.5480824112892151
3086,6111,T-47D,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","14.4,9.73,-5.0,-.70,6.72,3.07,4.41,1.78","6.16,5.05,8.39,9.01,15.0,2.42,7.87,15.7",8,Constant,,8.0,4.996741772,0.004786,T47D_BREAST,T47D,ACH-000147,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,1.2567367553710938
3087,6112,T84,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,41.1,-15,4.35,-31,-27,-56,-64","56.3,114,41.7,6.06,1.49,27.2,29.6,30.1",8,Constant,,8.0,-33.47037125,2.1085,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.0075517501682043076
3088,6113,TCCSUP,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,2.18,.39,4.10,2.11,-4.2,-5.8,-27","4.08,1.31,5.65,3.39,1.09,4.48,2.72,4.94",8,Sigmoid,8.246816515,8.0,-26.47454453,0.1675,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.2659503221511841
3089,6114,TE-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.46,-.65,-10,-16,-18,-18,-29,-33",".93,2.86,.52,3.50,3.44,1.79,8.27,1.23",8,Sigmoid,0.002542614,8.0,-32.57388687,1.0105,TE1_OESOPHAGUS,TE1,ACH-000647,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.8190063238143921
3090,6115,TE-11,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.11,-2.0,-7.8,-17,-27,-27,-51,-62","4.38,1.13,.78,2.31,11.6,.87,6.17,5.15",8,Sigmoid,8.480976372,3.257377863,-62.63676453,1.4826,TE11_OESOPHAGUS,TE11,ACH-000488,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.1809225352233819,-0.4391648471355438
3091,6116,TE-15,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.14,-18,-26,-48,-54,-64,-77,-75",".21,13.3,12.6,2.79,5.50,.90,4.77,5.37",8,Sigmoid,0.002542614,0.129075423,-77.67494202,2.8683,TE15_OESOPHAGUS,TE15,ACH-000353,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-2.047358371057355,-0.3399868607521057
3092,6117,TE-5,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.80,7.85,7.93,-3.6,-14,-22,-22,-22","3.17,1.02,5.42,4.05,6.17,.66,1.26,1.87",8,Sigmoid,0.115808681,8.0,-22.37048721,0.753,TE5_OESOPHAGUS,TE5,ACH-000408,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.251738578081131
3093,6118,TE 617.T,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-11,-19,-22,-46,-47,-57,-72","7.14,11.2,2.28,8.50,15.7,1.62,11.8,4.45",8,Sigmoid,0.899469912,1.004896998,-71.15689087,2.7097,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.004885046706387213,-0.9263570308685303
3094,6119,TE-9,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.13,4.48,.28,-15,-18,-11,-22,-32","1.29,10.2,1.66,5.54,4.97,10.6,20.2,7.35",8,Sigmoid,0.050337654,8.0,-30.34889603,0.9762,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.009109513834118843
3095,6120,TEN,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,-.49,2.78,11.8,-19,-1.7,-18,10.5","20.5,7.01,17.4,.79,9.38,12.8,21.3,5.07",8,Constant,,8.0,0.162587121,0.3764,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.12098700553178787
3096,6121,Toledo,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","16.2,6.08,-19,-4.6,-17,2.19,-28,-26","20.9,36.9,16.1,.54,3.24,40.3,37.8,5.72",8,Constant,,8.0,-11.51903915,0.283,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.4216900169849396
3097,6122,TOV-112D,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.90,-12,2.16,-15,-7.5,-17,-14,-40","3.46,4.74,5.91,12.9,10.5,12.8,2.52,7.74",8,Sigmoid,8.804137285,8.0,-38.54320526,0.8026,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.10241054743528366
3098,6123,TOV-21G,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.82,.42,3.40,-6.1,-10,-19,-35,-48","3.08,2.23,.40,.049,3.39,.99,2.22,3.78",8,Sigmoid,2.954659224,8.0,-47.92719269,1.3425,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-1.256658673286438
3099,6124,TT2609-C02,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-38,-60,-50,-66,-57,-78,-78","9.36,2.92,.81,1.43,.59,.84,.45,5.54",8,Sigmoid,0.002542614,0.029214961,-76.44178009,4.2844,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.533074337907314,-0.6004223227500916
3100,6125,TYK-nu,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.44,.66,-1.5,-33,-32,-41,-45,-54","3.46,1.50,1.24,8.21,11.7,3.78,3.17,.074",8,Sigmoid,0.158783853,3.710018873,-52.87522888,1.6836,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.3110369636683994,-0.20096522569656372
3101,6126,U-118 MG,PD-0325901,MEK,".0080,.025,.080,.25,.80,2.53,8","-.21,4.16,-1.5,11.3,-12,-4.0,-25","17.6,11.7,5.65,20.9,3.50,9.10,2.35",7,Constant,,8.0,-4.452364922,0.3997,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.23828181624412537
3102,6127,U-2 OS,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,-11,-7.4,-30,-12,-21,-24,-72","2.50,9.62,7.70,5.56,3.68,4.67,17.6,4.59",8,Sigmoid,8.523538533,5.427963257,-71.96920776,1.683,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.6915639727898002,-0.18337881565093994
3103,6128,U-87 MG,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-37,3.15,-2.8,2.28,-17,-23,-34,-53","45.0,9.44,4.55,2.27,5.83,17.9,3.92,1.81",8,Sigmoid,4.880723,6.600532055,-52.83995056,1.3091,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.8871502601771537,-0.2652868330478668
3104,6129,U-937,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","16.5,-3.7,-3.7,-5.0,-22,-31,-42,-56","14.3,14.8,17.7,7.14,11.8,10.3,11.6,4.35",8,Sigmoid,0.134510711,2.201559782,-54.07709122,1.5143,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,0.7891661009664859,-0.1771034449338913
3105,6130,UACC-257,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-29,-55,-68,-74,-74,-74,-72","3.56,5.43,2.96,1.99,.22,.62,.91,.99",8,Sigmoid,0.012512778,0.019956499,-73.38803864,4.2295,UACC257_SKIN,UACC257,ACH-000579,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.914200424284942,-0.8779411315917969
3106,6131,UACC-62,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-52,-60,-72,-76,-82,-86,-91","4.30,2.23,3.87,4.17,.70,2.59,3.48,.56",8,Sigmoid,0.002542614,0.010513669,-86.8898468,4.916,UACC62_SKIN,UACC62,ACH-000425,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-4.555079058914189,-1.1690969467163086
3107,6132,UACC-812,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","14.2,4.92,-.74,-17,-27,-27,-29,-51","26.0,7.44,62.4,16.9,61.6,47.6,66.6,38.5",8,Sigmoid,0.015660835,0.036591209,-69.53145599,1.0812,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.3079472586821868,1.3231968879699707
3108,6133,UM-UC-3,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.48,8.34,7.98,-4.3,-21,-28,-29,-35","2.15,2.09,.61,.91,.64,2.52,.52,3.09",8,Sigmoid,0.133011967,8.0,-31.66319847,0.9588,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.7282913327217102
3109,6134,VMRC-RCW,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.3,4.31,23.7,10.4,16.0,17.2,15.1,6.49","7.21,4.38,43.9,16.1,22.2,.51,29.4,20.6",8,Constant,,8.0,11.15503883,0.0,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.6697436571121216
3110,6135,VMRC-RCZ,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.0,6.91,-8.0,-15,2.69,-18,-21,-28","13.3,43.9,16.6,25.7,4.48,5.67,22.4,25.3",8,Constant,,8.0,-8.798200607,1.8358,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.4021141529083252
3111,6136,WM-115,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.9,-1.1,-26,-39,-43,-48,-50,-73","8.19,10.2,2.14,2.64,7.93,1.88,.51,4.22",8,Sigmoid,0.002542614,0.555520535,-63.91451263,2.0602,WM115_SKIN,WM115,ACH-000304,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-0.5878497038890342,-0.9079104065895081
3112,6137,WM1799,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,-33,-38,-58,-65,-73,-64,-70","1.50,5.02,1.13,1.04,.19,3.44,2.09,5.55",8,Sigmoid,0.002542614,0.036501385,-70.04901886,3.8317,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.310405073908113,-1.517653226852417
3113,6138,WM-266-4,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-11,-64,-77,-86,-88,-92,-91",".96,8.98,4.72,3.24,1.65,3.87,3.45,2.47",8,Sigmoid,0.01843877,0.019812323,-87.86264038,4.8727,WM2664_SKIN,WM2664,ACH-001239,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-3.9214511611384872,-1.2512847185134888
3114,6139,WM-793,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,-7.4,-26,-44,-50,-54,-60,-67","6.16,9.83,1.55,6.49,1.94,.50,4.00,14.2",8,Sigmoid,0.023960993,0.22173892,-61.36879349,3.0477,WM793_SKIN,WM793,ACH-000827,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-1.5062546252189277,-0.6033064126968384
3115,6140,WM-88,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-40,-71,-78,-86,-89,-90,-91,-91","1.13,.24,2.05,1.36,2.78,.41,.14,.084",8,Sigmoid,0.002542614,0.003394654,-90.66638947,6.2069,WM88_SKIN,WM88,ACH-000899,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-5.685553437745386,-0.9817270636558533
3116,6141,WM-983B,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-57,-80,-87,-89,-90,-89,-92","6.23,1.43,.64,1.31,5.19,3.32,.64,.68",8,Sigmoid,0.004887855,0.006414421,-90.22942352,6.3027,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,-5.049206542197629,-1.3135313987731934
3117,6142,YKG1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.49,.88,.43,-11,-20,-17,-29,-47","7.10,3.27,1.66,2.86,1.74,4.00,.065,1.08",8,Sigmoid,8.913640972,8.0,-44.98141479,0.8524,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,-0.32190069556236267
3118,6143,ZR-75-1,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-.68,-23,-11,-36,-31,-59,-47","36.4,34.6,27.7,7.64,32.3,.084,36.3,1.58",8,Constant,,8.0,-30.87976646,1.5942,ZR751_BREAST,ZR751,ACH-000097,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.44275474548339844
3119,6144,ZR-75-30,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.59,.49,19.6,6.46,40.8,31.4,51.9,6.44","19.2,33.7,6.22,15.3,2.37,9.74,6.22,12.6",8,Linear,,8.0,6.819937229,0.0,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2.0794415416798357,0.6694300770759583
3120,6145,SCC-25,PD-0325901,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.4,2.86,8.77,-9.7,-9.0,-35,-37,-76","1.31,1.99,7.79,8.76,1.69,1.82,.0081,4.02",8,Sigmoid,8.94147069,3.133640528,-73.50130463,1.3214,SCC25_UPPER_AERODIGESTIVE_TRACT,SCC25,ACH-000188,Head and Neck Cancer,14,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Discontinued,Pfizer ,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,1.142195436653222,-0.5901032090187073
3121,6146,A172,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","5.07,3.64,9.33,8.24,6.88,.13,3.12,-7.0","6.89,.84,7.80,4.55,9.54,.090,5.20,2.06",8,Constant,,8.0,3.604906797,0.0,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.639481544494629
3122,6147,A-204,PD-0332991,CDK4,".0080,.025,.080,.25,.80,2.53,8","-1.5,13.4,-11,-.60,-38,-20,-43",".73,2.12,1.56,2.86,5.47,6.16,9.79",7,Sigmoid,0.40728718,8.0,-34.42272186,0.8348,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.2080440521240234
3123,6148,A2058,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".43,5.14,6.32,2.62,1.38,.18,.31,3.54","11.3,.046,3.68,.46,.36,.28,5.74,5.35",8,Constant,,8.0,2.616293669,0.0,A2058_SKIN,A2058,ACH-000788,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.306978702545166
3124,6149,A-253,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,-.39,1.79,14.9,5.20,6.52,7.31,4.48","2.64,6.97,2.05,6.39,2.58,1.09,6.17,8.40",8,Constant,,8.0,3.868290901,0.009649,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.3048810958862305
3125,6150,A2780,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","9.31,3.25,9.06,7.54,-1.2,-18,-28,-42","9.50,9.07,6.58,1.65,9.90,6.85,7.15,1.85",8,Sigmoid,8.182728065,8.0,-43.54047775,0.6759,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.3036110401153564
3126,6151,A-375,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","5.05,-3.6,13.9,3.87,7.85,-8.1,-12,-27","3.31,3.95,.16,.22,.14,4.90,2.73,4.02",8,Sigmoid,2.720161438,8.0,-26.26582527,0.1961,A375_SKIN,A375,ACH-000219,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.0283706188201904
3127,6152,A549,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.66,-3.0,10.3,8.21,9.63,-3.7,-24,-29","6.20,0,1.21,.74,5.62,3.41,2.76,2.37",8,Sigmoid,1.144818544,8.0,-29.07390213,0.2405,A549_LUNG,A549,ACH-000681,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6918628215789795
3128,6153,A-673,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".94,1.82,.85,8.89,.54,-8.0,-13,-29","10.9,1.79,4.18,1.25,.18,1.76,1.18,3.52",8,Sigmoid,8.161316205,8.0,-28.52132416,0.2491,A673_BONE,A673,ACH-000052,Bone Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6712822914123535
3129,6154,ALL-SIL,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","10.1,13.3,10.6,13.5,5.77,-9.9,-11,-29","9.43,17.5,15.6,.74,6.51,3.59,7.92,13.1",8,Sigmoid,2.929170132,8.0,-27.7773304,0.7632,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.4622788429260254
3130,6155,AMO-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","18.9,-.96,2.41,3.78,4.52,-9.5,-7.6,-43","3.98,28.2,13.4,2.88,4.56,7.90,0,0",8,Sigmoid,8.781573376,8.0,-40.84783936,0.6168,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.828968048095703
3131,6156,AsPC-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.55,17.1,11.6,14.2,-6.7,18.6,5.98,6.24","13.7,20.9,19.8,6.15,3.60,14.5,2.41,27.8",8,Constant,,8.0,7.590629578,0.0,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7696638107299805
3132,6157,AU565,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","9.96,1.61,16.2,19.0,.24,-13,-38,-52","12.9,26.3,3.60,13.6,36.6,6.59,10.7,3.34",8,Sigmoid,0.992861688,7.564302444,-50.14849472,0.9007,AU565_BREAST,AU565,ACH-000248,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0234401346610444,2.9398975372314453
3133,6158,B-CPAP,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","4.25,3.00,12.3,9.86,1.05,-.81,-7.7,-19",".25,5.49,7.38,.68,2.38,7.44,1.26,2.24",8,Sigmoid,4.510300636,8.0,-18.45643425,0.3853,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.587158441543579
3134,6159,BDCM,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","20.9,12.3,17.0,5.38,13.1,-19,-35,-73","2.10,2.97,8.33,21.5,17.5,.90,34.2,7.88",8,Sigmoid,1.099745512,1.91660738,-73.19919586,0.8172,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.6505566334888269,2.5735690593719482
3135,6160,BFTC-909,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","9.39,5.39,16.9,1.46,9.36,3.54,-.44,-27","7.42,1.96,10.8,7.60,14.1,7.01,.81,11.6",8,Sigmoid,9.112115633,8.0,-26.43250847,0.2396,BFTC909_KIDNEY,BFTC909,ACH-000792,Kidney Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.508422374725342
3136,6161,BL-41,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.26,5.77,9.75,9.77,8.66,13.9,14.5,-36","10.5,1.73,4.96,1.58,2.82,8.10,3.78,7.58",8,Sigmoid,8.035946503,8.0,-36.1625824,0.2911,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.570218086242676
3137,6162,BL-70,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.05,.0076,-.053,13.9,-2.4,-15,-24,-84",".95,9.19,.85,13.9,6.92,.15,10.8,.52",8,Sigmoid,8.530419302,4.529109001,-83.50418854,1.1151,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.5105252316282474,2.5850343704223633
3138,6163,BT-20,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,5.74,7.58,21.0,9.47,10.3,20.2,12.5","8.19,4.01,8.47,48.9,28.5,31.1,14.9,.12",8,Constant,,8.0,9.358653069,0.1474,BT20_BREAST,BT20,ACH-000536,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.005502700805664
3139,6164,BT-474,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-15,-5.7,-20,-18,-24,-31,-40","1.51,23.5,8.78,14.3,4.43,10.2,3.16,4.35",8,Sigmoid,2.085233688,8.0,-39.83487701,1.0329,BT474_BREAST,BT474,ACH-000927,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.468456268310547
3140,6165,BT-549,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","9.79,7.30,24.1,21.1,12.7,10.8,7.12,4.08","11.9,2.65,18.1,8.69,25.9,9.46,4.33,1.06",8,Constant,,8.0,9.535829544,0.0,BT549_BREAST,BT549,ACH-000288,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8996188640594482
3141,6166,C2BBe1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".37,3.78,3.04,11.6,10.2,-1.7,-35,-50","5.90,30.6,6.45,28.8,1.33,15.9,24.8,1.57",8,Sigmoid,1.733106971,8.0,-49.42451477,0.7911,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.937519073486328
3142,6167,C32,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.64,2.65,3.91,12.2,.70,-3.4,-18,-15","3.92,1.76,5.62,9.50,3.42,.89,4.19,23.5",8,Sigmoid,2.478007555,8.0,-30.41609764,0.07469,C32_SKIN,C32,ACH-000580,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.4354209899902344
3143,6168,CAL 27,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.21,12.5,.53,5.25,7.96,13.1,-4.3,-9.8","2.71,4.26,4.33,3.37,2.46,1.34,1.05,3.95",8,Constant,,8.0,4.215794563,0.0,CAL27_UPPER_AERODIGESTIVE_TRACT,CAL27,ACH-000832,Head and Neck Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7048139572143555
3144,6169,CAL-85-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,7.26,-14,6.87,-6.0,.0047,-17,7.30","10.3,23.9,2.28,1.34,1.08,8.15,12.7,11.3",8,Constant,,8.0,-5.373597145,0.2048,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7896900177001953
3145,6170,Calu-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.46,2.04,12.4,11.4,16.1,4.98,6.91,-11","7.42,.034,19.1,3.73,7.99,11.6,11.0,15.7",8,Constant,,8.0,4.234856129,0.04588,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.1700093746185303
3146,6171,Calu-3,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","12.1,4.52,20.6,7.26,30.3,-13,-14,-19","17.0,38.4,9.38,9.06,9.75,8.00,24.9,11.1",8,Constant,,8.0,1.686583161,0.3678,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.0341291427612305
3147,6172,CAMA-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,.099,2.04,-3.2,-1.5,1.05,-22,-20","1.15,15.1,3.54,.63,8.82,7.57,19.9,13.7",8,Constant,,8.0,-3.964913368,0.2178,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.852566719055176
3148,6173,Capan-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","15.7,-17,-.25,3.06,-9.0,-6.2,1.11,-10.0","17.9,5.41,19.4,6.37,29.6,25.8,52.1,5.46",8,Constant,,8.0,-0.978929758,0.3713,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.024780035018921
3149,6174,CAS-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,4.19,-2.5,-11,-2.6,-11,-6.6,-19","4.75,.32,7.87,6.13,3.79,11.6,11.2,1.25",8,Constant,,8.0,-6.098876953,0.1407,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.914365768432617
3150,6175,CI-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","37.0,-19,29.8,-.57,4.81,-25,8.20,-72","11.0,39.9,6.79,31.3,29.9,13.0,9.01,7.84",8,Linear,,1.749890969,-69.5683136,1.0214,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.559553482565912,2.275956869125366
3151,6176,COLO-320,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","8.58,3.94,5.61,.40,1.17,-17,-24,-56","5.78,2.85,1.08,1.35,5.39,.61,5.74,14.4",8,Sigmoid,8.959784154,6.83245182,-54.78891373,0.846,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.921683587203566,2.6086292266845703
3152,6177,COLO-678,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","12.9,6.87,16.4,19.2,-3.0,-7.1,-5.2,-19","14.1,10.2,24.5,9.40,3.61,4.15,20.1,7.19",8,Sigmoid,0.221485421,8.0,-11.14879704,0.4865,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.095332145690918
3153,6178,COLO-679,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","17.2,-23,19.9,11.6,6.25,-9.1,-3.8,-42","15.0,5.28,4.43,5.80,13.8,4.25,6.66,5.38",8,Sigmoid,9.554208563,8.0,-41.10241699,0.4765,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.53912615776062
3154,6179,COR-L23,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".71,-.39,2.91,.29,-.44,2.08,.24,-8.0","4.15,6.94,3.27,4.05,12.7,2.12,3.15,3.53",8,Constant,,8.0,2.029177904,0.0,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.758579730987549
3155,6180,COV318,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-7.8,4.16,-14,6.93,2.56,6.22,-3.1","22.6,8.01,4.47,.55,9.89,1.98,10.5,12.1",8,Constant,,8.0,-0.217486829,0.2948,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.0866928100585938
3156,6181,COV504,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,9.19,-.62,12.1,-1.8,17.8,-14,-5.8","27.9,14.3,2.80,3.12,4.34,14.8,7.32,2.32",8,Constant,,8.0,0.40774411,0.0,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9248337745666504
3157,6182,Daoy,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-4.6,-6.0,2.69,-3.2,-3.1,-9.8,.88","27.3,18.2,29.2,11.4,28.4,13.9,30.3,12.6",8,Constant,,8.0,0.616528571,0.01077,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.4357266426086426
3158,6183,DBTRG-05MG,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.80,2.34,4.52,-5.2,3.17,-5.1,-8.8,-25","2.95,9.93,2.54,1.94,8.10,9.40,4.79,8.99",8,Sigmoid,8.414747474,8.0,-24.36649895,0.3863,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.661449432373047
3159,6184,Detroit 562,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,5.35,-4.5,3.72,-5.2,3.52,-44,-54","10.5,2.59,8.08,4.70,11.3,7.74,18.1,.16",8,Sigmoid,1.940104485,3.174485207,-54.21850586,0.9828,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.1551454796710616,2.704800605773926
3160,6185,DK-MG,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.38,3.06,9.53,-1.0,-2.2,-15,-19,-44","7.23,1.36,.70,7.87,1.01,6.24,12.6,3.44",8,Sigmoid,8.731462512,8.0,-43.32587433,0.5503,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.685159683227539
3161,6186,DMS 114,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".96,-.91,20.8,13.4,.64,-14,-37,-44",".23,6.17,5.10,3.09,17.7,10.1,14.3,15.6",8,Sigmoid,0.956522942,8.0,-43.71157455,0.8691,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.353362560272217
3162,6187,DOHH-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-.044,16.9,22.8,-4.1,-13,-39,-53","13.3,1.90,34.0,.17,27.5,23.3,9.36,2.48",8,Linear,,4.048234382,-53.61958694,1.2261,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.3982808310006838,2.8464975357055664
3163,6188,EB1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","15.9,17.1,.083,19.2,-3.7,10.1,-28,-47","2.55,.20,8.58,35.5,7.35,29.6,2.63,21.9",8,Sigmoid,2.205078363,8.0,-46.72693253,0.7713,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.376302719116211
3164,6189,EBC-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.53,-6.9,8.92,-7.2,-19,-24,-44,-36",".52,14.4,10.6,23.9,7.38,9.66,3.99,1.96",8,Sigmoid,0.242108315,8.0,-38.04798508,1.1729,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.853895902633667
3165,6190,EFE-184,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,2.95,-4.1,1.96,-2.3,3.64,-3.6,4.58","7.40,17.2,.14,21.7,7.47,16.5,9.24,10.7",8,Constant,,8.0,-4.147824287,0.03832,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9403374195098877
3166,6191,EFM-19,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","15.7,-1.3,30.0,3.11,11.0,-22,-18,-35","17.9,1.49,1.24,7.32,3.08,5.79,10.0,4.22",8,Sigmoid,0.565274596,8.0,-27.17058563,0.6936,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.06144380569458
3167,6192,EFO-21,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-1.5,6.73,8.05,-.87,4.42,-.66,3.10","11.2,2.62,6.51,5.10,.24,10.2,3.86,10.1",8,Linear,,8.0,-14.61812592,0.09228,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.890871047973633
3168,6193,EFO-27,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.48,-2.8,8.91,4.67,3.95,5.84,7.06,1.72","8.69,11.0,13.6,8.29,11.3,6.85,11.1,2.82",8,Constant,,8.0,2.437756062,0.0,EFO27_OVARY,EFO27,ACH-000936,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.450432300567627
3169,6194,EM-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.64,8.20,20.0,16.0,.39,-28,-53,-63","6.53,5.75,1.63,7.08,6.27,2.76,5.80,.77",8,Sigmoid,0.742015183,1.934057355,-61.78448486,1.5487,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.6596200527444183,2.5763556957244873
3170,6195,EN,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","18.2,6.09,-3.0,12.0,-1.4,4.75,-3.2,-4.0","6.73,2.26,10.4,2.44,7.58,4.89,4.97,1.03",8,Constant,,8.0,3.808119774,0.03136,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6708827018737793
3171,6196,ES-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.75,-2.9,10.1,2.36,9.23,-7.0,-5.4,-33",".67,.20,7.08,.14,10.1,.29,.36,8.98",8,Sigmoid,8.553304634,8.0,-32.93256378,0.2855,ES2_OVARY,ES2,ACH-000906,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6523096561431885
3172,6197,F-36P,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-.075,12.2,27.3,22.7,15.1,-.65,-22,-15","4.02,1.17,25.9,30.9,1.38,5.32,4.44,3.60",8,Sigmoid,0.914699435,8.0,-18.84746742,0.4814,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6293253898620605
3173,6198,FaDu,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.53,15.7,2.96,10.5,9.96,8.90,-19,-38","3.12,15.3,17.9,16.7,19.7,15.0,3.66,1.03",8,Sigmoid,2.298291683,8.0,-38.03094864,0.4639,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6250486373901367
3174,6199,FU-OV-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","15.8,-10,3.46,.36,14.8,9.20,22.4,8.59","22.3,24.6,4.74,13.2,12.7,12.6,14.4,4.16",8,Constant,,8.0,6.443371296,0.0499,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.587799072265625
3175,6200,G-361,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","10.7,-13,10.1,-.82,4.19,-14,-18,-36","9.51,9.75,14.4,4.26,16.5,1.16,12.8,17.7",8,Sigmoid,8.064015347,8.0,-35.08232117,0.6448,G361_SKIN,G361,ACH-000572,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.3032641410827637
3176,6201,G-401,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.19,.063,5.26,-8.1,-5.8,-25,-45,-44","14.5,12.9,3.90,4.62,4.13,13.8,3.83,7.78",8,Sigmoid,0.643615782,8.0,-46.4380455,1.3601,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.2147653102874756
3177,6202,GB-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.85,-9.2,12.9,-3.8,-6.9,-1.8,-12,-43","15.0,14.9,2.91,4.69,15.2,1.24,14.5,1.73",8,Sigmoid,8.495884836,8.0,-42.43699646,0.3521,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8501229286193848
3178,6203,GCT,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.28,3.81,4.58,4.41,1.93,-16,-32,-53","2.42,9.87,.13,1.69,3.97,17.5,16.2,4.47",8,Sigmoid,1.470052719,4.080997944,-52.57221603,0.9603,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.406341552625453,2.665419578552246
3179,6204,GMS-10,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-3.6,.11,1.57,-1.3,.31,-11,-27","3.43,3.03,.76,4.98,5.64,18.0,19.0,2.02",8,Sigmoid,2.798555374,8.0,-27.04238129,0.1815,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.423515796661377
3180,6205,GRANTA-519,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.08,23.0,13.4,-2.4,-15,-26,-53,-58","10.9,25.8,29.0,9.96,14.7,26.0,12.4,.85",8,Sigmoid,0.576317847,2.531948328,-58.6362114,1.6975,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.9289890964907538,2.6607775688171387
3181,6206,H4,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,-1.9,-3.2,-2.6,-8.9,-11,-23,-33","3.70,3.54,.89,4.20,.86,7.28,1.82,8.22",8,Sigmoid,2.52644825,8.0,-32.9184494,0.7428,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8331923484802246
3182,6207,HCC1187,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-2.9,6.35,9.71,-8.9,-5.7,-20,-21","15.2,20.7,23.4,12.9,7.66,5.70,9.59,6.79",8,Constant,,8.0,-9.361386299,0.3664,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.070990562438965
3183,6208,HCC-15,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","16.1,12.2,14.2,6.85,6.84,6.10,16.1,-12","5.02,9.36,19.1,.35,1.45,7.22,4.32,.29",8,Sigmoid,8.169823879,8.0,-12.01254845,0.1374,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.92415189743042
3184,6209,HCC1569,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","4.84,-6.4,30.6,-5.8,11.5,11.0,3.63,-39","1.55,6.62,3.05,5.98,14.1,14.4,7.04,1.01",8,Sigmoid,8.421156871,8.0,-39.11737823,0.312,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.036520004272461
3185,6210,HCC1806,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","13.2,-1.3,5.09,-14,18.4,.18,3.39,-11","5.75,6.23,17.2,11.4,2.41,11.5,19.2,14.3",8,Constant,,8.0,0.792109489,0.3205,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8744864463806152
3186,6211,HCC1954,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.97,7.43,-1.9,1.95,-2.0,-34,-46,-57","3.17,6.99,15.0,14.7,8.42,1.28,2.74,2.76",8,Sigmoid,0.596598744,2.50906539,-54.58472824,1.2174,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.9199103292208384,3.0745644569396973
3187,6212,HCC2935,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.51,-3.7,9.53,-19,-5.4,-19,-24,-8.6",".24,16.9,13.4,6.61,20.5,7.28,3.72,26.1",8,Constant,,8.0,-14.50867748,0.1876,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9443302154541016
3188,6213,HCC4006,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","5.68,1.63,3.89,-3.6,7.12,-25,-14,-25","3.11,17.4,5.61,7.75,3.42,22.1,1.24,4.31",8,Sigmoid,0.729842603,8.0,-19.62871361,0.6659,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.933574676513672
3189,6214,HCC-56,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","4.38,11.8,1.91,-9.8,.42,-1.0,-15,-12","14.2,23.2,11.8,5.33,5.64,1.77,9.75,8.50",8,Constant,,8.0,-4.351527691,0.3011,HCC56_LARGE_INTESTINE,HCC56,ACH-000467,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.4657983779907227
3190,6215,HCC70,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","13.1,-9.4,12.8,16.8,18.2,24.8,12.8,14.3","11.0,15.6,7.12,16.0,23.3,19.0,12.3,29.3",8,Linear,,8.0,-11.02896023,0.0002795,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.889645576477051
3191,6216,HCC-78,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.83,-1.4,7.12,4.30,2.53,-4.3,-5.8,-22","12.0,.40,2.82,8.46,1.58,10.3,.017,18.0",8,Sigmoid,8.258199538,8.0,-19.90436172,0.1592,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.0137295722961426
3192,6217,HCT 116,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.25,-9.5,12.4,-6.1,12.7,-8.8,7.42,-4.7","1.26,3.59,9.83,.62,8.21,9.03,4.84,6.57",8,Constant,,8.0,1.940330982,0.1507,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.4970829486846924
3193,6218,HCT-15,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","18.0,2.40,8.81,.77,-4.7,7.03,-14,-19","12.5,11.3,13.5,4.97,3.61,19.1,4.15,24.0",8,Constant,,8.0,-2.410456181,0.2188,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.805629014968872
3194,6219,HDQ-P1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,-9.5,4.29,-3.1,-22,-51,-53,-52","0,7.92,17.2,38.6,17.5,16.9,9.73,24.0",8,Linear,,6.033266816,-55.68481827,3.2073,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.7972886245705193,2.8639345169067383
3195,6220,HEC-151,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.94,10.8,-8.1,-3.8,-13,4.69,-25,-9.1","3.09,13.9,8.33,2.32,4.94,9.86,18.3,6.81",8,Constant,,8.0,-3.535616875,0.6006,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.303635358810425
3196,6221,HEC-1-A,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".51,7.29,3.96,28.7,16.5,-8.6,-14,-29","5.28,2.57,9.22,8.55,1.41,5.70,12.3,8.93",8,Sigmoid,0.764195979,8.0,-22.75514221,0.4081,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6039066314697266
3197,6222,HEC-1-B,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","22.4,5.45,-17,3.00,5.28,-24,-32,-59","20.4,5.77,18.2,9.21,3.46,8.29,10.9,6.44",8,Sigmoid,2.772366047,4.964954376,-58.51844025,1.3735,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.6024041083310485,2.572986602783203
3198,6223,HEC-251,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-11,-6.5,4.82,-9.1,3.10,5.63,-2.4","16.1,6.13,8.73,7.04,2.73,5.51,2.02,5.19",8,Constant,,8.0,-0.62556082,0.0,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8889665603637695
3199,6224,HEC-265,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","4.70,-5.2,5.34,-1.9,2.97,-7.5,19.2,-12","5.53,12.0,2.87,.98,2.34,12.0,2.34,23.9",8,Constant,,8.0,2.121147633,0.07914,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.548955202102661
3200,6225,HEC-59,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","5.55,4.16,15.4,5.12,15.0,8.54,.0047,-33","5.12,7.66,.19,2.04,6.13,1.66,6.96,2.20",8,Sigmoid,3.958518505,8.0,-33.06867218,0.1972,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.61611008644104
3201,6226,HEC-6,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.41,16.1,48.0,16.3,14.8,-27,-25,-32","1.17,9.93,104,50.2,9.19,31.5,25.5,20.0",8,Constant,,8.0,-1.583756804,1.186,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8552424907684326
3202,6227,HEL 92.1.7,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","20.4,9.93,12.9,5.01,11.5,.65,9.13,-2.5","6.26,18.7,5.84,16.5,3.69,18.7,11.5,15.6",8,Constant,,8.0,11.03911686,0.07361,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.383554458618164
3203,6228,Hep 3B2.1-7,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,27.3,-.034,29.1,-10.0,24.8,2.31,-2.3","1.49,15.5,13.9,12.4,31.0,32.2,18.6,.22",8,Constant,,8.0,6.256548405,0.0,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8786749839782715
3204,6229,Hep G2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.73,13.7,-1.4,8.67,-14,-16,-40,-36","1.16,22.3,6.47,5.61,35.9,10.5,11.3,6.23",8,Sigmoid,0.818560481,8.0,-38.10629654,0.8202,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.822700023651123
3205,6230,Hey-A8,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.83,-1.2,2.97,1.46,-3.6,-20,-29,-40","10.6,4.51,.75,6.22,7.41,7.41,7.84,.30",8,Sigmoid,0.946791947,8.0,-39.16795349,0.4718,HEYA8_OVARY,HEYA8,ACH-000542,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.4946506023406982
3206,6231,HGC-27,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.60,-1.5,4.82,-3.0,-17,-37,-55,-60","1.77,.090,.98,.14,.096,2.43,1.04,.99",8,Sigmoid,0.53913492,1.742808342,-60.17516327,1.3939,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.5554978018000732,2.4689717292785645
3207,6232,HH,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","11.1,-5.6,8.41,15.0,-.99,-28,-48,-39","12.5,1.32,19.8,2.05,11.1,5.33,.66,9.65",8,Sigmoid,0.559993267,8.0,-43.63085175,1.5875,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.5148544311523438
3208,6233,HLF,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","18.0,.12,.36,-2.1,18.0,3.59,14.0,-8.2",".92,2.75,3.71,1.28,4.14,2.04,2.76,7.50",8,Constant,,8.0,2.531801462,0.04018,HLF_LIVER,HLF,ACH-000393,Liver Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.5145621299743652
3209,6234,HMC-1-8,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.00,-.14,-3.6,1.55,-9.7,-11,-26,-20","2.64,.17,2.25,2.84,2.32,.73,.20,3.17",8,Sigmoid,0.644022286,8.0,-23.3461132,0.3245,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.5586659908294678
3210,6235,HMCB,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-.15,-6.1,9.55,2.13,1.83,-9.6,-13,-32","7.33,2.48,13.7,2.67,18.7,2.92,13.8,3.35",8,Sigmoid,8.098842052,8.0,-32.10168457,0.3092,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.3547239303588867
3211,6236,HOS,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.27,-5.1,.24,12.9,-9.9,-.18,-23,-22","41.2,29.1,1.65,31.5,44.5,2.55,.39,3.72",8,Constant,,8.0,-5.004763603,0.7598,HOS_BONE,HOS,ACH-000613,Bone Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.486201047897339
3212,6237,HPAC,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","8.69,5.79,-3.6,22.7,-.91,-19,-41,-37","19.8,4.21,8.34,22.6,5.52,23.3,16.8,18.6",8,Sigmoid,0.689942598,8.0,-39.65653229,0.8548,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8141043186187744
3213,6238,Hs 294T,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.04,-4.2,1.01,1.20,-4.1,-2.2,-18,-17","12.3,7.02,8.34,4.47,5.04,5.48,6.22,9.35",8,Constant,,8.0,-3.362692118,0.2844,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6935861110687256
3214,6239,Hs 578T,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.09,-12,4.33,1.51,.64,-3.1,-13,-34","1.14,1.64,4.91,5.44,7.23,3.81,.57,13.8",8,Sigmoid,8.344950145,8.0,-24.75224686,0.4447,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.78220534324646
3215,6240,Hs 683,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","8.46,.52,12.1,1.14,-5.3,5.43,-19,-17",".81,4.29,19.7,4.21,18.8,2.73,7.68,15.9",8,Sigmoid,1.639889836,8.0,-27.50852203,0.277,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.4314866065979004
3216,6241,Hs 695T,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.40,5.87,-3.2,-23,1.67,-1.8,-14,-9.3","4.33,4.16,12.5,32.0,2.67,4.76,11.2,3.90",8,Constant,,8.0,-1.411084652,0.294,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9254157543182373
3217,6242,Hs 746T,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,1.67,8.15,25.8,-7.6,-21,-14,-15","12.7,6.75,15.6,19.5,.45,7.15,15.2,4.40",8,Sigmoid,0.23062849,8.0,-17.43261147,0.6801,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.865675449371338
3218,6243,Hs 766T,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.6,-11,3.21,7.74,-3.0,5.32,-21,-18","0,0,4.30,1.86,12.1,4.18,6.01,8.40",8,Sigmoid,1.519561172,8.0,-19.98400879,0.5099,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6227731704711914
3219,6244,Hs 852.T,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","8.48,-5.9,7.18,3.77,-4.3,-13,-18,-24","9.89,10.3,10.3,11.2,15.7,18.3,8.35,5.56",8,Sigmoid,0.630788803,8.0,-23.02455711,0.44,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7244062423706055
3220,6245,Hs 936.T,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-.49,7.05,6.11,5.37,-8.0,-12,-17,-34","6.74,4.07,4.85,1.89,3.32,7.58,17.9,2.16",8,Sigmoid,0.922351778,8.0,-33.77940369,0.3558,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,1.6596876382827759
3221,6246,Hs 939.T,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.94,8.21,7.04,-1.8,-17,-5.0,-2.9,-42","26.2,7.88,5.79,1.51,8.16,3.94,13.0,15.5",8,Sigmoid,8.321300724,8.0,-41.6297226,0.5095,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.5394186973571777
3222,6247,Hs 944.T,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,4.41,3.74,5.91,-1.8,-13,-19,-16","2.81,4.37,1.22,.92,3.51,10.6,11.9,4.70",8,Constant,,8.0,-2.17781949,0.2519,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.3910510540008545
3223,6248,HSC-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.54,4.24,6.67,.56,-1.5,6.31,4.65,1.65",".96,3.51,1.67,3.01,11.0,5.77,5.63,3.06",8,Constant,,8.0,2.87411046,0.0,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.697827100753784
3224,6249,HT,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","5.72,-9.7,22.2,51.6,10.4,39.9,-9.4,14.3","20.9,19.6,4.57,36.2,2.14,14.1,9.09,29.5",8,Constant,,8.0,15.50488663,0.3291,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.759334087371826
3225,6250,HT-1080,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.60,3.77,6.28,5.13,9.41,8.06,6.93,-12",".24,2.30,.70,3.66,1.12,2.95,.19,8.83",8,Constant,,8.0,5.951750755,0.03595,HT1080_SOFT_TISSUE,HT1080,ACH-000054,Sarcoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.140146255493164
3226,6251,HT-1197,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","9.43,21.3,14.6,19.2,-2.8,-.41,.72,5.44","12.0,12.6,6.62,24.8,0,4.89,0,6.12",8,Constant,,8.0,6.185445309,0.0,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.970715045928955
3227,6252,HT-144,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","17.9,8.08,7.55,1.60,4.67,-.43,-7.1,-6.2","21.7,21.0,21.1,10.9,16.4,8.93,20.0,17.3",8,Constant,,8.0,4.385241508,0.01489,HT144_SKIN,HT144,ACH-000322,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.478858470916748
3228,6253,HuCCT1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.95,2.95,4.14,6.96,-3.6,2.95,-9.5,-15","7.43,7.45,5.56,9.09,.18,7.59,2.19,3.04",8,Constant,,8.0,-2.063984156,0.2356,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.690491199493408
3229,6254,huH-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","13.6,.13,11.1,2.30,-18,-3.0,-42,-48","22.6,13.7,12.9,2.37,32.0,10.6,16.5,.82",8,Sigmoid,1.376191974,8.0,-48.01133347,0.559,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6328225135803223
3230,6255,HUP-T3,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".17,11.7,10.3,1.23,15.8,-9.3,-15,-33","14.2,8.35,4.50,3.58,3.78,5.57,12.8,2.12",8,Sigmoid,1.910941005,8.0,-32.91024017,0.3721,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.183229446411133
3231,6256,HuT 78,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","8.31,11.7,-.93,22.4,-11,-12,-8.2,-41","30.3,28.2,15.9,37.6,38.0,9.68,25.3,4.73",8,Constant,,8.0,-6.156410694,0.6579,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.730215549468994
3232,6257,IA-LM,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","10.1,-19,18.6,-8.8,-.073,-13,-7.6,10.4","18.0,13.0,9.28,37.1,10.7,34.2,33.9,44.4",8,Constant,,8.0,2.616777182,0.2366,IALM_LUNG,IALM,ACH-000672,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.765376567840576
3233,6258,IGR-37,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,1.74,-3.7,4.86,-16,-14,-27,-21","1.14,7.66,2.88,9.16,17.7,4.23,14.7,8.70",8,Constant,,8.0,-4.699252605,0.9764,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.3795876502990723
3234,6259,IGR-39,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","18.6,-7.7,22.7,-11,30.6,-20,8.82,-21","9.03,14.1,6.78,6.72,6.39,3.52,5.19,1.64",8,Constant,,8.0,3.519588947,0.08489,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.529388189315796
3235,6260,IGROV1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.02,-.77,2.30,3.61,3.65,3.16,-2.2,-6.5",".26,2.95,2.19,4.19,3.29,2.64,2.92,1.49",8,Constant,,8.0,1.294943571,0.01444,IGROV1_OVARY,IGROV1,ACH-000966,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6730499267578125
3236,6261,IMR-32,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,8.71,.49,2.36,-17,-22,-46,-44","4.63,2.24,2.86,3.47,9.01,.15,2.78,.87",8,Sigmoid,0.690405667,8.0,-46.76364136,1.2198,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7528655529022217
3237,6262,IPC-298,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.67,3.72,-3.1,.55,.32,-4.2,-16,-13","1.21,2.85,.84,2.53,12.0,4.97,1.53,5.82",8,Constant,,8.0,-1.835035801,0.09373,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.595219135284424
3238,6263,IST-MES2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","4.85,8.98,-11,13.2,-29,-45,-61,-55","10.8,11.8,25.7,6.63,27.3,5.90,13.2,8.39",8,Sigmoid,0.234981507,0.427757025,-52.89757156,1.7991,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,-0.8491999432003325,2.7082455158233643
3239,6264,J82,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".16,-2.5,-5.1,7.09,.98,-.69,-6.3,-3.9","5.73,2.57,8.29,11.1,3.40,14.4,1.91,14.0",8,Constant,,8.0,-1.037299395,0.01258,J82_URINARY_TRACT,J82,ACH-000396,Bladder Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8457138538360596
3240,6265,JHH-4,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","4.17,.60,7.30,8.92,-.89,-1.1,-10.0,-12","15.4,1.44,4.75,20.9,10.9,5.94,15.5,17.5",8,Constant,,8.0,0.203935653,0.1503,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6596317291259766
3241,6266,JHOS-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,22.2,21.0,25.0,17.2,-6.4,14.2,5.48","5.18,28.9,8.18,18.9,24.4,2.45,21.2,11.5",8,Constant,,8.0,7.6709795,0.03892,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9477381706237793
3242,6267,JM1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","33.0,46.1,10.9,7.57,-10,9.49,-37,-46","41.1,47.7,9.00,17.1,.97,4.99,6.32,4.22",8,Linear,,8.0,-48.42575836,0.6972,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.618410110473633
3243,6268,JMSU-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-3.8,13.6,9.33,1.57,-22,-31,-48",".46,12.2,4.80,14.6,15.5,5.25,.58,1.61",8,Sigmoid,1.322960854,8.0,-46.31656265,0.9204,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9052462577819824
3244,6269,JURKAT,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","8.73,22.8,6.63,1.07,-3.3,-30,-50,-73","9.94,10.0,5.84,4.69,.27,2.16,1.23,2.62",8,Sigmoid,1.586204171,2.357683659,-72.42141724,1.778,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.857679636626843,2.5128390789031982
3245,6270,JVM-3,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","13.1,3.54,4.78,16.5,-29,-51,-72,-74","33.6,6.17,12.5,18.4,26.4,27.7,8.42,6.82",8,Sigmoid,0.355375916,0.435200393,-72.69086456,2.6673,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,-0.8319486804077236,2.9318065643310547
3246,6271,K029AX,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".58,3.08,2.95,.60,-8.4,-20,-24,-18",".77,13.2,8.17,12.2,10.3,4.35,10.7,6.69",8,Sigmoid,0.270012408,8.0,-20.9240551,0.4534,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.4770593643188477
3247,6272,KALS-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","15.0,-1.8,26.7,3.88,15.4,-5.9,-12,-32","17.2,33.2,4.76,27.4,17.1,36.4,3.88,15.8",8,Constant,,8.0,3.748779297,0.7226,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.465338706970215
3248,6273,KARPAS-422,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","17.9,-6.1,-4.1,.16,-1.7,6.39,-4.1,1.17","5.57,7.98,1.78,9.06,5.89,5.92,11.5,2.56",8,Constant,,8.0,0.834657431,0.4619,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.667407512664795
3249,6274,KASUMI-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","15.4,20.5,8.18,8.96,-4.5,-20,-39,-54","24.7,21.7,.62,25.2,3.57,6.86,3.03,1.28",8,Sigmoid,1.562127233,5.569698811,-54.02527618,1.2846,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.7173409790480878,2.5282561779022217
3250,6275,KCL-22,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.60,8.80,12.5,15.5,2.34,-8.1,-36,-69","21.7,4.33,6.71,12.2,4.00,6.33,4.69,2.66",8,Sigmoid,3.883752584,4.05649662,-69.47610474,1.2449,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.400319699622018,2.6057209968566895
3251,6276,KG-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.47,.78,15.9,31.7,-.19,12.7,10.1,-38",".86,28.3,22.3,18.5,20.5,30.1,13.1,19.9",8,Constant,,8.0,7.474541664,0.8043,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.66347599029541
3252,6277,KHM-1B,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","17.4,-1.5,25.4,-7.6,-16,-41,-44,-52","2.79,21.9,10.7,25.4,31.1,9.77,11.5,9.08",8,Sigmoid,0.142129675,8.0,-45.73068237,1.9908,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7972397804260254
3253,6278,KMBC-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.67,2.61,5.84,.96,-.18,2.74,2.10,-22","2.64,1.84,.22,4.58,1.19,4.87,.45,15.3",8,Sigmoid,6.72227335,8.0,-20.7253952,0.1997,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9537479877471924
3254,6279,KMM-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","22.9,17.7,2.17,18.5,-1.2,-8.0,-27,-52","27.6,2.54,3.11,6.64,10.9,11.5,2.83,.53",8,Sigmoid,8.68429744,7.422032356,-51.95979691,0.9088,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.004452922100744,2.9162533283233643
3255,6280,KMRC-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","10.3,-18,5.51,-8.0,-13,-16,-13,-34","1.50,19.8,2.45,21.3,4.14,9.69,.025,8.03",8,Sigmoid,8.38674897,8.0,-29.73348045,0.7256,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.851351737976074
3256,6281,KMRC-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","8.76,8.39,14.1,15.8,2.55,3.23,-4.8,-2.1","2.15,7.14,4.64,1.08,5.87,13.2,4.74,5.83",8,Constant,,8.0,6.893501759,0.0,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.3329553604125977
3257,6282,KMS-11,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","32.1,8.15,36.9,17.9,-7.3,-28,-53,-55","22.6,2.79,5.44,27.4,11.4,4.37,2.46,7.09",8,Sigmoid,0.431569993,2.474158525,-56.38141632,1.8915,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.9059003483119945,2.712244749069214
3258,6283,KMS-12-BM,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","11.8,-39,24.8,-25,-16,-48,-19,-48","17.6,14.8,.88,2.45,25.3,2.74,16.6,12.7",8,Constant,,8.0,-27.78267097,2.4095,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8124427795410156
3259,6284,KMS-34,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","21.6,4.68,15.5,12.1,-17,-38,-57,-63","18.5,6.81,15.6,21.6,4.69,12.1,2.40,6.66",8,Sigmoid,0.498377115,1.504676104,-63.84223557,1.8031,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.40857766175009946,2.771110773086548
3260,6285,KNS-60,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","4.02,-4.8,-.35,-7.1,-18,-24,-33,-39","2.04,9.87,1.92,1.26,7.04,3.85,7.43,6.09",8,Sigmoid,0.518169463,8.0,-39.25164413,1.0592,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7741427421569824
3261,6286,KNS-81,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","8.18,6.42,13.6,6.86,-21,-23,-36,-40","5.43,12.3,2.31,8.76,3.77,6.09,5.23,3.52",8,Sigmoid,0.205330342,8.0,-36.23894119,1.0933,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.803007125854492
3262,6287,KO52,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.70,13.0,11.4,10.1,-26,-36,-56,-55","2.95,4.55,20.1,14.3,.61,2.42,4.35,4.28",8,Sigmoid,0.294655979,1.654727578,-55.16308212,1.6632,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.5036363898419978,2.719228744506836
3263,6288,KP-N-SI9s,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,-4.8,.22,-5.4,-24,-42,-54,-65","2.43,5.44,.89,.72,5.22,.70,.37,5.10",8,Sigmoid,0.514721274,1.319718719,-62.55404282,2.1291,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.2774186222243577,2.7087831497192383
3264,6289,KU812,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".71,-7.0,25.0,7.35,-5.8,-19,-13,-63","3.94,1.93,4.98,17.0,.78,16.0,.23,2.94",8,Sigmoid,8.726435007,6.253096581,-60.92507172,0.7817,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.8330767940120176,2.536332368850708
3265,6290,KYSE-30,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,-1.8,3.04,.11,3.22,2.64,-1.1,-13","3.71,1.55,1.74,.82,2.33,5.60,.35,.87",8,Constant,,8.0,-0.582975864,0.09123,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9927847385406494
3266,6291,KYSE-520,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","11.0,7.05,3.76,8.44,9.00,7.30,5.22,-6.4","6.24,4.11,12.8,.051,11.1,4.93,8.36,12.7",8,Constant,,8.0,7.646201134,0.0,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.02311372756958
3267,6292,L3.3,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","4.97,-3.7,2.96,3.65,-2.5,-3.1,-1.1,-14","7.32,8.60,5.51,7.38,4.31,6.17,5.46,2.24",8,Constant,,8.0,-3.569274902,0.1368,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.820340156555176
3268,6293,L-363,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","18.1,9.40,-5.2,-23,10.1,-41,-71,-82","27.5,22.1,5.33,10.7,18.1,6.42,4.65,2.51",8,Sigmoid,0.803730547,0.891901791,-76.8398056,2.7606,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,-0.11439925223933765,2.7292728424072266
3269,6294,L-428,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,-3.6,22.9,28.6,9.72,-10,-35,-58",".44,.67,27.0,1.20,3.92,3.84,19.7,5.31",8,Sigmoid,1.783972383,4.438398838,-57.65975952,1.2728,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.490293689332285,2.8701062202453613
3270,6295,LCLC-103H,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","8.12,-.76,5.43,1.10,2.98,-1.6,9.34,-9.9","10.1,10.4,4.04,3.76,14.7,14.0,15.5,4.95",8,Constant,,8.0,2.066325188,0.1057,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.5975570678710938
3271,6296,LN-229,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.98,8.03,16.8,5.89,8.41,-9.6,-25,-40","11.4,3.54,4.99,6.34,2.57,12.1,8.69,1.36",8,Sigmoid,1.48233211,8.0,-39.23548889,0.6559,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.5596489906311035
3272,6297,LOU-NH91,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","13.6,14.5,7.73,17.8,9.04,34.6,13.2,18.2","12.7,17.2,7.01,22.6,29.4,22.8,8.00,52.9",8,Constant,,8.0,15.4628582,0.0,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7036123275756836
3273,6298,LOX IMVI,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.25,3.76,5.17,6.17,-.15,4.86,2.52,-7.7","1.14,1.38,.11,2.29,.67,2.39,.42,6.83",8,Constant,,8.0,2.820632696,0.02421,LOXIMVI_SKIN,LOXIMVI,ACH-000750,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.4095458984375
3274,6299,LP-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","101,11.5,23.4,-16,-10.0,-10.0,-22,-24","46.3,3.47,21.4,7.59,2.96,8.37,14.1,.98",8,Sigmoid,0.002542614,8.0,-15.88710403,2.2415,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7804367542266846
3275,6300,LS123,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","4.50,14.9,8.30,2.82,7.98,5.32,13.1,-2.3","10.4,6.59,13.9,.17,8.79,10.6,7.98,6.98",8,Constant,,8.0,5.334766388,0.0,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.828073501586914
3276,6301,LS513,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","34.3,6.14,27.0,-13,3.56,-6.5,-36,-69","44.9,5.99,8.28,6.21,8.97,12.0,4.15,7.06",8,Sigmoid,9.118967956,4.528065205,-66.73175049,1.3037,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.5102947411947236,2.967310905456543
3277,6302,LU99,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","9.34,-1.4,8.50,1.28,-11,-27,-50,-63","8.61,3.56,.67,2.23,5.47,4.64,1.87,4.30",8,Sigmoid,1.000812769,2.549120188,-63.27584457,1.362,LU99_LUNG,LU99,ACH-000444,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.9357482753220264,2.4167399406433105
3278,6303,LUDLU-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","10.9,-3.8,5.06,8.30,8.14,-12,-18,-27","14.4,7.95,1.20,26.4,14.1,8.89,2.95,2.37",8,Sigmoid,0.739751935,8.0,-22.41471291,0.6779,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.935601234436035
3279,6304,Malme-3M,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.96,-5.6,5.39,4.69,-7.8,-14,-14,-26","7.18,4.50,7.21,3.43,4.33,11.8,13.9,1.44",8,Sigmoid,0.714372873,8.0,-24.12692261,0.4133,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.546051025390625
3280,6305,MCAS,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,5.92,-.77,5.82,6.16,7.82,3.31,-12",".78,1.71,2.30,4.49,10.9,5.66,8.28,3.32",8,Constant,,8.0,0.14689292,0.06381,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8750412464141846
3281,6306,MCF7,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".61,9.81,-25,-18,-26,-11,-40,-44","18.6,25.3,30.8,27.8,29.5,.95,41.4,1.23",8,Constant,,8.0,-11.64649582,0.1991,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.129549741744995
3282,6307,MDA-MB-157,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.21,2.32,-7.5,8.83,2.97,23.9,17.0,8.33","4.34,41.7,41.1,3.45,14.0,12.6,29.4,16.3",8,Constant,,8.0,8.828674316,0.1157,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6206626892089844
3283,6308,MDA-MB-175-VII,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,8.89,-18,11.1,-14,-8.3,-27,-26","23.6,2.65,4.30,17.0,2.08,9.12,8.35,9.32",8,Constant,,8.0,-14.59160995,0.4732,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.1965365409851074
3284,6309,MDA-MB-415,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,26.8,18.1,1.59,-18,-13,-43,-50","4.66,18.0,20.8,26.8,18.6,18.5,7.25,16.3",8,Linear,,6.220910659,-51.42065048,0.9099,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.8279163042338107,3.0489180088043213
3285,6310,MDA-MB-436,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".34,-10,-5.3,-9.4,11.1,-3.6,-2.5,-22","3.28,6.12,16.8,17.5,.65,4.73,7.43,4.33",8,Constant,,8.0,-4.111074924,0.4081,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7756879329681396
3286,6311,MDA-MB-453,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,5.04,5.11,4.19,-8.6,-15,-23,-36","11.1,22.0,29.2,17.3,9.17,8.54,5.08,5.11",8,Sigmoid,3.409235477,8.0,-35.92456055,0.2768,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9826443195343018
3287,6312,MDA-MB-468,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,-28,6.42,-17,-4.7,-41,-4.3,-29","20.9,26.4,6.24,39.7,.85,11.2,5.35,13.2",8,Constant,,8.0,-9.091706276,0.903,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9047937393188477
3288,6313,MEG-01,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.89,21.7,4.51,10.2,3.25,.93,5.84,-18","4.68,18.1,8.69,8.14,9.94,18.8,9.00,20.9",8,Constant,,8.0,5.387190342,0.1798,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.546186923980713
3289,6314,MEL-HO,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,21.3,-6.1,15.5,-4.4,11.4,-19,.33","3.11,14.4,4.27,16.4,0,12.4,1.71,11.3",8,Constant,,8.0,0.298186213,0.2735,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.2396812438964844
3290,6315,MES-SA,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","8.49,12.2,-.25,1.05,9.44,-8.2,-18,-25",".99,6.38,1.08,4.33,2.36,4.99,5.40,5.47",8,Sigmoid,0.794819832,8.0,-21.76519012,0.2707,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.601792573928833
3291,6316,MeWo,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".89,-4.6,27.5,-5.6,-30,-36,-36,-28","2.18,10.5,49.5,13.6,20.7,21.6,31.2,42.8",8,Constant,,8.0,-13.11029625,1.0396,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.4277310371398926
3292,6317,MG-63,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.90,1.63,2.88,-.12,-6.4,-12,-20,-30","2.76,3.69,4.79,6.80,.63,5.30,2.93,12.8",8,Sigmoid,0.531697094,8.0,-22.64721489,0.6379,MG63_BONE,MG63,ACH-000359,Bone Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.489198684692383
3293,6318,Mino,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,18.6,16.0,13.8,-10,-42,-47,-69","9.95,27.4,4.11,25.6,12.6,9.00,4.13,1.98",8,Sigmoid,0.489362538,1.398233533,-62.19774628,1.0717,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.3352096777862754,2.839352607727051
3294,6319,MJ,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-5.9,5.99,20.2,-6.7,-29,-32,-62","2.02,22.2,14.8,21.3,9.98,5.47,9.70,3.93",8,Sigmoid,3.943963528,4.616918087,-60.33178329,1.0644,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.5297274017603635,2.4025115966796875
3295,6320,MKN-45,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-21,-12,11.5,.55,-1.0,-26,-13","9.92,12.6,11.1,.36,7.06,3.49,14.7,4.34",8,Constant,,8.0,-11.61296749,0.307,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.992043972015381
3296,6321,MKN7,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,48.1,4.51,12.5,-27,10.9,-15,22.4","2.71,50.1,35.7,.018,18.7,39.5,19.2,25.3",8,Constant,,8.0,1.737805605,0.6204,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.864144802093506
3297,6322,MKN74,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","9.27,-14,16.1,9.36,-18,5.37,2.70,-21","14.4,45.1,31.0,19.4,26.9,2.31,15.5,3.51",8,Constant,,8.0,-0.152585119,0.302,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6748886108398438
3298,6323,MOLP-8,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".67,1.05,63.6,17.8,-17,-48,-58,-69","1.64,3.92,15.2,9.56,6.72,11.4,9.32,1.27",8,Sigmoid,0.431767374,0.83833456,-64.98540497,2.1591,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,-0.17633802189680178,2.7788922786712646
3299,6324,MOLT-16,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","4.08,16.7,2.59,12.6,-34,-49,-65,-72","3.37,28.4,33.0,8.29,4.28,5.46,1.31,2.87",8,Sigmoid,0.263697416,0.551490188,-66.98913574,2.7305,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,-0.5951312319246379,2.1035659313201904
3300,6325,MONO-MAC-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","27.7,-7.7,19.7,-8.2,5.78,.33,2.78,-50","15.1,23.2,19.6,6.17,23.0,15.1,15.9,11.8",8,Linear,,8.0,-48.64807892,2.0811,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6781768798828125
3301,6326,MSTO-211H,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","15.1,16.9,26.2,-7.3,-.46,-9.4,-31,-60","1.51,16.8,14.8,20.0,1.25,6.40,28.6,8.68",8,Sigmoid,8.216740049,5.501162529,-60.44088745,0.7796,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.7049594388122555,2.7162442207336426
3302,6327,NCI-H1048,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.67,24.1,13.9,14.5,7.19,6.31,-2.5,3.44","16.4,15.1,4.79,12.4,28.7,9.10,9.42,.44",8,Constant,,8.0,8.466391563,0.01538,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9163827896118164
3303,6328,NCI-H1092,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.0,-2.2,33.1,6.99,-8.8,-12,5.46,-5.1","33.0,28.2,16.0,2.01,19.3,1.92,6.68,5.43",8,Constant,,8.0,2.548450947,0.0,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.293078660964966
3304,6329,NCI-H1184,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,10.7,-15,16.4,-13,-15,20.1,-13","3.54,44.0,35.2,41.9,33.4,36.8,4.19,18.1",8,Constant,,8.0,-6.36281538,0.5989,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.2414281368255615
3305,6330,NCI-H1341,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-.98,-18,-5.8,-5.6,47.8,-29,-3.1,5.59","7.24,29.2,21.7,6.60,61.9,6.10,8.31,3.92",8,Constant,,8.0,0.293576837,0.343,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7031002044677734
3306,6331,NCI-H1373,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","13.9,2.97,22.9,9.99,15.7,13.2,17.1,-9.3","27.2,.078,5.32,6.60,20.6,1.83,6.20,7.02",8,Constant,,8.0,12.45795441,0.001922,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.0713422298431396
3307,6332,NCI-H1568,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,4.77,-.55,9.23,-8.6,-10.0,-32,-49","4.14,8.61,1.97,15.4,5.75,10.8,23.6,20.0",8,Sigmoid,2.63043189,8.0,-49.39692688,1.0166,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9703969955444336
3308,6333,NCI-H1648,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-3.3,3.66,-7.0,6.29,-12,-18,-29","17.9,6.16,.86,11.8,.87,39.2,26.3,7.18",8,Constant,,8.0,-2.398995399,0.9064,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.801307201385498
3309,6334,NCI-H1650,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","20.6,17.9,3.76,11.2,27.9,17.0,-3.6,-17","17.5,1.07,16.8,10.1,24.1,.16,6.87,2.49",8,Sigmoid,2.373586416,8.0,-17.10330772,0.1289,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.988220453262329
3310,6335,NCI-H1651,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.72,-6.3,7.99,13.2,8.25,7.76,-7.6,-20",".60,15.6,18.2,20.0,5.69,7.05,5.87,1.16",8,Sigmoid,2.515671015,8.0,-19.54143333,0.3582,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9952478408813477
3311,6336,NCI-H1792,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".13,12.4,-1.5,20.9,-4.6,-.55,-22,-28","12.7,8.14,2.42,1.47,3.71,3.94,8.25,3.35",8,Sigmoid,1.499360442,8.0,-28.54704475,0.4562,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9030075073242188
3312,6337,NCI-H1793,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.4,13.8,3.77,7.15,6.03,-27,-50,-62","8.09,5.36,14.6,19.4,18.7,17.0,4.78,13.3",8,Sigmoid,0.880894065,2.038415432,-58.91511154,0.7979,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.7121727570106919,2.9006896018981934
3313,6338,NCI-H1915,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","16.8,19.6,9.59,-5.1,3.70,-12,-.83,-44","1.86,35.0,15.6,22.7,5.89,12.4,2.99,4.53",8,Sigmoid,8.862358339,8.0,-38.46764755,0.5238,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7223825454711914
3314,6339,NCI-H1944,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.22,-1.9,13.1,6.78,-11,9.17,-18,-55","2.69,6.87,8.97,.34,2.74,14.6,12.7,12.8",8,Sigmoid,2.848348379,4.488175869,-55.09791183,0.319,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.5014463539499507,2.802083969116211
3315,6340,NCI-H1975,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","8.18,-7.9,9.20,-3.2,4.51,-16,-2.1,-26","4.83,2.60,2.73,2.10,17.0,1.89,7.79,18.3",8,Constant,,8.0,-5.391607285,0.0,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.935163974761963
3316,6341,NCI-H2009,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.81,5.04,2.34,1.91,3.22,5.34,3.04,-9.0","32.8,3.21,12.4,16.9,7.18,9.42,4.04,3.44",8,Constant,,8.0,1.618835211,0.09706,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7310569286346436
3317,6342,NCI-H2023,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.84,.65,17.5,15.4,-18,-5.2,-45,-44","8.49,3.56,12.9,12.1,9.01,8.60,11.1,11.1",8,Sigmoid,1.123594999,8.0,-45.48042297,0.6846,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8894896507263184
3318,6343,NCI-H2030,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.34,2.53,7.72,2.24,4.64,-2.3,-1.6,-20","3.38,5.53,1.70,.71,2.41,8.21,6.55,10.5",8,Sigmoid,9.402382818,8.0,-20.04513359,0.1732,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.853132724761963
3319,6344,NCI-H2052,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.41,2.03,2.23,7.62,-6.7,-14,-28,-25","15.0,.93,13.6,16.0,22.0,11.4,12.5,18.1",8,Sigmoid,0.527890146,8.0,-26.95436478,0.7472,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.027780771255493
3320,6345,NCI-H2085,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,5.27,7.35,6.91,-2.0,.78,.85,-14","16.1,11.6,16.8,2.29,5.00,2.07,35.1,12.5",8,Constant,,8.0,-1.281748891,0.1523,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.0734574794769287
3321,6346,NCI-H2087,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.21,-4.7,9.69,9.19,-11,-19,-20,-27","1.89,7.99,6.20,4.62,8.69,5.03,6.82,6.71",8,Sigmoid,0.237557873,8.0,-21.85917091,0.6578,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.029902696609497
3322,6347,NCI-H211,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.59,-6.9,13.9,1.27,-6.9,-12,-29,-32","10.3,11.6,30.3,5.98,.41,8.22,13.3,4.27",8,Sigmoid,0.8770499,8.0,-32.21593857,0.7345,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9210734367370605
3323,6348,NCI-H2122,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-10.0,-1.9,10.1,-2.3,-41,-35,-57,-51","4.61,5.01,9.12,29.2,16.4,7.59,5.37,.99",8,Sigmoid,0.16724664,8.0,-48.36867523,1.274,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.5026328563690186
3324,6349,NCI-H2170,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,2.13,8.76,24.9,-5.4,-12,-26,-47","4.93,20.4,10.8,32.1,14.6,5.84,30.0,9.39",8,Sigmoid,1.535400033,8.0,-47.49738312,1.1408,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9528231620788574
3325,6350,NCI-H2172,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","31.1,-3.6,18.3,-7.9,22.5,18.4,16.3,-33","19.1,18.7,18.3,24.1,3.86,20.4,.64,51.3",8,Constant,,8.0,12.38638878,0.04726,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.024338960647583
3326,6351,NCI-H2228,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","10.3,-2.3,9.89,2.25,3.80,-10,-9.7,-14","5.97,3.12,8.60,5.84,13.0,11.1,9.52,.14",8,Constant,,8.0,-2.307086706,0.2845,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.759223461151123
3327,6352,NCI-H2286,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","16.2,-2.4,27.3,21.0,-21,-36,-51,-68","12.3,1.51,.21,8.45,14.6,27.1,19.4,5.83",8,Linear,,1.427565255,-67.80809784,2.3797,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.35597037428781914,2.646547794342041
3328,6353,NCI-H23,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,4.18,12.7,7.25,30.6,.29,-.35,-25","11.0,2.44,11.8,8.16,3.83,.065,15.4,11.5",8,Sigmoid,8.108988218,8.0,-25.07923317,0.2654,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.781277656555176
3329,6354,NCI-H2444,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.06,14.1,11.7,-2.3,-7.6,-3.3,-24,-57","8.66,15.3,14.6,21.2,26.2,8.97,10.5,9.80",8,Sigmoid,9.105597031,6.714149952,-56.35779953,0.7247,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.9042172325354263,2.8507814407348633
3330,6355,NCI-H2452,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,-18,-6.7,-2.4,-23,-37,-12,-41","1.34,7.62,17.0,24.8,.81,3.64,3.62,6.68",8,Constant,,8.0,-18.48583984,0.8849,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8612985610961914
3331,6356,NCI-H28,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.49,4.78,5.43,3.11,8.55,-15,-28,-54","7.16,20.5,10.1,16.6,7.26,.057,23.5,9.87",8,Sigmoid,1.980416894,6.050222397,-53.40722275,0.7641,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.8000950312018347,2.694903612136841
3332,6357,NCI-H322,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.16,7.51,-.60,6.23,-2.3,2.99,-9.1,-4.6","2.91,3.89,1.23,7.77,4.17,.33,6.20,8.82",8,Constant,,8.0,1.136001706,0.0,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.012153148651123
3333,6358,NCI-H3255,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.69,-4.5,12.2,1.18,4.54,7.27,31.9,13.6","4.36,7.82,3.48,4.51,2.66,11.2,12.6,.80",8,Linear,,8.0,-0.788573503,0.02764,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9255504608154297
3334,6359,NCI-H358,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","4.90,7.54,-1.7,10.3,-4.9,-4.0,-22,-28","3.59,.27,2.32,2.19,1.82,.88,6.67,3.08",8,Sigmoid,1.486920476,8.0,-28.13727951,0.5514,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.0601561069488525
3335,6360,NCI-H441,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-5.7,-5.4,-6.4,-8.9,-13,-24,-26","12.9,1.16,14.0,.52,6.51,8.04,2.51,18.7",8,Sigmoid,1.348770618,8.0,-28.94655228,0.5023,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7638635635375977
3336,6361,NCI-H522,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.40,2.53,-4.8,-2.0,6.75,-5.5,9.13,3.03","1.77,4.65,.034,.17,2.46,13.8,1.27,4.87",8,Constant,,8.0,1.402636647,0.1026,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.0270824432373047
3337,6362,NCI-H647,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,9.01,-7.2,-7.0,-5.7,-14,-27,-33","10.7,11.2,4.90,6.95,21.8,19.0,20.8,12.4",8,Sigmoid,8.108522436,8.0,-33.31723404,0.5271,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7258358001708984
3338,6363,NCI-H650,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-.060,3.11,2.13,19.9,7.18,3.45,2.56,-23",".76,9.86,5.53,4.68,2.50,1.60,2.92,7.00",8,Sigmoid,8.689155852,8.0,-22.78612328,0.1045,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6755714416503906
3339,6364,NCI-H661,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-5.4,21.9,7.63,13.4,11.8,16.6,-5.6","9.96,6.09,15.9,7.22,8.50,13.2,26.5,18.1",8,Sigmoid,8.345329093,8.0,-17.80127335,0.08016,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6948511600494385
3340,6365,NCI-H727,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,.11,3.48,-3.6,.14,37.6,-9.3,-11","17.5,27.3,32.4,19.2,8.65,53.6,12.2,19.8",8,Constant,,8.0,-6.243968487,0.315,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.183850049972534
3341,6366,NCI-H747,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.84,9.45,-3.1,-1.8,2.80,-23,-26,-46","33.1,21.7,4.58,21.5,8.19,.14,7.47,13.9",8,Sigmoid,3.941854954,8.0,-44.94260025,0.797,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9646551609039307
3342,6367,NCI-H810,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,8.80,3.63,12.5,-4.5,3.38,-8.4,-12","1.86,6.59,5.54,9.91,1.04,5.88,4.98,13.6",8,Sigmoid,8.289179272,8.0,-19.79752159,0.304,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.0863702297210693
3343,6368,NCI-N87,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,20.4,10.5,6.08,24.8,10.7,-28,-26","5.09,25.1,23.8,26.4,30.8,11.8,20.6,23.3",8,Constant,,8.0,-1.075243592,0.7402,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8349435329437256
3344,6369,NCO2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","18.9,8.87,2.61,13.6,3.52,-14,-16,-48","20.3,1.74,9.26,5.42,4.56,5.73,7.44,2.98",8,Sigmoid,8.96954512,8.0,-46.25040817,0.8892,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.462867498397827
3345,6370,NIH:OVCAR-3,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","15.4,11.1,6.12,-6.4,-3.7,20.2,-8.9,9.33",".19,11.3,28.6,8.08,9.62,18.9,2.40,10.5",8,Constant,,8.0,3.120512724,0.268,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7609963417053223
3346,6371,NUGC-3,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.88,-1.1,-2.5,11.7,-15,-11,-20,-18","3.51,8.91,10.6,7.20,10.0,11.8,.87,13.9",8,Sigmoid,0.178104579,8.0,-16.87470818,0.1617,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6958088874816895
3347,6372,NUGC-4,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","5.61,6.71,-3.6,-3.9,-6.0,-32,-58,-58","8.90,.53,2.83,2.28,5.36,9.80,.16,1.31",8,Sigmoid,0.714665949,1.606289268,-59.87081528,1.2862,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.47392671636646083,3.229724168777466
3348,6373,OCI-AML2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-1.6,.38,10.9,-.47,-23,-66,-79","3.72,3.43,3.64,.63,1.31,2.10,5.70,.82",8,Sigmoid,1.183135152,1.528368115,-78.31972504,1.6237,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.4242005746875771,2.229328155517578
3349,6374,OCI-AML5,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.71,-.44,5.71,-1.5,-23,-35,-46,-52","5.84,3.19,.011,.27,1.84,6.49,4.68,3.72",8,Sigmoid,0.314398468,5.799865246,-50.53947067,1.8102,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.7578346838341972,2.2283318042755127
3350,6375,OCUM-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","18.4,-.22,24.1,12.3,7.45,-15,-21,-40","25.7,1.77,.35,23.0,1.10,14.8,4.73,1.84",8,Sigmoid,1.369905353,8.0,-38.19293594,0.6016,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.775078773498535
3351,6376,OE21,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","21.0,-1.8,11.3,4.24,8.19,-27,-30,-66","8.42,17.6,20.6,8.65,26.7,5.20,31.6,16.9",8,Linear,,1.937264446,-64.98652649,0.9908,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.6612768985963081,2.58134126663208
3352,6377,OE33,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","10.1,7.65,-9.6,15.1,-11,-22,-37,-41","9.90,14.7,9.44,51.1,.22,6.25,13.8,11.2",8,Sigmoid,2.017190218,8.0,-40.52680969,0.9013,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.079596519470215
3353,6378,ONCO-DG-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-.62,12.3,4.71,10.8,3.37,-6.5,-9.9,-32","2.55,17.5,1.14,16.4,18.5,.30,11.4,20.2",8,Sigmoid,8.376531583,8.0,-30.91213608,0.501,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8595168590545654
3354,6379,ONS-76,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.09,-1.2,-.36,4.59,1.87,-.29,-27,-13",".82,3.41,1.84,5.50,.11,11.5,14.4,20.8",8,Sigmoid,1.361129642,8.0,-25.58442688,0.3628,ONS76_CENTRAL_NERVOUS_SYSTEM,ONS76,ACH-000776,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.880312919616699
3355,6380,OPM-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.49,49.2,46.5,25.8,33.6,30.1,26.5,2.88","11.7,87.7,8.56,6.14,4.55,18.2,3.39,9.84",8,Constant,,8.0,26.5227623,0.0,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.797980308532715
3356,6381,OV-90,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","11.8,-13,21.1,2.46,2.02,6.35,-9.3,-8.8","4.46,2.39,1.49,3.94,7.49,19.4,4.97,11.4",8,Constant,,8.0,-0.667852402,0.072,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6597070693969727
3357,6382,OVCAR-4,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.6,-9.8,-.21,-3.1,-3.6,-13,11.8,-11","8.04,3.89,9.17,3.93,7.45,.81,3.06,.055",8,Constant,,8.0,-6.785155296,0.1033,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9205739498138428
3358,6383,OVCAR-8,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,2.93,2.86,4.75,-.85,6.45,-2.6,2.67","6.11,6.41,7.73,.40,8.66,9.79,1.14,1.33",8,Constant,,8.0,2.34888196,0.0,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9359688758850098
3359,6384,OVMANA,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,5.83,-4.3,13.6,-8.9,3.53,-7.3,6.76",".047,18.3,9.10,8.05,2.81,13.8,5.26,8.83",8,Constant,,8.0,-4.715928078,0.2611,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.343301773071289
3360,6385,OVSAHO,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,3.81,23.2,1.90,4.20,-11,-9.7,-16","16.2,2.51,19.0,8.63,3.06,1.83,16.5,3.38",8,Sigmoid,0.613398671,8.0,-17.87054062,0.0811,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.122642993927002
3361,6386,OVTOKO,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,-6.1,10.3,1.05,6.21,-5.1,-3.1,-11","3.78,9.74,1.42,13.1,1.86,6.75,2.23,8.77",8,Constant,,8.0,-1.063205361,0.1509,OVTOKO_OVARY,OVTOKO,ACH-000663,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.581704616546631
3362,6387,P12-ICHIKAWA,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.61,.89,22.2,11.6,-14,-30,-52,-64","4.66,4.05,19.9,.56,2.35,5.84,5.49,4.78",8,Sigmoid,0.732101619,2.072611809,-62.7281189,1.6728,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.728809555426167,2.3160922527313232
3363,6388,P31/FUJ,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.85,-.31,24.4,-6.5,7.41,-4.8,-6.6,-13","5.27,11.0,9.52,6.47,6.87,8.41,5.74,16.5",8,Constant,,8.0,-0.570391953,0.4643,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.789518356323242
3364,6389,P3HR-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","9.24,10.2,10.6,11.8,5.90,-2.3,-14,-53","5.20,2.64,5.62,15.0,22.5,6.24,3.02,4.15",8,Sigmoid,8.758214396,7.55710125,-52.64783859,0.5391,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0224876841227064,2.9463937282562256
3365,6390,Panc 02.03,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.3,-2.0,-.35,-3.5,-9.6,-8.2,-36,-33","18.5,3.00,11.4,3.31,3.11,4.55,.39,2.77",8,Sigmoid,1.140153408,8.0,-35.00470352,0.8133,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.772752046585083
3366,6391,Panc 03.27,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.93,-11,1.11,6.84,3.61,20.8,12.1,-5.6","20.1,0,8.25,19.6,5.49,5.72,19.6,26.7",8,Constant,,8.0,6.608604908,0.03994,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7855238914489746
3367,6392,Panc 04.03,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.04,-8.2,19.2,11.7,12.9,-7.3,12.0,-21","34.6,13.7,16.3,4.49,5.45,20.0,10.5,16.9",8,Constant,,8.0,7.157999039,0.2123,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.2110652923583984
3368,6393,Panc 10.05,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","11.6,11.9,50.6,8.45,25.6,-13,10.5,-13","1.31,2.71,3.95,14.2,5.46,8.92,21.0,4.84",8,Constant,,8.0,11.64606094,0.1536,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.0174779891967773
3369,6394,PC-3,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,3.08,3.19,12.5,-8.1,.76,-3.8,4.46","1.81,13.0,4.44,12.0,7.51,11.3,.40,12.3",8,Constant,,8.0,-2.120139122,0.01016,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.069847822189331
3370,6395,Pfeiffer,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","33.7,25.1,-1.2,-2.0,-4.0,1.49,-11,-58","32.3,35.6,5.58,6.09,56.7,11.2,9.40,.40",8,Linear,,3.862196962,-58.38981247,0.6917,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.351236182705867,2.196333885192871
3371,6396,PK-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.11,2.01,1.75,-.98,2.15,-5.0,-3.2,-11","4.48,.80,7.25,2.73,2.44,.31,3.43,3.37",8,Constant,,8.0,-0.890507996,0.07151,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9605960845947266
3372,6397,PK-45H,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,15.5,-9.7,9.76,-8.8,3.34,-29,-17","9.70,2.55,14.6,3.90,3.97,15.3,9.40,11.6",8,Constant,,8.0,-6.510560989,0.4232,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.952341079711914
3373,6398,PK-59,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".70,3.09,-.16,1.53,4.96,-5.5,-27,-37",".20,1.26,2.48,.59,6.60,2.66,2.41,19.7",8,Sigmoid,1.507091522,8.0,-34.82408524,0.4778,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.882938861846924
3374,6399,PLC/PRF/5,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,3.30,.65,-3.6,-3.1,-9.0,-29,-41","26.8,33.5,4.49,8.90,16.0,.42,5.19,25.0",8,Sigmoid,1.791423202,8.0,-40.3506279,0.8374,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.314741611480713
3375,6400,Raji,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-1.1,1.83,20.5,-23,13.0,-8.2,2.05","4.01,22.8,.68,5.09,3.29,4.38,1.48,37.8",8,Constant,,8.0,-2.920687199,0.2033,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6185038089752197
3376,6401,RD,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","9.00,9.10,5.37,10.9,7.75,-5.6,-2.2,-6.0","4.86,6.46,.57,10.1,8.59,1.46,8.22,2.89",8,Constant,,8.0,4.473920822,0.002948,RD_SOFT_TISSUE,RD,ACH-000169,Sarcoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.918900728225708
3377,6402,Reh,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","13.0,12.2,7.75,-4.9,2.83,-11,-32,-58","10.8,.29,10.3,2.60,6.74,2.90,1.70,5.31",8,Sigmoid,8.749848324,5.912584305,-58.61103058,0.7898,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.7770830124901804,2.171234130859375
3378,6403,RERF-GC-1B,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.21,-6.0,5.40,15.8,-3.0,.88,-5.6,-3.6","31.6,1.13,13.2,6.34,18.1,8.58,4.65,16.9",8,Constant,,8.0,-2.941525221,0.01805,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.0513148307800293
3379,6404,RERF-LC-AI,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,-3.0,1.20,.45,-.51,-2.1,-9.5,-11","8.00,7.72,.30,3.47,2.26,.43,2.97,2.74",8,Constant,,8.0,-1.939204931,0.1348,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7888708114624023
3380,6405,RERF-LC-MS,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,7.10,2.74,-.48,.15,-6.0,-11,-29","5.75,3.97,4.55,8.89,6.36,9.17,20.3,14.4",8,Sigmoid,8.035103427,8.0,-28.08049583,0.0986,RERFLCMS_LUNG,RERFLCMS,ACH-000062,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.4789040088653564
3381,6406,RKO,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.69,-1.7,5.35,-4.5,-5.7,-15,-25,-34","4.93,4.53,.50,15.5,2.72,11.4,12.9,6.00",8,Sigmoid,2.449036121,8.0,-33.88129044,0.6835,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6652798652648926
3382,6407,RL95-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","14.4,2.10,18.7,.58,7.70,-19,-23,-35","19.1,3.43,1.54,4.33,11.4,8.96,29.4,31.1",8,Constant,,8.0,3.928061724,0.5663,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.894352436065674
3383,6408,RPMI-8402,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","30.7,3.71,9.05,1.33,-13,-32,-68,-79","2.23,9.84,17.9,8.01,15.9,22.7,10.4,.44",8,Sigmoid,1.112454653,1.42691958,-81.46915436,2.1229,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.3555179809150501,2.1729025840759277
3384,6409,RT-112,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.10,-3.2,12.4,9.99,-8.5,-4.7,-22,-32","22.0,7.05,6.31,4.11,1.24,1.69,8.77,3.33",8,Sigmoid,2.288099527,8.0,-32.48958969,0.5327,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.759289026260376
3385,6410,RT4,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-23,-.32,7.75,-25,-26,-29,-27","10.6,8.14,11.9,8.18,37.6,6.17,22.2,4.88",8,Constant,,8.0,-18.03347206,1.7181,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.826721429824829
3386,6411,RVH-421,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,15.7,-5.2,7.76,-9.7,-16,-27,-33","8.57,15.5,13.2,5.06,9.57,17.5,20.8,13.1",8,Sigmoid,0.688754082,8.0,-32.38103104,1.0254,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.50913143157959
3387,6412,SBC-5,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.13,1.94,7.17,8.50,-6.3,-1.4,-16,-19",".15,5.70,4.59,4.76,5.09,7.72,4.87,4.61",8,Sigmoid,1.105331659,8.0,-19.68625641,0.02076,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.4803340435028076
3388,6413,SCaBER,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-3.2,5.49,-2.5,-5.3,-12,-15,-18","17.6,1.41,7.57,5.70,13.9,1.57,1.78,.95",8,Constant,,8.0,-8.435956001,0.6056,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.976409912109375
3389,6414,SF126,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","9.20,.33,2.13,-2.8,4.97,-10.0,-18,-36",".77,4.77,2.34,2.00,.12,2.60,2.15,4.83",8,Sigmoid,8.461459439,8.0,-35.99268341,0.4761,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6546740531921387
3390,6415,SF-295,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-12,-1.2,2.53,-8.1,-18,-13,-29","11.5,6.94,2.33,5.27,13.9,8.49,5.55,.59",8,Sigmoid,8.276249773,8.0,-28.65094376,0.1626,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.545574188232422
3391,6416,SH-10-TC,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.13,-6.3,-10,-5.5,2.62,5.14,7.18,2.00","5.77,7.83,6.01,5.68,2.02,8.25,1.46,1.32",8,Constant,,8.0,0.380663395,0.0,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6979918479919434
3392,6417,SHP-77,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.36,-1.9,2.92,18.6,16.5,12.0,18.6,6.96","10.7,24.0,9.89,23.3,4.78,16.9,20.2,22.3",8,Constant,,8.0,10.01178455,0.0,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8614706993103027
3393,6418,SIG-M5,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,8.13,14.3,16.6,-40,-62,-76,-81","9.50,11.8,14.4,32.8,8.15,9.25,.24,.93",8,Sigmoid,0.258846432,0.397759676,-79.60136414,2.9168,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,-0.9219072852216671,2.0931596755981445
3394,6419,SIMA,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,35.2,33.1,-10,-17,-33,-24,-49","44.1,44.0,31.9,25.0,29.5,1.62,50.1,7.33",8,Linear,,8.0,-48.20514297,1.6616,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.632728099822998
3395,6420,SJSA-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,23.4,20.2,12.1,11.7,-5.4,-15,-22","21.3,16.9,10.5,10.2,29.1,3.48,20.4,15.3",8,Linear,,8.0,-21.46292496,0.6593,SJSA1_BONE,SJSA1,ACH-000748,Bone Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.510345458984375
3396,6421,SK-BR-3,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","15.3,2.66,26.1,15.0,2.41,23.4,32.3,5.98",".38,21.2,18.2,38.7,4.00,19.2,7.20,30.0",8,Constant,,8.0,15.31219482,0.0,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.0682120323181152
3397,6422,SK-CO-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","14.8,-4.9,9.87,-13,8.37,-3.4,8.94,-.97","2.24,7.11,12.0,9.05,6.97,.33,8.75,4.24",8,Constant,,8.0,1.870072842,0.16,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8384900093078613
3398,6423,SK-ES-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.01,1.97,-4.8,6.73,-13,-9.5,-29,-40",".91,12.6,16.8,20.1,6.20,5.59,6.27,12.7",8,Sigmoid,6.36880064,8.0,-40.25724792,0.5761,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8659591674804688
3399,6424,SK-HEP-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","14.4,6.57,12.4,-12,5.81,-31,-6.1,-42","6.37,8.33,2.50,1.32,.10,1.54,11.9,8.43",8,Sigmoid,0.515595198,8.0,-41.56534195,0.3311,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8263442516326904
3400,6425,SK-MEL-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-20,14.9,8.91,16.3,29.4,70.3,64.8","1.87,6.86,1.17,13.3,8.01,7.05,29.7,7.39",8,Linear,,8.0,-19.74870491,0.442,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.636598587036133
3401,6426,SK-MEL-24,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","3.12,6.94,-9.5,8.53,-23,-1.3,-3.8,-1.0","9.84,.72,7.55,2.11,.59,15.0,17.5,11.7",8,Constant,,8.0,1.51386106,0.1802,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6328227519989014
3402,6427,SK-MEL-30,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.96,4.88,-1.6,15.5,-1.3,4.63,-11,-7.2","8.51,1.46,1.22,4.67,1.67,2.84,3.51,.86",8,Constant,,8.0,-0.50586915,0.01621,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.234255075454712
3403,6428,SK-MEL-31,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.90,-6.8,-.22,4.53,-5.7,.63,10.3,-5.7","19.6,3.54,26.5,19.1,4.12,4.81,19.5,7.90",8,Constant,,8.0,-2.838592768,0.002502,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.524317741394043
3404,6429,SK-MEL-5,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-19,-16,-12,-6.9,-9.1,-23,-29","5.98,0,20.9,15.1,10.8,13.6,11.7,11.6",8,Constant,,8.0,-15.04181194,0.3079,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6619129180908203
3405,6430,SK-MM-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","4.15,-.61,3.87,-5.1,1.27,-4.1,-17,-29","4.52,2.07,3.48,3.87,6.17,2.32,18.8,4.59",8,Sigmoid,2.620040178,8.0,-28.88930702,0.5401,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.565194606781006
3406,6431,SK-N-AS,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,6.02,3.01,-1.9,-14,-12,-39,-42","8.14,6.15,4.40,18.9,.83,4.59,2.49,.23",8,Sigmoid,1.106391788,8.0,-43.47060013,0.8092,SKNAS_AUTONOMIC_GANGLIA,SKNAS,ACH-000260,Neuroblastoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.793962001800537
3407,6432,SK-N-BE(2),PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","30.5,22.1,-20,-19,-34,-28,-44,-57","46.8,40.2,13.5,1.62,10.5,7.86,15.2,8.73",8,Linear,,3.912641344,-57.97886276,2.048,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.3642126814757147,2.7844958305358887
3408,6433,SK-N-DZ,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".056,-11,1.65,-2.6,-3.8,-19,-29,-46","7.39,15.8,8.68,3.15,15.9,3.68,5.21,12.3",8,Sigmoid,2.727723837,8.0,-45.04755783,0.8865,SKNDZ_AUTONOMIC_GANGLIA,SKNDZ,ACH-000366,Neuroblastoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.633791923522949
3409,6434,SK-N-SH,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,12.7,2.09,.17,-18,-16,-34,-43","9.20,12.2,1.62,4.15,9.05,2.37,4.33,3.56",8,Sigmoid,1.245320916,8.0,-43.41130447,1.0097,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.711092472076416
3410,6435,SK-OV-3,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","14.5,-1.3,17.4,-.12,5.04,-25,-17,-15","5.36,7.82,7.11,14.2,7.91,25.8,8.64,4.23",8,Constant,,8.0,-2.55048871,0.06216,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.695291519165039
3411,6436,SNG-M,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.75,4.41,9.05,.63,1.81,3.63,-.29,-15","2.82,8.74,1.53,3.09,2.80,3.87,1.47,.27",8,Sigmoid,8.319401739,8.0,-15.00187969,0.1502,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.577655792236328
3412,6437,SNU-1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","11.0,21.2,3.24,13.4,7.07,-12,-41,-61","18.7,1.49,10.4,1.16,7.33,2.88,27.1,3.75",8,Sigmoid,8.293143769,5.734571934,-60.74353409,1.044,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.7465131068190973,2.54470157623291
3413,6438,SNU-182,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","16.3,7.82,7.88,-4.0,10.2,-9.3,-12,-31","2.62,6.15,18.2,9.01,9.25,5.36,31.5,5.93",8,Sigmoid,8.164375021,8.0,-32.57674026,0.4209,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7231669425964355
3414,6439,SNU-423,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-.54,-11,4.78,-.18,4.82,-31,-39","11.8,6.06,2.49,11.2,8.13,7.79,5.48,3.53",8,Sigmoid,2.014854193,8.0,-39.25258636,0.5886,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.697854995727539
3415,6440,SNU-449,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-.77,2.25,3.44,2.81,-.24,.79,1.48,3.42",".43,4.12,8.63,6.37,5.35,6.31,5.36,5.28",8,Constant,,8.0,-0.287550449,0.0,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.1743764877319336
3416,6441,SNU-C2A,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","17.4,31.6,7.57,23.9,-16,8.73,-27,-24","30.9,39.0,39.2,20.1,20.8,13.7,20.4,3.59",8,Constant,,8.0,-1.288414359,0.4366,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.813798189163208
3417,6442,SU.86.86,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-.67,.25,7.95,-1.3,-7.1,1.14,1.14","4.66,1.87,1.15,4.03,6.12,6.84,17.7,3.98",8,Constant,,8.0,0.028146591,0.0,SU8686_PANCREAS,SU8686,ACH-000114,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7748281955718994
3418,6443,SU-DHL-10,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.75,5.96,2.64,4.04,82.6,146,-52,-86","2.41,40.0,11.8,12.5,31.8,20.4,23.5,4.31",8,Linear,,0.256082005,-92.61406708,1.3344,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,-1.3622575537666757,2.798060655593872
3419,6444,SU-DHL-4,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-.41,18.1,4.92,17.2,-22,-56,-71,-79","5.27,3.32,2.88,13.9,3.33,9.84,3.42,4.47",8,Sigmoid,0.387049794,0.625150025,-77.02414703,2.4962,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,-0.4697636180507268,2.3884332180023193
3420,6445,SU-DHL-6,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","58.9,5.70,12.6,-40,9.30,-40,-47,-36","0,0,0,0,0,0,0,0",8,Linear,,8.0,-55.52148819,1.8035,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.3786659240722656
3421,6446,SU-DHL-8,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","11.5,5.84,8.57,-2.8,-20,-45,-57,-72","8.75,16.9,18.2,9.05,20.3,3.20,8.52,9.68",8,Sigmoid,0.475030184,1.212386608,-70.19011688,2.4264,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.19259082028105282,2.7789130210876465
3422,6447,SUIT-2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","5.43,-3.2,8.21,5.13,-3.2,-18,-12,-44","9.05,13.9,6.70,1.68,2.29,14.7,.97,9.37",8,Sigmoid,4.7831593,8.0,-19.0241127,0.3509,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.420957088470459
3423,6448,SUP-M2,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","9.18,-12,12.9,6.12,-2.0,-.46,-7.8,-78",".22,9.74,7.26,11.8,18.9,6.57,3.17,3.37",8,Sigmoid,8.123743062,5.921947002,-77.80221558,0.7352,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.7786652802979153,2.229390859603882
3424,6449,SUP-T1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,3.38,10.0,12.9,3.91,27.4,-17,-9.2","9.12,1.96,5.13,2.58,2.73,1.59,38.6,26.0",8,Constant,,8.0,6.157625675,0.4662,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.732107639312744
3425,6450,SW 1088,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","19.9,-3.2,4.16,-9.1,17.8,-4.9,-21,-32","18.2,25.9,14.5,21.6,9.88,7.29,3.20,5.56",8,Sigmoid,1.371440887,8.0,-31.13020706,0.1536,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8177714347839355
3426,6451,SW 1271,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","8.48,8.24,18.2,-4.4,-5.0,-3.1,-8.9,-24","1.51,5.62,15.9,17.5,3.60,1.21,1.23,.12",8,Sigmoid,8.952316379,8.0,-22.35134888,0.2713,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7308332920074463
3427,6452,SW 1353,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,22.0,-6.2,11.3,-19,7.04,-20,4.20","2.79,3.92,4.11,4.05,6.56,6.88,8.62,6.95",8,Constant,,8.0,-1.939238667,0.4901,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.759345769882202
3428,6453,SW1417,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,20.8,32.5,14.0,-7.7,-17,.75,-28","15.3,9.78,7.62,15.4,22.0,2.71,23.3,26.9",8,Sigmoid,0.158645242,8.0,-14.74428272,0.4307,SW1417_LARGE_INTESTINE,SW1417,ACH-000236,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.207822799682617
3429,6454,SW 1990,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","8.13,1.98,17.7,18.0,-.25,-5.1,-9.6,-24","17.8,8.23,18.2,11.5,2.83,6.88,11.3,6.13",8,Sigmoid,5.778882504,8.0,-23.13140488,0.3129,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.962409019470215
3430,6455,SW403,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,11.8,-7.0,-9.0,-16,-6.5,-35,-38","23.4,5.86,21.7,18.4,9.59,32.1,25.2,9.58",8,Constant,,8.0,-19.76434326,1.0767,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.110024929046631
3431,6456,SW48,PD-0332991,CDK4,".0080,.025,.080,.25,.80,2.53,8","34.3,-25,17.0,-24,-35,-47,-48","16.3,8.21,5.38,16.7,1.19,12.9,9.48",7,Linear,,8.0,-48.82185745,1.7552,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.4422004222869873
3432,6457,SW480,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,8.29,-.68,5.25,5.78,.90,-12,-14","12.0,2.59,10.0,.48,3.51,13.5,10.6,4.33",8,Sigmoid,1.235561371,8.0,-14.41541862,0.1182,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.0317749977111816
3433,6458,SW579,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".91,-1.5,3.63,-5.5,-2.4,-9.1,-19,-24","2.26,1.32,8.45,4.61,8.99,9.45,4.85,7.80",8,Sigmoid,1.303247333,8.0,-24.00342751,0.2898,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7915616035461426
3434,6459,SW620,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".50,-8.8,6.25,-17,1.65,-21,-30,-48","2.86,6.63,3.79,1.26,2.37,5.10,6.47,3.15",8,Sigmoid,2.933603525,8.0,-47.51211548,0.7942,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.557985782623291
3435,6460,SW 780,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","12.2,-4.1,-2.9,1.89,.37,-25,-53,-54","9.57,8.53,4.37,6.96,.69,2.47,2.06,4.34",8,Sigmoid,0.832434297,1.642117023,-54.25826645,0.2847,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.4959862770656609,2.900691509246826
3436,6461,SW 900,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,-1.2,4.08,-2.4,8.59,-7.3,-6.8,-22","4.96,6.44,14.4,28.3,4.23,1.67,8.78,12.4",8,Constant,,8.0,-5.500391483,0.4161,SW900_LUNG,SW900,ACH-000669,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.0416007041931152
3437,6462,T24,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,5.82,2.62,15.5,-7.4,2.18,-18,-5.0","13.6,2.01,9.65,3.21,12.8,8.35,12.9,5.25",8,Constant,,8.0,-0.178634033,0.5323,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6239023208618164
3438,6463,T3M-10,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,-15,3.71,14.8,-8.0,-14,-9.8,-14","12.7,14.2,4.87,4.34,16.4,18.4,3.02,9.34",8,Constant,,8.0,-6.815891743,0.2516,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.804474353790283
3439,6464,T-47D,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","11.8,2.00,1.30,11.5,5.26,-14,-35,-24","31.2,2.39,7.02,17.3,46.8,11.2,22.2,16.6",8,Constant,,8.0,-5.007502079,0.5315,T47D_BREAST,T47D,ACH-000147,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.290618419647217
3440,6465,T84,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-15,30.2,-9.1,23.0,-21,35.6,-40","53.4,3.72,32.0,24.8,33.8,6.54,6.78,20.3",8,Constant,,8.0,-5.810323715,0.8757,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9737327098846436
3441,6466,TCCSUP,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,-4.9,4.74,3.10,1.16,1.13,-18,-25","2.72,2.81,1.17,10.7,3.90,3.91,.13,4.17",8,Sigmoid,2.075614214,8.0,-24.85514641,0.168,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6367034912109375
3442,6467,TE 617.T,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","10.7,-8.7,-1.3,-2.5,-24,-45,-40,-59","9.08,7.24,8.68,8.97,23.0,11.6,31.7,1.68",8,Sigmoid,0.376659095,1.012163162,-59.90505981,1.6558,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.012089785142281168,2.055410146713257
3443,6468,TE-9,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.01,19.3,-5.7,7.51,8.42,18.1,-1.8,5.44","17.1,8.41,16.1,14.8,29.2,6.58,23.6,1.63",8,Constant,,8.0,9.456144333,0.0816,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.9114646911621094
3444,6469,TEN,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,26.3,-20,5.30,-21,13.9,-14,8.90","8.89,10.9,4.27,10.4,9.18,8.75,.70,7.04",8,Constant,,8.0,-6.051641464,0.7225,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.8925390243530273
3445,6470,Toledo,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","12.1,7.42,7.16,14.4,17.7,-3.7,-10,-47","12.9,4.38,5.09,7.63,41.6,9.62,15.2,1.92",8,Sigmoid,8.699465141,8.0,-46.79748917,0.3478,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.5546374320983887
3446,6471,TOV-112D,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-.22,-6.9,.088,-3.9,-6.2,-20,-29,-45","2.97,11.1,2.28,16.9,8.39,13.3,.99,4.37",8,Sigmoid,2.028833151,8.0,-44.53334808,0.7611,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.579371690750122
3447,6472,TOV-21G,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","5.51,-2.2,12.9,7.35,2.24,-7.1,3.34,-19","5.48,2.02,3.43,1.97,1.35,8.00,.63,15.3",8,Sigmoid,9.532913315,8.0,-18.15174484,0.1943,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,1.8947395086288452
3448,6473,TT2609-C02,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,14.5,15.9,-6.9,-8.5,-27,-52,-56","7.27,4.93,12.3,.53,2.31,1.06,5.02,.35",8,Sigmoid,0.728886366,3.043967247,-57.47081757,1.3716,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.1131616800860984,2.577664852142334
3449,6474,TYK-nu,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,-9.0,-7.1,-15,-2.8,-16,-23,-33","11.5,4.65,12.1,5.51,14.1,5.10,5.35,3.28",8,Sigmoid,8.454580861,8.0,-33.0753746,0.4732,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.802374839782715
3450,6475,U-118 MG,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","10.9,-2.9,-.35,1.93,-1.1,-15,-24,-19","14.0,4.50,17.7,15.7,5.26,10.5,14.7,1.27",8,Sigmoid,0.523249328,8.0,-21.0693779,0.3849,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.712218761444092
3451,6476,U-2 OS,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.78,.092,8.20,9.20,.97,-4.6,-12,-24","3.73,5.94,16.0,20.6,8.37,2.72,12.0,14.8",8,Sigmoid,3.618546963,8.0,-23.65304756,0.3956,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.7236459255218506
3452,6477,U-87 MG,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","2.18,9.41,6.66,16.3,.67,-2.5,-24,-38","4.46,13.8,3.77,25.5,.38,9.04,4.00,.97",8,Sigmoid,2.010424137,8.0,-38.17211914,0.6737,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.795602321624756
3453,6478,U-937,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","6.30,4.06,4.17,19.5,-3.0,-26,-26,-55","1.73,27.9,4.31,10.9,12.2,7.39,48.3,22.7",8,Sigmoid,0.84439683,1.640452862,-71.0440979,1.0682,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.49497233908360766,2.2248287200927734
3454,6479,UACC-812,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,-3.4,22.1,6.99,5.13,2.82,-21,-34","18.5,10.1,31.3,24.1,20.7,13.1,12.5,9.96",8,Constant,,8.0,-16.809412,0.3588,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.430488109588623
3455,6480,UM-UC-3,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","9.97,1.11,16.2,8.48,10.6,7.67,9.39,-36","12.6,6.96,7.64,8.01,4.48,.067,7.86,3.35",8,Sigmoid,8.355530982,8.0,-36.22028732,0.3181,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.3214452266693115
3456,6481,VMRC-RCW,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8",".36,-12,5.98,6.75,7.43,-4.4,7.70,5.47","3.50,23.5,3.50,6.89,6.72,2.83,15.9,.53",8,Constant,,8.0,3.204373598,0.09552,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.5373597145080566
3457,6482,VMRC-RCZ,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,9.54,.30,-.39,-3.3,12.8,-18,-20","10.6,8.83,4.34,9.02,13.0,3.52,5.44,16.4",8,Constant,,8.0,0.301350534,0.6809,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.617074489593506
3458,6483,WM1799,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,5.54,-.76,-7.1,-21,-26,-32,-30","6.77,3.30,3.72,3.15,14.7,3.32,2.14,3.08",8,Sigmoid,0.1766956,8.0,-30.9804287,1.0667,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.3271350860595703
3459,6484,WM-793,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","17.3,4.63,-7.8,-4.3,1.21,-28,-50,-62","21.5,17.6,14.6,4.98,6.21,10.8,1.69,6.07",8,Sigmoid,1.034532189,2.277235031,-60.14511108,1.4922,WM793_SKIN,WM793,ACH-000827,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,0.8229620013420036,2.915560245513916
3460,6485,WM-88,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,.48,11.3,9.49,-8.4,-14,-19,-33","1.33,5.10,6.21,2.57,12.3,8.69,.24,5.27",8,Sigmoid,1.58281076,8.0,-31.62926865,0.5886,WM88_SKIN,WM88,ACH-000899,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.6722474098205566
3461,6486,WM-983B,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","37.2,-1.4,16.7,-11,-35,-58,-66,-61","35.6,6.50,33.9,11.4,3.34,4.49,12.2,16.9",8,Sigmoid,0.21258013,0.512926102,-65.74452209,3.2376,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,-0.6676234948699248,2.392584800720215
3462,6487,YKG1,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.91,2.23,8.47,3.68,-11,-12,-31,-52","3.49,5.18,7.10,2.83,1.96,3.06,2.89,.46",8,Sigmoid,7.391107082,7.338364124,-51.67110825,0.672,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,1.9931159463972594,2.599247694015503
3463,6488,ZR-75-30,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","7.51,-13,-12,5.59,-8.0,19.7,13.2,-4.7","24.4,17.6,23.1,41.7,13.8,.18,25.4,29.3",8,Constant,,8.0,0.055153757,0.06974,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,3.253772735595703
3464,6489,SCC-25,PD-0332991,CDK4,".0025,.0080,.025,.080,.25,.80,2.53,8","1.15,5.27,21.0,1.71,11.4,-13,-27,-36",".34,17.3,12.6,15.5,2.55,14.0,22.4,18.4",8,Sigmoid,0.782006025,8.0,-32.0043869,0.5614,SCC25_UPPER_AERODIGESTIVE_TRACT,SCC25,ACH-000188,Head and Neck Cancer,10,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,,CDK4/6,CDK4/6 Inhibitor,Kinase inhibitor,Phase II,Pfizer ,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2.0794415416798357,2.45241117477417
3465,6490,A172,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-28,-43,-66,-71,-81,-78,-78","7.67,1.41,5.78,.70,5.86,4.75,3.64,3.98",8,Sigmoid,0.025582919,0.030916,-78.77007294,4.6157,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.4764814297375124,-2.523820638656616
3466,6491,A-204,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-57,-64,-78,-73,-79,-81,-76","0,3.55,2.11,15.9,2.34,3.56,.86,.37",8,Sigmoid,0.002542614,0.006528344,-77.92744446,4.3533,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.031601966630289,-3.3990230560302734
3467,6492,A2058,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-93,-96,-98,-98,-98,-99,-98","3.66,.12,.59,.094,1.21,.32,.070,.30",8,Sigmoid,0.002542614,0.002863176,-97.60799408,7.1679,A2058_SKIN,A2058,ACH-000788,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.855823780777262,-3.10707426071167
3468,6493,A-253,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-70,-70,-84,-75,-71,-72,-78","25.2,5.93,.68,3.63,3.56,1.95,4.84,6.11",8,Sigmoid,0.002542614,0.003566902,-75.2395401,5.6539,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.636057847050646,-3.6309688091278076
3469,6494,A2780,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-71,-88,-92,-93,-93,-92,-92","11.6,12.0,.71,.55,.55,.32,.51,1.44",8,Sigmoid,0.008888107,0.004648883,-91.95150757,6.5225,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.371128303292893,-3.2148022651672363
3470,6495,A-375,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,-50,-73,-83,-88,-92,-93,-90","9.06,4.96,4.59,1.30,.083,1.43,.40,.19",8,Sigmoid,0.011357177,0.007149658,-91.66561127,6.0932,A375_SKIN,A375,ACH-000219,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.940690755588047,-3.9306931495666504
3471,6496,A549,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-67,-85,-99,-105,-107,-105,-103","7.67,9.88,.39,7.73,3.61,4.24,6.16,6.09",8,Sigmoid,0.002542614,0.004999789,-105.7344131,4.9753,A549_LUNG,A549,ACH-000681,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.298359567438482,-2.4272842407226562
3472,6497,A-673,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-40,-90,-95,-96,-96,-96,-97,-96","36.7,3.12,.61,.16,1.02,.46,.25,.81",8,Sigmoid,0.002542614,0.0025,-96.183815,7.0239,A673_BONE,A673,ACH-000052,Bone Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-3.0040082931518555
3473,6498,ACHN,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-17,-23,-50,-62,-72,-73,-75","8.44,3.56,.26,.24,.40,.16,4.09,1.39",8,Sigmoid,0.075328134,0.095161244,-73.34645081,3.9915,ACHN_KIDNEY,ACHN,ACH-000046,Kidney Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.352182520913197,-2.4932665824890137
3474,6499,ALL-SIL,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-52,-66,-75,-88,-94,-93,-94,-95","4.59,2.49,8.95,1.43,2.49,5.83,2.39,.20",8,Sigmoid,0.011702765,0.0025,-94.71505737,6.7188,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-3.137899398803711
3475,6500,AMO-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,-59,-93,-94,-95,-95,-93,-96","0,0,0,0,0,0,0,0",8,Sigmoid,0.009094584,0.006434356,-94.87050629,6.5985,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.046103520642232,-2.3539485931396484
3476,6501,AsPC-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-46,-69,-71,-75,-78,-77,-75","4.76,12.2,2.57,2.08,3.90,6.18,1.21,2.68",8,Sigmoid,0.018581377,0.016337322,-73.57312775,4.0922,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.114303095270951,-2.466386318206787
3477,6502,AU565,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,-72,-99,-99,-100,-100,-100,-101","1.04,5.80,1.18,.96,1.19,2.11,.29,.59",8,Sigmoid,0.007013516,0.005203366,-99.91969299,6.6977,AU565_BREAST,AU565,ACH-000248,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.258449555115707,-2.385298252105713
3478,6503,B-CPAP,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-59,-73,-78,-86,-89,-87,-91,-89","2.26,8.71,4.55,1.22,2.98,1.42,1.22,2.87",8,Sigmoid,0.003602189,0.0025,-89.7921524,6.704,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-3.0568244457244873
3479,6504,BDCM,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-47,-53,-87,-94,-96,-95,-97,-97",".64,1.08,2.27,2.05,.30,.74,1.33,.99",8,Sigmoid,0.004356126,0.003238873,-97.01211548,6.3787,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.732529849194266,-2.7986631393432617
3480,6505,BFTC-909,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-35,-71,-81,-82,-76,-75,-75","11.7,.74,4.47,2.39,1.31,7.48,3.41,2.75",8,Sigmoid,0.01161005,0.012214486,-78.1867981,5.1868,BFTC909_KIDNEY,BFTC909,ACH-000792,Kidney Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.405132654568357,-2.809060573577881
3481,6506,BL-41,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-96,-99,-100,-100,-99,-99,-100","29.7,.84,.16,.096,.013,.060,.094,.022",8,Sigmoid,0.002542614,0.002803592,-99.41121674,7.1153,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.87685382681628,-3.210099458694458
3482,6507,BL-70,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-34,-98,-99,-100,-100,-100,-100","8.31,10.4,.011,.0058,.0030,4.9e-4,.020,.050",8,Sigmoid,0.010614841,0.00982259,-99.60674286,6.5657,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.623070443936832,-2.633409261703491
3483,6508,BT-20,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-72,-56,-67,-60,-73,-56,-59,-57","2.33,1.34,8.40,.63,9.99,1.82,4.99,6.82",8,Constant,,0.002542614,-60.9937973,4.959,BT20_BREAST,BT20,ACH-000536,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.5583605766296387
3484,6509,BT-474,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","2.39,-18,-64,-78,-81,-71,-82,-74","2.18,3.69,11.7,4.98,3.32,10.3,2.77,3.07",8,Sigmoid,0.012523146,0.016556622,-79.01792145,3.3674,BT474_BREAST,BT474,ACH-000927,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.100969136340143,-1.1335746049880981
3485,6510,BT-549,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-64,-73,-84,-80,-88,-86,-86","9.38,.82,1.65,1.28,4.24,2.13,4.45,1.25",8,Sigmoid,0.002542614,0.005155943,-85.27875519,5.817,BT549_BREAST,BT549,ACH-000288,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.2676052490477625,-1.8228453397750854
3486,6511,BxPC-3,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-45,-47,-62,-78,-76,-88,-87,-82","23.0,4.66,.16,8.53,5.44,3.57,3.06,.72",8,Sigmoid,0.010298566,0.010283807,-84.81829834,5.4667,BXPC3_PANCREAS,BXPC3,ACH-000535,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.577184756771322,-2.3859684467315674
3487,6512,C2BBe1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-23,-44,-50,-45,-44,-54,-53","7.20,10.1,3.01,13.7,2.51,3.38,8.13,5.40",8,Sigmoid,0.019737855,8.0,-48.60771942,3.4819,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.282283067703247
3488,6513,C32,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-31,-28,-30,-44,-58,-51,-58,-53","4.28,20.8,4.09,2.06,1.15,3.51,1.81,7.56",8,Sigmoid,0.079168119,0.099929944,-55.64474869,3.1892,C32_SKIN,C32,ACH-000580,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.303285898500871,-2.805655002593994
3489,6514,CAL-12T,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-50,-34,-77,-78,-84,-81,-84,-83","14.7,19.2,8.98,1.01,5.74,2.80,1.13,4.34",8,Sigmoid,0.005383338,0.006088181,-83.82426453,4.9761,CAL12T_LUNG,CAL12T,ACH-000826,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.10140592824709,-2.3390650749206543
3490,6515,CAL 27,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-46,-91,-95,-97,-98,-98,-97,-98","9.29,.88,.21,.37,.23,.63,1.53,1.24",8,Sigmoid,0.002542614,0.002677772,-97.51093292,7.1184,CAL27_UPPER_AERODIGESTIVE_TRACT,CAL27,ACH-000832,Head and Neck Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.922770173500424,-2.840243339538574
3491,6516,CAL-85-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-32,-40,-75,-80,-85,-83,-83,-80","15.4,1.09,17.9,.15,.36,3.75,2.84,1.97",8,Sigmoid,0.02366408,0.016368471,-82.49339294,5.3918,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.112398294527054,-2.4790334701538086
3492,6517,Calu-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-27,-56,-68,-68,-72,-74,-63","4.83,.23,3.84,.057,6.53,3.64,3.67,1.78",8,Sigmoid,0.018522579,0.020688187,-69.26807404,4.1905,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.8781924179370297,-1.8806159496307373
3493,6518,Calu-3,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-36,-36,-53,-42,-40,-29,-36","19.7,2.79,12.6,1.77,12.5,7.77,.28,8.90",8,Constant,,8.0,-36.42128372,3.2082,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.384101152420044
3494,6519,Calu-6,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-44,-74,-88,-87,-87,-94,-87,-90","30.5,5.43,.92,1.74,4.20,.98,3.27,3.32",8,Sigmoid,0.003747538,0.003513228,-89.22768402,6.5055,CALU6_LUNG,CALU6,ACH-000264,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.651220006011139,-2.756932258605957
3495,6520,CAMA-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-28,-70,-69,-69,-69,-68,-71","11.2,.88,4.34,.84,2.58,4.31,.20,3.90",8,Sigmoid,0.009369855,0.010846031,-69.24803925,4.3906,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.523956072370782,-2.4529013633728027
3496,6521,Capan-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-47,-52,-57,-52,-64,-47,-58,-56","7.90,22.2,3.38,3.92,12.7,10.4,1.39,12.3",8,Constant,,0.002542614,-56.48851395,3.4066,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.3697309494018555
3497,6522,CAS-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-37,-49,-66,-69,-60,-66,-60","3.61,11.9,4.43,3.15,1.08,8.60,.36,4.84",8,Sigmoid,0.020818679,0.025275866,-65.88123322,4.0347,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.6779052515567328,-1.8393325805664062
3498,6523,CCK-81,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,35.7,-17,-9.7,-47,-77,-94,-98","21.0,3.70,23.9,6.49,1.90,9.23,4.24,.041",8,Sigmoid,0.135436818,0.274032772,-99.78610992,3.4061,CCK81_LARGE_INTESTINE,CCK81,ACH-000963,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-1.294507573906859,-1.9724422693252563
3499,6524,CHP-212,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-61,-53,-57,-78,-77,-86,-92,-90","33.6,1.74,5.07,1.68,1.92,8.78,3.26,2.92",8,Sigmoid,0.014549782,0.007673397,-91.19612885,5.9257,CHP212_AUTONOMIC_GANGLIA,CHP212,ACH-000120,Neuroblastoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.8699958672580035,-2.7056989669799805
3500,6525,CI-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-77,-95,-93,-96,-98,-99,-97","4.21,5.14,.47,2.60,.20,.43,.47,.68",8,Sigmoid,0.003545192,0.004356804,-96.86329651,6.7624,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.436016517940169,-3.3772783279418945
3501,6526,COLO-320,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-19,-23,-24,-44,-79,-94,-97","5.99,3.96,1.34,2.42,12.3,2.30,1.74,.26",8,Sigmoid,0.41214174,0.316520303,-96.20610809,3.9828,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-1.150367890956123,-2.5407931804656982
3502,6527,COLO-678,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-26,-28,-24,-15,-28,-25,-39","9.73,9.14,7.11,7.83,13.0,11.4,.94,6.69",8,Constant,,8.0,-24.70333481,2.7143,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.548680305480957
3503,6528,COLO-679,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-48,-62,-65,-70,-65,-65,-62","2.82,9.34,1.99,1.05,1.59,1.41,1.54,4.17",8,Sigmoid,0.00616653,0.008852645,-65.48993683,4.5201,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.72703899455856,-2.586215019226074
3504,6529,COLO 741,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,-13,-59,-84,-88,-92,-93,-94","32.2,8.29,7.29,3.95,2.44,1.57,2.10,.37",8,Sigmoid,0.013485374,0.020055767,-92.36123657,5.4766,COLO741_SKIN,COLO741,ACH-000582,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.9092385356647092,-2.458937644958496
3505,6530,COR-L105,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-16,-35,-52,-49,-60,-62,-55","9.26,20.8,7.52,12.1,2.83,2.16,.58,4.35",8,Sigmoid,0.034859952,0.126990631,-59.31157684,2.6619,CORL105_LUNG,CORL105,ACH-000161,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.063641966898351,-1.760345220565796
3506,6531,COR-L23,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-58,-46,-56,-76,-78,-76,-70,-69","65.4,41.5,29.7,11.2,13.5,18.4,18.5,14.5",8,Sigmoid,0.002542614,0.031955611,-63.39335251,5.2187,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.443407495424291,-2.8399765491485596
3507,6532,COV318,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-16,-22,-30,-34,-38,-43,-48","8.70,1.88,9.88,1.67,5.61,10.6,1.61,1.08",8,Sigmoid,0.237964138,8.0,-47.03115463,2.8757,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-1.8745148181915283
3508,6533,COV504,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-47,-54,-69,-75,-74,-72,-68","22.3,10.6,2.76,6.01,6.28,2.04,8.16,2.87",8,Sigmoid,0.026835697,0.01918957,-72.13632965,3.7749,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.9533883767174887,-2.332869052886963
3509,6534,Daoy,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-31,-44,-66,-82,-89,-91,-95,-93","5.79,6.59,9.11,.067,.40,.37,2.55,3.63",8,Sigmoid,0.016800923,0.010945285,-93.30284119,5.9369,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.514846509058981,-3.2240536212921143
3510,6535,DBTRG-05MG,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-35,-53,-74,-85,-83,-82,-81","12.2,1.82,4.37,1.99,3.30,6.50,1.79,1.38",8,Sigmoid,0.027442006,0.021760648,-82.84296417,5.3756,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.8276520780260284,-2.675900459289551
3511,6536,Detroit 562,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-51,-38,-78,-82,-89,-85,-82,-82","20.7,13.4,4.30,3.05,2.09,1.43,2.20,.77",8,Sigmoid,0.017282298,0.013300325,-83.99176788,5.6996,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.31996680796276,-3.0051803588867188
3512,6537,DK-MG,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-21,-60,-85,-89,-88,-88,-88","4.75,2.01,1.38,.29,.47,1.46,5.86,4.07",8,Sigmoid,0.01999443,0.019846439,-88.53203583,5.3135,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.9197306834082237,-2.8086190223693848
3513,6538,DMS 114,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-58,-81,-82,-86,-87,-87,-83","17.1,11.2,7.00,3.48,1.42,.063,3.72,5.04",8,Sigmoid,0.005887663,0.005783329,-85.71673584,5.5617,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.152775810537198,-1.4329814910888672
3514,6539,DOHH-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-48,-60,-49,-51,-55,-65,-54,-63","20.0,3.17,12.9,9.71,1.28,2.66,.049,3.87",8,Constant,,0.002542614,-57.63304901,5.1909,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.38466215133667
3515,6540,DV-90,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-50,-85,-88,-93,-95,-93,-95","13.2,7.23,1.99,2.70,.99,1.76,1.01,.51",8,Sigmoid,0.012105352,0.00758911,-93.40631866,6.3835,DV90_LUNG,DV90,ACH-000925,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.88104095400208,-2.4056107997894287
3516,6541,EB1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-13,-71,-90,-79,-91,-90,-93","38.6,24.0,11.2,4.19,21.7,2.04,.53,1.67",8,Sigmoid,0.011070703,0.012966044,-91.83148956,5.6514,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.345421338744423,-3.041046380996704
3517,6542,EBC-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-56,-53,-77,-83,-85,-83,-84,-84","7.53,6.22,8.02,4.82,1.57,1.42,4.14,2.98",8,Sigmoid,0.020002564,0.0025,-83.82199097,5.7392,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.331289291381836
3518,6543,EFE-184,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,-2.2,-6.3,-14,-31,-37,-48,-49","7.26,3.57,4.47,11.2,2.75,4.01,13.4,10.1",8,Sigmoid,0.225404248,8.0,-48.25857925,2.0256,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.320767641067505
3519,6544,EFM-19,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-41,-91,-93,-89,-95,-94,-90","5.92,8.64,2.38,2.04,6.58,1.95,.50,.015",8,Sigmoid,0.009638786,0.009098331,-92.52811432,5.55,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.699664288873786,-1.9781084060668945
3520,6545,EFO-21,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-32,-49,-55,-60,-62,-55,-63","6.54,7.50,.37,3.54,2.13,9.37,1.86,3.98",8,Sigmoid,0.006518861,0.030291224,-59.75986862,3.8972,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.4968972453833964,-2.417449712753296
3521,6546,EFO-27,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-29,-54,-66,-77,-68,-68,-56",".088,5.64,6.83,.84,2.31,3.22,5.09,8.58",8,Sigmoid,0.015999835,0.020698361,-68.65492249,3.8972,EFO27_OVARY,EFO27,ACH-000936,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.8777007605895775,-2.889183282852173
3522,6547,EM-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-89,-87,-92,-93,-93,-87,-82,-76","1.59,3.31,.14,.40,1.40,1.03,2.51,2.41",8,Constant,,0.002542614,-88.82205963,7.0443,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-3.2212419509887695
3523,6548,EN,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-32,-48,-54,-62,-63,-59,-51,-40","5.25,7.68,1.70,4.27,2.25,3.41,7.15,1.93",8,Sigmoid,0.004075329,0.00999075,-58.40882874,4.0051,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.606095614064592,-2.586655855178833
3524,6549,ES-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-21,-52,-80,-82,-86,-89,-92","9.38,.79,4.21,4.74,3.37,.19,.36,2.43",8,Sigmoid,0.025155321,0.024387915,-87.64131165,5.3368,ES2_OVARY,ES2,ACH-000906,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.7136675562632906,-2.4661383628845215
3525,6550,ESS-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,-53,-90,-93,-91,-93,-92,-91","10.7,3.36,3.77,1.41,1.90,2.26,.49,.79",8,Sigmoid,0.00969001,0.007594008,-92.08197784,6.5069,ESS1_ENDOMETRIUM,ESS1,ACH-000913,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.880395763709821,-3.0403056144714355
3526,6551,F-36P,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-58,-70,-92,-93,-98,-93,-98,-97","12.1,1.70,1.90,1.35,1.12,3.37,.79,.069",8,Sigmoid,0.010931497,0.0025,-95.98835754,6.7817,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.5891761779785156
3527,6552,FaDu,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-51,-64,-71,-72,-67,-66,-67","7.03,7.79,4.06,7.78,1.28,2.08,.81,5.80",8,Sigmoid,0.003430047,0.007714884,-68.37945557,4.7772,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.864603828924897,-3.358997344970703
3528,6553,FU97,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-43,-57,-60,-70,-66,-69,-75","12.0,1.55,.92,7.28,5.90,8.42,.66,3.56",8,Sigmoid,0.004284119,0.013990878,-69.71281433,4.4367,FU97_STOMACH,FU97,ACH-000633,Gastric Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.269349733160365,-2.9569387435913086
3529,6554,FU-OV-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-50,-62,-67,-76,-72,-70,-77",".19,.32,8.87,4.50,4.77,5.89,.44,4.77",8,Sigmoid,0.002542614,0.00867361,-73.7935791,4.3524,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.74747019653505,-2.781651496887207
3530,6555,G-361,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-42,-56,-70,-85,-89,-87,-90,-82","1.27,5.21,3.61,4.87,4.60,.67,1.28,2.98",8,Sigmoid,0.01364277,0.005752318,-88.00565338,6.0134,G361_SKIN,G361,ACH-000572,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.158152374973337,-3.0507795810699463
3531,6556,G-401,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-59,-86,-92,-94,-94,-95,-93","13.6,8.73,3.65,2.66,1.78,1.22,.18,.059",8,Sigmoid,0.009683895,0.005486321,-93.83766937,6.559,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.20549737560105,-3.1176722049713135
3532,6557,G-402,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-44,-69,-78,-83,-85,-85,-85,-80","6.01,.18,.71,1.19,2.24,1.06,3.22,1.88",8,Sigmoid,0.002542614,0.003120293,-83.9866333,5.9752,G402_SOFT_TISSUE,G402,ACH-000375,Kidney Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.769828371313628,-2.8573389053344727
3533,6558,GAMG,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-17,-59,-77,-89,-93,-91,-89","8.63,27.0,.30,1.80,4.35,1.14,1.47,5.40",8,Sigmoid,0.01454006,0.017000178,-91.85874176,5.015,GAMG_CENTRAL_NERVOUS_SYSTEM,GAMG,ACH-000098,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.074531464392502,-2.206521511077881
3534,6559,GB-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-28,-34,-68,-81,-80,-91,-86","3.90,1.84,7.58,8.02,6.75,2.82,1.03,.97",8,Sigmoid,0.046106149,0.042211305,-86.44161224,4.6277,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.165067202821296,-2.1642768383026123
3535,6560,GCT,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,-86,-82,-89,-87,-93,-90,-91","7.15,.66,2.85,1.67,3.52,1.48,2.04,1.64",8,Sigmoid,0.002542614,0.002946121,-88.83956909,6.5265,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.827265889144288,-2.333334445953369
3536,6561,GI-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-29,-79,-82,-86,-84,-88,-86","4.36,10.5,1.63,.86,2.89,3.82,3.11,5.43",8,Sigmoid,0.013168042,0.01261146,-85.16335297,5.6551,GI1_CENTRAL_NERVOUS_SYSTEM,GI1,ACH-000756,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.373149354581336,-3.2101597785949707
3537,6562,GMS-10,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-43,-38,-61,-60,-76,-75,-78,-68","3.95,8.77,11.4,6.39,3.09,6.54,4.61,8.51",8,Sigmoid,0.005710164,0.010238567,-76.42914581,5.0009,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.581593610569738,-3.1433067321777344
3538,6563,GRANTA-519,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-70,-74,-87,-86,-88,-87,-88,-86","19.8,3.14,.91,2.08,1.03,2.02,1.25,1.75",8,Constant,,0.002542614,-86.91305542,6.7581,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.6950523853302
3539,6564,H4,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-13,-38,-74,-88,-95,-95,-97","16.0,2.07,6.52,3.14,4.38,.64,.16,1.59",8,Sigmoid,0.03547791,0.036614265,-95.78242493,5.2411,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.307317360410855,-2.459399461746216
3540,6565,HARA,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-44,-84,-94,-96,-95,-95,-93","17.1,27.5,2.44,3.23,2.25,1.72,.58,1.07",8,Sigmoid,0.008577128,0.007821566,-94.75524139,6.1217,HARA_LUNG,HARA,ACH-000843,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.850870488718948,-2.6846282482147217
3541,6566,HCC1187,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-45,-80,-91,-91,-90,-91,-91","10.5,6.86,4.41,1.59,1.22,3.51,2.29,.20",8,Sigmoid,0.012309728,0.009626306,-91.02165222,5.8226,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.643255719701427,-1.414487361907959
3542,6567,HCC1395,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-28,-86,-93,-96,-89,-91,-94","12.4,5.30,9.25,9.70,6.72,5.25,14.5,3.62",8,Sigmoid,0.010007542,0.011294067,-93.35600281,5.4493,HCC1395_BREAST,HCC1395,ACH-000699,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.483477735395627,-2.6370644569396973
3543,6568,HCC-15,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-54,-76,-74,-75,-69,-79,-71","27.1,3.06,3.78,4.51,5.48,4.44,1.22,1.03",8,Sigmoid,0.008919747,0.007085041,-74.22866821,5.2761,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.94976961898256,-1.9781408309936523
3544,6569,HCC1569,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-34,-32,-37,-43,-41,-41,-38","4.83,7.09,14.7,7.66,12.9,3.91,9.88,1.52",8,Constant,,8.0,-37.7364502,2.7161,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-1.913722276687622
3545,6570,HCC1806,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-40,-83,-89,-93,-94,-96,-97,-94","32.2,1.54,.65,.10,1.78,.76,7.2e-4,2.10",8,Sigmoid,0.002542614,0.002996833,-94.78574371,6.8819,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.8101992145892165,-2.4119701385498047
3546,6571,HCC1954,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,-29,-78,-92,-95,-94,-92,-93","4.47,19.0,9.24,1.00,.54,2.83,.53,2.09",8,Sigmoid,0.008352162,0.010001038,-93.73235321,5.6339,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.605066391374939,-2.167123556137085
3547,6572,HCC2935,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-13,-41,-41,-36,-35,-34,-13","15.1,14.7,8.31,2.02,14.8,1.11,22.9,13.9",8,Constant,,8.0,-33.28535461,2.4629,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.1727142333984375
3548,6573,HCC4006,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-66,-77,-88,-81,-86,-89,-83","10.4,7.86,9.36,2.10,.17,3.91,3.91,6.10",8,Sigmoid,0.002542614,0.004447281,-85.56391144,5.8944,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.415462380783381,-2.306980609893799
3549,6574,HCC-44,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-41,-67,-92,-90,-93,-90,-93","4.46,6.90,8.04,.080,1.84,1.57,1.15,2.97",8,Sigmoid,0.011043856,0.011513388,-92.56415558,5.8639,HCC44_LUNG,HCC44,ACH-000667,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.464244746824862,-2.584827423095703
3550,6575,HCC-56,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,-24,-18,-34,-63,-84,-92,-94","8.13,3.57,7.35,17.2,.82,4.48,3.50,.91",8,Sigmoid,0.171231195,0.147854075,-94.28004456,4.1463,HCC56_LARGE_INTESTINE,HCC56,ACH-000467,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-1.9115294713455107,-3.0891945362091064
3551,6576,HCC70,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-48,-71,-84,-86,-89,-81,-85","11.5,5.12,19.0,6.71,10.1,10.9,14.0,10.9",8,Sigmoid,5.986502122,0.004960467,-93.31398773,5.4912,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.306255389451631,-2.4477972984313965
3552,6577,HCC-78,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.5,-13,-40,-54,-63,-61,-67,-67","14.3,8.57,.33,2.76,4.00,6.59,.30,6.45",8,Sigmoid,0.018740568,0.052693762,-65.80760956,3.5376,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.9432581985623214,-1.8756623268127441
3553,6578,HCC827,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-19,-74,-65,-68,-73,-67,-73","39.9,8.22,16.3,6.42,3.83,6.72,7.51,2.57",8,Sigmoid,0.008939037,0.011236095,-69.41851044,4.5217,HCC827_LUNG,HCC827,ACH-000012,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.488623914809703,-2.2015221118927
3554,6579,HCT 116,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-69,-86,-91,-94,-95,-95,-95","5.61,4.78,1.56,2.35,1.50,2.01,2.50,1.74",8,Sigmoid,0.002542614,0.004276503,-94.81491852,6.4469,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.4546196594354415,-3.557089328765869
3555,6580,HCT-15,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,3.78,-4.9,-4.2,-45,-75,-89,-93","4.27,20.5,12.0,8.76,4.75,12.1,2.22,.67",8,Sigmoid,0.288159758,0.284276396,-90.44474792,3.1674,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-1.2578082887455664,-2.6536476612091064
3556,6581,HD-MY-Z,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-66,-82,-88,-90,-90,-91,-90,-84","3.60,.92,2.54,1.05,2.07,.36,1.37,1.36",8,Sigmoid,0.004230207,0.0025,-89.25959015,6.7594,HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HDMYZ,ACH-000190,Unknown,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.9239258766174316
3557,6582,HDQ-P1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-64,-72,-83,-82,-86,-85,-85,-80","41.0,17.6,1.93,3.79,3.59,2.98,5.56,5.92",8,Constant,,0.002542614,-83.65821838,6.3132,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.4408226013183594
3558,6583,HEC-151,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-75,-85,-88,-91,-93,-93,-91","24.4,6.16,1.59,2.96,2.72,.40,.14,.31",8,Sigmoid,0.002542614,0.003909792,-91.40710449,6.3134,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.544271103330816,-3.2264790534973145
3559,6584,HEC-1-A,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-34,-55,-60,-67,-69,-67,-69,-66","3.98,11.3,11.2,6.96,8.22,17.4,3.06,3.80",8,Sigmoid,0.002542614,0.006034548,-68.24246216,4.9047,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.110254323674969,-2.856166362762451
3560,6585,HEC-1-B,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-31,-53,-49,-60,-66,-61,-59","14.8,16.5,13.5,30.0,12.6,3.97,14.1,7.48",8,Sigmoid,0.005633388,0.022165507,-61.24622726,3.9821,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.8092179371464305,-2.900554895401001
3561,6586,HEC-251,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-37,-81,-68,-89,-79,-77,-76","5.60,13.4,7.50,.26,.18,1.12,.073,3.14",8,Sigmoid,0.011104086,0.010395308,-78.02204895,5.4401,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.56640072848148,-2.1645114421844482
3562,6587,HEC-265,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-74,-82,-86,-84,-88,-84,-90","3.65,12.0,3.49,1.27,5.42,4.69,5.93,5.94",8,Sigmoid,0.002542614,0.00400007,-86.39726257,5.8464,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.5214434180153695,-2.8093502521514893
3563,6588,HEC-59,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-61,-59,-57,-63,-57,-52,-48","8.30,5.00,2.37,5.78,2.63,.52,10.8,1.42",8,Constant,,0.002542614,-57.42330933,3.8476,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.920633316040039
3564,6589,HEC-6,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-51,-54,-51,-29,-43,-62,-59",".047,1.63,3.67,8.09,18.4,20.6,4.10,1.94",8,Sigmoid,0.002685017,0.007608487,-55.45720291,4.1261,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.878490944220929,-2.2946395874023438
3565,6590,HEL 92.1.7,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-27,-24,-71,-77,-90,-86,-92","4.80,.17,2.85,2.29,.016,1.26,.19,.0062",8,Sigmoid,0.066357106,0.060053825,-88.72557068,5.1205,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.812514035565473,-2.8394808769226074
3566,6591,Hep 3B2.1-7,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,-9.2,-51,-34,-70,-41,-66,-53","1.57,20.6,1.09,8.95,4.15,5.52,1.87,17.8",8,Constant,,8.0,-43.17967606,3.7909,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.0588455200195312
3567,6592,Hep G2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-31,-52,-58,-60,-59,-80,-80,-81","15.8,9.92,1.34,6.21,19.4,6.89,5.32,.21",8,Sigmoid,0.025884299,0.009877518,-81.83488464,4.8993,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.617494013356926,-2.290009021759033
3568,6593,Hey-A8,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-38,-71,-79,-80,-78,-80,-78","7.33,1.84,3.89,.72,1.95,4.51,3.41,1.87",8,Sigmoid,0.012455361,0.011858939,-79.17992401,5.1752,HEYA8_OVARY,HEYA8,ACH-000542,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.4346733497853705,-3.0382184982299805
3569,6594,HGC-27,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-51,-79,-85,-89,-84,-81,-78,-77","6.28,1.22,.024,.39,.093,1.77,.091,.41",8,Sigmoid,0.00513293,0.0025,-82.15921021,6.2021,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-3.249908685684204
3570,6595,HH,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-43,-67,-72,-69,-66,-75,-69","32.4,19.3,5.26,1.86,5.95,5.31,5.34,14.6",8,Sigmoid,0.010357419,0.010450869,-70.35569,5.0317,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.561070146134006,-2.8482518196105957
3571,6596,HLF,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-11,-20,-47,-80,-86,-89,-91","4.56,9.43,.97,4.29,2.18,2.57,2.51,.24",8,Sigmoid,0.095295236,0.088366963,-88.81010437,4.855,HLF_LIVER,HLF,ACH-000393,Liver Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.426257100909362,-2.9504151344299316
3572,6597,HMC-1-8,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-61,-75,-84,-87,-88,-85,-76",".22,2.22,1.34,.60,1.55,1.04,3.66,1.78",8,Sigmoid,0.002542614,0.005512764,-85.09510803,5.3291,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.200689148199455,-2.708754301071167
3573,6598,HMCB,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-48,-89,-95,-97,-97,-98,-97",".30,2.69,1.88,1.02,1.58,.11,.17,.21",8,Sigmoid,0.010383604,0.008362735,-97.03247833,6.5093,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.783969752278389,-3.3515419960021973
3574,6599,HOS,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-40,-53,-80,-87,-89,-90,-90,-91","16.0,5.43,1.58,3.21,2.40,2.13,2.60,.90",8,Sigmoid,0.006051697,0.005664105,-90.85223389,6.143,HOS_BONE,HOS,ACH-000613,Bone Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.173606384626955,-3.176499128341675
3575,6600,HPAC,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-57,-73,-83,-79,-80,-89,-82","13.5,1.19,2.97,2.19,6.75,2.50,4.05,2.34",8,Sigmoid,0.002542614,0.006082666,-83.54608154,5.5399,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.102312192269218,-2.4939775466918945
3576,6601,HPAF-II,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-37,-55,-66,-68,-58,-55,-64,-62","7.58,2.36,12.6,11.9,1.29,17.0,17.6,3.10",8,Sigmoid,0.006775625,0.006913234,-62.34807587,4.9936,HPAFII_PANCREAS,HPAFII,ACH-000094,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.9743177333223905,-1.966239094734192
3577,6602,Hs 294T,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-53,-65,-79,-81,-83,-84,-83","11.4,5.33,.44,.59,.75,4.23,1.22,5.93",8,Sigmoid,0.002542614,0.00757048,-83.75119019,4.8987,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.88349880535277,-2.398953437805176
3578,6603,Hs 578T,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-50,-68,-89,-95,-96,-97,-95,-97","12.9,1.15,1.07,.68,.13,.30,1.61,1.36",8,Sigmoid,0.012234147,0.0025,-96.14067078,6.8292,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.163668155670166
3579,6604,Hs 683,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-36,-76,-87,-91,-93,-92,-89","3.84,14.1,5.26,.74,1.07,1.05,1.84,3.60",8,Sigmoid,0.004462283,0.007497566,-92.84523773,5.9641,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.893176844445544,-2.8542656898498535
3580,6605,Hs 695T,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-14,-29,-49,-59,-57,-53,-59","17.0,4.84,1.16,6.04,9.39,3.05,12.5,6.81",8,Sigmoid,0.024153892,0.09689749,-59.17221069,3.3945,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.334101663413681,-2.0057456493377686
3581,6606,Hs 729,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-41,-56,-68,-77,-78,-79,-77","16.3,13.3,1.17,3.95,7.61,1.78,2.34,1.97",8,Sigmoid,0.013568742,0.016439535,-78.87841797,5.2003,HS729_SOFT_TISSUE,HS729,ACH-000133,Unknown,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.108066174425655,-2.1703314781188965
3582,6607,Hs 746T,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-40,-46,-60,-64,-73,-75,-76,-71","1.58,5.66,8.69,4.54,3.76,4.91,1.54,1.04",8,Sigmoid,0.021506285,0.01275917,-74.13769531,5.1829,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.361505050203086,-1.9295737743377686
3583,6608,Hs 766T,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-38,-29,-29,-36,-37,-36,-34","24.0,3.28,4.27,12.6,12.0,2.39,9.29,4.85",8,Constant,,8.0,-35.40342712,3.1435,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.839357852935791
3584,6609,Hs 852.T,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-31,-41,-46,-55,-74,-81,-73,-73","5.35,9.30,1.62,2.77,2.48,3.79,3.69,3.09",8,Sigmoid,0.016041098,0.025221951,-77.39338684,4.7678,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.680040592198736,-2.2871174812316895
3585,6610,Hs 936.T,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-57,-56,-62,-70,-73,-73,-66,-56","3.38,1.23,4.00,2.27,4.57,2.32,.85,4.11",8,Constant,,0.002542614,-64.9540329,5.0763,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-3.8467297554016113
3586,6611,Hs 939.T,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-31,-29,-42,-54,-56,-61,-56,-54","1.12,11.6,2.44,5.51,2.15,7.65,3.29,9.87",8,Sigmoid,0.007074956,0.066444561,-58.33095169,3.864,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.7113873481886612,-2.7100706100463867
3587,6612,Hs 944.T,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-43,-63,-78,-88,-90,-94,-93,-94","1.06,.17,2.01,2.06,.57,.60,.17,.69",8,Sigmoid,0.004274909,0.003847174,-93.60596466,6.4682,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.560416426185438,-2.949815034866333
3588,6613,HSC-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-50,-49,-74,-60,-74,-68,-52","11.1,15.9,14.9,7.17,1.28,2.54,10.6,3.49",8,Sigmoid,0.00259418,0.009923753,-65.14710999,4.6615,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.61282410261992,-2.5450820922851562
3589,6614,HT,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-54,-84,-88,-87,-85,-84,-86,-81","7.17,7.01,3.09,4.04,6.72,2.51,8.52,1.78",8,Sigmoid,0.004039119,0.0025,-85.13150024,6.6008,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.5641231536865234
3590,6615,HT-1080,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-56,-93,-97,-97,-98,-98,-98","14.8,8.96,.72,.26,.85,.52,.35,.61",8,Sigmoid,0.012425525,0.005339894,-97.57187653,6.7248,HT1080_SOFT_TISSUE,HT1080,ACH-000054,Sarcoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.232549476394317,-3.580028533935547
3591,6616,HT-1197,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-12,-14,-32,-33,-29,-25,-29",".98,5.53,5.78,8.70,0,30.3,9.11,.88",8,Constant,,8.0,-19.1861515,1.967,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-1.9094293117523193
3592,6617,HT-144,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-38,-54,-68,-71,-75,-74,-70",".40,17.9,6.05,1.39,2.83,1.91,1.78,.43",8,Sigmoid,0.019046592,0.021828279,-72.44911194,4.6768,HT144_SKIN,HT144,ACH-000322,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.824548947991624,-2.731412410736084
3593,6618,HuCCT1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-43,-63,-68,-62,-64,-60,-56","6.16,3.54,.28,.78,.54,5.38,2.31,2.02",8,Sigmoid,0.007226141,0.009130674,-62.06796646,4.1198,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.696115764537032,-2.7236318588256836
3594,6619,huH-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-42,-28,-59,-70,-82,-92,-80,-86","13.9,14.4,17.0,2.41,7.37,3.49,1.84,.77",8,Sigmoid,0.052121904,0.028643915,-85.70484924,4.4053,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.5528142493044914,-2.5164127349853516
3595,6620,HUP-T3,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-26,-58,-60,-73,-76,-82,-76","7.03,13.1,5.86,9.21,12.3,11.2,6.69,.23",8,Sigmoid,0.014928265,0.023696937,-78.26335907,4.484,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.7424094796996545,-2.133930206298828
3596,6621,HuT 78,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-47,-84,-93,-95,-97,-97,-96","38.2,14.5,9.66,1.22,.59,1.32,.12,2.05",8,Sigmoid,0.011621781,0.008045927,-96.20710754,6.5788,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.8225892783269195,-2.6974000930786133
3597,6622,IA-LM,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-14,-15,-23,-14,-36,-20,-14","23.1,12.7,5.75,22.7,10.0,.70,14.7,7.50",8,Constant,,8.0,-18.60102844,1.3967,IALM_LUNG,IALM,ACH-000672,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.525707244873047
3598,6623,IGR-37,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-53,-78,-91,-93,-89,-94,-89","4.97,9.62,5.96,1.55,2.24,4.11,1.57,.44",8,Sigmoid,0.009395475,0.007616556,-91.72394562,6.1199,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.87743097995607,-3.0417027473449707
3599,6624,IGR-39,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-41,-49,-55,-74,-87,-93,-91,-92","2.79,15.9,2.81,1.89,4.36,.99,.67,.40",8,Sigmoid,0.049009342,0.018589534,-92.1559906,5.1485,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.9851565448034245,-2.7517824172973633
3600,6625,IGROV1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-47,-41,-49,-66,-63,-57,-56","15.3,7.04,2.42,5.35,.28,.39,2.98,14.1",8,Sigmoid,0.002542614,0.027501697,-59.62561035,3.7989,IGROV1_OVARY,IGROV1,ACH-000966,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.59350756712263,-2.7036614418029785
3601,6626,IMR-32,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-93,-94,-96,-96,-97,-96,-96,-93",".88,1.44,.19,.57,.73,2.86,.020,.37",8,Constant,,0.002542614,-96.07091522,7.4776,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.885791301727295
3602,6627,IPC-298,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-59,-51,-58,-73,-78,-87,-77,-62","6.18,.97,1.57,1.04,1.09,7.20,2.18,2.22",8,Sigmoid,0.044096105,0.0025,-78.2250061,5.3262,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.616248607635498
3603,6628,IST-MES2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-57,-82,-90,-92,-91,-93,-87","6.57,16.3,2.28,1.97,1.16,1.14,.091,2.07",8,Sigmoid,0.009679077,0.005989203,-90.98800659,6.3544,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.117796930799213,-2.5745575428009033
3604,6629,J82,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-28,-46,-49,-50,-61,-59,-61","2.75,7.67,8.03,1.23,.58,5.15,.12,8.55",8,Sigmoid,0.012702885,0.096582435,-60.5679512,3.7283,J82_URINARY_TRACT,J82,ACH-000396,Bladder Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.337358386595298,-2.4690170288085938
3605,6630,JHH-4,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-14,-30,-52,-61,-74,-83,-83","4.56,8.58,2.17,13.4,.087,3.07,1.35,2.55",8,Sigmoid,0.09941759,0.110504739,-83.71716309,4.1514,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.202696872066117,-2.623553991317749
3606,6631,JHOS-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-34,-50,-71,-73,-74,-76,-60","3.05,3.14,5.13,6.59,2.75,7.96,4.28,6.97",8,Sigmoid,0.024934974,0.024209864,-73.71760559,4.1841,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.7209951255613722,-2.272372245788574
3607,6632,JHUEM-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-57,-85,-90,-91,-92,-91,-93","10.1,3.33,1.19,.58,.51,.92,.83,1.69",8,Sigmoid,0.006095077,0.00658232,-91.67138672,6.1947,JHUEM2_ENDOMETRIUM,JHUEM2,ACH-000909,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.023368012201272,-3.042111396789551
3608,6633,JM1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-53,-24,-86,-92,-94,-96,-96,-98","13.2,11.5,4.03,1.79,1.55,.59,1.54,1.20",8,Sigmoid,0.01782012,0.014962113,-95.00492096,6.1963,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.202234073094195,-3.0637400150299072
3609,6634,JMSU-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-38,-81,-87,-92,-92,-96,-94","1.37,11.0,3.43,3.18,.18,.60,.77,.26",8,Sigmoid,0.014730503,0.011445143,-92.66586304,6.0871,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.4701898311165635,-2.156381607055664
3610,6635,JURKAT,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-60,-81,-93,-96,-97,-97,-98,-98","2.00,2.18,1.16,.67,.16,.23,.78,.0025",8,Sigmoid,0.00275075,0.0025,-97.73234558,7.2847,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-3.2079763412475586
3611,6636,JVM-3,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-83,-92,-93,-95,-97,-97,-96,-97",".37,.30,.56,2.09,.44,.99,.90,.82",8,Constant,,0.002542614,-95.64591217,7.5086,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-1.814314365386963
3612,6637,K029AX,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-57,-65,-76,-78,-77,-71,-69","33.0,3.86,5.89,5.28,.93,3.10,5.19,8.61",8,Constant,,0.002542614,-71.0983429,5.2658,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.8842954635620117
3613,6638,KALS-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-56,-74,-81,-87,-89,-84,-78","21.1,1.86,11.0,4.59,1.74,.34,1.84,3.08",8,Sigmoid,0.010822855,0.005295292,-84.73720551,6.0363,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.240937155084778,-3.0171642303466797
3614,6639,KARPAS-422,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,2.60,-29,-47,-40,-49,-42,-30","5.68,11.7,19.9,1.50,1.91,4.88,8.44,34.5",8,Sigmoid,0.022759313,8.0,-45.63698196,2.2649,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.9205243587493896
3615,6640,KASUMI-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-34,-80,-85,-90,-90,-91,-89,-91","27.8,8.55,1.35,1.24,.026,2.67,.64,.23",8,Sigmoid,0.002542614,0.003222198,-89.95956421,6.5453,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.737691543601517,-2.8548007011413574
3616,6641,KCL-22,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-52,-72,-84,-96,-97,-98,-98,-98","5.40,7.98,.058,1.17,.59,.088,.31,.39",8,Sigmoid,0.00552177,0.0025,-98.54151917,7.0551,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.59674334526062
3617,6642,KG-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-33,-41,-58,-80,-87,-89,-82","21.0,35.5,21.2,7.76,1.83,5.38,.21,7.21",8,Sigmoid,0.108431116,0.053802088,-86.42857361,4.9233,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.9224430021585808,-2.674542188644409
3618,6643,KHM-1B,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-51,-63,-78,-81,-77,-81,-87,-80","42.1,2.19,8.67,5.19,8.56,6.60,1.74,2.78",8,Constant,,0.002542614,-78.6761322,6.2541,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.4859094619750977
3619,6644,KMBC-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-24,-50,-78,-83,-85,-83,-85",".0043,5.29,.81,3.09,.25,2.31,2.74,1.13",8,Sigmoid,0.029661015,0.026095331,-83.78139496,5.1202,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.645998869544904,-2.285008430480957
3620,6645,KMM-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-55,-74,-78,-87,-84,-88,-88,-89",".74,4.99,1.90,2.17,4.96,1.25,1.78,1.19",8,Sigmoid,0.002542614,0.0025,-88.26657104,6.5537,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.3769617080688477
3621,6646,KMRC-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-45,-19,-36,-53,-49,-59,-67,-65","10.7,.36,6.70,1.66,1.66,3.15,3.82,.73",8,Sigmoid,0.078431025,0.146975428,-65.22598267,4.304,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-1.9174898626381844,-1.7041462659835815
3622,6647,KMRC-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-35,-55,-51,-57,-47,-54,-38","1.02,.27,3.90,1.98,6.15,2.23,4.49,9.44",8,Sigmoid,0.008518232,0.015890298,-51.16585159,3.9946,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.142046544676074,-3.0061817169189453
3623,6648,KMS-11,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-72,-92,-95,-95,-96,-97,-96,-97","11.9,.17,.29,.37,.011,.21,2.05,1.03",8,Sigmoid,0.00343226,0.0025,-96.01049042,7.4167,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.5468087196350098
3624,6649,KMS-12-BM,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-48,-88,-91,-91,-95,-96,-94,-97","8.67,7.90,10.0,8.88,5.08,5.67,9.21,3.53",8,Sigmoid,0.002588813,0.002641938,-94.36374664,7.086,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.93624254022776,-2.493223190307617
3625,6650,KMS-34,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-64,-35,-76,-89,-96,-95,-96,-94","44.6,8.41,.23,3.12,2.31,.17,3.74,3.28",8,Sigmoid,0.019567162,0.014584946,-94.48430634,6.6117,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.227765378103314,-2.632721424102783
3626,6651,KNS-60,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-73,-90,-96,-98,-97,-99,-98","3.84,6.05,1.40,.47,.045,.52,.12,2.27",8,Sigmoid,0.005421062,0.004634195,-97.2620163,6.8034,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.374292773581083,-2.6131479740142822
3627,6652,KNS-62,Paclitaxel,TUBB1,".0080,.025,.080,.25,.80,2.53,8","-52,-59,-60,-77,-76,-87,-78","2.73,13.4,9.89,1.60,3.67,4.16,3.43",7,Sigmoid,0.109460443,0.008,-79.96215057,4.9409,KNS62_LUNG,KNS62,ACH-000858,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.8283137373023015,-3.042907953262329
3628,6653,KNS-81,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-31,-44,-63,-66,-66,-69,-66","13.7,6.92,6.86,2.16,2.53,5.81,10.1,4.29",8,Sigmoid,0.029823666,0.033557992,-66.78887939,4.5833,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.394480232307889,-2.2133617401123047
3629,6654,KO52,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-20,-66,-85,-92,-94,-96,-96","10.3,4.35,3.42,.56,.94,.43,1.34,.14",8,Sigmoid,0.022052443,0.019697005,-92.92024231,6.1507,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.9272886852528486,-2.5953598022460938
3630,6655,KP-N-SI9s,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,-63,-80,-87,-89,-91,-93,-92","10.1,1.29,1.62,.37,4.01,.81,.56,.90",8,Sigmoid,0.002542614,0.004405395,-92.12630463,6.2491,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.4249253527855785,-2.3332157135009766
3631,6656,KU812,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-57,-74,-96,-97,-98,-98,-98,-99","9.42,3.61,.18,.50,.24,1.27,.30,.15",8,Sigmoid,0.008656399,0.0025,-98.11937714,7.1048,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.3026304244995117
3632,6657,KYM-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-45,-53,-93,-95,-97,-98,-98,-99","5.82,13.3,1.17,.41,.37,.45,.032,.20",8,Sigmoid,0.010440577,0.004644886,-97.67601013,6.895,KYM1_SOFT_TISSUE,KYM1,ACH-000607,Rhabdoid,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.371988449536345,-3.2893905639648438
3633,6658,KYSE-140,Paclitaxel,TUBB1,".025,.080,.25,.80,2.53,8","-66,-64,-71,-68,-66,-58","2.30,9.95,3.09,8.22,4.38,7.06",6,Constant,,0.02538952,-65.86099243,3.5397,KYSE140_OESOPHAGUS,KYSE140,ACH-000823,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.6734187885249936,-2.654412031173706
3634,6659,KYSE-150,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-14,-71,-80,-79,-73,-72,-58","10.7,12.9,5.79,5.71,.29,.47,4.61,14.1",8,Sigmoid,0.014795695,0.016105084,-75.15450287,4.5075,KYSE150_OESOPHAGUS,KYSE150,ACH-000855,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.128620280441077,-2.0476646423339844
3635,6660,KYSE-180,Paclitaxel,TUBB1,".0080,.025,.080,.25,.80,2.53,8","-87,-94,-95,-97,-98,-97,-96","3.51,.23,.62,1.90,.19,.56,1.13",7,Constant,,0.00803466,-95.41982269,6.5708,KYSE180_OESOPHAGUS,KYSE180,ACH-000693,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.823990595560393,-2.946396827697754
3636,6661,KYSE-30,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-54,-78,-87,-80,-78,-80,-79","6.76,8.79,6.88,2.92,4.79,.88,8.19,3.44",8,Sigmoid,0.00794831,0.007177499,-80.74041748,5.8173,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.936804285293342,-1.9355230331420898
3637,6662,KYSE-510,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-74,-72,-88,-91,-86,-87,-85,-79","25.3,5.43,2.76,1.52,2.20,4.50,4.16,.99",8,Constant,,0.002542614,-85.35517883,6.5046,KYSE510_OESOPHAGUS,KYSE510,ACH-000824,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.4130632877349854
3638,6663,KYSE-520,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,-56,-73,-73,-78,-76,-75,-74","4.39,5.70,9.84,3.74,.64,.097,2.79,1.07",8,Sigmoid,0.005902303,0.006054605,-75.49595642,5.3639,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.106936139447691,-2.1852269172668457
3639,6664,KYSE-70,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-53,-81,-81,-82,-86,-89,-84",".062,9.62,1.12,.41,3.57,.54,4.74,3.79",8,Sigmoid,0.006693674,0.007472156,-84.41840363,5.5901,KYSE70_OESOPHAGUS,KYSE70,ACH-000784,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.896571700329211,-2.7673792839050293
3640,6665,L3.3,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-48,-70,-79,-90,-94,-95,-95,-95","25.2,15.7,2.95,5.45,2.65,1.83,3.66,4.96",8,Sigmoid,0.002542614,0.005354926,-91.60383606,6.4953,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.229738394038784,-2.391848564147949
3641,6666,L-363,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-81,-94,-96,-96,-96,-95,-96","29.7,.31,2.00,.35,1.70,1.41,.91,.042",8,Sigmoid,0.003956287,0.003210538,-95.83437347,6.817,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.7413167546376265,-2.7922096252441406
3642,6667,L-428,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-16,-21,-46,-69,-74,-81,-83","17.5,23.6,8.76,.95,3.40,2.30,2.98,1.68",8,Sigmoid,0.100718856,0.101714127,-81.0582428,4.3178,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.2855890770199503,-2.4067397117614746
3643,6668,LCLC-103H,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-26,-61,-86,-91,-93,-91,-73",".10,1.48,1.50,4.09,1.77,1.93,5.27,15.3",8,Sigmoid,0.024391761,0.020929208,-89.86139679,5.5755,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.8666095836606447,-2.8811163902282715
3644,6669,LN-229,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-29,-67,-88,-90,-91,-93,-92","7.64,9.23,.84,.32,1.97,1.35,1.11,3.11",8,Sigmoid,0.017079864,0.015199102,-91.69471741,5.688,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.186518931822505,-2.9247522354125977
3645,6670,LOU-NH91,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-56,-81,-90,-88,-85,-87,-90","5.37,13.3,2.41,.94,3.05,1.75,4.49,.54",8,Sigmoid,0.008317675,0.006858335,-88.37870026,6.1409,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.982290578073777,-2.502084970474243
3646,6671,LOX IMVI,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-65,-69,-76,-71,-71,-72,-61",".54,.56,.90,.13,1.81,3.51,.79,1.97",8,Sigmoid,0.002542614,0.004568389,-70.79938507,4.9676,LOXIMVI_SKIN,LOXIMVI,ACH-000750,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.388594652635918,-2.7950758934020996
3647,6672,LP-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-15,-34,-7.6,-16,-48,-47,-41","4.60,2.45,9.05,23.0,6.92,2.37,4.10,5.20",8,Sigmoid,0.468396187,8.0,-45.7021904,3.0682,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.4859204292297363
3648,6673,LS123,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-17,-19,-38,-46,-41,-51,-52","16.4,3.01,11.3,3.21,6.75,24.5,5.97,9.89",8,Sigmoid,0.07187251,0.348962843,-51.61020279,2.9985,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-1.052789829496439,-2.658761978149414
3649,6674,LS411N,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-49,-79,-82,-77,-80,-83,-77,-74","5.68,4.68,4.03,11.1,3.30,3.52,11.8,1.82",8,Sigmoid,0.003219193,0.002590775,-79.17605591,5.834,LS411N_LARGE_INTESTINE,LS411N,ACH-000985,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.955798220231172,-2.7950234413146973
3650,6675,LS513,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-53,-31,-79,-69,-85,-83,-89","10.7,7.55,8.67,11.1,6.82,1.70,2.52,5.16",8,Sigmoid,0.002542614,0.018824603,-89.21705627,4.8331,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.972590594495979,-2.1977298259735107
3651,6676,LU99,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-53,-73,-81,-78,-87,-85,-86,-84",".34,2.00,2.59,2.88,.30,1.33,.14,2.25",8,Sigmoid,0.002542614,0.0025,-84.65418243,6.1904,LU99_LUNG,LU99,ACH-000444,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-3.2144532203674316
3652,6677,LUDLU-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-34,-55,-94,-93,-96,-101,-99,-103","15.4,25.7,1.80,3.72,4.14,5.25,1.94,6.83",8,Sigmoid,0.002542614,0.003740356,-99.4369278,5.9003,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.588574484919932,-2.352839946746826
3653,6678,Malme-3M,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-36,-52,-62,-61,-65,-56,-44","3.67,13.7,9.37,.11,11.0,2.88,4.01,1.22",8,Sigmoid,0.006868892,0.017527899,-58.53517532,3.8672,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.04396143891461,-2.649813413619995
3654,6679,MCAS,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-69,-90,-92,-94,-93,-94,-93","10.1,12.3,1.05,1.58,1.27,1.03,1.21,.34",8,Sigmoid,0.007130012,0.006575953,-92.7717514,6.4269,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.024335768455746,-2.15431547164917
3655,6680,MCF7,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-82,-58,-95,-111,-103,-94,-88,-96","4.19,6.21,7.29,23.8,1.69,19.4,21.3,13.7",8,Sigmoid,0.018153984,0.0025,-98.35580444,3.7399,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-1.8510652780532837
3656,6681,MDA-MB-157,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-40,-54,-63,-52,-44,-48,-38","11.4,12.2,6.72,4.50,3.80,3.84,8.30,7.88",8,Sigmoid,0.006675275,8.0,-49.85776138,3.8675,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.8240773677825928
3657,6682,MDA-MB-175-VII,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-32,-10.0,-34,-30,-31,-33,-33,-19","13.9,18.9,11.6,9.08,7.11,23.0,3.09,14.5",8,Constant,,8.0,-27.41684151,2.2575,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-1.619072675704956
3658,6683,MDA-MB-415,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-43,-43,-40,-54,-38,-53,-62,-53","4.07,2.37,13.9,27.7,2.64,23.5,5.32,30.7",8,Constant,,8.0,-43.37302399,2.8461,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-1.817167043685913
3659,6684,MDA-MB-436,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-19,-62,-75,-76,-72,-74,-78","13.2,12.2,.93,.014,2.75,3.86,1.87,.56",8,Sigmoid,0.014086062,0.016697872,-75.29532623,4.6231,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.092473992828403,-2.702815055847168
3660,6685,MDA-MB-453,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-45,-70,-82,-81,-80,-85,-78,-82","33.8,2.72,.85,1.73,3.32,1.74,2.29,2.64",8,Constant,,0.002542614,-80.16636658,5.5396,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.138760566711426
3661,6686,MDA-MB-468,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-54,-71,-79,-85,-82,-81,-76,-82","5.75,1.75,.75,2.43,6.00,4.26,2.62,3.28",8,Sigmoid,0.00576519,0.0025,-81.0297699,6.075,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.398900032043457
3662,6687,MEG-01,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-25,-39,-55,-62,-71,-75,-76","21.3,14.1,7.26,10.4,2.81,2.06,2.73,.52",8,Sigmoid,0.066890962,0.068457693,-75.60985565,4.1212,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.6815393449579843,-2.3376965522766113
3663,6688,MEL-HO,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-42,-53,-61,-59,-65,-52,-57","4.68,8.81,6.88,3.05,4.39,1.07,3.71,4.25",8,Sigmoid,0.002581549,0.013635262,-58.94882584,4.24,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.295096047614337,-3.237401247024536
3664,6689,MES-SA,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","5.31,-56,-78,-79,-86,-89,-91,-89","7.10,1.22,.68,1.87,.40,1.58,.68,.19",8,Sigmoid,0.002542614,0.006836666,-88.3152771,5.6311,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.98545509307937,-2.7790701389312744
3665,6690,MeWo,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-34,-49,-61,-65,-62,-58,-38","7.56,4.20,1.06,1.21,.85,9.60,5.64,4.84",8,Sigmoid,0.009305894,0.023242673,-62.05176163,3.5542,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.761765336400695,-2.8492050170898438
3666,6691,MFE-296,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-40,-53,-79,-85,-89,-93,-95,-92","3.13,2.63,2.98,.034,3.39,.73,.43,2.18",8,Sigmoid,0.012253076,0.00617474,-92.28229523,5.9629,MFE296_ENDOMETRIUM,MFE296,ACH-000879,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.087288502617706,-2.8850173950195312
3667,6692,MG-63,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-62,-81,-82,-87,-85,-88,-82","5.26,6.12,.22,.51,1.08,.77,1.24,2.78",8,Sigmoid,0.006151426,0.005069706,-85.19876099,5.9739,MG63_BONE,MG63,ACH-000359,Bone Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.2844724512261045,-2.8378713130950928
3668,6693,Mino,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-40,-93,-98,-98,-99,-100,-100,-100","18.1,5.54,.41,.18,.095,.057,.012,.018",8,Sigmoid,0.003631432,0.002870928,-99.07964325,7.1403,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.853119956527584,-2.173424482345581
3669,6694,MJ,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-48,-77,-92,-94,-96,-94,-94,-98","24.2,15.5,.86,1.57,1.69,2.47,.66,.11",8,Sigmoid,0.008552494,0.0025,-95.21038818,6.9625,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.890772819519043
3670,6695,MKN-45,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-53,-71,-71,-81,-79,-84,-84,-80","21.0,.63,1.63,1.04,1.17,7.42,1.02,3.74",8,Sigmoid,0.002542614,0.0025,-82.75807953,5.8234,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.1571052074432373
3671,6696,MKN7,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-40,-32,-59,-43,-53,-34,-61,-34","24.9,2.57,14.2,12.4,6.84,17.7,8.54,11.0",8,Constant,,8.0,-47.26276779,3.6733,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.455244541168213
3672,6697,MKN74,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-3.4,-56,-58,-42,-64,-64,-71","7.87,1.35,4.75,7.39,21.7,1.95,24.3,14.4",8,Sigmoid,0.018099422,0.022440279,-61.83725357,3.5975,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.7968977652498523,-2.9216806888580322
3673,6698,MOLP-8,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-43,-39,-60,-52,-69,-64,-72,-66","43.5,24.5,13.8,22.8,6.09,15.6,7.81,7.44",8,Constant,,0.002542614,-65.75939178,4.819,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.52787709236145
3674,6699,MOLT-16,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-79,-90,-90,-92,-90,-93,-91","5.58,1.28,.81,1.75,.44,1.27,.19,.58",8,Sigmoid,0.002978521,0.003948967,-91.46961975,6.7558,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.534301253258501,-3.302536964416504
3675,6700,MONO-MAC-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.8,-95,-97,-99,-99,-99,-99,-99","5.82,.82,.37,.32,.060,.14,.59,.14",8,Sigmoid,0.002718177,0.003496323,-98.87340546,7.0911,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.656043434152314,-2.655829906463623
3676,6701,MOR/CPR,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-58,-93,-98,-99,-100,-99,-99","4.65,13.5,2.25,.69,.80,.53,.91,.17",8,Sigmoid,0.008230341,0.006695316,-99.05334473,6.6116,MORCPR_LUNG,MORCPR,ACH-000851,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.006347101550319,-2.642763614654541
3677,6702,MSTO-211H,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-39,-63,-78,-80,-86,-85,-86","7.79,7.90,10.3,7.29,1.31,5.46,.41,4.76",8,Sigmoid,0.01144923,0.013478238,-85.11711121,5.3017,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.306678894207728,-2.2994487285614014
3678,6703,NCI-H1048,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-77,-93,-95,-97,-98,-98,-95","7.68,2.27,1.97,.25,.36,.11,.23,1.83",8,Sigmoid,0.002542614,0.00391821,-96.75314331,6.7078,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.542120362121266,-2.5851402282714844
3679,6704,NCI-H1092,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-26,-38,1.76,-38,-33,-40,-42","24.0,22.3,6.01,28.1,2.84,12.0,10.7,17.0",8,Constant,,8.0,-35.08072662,1.7118,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-1.3798412084579468
3680,6705,NCI-H1155,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-27,-38,-72,-90,-92,-94,-96","6.00,3.58,4.05,10.5,.37,1.35,2.23,.83",8,Sigmoid,0.055190425,0.040493838,-93.98231506,5.3744,NCIH1155_LUNG,NCIH1155,ACH-000980,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.2066054645934954,-2.3533003330230713
3681,6706,NCI-H1184,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-31,-60,-68,-59,-51,-59,-64,-72","5.33,.41,14.9,8.95,21.8,12.6,4.89,5.38",8,Sigmoid,0.005472838,0.005819601,-64.24343872,4.6431,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.1465235762899395,-1.6272578239440918
3682,6707,NCI-H1341,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-44,-64,-84,-80,-71,-85,-93,-81","31.4,8.59,3.51,11.3,4.61,8.66,8.58,6.19",8,Constant,,0.002542614,-78.38348389,6.0169,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.6864821910858154
3683,6708,NCI-H1373,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-40,-50,-52,-51,-56,-54,-45","5.75,5.16,5.01,6.01,7.70,6.17,10.4,14.4",8,Constant,,8.0,-47.67835236,3.5616,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.1587462425231934
3684,6709,NCI-H1568,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","1.58,-35,-80,-87,-88,-88,-90,-87","22.2,2.70,2.37,2.65,.99,.36,5.49,3.42",8,Sigmoid,0.010884135,0.010964806,-87.80363464,5.6099,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.513064589927261,-2.1643004417419434
3685,6710,NCI-H1648,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-60,-70,-82,-87,-84,-88,-87,-87","5.65,13.4,6.46,9.11,2.76,2.33,4.96,6.83",8,Sigmoid,0.009235901,0.0025,-86.69805145,5.9981,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.7172484397888184
3686,6711,NCI-H1650,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-41,-69,-68,-67,-63,-60,-63","19.7,4.50,4.29,8.90,3.44,6.52,6.42,3.56",8,Sigmoid,0.009383617,0.009901977,-65.08132935,4.3317,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.615020844808682,-2.2658028602600098
3687,6712,NCI-H1651,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-10,-58,-63,-76,-76,-81,-71","1.69,6.29,4.97,4.23,.78,11.1,2.00,3.66",8,Sigmoid,0.02082637,0.022404801,-73.70367432,4.2575,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.7984800127294696,-1.9091964960098267
3688,6713,NCI-H1792,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-26,-76,-83,-92,-93,-95,-94","2.18,.86,1.38,2.60,1.85,1.44,1.22,.10",8,Sigmoid,0.021048699,0.018022098,-93.7846756,5.8456,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.016156607385829,-2.343390464782715
3689,6714,NCI-H1793,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-28,-71,-71,-86,-93,-85,-71","4.16,10.3,3.07,2.25,3.64,2.87,10.3,10.1",8,Sigmoid,0.014984522,0.014615449,-82.95400238,3.6008,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.2256761590297325,-2.5422115325927734
3690,6715,NCI-H1915,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-63,-75,-85,-80,-81,-84,-84","7.65,2.94,2.16,2.23,1.66,1.85,1.40,1.90",8,Sigmoid,0.003122467,0.004253245,-83.07482147,6.0863,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.4600730579743395,-2.8679609298706055
3691,6716,NCI-H1944,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-26,-79,-100,-106,-106,-101,-108","6.14,20.8,.88,5.91,7.71,2.34,6.18,2.92",8,Sigmoid,0.016089918,0.011522057,-105.5290146,4.4533,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.46349208062638,-2.263451099395752
3692,6717,NCI-H1975,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-50,-61,-76,-88,-84,-89,-81,-84","3.81,.18,9.46,1.71,2.46,.16,7.92,6.61",8,Sigmoid,0.011381867,0.00264905,-86.4703598,5.9467,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.933554193823149,-2.3819048404693604
3693,6718,NCI-H2009,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,-36,-62,-71,-73,-73,-68,-69","2.72,2.55,14.2,5.30,4.32,.60,.25,1.15",8,Sigmoid,0.020039976,0.01844758,-70.66914368,4.9461,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.9928220824101754,-2.971158504486084
3694,6719,NCI-H2023,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-43,-79,-86,-82,-83,-87,-84","2.87,16.4,6.19,1.36,.82,4.26,.64,4.69",8,Sigmoid,0.010506582,0.009333471,-84.34606934,4.676,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.674148307583823,-2.132378339767456
3695,6720,NCI-H2030,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.9,-40,-48,-67,-80,-89,-91,-94","3.49,19.9,18.1,5.21,3.06,.10,.91,.16",8,Sigmoid,0.019493317,0.028944699,-93.77498627,5.1832,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.5423682005378874,-2.44140362739563
3696,6721,NCI-H2052,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,-26,-43,-57,-67,-68,-72,-70","13.4,3.37,4.55,6.05,2.43,4.16,.29,3.41",8,Sigmoid,0.032463118,0.04403678,-70.43738556,4.3199,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.1227300851503976,-2.337068557739258
3697,6722,NCI-H2085,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-56,-74,-69,-76,-71,-75,-78","25.2,2.96,5.73,.80,3.15,4.45,4.08,8.17",8,Sigmoid,0.007616912,0.007059727,-73.63291931,5.0352,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.953348896779875,-1.4749226570129395
3698,6723,NCI-H2087,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-38,-78,-79,-82,-83,-82,-84","7.46,9.24,2.36,2.98,1.14,2.38,.060,2.82",8,Sigmoid,0.010950245,0.010453116,-82.23773956,5.5116,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.5608551632004986,-2.167847156524658
3699,6724,NCI-H211,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-68,-82,-79,-82,-76,-81,-78","30.1,8.59,5.10,4.49,1.14,7.64,3.55,8.77",8,Sigmoid,0.007405128,0.008475381,-73.72000122,5.7354,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.77058967097389,-2.255730390548706
3700,6725,NCI-H2122,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-37,-87,-96,-102,-104,-104,-103,-105","20.2,2.97,1.48,1.63,1.02,2.61,1.05,1.29",8,Sigmoid,0.002542614,0.003066643,-103.7880096,6.6492,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.787171801016336,-3.115732192993164
3701,6726,NCI-H2170,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-57,-69,-84,-89,-88,-87,-89,-89","30.1,7.34,1.32,1.51,3.13,5.92,3.38,2.99",8,Constant,,0.002542614,-86.52245331,6.47,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.1571271419525146
3702,6727,NCI-H2172,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-46,-81,-93,-153,-167,-203,-108,-157","41.9,27.4,2.36,12.2,13.0,49.5,1.64,8.90",8,Sigmoid,0.041482486,0.0025,-163.2444,2.1174,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-1.863390564918518
3703,6728,NCI-H2228,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-50,-71,-85,-81,-77,-75,-75,-70","6.52,4.45,5.07,2.90,6.56,1.13,2.29,2.43",8,Sigmoid,0.006199118,0.002949517,-76.99151611,5.1908,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.826113850848993,-2.535482883453369
3704,6729,NCI-H2286,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-73,-89,-91,-94,-94,-95,-95","5.84,5.95,1.50,.32,2.13,.57,.18,.36",8,Sigmoid,0.002542614,0.004381975,-94.09746552,6.627,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.430255742982599,-2.609384059906006
3705,6730,NCI-H23,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,-72,-86,-87,-91,-90,-90,-91","0,5.63,6.22,2.29,.19,1.43,.27,4.77",8,Sigmoid,0.002542614,0.003537219,-90.25421143,6.5769,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.644414453796854,-2.740419864654541
3706,6731,NCI-H2444,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-33,-44,-55,-77,-60,-71,-75","2.57,7.81,11.6,6.53,1.98,10.8,12.4,6.82",8,Sigmoid,0.021487858,0.036365941,-72.26730347,4.1579,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.3141226291807944,-2.3265433311462402
3707,6732,NCI-H2452,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-44,-52,-71,-82,-78,-87,-76,-84","4.51,4.40,1.41,1.68,.16,2.54,2.02,.038",8,Sigmoid,0.015433614,0.007106951,-81.99166107,5.6526,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.946681959772094,-1.9730048179626465
3708,6733,NCI-H28,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-14,-41,-58,-60,-71,-65,-63","2.24,1.01,6.13,4.75,4.92,1.64,2.30,1.38",8,Sigmoid,0.023487091,0.0396,-64.48169708,3.249,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.228926160721702,-2.527134418487549
3709,6734,NCI-H322,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-32,-34,-68,-93,-90,-93,-88,-86","19.7,5.53,6.19,.12,3.70,.12,6.14,4.03",8,Sigmoid,0.013363719,0.013226771,-90.70172119,4.7617,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.325512397159847,-1.917414665222168
3710,6735,NCI-H3255,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-31,-37,-38,-39,-40,-51,-55","4.44,19.2,17.1,4.72,9.72,1.40,3.07,4.93",8,Sigmoid,0.238102317,2.847905159,-53.7743454,3.1413,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,1.0465836920823204,-2.2958483695983887
3711,6736,NCI-H358,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-47,-71,-89,-90,-94,-90,-92","11.3,3.13,1.08,1.66,1.09,.17,1.03,.88",8,Sigmoid,0.014943436,0.009548982,-92.24975586,5.6597,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.651320727029986,-2.171038866043091
3712,6737,NCI-H441,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-33,-63,-64,-72,-73,-70,-67","9.17,2.64,3.40,3.24,4.74,5.69,3.05,2.23",8,Sigmoid,0.009890085,0.013821052,-69.29811859,4.4553,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.28156234197676,-2.411606788635254
3713,6738,NCI-H460,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,-15,-44,-84,-88,-89,-93,-95","1.80,3.95,3.17,7.90,3.73,7.19,.030,1.20",8,Sigmoid,0.029502366,0.029035103,-91.87382507,4.9726,NCIH460_LUNG,NCIH460,ACH-000463,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.5392497327216743,-2.5621135234832764
3714,6739,NCI-H522,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-44,-62,-81,-85,-86,-83,-84","5.99,1.43,1.00,2.13,2.53,.036,.59,2.91",8,Sigmoid,0.006420047,0.011133007,-85.50380707,5.4331,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.497840979474424,-2.3489484786987305
3715,6740,NCI-H647,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-46,-59,-73,-67,-70,-71,-74","8.16,.87,10.5,.15,.49,2.74,9.98,4.47",8,Sigmoid,0.004724338,0.009898632,-71.38821411,4.6377,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.615358713207762,-2.7913331985473633
3716,6741,NCI-H650,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-46,-42,-61,-71,-69,-62,-60,-46","4.19,1.44,11.0,1.63,2.95,11.8,2.88,4.91",8,Constant,,0.002542614,-55.94945145,4.2852,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.734786033630371
3717,6742,NCI-H661,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-13,-21,-35,-48,-50,-45,-55","5.45,2.34,7.33,31.6,38.8,51.1,56.4,39.4",8,Sigmoid,0.061157774,0.063754819,-82.84870148,2.5108,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.752710505643682,-2.549481153488159
3718,6743,NCI-H727,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-18,-20,4.86,-35,-32,-24,-27","5.88,21.4,12.7,25.1,12.2,11.5,18.5,16.6",8,Constant,,8.0,-34.31637192,1.9411,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.1078975200653076
3719,6744,NCI-H747,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-51,-46,-50,-56,-64,-59,-74,-72","22.3,14.7,1.71,3.64,8.48,.032,.70,5.03",8,Sigmoid,0.002542614,0.025522847,-72.71292114,4.5944,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.6681812671667244,-2.374098300933838
3720,6745,NCI-H810,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-55,-58,-65,-69,-65,-59,-58","6.24,6.14,.86,2.38,3.02,12.5,3.54,5.31",8,Sigmoid,0.010666084,0.011509144,-62.91592407,4.6234,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.464613429126885,-1.563429832458496
3721,6746,NCI-N87,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-51,-69,-87,-84,-77,-80,-83","18.0,10.4,12.0,14.9,3.88,6.93,1.25,3.18",8,Sigmoid,0.008517152,0.008005857,-81.66069794,5.695,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.827581880175073,-2.622950553894043
3722,6747,NCO2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-74,-80,-86,-85,-87,-89,-88,-88","18.3,2.49,7.43,6.44,4.29,2.04,3.90,5.38",8,Constant,,0.002542614,-85.8021698,6.8572,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.7916579246520996
3723,6748,NIH:OVCAR-3,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,-63,-67,-70,-72,-74,-71,-74","10.0,6.80,4.43,3.71,.42,1.41,2.91,2.48",8,Sigmoid,0.002542614,0.004321144,-72.27651978,5.2836,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.444235096968558,-2.5595126152038574
3724,6749,NUGC-3,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-60,-81,-91,-92,-95,-96,-96,-95","2.60,1.90,.25,.68,2.11,1.24,.59,1.97",8,Sigmoid,0.002542614,0.0025,-95.65821075,7.0402,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.7084527015686035
3725,6750,NUGC-4,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-57,-86,-91,-92,-90,-91,-89","18.0,6.84,3.83,2.68,3.08,4.31,1.66,.31",8,Sigmoid,0.013034794,0.003304154,-90.7846756,6.0989,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.712574814240134,-1.7043273448944092
3726,6751,OCI-AML2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-39,-96,-98,-98,-99,-99,-99","6.93,28.6,.011,.18,.016,.014,.024,.020",8,Sigmoid,0.007833721,0.007498603,-98.89511108,6.3485,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.8930385424563285,-3.280433177947998
3727,6752,OCI-AML5,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-41,-65,-92,-95,-97,-97,-97,-98","36.9,21.6,2.18,1.60,.34,.45,.33,.44",8,Sigmoid,0.017907575,0.0025,-96.96186829,6.9156,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-3.3307929039001465
3728,6753,OCUM-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-41,-52,-58,-70,-79,-72,-78,-79","7.27,2.62,2.62,.97,2.88,.31,6.63,2.87",8,Sigmoid,0.01839678,0.008336824,-77.98366547,5.3406,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.787072950487782,-2.315345287322998
3729,6754,OE21,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-54,-77,-83,-88,-88,-88,-87,-92","1.12,1.01,1.58,5.39,2.45,3.23,3.85,1.08",8,Sigmoid,0.002542614,0.0025,-88.82823944,6.2262,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.976998805999756
3730,6755,OE33,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-56,-53,-63,-60,-69,-70,-68,-63","3.98,7.03,.70,.97,7.97,5.69,4.83,5.59",8,Constant,,0.002542614,-62.71783447,4.8996,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.2736976146698
3731,6756,ONCO-DG-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-47,-44,-94,-96,-97,-97,-98,-97","20.1,1.58,1.60,.75,.81,2.13,1.02,2.74",8,Sigmoid,0.014300194,0.010235737,-96.76531219,6.6738,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.581870054645006,-2.4325826168060303
3732,6757,OPM-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-44,-24,-23,-32,-53,-59,-71,-68","5.32,18.1,.53,25.3,5.68,1.18,1.99,3.65",8,Sigmoid,0.242961571,0.248270139,-68.43845367,3.6015,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-1.3932378554801486,-2.172653913497925
3733,6758,OV-90,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-48,-45,-60,-56,-53,-49,-53","2.13,6.84,.41,1.81,1.69,.21,11.5,5.86",8,Sigmoid,0.002542614,0.011053084,-53.58802795,3.4582,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.505045794935522,-2.288330316543579
3734,6759,OVCAR-4,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8",".15,-49,-68,-72,-67,-71,-72,-77","3.78,.39,4.43,1.15,2.95,2.51,.99,1.19",8,Sigmoid,0.003192322,0.008228295,-71.81661987,4.5514,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.800176454649887,-2.4095263481140137
3735,6760,OVCAR-8,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-59,-86,-93,-92,-94,-93,-92","46.4,8.26,3.35,2.06,1.44,1.01,.55,.99",8,Sigmoid,0.011521365,0.005111858,-93.08966064,6.193,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.276192340070491,-2.242558002471924
3736,6761,OVMANA,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.0,-15,-21,-36,-37,-34,-34,-35","1.42,1.88,1.43,11.9,8.15,3.29,3.33,5.88",8,Sigmoid,0.021972664,8.0,-34.87543106,2.7268,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-3.2709884643554688
3737,6762,OVSAHO,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-33,-29,-30,-35,-41,-40,-43","15.0,.67,4.20,3.34,2.63,5.17,4.25,3.66",8,Constant,,8.0,-33.91451263,3.0491,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-1.9308782815933228
3738,6763,OVTOKO,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.0,-13,-4.3,-27,-40,-45,-49,-49","16.1,17.1,13.3,11.6,12.3,9.11,10.8,13.0",8,Sigmoid,0.099278033,8.0,-47.83106232,2.0493,OVTOKO_OVARY,OVTOKO,ACH-000663,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.8799009323120117
3739,6764,P12-ICHIKAWA,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-89,-96,-98,-99,-98,-98,-98","6.11,1.05,.78,.031,.10,.0096,.80,.53",8,Sigmoid,0.002542614,0.003325286,-98.23757172,6.9777,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.706199593535807,-3.3638103008270264
3740,6765,P31/FUJ,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-43,-77,-86,-84,-84,-84,-77",".61,9.00,7.16,1.92,1.51,.60,4.41,.47",8,Sigmoid,0.00848958,0.009502594,-83.01322174,5.4592,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.656190465016148,-2.5013434886932373
3741,6766,P3HR-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-31,-72,-84,-87,-90,-89,-92","29.9,18.7,7.42,.12,.73,1.95,.74,1.27",8,Sigmoid,0.006466428,0.010103884,-90.39302826,5.7467,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.594835374601591,-1.739736557006836
3742,6767,Panc 02.03,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-33,-58,-54,-65,-67,-58,-64",".84,.54,2.22,7.09,3.13,.77,3.82,9.29",8,Sigmoid,0.011924825,0.016453935,-63.21798706,4.0096,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.107190620650397,-2.7919957637786865
3743,6768,Panc 03.27,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-41,-72,-73,-81,-78,-82,-75,-74","6.19,9.94,5.65,4.59,.11,.42,5.01,1.77",8,Sigmoid,0.002542614,0.003208714,-77.86955261,5.8073,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.741885045164027,-2.961947202682495
3744,6769,Panc 04.03,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-39,-69,-77,-77,-84,-82,-84","15.9,15.3,4.53,4.20,9.98,6.77,.38,.098",8,Sigmoid,0.011236447,0.010263606,-82.38238525,3.9711,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.579151038999506,-1.8740586042404175
3745,6770,Panc 10.05,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-41,-68,-75,-73,-78,-80,-80,-82","17.7,3.46,1.98,8.41,.53,.32,2.97,1.86",8,Sigmoid,0.002542614,0.003355819,-79.15635681,5.4204,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.697059425085501,-2.4019486904144287
3746,6771,PA-TU-8902,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-28,-39,-39,-41,-51,-49,-49",".52,7.11,4.91,2.16,2.12,7.59,.33,8.01",8,Sigmoid,0.002542614,8.0,-48.66418076,3.2911,PATU8902_PANCREAS,PATU8902,ACH-000599,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.666139841079712
3747,6772,PC-3,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-32,-41,-54,-66,-67,-74,-68,-65","7.06,2.00,3.96,2.34,1.95,1.26,.82,3.70",8,Sigmoid,0.017930953,0.017974542,-68.94603729,4.2393,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.0187988555327445,-2.006826877593994
3748,6773,Pfeiffer,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-59,-85,-92,-97,-96,-97,-97,-96","20.3,2.61,.043,.54,.55,.83,2.12,.92",8,Sigmoid,0.002542614,0.0025,-96.84370422,7.1858,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-3.584702968597412
3749,6774,PK-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,-54,-64,-79,-82,-82,-77,-75","7.01,12.2,2.20,.43,1.42,1.53,4.73,.28",8,Sigmoid,0.010696046,0.008773311,-79.63961029,5.4913,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.736041006789075,-2.554128646850586
3750,6775,PK-45H,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-48,-37,-69,-68,-81,-77,-82,-76","4.99,.63,.66,6.74,2.95,4.41,.41,5.42",8,Sigmoid,0.020173337,0.015860058,-77.53580475,5.3968,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.143951405783383,-1.9707281589508057
3751,6776,PK-59,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-36,-56,-55,-72,-69,-63,-56","2.67,1.91,3.84,8.66,3.64,3.89,8.56,2.92",8,Sigmoid,0.009069322,0.018169707,-64.08506775,4.3007,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.007999522185637,-2.8968584537506104
3752,6777,PLC/PRF/5,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-42,-61,-83,-87,-84,-88,-85","5.54,11.6,13.1,2.95,2.77,2.71,3.19,4.65",8,Sigmoid,0.011064798,0.011762056,-86.20959473,5.357,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.442876521860655,-3.1516687870025635
3753,6778,PSN1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-27,-68,-80,-90,-92,-94,-92","6.15,1.13,4.26,.99,3.68,.29,.41,.84",8,Sigmoid,0.021295547,0.01755916,-90.44123077,5.7164,PSN1_PANCREAS,PSN1,ACH-000320,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.042179527910232,-2.7871780395507812
3754,6779,QGP-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-67,-81,-65,-67,-65,-69,-68,-70","54.9,12.1,13.0,4.16,7.47,1.31,.53,2.09",8,Constant,,0.002542614,-69.19559479,5.2985,QGP1_PANCREAS,QGP1,ACH-000347,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-1.6809413433074951
3755,6780,Raji,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-37,-80,-86,-93,-93,-93,-94","46.5,.22,1.56,2.94,1.42,1.00,1.76,1.39",8,Sigmoid,0.008241517,0.010622928,-92.3972168,6.0218,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.544740594953629,-2.7162227630615234
3756,6781,RD,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-34,-64,-77,-81,-87,-88,-89,-85","43.7,15.1,4.60,4.13,1.94,1.32,1.86,.86",8,Sigmoid,0.02091353,0.0025,-87.39704132,5.9449,RD_SOFT_TISSUE,RD,ACH-000169,Sarcoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.104764461517334
3757,6782,Reh,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-72,-97,-98,-99,-99,-99,-99","11.7,.074,.24,.12,.053,.028,.043,.085",8,Sigmoid,0.006309407,0.005274509,-98.61517334,6.7887,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.244869684520992,-3.931180238723755
3758,6783,RERF-GC-1B,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-36,-52,-60,-74,-74,-79,-73","9.00,14.7,5.62,7.88,7.62,4.88,.92,5.62",8,Sigmoid,0.013826853,0.022975717,-76.85042572,4.5754,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.773317403392738,-1.7872295379638672
3759,6784,RERF-LC-AI,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-46,-73,-91,-94,-96,-96,-95,-95","3.82,.97,.74,.042,.46,1.57,.0046,.74",8,Sigmoid,0.005376166,0.003108381,-95.46511078,6.7642,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.7736532671173055,-2.3714680671691895
3760,6785,RERF-LC-MS,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-45,-47,-83,-99,-104,-108,-109,-108","24.4,8.35,8.85,4.59,2.39,5.44,2.85,2.21",8,Sigmoid,0.013291467,0.008268842,-107.8221054,5.9558,RERFLCMS_LUNG,RERFLCMS,ACH-000062,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.795260803934635,-2.5480425357818604
3761,6786,RKO,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-39,-62,-83,-90,-95,-97,-97,-97","23.6,1.83,.34,.94,.24,.42,.72,1.49",8,Sigmoid,0.015762696,0.0025,-96.60572815,6.6097,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.642321825027466
3762,6787,RL95-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-59,-60,-73,-84,-87,-85,-87,-86","28.4,8.06,4.40,2.78,1.24,3.80,4.22,4.11",8,Sigmoid,0.002542614,0.0025,-83.73366547,6.095,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.106407403945923
3763,6788,RPMI-7951,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-56,-70,-92,-92,-96,-97,-98,-97","11.3,2.18,2.69,.84,.63,1.16,.22,1.55",8,Sigmoid,0.010150018,0.0025,-96.61234283,6.9914,RPMI7951_SKIN,RPMI7951,ACH-000348,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.4190444946289062
3764,6789,RPMI-8402,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.3,-77,-88,-91,-93,-94,-93,-94",".68,.25,.34,.16,.21,1.96,1.92,.85",8,Sigmoid,0.002542614,0.004104584,-93.12869263,6.4498,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.495650881042449,-3.675321102142334
3765,6790,RT-112,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-77,-96,-98,-98,-99,-98,-98","14.4,4.23,.039,.040,.031,.48,.042,.52",8,Sigmoid,0.005572324,0.003794526,-98.34321594,6.9774,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.574195777121117,-2.2910962104797363
3766,6791,RT4,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-69,-87,-86,-88,-87,-91,-88","7.23,8.07,2.40,2.49,1.76,3.11,1.20,2.67",8,Sigmoid,0.004684042,0.004950418,-88.26804352,6.3166,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.308283261522325,-2.5672316551208496
3767,6792,RVH-421,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-28,-40,-52,-67,-65,-72,-59","3.14,2.85,1.39,.13,9.69,5.83,2.10,1.03",8,Sigmoid,0.029899554,0.055785839,-66.34062958,3.8473,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.8862352231648183,-2.924355983734131
3768,6793,SBC-5,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-59,-69,-97,-99,-100,-101,-100,-101","7.78,.33,.73,.34,.15,.32,.21,.14",8,Sigmoid,0.011645077,0.0025,-100.3009796,6.4903,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-3.099832057952881
3769,6794,SCaBER,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-52,-79,-89,-92,-91,-93,-90,-90","36.3,3.41,4.53,.76,.11,1.46,.59,.22",8,Constant,,0.002542614,-90.31894684,6.5622,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.3896570205688477
3770,6795,SCC-9,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-34,-55,-65,-65,-81,-76,-74,-75","9.31,4.36,9.18,5.79,6.43,6.79,3.16,1.17",8,Sigmoid,0.002542614,0.005892467,-76.37956238,5.2099,SCC9_UPPER_AERODIGESTIVE_TRACT,SCC9,ACH-000181,Head and Neck Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.134080523509084,-3.040663003921509
3771,6796,SF126,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-11,-19,-58,-86,-93,-92,-95","3.73,6.55,5.56,3.58,1.43,.24,1.70,.64",8,Sigmoid,0.073836654,0.068713717,-92.92008972,4.6195,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.6778064344732164,-2.8254146575927734
3772,6797,SF-295,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-28,-41,-68,-78,-85,-88,-90","4.71,2.05,.82,5.23,3.10,.33,2.87,2.84",8,Sigmoid,0.049037684,0.03881523,-87.88292694,4.5241,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.248942583597801,-3.1873481273651123
3773,6798,SH-10-TC,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-18,-66,-92,-95,-97,-97,-97","3.68,9.60,6.76,3.22,.50,.51,.70,.095",8,Sigmoid,0.02353929,0.019594096,-95.75106812,5.5243,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.932526982612671,-2.5714211463928223
3774,6799,SHP-77,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,16.9,-17,27.9,-52,-92,-96,-98","28.1,23.1,16.5,19.2,7.11,1.00,.43,.052",8,Sigmoid,0.234951496,0.250442058,-95.57901764,3.8193,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-1.3845276906016564,-2.349456310272217
3775,6800,SIG-M5,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-53,-94,-97,-97,-98,-99,-99,-99",".21,1.06,1.36,.32,.10,.067,.29,.62",8,Sigmoid,0.002542614,0.0025,-98.25598145,7.4525,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-3.7847237586975098
3776,6801,SIMA,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-53,-42,-52,-78,-77,-85,-83,-83","69.1,13.6,27.4,7.92,6.58,1.13,.92,4.44",8,Constant,,0.002542614,-80.86065674,5.5779,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.3540890216827393
3777,6802,SJSA-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,-29,-62,-74,-81,-85,-91,-78","9.90,13.2,7.66,4.57,2.36,.14,2.77,1.72",8,Sigmoid,0.009850824,0.016656112,-84.43888092,5.3659,SJSA1_BONE,SJSA1,ACH-000748,Bone Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.094978042828577,-3.2260656356811523
3778,6803,SK-BR-3,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-26,-80,-72,-82,-86,-83,-79","13.2,14.1,7.01,5.88,5.75,2.74,5.47,6.69",8,Sigmoid,0.010640944,0.011064467,-80.83483124,5.046,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.504016476544438,-2.157724618911743
3779,6804,SK-CO-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,-30,-32,-27,-36,-33,-34,-41","4.18,3.30,15.1,11.1,5.93,2.24,6.35,9.40",8,Sigmoid,0.002802407,8.0,-35.20038986,2.6585,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.531263828277588
3780,6805,SK-ES-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-43,-80,-86,-89,-93,-95,-94,-94","49.7,4.99,2.91,.53,.19,1.39,1.62,1.05",8,Constant,,0.002542614,-91.0738678,6.7784,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.49871563911438
3781,6806,SK-HEP-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-51,-59,-63,-83,-79,-89,-83,-83","15.8,2.32,.37,4.31,2.54,1.00,1.03,.46",8,Sigmoid,0.038306262,0.0025,-83.54299927,4.968,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.5629398822784424
3782,6807,SK-MEL-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","7.30,20.7,-45,-70,-71,-66,-72,-62","24.8,.079,10.4,3.78,13.0,5.79,1.31,15.3",8,Sigmoid,0.020730669,0.026818315,-69.9467392,3.657,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.618670229351324,-2.6868181228637695
3783,6808,SK-MEL-24,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-23,-34,-46,-58,-58,-60,-55","10.6,1.96,4.93,.76,6.09,5.32,2.11,4.32",8,Sigmoid,0.042267546,0.102132171,-58.25354767,3.0234,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.2814875103968726,-2.4515504837036133
3784,6809,SK-MEL-30,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,-41,-54,-56,-64,-60,-58,-43","15.2,10.7,9.35,6.44,1.00,1.25,3.62,7.99",8,Sigmoid,0.010130499,0.015178802,-57.41324997,3.9556,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.187855429760065,-3.268233299255371
3785,6810,SK-MEL-31,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-21,-48,-60,-65,-72,-66,-64","2.85,4.33,.87,12.7,15.1,2.87,2.83,6.30",8,Sigmoid,0.024401404,0.026501333,-68.65174103,4.1256,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.6305602453682657,-2.8406667709350586
3786,6811,SK-MEL-5,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-45,-56,-71,-81,-86,-80,-81,-72","34.7,13.6,6.54,1.16,7.06,7.32,.76,3.16",8,Sigmoid,0.024308879,0.0025,-80.1210022,4.9196,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.498438835144043
3787,6812,SK-MES-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-35,-56,-77,-76,-77,-75,-81","1.20,2.27,1.75,6.07,.33,5.30,3.20,2.84",8,Sigmoid,0.021067705,0.019149521,-77.62593079,4.9906,SKMES1_LUNG,SKMES1,ACH-000665,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.955477576723144,-1.5325559377670288
3788,6813,SK-MM-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,-69,-87,-92,-93,-94,-94,-94","17.2,2.60,3.03,.84,.96,.34,1.97,.49",8,Sigmoid,0.004783915,0.005710234,-92.7648468,6.3364,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.165495275418354,-3.0171279907226562
3789,6814,SK-N-AS,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-51,-67,-71,-76,-83,-84,-82","9.80,6.69,.25,1.33,2.02,6.61,1.70,.44",8,Sigmoid,0.002542614,0.007667506,-82.90583038,5.2472,SKNAS_AUTONOMIC_GANGLIA,SKNAS,ACH-000260,Neuroblastoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.870763879452535,-2.382244110107422
3790,6815,SK-N-BE(2),Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-71,-87,-80,-85,-84,-84,-86","33.9,9.97,1.61,2.18,3.60,3.14,2.56,3.77",8,Sigmoid,0.006816553,0.005319262,-84.28624725,5.9311,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.236420707055855,-2.2473366260528564
3791,6816,SK-N-DZ,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-46,-54,-71,-72,-80,-82,-87,-80","24.9,1.44,.64,1.10,2.77,3.23,1.46,.29",8,Sigmoid,0.002542614,0.006010402,-83.34185791,5.864,SKNDZ_AUTONOMIC_GANGLIA,SKNDZ,ACH-000366,Neuroblastoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.114263644152824,-2.8247230052948
3792,6817,SK-N-FI,Paclitaxel,TUBB1,".0025,.025,.080,.25,.80,2.53,8","-7.2,-26,-27,-30,-57,-73,-88","10.5,7.72,4.71,33.0,.17,4.18,4.37",7,Sigmoid,5.011042595,0.432275355,-87.75576019,3.4138,SKNFI_AUTONOMIC_GANGLIA,SKNFI,ACH-000341,Neuroblastoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-0.8386924979551399,-1.8647034168243408
3793,6818,SK-N-SH,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-43,-47,-68,-79,-81,-84,-83","10.2,8.18,5.49,6.31,5.28,4.56,3.69,8.56",8,Sigmoid,0.034470201,0.024853488,-83.9232254,4.8643,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.694757174116309,-2.296896457672119
3794,6819,SK-OV-3,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,-39,-60,-75,-78,-81,-87,-88","6.31,7.20,2.22,1.92,5.18,4.34,2.89,2.61",8,Sigmoid,0.027344441,0.013747575,-87.03084564,5.0501,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.286892834059815,-3.0097081661224365
3795,6820,SNG-M,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-26,-65,-88,-89,-92,-89,-92",".20,11.7,10.2,1.73,.39,4.42,6.46,5.78",8,Sigmoid,0.020825231,0.018114803,-90.41781616,5.7321,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.011025829659728,-2.8537769317626953
3796,6821,SNU-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-61,-80,-69,-67,-65,-62,-58","6.38,2.42,3.53,2.05,4.32,3.50,4.15,.45",8,Sigmoid,0.005099222,0.005922596,-65.82555389,4.8994,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.128980412691662,-2.698322057723999
3797,6822,SNU-182,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-19,-28,-70,-88,-91,-90,-89","3.14,3.06,5.89,2.17,1.18,2.71,2.74,.74",8,Sigmoid,0.052304633,0.048124224,-90.05990601,4.6237,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.0339696111795176,-2.2994165420532227
3798,6823,SNU-387,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-43,-48,-69,-69,-66,-77,-69","7.98,6.29,5.76,.82,2.72,2.91,7.03,2.13",8,Sigmoid,0.002542614,0.015857622,-71.92880249,4.7368,SNU387_LIVER,SNU387,ACH-000478,Liver Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.144105010965401,-2.4974703788757324
3799,6824,SNU-398,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-42,-83,-97,-98,-99,-97,-98,-95","21.5,1.71,1.11,.87,.86,.91,1.21,1.10",8,Sigmoid,0.006730711,0.0025,-97.55992889,6.988,SNU398_LIVER,SNU398,ACH-000221,Liver Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-2.3237342834472656
3800,6825,SNU-423,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-46,-41,-60,-69,-73,-79,-77,-81","10.3,12.3,8.31,3.35,6.10,2.95,.75,.62",8,Sigmoid,0.03212693,0.010886092,-78.95396423,4.9445,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.520269267784087,-2.2653861045837402
3801,6826,SNU-449,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,-1.7,-12,-13,-18,-24,-52,-67","3.29,1.45,5.24,8.59,2.06,9.12,9.00,1.05",8,Sigmoid,2.421851397,2.699324846,-67.80815125,1.808,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,0.9930016847037726,-1.4563121795654297
3802,6827,SNU-475,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,-59,-52,-79,-70,-65,-76,-80","15.9,3.43,19.9,5.65,8.49,8.19,.38,7.84",8,Sigmoid,0.002542614,0.007151415,-72.93730927,5.0,SNU475_LIVER,SNU475,ACH-000422,Liver Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.940445039758355,-2.2214303016662598
3803,6828,SNU-C2A,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-26,-35,-59,-64,-65,-64,-60","6.04,1.85,2.98,4.72,10.1,.15,3.63,.32",8,Sigmoid,0.033058468,0.047947861,-63.48159409,3.9497,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.037641087615374,-2.53519344329834
3804,6829,Sq-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,-22,-56,-64,-56,-73,-78,-65","15.2,9.66,17.1,9.95,5.09,2.00,3.70,20.3",8,Sigmoid,0.010066535,0.022958782,-69.19540405,4.5905,SQ1_LUNG,SQ1,ACH-000553,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.7740547577183956,-2.2586727142333984
3805,6830,SU.86.86,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-40,-54,-60,-53,-54,-63,-53","11.3,6.78,1.81,4.77,4.41,4.59,9.49,2.03",8,Constant,,0.002542614,-53.23056412,4.1376,SU8686_PANCREAS,SU8686,ACH-000114,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.483830451965332
3806,6831,SU-DHL-10,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-97,-96,-97,-99,-98,-98,-100",".77,.28,.34,.14,.067,.056,.021,.021",8,Sigmoid,0.003461878,0.003111677,-98.150177,7.2354,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.77259346982651,-2.3972349166870117
3807,6832,SU-DHL-4,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-71,-91,-96,-97,-96,-96,-97","6.04,7.85,.52,.98,.94,.40,1.07,.13",8,Sigmoid,0.004564515,0.004502342,-96.36992645,6.9533,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.403157573145657,-3.1468141078948975
3808,6833,SU-DHL-6,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-80,-92,-95,-98,-97,-97,-96,-95","4.20,1.00,2.00,.58,3.63,1.39,.62,1.07",8,Constant,,0.002542614,-95.71515656,7.4814,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-3.5168404579162598
3809,6834,SU-DHL-8,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-49,-87,-85,-81,-90,-90,-87,-83","10.8,2.98,.012,1.55,.90,2.87,3.98,.30",8,Sigmoid,0.002542614,0.002547168,-86.21634674,6.7813,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.972773125207193,-2.9694366455078125
3810,6835,SUIT-2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","3.58,-9.4,-8.5,-44,-50,-69,-70,-77","26.3,7.57,1.15,12.7,4.63,9.84,2.97,6.09",8,Sigmoid,0.039788041,0.297967613,-81.23284149,3.2842,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-1.2107704795910166,-3.3742012977600098
3811,6836,SUP-M2,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-79,-96,-98,-99,-99,-99,-99,-99","9.43,.93,.10,.30,.27,.018,.089,.094",8,Constant,,0.002542614,-98.6079483,7.6077,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-3.081296443939209
3812,6837,SUP-T1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","5.04,-51,-66,-85,-85,-86,-88,-89","7.18,10.6,3.23,1.73,1.54,.92,1.10,.81",8,Sigmoid,0.002542614,0.00852356,-88.43585205,5.2309,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.7649211850363065,-2.5312325954437256
3813,6838,SW 1088,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-61,-55,-77,-70,-75,-75,-67,-64","8.57,4.81,8.68,5.50,3.89,1.84,13.7,5.76",8,Constant,,0.002542614,-69.42562866,4.9997,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.274379253387451
3814,6839,SW 1271,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-40,-62,-59,-62,-54,-62,-67","21.4,.065,3.72,3.21,.026,1.14,5.65,1.85",8,Sigmoid,0.00869495,0.010101246,-61.16473007,4.1891,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.59509649640729,-3.01525616645813
3815,6840,SW 1353,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-20,-62,-85,-90,-86,-88,-78","6.81,30.1,.73,1.57,1.39,1.37,1.92,3.13",8,Sigmoid,0.012006343,0.01130726,-87.38870239,5.3868,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.482310281688289,-2.37245512008667
3816,6841,SW1417,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-31,-47,-51,-72,-77,-75,-75,-78","3.33,19.4,3.73,9.02,6.06,1.03,10.2,8.98",8,Sigmoid,0.027966568,0.024212839,-75.94257355,5.1654,SW1417_LARGE_INTESTINE,SW1417,ACH-000236,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.7208722493145117,-1.8447054624557495
3817,6842,SW 1573,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-35,-56,-59,-57,-59,-62,-59","8.14,3.09,5.94,1.74,2.13,.38,4.89,2.82",8,Sigmoid,0.009652582,0.015798051,-58.84243774,3.8372,SW1573_LUNG,SW1573,ACH-000677,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.147868700988379,-2.894150733947754
3818,6843,SW 1990,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-41,-44,-68,-74,-70,-70,-68","2.68,.80,8.24,1.91,3.19,.53,3.66,3.46",8,Sigmoid,0.041163512,0.034169219,-70.4870224,4.7138,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.3764300694228475,-2.5054750442504883
3819,6844,SW403,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-34,-58,-72,-80,-85,-82,-85,-88","4.99,6.23,6.12,2.90,3.52,5.63,6.51,4.60",8,Sigmoid,0.003060008,0.005492983,-85.66223907,5.8697,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.204283819474431,-2.234997034072876
3820,6845,SW48,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-79,-91,-91,-91,-94,-92,-93","8.60,4.67,.33,.47,2.10,.91,.66,1.31",8,Sigmoid,0.002592657,0.003591424,-92.57591248,6.6415,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.6292064977480765,-3.0053441524505615
3821,6846,SW480,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-35,-55,-71,-68,-68,-64,-63","3.81,5.23,8.45,2.87,3.32,1.68,2.96,.93",8,Sigmoid,0.010175461,0.015503779,-66.54091644,3.6134,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.166671478321287,-1.854363203048706
3822,6847,SW579,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-34,-63,-79,-87,-89,-92,-90",".39,2.96,2.93,4.14,1.39,1.61,2.61,3.18",8,Sigmoid,0.017293759,0.015498778,-90.05263519,5.6305,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.166994096874548,-2.0561254024505615
3823,6848,SW620,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-41,-71,-82,-86,-91,-90,-86,-72","13.6,2.01,1.74,1.71,.36,1.24,.27,2.40",8,Sigmoid,0.002542614,0.002583542,-88.8600235,6.0438,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.958593953353502,-3.005375385284424
3824,6849,SW 780,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-47,-47,-63,-89,-93,-94,-92,-91","4.79,4.04,16.5,2.71,.27,1.46,2.72,6.12",8,Sigmoid,0.02869698,0.010781743,-92.64208221,5.5322,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.5299010382597436,-2.271401882171631
3825,6850,SW 900,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-35,-52,-74,-78,-85,-84,-84","8.26,1.70,5.26,1.51,5.86,2.41,6.54,1.67",8,Sigmoid,0.010703176,0.0188492,-84.7631073,4.5352,SW900_LUNG,SW900,ACH-000669,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.9712848063070356,-2.0554146766662598
3826,6851,T24,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-34,-29,-57,-74,-89,-91,-95,-95","3.57,9.29,2.87,2.54,1.50,.49,1.99,.032",8,Sigmoid,0.036396265,0.018219179,-94.64691925,5.7734,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.00528044853879,-2.6227896213531494
3827,6852,T3M-10,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-40,-42,-37,-61,-69,-76,-77,-76","3.39,15.1,2.70,.94,7.08,13.4,1.66,11.4",8,Sigmoid,0.072129786,0.062078975,-74.44713593,4.1385,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.779347914197089,-2.711092710494995
3828,6853,T-47D,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-43,-48,-47,-55,-47,-46,-41","24.6,3.16,6.68,.31,7.16,7.89,17.8,10.8",8,Constant,,8.0,-45.69276428,3.3375,T47D_BREAST,T47D,ACH-000147,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-1.4284464120864868
3829,6854,T84,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-34,-7.4,-37,-63,-66,-63,-73,-83","22.2,69.9,2.94,6.90,25.7,27.3,22.4,4.37",8,Sigmoid,0.06753663,0.057363126,-73.17120361,4.1065,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.8583535862677794,-2.088595390319824
3830,6855,TCCSUP,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-63,-68,-76,-81,-81,-80,-77,-77","17.6,8.49,6.72,2.50,3.53,3.08,.15,4.28",8,Constant,,0.002542614,-77.90306091,5.7387,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.6135969161987305
3831,6856,TE-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-37,-53,-67,-60,-67,-58,-57",".060,11.9,7.81,1.22,2.30,3.93,2.87,2.36",8,Sigmoid,0.011530357,0.017809903,-61.52895737,4.1517,TE1_OESOPHAGUS,TE1,ACH-000647,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.028000628073838,-2.741471290588379
3832,6857,TE-11,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-85,-92,-92,-95,-97,-94,-96,-94","12.5,1.02,3.50,.13,.13,4.48,1.05,.24",8,Constant,,0.002542614,-94.59170532,7.3115,TE11_OESOPHAGUS,TE11,ACH-000488,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.8127830028533936
3833,6858,TE-15,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,-59,-86,-101,-100,-102,-104,-106","3.35,2.02,3.50,3.92,4.48,3.22,3.54,4.38",8,Sigmoid,0.010010515,0.005525481,-103.7845535,6.4203,TE15_OESOPHAGUS,TE15,ACH-000353,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.19838497654419,-2.4684038162231445
3834,6859,TE-5,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-39,-67,-81,-83,-83,-87,-85","7.90,15.3,.88,5.03,3.56,6.81,.19,4.70",8,Sigmoid,0.009768344,0.012177017,-84.97931671,5.4258,TE5_OESOPHAGUS,TE5,ACH-000408,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.408204956383674,-2.87302565574646
3835,6860,TE 617.T,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-73,-92,-95,-95,-96,-96,-91","21.1,7.91,2.10,2.87,3.04,.79,1.46,2.62",8,Sigmoid,0.003469334,0.003053997,-95.17578888,6.7285,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.79130405450445,-3.5967323780059814
3836,6861,TE-9,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,-75,-88,-91,-92,-94,-96,-94","21.3,9.50,3.20,4.01,4.17,2.12,.42,2.18",8,Sigmoid,0.002542614,0.003389495,-93.95977783,6.6468,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.687074336238168,-2.18447208404541
3837,6862,TEN,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-42,-20,-43,-54,-47,-54,-56,-50","16.7,9.55,13.3,5.60,1.48,1.24,6.61,3.14",8,Sigmoid,0.022663632,0.036272764,-52.20996475,4.0307,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.3166881223598286,-2.4653124809265137
3838,6863,Toledo,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-19,-7.1,-33,-46,-72,-61,-65","19.2,15.0,24.2,3.54,6.39,9.52,7.42,11.2",8,Sigmoid,0.140151396,0.243933931,-65.80413055,2.3948,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-1.4108578649451575,-3.1566734313964844
3839,6864,TOV-112D,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,-68,-87,-99,-99,-100,-97,-89","5.84,.28,2.88,.47,1.07,.100,1.38,1.60",8,Sigmoid,0.002542614,0.005249934,-97.15920258,6.2674,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.249539773886197,-2.7291812896728516
3840,6865,TOV-21G,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-46,-57,-70,-75,-81,-80,-77,-78","9.34,9.31,3.18,8.51,2.82,2.72,1.44,2.42",8,Sigmoid,0.01063237,0.003941573,-78.85817719,5.0367,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.53617539676813,-3.7437801361083984
3841,6866,TT2609-C02,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-66,-72,-84,-85,-90,-90,-89,-84","4.08,3.29,.0019,.22,3.63,.32,.25,8.26",8,Sigmoid,0.011632246,0.0025,-88.15857697,6.6567,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-3.017666816711426
3842,6867,TYK-nu,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-47,-51,-64,-73,-68,-77,-69,-65","29.6,11.1,13.2,3.82,10.5,4.62,12.3,14.9",8,Constant,,0.002542614,-68.37091064,5.115,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-2.63259220123291
3843,6868,U-118 MG,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-51,-70,-75,-86,-81,-84,-80","16.8,4.96,4.38,1.14,.0069,6.67,.71,5.05",8,Sigmoid,0.011908124,0.007376922,-82.74376678,4.7636,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.909398800539694,-2.3544816970825195
3844,6869,U-2 OS,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.2,-29,-50,-73,-82,-85,-88,-89","30.1,4.66,4.25,3.03,7.45,4.73,2.73,.76",8,Sigmoid,0.031713322,0.026384344,-87.50041199,5.1548,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.634984475044918,-2.2490029335021973
3845,6870,U-87 MG,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-35,-62,-71,-74,-78,-78,-73","3.68,19.3,2.59,1.06,2.25,1.95,5.41,.25",8,Sigmoid,0.002542614,0.009391576,-76.35894012,4.303,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.667942161719543,-2.2402164936065674
3846,6871,U-937,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-75,-82,-96,-97,-98,-99,-98,-99","23.4,15.4,.21,.56,.29,.85,1.31,.91",8,Sigmoid,0.007595447,0.004307028,-98.91239166,7.4369,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.4475071718864845,-3.482989549636841
3847,6872,UACC-257,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,-35,-58,-52,-54,-46,-48,-38","18.7,1.99,11.2,3.68,.16,8.58,.013,2.58",8,Constant,,8.0,-47.93900299,3.6187,UACC257_SKIN,UACC257,ACH-000579,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.0239205360412598
3848,6873,UACC-62,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-37,-65,-83,-80,-80,-77,-79","6.02,9.05,3.00,.54,1.13,.32,4.29,2.57",8,Sigmoid,0.018216051,0.015443877,-79.99285889,5.3255,UACC62_SKIN,UACC62,ACH-000425,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.170542664869826,-2.7303078174591064
3849,6874,UACC-812,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-54,-45,-72,-75,-61,-68,-56,-65","11.5,44.9,9.52,5.74,3.83,5.43,9.23,8.42",8,Constant,,0.002542614,-61.24596405,4.0004,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.9745625932886295,-1.3091017007827759
3850,6875,UM-UC-3,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-49,-75,-82,-85,-89,-90,-84","3.57,1.94,1.37,2.71,.55,.59,2.98,1.00",8,Sigmoid,0.007703873,0.008238792,-87.16121674,5.4626,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.79890154774962,-3.3148765563964844
3851,6876,VMRC-RCW,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-23,-8.1,-20,.69,-14,-13,-25","8.98,9.08,7.47,15.5,6.76,4.08,4.54,9.85",8,Constant,,8.0,-14.51786041,1.0722,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,2.0794415416798357,-2.8225860595703125
3852,6877,VMRC-RCZ,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-46,-25,-43,-47,-69,-64,-70,-64","15.9,13.2,19.3,14.2,10.3,3.44,1.72,.35",8,Sigmoid,0.08903899,0.087297022,-66.42607117,3.9578,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.4384389289750033,-2.6458821296691895
3853,6878,WM-115,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-19,-40,-50,-57,-63,-64,-69",".37,3.96,.047,.044,6.73,.48,4.05,6.25",8,Sigmoid,0.032111879,0.077774294,-65.39766693,3.5617,WM115_SKIN,WM115,ACH-000304,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-2.553944313706689,-2.6800734996795654
3854,6879,WM1799,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-44,-49,-57,-71,-70,-70,-68","5.66,.67,7.65,2.13,3.76,5.28,2.29,1.14",8,Sigmoid,0.008638385,0.020549456,-70.30335999,4.8909,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.8849208104097483,-3.274097204208374
3855,6880,WM-266-4,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,-45,-59,-56,-61,-63,-64,-57","19.7,9.14,.56,.81,4.34,3.63,.51,5.56",8,Sigmoid,0.010119976,0.010564829,-60.36123657,4.0908,WM2664_SKIN,WM2664,ACH-001239,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.550224813563324,-2.8485634326934814
3856,6881,WM-793,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-54,-51,-58,-75,-77,-78,-80,-80","22.7,1.16,14.4,5.80,.62,8.43,1.62,3.33",8,Sigmoid,0.033615757,0.009883286,-79.16955566,5.6275,WM793_SKIN,WM793,ACH-000827,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.6169102314254005,-2.1499156951904297
3857,6882,WM-88,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-43,-55,-64,-64,-71,-70,-69,-61","1.82,1.84,.75,.26,.90,3.36,.94,4.42",8,Sigmoid,0.005297495,0.005031998,-67.70186615,5.0682,WM88_SKIN,WM88,ACH-000899,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.291938157040357,-2.4614853858947754
3858,6883,WM-983B,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,-17,-52,-75,-87,-91,-88,-87","17.6,52.7,40.0,18.9,7.20,6.35,7.52,5.01",8,Sigmoid,0.007726429,0.007563737,-88.65149689,5.6824,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.884389898753398,-3.1439759731292725
3859,6884,YKG1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-42,-77,-79,-88,-91,-90,-85","5.68,2.82,.67,3.05,2.42,1.04,.92,1.72",8,Sigmoid,0.011588358,0.010191021,-87.56375885,5.5701,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-4.586248240495961,-2.782158374786377
3860,6885,ZR-75-1,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-64,-79,-79,-66,-70,-75,-54","20.5,3.58,4.71,3.56,10.4,7.20,1.30,3.95",8,Sigmoid,0.006129042,0.005975602,-72.4180069,4.4743,ZR751_BREAST,ZR751,ACH-000097,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.120070433101744,-2.4612419605255127
3861,6886,ZR-75-30,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-22,-51,-54,-53,-58,-44,-43","16.3,1.72,22.8,6.02,5.33,7.39,15.7,1.03",8,Sigmoid,0.013243685,0.028183434,-50.68854904,2.1929,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-3.569020920461061,-1.7660913467407227
3862,6887,SCC-25,Paclitaxel,TUBB1,".0025,.0080,.025,.080,.25,.80,2.53,8","-47,-85,-92,-94,-93,-94,-93,-96","30.2,4.21,1.15,.22,1.68,.89,.032,3.34",8,Sigmoid,0.003618645,0.0025,-93.95719147,6.8063,SCC25_UPPER_AERODIGESTIVE_TRACT,SCC25,ACH-000188,Head and Neck Cancer,21,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,Taxol,beta-tubulin ,Microtubule-Stabilizing Agents,Cytotoxic,Launched-1993,Bristol-Myers Squibb,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,-5.991464547107982,-3.0434203147888184
3863,6888,A172,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.3,-.70,-.54,-1.3,-12,-8.1,-7.6,-16","2.60,13.4,7.45,5.86,3.58,5.59,4.22,.99",8,Constant,,8.0,-6.786345482,0.2375,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.527226209640503
3864,6889,A-204,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,6.63,-11,3.21,-2.6,-5.0,-7.0,-18",".16,3.90,8.23,4.83,6.08,2.11,6.97,17.1",8,Constant,,8.0,-5.755045414,0.117,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.4552669525146484
3865,6890,A2058,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-7.9,-7.6,-8.5,-27,-38,-51,-50",".89,4.47,11.7,5.69,5.36,2.55,4.87,1.22",8,Sigmoid,0.346551329,5.036472321,-50.57911682,1.8154,A2058_SKIN,A2058,ACH-000788,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.6167059007039726,1.9422615766525269
3866,6891,A-253,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,-8.7,-.60,-2.2,-16,-18,-41,-48",".14,2.08,3.80,3.16,5.19,2.88,3.20,2.99",8,Sigmoid,1.226856112,8.0,-48.80519485,1.548,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.332516670227051
3867,6892,A2780,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-15,-15,-11,-37,-39,-62,-71","3.91,14.1,13.1,14.7,9.30,8.58,2.49,1.33",8,Sigmoid,1.164510131,1.579616904,-70.35791779,2.5348,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.45718235181650074,2.672492504119873
3868,6893,A-375,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,-3.2,-10,-39,-71,-74,-77,-75","6.75,6.26,3.17,2.73,1.64,.21,1.75,.78",8,Sigmoid,0.081431821,0.106830887,-75.80161285,3.2996,A375_SKIN,A375,ACH-000219,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.2365081901476427,1.7445253133773804
3869,6894,A549,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,-9.9,-5.5,-16,-28,-43,-46,-74","3.48,.85,0,1.71,4.11,2.93,1.68,.27",8,Sigmoid,8.680621804,2.122098207,-72.34332275,1.8637,A549_LUNG,A549,ACH-000681,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.75240531951674,2.546499729156494
3870,6895,A-673,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,-15,-15,-11,-14,-22,-26,-25","20.0,3.21,18.3,15.2,4.60,12.7,4.85,3.28",8,Constant,,8.0,-19.37708282,1.3769,A673_BONE,A673,ACH-000052,Bone Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0304934978485107
3871,6896,ACHN,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.9,-6.8,-2.4,-11,-14,-21,-30,-36","1.94,.92,6.76,5.51,3.09,10.5,2.88,2.54",8,Sigmoid,0.888495207,8.0,-35.66556931,0.6881,ACHN_KIDNEY,ACHN,ACH-000046,Kidney Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.425544261932373
3872,6897,ALL-SIL,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,-4.7,-2.8,1.37,-15,-15,-35,-34","8.09,18.0,10.9,10.5,1.80,16.1,3.34,5.68",8,Sigmoid,0.379500955,8.0,-35.05550766,1.2336,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9748423099517822
3873,6898,AMO-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-5.8,-21,-13,-17,-21,-32,-42","17.1,16.2,17.4,15.9,4.74,10.4,7.31,7.31",8,Sigmoid,8.296634545,8.0,-42.45096588,1.6147,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.187101364135742
3874,6899,AsPC-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-7.3,-27,-3.2,-41,-44,-59,-77","21.7,5.06,6.65,5.74,8.38,3.19,1.74,2.82",8,Sigmoid,2.141568422,1.271577716,-72.31533051,2.1312,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.24025842552222135,2.5128931999206543
3875,6900,AU565,AZD6244,MEK,".0080,.025,.080,.25,.80,2.53,8","-2.5,-4.2,5.97,10.8,15.4,11.3,12.4","9.86,12.8,7.65,11.6,15.6,11.4,3.05",7,Constant,,8.0,4.667366028,0.09979,AU565_BREAST,AU565,ACH-000248,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.904073715209961
3876,6901,B-CPAP,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,-3.0,-7.2,-13,-27,-28,-42,-44","2.76,2.37,.67,3.07,16.9,13.1,5.62,4.56",8,Sigmoid,0.310981452,8.0,-44.48633194,2.518,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.3771684169769287
3877,6902,BDCM,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,4.86,-8.2,-12,-32,-51,-55,-48","4.58,1.41,1.91,28.1,10.3,5.31,.23,1.06",8,Sigmoid,0.240021586,0.465061456,-51.57645798,1.4573,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.7655857186867386,3.114926815032959
3878,6903,BFTC-909,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".27,-3.1,-8.9,-15,-8.0,-5.5,-16,-19","1.13,6.43,5.02,2.35,.41,4.33,.82,.35",8,Constant,,8.0,-8.290857315,0.3552,BFTC909_KIDNEY,BFTC909,ACH-000792,Kidney Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.3699357509613037
3879,6904,BL-41,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,.049,-8.6,4.39,.29,9.78,-.70,5.78","5.37,6.89,1.48,8.61,3.54,3.98,7.13,6.08",8,Constant,,8.0,0.196135953,0.05747,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.1532304286956787
3880,6905,BL-70,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.4,15.4,-.75,5.09,1.00,17.5,-11,-2.5","19.9,2.14,12.9,1.75,17.2,6.38,29.1,5.74",8,Constant,,8.0,6.073829174,0.113,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.209522247314453
3881,6906,BT-20,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.3,-.28,10.9,6.74,11.5,-11,-1.3,-4.2","25.8,18.6,15.3,15.0,6.85,1.30,1.87,5.42",8,Constant,,8.0,-0.317550689,0.01832,BT20_BREAST,BT20,ACH-000536,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0653114318847656
3882,6907,BT-474,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,-19,-11,-7.6,2.35,2.61,-4.6,.74","4.75,30.3,7.70,1.51,16.8,10.5,11.5,21.5",8,Constant,,8.0,-6.134223938,0.1287,BT474_BREAST,BT474,ACH-000927,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.6724109649658203
3883,6908,BT-549,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.089,-18,9.51,-8.3,8.75,-15,-7.1,-9.6","3.80,1.00,13.6,8.94,5.27,1.59,20.5,13.3",8,Constant,,8.0,-2.473997831,0.2601,BT549_BREAST,BT549,ACH-000288,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.069817543029785
3884,6909,BxPC-3,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,4.79,-19,-3.0,-35,-39,-45,-58","7.12,15.0,26.9,8.85,5.25,.96,1.03,.61",8,Sigmoid,0.217092425,8.0,-46.88585663,1.9699,BXPC3_PANCREAS,BXPC3,ACH-000535,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7503650188446045
3885,6910,C2BBe1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","17.5,-13,-5.4,-8.0,-16,-51,-43,-53","16.3,13.9,29.0,6.28,23.0,2.50,10.6,1.52",8,Sigmoid,0.30483374,8.0,-49.42071152,1.6091,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6916351318359375
3886,6911,C32,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.50,-.77,8.98,-9.1,-26,-30,-67,-74","7.89,1.64,32.1,14.4,23.2,2.73,.036,5.37",8,Sigmoid,0.982823133,1.360162973,-74.78160095,1.8523,C32_SKIN,C32,ACH-000580,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.307604525656785,2.071495532989502
3887,6912,CAL-12T,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-1.3,-19,-17,1.00,-24,-42,-66","6.31,4.60,9.76,3.37,1.12,9.01,9.79,.064",8,Sigmoid,2.367756367,3.317574024,-65.39175415,1.2348,CAL12T_LUNG,CAL12T,ACH-000826,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.1992338001629312,2.743253231048584
3888,6913,CAL 27,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,-12,-12,-24,-45,-55,-64,-68",".74,6.38,1.62,1.87,3.07,1.53,4.84,.88",8,Sigmoid,0.172338858,0.437977016,-67.19600677,2.3452,CAL27_UPPER_AERODIGESTIVE_TRACT,CAL27,ACH-000832,Head and Neck Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.8255888448683907,2.7533702850341797
3889,6914,CAL-85-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,-6.9,-3.7,-17,-36,-34,-40,-67","5.12,13.0,6.89,17.6,3.78,.046,3.51,7.99",8,Sigmoid,8.430301747,3.014279604,-63.81671143,1.7048,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.103360864315648,2.9623546600341797
3890,6915,Calu-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,-10,-15,-22,-34,-32,-39,-40","11.5,4.75,.016,1.05,2.16,.43,9.82,7.34",8,Sigmoid,0.057250198,8.0,-38.89622116,1.6146,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0460638999938965
3891,6916,Calu-3,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-24,-12,-27,-24,-25,-32,-50","14.1,7.93,6.56,0,21.8,4.74,13.6,18.0",8,Sigmoid,8.619947882,8.0,-49.1544342,2.3689,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0479373931884766
3892,6917,Calu-6,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,10.5,1.88,11.4,-17,-31,-45,-58","14.4,5.65,2.30,25.4,1.43,12.9,5.41,10.5",8,Sigmoid,0.754195035,3.664028168,-56.57898331,1.5986,CALU6_LUNG,CALU6,ACH-000264,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.2985631345552588,2.4396557807922363
3893,6918,CAMA-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,-1.5,-6.8,-9.4,-7.2,3.55,-9.8,-1.5",".12,6.50,8.49,5.91,1.59,4.67,4.40,8.69",8,Constant,,8.0,-6.486790657,0.06316,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.147977828979492
3894,6919,Capan-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,3.22,-10,-4.1,-41,-47,-56,-51","43.1,16.7,14.1,27.9,17.2,10.5,15.7,6.85",8,Sigmoid,0.243209943,0.503727555,-51.18845749,1.5237,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.6857197225451503,2.865196466445923
3895,6920,CAS-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,-.64,-8.2,-4.8,2.08,-4.5,-5.8,-19","4.42,1.57,1.62,11.4,7.38,3.07,1.34,1.80",8,Constant,,8.0,-5.734571457,0.103,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9675488471984863
3896,6921,CCK-81,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","12.0,11.1,-17,-31,5.39,-49,-41,-55","38.2,46.1,6.45,18.9,18.4,4.90,11.1,21.9",8,Constant,,8.0,-20.42794991,2.0146,CCK81_LARGE_INTESTINE,CCK81,ACH-000963,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.908496618270874
3897,6922,CHP-212,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-29,-71,-79,-83,-84,-89,-90","5.43,20.0,1.35,7.18,1.77,4.62,3.23,6.05",8,Sigmoid,0.01387505,0.011546331,-86.20879364,5.5723,CHP212_AUTONOMIC_GANGLIA,CHP212,ACH-000120,Neuroblastoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-4.461387554817365,2.4802370071411133
3898,6923,CI-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","32.5,19.1,23.9,5.64,-21,42.1,-39,24.5","49.2,2.66,50.3,60.0,11.5,22.0,2.42,9.40",8,Constant,,8.0,17.78594398,0.5656,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8463730812072754
3899,6924,COLO-320,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,4.34,2.07,-.95,5.20,2.87,3.29,-1.3","3.98,.42,8.95,9.41,.53,1.00,.92,1.20",8,Constant,,8.0,3.107025623,0.02962,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.918933868408203
3900,6925,COLO-678,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.2,7.98,-22,-15,-29,-34,-46,-49","23.7,5.10,4.21,8.04,3.07,3.58,4.07,.95",8,Sigmoid,0.002542614,8.0,-49.41535568,1.8733,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.831688165664673
3901,6926,COLO-679,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,4.59,-12,-40,-63,-73,-73,-80","16.2,7.30,14.8,4.43,.19,.40,1.63,.41",8,Sigmoid,0.071850047,0.123343363,-76.42716217,3.3142,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.092783243696779,2.217517614364624
3902,6927,COLO 741,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.24,25.2,-22,-14,-12,-34,-53,-65","21.9,5.38,2.22,4.30,8.10,9.35,1.05,2.02",8,Sigmoid,8.138255578,2.675052404,-66.02548981,2.4876,COLO741_SKIN,COLO741,ACH-000582,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.9839689704364567,2.3408617973327637
3903,6928,COR-L105,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-30,-3.4,-1.0,.72,-21,-33,-49","16.7,15.6,26.1,8.30,28.5,4.03,20.0,5.97",8,Linear,,8.0,-48.05744553,1.1293,CORL105_LUNG,CORL105,ACH-000161,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0605268478393555
3904,6929,COR-L23,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,-4.9,-4.3,-.68,.72,2.25,.86,-5.1","1.41,2.31,3.00,2.41,2.23,8.76,3.77,5.75",8,Constant,,8.0,-1.826972842,0.02408,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9778571128845215
3905,6930,COV318,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,9.09,3.67,8.76,8.05,4.39,3.69,5.99",".34,7.64,8.17,17.5,21.2,8.50,3.08,17.7",8,Constant,,8.0,2.819116354,0.07562,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.3116939067840576
3906,6931,COV504,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,2.18,-8.3,.33,-6.7,-18,-19,-28","11.6,15.9,17.8,12.0,.67,12.2,21.4,6.75",8,Constant,,8.0,-8.051746368,0.1949,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9139504432678223
3907,6932,Daoy,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,-.22,-5.2,-7.5,2.87,1.29,-14,-11","1.83,15.2,16.2,35.0,6.73,14.5,16.5,16.7",8,Constant,,8.0,-5.535102844,0.3316,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5709047317504883
3908,6933,DBTRG-05MG,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,-2.1,-21,-33,-52,-52,-53,-51","3.64,6.04,16.0,6.16,12.9,11.4,17.5,9.23",8,Sigmoid,0.054482624,0.329752356,-52.94559097,3.1418,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.1094133426035653,2.6695570945739746
3909,6934,Detroit 562,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-4.8,-6.0,-11,-6.7,-21,-37,-20",".75,12.9,11.5,4.70,9.43,3.90,9.31,6.00",8,Sigmoid,0.700736642,8.0,-28.42326736,1.0097,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6489877700805664
3910,6935,DK-MG,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.37,-2.1,-16,-17,-18,-19,-34,-32","8.74,2.29,3.08,3.23,1.64,2.63,2.00,4.76",8,Sigmoid,0.040257901,8.0,-31.77108955,1.1426,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7449870109558105
3911,6936,DMS 114,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.10,-1.1,-7.5,-12,-5.6,-13,-8.3,-5.7","5.90,8.37,3.90,8.45,.039,9.29,.057,7.84",8,Constant,,8.0,-6.638475418,0.7486,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.5773706436157227
3912,6937,DOHH-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,1.13,14.9,-4.5,-24,42.3,-4.3,28.2","1.30,1.20,32.4,28.6,8.87,57.2,6.26,32.0",8,Constant,,8.0,0.080330104,0.1338,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.2909770011901855
3913,6938,DV-90,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-2.6,-6.5,-45,-39,-44,-70,-77",".64,71.6,43.6,18.5,11.7,25.7,9.34,3.22",8,Sigmoid,1.395704269,1.040045857,-76.96092987,3.5067,DV90_LUNG,DV90,ACH-000925,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.039264805450432406,2.755504608154297
3914,6939,EB1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.54,17.9,26.6,42.1,53.4,16.5,9.62,6.72","6.78,13.5,6.17,47.8,3.21,27.3,32.9,3.59",8,Constant,,8.0,17.28858948,0.0,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.986863851547241
3915,6940,EBC-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,-.64,-4.3,-11,-29,-45,-75,-88","1.03,.34,17.1,1.71,6.08,9.16,.0027,.69",8,Sigmoid,0.703030765,0.73845458,-87.62164307,2.6304,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.30319568194880886,2.765040397644043
3916,6941,EFE-184,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.4,-4.2,-10,-7.6,-24,-20,-29,-28","6.11,9.02,1.13,18.7,3.51,18.2,4.17,7.46",8,Sigmoid,0.174795464,8.0,-28.27580833,1.1417,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0249686241149902
3917,6942,EFM-19,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.7,6.58,-8.8,5.79,.88,11.6,10.1,14.4","4.74,.26,15.9,11.5,20.5,13.5,10.6,13.7",8,Constant,,8.0,6.579556465,0.0802,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.2726471424102783
3918,6943,EFO-21,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-1.1,-9.2,.48,-16,-6.8,-22,-34","1.15,3.29,9.19,10.2,.20,8.35,3.34,10.7",8,Sigmoid,2.48457551,8.0,-33.81333542,0.8452,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.94150710105896
3919,6944,EFO-27,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,3.54,.33,1.59,-1.9,-.33,-17,-32","7.36,.89,2.95,7.56,.34,8.72,5.51,3.72",8,Sigmoid,2.535234451,8.0,-32.41779709,0.3168,EFO27_OVARY,EFO27,ACH-000936,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.4772703647613525
3920,6945,EM-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,-26,-15,-34,-50,-57,-63,-74","26.2,6.16,8.91,7.81,3.00,3.05,2.71,2.84",8,Sigmoid,0.315507233,0.38364476,-71.395401,3.654,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.9580382587340266,3.0806021690368652
3921,6946,EN,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,4.09,-6.3,-5.5,-7.2,2.09,-12,-5.6",".21,3.93,4.40,5.41,.36,6.00,3.33,1.85",8,Constant,,8.0,-6.914192677,0.2629,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0498292446136475
3922,6947,ES-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,5.77,4.19,-.45,-37,-46,-58,-67","4.62,5.10,.15,1.93,4.86,4.05,3.28,.32",8,Sigmoid,0.238065839,0.634661794,-61.4666214,1.9236,ES2_OVARY,ES2,ACH-000906,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.4546630298494168,2.4584035873413086
3923,6948,ESS-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.72,4.74,-4.8,-15,15.5,3.26,-5.4,-23","10.2,.27,.25,2.30,8.94,.20,6.44,.77",8,Sigmoid,8.531389394,8.0,-23.37719727,0.5129,ESS1_ENDOMETRIUM,ESS1,ACH-000913,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6085727214813232
3924,6949,F-36P,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-26,-2.6,-26,-46,-48,-65,-60,-57","4.90,5.19,4.80,1.34,6.67,6.69,.45,8.21",8,Sigmoid,0.050896905,0.116800621,-58.94649506,3.2726,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.1472868918213224,3.0532774925231934
3925,6950,FaDu,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-7.4,-14,-33,-33,-49,-52,-45","10.8,12.7,1.73,.85,14.8,3.32,7.63,.23",8,Sigmoid,0.042181518,8.0,-47.05667877,2.4745,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.615966796875
3926,6951,FU97,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.63,-4.2,8.63,-.97,-5.4,-25,-46,-52","4.16,20.8,1.13,4.45,21.6,11.7,15.3,3.41",8,Sigmoid,0.840691864,4.365504265,-52.3157959,1.0491,FU97_STOMACH,FU97,ACH-000633,Gastric Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.4737337072468302,2.4597811698913574
3927,6952,FU-OV-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.88,-22,-26,-21,-25,-35,-23,-37","5.19,17.0,13.3,2.85,2.70,10.1,9.46,11.6",8,Sigmoid,0.002542614,8.0,-27.35128975,1.8458,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8122024536132812
3928,6953,G-361,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-3.4,-2.1,3.04,-44,-57,-81,-79","13.1,8.88,21.5,.88,13.5,7.23,2.51,1.02",8,Sigmoid,0.321054727,0.419003129,-78.39828491,2.7378,G361_SKIN,G361,ACH-000572,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.8698768913074535,1.8845839500427246
3929,6954,G-401,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-.31,-26,-12,-23,-10,-29,-30","14.7,3.35,6.22,7.94,.22,5.26,5.66,2.70",8,Constant,,8.0,-22.46729088,1.9268,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.457031011581421
3930,6955,G-402,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,2.16,-12,-11,-11,-13,-13,-8.7","16.5,5.57,33.0,8.27,16.4,3.00,13.0,2.81",8,Constant,,8.0,-8.669466019,0.06311,G402_SOFT_TISSUE,G402,ACH-000375,Kidney Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.641723155975342
3931,6956,GAMG,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,3.79,-8.6,10.7,-6.9,3.45,6.85,-12","8.61,24.2,1.20,23.1,21.9,8.93,26.7,3.43",8,Constant,,8.0,-8.597065926,0.2266,GAMG_CENTRAL_NERVOUS_SYSTEM,GAMG,ACH-000098,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8852903842926025
3932,6957,GB-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,12.8,5.58,-2.6,-4.0,-19,-17,-31","11.5,20.8,7.48,16.8,23.1,3.00,28.7,11.5",8,Sigmoid,0.586713016,8.0,-29.85169792,0.6831,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8931124210357666
3933,6958,GCT,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","24.0,-2.5,24.5,-11,-2.8,-41,-18,-40",".38,5.61,2.03,1.95,8.42,4.05,3.57,5.94",8,Sigmoid,0.158939824,8.0,-34.46195602,1.3028,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5594637393951416
3934,6959,GI-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.07,21.2,-9.1,-26,6.81,.73,-14,-21","17.2,16.2,2.38,3.71,8.99,11.1,8.44,3.50",8,Constant,,8.0,-7.856185913,0.6094,GI1_CENTRAL_NERVOUS_SYSTEM,GI1,ACH-000756,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.560903549194336
3935,6960,GMS-10,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-4.2,-11,-4.3,-.60,2.78,-18,-11","7.08,22.2,8.31,11.1,5.27,8.57,1.44,26.9",8,Constant,,8.0,-5.721827984,0.2219,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6872010231018066
3936,6961,GRANTA-519,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,8.24,-6.5,52.1,-19,1.41,-18,2.04","5.73,15.9,3.53,7.00,8.27,15.7,26.9,6.45",8,Constant,,8.0,-2.316222668,0.5534,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.1182265281677246
3937,6962,H4,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-1.1,-1.7,4.10,5.14,8.22,3.94,1.15",".013,3.48,2.84,1.08,1.31,1.55,2.39,.97",8,Constant,,8.0,2.069390297,0.2843,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7475128173828125
3938,6963,HARA,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-7.1,-3.3,2.78,-5.8,2.00,-3.7,-18","4.25,1.17,9.78,18.2,5.15,8.24,7.00,11.4",8,Constant,,8.0,-8.11948967,0.2773,HARA_LUNG,HARA,ACH-000843,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.64363169670105
3939,6964,HCC1187,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,-14,10.2,-14,1.13,-14,-13,-23","3.00,10.9,3.62,2.13,24.4,.19,19.6,2.63",8,Constant,,8.0,-12.9724617,0.4582,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.4110212326049805
3940,6965,HCC1395,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.92,23.1,-18,-22,8.98,-5.0,-.34,-21","21.0,1.70,2.73,14.5,10.2,.39,6.08,3.20",8,Constant,,8.0,-5.003770828,0.6753,HCC1395_BREAST,HCC1395,ACH-000699,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8117117881774902
3941,6966,HCC-15,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.2,9.62,-5.0,7.42,-23,-13,-35,-39","30.1,6.70,16.5,4.53,12.6,11.5,22.0,3.61",8,Sigmoid,8.147726577,8.0,-39.78074265,1.4084,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7979612350463867
3942,6967,HCC1569,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,-.45,12.6,.34,-3.2,-11,2.76,-9.9","6.97,22.1,3.80,4.32,.53,1.94,2.91,3.63",8,Constant,,8.0,-3.208449364,0.0,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.256232500076294
3943,6968,HCC1806,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.32,-5.3,-14,-19,-29,-34,-48,-38","5.62,7.88,11.3,8.95,11.6,21.3,.29,7.97",8,Sigmoid,0.08744017,8.0,-43.23558044,1.6198,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0279598236083984
3944,6969,HCC1954,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,2.20,-12,4.56,-18,-12,-21,-32",".76,9.6e-4,34.2,2.21,7.20,5.86,.42,6.05",8,Constant,,8.0,-10.6373682,0.9032,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.2591004371643066
3945,6970,HCC2935,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,-2.8,-14,2.70,-22,-18,-38,-33","37.7,31.2,10.5,6.95,6.07,21.5,9.11,6.76",8,Constant,,8.0,-22.45702362,0.7347,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.027210235595703
3946,6971,HCC4006,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,14.8,5.48,3.05,.59,-3.1,-19,-38","6.78,3.27,3.14,6.48,4.03,6.13,3.41,11.2",8,Sigmoid,4.118072033,8.0,-37.92431259,0.1997,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.088165760040283
3947,6972,HCC-44,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,-3.1,-6.6,-7.5,-7.9,-5.8,-14,-28","6.59,11.6,3.04,11.2,4.32,12.3,8.48,13.2",8,Sigmoid,2.866830111,8.0,-27.23424911,0.7028,HCC44_LUNG,HCC44,ACH-000667,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.808899164199829
3948,6973,HCC-56,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,-16,-15,-33,-66,-81,-80,-87","6.59,16.6,6.41,4.84,5.38,8.84,1.92,2.44",8,Sigmoid,0.124425307,0.141207814,-84.3340683,3.7803,HCC56_LARGE_INTESTINE,HCC56,ACH-000467,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.957522615510851,2.5366806983947754
3949,6974,HCC70,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-9.0,3.64,-16,-19,-19,-7.7,-35","14.6,10.2,7.70,11.4,26.1,27.4,47.3,29.3",8,Sigmoid,0.125415251,8.0,-46.66360855,1.2257,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.220480442047119
3950,6975,HCC-78,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,3.84,.80,-6.7,-7.5,-5.1,-13,-10","9.36,5.58,4.06,4.44,7.24,7.47,1.44,14.1",8,Constant,,8.0,-3.190572977,0.1545,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.081399440765381
3951,6976,HCC827,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,32.5,-7.0,25.7,30.0,9.49,-.97,6.60","8.66,34.0,2.92,16.2,56.1,36.5,.86,7.03",8,Constant,,8.0,1.289733052,0.0,HCC827_LUNG,HCC827,ACH-000012,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.834970712661743
3952,6977,HCT 116,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-6.9,7.19,-6.2,-25,-13,-52,-69","12.3,18.7,13.3,30.7,33.4,15.9,25.7,10.8",8,Linear,,0.518957612,-70.17031097,1.9489,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.6559330715986378,2.5234177112579346
3953,6978,HCT-15,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,9.34,-6.8e-4,-10,-9.5,-10,-8.7,-17","3.47,1.20,14.6,2.06,1.15,5.96,11.6,3.61",8,Constant,,8.0,-9.873037338,0.6149,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.598820209503174
3954,6979,HD-MY-Z,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-13,-13,-26,-51,-62,-73,-81","14.2,4.55,2.50,5.40,1.16,1.44,1.28,.52",8,Sigmoid,0.24595207,0.312553406,-79.01248932,2.7557,HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HDMYZ,ACH-000190,Unknown,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.1629799252072857,2.5948119163513184
3955,6980,HDQ-P1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-13,-3.3,-12,-26,-16,-43,-38","5.57,7.35,9.25,19.7,3.74,11.5,11.2,9.14",8,Sigmoid,0.74307102,8.0,-39.95902634,1.4415,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.141605854034424
3956,6981,HEC-151,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-27,-32,-29,-48,-45,-65,-62","9.00,5.04,13.9,6.77,13.1,3.50,13.0,5.91",8,Sigmoid,1.463135958,0.881319225,-64.01053619,3.233,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.12633537474930961,2.3441758155822754
3957,6982,HEC-1-A,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".79,-5.9,6.62,-15,-5.6,-15,-.29,-37","1.28,22.1,16.6,32.8,26.6,5.72,2.37,16.0",8,Constant,,8.0,-3.167937994,1.0471,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.586618661880493
3958,6983,HEC-1-B,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-8.7,-30,-42,-48,-45,-47,-48","10.0,6.76,2.06,11.4,4.68,16.3,5.42,7.72",8,Sigmoid,0.023842728,8.0,-47.00248337,2.2178,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.568265438079834
3959,6984,HEC-251,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-14,-12,-22,-44,-6.3,-17,-25","4.76,2.55,23.1,12.6,14.8,2.71,14.0,5.33",8,Constant,,8.0,-23.85111427,1.3455,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.969541072845459
3960,6985,HEC-265,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,2.63,.17,12.3,12.0,21.0,5.90,17.6","15.4,9.25,9.34,2.71,5.98,3.02,2.68,10.7",8,Constant,,8.0,8.393115997,0.07603,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.482914447784424
3961,6986,HEC-59,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,9.59,3.41,16.8,-7.8,-6.8,-8.6,-15","10.7,7.83,2.42,5.04,4.32,11.9,6.65,3.07",8,Constant,,8.0,-1.47577548,0.03026,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.790099620819092
3962,6987,HEC-6,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","22.5,18.5,35.5,4.50,14.4,-1.8,17.8,-15","44.4,2.21,14.1,21.6,52.6,22.1,85.5,7.46",8,Constant,,8.0,14.97769356,0.3154,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8976731300354004
3963,6988,HEL 92.1.7,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,-11,.64,-3.6,2.59,3.73,-5.8,-19",".88,28.1,5.23,11.0,.86,17.9,1.91,3.27",8,Constant,,8.0,-5.48204565,0.6032,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8981945514678955
3964,6989,Hep 3B2.1-7,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,9.05,-5.1,13.1,.063,-2.2,-28,-68",".63,26.1,.072,12.7,3.05,.73,.93,2.48",8,Sigmoid,2.789827347,3.375251055,-67.87160492,1.026,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.216469708224609,2.841623306274414
3965,6990,Hep G2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,-19,-7.8,-40,-52,-54,-72,-70","3.16,6.00,30.3,8.78,6.96,1.26,6.06,4.39",8,Sigmoid,0.00298507,0.24894993,-71.26669312,3.0232,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.3905034870749449,2.4891510009765625
3966,6991,Hey-A8,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,-.82,-7.7,-6.4,-22,-25,-35,-51","5.34,4.79,7.93,8.28,4.30,4.79,2.80,.61",8,Sigmoid,8.387392594,7.457576275,-50.99153137,0.9399,HEYA8_OVARY,HEYA8,ACH-000542,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0092304653128923,2.285971164703369
3967,6992,HGC-27,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,-7.3,-.64,-.86,-.19,-1.8,7.64,6.35","3.00,1.14,.27,4.93,1.11,.27,4.90,3.12",8,Constant,,8.0,-0.873211443,0.08234,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.617852210998535
3968,6993,HH,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","18.1,.79,2.25,-.15,-18,.59,-10,14.1","19.3,18.5,13.6,2.66,12.6,16.0,8.57,7.49",8,Constant,,8.0,-0.154027432,0.8535,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9202420711517334
3969,6994,HLF,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-10,-9.5,-2.4,-9.8,-13,-16,-17","6.46,.70,15.1,7.11,14.5,4.42,10.6,7.41",8,Constant,,8.0,-11.37788582,1.1747,HLF_LIVER,HLF,ACH-000393,Liver Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.553396463394165
3970,6995,HMC-1-8,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-12,-18,-34,-51,-57,-63,-68",".083,1.93,2.99,2.40,.65,.28,.0049,3.66",8,Sigmoid,0.127403423,0.254361957,-64.56193542,2.9909,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.3689969987927442,2.754685163497925
3971,6996,HMCB,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,-4.2,.15,-2.7,-11,-11,-9.3,-29","1.40,1.74,4.08,4.81,.96,.12,4.55,8.85",8,Sigmoid,8.880482931,8.0,-27.87450981,0.4484,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.42326021194458
3972,6997,HOS,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".029,20.5,.40,24.2,-12,3.58,-6.4,-14","2.20,31.9,2.51,2.69,8.54,2.14,5.58,13.3",8,Constant,,8.0,-1.016309381,0.3858,HOS_BONE,HOS,ACH-000613,Bone Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.673515796661377
3973,6998,HPAC,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-15,-2.8,16.0,-37,-32,-71,-54","38.5,19.4,28.3,31.6,.85,4.63,5.48,17.7",8,Linear,,2.177905638,-62.80304337,2.1314,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.7783636985033403,2.7849016189575195
3974,6999,HPAF-II,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.2,-4.3,-16,8.72,-10,-46,-46,-57","5.46,11.0,2.26,26.8,17.0,32.9,9.65,.72",8,Linear,,3.959347245,-56.33869934,2.0653,HPAFII_PANCREAS,HPAFII,ACH-000094,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.3760791745580456,3.3375802040100098
3975,7000,Hs 294T,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,2.83,2.01,5.82,-18,-21,-37,-35","4.86,16.3,4.45,9.22,3.26,6.19,1.91,.81",8,Sigmoid,0.342419237,8.0,-36.21473312,1.0543,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.337402820587158
3976,7001,Hs 578T,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.57,-8.4,-6.4,-5.9,-13,-10,-22,-18","5.42,1.99,14.1,7.89,3.32,4.05,5.99,3.98",8,Constant,,8.0,-10.89676189,0.2979,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.635117769241333
3977,7002,Hs 683,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-2.5,-7.1,.23,-5.5,-5.7,-9.1,-7.4","5.33,8.38,2.67,14.2,7.62,3.16,8.20,7.58",8,Constant,,8.0,-3.527776957,0.4306,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.507995843887329
3978,7003,Hs 695T,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-2.9,9.15,1.86,-11,-32,-44,-49","31.5,7.33,16.7,1.82,2.37,4.25,1.62,.94",8,Sigmoid,0.518636703,8.0,-48.3859024,1.5491,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.597716808319092
3979,7004,Hs 729,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,13.1,-1.0,-6.4,6.62,3.05,-14,-16","1.56,12.7,1.18,10.3,7.63,5.20,1.63,9.08",8,Constant,,8.0,-1.115840793,0.5233,HS729_SOFT_TISSUE,HS729,ACH-000133,Unknown,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.72133207321167
3980,7005,Hs 746T,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,-16,-2.9,-15,-16,-33,-29,-51","19.6,7.81,18.3,2.38,1.42,10.1,.60,.75",8,Sigmoid,8.859736668,8.0,-49.99831009,1.5266,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7013068199157715
3981,7006,Hs 766T,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-26,-37,-32,-49,-54,-53,-54","4.14,1.53,3.86,3.12,.94,2.20,4.84,15.5",8,Sigmoid,0.002542614,0.65779978,-56.49887085,2.7227,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.418854679675397,2.5819787979125977
3982,7007,Hs 852.T,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.46,3.91,.87,-14,-30,-29,-30,-47","6.74,11.4,5.95,7.71,.38,3.42,4.08,7.41",8,Sigmoid,0.094172932,8.0,-35.7544899,1.3702,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5834484100341797
3983,7008,Hs 936.T,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,.61,-8.3,-20,-51,-66,-78,-80",".55,8.64,4.43,1.70,.18,1.38,2.28,2.43",8,Sigmoid,0.182331875,0.272241116,-79.4587326,2.825,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.3010671494737631,1.4119231700897217
3984,7009,Hs 939.T,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.5,-1.9,9.06,-33,-38,-54,-58,-71","5.32,9.23,7.87,5.24,2.83,4.16,5.05,4.51",8,Sigmoid,0.129027545,0.494374901,-65.75254822,2.5274,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.7044611407130833,2.0329432487487793
3985,7010,Hs 944.T,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,-4.2,-7.8,-22,-32,-47,-57,-68","6.46,4.62,7.80,1.28,.55,6.81,2.29,1.01",8,Sigmoid,0.528259277,1.176047325,-67.33055115,2.5552,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.1621590910136725,2.049612045288086
3986,7011,HSC-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,.48,1.05,3.88,8.06,6.87,8.44,-.70","6.07,8.39,4.45,1.84,6.11,.29,6.66,.78",8,Constant,,8.0,3.991785765,0.0567,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.662662982940674
3987,7012,HT,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.60,-8.5,11.5,-20,-25,-21,-8.6,-9.9","10.7,9.97,28.0,5.77,.66,7.15,4.01,2.78",8,Constant,,8.0,-11.52360344,1.5451,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.247112989425659
3988,7013,HT-1080,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-4.1,-.64,-8.2,-35,-47,-52,-59",".74,3.56,4.00,2.49,3.46,1.76,3.69,1.49",8,Sigmoid,0.21067825,0.739373982,-54.37378311,1.8734,HT1080_SOFT_TISSUE,HT1080,ACH-000054,Sarcoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.3019514210889797,2.152981996536255
3989,7014,HT-1197,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-13,-1.3,-9.9,-19,-31,-37,-42","3.49,8.43,4.65,4.89,1.34,.28,3.16,10.2",8,Sigmoid,0.335529506,8.0,-38.44807434,1.1711,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8905105590820312
3990,7015,HT-144,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.58,-5.9,-18,-30,-44,-57,-70,-71","10.7,1.95,9.43,8.54,10.0,6.38,4.11,2.14",8,Sigmoid,0.109943047,0.373916358,-72.63398743,2.8194,HT144_SKIN,HT144,ACH-000322,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.9837231482903717,2.04514479637146
3991,7016,HuCCT1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.38,-5.0,-7.1,-17,-25,-29,-36,-39",".94,5.58,5.37,6.82,2.58,9.54,.85,9.20",8,Sigmoid,0.109219298,8.0,-38.69515991,1.4631,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.734971523284912
3992,7017,huH-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,-13,3.03,-.25,1.71,-3.7,-8.4,-28","32.4,21.6,.46,8.98,7.63,8.08,3.45,14.9",8,Constant,,8.0,-4.747067451,0.1214,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5510218143463135
3993,7018,HUP-T3,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-.24,-2.6,-13,-33,-40,-46,-55","7.48,8.42,2.83,5.58,9.09,11.7,11.1,1.94",8,Sigmoid,0.2241676,1.915635943,-53.14979553,1.6739,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.6500496526220446,3.0882980823516846
3994,7019,HuT 78,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-15,-25,-56,-66,-69,-88,-88","18.1,26.2,3.19,12.8,25.4,4.38,2.04,1.89",8,Sigmoid,0.074428268,0.091557629,-87.24189758,4.2205,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.3907866798206605,2.9888052940368652
3995,7020,IA-LM,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.12,4.20,-8.2,-7.1,7.69,11.1,-2.5,15.0","5.59,15.8,29.6,25.5,30.1,43.6,25.5,29.0",8,Constant,,8.0,6.119959354,0.1423,IALM_LUNG,IALM,ACH-000672,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7016000747680664
3996,7021,IGR-37,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,-3.4,-20,-25,-57,-61,-77,-71","6.32,2.30,4.78,7.93,1.01,2.19,3.52,.017",8,Sigmoid,0.165571898,0.21325025,-71.51417542,3.6362,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.545288920278093,2.1467013359069824
3997,7022,IGR-39,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,11.5,-8.7,3.48,-19,-6.1,-24,-29","10.1,2.53,8.68,8.46,.48,14.1,13.0,.78",8,Sigmoid,2.692181587,8.0,-28.92397118,0.575,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.2707691192626953
3998,7023,IGROV1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-5.2,-1.2,-5.2,-7.1,-19,-21,-36","3.80,2.63,5.56,4.78,2.37,6.97,1.11,8.82",8,Sigmoid,8.158737239,8.0,-35.11797714,0.6622,IGROV1_OVARY,IGROV1,ACH-000966,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6115903854370117
3999,7024,IMR-32,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.4,25.2,-2.6,-13,-8.1,-3.1,-17,-8.4","12.9,26.2,9.55,3.47,20.8,7.20,22.2,3.68",8,Constant,,8.0,-6.967733383,0.192,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.223221778869629
4000,7025,IPC-298,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.4,-9.7,-25,-51,-74,-79,-81,-85","7.29,3.56,.64,.039,3.52,.98,.89,.79",8,Sigmoid,0.059587378,0.074961409,-82.6733017,3.8036,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.590781844537057,2.1700685024261475
4001,7026,IST-MES2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","12.8,-1.4,-6.5,20.5,10.1,11.6,4.18,-11","15.0,7.22,6.51,1.50,13.2,1.51,3.05,7.66",8,Constant,,8.0,3.087348223,0.2557,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8315720558166504
4002,7027,J82,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-8.6,5.22,-7.6,-14,-18,-7.5,-21","5.16,7.87,3.80,15.2,11.9,4.24,6.84,6.97",8,Constant,,8.0,-12.92778969,0.8117,J82_URINARY_TRACT,J82,ACH-000396,Bladder Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7465715408325195
4003,7028,JHH-4,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,-1.2,-13,13.3,2.04,19.9,-14,-50","3.93,15.9,.32,13.9,5.83,9.99,2.89,3.07",8,Sigmoid,3.032397509,8.0,-49.7089386,0.9964,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6474125385284424
4004,7029,JHOS-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.55,-18,-13,-12,-11,-11,-23,-45","46.8,17.7,23.5,27.0,4.71,11.8,9.67,6.90",8,Constant,,8.0,-17.97790527,1.2776,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.946674108505249
4005,7030,JHUEM-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.8,-5.8,16.2,2.41,15.3,-1.1,-4.2,-14","15.6,5.58,2.61,2.29,11.6,14.4,10.6,10.7",8,Constant,,8.0,3.391951323,0.1476,JHUEM2_ENDOMETRIUM,JHUEM2,ACH-000909,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5425310134887695
4006,7031,JM1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.4,-2.5,26.5,-16,16.7,-14,1.53,-28","7.05,16.7,17.9,6.07,.74,18.7,9.39,4.40",8,Constant,,8.0,-3.719245195,0.1883,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.1665616035461426
4007,7032,JMSU-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.56,-11,-7.9,-8.3,-18,-29,-32,-61",".26,10.8,3.38,15.6,5.42,11.2,2.05,.0053",8,Sigmoid,8.564432123,5.112239361,-58.40109634,1.3179,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.6316375393358622,3.0037758350372314
4008,7033,JURKAT,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-2.6,6.49,9.36,-8.5,1.34,-11,-12","11.6,28.0,11.8,.28,5.90,2.46,6.54,.31",8,Constant,,8.0,-4.331113338,1.273,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.1381733417510986
4009,7034,JVM-3,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-18,-29,-28,-42,-45,-43,-38","11.4,2.27,7.00,5.94,11.1,.084,5.86,1.42",8,Sigmoid,0.052935768,8.0,-41.96641159,3.1872,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.291926622390747
4010,7035,K029AX,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,-3.0,-7.9,-27,-46,-54,-60,-68","14.6,20.7,13.8,5.61,8.34,2.39,4.90,4.41",8,Sigmoid,0.151669219,0.459148288,-65.70117188,2.493,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.7783820535585455,2.0202627182006836
4011,7036,KALS-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.70,-7.8,.76,-17,-17,-22,-29,-38","12.9,10.7,3.46,17.5,14.3,7.60,9.47,8.32",8,Sigmoid,8.2340064,8.0,-37.43192673,1.2031,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8521642684936523
4012,7037,KARPAS-422,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","12.8,-7.2,-17,-3.6,-9.2,-9.4,-9.5,-11","1.07,9.21,2.47,9.71,.59,14.8,11.5,.20",8,Sigmoid,0.005511086,8.0,-10.29793644,0.7856,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.2213587760925293
4013,7038,KASUMI-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.64,-4.7,-11,-18,-27,-40,-31,-33","1.08,6.50,15.9,10.1,9.48,40.7,.55,4.21",8,Sigmoid,0.002542614,8.0,-32.26589584,1.9695,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.044938564300537
4014,7039,KCL-22,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.34,-13,-12,-27,-40,-59,-64,-68","2.51,5.57,17.6,4.67,4.31,4.53,9.70,3.34",8,Sigmoid,0.141707614,0.482571959,-69.53473663,3.1959,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.7286252314992019,2.948145866394043
4015,7040,KG-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.64,-12,17.9,-9.4,-7.1,-40,-49,-70","5.40,30.1,10.9,3.17,26.9,2.93,27.6,12.6",8,Sigmoid,0.597613811,1.402923942,-69.43467712,1.3541,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.33855858867437677,3.1798434257507324
4016,7041,KHM-1B,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,.26,-24,-11,-45,-39,-37,-40","5.26,14.8,14.1,20.4,8.23,1.02,3.88,19.5",8,Sigmoid,0.082825981,8.0,-39.75952911,2.674,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0814037322998047
4017,7042,KMBC-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,-.0033,3.93,-7.2,-11,-22,-39,-54","3.46,1.28,.40,3.95,9.30,11.7,5.07,19.6",8,Sigmoid,1.653790593,6.083213329,-52.71838379,1.2196,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.80553306442609,3.0243797302246094
4018,7043,KMM-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.81,-5.5,-5.4,-27,-25,-36,-42,-46","12.7,27.4,10.8,.032,.050,6.74,4.74,2.94",8,Sigmoid,0.061245881,8.0,-45.61710358,2.0524,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.2202224731445312
4019,7044,KMRC-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,6.38,-13,1.49,-25,-9.8,-27,-20","13.7,3.40,1.30,7.63,12.8,1.44,1.82,3.31",8,Constant,,8.0,-12.99727345,0.703,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.759483814239502
4020,7045,KMRC-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,14.9,-8.2,-4.2,-11,-5.6,-4.4,-15","12.2,0,16.0,8.06,.22,6.81,2.40,4.59",8,Constant,,8.0,-9.580644608,0.5113,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.4233689308166504
4021,7046,KMS-11,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.84,3.49,-2.6,6.87,-13,-20,-3.5,18.2","5.93,2.20,16.4,10.4,.73,22.0,10.3,18.8",8,Constant,,8.0,0.99601531,1.1922,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.113628387451172
4022,7047,KMS-12-BM,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,16.3,-12,-24,-7.2,-1.4,-15,-19","29.6,34.1,6.34,14.9,12.9,23.8,7.76,28.2",8,Constant,,8.0,-12.03760338,1.3018,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.195892810821533
4023,7048,KMS-34,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".84,.0020,12.5,4.63,-1.7,-23,8.28,1.63","0,0,0,0,0,0,0,0",8,Constant,,8.0,1.231874466,0.7945,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.278770923614502
4024,7049,KNS-60,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,-26,-10,-35,-6.1,-29,-12,-32","10.7,.31,7.93,3.03,9.26,4.41,12.9,13.0",8,Constant,,8.0,-22.018507,1.1826,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.805530548095703
4025,7050,KNS-62,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-5.7,-1.4,4.62,-16,-13,-44,-39","16.2,21.8,1.64,5.19,11.6,1.87,1.48,.59",8,Sigmoid,0.942772448,8.0,-41.88511276,1.1768,KNS62_LUNG,KNS62,ACH-000858,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.4748289585113525
4026,7051,KNS-81,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,-.64,.75,-2.3,-18,-11,-29,-24","16.7,2.21,9.72,.024,2.73,14.1,3.67,.82",8,Sigmoid,0.190897599,8.0,-25.16970634,1.062,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9351325035095215
4027,7052,KO52,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-41,-50,-56,-69,-66,-75,-73","5.36,5.68,5.19,8.31,.50,2.30,4.04,2.79",8,Sigmoid,0.028687166,0.026235208,-73.49414063,5.0531,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-3.6406529535348873,3.1818768978118896
4028,7053,KP-N-SI9s,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,4.24,-11,-9.3,-50,-56,-59,-62","8.62,.40,2.95,21.5,16.4,6.97,.96,2.59",8,Sigmoid,0.148042455,0.27292785,-59.62613678,2.9897,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.2985478044410868,2.8213863372802734
4029,7054,KU812,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.9,-11,1.90,-33,-58,-74,-84,-85","20.8,5.18,10.9,5.63,3.56,3.30,2.67,1.71",8,Sigmoid,0.140538454,0.180799469,-85.0256424,3.3419,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.7103667679752765,3.021095037460327
4030,7055,KYM-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,1.55,-5.7,5.15,10.8,-3.0,-19,-40","3.01,16.0,19.5,12.8,32.8,16.0,7.77,1.72",8,Sigmoid,2.674337626,8.0,-39.77814102,1.0501,KYM1_SOFT_TISSUE,KYM1,ACH-000607,Rhabdoid,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.267029285430908
4031,7056,KYSE-140,AZD6244,MEK,".025,.080,.25,.80,2.53,8","-3.0,8.80,-1.5,-8.6,-22,-28","5.04,18.2,4.98,10.8,2.75,8.30",6,Sigmoid,1.488470078,8.0,-28.30496407,0.1921,KYSE140_OESOPHAGUS,KYSE140,ACH-000823,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7988638877868652
4032,7057,KYSE-150,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.5,7.18,-5.5,.032,-1.8,.96,-1.2,-5.5","3.97,14.0,3.98,7.23,2.75,7.24,21.4,12.0",8,Constant,,8.0,-3.225860596,0.08227,KYSE150_OESOPHAGUS,KYSE150,ACH-000855,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.900529146194458
4033,7058,KYSE-180,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-6.1,-3.0,2.60,2.14,2.99,-14,-8.5","14.0,1.58,4.96,9.40,10.9,6.37,3.80,4.22",8,Constant,,8.0,-5.423886299,0.3191,KYSE180_OESOPHAGUS,KYSE180,ACH-000693,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7420568466186523
4034,7059,KYSE-30,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-7.8,-24,-30,-44,-48,-60,-64","3.29,8.04,1.49,7.92,2.95,6.84,1.03,3.90",8,Sigmoid,0.141638041,0.604180574,-64.30263519,3.1061,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.503882162151868,2.893378257751465
4035,7060,KYSE-510,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.76,-5.7,2.25,2.58,13.0,7.69,-4.8,-.36","13.6,4.97,9.68,12.5,2.46,6.61,9.31,7.85",8,Constant,,8.0,2.329567194,0.2195,KYSE510_OESOPHAGUS,KYSE510,ACH-000824,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7064099311828613
4036,7061,KYSE-520,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.79,2.93,-4.9,-13,-18,-17,-31,-38",".59,7.03,4.43,12.3,2.32,1.75,1.88,3.79",8,Sigmoid,8.039360987,8.0,-38.31993484,0.6335,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8432183265686035
4037,7062,KYSE-70,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,-5.0,-27,-21,-21,-18,-35,-40","1.26,7.85,2.04,3.61,15.6,15.3,1.82,2.21",8,Sigmoid,0.002542614,8.0,-37.09066772,1.3876,KYSE70_OESOPHAGUS,KYSE70,ACH-000784,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7512521743774414
4038,7063,L3.3,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,-9.0,-7.0,-7.3,-13,-26,-29,-44","5.05,1.94,3.53,1.53,4.01,6.86,1.10,4.19",8,Sigmoid,2.8490095,8.0,-43.29280472,1.3015,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.949735641479492
4039,7064,L-363,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-.78,-16,-12,-15,-12,-5.5,-12","17.5,4.05,12.7,7.53,9.88,8.85,22.1,11.9",8,Constant,,8.0,-7.987157822,0.7485,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.157076835632324
4040,7065,L-428,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.9,5.58,4.96,9.23,4.94,4.52,4.42,1.69","17.7,5.01,12.8,4.66,11.0,10.5,15.3,9.15",8,Constant,,8.0,4.181221962,0.4134,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.1655826568603516
4041,7066,LCLC-103H,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.86,9.60,5.00,-7.9,-1.9,-7.3,-8.2,-7.0","2.24,5.97,7.73,1.46,1.91,8.89,1.99,10.6",8,Constant,,8.0,-1.017602444,0.5019,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.55820369720459
4042,7067,LN-229,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,9.11,-9.2,.14,-27,-23,-29,-29","11.3,4.76,4.14,9.03,6.26,1.71,.99,4.88",8,Sigmoid,0.145130962,8.0,-27.48942947,1.1769,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.3270139694213867
4043,7068,LOU-NH91,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-13,-20,22.6,9.29,1.88,2.93,-5.6","29.0,2.72,.24,9.25,.021,.91,1.13,.30",8,Constant,,8.0,1.723066807,0.4429,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.4726686477661133
4044,7069,LOX IMVI,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,-8.5,-4.6,-9.9,-40,-47,-51,-60","1.26,7.00,6.13,.55,3.90,4.83,.19,2.36",8,Sigmoid,0.172177166,0.589701712,-51.72468185,2.4416,LOXIMVI_SKIN,LOXIMVI,ACH-000750,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.5281384428087889,2.1854043006896973
4045,7070,LP-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-24,-6.5,2.10,-3.0,-8.4,5.31,17.6","38.7,18.1,2.87,30.8,23.7,15.4,28.4,38.6",8,Constant,,8.0,-8.280497551,1.3771,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.364682674407959
4046,7071,LS123,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,-10,-1.3,-8.2,-26,-27,-35,-44","1.62,18.5,1.76,12.7,1.64,1.42,8.63,9.82",8,Sigmoid,0.359863698,8.0,-41.24002838,1.76,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9060792922973633
4047,7072,LS411N,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-13,-24,-36,-66,-79,-83,-86","15.4,11.8,18.9,4.25,7.67,6.03,1.21,3.93",8,Sigmoid,0.145424291,0.139588103,-84.63279724,4.2582,LS411N_LARGE_INTESTINE,LS411N,ACH-000985,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.9690593143485087,2.7034730911254883
4048,7073,LS513,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,15.1,-18,-22,-24,-56,-84,-91","32.0,26.0,12.6,6.92,62.4,.63,6.82,2.35",8,Sigmoid,0.606964946,0.436459094,-93.10590363,2.6515,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.8290606217250338,2.857107400894165
4049,7074,LU99,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.09,-8.9,13.0,-11,-23,-46,-51,-63","7.98,5.87,4.19,4.96,10.3,2.81,3.22,.43",8,Sigmoid,0.339527905,1.274648309,-59.83811569,2.0438,LU99_LUNG,LU99,ACH-000444,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.24267030448218987,2.407224655151367
4050,7075,LUDLU-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.9,-11,-20,-11,-12,-27,-7.7,-28","3.56,5.17,2.21,1.85,9.99,4.25,11.6,10.1",8,Sigmoid,0.002671892,8.0,-18.56907082,1.1293,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0369887351989746
4051,7076,Malme-3M,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-23,-33,-68,-88,-92,-94,-94","13.8,12.7,2.37,.80,1.92,2.56,.66,.13",8,Sigmoid,0.052478261,0.046187453,-93.93412781,4.9654,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-3.075047097865574,2.18562650680542
4052,7077,MCAS,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,6.21,-.53,-4.6,-11,-18,-28,-57","1.35,2.88,3.40,2.45,5.72,2.43,4.76,.52",8,Sigmoid,9.146393092,6.324002743,-56.12895203,0.7299,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.844352353091597,2.7559585571289062
4053,7078,MCF7,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,.30,-54,10.4,-29,-24,-32,-2.5","37.0,18.4,31.3,26.5,23.5,11.8,10.3,15.3",8,Constant,,8.0,-14.46367168,0.5816,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.1753435134887695
4054,7079,MDA-MB-157,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-2.9,6.03,-3.9,-13,-5.8,-12,-17","16.7,14.6,3.95,12.9,5.28,9.93,31.1,1.70",8,Constant,,8.0,-10.87219334,0.6353,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7537155151367188
4055,7080,MDA-MB-175-VII,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-1.3,-11,-.80,4.28,-7.0,-16,-29","10.8,6.12,13.7,2.31,1.43,.46,1.43,.21",8,Sigmoid,2.984814882,8.0,-28.85728836,0.7065,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.2286179065704346
4056,7081,MDA-MB-415,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-2.3,-5.0,-9.9,-2.8,8.78,-12,1.21","15.5,.32,3.81,11.5,10.4,30.3,28.4,2.76",8,Constant,,8.0,-2.449921131,0.3868,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9310379028320312
4057,7082,MDA-MB-436,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,4.03,-15,-3.0,-2.4,-7.8,-13,-21",".68,6.29,23.2,12.3,12.9,13.6,2.41,1.92",8,Constant,,8.0,-10.26598167,0.8398,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7607598304748535
4058,7083,MDA-MB-453,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,-1.4,3.99,21.5,18.8,16.5,5.36,-14","6.60,6.46,15.1,4.29,1.99,12.8,13.2,2.24",8,Sigmoid,5.353428841,8.0,-13.83815002,0.0,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.383030891418457
4059,7084,MDA-MB-468,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.9,21.2,-26,-9.0,-14,-.078,-24,-21","15.4,9.11,12.3,26.2,7.74,33.0,1.39,24.9",8,Constant,,8.0,-18.53924751,0.9323,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.2344279289245605
4060,7085,MEG-01,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.2,-12,-3.9,-7.0,-6.5,-36,-53,-83","25.9,16.3,2.10,1.22,1.51,2.80,3.09,3.01",8,Sigmoid,3.478474855,2.041517973,-82.90008545,1.6161,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.71369363555946,2.944068431854248
4061,7086,MEL-HO,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.70,-9.0,-.049,-39,-73,-82,-80,-86","2.87,3.58,5.14,4.35,1.84,.066,4.75,2.06",8,Sigmoid,0.080764636,0.10809873,-83.26880646,3.391,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.224710302787116,1.7023661136627197
4062,7087,MES-SA,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.61,-4.7,-1.4,-4.0,-11,-9.7,-12,-16","2.17,2.85,9.73,7.65,.46,2.07,.98,.37",8,Constant,,8.0,-8.702703476,0.4372,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5875043869018555
4063,7088,MeWo,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","36.2,1.32,2.70,17.8,-2.6,1.05,-11,-22","6.09,.92,25.3,18.1,10.7,8.81,21.6,15.9",8,Linear,,8.0,-22.34084511,0.3584,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.2910027503967285
4064,7089,MFE-296,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-16,2.95,3.69,13.4,15.1,.94,-7.5",".51,6.17,2.69,9.77,12.8,1.63,9.88,7.66",8,Constant,,8.0,-0.602542341,0.314,MFE296_ENDOMETRIUM,MFE296,ACH-000879,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5466108322143555
4065,7090,MG-63,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,3.62,-.96,5.67,7.40,14.1,1.08,-3.9","6.55,3.06,13.8,3.13,10.8,.78,3.09,1.32",8,Constant,,8.0,2.359565258,0.2346,MG63_BONE,MG63,ACH-000359,Bone Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5138731002807617
4066,7091,Mino,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,19.1,.82,.15,-18,-5.8,-21,-27","9.80,10.5,2.26,8.36,12.8,1.67,2.13,16.5",8,Sigmoid,2.832027435,8.0,-27.49198341,0.2098,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.292921304702759
4067,7092,MJ,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","22.1,-5.7,-1.6,19.0,.14,8.61,-35,-20","41.0,7.54,1.89,8.27,3.79,20.5,7.18,36.3",8,Constant,,8.0,-1.537849307,0.3342,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9646966457366943
4068,7093,MKN-45,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,5.92,1.66,11.8,-15,-39,-54,-68","2.34,5.05,15.7,2.28,6.99,7.39,.58,3.89",8,Sigmoid,0.624791682,1.375206113,-64.92112732,1.5757,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.3186036202482341,3.0918045043945312
4069,7094,MKN7,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.74,25.5,-3.7,-5.2,4.80,19.9,-22,-4.7","5.86,22.2,5.10,15.4,.15,26.5,4.51,18.1",8,Constant,,8.0,2.679849863,0.5792,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9634361267089844
4070,7095,MKN74,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,2.90,2.70,10.6,2.15,-12,5.77,6.13","5.72,8.03,3.40,3.32,5.91,10.3,24.6,1.86",8,Constant,,8.0,2.662237167,0.00429,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.772617816925049
4071,7096,MOLP-8,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,18.1,-1.4,-14,-47,-30,-37,-50","11.2,27.6,15.4,.21,13.5,24.1,12.0,4.54",8,Sigmoid,0.098130897,8.0,-44.22358704,2.179,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.1739888191223145
4072,7097,MOLT-16,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-8.0,-12,-2.1,5.75,-24,-17,24.3","1.62,13.5,7.94,23.4,9.74,.68,21.6,50.3",8,Constant,,8.0,-11.46232319,1.4634,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.823538064956665
4073,7098,MONO-MAC-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,-19,-36,-28,-29,-33,-23,-35","20.0,1.26,14.8,16.3,4.43,20.8,5.10,13.9",8,Constant,,8.0,-26.04088974,2.892,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.1382670402526855
4074,7099,MOR/CPR,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,-.47,7.90,3.33,1.64,-11,-29,-13","22.6,13.8,20.5,15.7,12.9,3.38,13.4,22.9",8,Constant,,8.0,-7.045042038,0.1858,MORCPR_LUNG,MORCPR,ACH-000851,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.876068353652954
4075,7100,MSTO-211H,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.89,-11,-15,-14,-23,-28,-23,-41","5.35,10.3,3.09,5.29,6.84,9.51,5.01,10.7",8,Sigmoid,0.64525342,8.0,-35.14170074,1.2301,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6258816719055176
4076,7101,NCI-H1048,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-9.3,4.17,12.9,-11,-5.5,14.5,-7.6","2.83,4.83,8.03,34.2,1.22,32.0,10.6,9.24",8,Constant,,8.0,-8.014388084,0.08808,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.2029120922088623
4077,7102,NCI-H1092,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-13,11.3,15.2,-24,1.57,9.63,23.5","9.66,7.72,16.9,14.3,.99,3.22,11.8,32.0",8,Constant,,8.0,0.878484845,0.4517,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.7346818447113037
4078,7103,NCI-H1155,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-12,-12,-7.9,-16,-5.7,-26,-21","11.8,1.29,6.61,1.35,7.11,12.1,1.26,.79",8,Constant,,8.0,-13.95914745,0.1612,NCIH1155_LUNG,NCIH1155,ACH-000980,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.1384811401367188
4079,7104,NCI-H1184,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","17.5,27.0,-21,-27,-17,-25,7.81,6.48","101,19.3,7.29,6.09,74.6,27.0,16.2,78.3",8,Constant,,8.0,-11.85104561,1.0545,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.688943862915039
4080,7105,NCI-H1341,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,16.2,-9.4,24.3,19.8,8.14,-27,1.29","37.8,1.15,29.3,12.1,.75,27.6,25.0,21.9",8,Constant,,8.0,15.63522911,0.4363,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0013394355773926
4081,7106,NCI-H1373,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,-2.5,5.07,-1.4,-10,-9.7,-19,-19","10.3,2.04,5.72,.43,1.43,1.52,1.50,7.64",8,Constant,,8.0,-8.453059196,0.486,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8597230911254883
4082,7107,NCI-H1568,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.65,-1.4,-10,-22,-15,-20,-23,-23","5.97,6.73,17.3,10.7,4.16,1.47,9.20,5.23",8,Sigmoid,0.002542614,8.0,-22.32554626,1.2459,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0409696102142334
4083,7108,NCI-H1648,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,1.29,-16,-11,1.71,1.22,-12,-20","2.69,19.0,.17,0,3.46,1.89,5.06,16.2",8,Constant,,8.0,-11.27791691,1.076,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.941481351852417
4084,7109,NCI-H1650,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,.69,-15,4.03,.84,8.34,-.29,-6.8","16.5,2.38,12.2,5.29,.49,3.98,1.54,1.78",8,Constant,,8.0,-0.198653072,0.3713,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.044631242752075
4085,7110,NCI-H1651,AZD6244,MEK,".0080,.025,.080,.25,.80,2.53,8","-8.9,-17,-9.1,7.78,9.05,-1.3,-12","9.49,17.6,15.0,6.93,5.72,5.97,11.3",7,Constant,,8.0,-3.723740578,0.5348,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8704748153686523
4086,7111,NCI-H1792,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,1.38,-13,-6.0,-14,-19,-38,-31","1.36,3.07,2.43,2.19,2.40,3.73,8.94,2.28",8,Sigmoid,0.863005519,8.0,-31.95566177,0.7937,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9084975719451904
4087,7112,NCI-H1793,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-16,-1.2,-24,-24,-37,-40,-40",".40,20.0,5.41,12.6,26.2,1.64,21.7,17.3",8,Sigmoid,0.200817049,8.0,-40.52479935,1.1445,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8121936321258545
4088,7113,NCI-H1915,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,.97,-19,-30,-37,-27,-61,-74","2.93,7.68,10.1,12.7,2.48,5.52,6.32,3.14",8,Sigmoid,8.758025761,1.592065454,-73.66355896,2.2654,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.46503220089862884,2.5082666873931885
4089,7114,NCI-H1944,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-16,-8.4,-24,-37,-34,-48,-50","17.2,12.0,8.70,3.35,4.97,9.10,3.62,11.4",8,Sigmoid,0.170494765,8.0,-49.07419205,1.3191,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6745834350585938
4090,7115,NCI-H1975,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,17.4,-3.8,4.16,-12,-3.5,-23,-22","6.84,3.85,7.57,9.15,16.9,1.27,10.3,6.65",8,Sigmoid,1.181802034,8.0,-22.65902138,0.4696,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7643094062805176
4091,7116,NCI-H2009,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,4.45,-2.5,-5.7,-14,-15,-28,-30","9.54,11.0,12.6,17.3,18.4,16.5,25.0,29.0",8,Constant,,8.0,-10.99929333,1.9691,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.670197010040283
4092,7117,NCI-H2023,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.27,-1.1,-.89,-7.5,1.03,-9.9,-27,-33","9.95,16.5,24.6,6.99,21.8,17.2,18.0,6.20",8,Sigmoid,1.361826181,8.0,-33.26667786,0.3972,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8034286499023438
4093,7118,NCI-H2030,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-8.5,-16,-18,-26,-28,-27,-31","5.14,2.39,1.12,.12,1.87,3.68,1.57,3.29",8,Sigmoid,0.03076441,8.0,-29.69524765,1.0569,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7925519943237305
4094,7119,NCI-H2052,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-9.1,-9.5,-13,-6.2,-1.8,-22,-9.7","6.54,3.63,.81,2.86,16.6,1.55,10.8,3.80",8,Constant,,8.0,-10.53048515,0.9725,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9530348777770996
4095,7120,NCI-H2085,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-3.4,-13,17.3,-18,-9.8,-22,-22","13.1,27.8,.92,4.25,14.7,10.1,7.31,4.30",8,Constant,,8.0,-14.98119068,0.5237,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.1553006172180176
4096,7121,NCI-H2087,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-20,-35,-43,-47,-48,-59,-66","8.44,.86,2.71,2.32,2.31,1.87,7.33,2.37",8,Sigmoid,0.002542614,0.411084592,-64.03623199,3.0122,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.8889562657125845,2.859492301940918
4097,7122,NCI-H211,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,4.28,-7.4,-13,-18,-21,-9.9,-18","11.6,17.4,8.55,5.06,9.99,3.65,4.19,1.97",8,Sigmoid,0.049248695,8.0,-21.95863914,0.6744,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.4508566856384277
4098,7123,NCI-H2122,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","12.5,-15,-4.9,-22,-42,-69,-65,-99","27.0,7.48,15.1,5.60,13.0,12.4,8.69,.43",8,Sigmoid,8.102182457,0.625899553,-97.0306778,3.0327,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.4685653792233292,2.4354538917541504
4099,7124,NCI-H2170,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,9.62,-7.4,-4.3,-11,4.24,5.87,1.96","19.2,8.24,14.9,14.8,27.2,1.41,4.63,4.65",8,Constant,,8.0,3.711678505,0.3377,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0412232875823975
4100,7125,NCI-H2172,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-53,1.09,8.59,8.31,14.5,-16,-106,-55","11.9,18.8,43.1,52.2,36.6,25.7,2.02,69.4",8,Linear,,0.002542614,-99.74856567,0.3521,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-5.9745625932886295,2.940826654434204
4101,7126,NCI-H2228,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-4.5,-.41,-.67,-21,-15,-14,-23","3.03,16.4,12.3,12.2,19.3,13.3,5.90,10.1",8,Constant,,8.0,-8.707671165,0.4632,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7428085803985596
4102,7127,NCI-H2286,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-9.9,-10,-16,-29,-38,-35,-40","2.78,4.92,3.82,5.82,1.98,4.10,5.05,1.88",8,Sigmoid,0.178703278,8.0,-38.53862,2.8138,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5731749534606934
4103,7128,NCI-H23,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-5.5,-9.7,-9.6,-8.5,-6.2,-25,-28","9.51,12.1,3.89,1.86,21.1,7.12,3.15,17.2",8,Constant,,8.0,-11.62424278,1.0566,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.891758918762207
4104,7129,NCI-H2444,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".32,-12,-3.6,-3.7,-17,-25,-32,-48","8.48,14.3,.90,24.0,27.0,5.61,15.9,3.89",8,Sigmoid,8.180981097,8.0,-47.54534149,1.2551,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.883636951446533
4105,7130,NCI-H2452,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,4.05,-29,-6.3,-18,2.28,-27,-7.6","4.81,4.13,5.08,.78,8.43,4.61,5.14,6.52",8,Constant,,8.0,-11.60141373,0.8245,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.770493745803833
4106,7131,NCI-H28,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-2.2,-13,-10,-15,-15,-26,-28","18.7,4.68,18.8,18.8,4.91,21.0,5.60,3.95",8,Constant,,8.0,-20.18597794,1.3218,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.638991355895996
4107,7132,NCI-H322,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-21,-25,-39,-53,-56,-59,-63","6.90,4.34,4.05,8.34,2.18,6.69,3.71,.68",8,Sigmoid,0.052704491,0.222787127,-62.04423141,2.4814,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.501538550874718,3.164637804031372
4108,7133,NCI-H3255,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,10.5,-5.2,10.6,-15,8.63,-14,-36","4.16,7.79,12.0,4.81,1.83,4.14,3.94,5.47",8,Sigmoid,2.647185564,8.0,-35.88779068,0.5055,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8632864952087402
4109,7134,NCI-H358,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-14,-27,-31,-39,-42,-54,-59","4.75,5.08,6.43,6.39,6.73,6.50,5.62,1.79",8,Sigmoid,0.142023861,1.744710326,-58.76929092,2.4557,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.5565885395822214,3.0782084465026855
4110,7135,NCI-H441,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-12,-11,-17,-16,-29,-21,-34","2.47,4.63,.87,.89,14.8,1.48,4.08,5.43",8,Constant,,8.0,-16.90516663,1.6292,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.634451150894165
4111,7136,NCI-H460,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.3,-12,-5.9,-10,-8.7,-10,-33,-33","3.65,1.14,10.9,8.45,23.8,.96,14.3,.55",8,Sigmoid,1.448657274,8.0,-33.47046661,0.6252,NCIH460_LUNG,NCIH460,ACH-000463,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5757219791412354
4112,7137,NCI-H522,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,-11,3.13,-6.8,8.58,4.00,-3.9,-14",".42,7.33,7.08,9.54,12.4,2.14,17.3,10.1",8,Constant,,8.0,-1.583265066,0.3785,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.133821964263916
4113,7138,NCI-H647,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","27.7,-12,22.1,-7.7,30.9,-4.6,-3.9,-41","35.3,4.68,9.93,8.70,16.6,1.75,5.83,1.74",8,Linear,,8.0,-39.30274582,0.3915,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.76664137840271
4114,7139,NCI-H650,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.65,-.38,5.36,-11,-9.4,-15,-21,-27","1.60,8.46,14.6,6.96,.73,9.79,9.06,.75",8,Sigmoid,3.056631088,8.0,-26.31864738,0.5544,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.660046339035034
4115,7140,NCI-H661,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,6.85,-4.3,11.1,-11,8.35,-8.1,9.22","10.7,7.47,10.7,5.11,15.2,3.02,15.0,2.49",8,Constant,,8.0,5.290395737,0.1862,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8015739917755127
4116,7141,NCI-H727,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.7,-11,-14,-24,-31,-42,-56,-48","16.6,1.14,8.50,8.51,20.8,19.0,23.0,28.0",8,Sigmoid,0.191319987,0.404451102,-70.16491699,1.7299,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.9052244348340397,3.015784502029419
4117,7142,NCI-H747,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,-14,-34,-30,-67,-67,-79,-80","2.51,14.4,20.1,4.61,2.33,4.86,1.18,1.13",8,Sigmoid,0.17259562,0.16377683,-78.54241943,3.9755,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.8092505705600388,2.930725574493408
4118,7143,NCI-H810,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.80,12.1,-6.6,2.84,-2.1,1.50,-1.0,14.3","4.02,15.5,16.1,8.53,14.6,10.5,22.9,8.24",8,Constant,,8.0,5.461338997,0.1913,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.407172203063965
4119,7144,NCI-N87,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-7.0,-14,-9.8,-17,-6.6,-30,-26","16.9,40.2,15.3,2.09,6.49,34.4,16.8,10.3",8,Constant,,8.0,-18.98007393,1.7723,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8314571380615234
4120,7145,NCO2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-7.8,-23,1.07,-12,-31,-59,-83","23.2,16.4,13.7,23.9,7.08,4.05,19.4,10.9",8,Sigmoid,1.808104873,1.754736066,-82.77967072,3.0029,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.562318455864568,2.9579033851623535
4121,7146,NIH:OVCAR-3,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-14,-28,-4.6,-5.6,3.64,-39,-18","11.6,2.91,.42,15.0,21.7,4.29,38.0,10.5",8,Constant,,8.0,-15.51537228,1.5972,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9001545906066895
4122,7147,NUGC-3,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,7.18,17.5,-21,-16,-27,-32,-48","0,4.56,17.3,9.83,3.59,8.71,8.80,1.24",8,Sigmoid,3.224943876,8.0,-46.01590729,1.6916,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6271848678588867
4123,7148,NUGC-4,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.4,-10,-34,-53,-69,-69,-74,-79","1.87,1.69,9.08,2.56,1.92,1.62,3.05,4.63",8,Sigmoid,0.043063805,0.067623615,-73.96006012,3.634,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.693798022616719,3.0781428813934326
4124,7149,OCI-AML2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-31,-78,-94,-96,-96,-96,-97",".45,6.18,.66,.20,.35,.49,.39,.29",8,Sigmoid,0.013768789,0.012838798,-96.24884796,5.9343,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-4.355283598809524,2.7394306659698486
4125,7150,OCI-AML5,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-11,-11,-14,-21,-32,-55,-60",".71,1.06,4.36,2.41,1.27,6.41,9.07,10.4",8,Sigmoid,0.988124788,2.24517417,-61.08834457,3.0387,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.8087830994767042,2.657203197479248
4126,7151,OCUM-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,11.6,-22,-59,-77,-86,-93,-96","7.58,16.5,2.29,.015,.79,1.32,1.58,2.49",8,Sigmoid,0.058630221,0.067574807,-92.74634552,4.2032,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.694520042909535,2.419455051422119
4127,7152,OE21,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-9.1,-2.1,-7.9,-3.6,-15,-45,-60","3.56,4.63,16.4,.37,9.65,2.99,8.73,4.26",8,Sigmoid,1.891202331,3.085490942,-59.60380936,1.541,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.1267107831078467,2.5696544647216797
4128,7153,OE33,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,-15,13.3,3.72,-1.1,-5.0,-30,-38","8.16,18.0,14.5,0,7.39,23.1,5.14,1.36",8,Sigmoid,1.143530488,8.0,-37.47845459,0.9345,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.900333881378174
4129,7154,ONCO-DG-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,-11,-8.1,.95,-3.3,-11,-16,-22",".018,6.69,5.74,12.3,14.6,6.07,9.91,6.90",8,Constant,,8.0,-8.711979866,0.528,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0439891815185547
4130,7155,ONS-76,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.8,-6.9,-8.3,-20,-50,-56,-68,-71","1.41,2.94,3.67,1.13,3.21,2.38,.33,1.48",8,Sigmoid,0.177615568,0.317494243,-68.33330536,2.8866,ONS76_CENTRAL_NERVOUS_SYSTEM,ONS76,ACH-000776,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.147295593097247,2.940943479537964
4131,7156,OPM-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.63,-16,-23,-4.2,2.01,-6.3,-9.7,-20","11.5,.14,23.8,11.2,36.8,11.8,9.09,16.8",8,Constant,,8.0,-10.31114292,0.4856,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.255220413208008
4132,7157,OV-90,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-.20,-17,-39,-61,-66,-72,-80","20.3,12.6,3.61,9.72,.68,.93,.24,4.92",8,Sigmoid,0.062618591,0.144641533,-75.61215973,3.4602,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.9334967836665609,2.5839900970458984
4133,7158,OVCAR-4,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.49,3.29,-.68,-1.6,.47,1.90,-3.5,-10","12.2,5.02,1.55,8.16,11.7,1.01,2.06,2.59",8,Constant,,8.0,-0.883701682,0.0,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.026048421859741
4134,7159,OVCAR-8,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.42,-4.8,-4.3,1.90,.18,-17,-16,-22","9.68,7.32,12.9,11.0,10.4,.26,2.51,15.3",8,Constant,,8.0,-8.185592651,0.3024,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.885687828063965
4135,7160,OVMANA,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.57,-.91,.23,-3.2,.55,-8.6,-10,-12","3.00,9.28,8.18,11.1,7.48,10.8,1.20,6.86",8,Constant,,8.0,-4.830527782,0.623,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.563429117202759
4136,7161,OVSAHO,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,-4.8,2.23,-17,-17,-21,-6.5,-20","1.37,2.00,2.68,12.5,14.2,6.98,.79,4.01",8,Constant,,8.0,-7.157561779,0.7329,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.288017749786377
4137,7162,OVTOKO,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,-4.5,-3.7,1.33,-3.4,-6.2,-.96,-8.3","5.85,7.87,3.72,9.86,0,.60,8.10,11.0",8,Constant,,8.0,-5.241326332,0.3445,OVTOKO_OVARY,OVTOKO,ACH-000663,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.446986675262451
4138,7163,P12-ICHIKAWA,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.7,3.98,-3.6,-29,-38,-41,-45,-45","2.30,3.42,15.9,.35,4.56,12.6,6.69,2.37",8,Sigmoid,0.039612882,8.0,-44.13575745,1.7805,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.912759780883789
4139,7164,P31/FUJ,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-21,-19,-38,-48,-56,-66,-72","9.79,1.82,5.59,1.05,7.06,3.80,1.06,5.67",8,Sigmoid,0.221212178,0.362001896,-71.5198288,3.4009,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.0161058296010212,3.144866943359375
4140,7165,P3HR-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-4.7,3.07,-10,-1.8,-1.3,-1.7,-4.7","13.5,16.5,18.6,18.0,9.36,5.39,14.5,22.7",8,Constant,,8.0,-1.607227206,0.1024,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.365161895751953
4141,7166,Panc 02.03,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-14,-28,-38,-63,-66,-72,-83","3.63,8.45,14.6,8.70,1.10,3.63,2.08,3.98",8,Sigmoid,0.084515758,0.150403783,-79.66278076,3.4381,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.8944317148571952,2.5968008041381836
4142,7167,Panc 03.27,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.34,-.80,-12,-8.5,-20,-29,-38,-46","11.4,16.9,5.73,6.77,10.6,3.95,11.4,8.66",8,Sigmoid,1.066014171,8.0,-45.83073807,1.2338,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.888331413269043
4143,7168,Panc 04.03,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.87,1.92,9.24,-13,-34,-36,-45,-55","12.6,6.38,24.1,2.62,5.25,11.5,2.02,15.5",8,Sigmoid,0.121570632,8.0,-44.68601227,1.4602,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9983017444610596
4144,7169,Panc 10.05,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-.24,-7.8,-29,-26,-46,-41,-50","21.3,26.5,1.20,12.5,7.78,1.47,2.69,9.97",8,Sigmoid,0.162169084,8.0,-47.85654831,2.0182,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9944071769714355
4145,7170,PA-TU-8902,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,-6.9,-8.7,-13,-22,-25,-35,-37","3.84,2.81,.71,1.36,4.22,3.23,5.44,2.85",8,Sigmoid,0.359340876,8.0,-37.17363739,1.4749,PATU8902_PANCREAS,PATU8902,ACH-000599,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6551456451416016
4146,7171,PC-3,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".62,-5.4,-7.2,-7.7,.28,5.63,-4.3,1.76","11.9,.057,3.47,.51,2.85,1.06,9.70,.59",8,Constant,,8.0,-3.256629229,0.2844,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.139227867126465
4147,7172,Pfeiffer,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,1.58,-7.1,-.62,11.8,2.77,-9.0,-31",".48,8.34,12.6,7.81,16.7,10.9,5.62,4.79",8,Sigmoid,3.206157207,8.0,-31.41580772,0.2601,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8051037788391113
4148,7173,PK-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-6.9,-9.7,-16,-18,-28,-32,-45","4.54,5.00,1.10,.79,1.08,10.5,1.66,5.09",8,Sigmoid,8.52435682,8.0,-44.31058502,1.5048,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.809812545776367
4149,7174,PK-45H,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-11,-30,-40,-61,-61,-76,-72","4.78,17.2,4.52,.45,.19,6.43,5.61,2.51",8,Sigmoid,0.091730297,0.137997568,-73.45618439,3.606,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.9805192171686286,2.8581793308258057
4150,7175,PK-59,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,-7.8,-9.3,-8.6,-13,-23,-35,-48","6.09,.77,.38,1.10,.80,6.08,12.8,9.51",8,Sigmoid,1.841352224,8.0,-47.42253876,1.0042,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7507779598236084
4151,7176,PLC/PRF/5,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-11,-16,-12,-16,-22,-25,-31","2.91,7.72,8.81,1.78,3.45,3.18,.63,6.62",8,Constant,,8.0,-17.18809128,0.8398,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.2450008392333984
4152,7177,PSN1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,-3.9,-8.1,-12,-36,-45,-72,-82","3.02,3.73,1.13,.68,3.33,4.36,.65,2.28",8,Sigmoid,0.705370188,0.797091246,-82.03491974,2.4693,PSN1_PANCREAS,PSN1,ACH-000320,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.22678611991944245,2.654359817504883
4153,7178,QGP-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-35,-30,-24,-51,-56,-47,-68,-67","5.95,6.67,7.63,14.3,3.65,5.25,6.42,6.00",8,Sigmoid,0.068285875,0.078835241,-59.90897751,3.5502,QGP1_PANCREAS,QGP1,ACH-000347,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.540395161279543,3.459247350692749
4154,7179,Raji,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.75,-1.8,29.8,1.62,15.9,14.8,-28,9.33","7.09,10.5,16.8,14.0,18.4,17.0,13.0,26.6",8,Constant,,8.0,3.789465666,0.2204,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.216766595840454
4155,7180,RD,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.0,-5.3,-20,-29,-28,-50,-54,-62","12.9,3.36,7.88,11.1,29.7,4.80,3.63,3.92",8,Sigmoid,0.002542614,1.379035115,-61.26465988,2.5031,RD_SOFT_TISSUE,RD,ACH-000169,Sarcoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.3213840625913834,2.996701240539551
4156,7181,Reh,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,.53,-1.9,1.39,-2.5,3.84,5.12,5.88",".81,4.70,1.32,7.42,2.52,5.21,3.00,9.02",8,Constant,,8.0,-0.490595549,0.04644,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.909106969833374
4157,7182,RERF-GC-1B,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.12,-10,-18,-19,-24,-15,-31,-44","7.11,4.20,1.12,3.49,12.7,32.8,16.5,14.4",8,Sigmoid,0.002542614,8.0,-37.43273926,1.7254,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.10459303855896
4158,7183,RERF-LC-AI,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-11,-9.0,-7.5,-11,-13,-23,-22","4.90,.74,4.52,5.12,5.00,3.29,3.62,1.74",8,Constant,,8.0,-13.20329189,1.0537,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7777256965637207
4159,7184,RKO,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-9.6,3.40,-5.5,-32,-37,-49,-63","14.4,3.98,6.49,4.43,2.21,3.41,6.63,4.88",8,Sigmoid,0.532536209,1.899022937,-59.99345398,2.2005,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.6413395102195534,2.6164963245391846
4160,7185,RL95-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-19,-24,-30,-42,-44,-61,-66","11.2,7.46,12.8,3.57,9.63,6.91,2.81,2.46",8,Sigmoid,8.42693841,1.525693893,-68.48975372,2.7961,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.42244931837617355,2.8281898498535156
4161,7186,RPMI-7951,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-8.9,4.29,-1.6,-7.7,-21,-36,-40","7.58,11.6,7.65,2.68,1.23,9.35,12.0,10.2",8,Sigmoid,0.894238353,8.0,-39.78167343,1.1178,RPMI7951_SKIN,RPMI7951,ACH-000348,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6884238719940186
4162,7187,RPMI-8402,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,4.61,.44,1.14,-14,2.02,2.51,-12","2.97,2.86,9.91,1.63,8.77,2.65,24.2,2.28",8,Constant,,8.0,-3.056209087,0.6701,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8531923294067383
4163,7188,RT-112,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,-9.7,-4.6,-15,-29,-30,-39,-57","1.71,1.47,1.30,2.53,3.14,3.95,10.4,1.42",8,Sigmoid,2.379562378,3.992265224,-57.17276001,1.6626,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.3843587951200085,2.843212127685547
4164,7189,RT4,AZD6244,MEK,".0080,.025,.080,.25,.80,2.53,8","-20,-20,-15,7.88,-.75,-24,-55","2.82,24.0,1.36,7.34,10.5,22.4,17.1",7,Sigmoid,2.980108261,4.402423859,-55.35996246,1.6026,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.4821552662926114,3.0396015644073486
4165,7190,RVH-421,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,2.81,-12,-20,-53,-62,-72,-75","4.68,7.15,.87,4.01,1.68,2.77,3.66,1.16",8,Sigmoid,0.163197249,0.257206768,-72.74133301,2.5274,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.3578749728124735,2.0703012943267822
4166,7191,SBC-5,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-7.0,-5.0,-3.7,-8.0,-12,-34,-47",".96,4.00,.14,2.15,5.57,.74,3.91,.41",8,Sigmoid,1.961591363,8.0,-47.38705826,0.5487,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5002827644348145
4167,7192,SCaBER,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-10,-7.7,-24,-21,-38,-26,-52","9.26,7.78,8.90,9.79,2.87,14.6,7.14,6.07",8,Sigmoid,8.972889219,8.0,-48.40286255,1.7235,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8284997940063477
4168,7193,SCC-9,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-.37,-11,-21,-29,-39,-46,-52","17.1,5.00,24.8,25.1,4.87,12.6,15.8,14.0",8,Sigmoid,0.223480344,5.701106071,-50.9059639,1.6772,SCC9_UPPER_AERODIGESTIVE_TRACT,SCC9,ACH-000181,Head and Neck Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.7406602035595746,2.593709945678711
4169,7194,SF126,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-4.1,-2.1,-7.7,-3.9,-9.5,-5.1,-14","10.8,7.36,14.0,.77,.55,5.92,7.77,.99",8,Constant,,8.0,-7.709593773,0.2737,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6602938175201416
4170,7195,SF-295,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.3,-3.6,-18,.51,-11,-2.0,-15,-6.8",".41,15.4,5.99,1.75,9.05,6.45,3.77,9.29",8,Constant,,8.0,-8.32831955,0.466,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6590771675109863
4171,7196,SH-10-TC,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,1.10,-6.3,-2.4,4.13,3.25,3.61,.18","2.97,1.83,1.10,.88,6.29,3.12,1.32,1.95",8,Constant,,8.0,-0.088884525,0.04748,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5757758617401123
4172,7197,SHP-77,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,41.3,9.72,33.9,.56,-2.4,-22,27.4","12.8,15.3,4.91,35.5,3.20,9.75,15.4,9.22",8,Linear,,8.0,-17.79380608,0.2575,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.1124141216278076
4173,7198,SIG-M5,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,-58,-87,-92,-93,-94,-94,-94",".49,16.0,.48,1.07,1.03,1.68,.75,1.09",8,Sigmoid,0.007301298,0.006444348,-93.4150238,6.4934,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-5.044551811401163,2.5977299213409424
4174,7199,SIMA,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".95,14.7,-15,-1.8,-24,-33,-42,-42","42.1,21.3,19.6,23.3,7.39,9.00,26.3,4.98",8,Sigmoid,0.002542614,8.0,-44.59009552,1.7358,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8521759510040283
4175,7200,SJSA-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.15,-1.7,2.50,4.35,-7.4,-24,-29,-30","31.3,17.1,24.8,11.1,4.21,37.0,12.0,12.5",8,Constant,,8.0,-11.64386082,0.833,SJSA1_BONE,SJSA1,ACH-000748,Bone Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5029194355010986
4176,7201,SK-BR-3,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,4.43,-5.1,18.6,2.59,15.2,16.6,20.3","27.0,26.6,17.8,25.0,18.6,36.2,21.1,15.3",8,Constant,,8.0,8.363933563,0.0,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.1661324501037598
4177,7202,SK-CO-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-6.2,-14,-24,-34,-48,-60,-71","3.44,.040,15.0,9.52,.83,1.39,6.95,1.29",8,Sigmoid,0.589050233,0.922984838,-70.29551697,2.6927,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.08014247148311315,2.6197543144226074
4178,7203,SK-ES-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-54,-11,-6.4,-1.2,1.62,-2.3,7.33,-6.4","9.39,21.0,16.5,6.56,24.9,3.39,10.6,3.57",8,Constant,,8.0,-4.314377308,0.7745,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.38435697555542
4179,7204,SK-HEP-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-3.7,-16,-11,-1.6,-21,-22,-33","9.05,6.21,4.44,3.94,13.9,2.62,6.60,2.13",8,Sigmoid,8.14342681,8.0,-32.82242584,1.2855,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7846808433532715
4180,7205,SK-MEL-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.18,-19,19.4,-13,8.41,-25,-50,-68","12.9,17.6,10.1,.69,17.6,1.49,2.79,1.04",8,Sigmoid,1.319559216,2.413272142,-67.47341919,1.7595,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.8809835618831966,2.411511182785034
4181,7206,SK-MEL-24,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,-4.0,-11,-13,-32,-37,-52,-60","10.4,1.12,14.6,13.4,17.4,.80,10.4,2.27",8,Sigmoid,0.682797134,2.3126297,-60.05052567,2.0305,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.8383852753181416,2.3610715866088867
4182,7207,SK-MEL-30,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.2,-8.0,-23,-45,-70,-72,-76,-76","12.2,6.32,5.80,3.24,2.35,2.27,1.02,5.09",8,Sigmoid,0.061942652,0.09143956,-76.06231689,3.251,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.3920770714056716,2.0217809677124023
4183,7208,SK-MEL-31,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-1.4,1.83,10.5,-3.2,-.063,-31,-33","3.74,.99,2.52,13.5,12.1,18.4,5.54,6.06",8,Sigmoid,1.532272696,8.0,-33.31385422,0.8945,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.0789988040924072
4184,7209,SK-MEL-5,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,2.33,-25,-39,-58,-62,-67,-68","36.2,2.28,2.49,2.93,6.68,.74,2.90,4.07",8,Sigmoid,0.074887127,0.168868572,-67.69111633,2.9562,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.7786345470827643,2.133892297744751
4185,7210,SK-MES-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","18.9,24.3,-7.8,-5.3,28.8,4.08,-24,-44","28.3,3.21,20.8,13.9,24.8,18.9,.38,2.33",8,Linear,,8.0,-43.71248627,0.8823,SKMES1_LUNG,SKMES1,ACH-000665,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0028605461120605
4186,7211,SK-MM-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-17,-19,-28,-19,-18,-25,-35","5.46,5.73,5.35,4.24,13.8,2.17,6.79,9.87",8,Sigmoid,0.003183726,8.0,-24.04728699,1.3523,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0791738033294678
4187,7212,SK-N-AS,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,-11,-8.8,-29,-56,-64,-71,-74","3.48,2.19,3.94,2.62,1.81,1.07,4.15,.10",8,Sigmoid,0.129300579,0.203245521,-71.8640213,3.1582,SKNAS_AUTONOMIC_GANGLIA,SKNAS,ACH-000260,Neuroblastoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.5933405676974022,2.8790671825408936
4188,7213,SK-N-BE(2),AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,7.19,-11,3.54,-19,-33,-44,-47","9.99,22.6,3.12,21.8,21.8,1.38,2.00,11.0",8,Sigmoid,0.715409517,8.0,-45.24546432,1.5398,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9951066970825195
4189,7214,SK-N-DZ,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.04,-5.0,-7.0,-12,-6.7,-3.4,-8.1,-15","29.9,17.4,.061,15.8,4.44,18.3,16.0,21.3",8,Constant,,8.0,-6.951611042,0.7211,SKNDZ_AUTONOMIC_GANGLIA,SKNDZ,ACH-000366,Neuroblastoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.780630588531494
4190,7215,SK-N-FI,AZD6244,MEK,".0025,.025,.080,.25,.80,2.53,8","-22,-35,19.0,-35,-6.3,-50,-15","50.4,14.1,5.83,38.6,14.0,14.8,25.9",7,Constant,,8.0,-20.79537392,1.8228,SKNFI_AUTONOMIC_GANGLIA,SKNFI,ACH-000341,Neuroblastoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.876509428024292
4191,7216,SK-N-SH,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.9,6.17,6.10,2.50,-1.1,1.91,-12,-30","21.0,1.29,8.20,10.2,15.7,11.2,21.8,2.78",8,Sigmoid,8.527484133,8.0,-29.40850449,0.5364,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7826128005981445
4192,7217,SK-OV-3,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,6.46,-14,.72,-4.7,4.17,-10,2.97","18.1,10.7,4.75,5.76,6.38,12.5,5.09,6.75",8,Constant,,8.0,-9.3757267,0.334,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6939969062805176
4193,7218,SNG-M,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,-5.9,-5.6,-10,-12,-14,-23,-23","7.18,4.84,1.09,.21,6.00,1.96,8.78,9.30",8,Constant,,8.0,-11.13339806,1.1646,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5061395168304443
4194,7219,SNU-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.42,-8.6,-5.2,-27,-32,-43,-49,-58","6.12,18.0,9.18,.76,2.26,3.90,7.17,1.88",8,Sigmoid,0.038207211,2.090872049,-57.50772476,1.9704,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.7375812272782022,2.991258382797241
4195,7220,SNU-182,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,1.40,-11,-3.7,-7.7,-18,-36,-50","15.2,5.97,8.15,6.19,25.2,4.64,7.21,11.6",8,Sigmoid,1.772217393,8.0,-49.949646,1.7,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.796700954437256
4196,7221,SNU-387,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.31,-10,14.0,-4.8,-.14,-13,-4.5,-19","26.4,6.60,7.01,27.8,3.43,2.78,22.5,13.1",8,Constant,,8.0,-7.63163662,0.4998,SNU387_LIVER,SNU387,ACH-000478,Liver Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6026358604431152
4197,7222,SNU-398,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.10,-18,-9.8,.49,-17,-25,-33,-46","12.8,4.35,7.43,17.5,.46,12.0,4.11,8.44",8,Sigmoid,8.515384785,8.0,-46.13850784,1.4041,SNU398_LIVER,SNU398,ACH-000221,Liver Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8021602630615234
4198,7223,SNU-423,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-4.5,-12,3.26,-11,-3.1,-.080,-2.9","5.66,.68,14.8,6.06,1.01,10.5,5.52,10.5",8,Constant,,8.0,-4.504833221,0.3714,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9072422981262207
4199,7224,SNU-449,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.73,-3.1,-2.3,-2.1,6.02,.79,-15,-23","1.45,6.43,15.4,2.94,5.44,8.37,2.99,3.25",8,Sigmoid,2.253533125,8.0,-22.84470177,0.2108,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.1902265548706055
4200,7225,SNU-475,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.71,35.8,-36,-6.2,16.2,57.6,9.34,-3.8","11.5,14.5,41.4,31.1,12.2,3.28,5.70,2.06",8,Constant,,8.0,10.57923603,0.9279,SNU475_LIVER,SNU475,ACH-000422,Liver Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7553186416625977
4201,7226,SNU-C2A,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,-12,-14,7.67,-13,-1.2,-38,-26","3.62,25.1,.56,12.0,13.9,6.16,7.67,6.21",8,Constant,,8.0,-11.65582561,1.3236,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8489489555358887
4202,7227,Sq-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,11.7,-20,-11,-6.9,2.55,-22,-19","2.87,4.23,5.01,1.45,1.82,2.02,5.86,1.91",8,Constant,,8.0,-9.448718071,0.9389,SQ1_LUNG,SQ1,ACH-000553,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9661643505096436
4203,7228,SU.86.86,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,-2.9,.13,-.96,3.18,-1.4,-26,-28","5.25,4.55,5.80,3.69,2.82,5.10,12.6,5.62",8,Sigmoid,1.660895109,8.0,-28.29798508,0.616,SU8686_PANCREAS,SU8686,ACH-000114,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8107290267944336
4204,7229,SU-DHL-10,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-4.6,-3.1,-1.6,-27,-9.8,-.61,2.14","16.4,5.94,3.85,15.7,20.5,12.9,31.1,33.5",8,Constant,,8.0,-7.130740166,0.4243,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.2340340614318848
4205,7230,SU-DHL-4,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,-13,-8.8,2.59,-13,-15,2.39,-2.7","10.00,12.5,1.59,6.47,11.8,10.4,1.53,4.75",8,Constant,,8.0,-5.568696499,1.7324,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.0040698051452637
4206,7231,SU-DHL-6,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.05,20.6,-12,-14,-5.9,15.2,-14,29.1","46.6,31.8,40.9,18.0,26.8,6.41,53.9,22.4",8,Constant,,8.0,11.45012665,0.5246,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9591119289398193
4207,7232,SU-DHL-8,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,13.6,-10,5.09,-16,-11,-20,.92","15.2,2.40,9.92,3.51,.81,4.92,4.38,4.49",8,Constant,,8.0,-5.597966194,1.5696,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.2610509395599365
4208,7233,SUIT-2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.63,2.79,-11,-17,-33,-43,-63,-66","6.87,3.84,12.3,9.82,7.06,10.4,3.02,5.36",8,Sigmoid,0.276105106,0.552702963,-66.62461853,2.0782,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.5929345592019793,2.3719143867492676
4209,7234,SUP-M2,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".096,2.05,-1.1,8.32,-4.1,-14,-54,-56","32.6,8.18,26.2,7.87,16.8,7.23,45.7,3.54",8,Sigmoid,8.076359556,6.54872036,-55.28603745,1.0256,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.8792696656754593,2.683673858642578
4210,7235,SUP-T1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.83,.34,10.3,-.23,-1.1,3.39,-2.8,-.38",".87,18.8,14.4,13.6,2.43,26.9,7.29,15.1",8,Constant,,8.0,1.379644871,0.02767,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.274081230163574
4211,7236,SW 1088,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","33.9,3.19,11.7,2.58,10.5,16.1,2.92,5.61",".89,8.43,28.7,2.24,5.22,3.41,17.2,.75",8,Constant,,8.0,7.912451744,0.0,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.9130687713623047
4212,7237,SW 1271,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.1,-.45,-4.7,-7.2,-16,-45,-52,-59","13.4,8.21,2.13,2.29,4.35,8.91,2.79,.32",8,Sigmoid,0.437268376,1.708139181,-58.49014282,1.669,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,0.5354045797513535,2.817579984664917
4213,7238,SW 1353,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,1.65,-16,-9.0,-32,-2.1,-12,-13","3.15,12.3,.52,3.42,5.42,4.03,1.36,14.2",8,Constant,,8.0,-8.827929497,0.9301,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6769514083862305
4214,7239,SW1417,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","19.1,25.0,-15,-18,-51,-53,-78,-71","38.3,11.8,5.12,17.3,4.66,21.1,.98,4.06",8,Sigmoid,0.01245673,0.200470254,-75.21798706,2.4436,SW1417_LARGE_INTESTINE,SW1417,ACH-000236,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.6070894023440578,2.9645602703094482
4215,7240,SW 1573,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-9.2,-13,-7.8,-9.2,-14,-33,-38",".34,5.07,.89,2.04,1.45,.52,1.36,.063",8,Sigmoid,1.679233551,8.0,-38.42419815,0.9396,SW1573_LUNG,SW1573,ACH-000677,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.4549694061279297
4216,7241,SW 1990,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-.25,-.54,-8.3,-20,-24,-43,-62","6.32,.89,.15,14.9,2.63,5.59,1.59,9.11",8,Sigmoid,5.135966301,3.996007919,-60.75972366,1.5884,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.3852958425160753,2.8025245666503906
4217,7242,SW403,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,-8.2,-37,-44,-62,-72,-79,-70","13.7,4.78,.88,15.1,1.59,1.18,.76,9.71",8,Sigmoid,0.012638541,0.064917043,-78.05316162,2.9688,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.7346450857403264,2.9118480682373047
4218,7243,SW48,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-44,-30,-48,-55,-69,-66,-78,-76","44.4,16.5,12.5,7.17,1.14,5.65,.82,5.41",8,Sigmoid,0.002542614,0.036256053,-77.27957153,4.7855,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-3.3171489323106016,2.321401357650757
4219,7244,SW480,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,7.91,-22,-20,-29,-41,-49,-57","9.30,2.30,11.2,1.82,1.77,.24,3.27,6.79",8,Sigmoid,0.237659663,2.803628922,-56.8574028,2.2851,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.03091462161308,2.815779685974121
4220,7245,SW579,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,4.17,-16,4.04,-.50,7.48,3.46,-13","3.93,5.52,3.47,1.82,17.7,2.57,3.95,1.83",8,Constant,,8.0,0.656041086,0.3181,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.69305682182312
4221,7246,SW620,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-31,-33,-48,-64,-66,-72,-73","4.06,3.10,9.22,7.27,1.42,2.70,.041,.21",8,Sigmoid,0.002542614,0.058131345,-73.60009766,3.5274,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.8450502597419542,2.378507137298584
4222,7247,SW 780,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".59,-18,-30,-6.9,-23,-24,-48,-56","6.81,2.29,3.98,12.1,10.9,2.96,5.00,.71",8,Sigmoid,8.243863593,4.865739346,-57.19132614,1.8812,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,1.5822186765476451,2.7343380451202393
4223,7248,SW 900,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,1.41,-4.3,20.7,-13,1.37,-11,-2.8","6.00,4.32,4.13,7.06,9.08,17.0,3.56,.83",8,Constant,,8.0,-4.578506947,0.3037,SW900_LUNG,SW900,ACH-000669,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.957365036010742
4224,7249,T24,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.61,-5.7,-15,-20,-21,-22,-31,-38","8.42,3.90,3.23,3.41,1.62,4.62,3.43,1.13",8,Sigmoid,0.027460065,8.0,-35.74660873,1.535,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.48380708694458
4225,7250,T3M-10,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-18,6.05,-8.0,-30,-23,-39,-44",".28,15.7,22.8,29.4,8.30,1.71,1.04,5.25",8,Sigmoid,8.078740562,8.0,-43.94812393,1.1293,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.683966875076294
4226,7251,T-47D,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".76,-5.4,-8.1,17.4,-15,-2.5,-17,-7.4","2.39,12.4,13.1,13.9,2.42,11.0,8.17,1.03",8,Constant,,8.0,-7.351501465,0.6917,T47D_BREAST,T47D,ACH-000147,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.5118021965026855
4227,7252,T84,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.04,40.3,-24,8.69,-33,62.7,-38,-61","63.5,79.8,27.8,15.4,31.6,203,7.81,1.30",8,Constant,,8.0,-23.03603935,1.568,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.945542335510254
4228,7253,TCCSUP,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.35,.76,2.85,10.6,2.70,9.19,3.53,6.06","5.09,.76,15.4,1.37,11.9,2.81,10.1,2.17",8,Constant,,8.0,6.031919003,0.0,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.722529888153076
4229,7254,TE-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,-15,-14,-4.4,-4.3,-15,-20,-28","12.7,3.63,4.39,1.09,.017,14.3,.83,2.34",8,Constant,,8.0,-13.72025013,1.114,TE1_OESOPHAGUS,TE1,ACH-000647,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.492119550704956
4230,7255,TE-11,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-15,-3.9,.083,-7.0,-11,-15,-19","1.21,4.55,4.47,5.61,13.3,1.68,.023,10.3",8,Constant,,8.0,-12.28723526,0.3205,TE11_OESOPHAGUS,TE11,ACH-000488,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6818370819091797
4231,7256,TE-15,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,18.8,-46,-46,-37,-19,-57,-65","33.1,2.70,30.3,7.20,27.4,4.92,13.4,.022",8,Linear,,0.953287825,-66.685112,2.7173,TE15_OESOPHAGUS,TE15,ACH-000353,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.047838400989734284,2.7699570655822754
4232,7257,TE-5,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,-2.2,-2.5,.29,-.42,-6.7,-22,-25","3.44,3.62,1.29,5.07,6.59,.55,1.12,2.23",8,Sigmoid,1.334295034,8.0,-24.95788574,0.6396,TE5_OESOPHAGUS,TE5,ACH-000408,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.799558401107788
4233,7258,TE 617.T,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,-18,-18,-20,-28,-50,-52,-59","32.2,13.4,22.7,13.1,17.0,2.97,3.68,2.92",8,Sigmoid,0.397453219,0.926280141,-56.5108223,2.5837,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-0.07657856201059544,2.2130329608917236
4234,7259,TE-9,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.4,-12,-16,-14,-2.4,.33,-5.3,-15","3.49,10.8,9.36,11.9,4.13,1.07,8.45,1.57",8,Constant,,8.0,-7.940888405,0.8854,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8922207355499268
4235,7260,TEN,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,13.6,-18,18.7,-1.1,22.0,1.19,4.93","4.67,15.5,4.46,20.5,25.1,6.73,6.21,6.27",8,Constant,,8.0,4.14094305,0.6637,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.8851780891418457
4236,7261,Toledo,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".33,-13,-3.2,11.8,13.4,7.31,-8.8,-22","4.73,.20,3.75,34.5,4.36,21.2,4.72,4.13",8,Constant,,8.0,-5.662262917,0.05558,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.077364921569824
4237,7262,TOV-112D,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.25,9.03,-.44,7.39,-4.8,-3.2,4.33,-7.9","2.59,9.81,3.23,8.75,5.55,2.25,3.81,7.83",8,Constant,,8.0,0.538654327,0.09705,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.740084648132324
4238,7263,TOV-21G,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-11,-2.7,-3.7,2.27,-7.7,-9.3,-29","6.58,17.0,10.9,2.10,14.9,14.5,7.13,9.82",8,Sigmoid,7.731427193,8.0,-28.50517464,1.2785,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,1.9610109329223633
4239,7264,TT2609-C02,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,-9.4,-24,-34,-51,-49,-62,-66","8.04,9.00,21.9,6.53,8.38,12.6,10.6,7.50",8,Sigmoid,0.073574282,0.35643959,-64.65503693,3.1457,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.0315905065019986,2.523362159729004
4240,7265,TYK-nu,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,15.2,-4.4,10.5,-15,-16,-34,-29","8.98,7.47,2.15,12.6,3.32,8.09,3.93,11.2",8,Sigmoid,0.399597466,8.0,-31.35321617,0.6276,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.842805862426758
4241,7266,U-118 MG,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,-.96,6.47,7.81,5.31,-1.5,-1.1,-12","1.84,3.07,2.27,6.94,10.9,4.76,19.4,14.6",8,Constant,,8.0,-0.398842841,0.1341,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6988587379455566
4242,7267,U-2 OS,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.15,-3.2,-.014,-20,-16,-26,-18,-29",".64,21.7,8.42,18.4,1.37,11.0,.21,28.7",8,Constant,,8.0,-16.20476341,1.2003,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.7046315670013428
4243,7268,U-87 MG,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,6.43,-7.1,1.97,2.41,13.9,-7.1,-5.0","2.05,5.86,7.82,6.34,4.13,.97,4.08,7.33",8,Constant,,8.0,-1.112144113,0.4738,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.718487024307251
4244,7269,U-937,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-13,-7.7,-5.7,-7.1,-10.0,-17,-31","10.8,9.17,8.78,1.80,15.7,10.0,22.1,16.1",8,Sigmoid,2.234367371,8.0,-41.7820549,1.1403,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.720114231109619
4245,7270,UACC-257,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.3,-4.5,-7.4,-28,-51,-68,-71,-78",".30,12.5,11.2,.041,1.15,1.67,1.31,2.80",8,Sigmoid,0.146748021,0.234048441,-75.31748962,2.9813,UACC257_SKIN,UACC257,ACH-000579,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.4522271722281201,2.099444627761841
4246,7271,UACC-62,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".98,9.38,-35,-65,-67,-65,-79,-82","8.99,7.79,6.01,1.46,1.25,.49,2.26,.62",8,Sigmoid,0.024995618,0.035012472,-71.90910339,3.9363,UACC62_SKIN,UACC62,ACH-000425,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-3.3520509381106174,2.095308303833008
4247,7272,UACC-812,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-4.7,-7.4,-18,-28,-15,-33,-38","12.5,24.2,13.3,14.2,27.3,19.9,48.2,43.4",8,Constant,,8.0,-2.037965059,0.9361,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.625838279724121
4248,7273,UM-UC-3,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.87,2.75,8.39,11.6,4.69,-5.3,-30,-29","1.16,1.47,3.68,1.45,7.78,2.44,4.04,4.89",8,Sigmoid,0.918555737,8.0,-29.59300232,0.5331,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.3768134117126465
4249,7274,VMRC-RCW,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,14.7,6.98,19.8,13.3,25.5,8.58,20.4","1.21,3.34,3.69,26.0,8.65,17.4,4.85,27.0",8,Constant,,8.0,10.6262598,0.03365,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.484651565551758
4250,7275,VMRC-RCZ,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,17.3,-1.4,8.04,-5.1,-14,-5.4,-4.8","14.3,17.1,3.83,5.65,11.9,2.36,8.74,1.98",8,Constant,,8.0,-3.689450502,1.3659,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6497647762298584
4251,7276,WM-115,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,8.81,-1.0,-2.3,-38,-34,-44,-47","12.1,12.8,17.6,1.51,10.4,2.89,1.42,12.2",8,Sigmoid,0.167395651,8.0,-41.65719604,1.5979,WM115_SKIN,WM115,ACH-000304,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.35864520072937
4252,7277,WM1799,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".21,2.48,-5.8,-21,-45,-58,-67,-67",".79,6.28,16.0,.35,.087,1.15,1.93,2.80",8,Sigmoid,0.140531823,0.350596309,-66.93295288,2.9523,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.048119834217276,1.867492914199829
4253,7278,WM-266-4,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8",".60,-6.7,-1.2,-40,-61,-77,-84,-88","1.98,6.20,8.84,16.4,7.87,3.16,.086,.25",8,Sigmoid,0.129444852,0.165270492,-86.85059357,3.4457,WM2664_SKIN,WM2664,ACH-001239,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-1.800171801887019,1.9640134572982788
4254,7279,WM-793,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-7.4,6.09,4.95,-24,-44,-45,-53","7.96,1.49,5.99,7.71,4.47,11.9,1.15,7.51",8,Sigmoid,0.255530983,8.0,-47.56628418,2.07,WM793_SKIN,WM793,ACH-000827,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.5428037643432617
4255,7280,WM-88,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-18,-29,-64,-81,-86,-90,-90",".40,5.26,.48,2.34,1.98,.75,.17,1.04",8,Sigmoid,0.050861735,0.051433355,-88.92767334,4.1904,WM88_SKIN,WM88,ACH-000899,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.967468387023929,2.2787134647369385
4256,7281,WM-983B,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-17,-26,-32,-69,-87,-90,-90","9.27,12.3,14.1,28.7,10.6,7.25,4.01,5.26",8,Sigmoid,0.0945023,0.087770343,-90.84373474,4.8064,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,-2.4330316144445367,2.1144766807556152
4257,7282,YKG1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-17,-10,-5.7,-7.9,-2.4,-17,-20","7.20,12.0,2.15,7.97,4.52,4.64,2.37,2.24",8,Constant,,8.0,-11.25757217,0.8278,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.6981515884399414
4258,7283,ZR-75-1,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-15,2.50,12.6,-4.8,-12,-9.2,-28","4.40,10.6,9.17,2.02,.40,17.7,5.29,6.93",8,Sigmoid,8.176895438,8.0,-27.31182861,0.7315,ZR751_BREAST,ZR751,ACH-000097,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.131967544555664
4259,7284,ZR-75-30,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,40.7,5.31,23.3,26.1,50.9,35.8,51.0","10.7,11.4,5.57,30.6,19.8,12.8,3.00,24.9",8,Linear,,8.0,-16.49059677,0.04301,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,3.3658952713012695
4260,7285,SCC-25,AZD6244,MEK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,1.45,17.5,3.26,14.5,2.62,-30,-40","16.0,10.2,9.03,4.60,3.90,4.33,7.48,.76",8,Sigmoid,1.651095033,8.0,-40.28552628,0.494,SCC25_UPPER_AERODIGESTIVE_TRACT,SCC25,ACH-000188,Head and Neck Cancer,15,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,MEK,MEK1 and MEK2 Inhibitor,Kinase inhibitor,Phase II,AstraZeneca,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2.0794415416798357,2.4808788299560547
4261,7286,A172,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,-4.7,-6.2,-3.6,-6.7,-4.4,-1.1,5.22",".46,5.09,2.01,4.49,.38,5.01,2.28,3.07",8,Constant,,8.0,-5.610572815,0.01494,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.26930046081543
4262,7287,A-204,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,11.7,-5.4,-.41,-4.3,.77,-5.4,-28","1.30,10.8,11.1,11.9,5.14,4.16,3.59,11.7",8,Sigmoid,7.102776051,8.0,-28.01687622,0.05216,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.084179878234863
4263,7288,A2058,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-5.7,.29,2.38,-.85,-18,-23,-29","4.57,5.34,6.42,3.02,.93,1.63,1.07,3.33",8,Sigmoid,0.698621452,8.0,-25.57912827,0.7129,A2058_SKIN,A2058,ACH-000788,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,3.9915027618408203
4264,7289,A-253,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-3.8,-.78,-5.6,9.58,5.64,-5.7,-19","9.02,12.5,5.30,8.32,2.43,6.17,6.98,6.76",8,Constant,,8.0,-0.517714977,0.1243,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.146704196929932
4265,7290,A2780,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-6.0,.31,.16,13.7,-.36,-.97,-39","3.20,12.5,10.3,6.02,6.03,14.3,4.74,12.3",8,Sigmoid,3.54411912,8.0,-41.61927795,0.3847,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.115506649017334
4266,7291,A-375,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-3.0,-3.5,-14,-51,-71,-78,-82","1.50,.79,.19,2.56,.41,.078,.057,.57",8,Sigmoid,0.202794954,0.258287698,-79.39503479,2.9645,A375_SKIN,A375,ACH-000219,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-1.3536812068050874,3.891125440597534
4267,7292,A549,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","3.29,1.96,1.63,1.64,1.08,2.38,3.40,-23","6.23,3.40,8.05,1.71,3.61,7.39,7.96,8.33",8,Sigmoid,6.212217331,8.0,-23.13142967,0.0,A549_LUNG,A549,ACH-000681,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.305110454559326
4268,7293,A-673,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-2.6,-5.0,7.09,-6.5,-7.9,-17,-27","8.86,8.30,1.47,.099,2.90,.18,2.16,14.1",8,Sigmoid,2.63427043,8.0,-26.22262192,0.7895,A673_BONE,A673,ACH-000052,Bone Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4226155281066895
4269,7294,ACHN,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,-5.1,.29,-2.8,7.01,4.57,-21,-37","3.28,1.70,7.75,16.4,5.64,4.22,2.08,7.06",8,Sigmoid,2.402731419,8.0,-36.74848175,0.3817,ACHN_KIDNEY,ACHN,ACH-000046,Kidney Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.3072190284729
4270,7295,ALL-SIL,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-9.6,4.73,5.45,-15,-3.5,-14,-56","9.35,2.06,1.48,6.11,22.2,8.63,7.43,1.65",8,Sigmoid,5.82069397,6.943338871,-55.72037125,1.0265,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.9377827641560612,4.296274662017822
4271,7296,AMO-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","8.06,14.7,-1.7,14.5,17.2,5.61,17.6,-40","5.47,4.08,10.7,.48,12.7,20.5,18.7,76.6",8,Constant,,8.0,11.15584469,0.4187,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4254984855651855
4272,7297,AsPC-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-.16,1.90,-8.0,-14,2.12,-3.0,-7.1,-21","9.70,8.28,7.92,10.2,4.41,9.34,14.0,24.0",8,Constant,,8.0,-0.366633981,0.2848,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.582551956176758
4273,7298,AU565,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,3.15,-9.2,-5.9,13.3,-14,5.56,-29",".088,4.64,7.44,8.57,3.40,9.10,1.87,5.92",8,Constant,,8.0,-6.279292583,0.6038,AU565_BREAST,AU565,ACH-000248,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.533875465393066
4274,7299,B-CPAP,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,3.60,3.80,4.08,-19,-30,-40,-51","1.64,2.44,.35,.40,.47,.23,3.88,1.84",8,Sigmoid,0.488040358,8.0,-48.13626862,1.2235,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.319452285766602
4275,7300,BDCM,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-36,10.9,-11,8.70,-17,20.4,-4.1,-7.0","2.37,26.2,31.8,11.0,10.4,11.7,.57,24.6",8,Constant,,8.0,-4.125534534,0.2138,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.335479259490967
4276,7301,BFTC-909,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,3.16,-6.3,-6.3,6.32,5.46,7.26,8.06","1.26,4.93,3.70,4.59,3.05,7.11,10.2,4.93",8,Constant,,8.0,0.588977039,0.1107,BFTC909_KIDNEY,BFTC909,ACH-000792,Kidney Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.209226608276367
4277,7302,BL-41,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-1.5,17.3,3.28,9.17,11.2,.24,-6.1",".81,10.2,4.84,5.63,3.07,5.09,6.37,4.22",8,Constant,,8.0,4.883123875,0.005313,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.331666946411133
4278,7303,BL-70,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,1.52,-1.8,7.84,-3.6,9.34,-18,-25","7.70,19.1,1.63,14.9,8.62,17.1,3.10,9.57",8,Sigmoid,2.152697563,8.0,-24.82916832,0.6149,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.319217681884766
4279,7304,BT-20,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","22.7,22.3,16.0,11.1,8.01,16.5,-3.6,-4.5","6.99,2.86,4.49,27.0,8.28,24.9,10.2,7.12",8,Constant,,8.0,13.25427437,0.0,BT20_BREAST,BT20,ACH-000536,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.7415242195129395
4280,7305,BT-474,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-13,22.4,-12,-9.9,-4.3,3.63,-13","16.9,8.77,28.8,19.1,15.5,7.09,8.90,1.87",8,Constant,,8.0,-4.505862713,0.1735,BT474_BREAST,BT474,ACH-000927,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.974717617034912
4281,7306,BT-549,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,1.30,-4.5,-9.8,-2.9,-3.6,-19,-46","3.57,18.7,3.16,5.93,9.83,7.08,11.1,2.71",8,Sigmoid,2.96090889,8.0,-45.56085205,0.4886,BT549_BREAST,BT549,ACH-000288,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.499490737915039
4282,7307,BxPC-3,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","10.7,-3.7,17.7,14.3,35.8,19.5,-40,-60","12.5,19.8,.18,.31,15.0,4.29,37.2,28.8",8,Sigmoid,2.096042395,3.000696659,-60.71613693,0.8857,BXPC3_PANCREAS,BXPC3,ACH-000535,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.098844481375963,4.485154151916504
4283,7308,C2BBe1,PLX4720,RAF,".0080,.025,.080,.25,.80,2.53,8","-15,-23,-5.3,17.9,8.74,-1.4,-.83","2.04,9.57,16.9,6.09,13.2,1.21,21.1",7,Linear,,8.0,-25.2866993,0.4087,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.5562663078308105
4284,7309,C32,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,8.28,8.34,-.45,-18,-39,-42,-74","6.72,6.12,1.52,.0044,9.95,6.69,6.06,3.79",8,Sigmoid,1.607520461,2.206977606,-70.74720764,1.2483,C32_SKIN,C32,ACH-000580,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,0.7916239804175017,4.077445030212402
4285,7310,CAL-12T,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-13,-1.1,3.90,4.58,-3.5,-5.4,-57","20.6,3.39,4.57,.018,1.39,11.0,4.54,3.03",8,Sigmoid,4.246960163,5.935973167,-56.78736496,0.5977,CAL12T_LUNG,CAL12T,ACH-000826,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.7810309854707653,4.4698662757873535
4286,7311,CAL 27,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,1.70,1.53,.44,5.49,8.84,-7.3,-7.5","4.89,3.05,2.57,2.58,.82,4.25,.50,7.59",8,Constant,,8.0,-0.259093165,0.0,CAL27_UPPER_AERODIGESTIVE_TRACT,CAL27,ACH-000832,Head and Neck Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.427292823791504
4287,7312,CAL-85-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-12,-11,-41,-11,-12,-14,-5.5","12.5,16.0,7.71,48.1,5.27,21.4,11.1,28.3",8,Constant,,8.0,-11.49657345,0.2709,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.504236698150635
4288,7313,Calu-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,-6.2,-5.9,3.84,3.05,10.2,9.62,-.10","16.1,9.59,.91,2.23,7.39,6.38,11.8,10.7",8,Constant,,8.0,2.044317245,0.0,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.852787494659424
4289,7314,Calu-3,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","1.15,3.96,-11,17.6,6.01,18.1,7.61,-.80","2.74,21.5,4.61,27.6,26.3,20.8,16.9,.38",8,Constant,,8.0,-0.60958308,0.003985,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.70623254776001
4290,7315,Calu-6,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","5.11,-10,15.8,-9.1,13.5,-2.8,-28,-72","23.4,6.77,26.2,19.1,.33,16.5,5.96,28.3",8,Linear,,0.809417602,-71.1733551,1.0378,CALU6_LUNG,CALU6,ACH-000264,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-0.21144029980376736,4.313515663146973
4291,7316,CAMA-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","3.75,-6.1,-3.8,-6.5,2.61,4.03,-6.6,7.29","2.57,.80,.95,1.18,.63,1.70,6.80,6.01",8,Constant,,8.0,-0.009278068,0.07136,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.544223308563232
4292,7317,Capan-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-18,-24,14.9,27.6,12.1,-9.9,9.04","20.5,8.40,19.0,36.1,6.29,56.1,6.84,2.19",8,Linear,,8.0,-18.54336929,0.3741,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.780998229980469
4293,7318,CAS-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,6.98,-1.6,11.5,-3.3,12.2,-12,.80","3.31,6.81,11.8,5.91,8.95,9.64,7.23,21.6",8,Constant,,8.0,2.550043344,0.06697,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.526804447174072
4294,7319,CCK-81,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","7.66,-11,32.7,2.99,-19,-9.1,15.3,14.3","12.0,31.2,51.1,4.98,10.9,13.5,25.2,8.88",8,Constant,,8.0,-0.216815099,0.2626,CCK81_LARGE_INTESTINE,CCK81,ACH-000963,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.537630558013916
4295,7320,CHP-212,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,7.15,-19,-1.4,46.4,10.8,5.36,-4.8","2.71,2.61,3.81,47.5,4.31,27.1,9.41,2.17",8,Constant,,8.0,-2.148559809,0.3921,CHP212_AUTONOMIC_GANGLIA,CHP212,ACH-000120,Neuroblastoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.332413673400879
4296,7321,CI-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,29.9,19.3,14.6,24.3,9.90,24.0,6.03","30.0,7.79,9.76,50.1,66.4,36.0,2.93,4.55",8,Constant,,8.0,17.40524864,0.1793,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.027548789978027
4297,7322,COLO-320,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-.32,1.97,-9.1,3.38,.19,-.61,-1.4,-32","7.99,2.76,7.35,4.71,1.13,2.96,7.12,6.52",8,Sigmoid,7.52420187,8.0,-32.21826172,0.2642,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.241835117340088
4298,7323,COLO-678,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","1.32,-10,16.4,6.53,7.10,10.8,16.3,-25","6.09,6.59,5.88,4.44,2.39,8.50,3.27,2.19",8,Linear,,8.0,-24.67886925,0.4074,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.870398998260498
4299,7324,COLO-679,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,-5.9,2.43,-14,-21,-63,-74,-82","2.46,13.9,.25,8.67,4.37,2.21,2.82,1.00",8,Sigmoid,0.449920207,0.554165304,-79.57104492,2.2166,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-0.5902922540706292,4.2052083015441895
4300,7325,COLO 741,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","12.5,14.3,-1.7,-12,22.9,-26,-40,-68","5.33,13.6,4.18,15.4,3.04,13.6,10.2,1.38",8,Sigmoid,8.193477834,4.03970623,-67.99868774,1.3751,COLO741_SKIN,COLO741,ACH-000582,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.396171973982635,4.245210647583008
4301,7326,COR-L105,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-25,6.89,-5.9,-7.4,1.42,-14,-16","15.3,2.25,5.90,7.98,27.0,12.1,6.99,2.43",8,Constant,,8.0,-10.22265339,0.3126,CORL105_LUNG,CORL105,ACH-000161,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.569088459014893
4302,7327,COR-L23,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".17,-3.0,-.80,-4.9,8.94,5.73,11.4,-7.5","4.91,14.1,4.67,8.24,3.03,6.08,1.86,2.97",8,Constant,,8.0,-2.578454971,0.0,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.522078514099121
4303,7328,COV318,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,-3.5,-8.4,-7.3,5.58,33.0,-14,-4.5","18.9,20.8,10.2,7.61,17.4,6.93,12.8,16.2",8,Constant,,8.0,-3.649721384,0.5288,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.695933818817139
4304,7329,COV504,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,10.2,-15,1.61,.098,11.8,3.94,4.39","6.95,.34,1.36,14.2,13.5,26.6,5.36,31.0",8,Constant,,8.0,-2.807261467,0.1145,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.59926176071167
4305,7330,Daoy,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,-3.5,-.55,-1.8,5.41,-.098,-2.5,-31","4.46,1.09,7.99,.088,6.58,11.5,2.33,11.9",8,Sigmoid,4.572468758,8.0,-30.57449532,0.2072,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.130862712860107
4306,7331,DBTRG-05MG,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","2.09,-6.1,-5.0,-9.9,-20,-39,-44,-73","11.7,.51,4.28,15.9,3.57,2.05,6.18,4.44",8,Sigmoid,8.567197854,2.652912855,-71.28643799,1.8659,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,0.9756582268965416,4.475796699523926
4307,7332,Detroit 562,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-7.9,-1.3,-1.8,-3.9,-4.9,-3.1,6.03","7.62,16.6,1.94,20.7,.73,.76,9.24,14.3",8,Constant,,8.0,-3.936322689,0.1153,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.461756229400635
4308,7333,DK-MG,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,-1.1,-11,8.20,-.57,24.2,-1.5,1.79","5.99,6.66,3.16,8.11,5.79,21.0,.35,4.72",8,Constant,,8.0,-1.312457323,0.0,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.415339946746826
4309,7334,DMS 114,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","2.91,1.70,.37,8.88,10.3,21.5,16.6,3.36","7.89,1.59,10.6,25.8,20.4,10.4,32.8,8.17",8,Constant,,8.0,5.091643333,0.06617,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.930721759796143
4310,7335,DOHH-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,34.8,.22,31.5,49.4,18.3,19.3,-22","40.5,7.06,38.7,35.3,60.1,33.0,58.5,3.37",8,Constant,,8.0,10.64884186,1.3751,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.47667121887207
4311,7336,DV-90,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,11.4,-2.0,15.1,2.11,-4.0,53.0,13.1","39.5,69.1,37.7,22.6,16.4,7.74,38.1,25.1",8,Constant,,8.0,7.070795536,0.09542,DV90_LUNG,DV90,ACH-000925,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.419724941253662
4312,7337,EB1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","15.0,20.8,4.95,21.9,23.2,29.7,-4.5,-8.8","33.2,3.90,39.4,11.5,24.5,12.8,18.1,10.0",8,Constant,,8.0,16.20677757,0.1546,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.117218494415283
4313,7338,EBC-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","13.4,3.62,18.6,5.36,16.7,27.8,-.81,-17","16.7,1.66,4.90,13.2,15.9,7.07,16.2,5.97",8,Sigmoid,2.590489626,8.0,-17.23865128,0.07623,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.476160049438477
4314,7339,EFE-184,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,-1.7,7.59,9.94,6.25,7.69,-3.1,.35","7.58,13.8,8.07,1.61,20.3,2.83,3.17,1.10",8,Constant,,8.0,1.649572372,0.0,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.603514194488525
4315,7340,EFM-19,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".41,-1.9,-2.8,2.83,1.93,3.59,5.16,5.05","6.13,6.33,1.39,4.02,.31,13.6,9.40,3.50",8,Constant,,8.0,1.932400823,0.0,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.6818342208862305
4316,7341,EFO-21,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.0,-11,3.20,-7.6,-.45,-.82,6.77,-39","1.39,14.9,25.0,1.39,7.07,24.5,6.64,12.2",8,Sigmoid,7.295510769,8.0,-38.68314743,0.2946,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.607219219207764
4317,7342,EM-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-.70,-5.4,-.36,-3.0,-3.8,6.81,2.26,-45","14.5,14.5,7.91,7.99,17.4,21.3,7.62,3.73",8,Sigmoid,7.605941296,8.0,-45.14320374,1.0564,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.433712482452393
4318,7343,EN,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","2.17,6.65,11.5,-2.3,10.2,9.02,18.7,10.9","5.44,13.5,12.3,6.52,11.2,11.0,7.33,2.17",8,Constant,,8.0,7.627213478,0.0,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.372421741485596
4319,7344,ES-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,13.1,-3.9,15.1,-2.6,2.72,-38,-48","8.30,.20,4.68,3.76,11.1,11.4,1.42,4.23",8,Sigmoid,1.899696112,8.0,-48.19634628,0.8935,ES2_OVARY,ES2,ACH-000906,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.295422077178955
4320,7345,ESS-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.9,.88,-18,-5.4,6.90,.26,-.011,-39","7.43,11.5,10.1,10.1,.33,3.73,2.59,4.31",8,Sigmoid,7.498805046,8.0,-38.48992538,0.8378,ESS1_ENDOMETRIUM,ESS1,ACH-000913,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.191689968109131
4321,7346,F-36P,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,5.15,33.5,.17,14.2,11.0,51.9,-28","22.8,7.35,15.6,14.5,12.8,38.4,15.0,13.5",8,Constant,,8.0,9.623569489,0.3779,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.354789733886719
4322,7347,FaDu,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,3.16,-10,.46,3.56,18.4,-.49,-7.8","3.44,4.73,15.5,6.33,13.4,8.48,11.6,3.75",8,Constant,,8.0,-1.877918482,0.2541,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4461822509765625
4323,7348,FU97,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-12,9.04,13.5,15.2,-6.7,-16,-44","2.72,10.7,8.56,12.2,27.1,11.4,6.14,4.18",8,Sigmoid,6.384712219,8.0,-43.77591705,0.6619,FU97_STOMACH,FU97,ACH-000633,Gastric Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.12741231918335
4324,7349,FU-OV-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-14,-19,-.99,.085,12.8,24.8,3.26","8.90,6.83,.90,9.48,36.6,29.1,18.1,.41",8,Linear,,8.0,-17.74464417,0.1328,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.262712001800537
4325,7350,G-361,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".28,17.5,-7.5,7.43,-12,-37,-66,-79","6.92,6.79,10.0,14.4,15.7,5.60,1.06,.20",8,Sigmoid,0.924262345,1.286707997,-79.34484863,1.8445,G361_SKIN,G361,ACH-000572,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,0.2520870163134541,3.98225736618042
4326,7351,G-401,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,4.25,-15,-1.4,.93,2.55,-5.1,-26","11.3,1.30,3.86,.94,8.32,13.9,.097,15.9",8,Constant,,8.0,-4.82958889,0.5567,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.033830165863037
4327,7352,G-402,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,7.51,-12,-7.8,5.17,-2.9,12.3,-19","9.79,9.91,2.95,7.57,13.7,16.8,26.8,11.5",8,Constant,,8.0,-7.768877983,0.1487,G402_SOFT_TISSUE,G402,ACH-000375,Kidney Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.230331897735596
4328,7353,GAMG,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","9.30,-20,6.54,3.64,5.96,.45,4.63,-.74","6.92,9.57,2.96,.71,1.54,1.14,23.4,9.49",8,Constant,,8.0,4.339282036,0.154,GAMG_CENTRAL_NERVOUS_SYSTEM,GAMG,ACH-000098,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.442347526550293
4329,7354,GB-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,5.51,-10,5.13,-25,-3.6,-27,-52","14.2,7.17,10.1,9.79,34.6,9.41,6.70,2.51",8,Sigmoid,2.528630733,4.628991127,-52.18955231,0.845,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.5323389452186076,4.446666717529297
4330,7355,GCT,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","1.07,-1.4,-2.9,-1.1,-15,-24,-34,-60","1.23,2.90,2.66,20.8,7.35,7.90,1.29,.92",8,Sigmoid,8.703121904,5.271176815,-59.38286972,1.5137,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.6622536421785996,4.3068366050720215
4331,7356,GI-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,2.12,-14,-4.0,5.51,-.57,-18,-13","11.3,12.9,8.36,4.13,.87,11.7,9.42,.91",8,Constant,,8.0,-7.394528389,0.6865,GI1_CENTRAL_NERVOUS_SYSTEM,GI1,ACH-000756,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.161159992218018
4332,7357,GMS-10,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-.48,-7.1,8.93,-.42,6.09,-11,3.69","5.97,5.33,4.79,16.0,.43,6.39,2.06,4.39",8,Constant,,8.0,-0.417022377,0.06015,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.200109004974365
4333,7358,GRANTA-519,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,1.32,13.5,22.9,17.8,11.3,21.4,1.11","18.8,15.4,13.3,3.31,7.02,1.65,25.0,16.4",8,Constant,,8.0,11.83864403,0.1942,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.35574197769165
4334,7359,H4,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,-5.1,-.30,-2.9,14.8,-1.5,-6.7,-41","4.31,4.3e-4,2.27,.44,5.93,.17,7.10,44.1",8,Constant,,8.0,-2.450266838,0.6343,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.464043140411377
4335,7360,HARA,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,-7.5,-20,7.25,2.48,2.15,-16,.51","1.75,5.67,12.9,12.8,6.81,7.97,1.80,.52",8,Constant,,8.0,-2.619066715,0.1449,HARA_LUNG,HARA,ACH-000843,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.275963306427002
4336,7361,HCC1187,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,.80,-2.4,13.3,5.59,31.0,.35,5.02","8.62,14.8,6.93,8.57,2.04,12.7,8.35,7.09",8,Constant,,8.0,5.073982716,0.1792,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.60090446472168
4337,7362,HCC1395,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","3.62,9.79,-23,-6.9,19.0,23.3,4.95,18.2","16.4,20.2,2.54,2.61,11.3,12.2,13.6,2.92",8,Constant,,8.0,12.76879787,0.3832,HCC1395_BREAST,HCC1395,ACH-000699,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.364306926727295
4338,7363,HCC-15,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","2.77,1.97,1.92,9.24,13.2,11.4,-18,-9.6","7.62,19.3,7.29,18.5,12.2,9.22,6.29,13.0",8,Constant,,8.0,2.046608686,0.5192,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.541128635406494
4339,7364,HCC1569,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,-4.2,2.24,-3.1,-.51,19.2,-11,-15","10.0,9.89,16.5,13.0,11.1,19.3,7.67,8.49",8,Constant,,8.0,-6.94933176,0.01235,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.616227149963379
4340,7365,HCC1806,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","14.3,-1.1,-9.5,3.31,21.4,-.26,13.5,-22","8.71,2.13,6.43,7.52,.31,9.44,6.97,2.90",8,Constant,,8.0,3.164787292,0.2989,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.539599895477295
4341,7366,HCC1954,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-2.5,-7.6,8.60,7.79,18.7,-6.6,3.09","10.00,3.46,12.5,10.5,8.27,12.2,1.32,4.86",8,Constant,,8.0,1.167902708,0.02614,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.695873260498047
4342,7367,HCC2935,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-34,1.70,-24,7.03,-11,28.0,-18,16.4","11.5,10.7,26.1,12.8,65.2,40.5,10.3,12.6",8,Constant,,8.0,-3.451612234,0.7655,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.578226089477539
4343,7368,HCC4006,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,-3.6,7.80,3.95,-2.1,-1.7,-4.3,-11","12.8,8.69,6.45,.34,8.19,12.9,2.38,10.3",8,Constant,,8.0,-0.270361781,0.08633,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.613169193267822
4344,7369,HCC-44,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,2.24,-7.1,-1.8,.77,8.17,-12,-20","5.91,.0029,8.56,3.11,2.27,3.67,4.51,.93",8,Constant,,8.0,-2.634681225,0.5668,HCC44_LUNG,HCC44,ACH-000667,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4958906173706055
4345,7370,HCC-56,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","6.72,6.01,-7.1,-10,15.6,11.5,1.71,15.3","12.7,16.1,.63,5.30,6.26,6.55,8.46,.57",8,Constant,,8.0,7.223081589,0.0,HCC56_LARGE_INTESTINE,HCC56,ACH-000467,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.3601298332214355
4346,7371,HCC70,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-4.1,6.57,-7.4,4.53,.36,-3.2,-1.2","16.3,6.66,5.04,4.42,2.77,8.60,17.0,5.95",8,Constant,,8.0,-2.268801689,0.05906,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.525728702545166
4347,7372,HCC-78,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,-.062,-3.1,-3.9,-13,-1.4,-8.1,2.47","2.97,10.2,.31,3.01,.84,6.86,2.78,15.8",8,Constant,,8.0,-4.989404202,0.2376,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.620682239532471
4348,7373,HCC827,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,-24,-7.3,-5.1,-15,27.5,.042,1.68","27.8,32.1,29.9,.76,20.8,13.5,3.02,14.7",8,Constant,,8.0,-2.189546585,0.3699,HCC827_LUNG,HCC827,ACH-000012,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.444337368011475
4349,7374,HCT 116,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,1.96,-1.8,15.4,-3.7,11.0,6.41,-2.5","7.25,5.45,11.5,1.39,36.8,.34,11.9,.035",8,Constant,,8.0,2.032201052,0.171,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.299982070922852
4350,7375,HCT-15,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-.59,1.76,1.00,-2.6,7.64,-4.2,.36,-32","9.07,1.07,.048,5.18,24.2,7.44,19.2,2.72",8,Sigmoid,8.001684309,8.0,-32.35224152,0.1654,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.54801082611084
4351,7376,HD-MY-Z,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-7.5,-5.9,2.02,-4.2,-4.7,-9.9,-55","2.11,6.76,4.28,5.68,2.55,8.81,6.97,4.24",8,Sigmoid,4.150444984,6.105682373,-54.56596756,0.7874,HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HDMYZ,ACH-000190,Unknown,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.8092198741257257,4.159574031829834
4352,7377,HDQ-P1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-33,3.42,-1.7,-8.7,2.34,4.43,-4.2","10.7,.10,5.17,7.31,13.0,21.3,5.11,5.58",8,Constant,,8.0,-2.917572737,0.3534,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.576816082000732
4353,7378,HEC-151,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".97,8.60,8.23,9.61,6.73,33.3,13.8,24.9","9.89,14.4,14.9,2.80,17.7,12.3,3.65,22.3",8,Constant,,8.0,11.41045761,0.0,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.027406215667725
4354,7379,HEC-1-A,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-2.5,8.17,-6.1,9.50,24.5,2.47,-22","5.23,5.60,32.5,36.1,35.3,4.04,27.0,3.16",8,Constant,,8.0,-9.878314018,0.2945,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.337498188018799
4355,7380,HEC-1-B,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","20.1,-18,2.05,1.71,51.9,22.0,28.6,-26","12.7,5.32,1.58,1.59,7.76,20.9,31.6,25.2",8,Linear,,8.0,-23.76234627,0.3746,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.317004680633545
4356,7381,HEC-251,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,2.33,-14,-14,-.15,10.8,1.62,.68","3.72,18.6,7.94,2.16,4.58,16.7,22.1,8.44",8,Constant,,8.0,-3.559362411,0.1457,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.546224594116211
4357,7382,HEC-265,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,9.14,-12,-6.8,1.49,.97,-9.1,8.09","8.73,7.85,1.25,3.38,2.89,4.30,9.42,5.72",8,Constant,,8.0,-2.336497068,0.215,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.177598476409912
4358,7383,HEC-59,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,-2.2,.051,4.34,-.59,-6.0,-9.0,-25","7.45,4.96,3.13,2.29,9.16,1.88,9.62,4.77",8,Sigmoid,8.116057058,8.0,-24.4785099,0.1145,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.343432903289795
4359,7384,HEC-6,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","2.23,-20,16.6,8.84,32.9,30.6,3.89,-11","11.1,15.8,51.3,6.67,2.07,19.4,23.4,29.7",8,Constant,,8.0,9.27556324,0.9701,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.5107855796813965
4360,7385,HEL 92.1.7,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-.38,-6.1,.25,-1.8,8.07,.44,-3.8,-8.2","2.84,1.90,9.91,7.46,5.52,6.87,4.82,8.30",8,Constant,,8.0,-2.452172518,0.09693,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.15106725692749
4361,7386,Hep 3B2.1-7,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,28.8,2.48,9.68,23.9,8.26,-12,4.63","6.28,23.1,6.62,22.2,.16,1.85,12.2,13.6",8,Constant,,8.0,6.957102776,0.2675,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.521571159362793
4362,7387,Hep G2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","8.44,-.98,-18,-7.3,-13,-21,-41,-61","1.32,7.36,7.69,24.8,37.3,5.86,5.26,3.33",8,Sigmoid,9.10297665,4.706068516,-60.77504349,1.1158,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.5488528494852032,4.4692583084106445
4363,7388,HGC-27,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,-.10,-4.7,4.91,5.75,-.30,-6.3,-24","2.19,1.20,8.63,2.36,4.81,5.68,3.16,3.88",8,Sigmoid,4.040738106,8.0,-24.04488182,0.2173,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.19254732131958
4364,7389,HH,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","9.05,14.3,-12,4.28,25.2,33.0,6.29,-7.3","20.0,17.7,10.8,4.37,21.5,.12,8.13,5.66",8,Constant,,8.0,4.850764275,0.1086,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.204437255859375
4365,7390,HLF,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,1.35,-13,-5.0,-4.5,-.85,-5.8,-24","3.12,6.73,9.33,7.67,6.50,4.79,.80,.77",8,Constant,,8.0,-6.326461315,0.5801,HLF_LIVER,HLF,ACH-000393,Liver Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.194942951202393
4366,7391,HMC-1-8,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-8.6,-4.8,-4.5,6.33,8.54,9.66,-.21","3.20,4.55,8.62,.32,3.94,9.30,3.36,8.35",8,Constant,,8.0,-1.384085536,0.07445,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.230926036834717
4367,7392,HMCB,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-9.6,-11,-1.3,-5.3,.18,-16,-43","8.01,11.5,5.12,2.23,5.00,1.51,1.62,5.36",8,Sigmoid,3.051427126,8.0,-42.98620224,0.4418,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.097593784332275
4368,7393,HOS,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.2,21.3,4.32,18.6,-18,11.0,8.28,1.66","8.03,15.5,3.42,12.2,3.13,38.9,14.3,22.9",8,Constant,,8.0,4.317868233,0.1291,HOS_BONE,HOS,ACH-000613,Bone Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.274622917175293
4369,7394,HPAC,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,9.24,10.2,8.84,22.3,1.73,-33,-34","4.79,42.5,13.7,34.2,5.70,5.30,17.2,50.7",8,Linear,,8.0,-38.96272659,0.8802,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.660294055938721
4370,7395,HPAF-II,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,4.05,7.36,3.58,7.49,25.6,-24,-3.0","10.2,16.9,34.6,49.0,53.9,86.9,.27,.51",8,Constant,,8.0,-7.168582916,0.2772,HPAFII_PANCREAS,HPAFII,ACH-000094,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.904703140258789
4371,7396,Hs 294T,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,2.38,-7.3,-3.6,4.48,-2.4,-24,-39",".26,3.07,3.09,4.60,2.42,1.38,8.13,4.33",8,Sigmoid,2.328400135,8.0,-38.53512955,0.6301,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.3893280029296875
4372,7397,Hs 578T,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,-7.1,1.77,6.75,8.15,11.1,-8.4,-35","2.13,3.98,13.7,6.04,.011,6.09,8.51,45.1",8,Sigmoid,2.436517715,8.0,-17.66795731,0.3128,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.43837833404541
4373,7398,Hs 683,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,-5.1,3.69,-5.8,4.36,.97,-4.6,-18","7.04,6.73,3.24,13.3,7.85,10.3,13.0,3.76",8,Constant,,8.0,-4.012074947,0.1648,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.0996503829956055
4374,7399,Hs 695T,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.9,-11,-3.9,4.06,-.84,-6.3,-25,-51","11.8,1.64,8.55,4.73,.030,9.08,4.45,.014",8,Sigmoid,2.851969004,7.264561176,-50.83710861,0.752,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.9830078927203105,4.546744346618652
4375,7400,Hs 729,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","8.37,4.38,12.2,-.94,7.55,-2.5,3.35,-27","18.5,1.60,3.13,8.48,16.3,5.97,12.1,10.2",8,Sigmoid,7.39130497,8.0,-26.55585289,0.2016,HS729_SOFT_TISSUE,HS729,ACH-000133,Unknown,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.3300580978393555
4376,7401,Hs 746T,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","7.40,-13,-5.4,-6.3,-2.2,8.35,3.01,-1.8","1.76,13.0,8.36,17.8,.60,11.5,1.74,3.84",8,Constant,,8.0,0.43914479,0.2152,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.479868412017822
4377,7402,Hs 766T,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","12.2,12.4,-14,19.2,5.46,48.7,7.82,4.08","9.44,13.5,13.3,11.3,6.86,6.17,22.5,13.6",8,Constant,,8.0,10.85968494,0.09305,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.337718963623047
4378,7403,Hs 852.T,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.7,-4.0,.89,5.67,-2.4,9.71,9.65,1.41","15.7,8.59,2.85,5.00,8.95,15.4,7.16,6.03",8,Constant,,8.0,2.065104485,0.1203,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.420019149780273
4379,7404,Hs 936.T,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-4.1,-1.4,-.61,-1.1,8.66,-6.2,-48","4.20,.34,4.16,3.58,14.2,6.43,11.2,15.6",8,Sigmoid,3.985270739,8.0,-47.41249084,0.5499,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,3.384678363800049
4380,7405,Hs 939.T,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","3.01,10.2,2.46,1.17,-2.4,-29,-52,-61","11.1,15.9,5.23,15.9,9.47,5.79,.37,.067",8,Sigmoid,0.847466707,2.102822304,-60.82820511,1.2778,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,0.7432803967168718,4.2448625564575195
4381,7406,Hs 944.T,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,-1.9,1.08,-4.6,10.8,8.12,-18,-51","7.87,6.25,13.3,3.10,5.43,11.9,9.54,1.16",8,Sigmoid,2.805363655,5.65844059,-51.26690674,0.7113,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.7331483401198242,4.121159076690674
4382,7407,HSC-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-.73,5.76,-4.1,-2.4,-3.7,-1.9,1.09,10.8","9.73,2.90,.60,2.95,.99,3.36,.47,1.15",8,Constant,,8.0,-0.071864046,0.2626,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.392802715301514
4383,7408,HT,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","14.4,16.8,21.7,33.5,29.9,5.69,15.6,5.38","22.4,49.8,41.8,39.7,24.3,31.8,13.5,57.3",8,Constant,,8.0,19.14817619,0.0,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4219489097595215
4384,7409,HT-1080,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".48,1.97,3.80,3.84,2.34,2.70,-15,-18","4.07,3.93,2.70,2.86,1.17,3.26,11.1,4.98",8,Sigmoid,1.891530514,8.0,-18.03840828,0.07934,HT1080_SOFT_TISSUE,HT1080,ACH-000054,Sarcoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,3.893019676208496
4385,7410,HT-1197,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,-5.2,7.15,1.26,.48,-4.6,6.20,-7.8","3.02,2.56,6.35,12.4,19.7,5.79,1.52,14.3",8,Constant,,8.0,-0.432484061,0.0,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.562380790710449
4386,7411,HT-144,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,2.36,-13,-13,-29,-37,-55,-72","8.98,1.92,9.89,6.97,.39,12.7,2.91,.76",8,Sigmoid,0.829790115,1.336324811,-71.07971191,2.267,HT144_SKIN,HT144,ACH-000322,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,0.28992316757107633,4.171027660369873
4387,7412,HuCCT1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","2.25,-1.6,2.77,-.60,-1.9,-2.9,.10,-21","4.22,2.49,5.99,1.90,6.28,.44,5.88,4.04",8,Sigmoid,8.116095853,8.0,-21.02931404,0.2696,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.490731716156006
4388,7413,huH-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-6.4,-5.8,4.39,17.2,24.6,-4.4,-15","11.7,16.1,2.70,24.6,3.79,6.31,6.67,21.1",8,Linear,,8.0,-15.41987896,0.09978,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.266806602478027
4389,7414,HUP-T3,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,-2.8,-7.5,6.18,-5.3,6.88,14.1,-4.1","22.9,12.4,22.0,21.2,.82,20.3,5.07,7.92",8,Constant,,8.0,-5.335407734,0.1687,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.82930326461792
4390,7415,HuT 78,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,22.4,6.87,35.4,30.8,65.0,6.92,92.0","12.6,31.8,12.5,45.6,62.7,7.44,14.9,73.7",8,Constant,,8.0,16.058218,0.109,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4559550285339355
4391,7416,IA-LM,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-2.2,-13,-2.3,-6.9,-2.1,7.15,-19","11.9,27.0,22.2,36.2,2.21,13.9,18.3,6.33",8,Constant,,8.0,-6.877966881,0.3496,IALM_LUNG,IALM,ACH-000672,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.396036624908447
4392,7417,IGR-37,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.3,5.94,-2.6,-16,-24,-44,-66,-64","8.12,4.45,3.31,7.71,5.53,13.6,.78,7.09",8,Sigmoid,0.401444614,0.904429674,-67.25234222,2.2723,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-0.10045072841335301,4.086777210235596
4393,7418,IGR-39,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.3,-3.4,-2.4,.87,15.1,2.40,-13,-30","22.4,6.08,19.7,1.16,3.84,2.84,1.45,16.0",8,Sigmoid,2.593881369,8.0,-29.76954079,0.187,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.2545695304870605
4394,7419,IMR-32,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","8.03,16.9,6.96,17.8,9.47,12.3,.97,-95","34.6,7.66,21.1,16.9,.48,7.85,5.26,.14",8,Sigmoid,8.064737108,5.588811874,-94.31872559,0.9383,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.720766719674529,4.46317720413208
4395,7420,IPC-298,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".049,10.3,9.06,5.98,-3.9,-11,-15,-49","2.38,1.59,2.10,12.4,4.96,6.45,3.67,1.82",8,Sigmoid,8.615665324,8.0,-47.75841522,0.5122,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.295302867889404
4396,7421,IST-MES2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,-5.3,-13,2.07,-8.0,7.42,-17,-84","1.75,1.90,11.6,9.93,9.70,6.73,7.90,1.06",8,Sigmoid,3.47233057,3.671973228,-84.49968719,1.2888,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.3007291818819926,4.367672443389893
4397,7422,J82,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","1.37,-8.9,8.06,1.93,1.83,-2.1,11.6,-2.1","3.94,14.0,4.31,7.26,7.06,13.6,8.58,5.29",8,Constant,,8.0,2.709051609,0.05758,J82_URINARY_TRACT,J82,ACH-000396,Bladder Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.48390531539917
4398,7423,JHH-4,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".34,-5.8,-1.1,-8.9,6.02,21.0,-19,-53","1.98,9.31,7.09,4.60,15.5,11.3,22.4,17.4",8,Sigmoid,2.80483532,4.928554535,-52.77037048,0.7605,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.5950457472949668,4.30559778213501
4399,7424,JHOS-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-1.9,15.9,-.58,20.6,5.92,-.14,-27","13.4,16.7,4.98,6.58,26.4,4.42,1.37,4.06",8,Sigmoid,3.434293985,8.0,-26.96213531,0.6494,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.593571662902832
4400,7425,JHUEM-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-12,-17,-17,-.11,-5.8,-15,-17","14.4,16.3,20.0,10.6,.75,4.19,4.63,24.1",8,Constant,,8.0,-9.060912132,0.5751,JHUEM2_ENDOMETRIUM,JHUEM2,ACH-000909,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.216523170471191
4401,7426,JM1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","5.82,10.9,40.9,10.9,30.7,6.25,-4.3,.50","30.8,3.42,9.10,1.48,23.2,2.20,9.38,17.8",8,Constant,,8.0,10.91869545,0.0,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.375335693359375
4402,7427,JMSU-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.6,1.25,-3.1,-.33,6.24,-.86,-17,-60","7.74,8.90,7.27,3.96,4.87,5.05,1.43,2.96",8,Sigmoid,3.365991354,5.027737141,-59.5222435,0.5902,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.6149700103240139,4.5838751792907715
4403,7428,JURKAT,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-9.9,-18,7.97,-8.7,-.77,-23,-66","4.87,5.22,15.1,2.23,7.11,12.6,7.33,1.75",8,Sigmoid,3.102253437,3.758895636,-65.6443634,1.4195,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.324125200429661,4.354034900665283
4404,7429,JVM-3,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","3.23,-20,.51,17.8,3.34,-23,-34,-80","2.57,7.13,7.05,5.79,12.5,7.53,8.56,5.68",8,Sigmoid,8.020359801,3.727098703,-79.61196136,1.7807,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.315630103376927,4.5084662437438965
4405,7430,K029AX,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,-7.7,-4.5,-15,-27,-42,-51,-55","13.6,2.59,13.5,1.08,4.94,.95,1.87,7.06",8,Sigmoid,0.349658072,2.110589266,-55.50765228,1.433,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,0.7469671814843157,4.151334285736084
4406,7431,KALS-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,-4.7,-9.7,3.84,-8.3,-3.1,-7.3,-33","3.45,11.7,10.6,3.04,7.53,2.66,14.2,2.12",8,Sigmoid,4.453267574,8.0,-33.16865921,0.615,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.291087627410889
4407,7432,KARPAS-422,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,6.25,-3.2,18.2,3.60,14.2,13.8,7.17","25.7,9.50,1.64,6.01,22.3,20.4,5.45,16.5",8,Constant,,8.0,11.37964058,0.0,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.428720951080322
4408,7433,KASUMI-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","1.56,-14,-5.8,.093,-2.1,3.65,-6.5,-28","11.7,1.55,10.9,6.55,13.0,12.8,6.58,11.4",8,Constant,,8.0,-5.584051132,0.6096,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.302096366882324
4409,7434,KCL-22,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,-5.2,.86,11.6,13.1,7.27,6.46,-24","2.31,6.19,3.45,10.0,12.8,27.7,.20,3.06",8,Sigmoid,8.098471191,8.0,-24.39005089,0.3954,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.2836737632751465
4410,7435,KG-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","10.5,-33,-7.2,33.3,-20,4.82,-11,9.07","8.19,11.1,30.2,20.5,7.05,5.28,3.10,58.0",8,Constant,,8.0,-3.574113846,0.6241,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.375175952911377
4411,7436,KHM-1B,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-.71,-1.8,-21,6.23,16.4,15.0,3.99,.58","1.47,11.2,17.0,.29,24.6,5.13,10.2,16.7",8,Constant,,8.0,3.004493713,0.2295,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.450800895690918
4412,7437,KMBC-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,-1.0,3.56,.45,.23,2.33,.40,-3.3",".026,1.86,1.87,3.68,.43,3.80,.52,2.70",8,Constant,,8.0,-0.004207737,0.0,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.639607906341553
4413,7438,KMM-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".13,-.85,9.95,37.1,-16,14.4,25.9,-3.6","6.16,6.47,7.68,21.3,17.4,8.72,24.2,5.20",8,Constant,,8.0,4.530965805,0.1556,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4990973472595215
4414,7439,KMRC-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-25,3.93,6.32,12.9,12.7,12.9,4.21,-7.5","4.43,7.00,9.17,3.62,5.34,7.70,2.18,1.61",8,Constant,,8.0,6.714067936,0.2211,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.412197589874268
4415,7440,KMRC-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","1.21,11.1,-10,-19,14.3,8.49,-7.6,-27","10.6,31.4,21.8,16.1,23.7,28.6,17.0,15.7",8,Constant,,8.0,-7.133453846,0.5086,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.059056758880615
4416,7441,KMS-11,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,-.43,3.85,7.64,5.20,7.87,2.44,13.7","2.59,5.83,16.0,4.44,6.15,20.4,10.4,1.04",8,Constant,,8.0,4.063287258,0.5022,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.380137920379639
4417,7442,KMS-12-BM,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","12.7,15.8,15.2,-11,4.87,38.0,26.1,-28","30.5,10.4,29.2,16.8,17.5,20.9,6.59,43.6",8,Linear,,8.0,-28.85858727,0.4044,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.396762847900391
4418,7443,KMS-34,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-10.0,-28,-23,21.0,-18,25.0,-.20,-26","0,0,0,0,0,0,0,0",8,Constant,,8.0,-13.8389864,1.258,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.434553623199463
4419,7444,KNS-60,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-2.4,5.06,-6.3,5.87,7.22,23.6,26.6","8.58,1.62,7.72,13.7,12.3,16.8,15.4,2.86",8,Linear,,8.0,-13.39118385,0.01322,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.461705684661865
4420,7445,KNS-62,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","10.2,-27,5.77,25.7,5.70,5.69,-12,-4.8","2.98,24.2,24.1,18.0,11.8,5.38,1.18,4.95",8,Constant,,8.0,0.294472307,0.2596,KNS62_LUNG,KNS62,ACH-000858,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.34460973739624
4421,7446,KNS-81,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.5,5.36,1.82,12.6,-4.8,-5.4,8.47,11.3","1.13,11.2,25.5,42.3,7.95,15.9,.44,10.2",8,Constant,,8.0,2.454200506,0.3015,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.467272758483887
4422,7447,KO52,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-.27,20.5,30.7,50.1,111,49.6,-17","2.86,14.6,15.2,5.67,27.8,6.59,2.12,4.52",8,Linear,,8.0,-19.63159752,0.6209,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.49798059463501
4423,7448,KP-N-SI9s,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,.95,-18,-.22,2.45,-2.1,-10,-39","1.78,4.37,.0073,6.56,13.7,9.05,6.68,5.22",8,Sigmoid,3.489583969,8.0,-38.81241608,0.7281,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.372395038604736
4424,7449,KU812,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","1.00,-15,9.28,2.98,15.1,.36,11.8,12.6","6.25,5.79,22.7,2.47,26.3,3.13,14.7,18.8",8,Constant,,8.0,1.662617087,0.1505,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.284420490264893
4425,7450,KYM-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,6.10,-4.7,2.10,23.4,-4.7,-4.9,-19","4.63,12.2,.10,16.9,17.3,7.60,29.9,11.6",8,Constant,,8.0,-4.362408161,0.1605,KYM1_SOFT_TISSUE,KYM1,ACH-000607,Rhabdoid,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,3.9779181480407715
4426,7451,KYSE-140,PLX4720,RAF,".025,.080,.25,.80,2.53,8","-5.5,.37,-2.1,-16,-22,-57","4.39,14.8,24.2,6.14,.68,5.12",6,Sigmoid,8.634032347,6.805239201,-56.32682037,0.4187,KYSE140_OESOPHAGUS,KYSE140,ACH-000823,Esophageal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.9176927862571471,4.324619770050049
4427,7452,KYSE-150,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".97,-6.1,-6.0,12.0,6.94,10.9,-5.1,-14","7.71,3.59,19.7,3.57,7.26,13.2,12.5,.27",8,Constant,,8.0,2.106756687,0.1422,KYSE150_OESOPHAGUS,KYSE150,ACH-000855,Esophageal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.563454627990723
4428,7453,KYSE-180,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-31,-24,-9.8,-5.0,-1.4,-15,-13,-37","4.87,1.51,19.1,1.63,18.1,14.4,16.5,3.56",8,Sigmoid,8.309860853,8.0,-37.45914459,0.5049,KYSE180_OESOPHAGUS,KYSE180,ACH-000693,Esophageal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.323476314544678
4429,7454,KYSE-30,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,-2.3,-4.7,-6.4,2.08,-.028,-11,-36","1.54,.090,1.23,5.16,1.80,.17,7.80,5.14",8,Sigmoid,3.180639505,8.0,-35.75482941,0.8567,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.642861843109131
4430,7455,KYSE-510,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","3.01,-3.4,-.13,9.98,-1.5,2.14,-7.9,-22","9.34,7.97,.017,21.0,3.92,5.09,5.99,8.19",8,Sigmoid,2.873656511,8.0,-21.77025414,0.4983,KYSE510_OESOPHAGUS,KYSE510,ACH-000824,Esophageal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.486351490020752
4431,7456,KYSE-520,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-.084,-5.9,4.73,1.54,13.2,4.25,-15","6.11,11.8,4.45,.51,4.84,1.97,2.02,15.1",8,Linear,,8.0,-15.71466255,0.2625,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.648182392120361
4432,7457,KYSE-70,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,-7.8,-20,-21,6.55,4.18,-15,-28","16.4,16.5,2.16,15.9,11.2,5.20,5.61,2.23",8,Constant,,8.0,-14.64668274,0.7607,KYSE70_OESOPHAGUS,KYSE70,ACH-000784,Esophageal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.2814764976501465
4433,7458,L3.3,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-8.0,-5.8,-1.9,.74,10.4,1.52,-20","2.68,9.66,3.53,3.60,6.92,16.7,4.17,11.4",8,Constant,,8.0,-5.799747944,0.3614,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.487748622894287
4434,7459,L-363,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","22.0,-2.5,-22,10.3,-12,3.84,1.88,-35","6.35,8.97,19.7,5.23,10.0,8.52,4.78,87.9",8,Constant,,8.0,1.09199059,0.9127,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.351031303405762
4435,7460,L-428,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,3.61,11.7,3.81,-4.4,6.69,-7.5,-41",".81,14.6,5.64,10.5,13.0,5.11,10.4,1.54",8,Sigmoid,3.235692739,8.0,-40.82012558,0.6253,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.479936599731445
4436,7461,LCLC-103H,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","2.66,7.82,1.79,5.42,11.6,6.09,6.52,-14","1.06,15.6,13.2,9.80,11.4,4.20,6.82,3.01",8,Constant,,8.0,3.332103252,0.08282,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.236145496368408
4437,7462,LN-229,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.3,-.43,-12,.35,11.1,-1.8,4.01,-12","1.50,4.43,10.3,5.85,19.4,4.27,6.94,11.2",8,Constant,,8.0,-2.550527811,0.1665,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.321704387664795
4438,7463,LOU-NH91,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-27,-5.8,-12,12.4,-16,-15,-28","18.4,40.2,5.67,7.99,1.61,10.8,19.1,18.3",8,Constant,,8.0,-9.039954185,1.1699,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.318291664123535
4439,7464,LOX IMVI,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.3,-.94,-5.6,-5.8,-6.1,-11,-33,-37",".19,1.13,6.27,8.83,3.20,.87,2.56,7.27",8,Sigmoid,1.317177534,8.0,-37.29179001,1.0243,LOXIMVI_SKIN,LOXIMVI,ACH-000750,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.063789367675781
4440,7465,LP-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","73.8,30.2,66.0,-9.8,34.0,-4.9,86.7,27.8","4.76,44.4,26.1,47.7,5.95,27.2,48.6,39.1",8,Constant,,8.0,43.31185913,0.3489,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4402899742126465
4441,7466,LS123,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-16,-8.7,-7.2,-.23,3.70,4.53,-6.9","1.12,12.0,5.67,6.86,14.9,46.9,1.46,3.77",8,Constant,,8.0,-4.65901804,0.5484,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.615182399749756
4442,7467,LS411N,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-10.0,-13,2.33,23.1,-25,-40,-68,-69","4.70,13.0,25.9,10.6,24.4,10.5,2.00,1.25",8,Sigmoid,0.798008144,0.925284624,-68.75892639,2.1759,LS411N_LARGE_INTESTINE,LS411N,ACH-000985,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-0.07765388717852537,4.408833026885986
4443,7468,LS513,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","25.9,-24,20.1,30.2,55.6,8.88,29.8,5.10","34.7,38.8,3.40,39.6,64.2,41.2,15.1,48.7",8,Constant,,8.0,18.8094635,0.2252,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.720146656036377
4444,7469,LU99,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,17.4,.13,18.0,-6.7,15.7,-31,-51","3.91,2.31,4.87,3.52,4.87,6.48,5.73,8.62",8,Sigmoid,2.227716208,4.744394779,-51.20467377,0.6577,LU99_LUNG,LU99,ACH-000444,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.5569638747171046,4.066951274871826
4445,7470,LUDLU-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","2.57,3.59,-6.0,-9.0,7.82,13.6,-1.4,-21","14.2,6.07,4.72,15.1,7.98,23.7,.0078,.36",8,Sigmoid,8.314210126,8.0,-21.29015923,0.1109,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.580358505249023
4446,7471,Malme-3M,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-3.1,-2.3,-20,-45,-81,-91,-91","4.73,3.47,2.49,9.98,4.40,7.16,4.07,.37",8,Sigmoid,0.276334286,0.285528094,-91.88554382,3.0335,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-1.2534148519252086,4.255779266357422
4447,7472,MCAS,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,-2.0,6.64,2.22,5.32,5.91,-2.6,-6.7","1.34,3.05,1.65,7.03,.91,1.54,4.72,7.32",8,Constant,,8.0,-0.333848149,0.0,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.532994747161865
4448,7473,MCF7,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","11.2,6.79,-34,-45,-34,-33,-52,-49","46.9,14.4,79.5,65.8,76.4,73.1,41.6,68.3",8,Constant,,8.0,-11.98044014,0.5813,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.754213333129883
4449,7474,MDA-MB-157,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","31.2,2.89,.89,-11,17.0,-.14,10.8,-1.1","9.71,8.35,22.1,.93,20.7,26.0,.54,6.23",8,Constant,,8.0,5.857423306,0.0486,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.247020721435547
4450,7475,MDA-MB-175-VII,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-12,-9.2,-7.9,-6.7,-6.1,-4.0,-3.2","18.7,24.9,16.7,4.04,18.2,15.4,1.36,12.4",8,Constant,,8.0,-5.079953671,0.3373,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.8052978515625
4451,7476,MDA-MB-415,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,4.23,3.52,-15,-5.5,8.09,12.0,-5.8","5.14,2.69,9.46,16.1,19.3,7.48,15.3,1.10",8,Linear,,8.0,-21.62174606,0.05878,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.608035564422607
4452,7477,MDA-MB-436,PLX4720,RAF,".0080,.025,.080,.25,.80,2.53,8","4.30,-7.8,-5.3,2.13,10.6,9.90,1.10","1.46,6.04,13.0,.76,17.4,14.2,1.23",7,Constant,,8.0,1.771779537,0.07696,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.444157123565674
4453,7478,MDA-MB-453,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,11.1,8.54,2.30,-5.0,-6.3,-2.1,-25","0,8.29,0,9.08,0,6.77,0,2.31",8,Sigmoid,8.458834104,8.0,-24.04188156,0.1361,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.587695598602295
4454,7479,MDA-MB-468,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-.66,-7.4,14.1,19.6,14.9,9.52,-2.2","9.14,8.44,11.8,9.08,4.59,12.9,.84,10.1",8,Constant,,8.0,5.629932404,0.1516,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.538113117218018
4455,7480,MEG-01,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-9.3,7.18,-9.0,4.68,7.01,-2.4,-13","18.3,8.59,8.18,15.9,11.3,18.2,11.4,1.53",8,Constant,,8.0,-3.215367556,0.5659,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.167102813720703
4456,7481,MEL-HO,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,-2.5,-9.6,-13,-41,-74,-78,-79","8.63,2.00,1.24,3.83,8.83,2.71,.19,2.55",8,Sigmoid,0.258539736,0.312976211,-79.06602478,2.9418,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-1.1616280945252613,3.9245896339416504
4457,7482,MES-SA,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.3,2.77,-.99,.30,4.87,5.35,-3.1,-7.0","5.64,1.87,2.16,4.20,1.82,5.61,.32,11.8",8,Constant,,8.0,0.651362896,0.02023,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.294894695281982
4458,7483,MeWo,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-1.6,13.5,22.0,-14,3.69,-23,-4.4","10.7,27.1,14.4,43.8,2.18,22.0,15.5,.088",8,Constant,,8.0,-6.777186394,0.1847,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.083990097045898
4459,7484,MFE-296,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-16,5.39,-8.7,2.86,-1.8,-4.0,-37","1.22,1.32,7.47,8.47,7.58,1.91,2.34,10.3",8,Sigmoid,6.209597111,8.0,-37.26781082,0.3759,MFE296_ENDOMETRIUM,MFE296,ACH-000879,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.2398834228515625
4460,7485,MG-63,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,4.20,-.85,4.88,4.97,9.96,-6.4,-7.4","7.07,8.78,4.32,5.16,4.00,4.80,8.99,1.12",8,Constant,,8.0,1.132577658,0.1757,MG63_BONE,MG63,ACH-000359,Bone Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.199286937713623
4461,7486,Mino,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,-6.3,10.9,18.7,4.05,-6.5,-31,-49","11.2,21.4,3.81,7.47,13.7,8.56,9.56,13.7",8,Sigmoid,1.826708555,8.0,-49.06587219,0.6648,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.472567558288574
4462,7487,MJ,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","11.0,-2.2,-3.7,-9.8,-.47,3.47,10.9,-5.7","9.98,12.3,44.8,13.1,3.63,2.99,11.2,27.2",8,Constant,,8.0,2.691875935,0.06624,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.18750524520874
4463,7488,MKN-45,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,13.8,1.07,14.5,7.18,6.43,5.06,-7.2","14.8,10.1,.43,12.7,4.98,4.00,11.8,4.85",8,Constant,,8.0,3.805671692,0.0819,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.601982116699219
4464,7489,MKN7,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","4.17,20.5,-25,12.8,-8.5,10.2,.29,12.9",".35,7.22,1.42,23.4,9.05,18.4,.017,7.48",8,Constant,,8.0,2.116399765,0.3992,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.549019813537598
4465,7490,MKN74,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-23,1.18,17.0,1.19,17.2,13.6,-12","23.2,4.62,7.77,11.4,25.1,.25,11.5,6.87",8,Linear,,8.0,-24.24282837,0.05401,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.447671413421631
4466,7491,MOLP-8,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-11,-6.9,32.7,13.9,.82,29.8,38.2","28.7,11.6,.21,8.93,22.2,15.6,11.7,5.98",8,Linear,,8.0,-18.62849998,0.333,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.42771053314209
4467,7492,MOLT-16,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,-22,10.7,9.96,1.36,-6.3,-4.7,-36","4.94,8.06,14.4,3.20,6.41,30.2,17.7,8.93",8,Linear,,8.0,-35.3088913,1.8282,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.043099403381348
4468,7493,MONO-MAC-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-10.0,-24,-36,-1.7,-3.8,18.1,7.43,-46",".38,19.3,8.14,21.9,21.3,8.43,9.68,15.5",8,Linear,,8.0,-46.71231842,1.403,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.466041088104248
4469,7494,MOR/CPR,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,18.1,-.26,-.60,1.82,11.4,2.23,-.35",".66,1.58,3.58,2.59,2.71,7.86,8.84,12.6",8,Constant,,8.0,1.626288414,0.0,MORCPR_LUNG,MORCPR,ACH-000851,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.409533977508545
4470,7495,MSTO-211H,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-11,-17,-21,-8.0,-2.8,-2.4,-46","3.26,8.87,.53,17.6,.53,16.7,.53,24.0",8,Sigmoid,7.339414597,8.0,-43.91520309,0.8892,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.2914910316467285
4471,7496,NCI-H1048,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".77,-12,9.11,8.99,-10.0,1.38,-1.8,-14","14.0,3.71,11.0,13.4,24.9,10.3,7.87,9.48",8,Constant,,8.0,-2.724458218,0.0554,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.60797643661499
4472,7497,NCI-H1092,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-12,-1.9,18.5,18.9,19.4,-3.1,13.7","12.0,8.03,1.64,10.5,11.3,20.7,.055,.75",8,Linear,,8.0,-16.46884537,0.06505,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.812617778778076
4473,7498,NCI-H1155,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-17,5.39,-13,.72,-1.5,-11,-47","24.2,2.98,3.30,20.4,13.0,17.2,5.84,22.4",8,Sigmoid,3.834075928,8.0,-47.36701584,0.581,NCIH1155_LUNG,NCIH1155,ACH-000980,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.41365385055542
4474,7499,NCI-H1184,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,10.8,45.2,29.5,28.0,19.6,-6.3,48.3","29.1,34.4,36.8,53.8,21.1,6.70,14.0,17.7",8,Constant,,8.0,17.91274261,0.136,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.8339009284973145
4475,7500,NCI-H1341,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,28.8,-5.5,-.17,-5.5,2.49,-8.3,-.26","27.4,48.8,28.1,19.6,13.1,22.9,24.7,17.9",8,Constant,,8.0,-0.250531942,0.03845,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.372059345245361
4476,7501,NCI-H1373,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,.48,2.57,-8.9,-17,3.98,-6.3,-31","10.0,16.3,11.9,.58,8.68,5.82,7.54,5.39",8,Sigmoid,7.18575573,8.0,-31.23604774,0.4231,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.763248920440674
4477,7502,NCI-H1568,PLX4720,RAF,".0080,.025,.080,.25,.80,2.53,8","4.52,-20,12.2,-4.5,10.3,-13,-57","11.0,10.2,3.40,16.5,12.2,7.93,12.5",7,Sigmoid,3.122279882,4.620815754,-56.90914917,0.9667,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.5305712596368468,4.591836452484131
4478,7503,NCI-H1648,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,8.83,-17,-18,8.93,.50,-7.6,-72","3.59,8.04,2.64,6.05,28.9,.51,.76,5.52",8,Sigmoid,5.36035347,5.766373158,-71.75011444,0.9942,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.7520433140836567,4.451894283294678
4479,7504,NCI-H1650,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,-1.2,-5.7,-5.2,8.99,2.93,-26,-22","1.09,7.28,1.04,6.33,1.35,11.0,15.8,7.50",8,Sigmoid,1.554338217,8.0,-23.45802116,0.3035,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.6349992752075195
4480,7505,NCI-H1651,PLX4720,RAF,".0080,.025,.080,.25,.80,2.53,8","-.50,.51,-14,9.67,20.3,12.0,-8.0",".048,8.39,3.72,.51,.17,5.56,10.6",7,Constant,,8.0,2.818040371,0.03442,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.591188907623291
4481,7506,NCI-H1792,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,5.31,.011,-3.4,13.9,15.8,-.53,-44","2.87,1.66,3.29,6.06,6.97,1.10,2.79,70.7",8,Constant,,8.0,1.770578027,0.4574,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.55303430557251
4482,7507,NCI-H1793,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,7.87,11.1,-2.7,11.6,20.8,20.3,13.9","20.7,14.6,36.4,10.6,10.7,37.8,27.5,1.85",8,Constant,,8.0,6.409754753,0.02881,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.5883402824401855
4483,7508,NCI-H1915,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-3.0,11.7,.32,3.41,1.06,.74,-26","42.0,22.6,51.5,29.7,12.8,20.1,6.63,14.8",8,Constant,,8.0,-4.384116173,0.1486,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.398738384246826
4484,7509,NCI-H1944,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,-9.5,1.43,-16,7.46,18.4,30.1,28.1","1.37,1.49,4.38,8.04,10.5,13.6,17.2,5.80",8,Linear,,8.0,-8.411784172,0.03804,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.353067398071289
4485,7510,NCI-H1975,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,8.43,5.75,-4.1,18.4,-1.2,-2.7,-20","2.93,5.09,7.85,.83,1.57,12.1,13.2,6.42",8,Sigmoid,4.19251585,8.0,-20.05789948,0.06596,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.614712238311768
4486,7511,NCI-H2009,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.9,-16,-2.4,3.94,8.13,1.57,-8.1,-26","9.40,9.27,41.9,11.4,11.9,11.7,14.9,1.99",8,Constant,,8.0,-4.960725784,0.4112,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.508093357086182
4487,7512,NCI-H2023,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-2.9,7.12,-5.7,20.4,10.7,7.70,9.23","6.76,3.93,29.7,3.95,2.64,12.7,10.5,22.9",8,Constant,,8.0,0.365228534,0.0,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.539150238037109
4488,7513,NCI-H2030,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","2.04,-7.2,-2.5,-.95,4.74,1.61,7.33,-23","5.27,0,.24,1.64,3.67,3.19,3.71,4.24",8,Sigmoid,7.242505074,8.0,-22.81137657,0.2542,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.496753215789795
4489,7514,NCI-H2052,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,3.88,-3.5,5.67,1.90,14.0,16.4,-29","6.97,6.17,8.87,4.43,4.77,7.68,29.2,6.59",8,Sigmoid,3.476384163,8.0,-28.75107956,0.2665,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.743045330047607
4490,7515,NCI-H2085,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,-14,-11,6.46,16.2,7.93,-3.5,-23","12.2,9.90,7.91,14.6,9.02,8.66,1.72,3.65",8,Linear,,8.0,-22.71506691,0.6078,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.629521369934082
4491,7516,NCI-H2087,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,.35,6.97,6.17,14.0,34.6,2.06,-71","2.38,8.62,.63,1.00,10.7,22.7,.12,1.17",8,Sigmoid,4.428668499,5.211354733,-71.11410522,0.7931,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.6508398474923285,4.684367656707764
4492,7517,NCI-H211,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,-6.2,-8.5,-4.0,3.07,-3.4,1.02,-9.3","16.2,2.38,8.47,1.52,10.8,8.96,18.2,2.38",8,Constant,,8.0,-5.157488346,0.2859,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.530740737915039
4493,7518,NCI-H2122,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","39.5,33.5,17.3,44.1,3.21,21.4,2.35,-23","13.4,12.2,5.92,6.43,16.8,19.0,11.8,1.73",8,Sigmoid,8.412696546,8.0,-21.69083405,0.8008,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.284012317657471
4494,7519,NCI-H2170,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","12.6,33.1,22.7,29.9,4.64,-2.1,-10,-1.9","11.6,12.3,4.33,24.8,11.9,4.93,8.31,3.96",8,Sigmoid,0.22329548,8.0,-4.27095747,0.01563,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.588059902191162
4495,7520,NCI-H2172,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-234,-9.2,25.5,9.06,-5.2,-9.3,-51,-59","318,35.4,4.64,11.8,1.46,40.9,.57,3.64",8,Constant,,8.0,-14.12266445,0.7171,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.6057209968566895
4496,7521,NCI-H2228,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","8.42,.74,7.30,5.96,7.41,13.9,8.47,-18","7.76,21.3,10.7,11.1,6.19,6.76,14.0,11.9",8,Sigmoid,8.002455263,8.0,-18.13095093,0.1109,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.427159786224365
4497,7522,NCI-H2286,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,-8.3,4.16,2.48,-.76,8.90,-3.7,-60","3.95,5.05,5.28,15.4,4.78,9.13,3.04,6.14",8,Sigmoid,4.662463665,6.033330441,-59.59452438,1.2174,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.7972991702112904,4.292952537536621
4498,7523,NCI-H23,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,-16,11.1,-18,28.0,19.4,11.6,-84","11.9,2.73,.20,5.99,.30,2.77,.11,1.73",8,Linear,,0.211737986,-82.5814743,1.1365,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-1.5524056837773894,4.470188617706299
4499,7524,NCI-H2444,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-3.8,15.6,14.8,-12,6.43,-1.3,-1.0","19.0,3.89,19.1,.40,7.74,4.49,39.5,18.1",8,Constant,,8.0,1.794167757,0.1747,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4612555503845215
4500,7525,NCI-H2452,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-11,-13,-14,.69,-.75,-4.9,-24","5.61,6.13,10.0,8.60,12.1,12.0,4.75,3.01",8,Constant,,8.0,-8.695755005,0.7483,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.469239234924316
4501,7526,NCI-H28,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-1.6,-12,-1.7,8.69,11.8,-13,-24","9.23,1.36,2.52,1.38,4.71,6.61,3.42,47.3",8,Constant,,8.0,-1.658129811,0.161,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.340008735656738
4502,7527,NCI-H322,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-6.4,1.66,1.19,5.60,11.6,-.21,-9.7","16.4,3.22,20.0,4.10,17.3,.33,19.5,1.09",8,Constant,,8.0,-2.87955451,0.02021,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.57409143447876
4503,7528,NCI-H3255,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.6,8.30,1.44,14.0,3.58,9.64,5.11,-12","15.6,6.88,16.7,2.99,5.98,3.92,6.18,6.45",8,Constant,,8.0,5.373606682,0.1538,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.562188625335693
4504,7529,NCI-H358,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,-1.2,-.43,9.53,9.20,17.8,-7.2,-58","8.18,.88,3.00,11.5,7.80,4.29,9.17,28.7",8,Sigmoid,3.364368439,5.514954567,-53.8264122,0.7734,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.7074634145935634,4.767720699310303
4505,7530,NCI-H441,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".95,3.85,9.10,-.69,-.72,4.13,2.89,-22","9.02,5.86,.084,22.1,1.28,9.54,3.50,1.69",8,Sigmoid,5.261362553,8.0,-21.79949951,0.1424,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.390097141265869
4506,7531,NCI-H460,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,7.16,-6.5,-4.0,13.0,21.2,-3.2,-17","2.60,.12,1.27,10.1,9.61,19.1,.37,4.41",8,Linear,,8.0,-17.88070488,0.1837,NCIH460_LUNG,NCIH460,ACH-000463,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.269103527069092
4507,7532,NCI-H522,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","12.3,7.41,1.77,-3.0,19.1,15.1,-4.3,-.36","17.9,22.4,18.8,7.09,11.3,2.04,.085,12.5",8,Constant,,8.0,4.859572411,0.0,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.689713954925537
4508,7533,NCI-H647,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","7.28,-14,22.4,.60,35.4,2.94,6.29,-22","11.7,13.0,11.0,9.49,21.7,6.79,24.3,7.05",8,Constant,,8.0,3.192815065,0.3382,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.418910503387451
4509,7534,NCI-H650,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-1.4,1.05,1.03,-1.9,-.59,-5.6,-13","11.6,18.5,13.2,6.08,20.8,.49,3.38,2.48",8,Constant,,8.0,-3.165264368,0.03584,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.343881607055664
4510,7535,NCI-H661,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,6.09,-.052,7.57,-3.2,7.89,-7.0,.78","3.96,3.20,3.90,11.7,9.68,4.39,4.05,11.6",8,Constant,,8.0,0.151828542,0.3142,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.30436372756958
4511,7536,NCI-H727,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","6.00,25.8,-16,-1.4,-12,15.7,-11,3.23","2.14,48.1,18.8,6.39,5.50,16.9,16.6,9.93",8,Constant,,8.0,3.891901493,0.1817,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.8696208000183105
4512,7537,NCI-H747,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.6,3.76,4.35,-7.7,18.9,14.7,-7.6,13.1","4.76,6.15,15.2,.87,17.0,17.9,12.7,24.4",8,Constant,,8.0,0.235850751,0.1485,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.712031841278076
4513,7538,NCI-H810,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-.97,-14,.29,1.25,3.32,20.9,7.43","6.05,.73,5.91,2.37,2.78,5.06,8.85,22.3",8,Linear,,8.0,-12.4192524,0.2752,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.581381320953369
4514,7539,NCI-N87,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-11,8.74,-9.1,7.38,22.7,5.88,-8.3","30.2,.75,5.96,.038,15.7,48.9,54.0,11.7",8,Constant,,8.0,-8.224456787,0.6974,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.55927038192749
4515,7540,NCO2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,-16,-19,-20,-4.7,-35,-27,-69","5.61,25.7,44.3,13.1,2.16,7.73,28.4,3.85",8,Linear,,0.880665138,-67.23467255,1.7843,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-0.12707781837569004,4.24326753616333
4516,7541,NIH:OVCAR-3,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,11.8,-12,-20,-11,25.9,-13,-10","19.1,27.6,6.46,10.3,6.15,19.0,12.4,1.88",8,Constant,,8.0,-8.400490761,0.3427,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.426080226898193
4517,7542,NUGC-3,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-9.9,5.94,-4.1,4.32,4.35,-14,-49","26.6,7.17,1.09,8.03,1.38,14.1,14.3,9.30",8,Sigmoid,3.008663893,8.0,-49.07966995,0.8798,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.412015914916992
4518,7543,NUGC-4,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","12.7,2.10,.15,2.38,23.4,27.6,32.4,26.6","14.6,5.79,4.99,2.03,13.0,4.02,10.8,13.0",8,Linear,,8.0,-1.330666065,0.0,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.888134479522705
4519,7544,OCI-AML2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,4.52,2.83,3.70,-23,-31,-36,-41",".58,3.87,1.91,1.90,1.17,4.87,1.98,1.79",8,Sigmoid,0.222550154,8.0,-36.29880524,0.9367,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.124735355377197
4520,7545,OCI-AML5,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".47,-6.1,-6.3,7.22,-1.9,10.6,-7.4,-3.7",".21,.24,9.28,11.5,10.8,5.32,12.9,5.44",8,Constant,,8.0,-0.074782997,1.1923,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.089763164520264
4521,7546,OCUM-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","1.28,16.0,-1.1,10.5,3.68,-.36,-14,-3.5","34.7,3.92,8.92,.26,4.39,2.38,4.01,.13",8,Constant,,8.0,0.985936105,0.1104,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.5277533531188965
4522,7547,OE21,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-6.5,.82,-16,1.24,25.2,-5.9,-35","6.12,31.3,6.20,4.15,7.23,12.0,7.88,23.1",8,Linear,,8.0,-35.91925049,0.2198,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.250376224517822
4523,7548,OE33,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-1.0,-8.8,-18,.54,3.99,-3.4,-17","7.97,18.8,5.43,25.6,7.14,.73,3.68,23.7",8,Constant,,8.0,-4.692173958,0.4093,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.768730640411377
4524,7549,ONCO-DG-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","2.90,-14,-3.2,-16,8.28,-4.0,4.44,-32","14.2,14.6,3.57,.67,7.95,9.92,15.4,10.4",8,Constant,,8.0,-5.734022141,0.396,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.5917840003967285
4525,7550,ONS-76,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".36,5.62,7.28,13.9,2.46,-2.1,-11,-18",".82,9.09,1.10,8.18,2.85,.51,1.37,3.47",8,Sigmoid,1.656550765,8.0,-17.9703598,0.1695,ONS76_CENTRAL_NERVOUS_SYSTEM,ONS76,ACH-000776,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.6068806648254395
4526,7551,OPM-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-2.9,-1.1,-11,11.1,9.12,27.1,50.4","4.39,12.2,14.8,15.2,2.82,1.28,1.77,6.32",8,Linear,,8.0,-21.06645203,0.09389,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.403451442718506
4527,7552,OV-90,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,-5.8,1.17,-5.3,12.0,1.68,16.9,-24","7.04,0,16.8,18.3,15.4,22.9,13.8,1.35",8,Constant,,8.0,1.33275497,0.1413,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.270787715911865
4528,7553,OVCAR-4,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,3.97,1.81,6.55,-4.5,7.21,-3.0,-3.0","1.63,2.53,2.68,.84,.19,2.51,7.82,1.34",8,Constant,,8.0,1.108205199,0.0,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.560766696929932
4529,7554,OVCAR-8,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","9.27,4.09,13.5,-.038,21.8,.62,14.1,-25","8.03,8.44,12.1,3.84,2.09,.37,.95,7.10",8,Sigmoid,8.048635371,8.0,-24.87510109,0.1871,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.55169153213501
4530,7555,OVMANA,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-.076,-.82,-9.5,-12,-2.6,-16,-11,-33","2.89,5.52,1.09,1.68,4.05,3.76,.41,4.37",8,Sigmoid,8.802046497,8.0,-32.06748962,0.7003,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.140413284301758
4531,7556,OVSAHO,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,7.22,-5.7,-.17,12.6,6.82,4.02,-10","1.44,6.06,20.1,21.0,10.6,23.0,.25,14.8",8,Constant,,8.0,3.514645815,0.02867,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.702310562133789
4532,7557,P12-ICHIKAWA,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".43,-6.0,11.6,7.31,4.64,-2.6,-15,-35",".19,2.49,7.30,12.2,.79,4.60,5.51,11.5",8,Sigmoid,3.420782089,8.0,-35.06628036,0.5583,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.103470802307129
4533,7558,P31/FUJ,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,-6.3,-11,-4.0,9.01,18.0,3.79,-8.1","1.81,3.66,12.3,11.9,1.45,13.1,27.0,7.53",8,Constant,,8.0,-3.547194719,0.3729,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.446237087249756
4534,7559,P3HR-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","7.04,1.18,7.72,-3.7,12.1,11.9,9.41,-1.2","36.0,10.7,22.5,16.3,6.46,34.0,20.3,26.1",8,Constant,,8.0,7.498322487,0.0,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.5132737159729
4535,7560,Panc 02.03,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-8.2,-7.2,-5.7,5.22,9.83,2.03,-4.5","1.06,1.67,5.54,3.09,3.36,5.38,3.07,10.3",8,Constant,,8.0,-3.526297808,0.1131,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.569143772125244
4536,7561,Panc 03.27,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","13.7,-1.7,16.7,-4.7,12.7,3.54,11.3,-29","10.9,0,8.95,2.46,10.4,1.46,13.6,8.01",8,Sigmoid,8.31611513,8.0,-28.5905838,0.2345,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.643348217010498
4537,7562,Panc 04.03,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,3.61,-8.4,15.2,-3.7,9.71,-12,4.02","4.22,22.2,4.02,7.81,23.5,8.61,8.57,18.7",8,Constant,,8.0,-6.258384228,0.09336,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.929845333099365
4538,7563,Panc 10.05,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-12,3.87,-6.4,11.8,19.9,13.7,-5.8","3.96,5.15,28.7,28.5,15.1,19.1,38.6,19.1",8,Constant,,8.0,-3.582230806,0.1674,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.756082057952881
4539,7564,PA-TU-8902,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,-.56,-3.4,2.84,9.78,5.72,1.80,-12",".61,2.15,5.28,3.21,.33,2.62,5.46,9.75",8,Constant,,8.0,0.392520517,0.2355,PATU8902_PANCREAS,PATU8902,ACH-000599,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.351764678955078
4540,7565,PC-3,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-6.7,-5.8,2.79,.23,5.68,-18,-37","5.95,2.00,10.1,7.16,12.1,.52,4.95,2.10",8,Sigmoid,2.634730339,8.0,-37.39108276,0.1995,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.686131954193115
4541,7566,Pfeiffer,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-13,16.3,9.15,-6.5,.0090,-13,-45","10.5,3.01,10.1,9.47,7.13,26.0,15.6,12.7",8,Sigmoid,3.533929586,8.0,-44.38255692,0.484,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,3.915182113647461
4542,7567,PK-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,-2.0,-1.2,-4.6,3.67,-1.1,-.17,-28","6.50,5.96,.037,8.96,2.84,4.01,5.39,9.02",8,Sigmoid,7.231378078,8.0,-27.82492638,0.4061,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.6645636558532715
4543,7568,PK-45H,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,.64,-6.9,-3.0,-.12,21.6,-16,-24","5.87,2.13,4.60,1.75,2.75,7.07,4.22,1.79",8,Sigmoid,2.311959505,8.0,-24.44833946,0.6814,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.58416223526001
4544,7569,PK-59,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".21,.81,.62,4.82,2.44,7.75,9.74,-16","1.63,9.02,6.22,.70,6.70,1.74,1.90,10.4",8,Constant,,8.0,4.554397106,0.01353,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.685025691986084
4545,7570,PLC/PRF/5,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-3.7,-4.8,6.06,-9.1,6.33,-17,-22","27.6,9.65,12.1,7.61,11.9,5.94,24.2,6.11",8,Constant,,8.0,-0.887637615,0.2036,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.043612957000732
4546,7571,PSN1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,6.68,-2.7,4.75,2.06,6.53,-15,-10","4.52,12.5,3.37,10.2,7.74,8.72,3.00,13.5",8,Constant,,8.0,-1.467758656,0.07306,PSN1_PANCREAS,PSN1,ACH-000320,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.400394439697266
4547,7572,QGP-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-25,-26,-7.0,-17,11.5,12.0,13.9","13.8,8.84,.61,1.07,18.2,.32,4.82,11.7",8,Linear,,8.0,-29.88838387,0.6036,QGP1_PANCREAS,QGP1,ACH-000347,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.683862686157227
4548,7573,Raji,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","1.74,17.9,-11,17.9,17.2,15.0,16.7,34.5","6.62,5.56,6.98,.91,45.0,9.24,25.0,8.76",8,Constant,,8.0,15.78165245,0.121,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.286707401275635
4549,7574,RD,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","4.92,-6.6,10.7,-2.9,8.28,9.09,4.32,-13","3.28,8.95,10.2,8.99,3.57,3.41,3.57,10.8",8,Constant,,8.0,3.48893404,0.1876,RD_SOFT_TISSUE,RD,ACH-000169,Sarcoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.571728229522705
4550,7575,Reh,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,-8.2,-10,-4.5,5.91,-2.3,-48,-15","4.82,11.9,14.4,5.12,9.27,3.11,71.9,26.0",8,Constant,,8.0,-2.262962818,0.8706,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.131627559661865
4551,7576,RERF-GC-1B,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,-10,-7.2,-4.7,4.12,12.5,-4.4,-8.5","2.57,1.06,.71,4.49,17.8,1.64,5.67,9.17",8,Constant,,8.0,-7.210497379,0.5411,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.661428928375244
4552,7577,RERF-LC-AI,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-6.4,.29,-3.4,5.82,-.46,3.84,-12","3.84,6.19,2.86,5.62,.23,1.68,6.29,4.88",8,Constant,,8.0,-1.600037336,0.1812,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.413301944732666
4553,7578,RERF-LC-MS,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-7.8,-2.2,1.28,-12,13.9,.46,-23","14.7,9.62,2.71,.31,28.9,9.75,18.5,9.92",8,Constant,,8.0,-2.7121346,0.482,RERFLCMS_LUNG,RERFLCMS,ACH-000062,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.1594390869140625
4554,7579,RKO,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,-12,-.099,-18,-5.8,-24,-29,-39","1.45,.89,6.45,.42,.83,4.79,8.95,.64",8,Sigmoid,1.060120583,8.0,-37.83834457,0.9622,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.29022216796875
4555,7580,RL95-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-10,6.18,3.13,10.9,16.0,41.7,2.60","14.8,4.82,18.8,1.12,6.84,8.46,15.1,20.1",8,Constant,,8.0,7.330554485,0.228,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.559327602386475
4556,7581,RPMI-7951,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.7,-8.6,.54,-4.4,19.0,-9.1,-17,-11","6.72,.74,4.08,11.4,14.3,3.43,8.05,8.81",8,Constant,,8.0,-7.484624386,0.54,RPMI7951_SKIN,RPMI7951,ACH-000348,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.5162858963012695
4557,7582,RPMI-8402,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,1.17,4.87,10.4,-5.1,-12,-9.4,-25",".022,14.3,24.4,6.63,5.34,7.97,.38,3.62",8,Sigmoid,8.49146784,8.0,-24.89136696,0.2035,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.105053424835205
4558,7583,RT-112,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,-10,-13,1.46,3.40,-.33,17.0,-2.5","1.55,15.5,10.2,9.42,3.15,9.56,5.78,3.46",8,Linear,,8.0,-12.86023521,0.02544,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.382043361663818
4559,7584,RT4,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,3.31,-11,1.30,-7.7,17.6,8.10,-16","13.1,24.6,34.1,17.4,31.3,3.71,26.4,52.1",8,Constant,,8.0,8.42927742,0.3804,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.529965400695801
4560,7585,RVH-421,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","17.2,-2.6,14.1,-8.1,-14,-57,-62,-72","7.11,9.78,2.71,.25,2.35,5.44,4.04,1.50",8,Sigmoid,0.365521431,0.770638406,-70.78510284,2.1201,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-0.2605360089455797,4.260746955871582
4561,7586,SBC-5,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,-4.5,-.56,-2.0,-.37,8.45,5.05,4.60","1.57,.68,.14,3.80,5.71,6.05,3.07,1.92",8,Constant,,8.0,0.03495403,0.1305,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.188296318054199
4562,7587,SCaBER,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,1.87,-1.6,-6.0,-.56,-5.1,2.65,-39","4.55,1.67,4.98,.098,6.55,6.99,7.47,10.7",8,Sigmoid,7.950903416,8.0,-38.42789078,0.2984,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.648504734039307
4563,7588,SCC-9,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,-.18,19.8,-21,5.88,-6.0,22.2,-23","6.24,8.69,15.5,20.4,12.5,11.5,7.59,12.3",8,Constant,,8.0,-0.40816766,0.2032,SCC9_UPPER_AERODIGESTIVE_TRACT,SCC9,ACH-000181,Head and Neck Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.267099857330322
4564,7589,SF126,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.8,.21,-3.7,-5.1,1.68,4.85,-3.7,-25","6.61,1.31,7.53,3.05,7.51,3.23,9.49,6.03",8,Sigmoid,4.047815323,8.0,-24.77730751,0.2292,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.343113422393799
4565,7590,SF-295,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-9.2,-5.3,-1.7,3.60,3.87,-2.1,-15","2.84,5.59,4.77,.78,3.99,.29,3.82,2.02",8,Constant,,8.0,-3.461969376,0.2133,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.260056972503662
4566,7591,SH-10-TC,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","4.81,-1.2,-1.7,-4.8,11.7,7.58,5.78,-27","1.50,6.06,2.08,.74,4.76,13.9,10.3,8.41",8,Sigmoid,7.944036961,8.0,-26.90328789,0.1525,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.3570075035095215
4567,7592,SHP-77,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,39.5,3.00,8.56,-7.3,27.3,4.40,6.31","3.29,18.5,15.8,4.96,5.41,6.25,47.8,24.6",8,Constant,,8.0,8.557785034,0.1171,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4732279777526855
4568,7593,SIG-M5,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","6.32,-29,-35,-65,-88,-95,-95,-96","1.83,7.32,9.33,9.07,.30,.48,.55,.17",8,Sigmoid,0.018369524,0.033569854,-97.90016937,5.2178,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-3.39412681712089,4.040261745452881
4569,7594,SIMA,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","19.0,-1.5,-5.2,-19,46.1,.18,60.2,35.1","3.05,7.59,30.1,9.20,34.8,14.1,55.9,64.2",8,Constant,,8.0,12.23438549,0.1373,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.273928165435791
4570,7595,SJSA-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".73,5.64,.47,3.41,11.3,18.5,14.9,.36","1.66,13.3,30.1,25.1,6.48,27.1,23.2,8.35",8,Constant,,8.0,3.885292053,0.0,SJSA1_BONE,SJSA1,ACH-000748,Bone Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.268888473510742
4571,7596,SK-BR-3,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-7.8,-1.1,-7.4,-14,2.30,-3.1,-18","8.48,20.8,2.69,15.6,7.92,17.3,20.0,21.3",8,Constant,,8.0,-8.800782204,0.19,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.649691104888916
4572,7597,SK-CO-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-13,-6.0,-3.7,15.0,18.7,8.94,-7.1",".23,16.9,17.9,13.8,18.9,20.9,1.10,26.5",8,Linear,,8.0,-29.01522446,0.4569,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.518846035003662
4573,7598,SK-ES-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,-13,-7.2,-5.0,-11,-1.9,-24,-43","3.09,20.3,17.4,13.1,13.4,9.94,2.05,6.74",8,Sigmoid,2.51946187,8.0,-42.74921036,1.0572,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.5408501625061035
4574,7599,SK-HEP-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","9.97,-5.5,2.87,-9.3,11.0,-10,-13,-49","6.35,12.1,13.1,4.55,20.7,9.06,3.32,3.74",8,Sigmoid,9.074443248,8.0,-49.14461517,0.4923,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.543074607849121
4575,7600,SK-MEL-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53","-23,4.79,-7.4,6.25,-3.2,2.68,18.3","2.39,13.5,.62,21.0,.72,8.04,10.3",7,Linear,,2.531646013,-21.45771599,0.4425,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,0.9288696892159999,4.381828308105469
4576,7601,SK-MEL-24,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","13.2,-2.7,4.21,-13,-13,-20,-41,-58","10.6,1.85,19.5,2.15,10.7,.31,18.3,1.28",8,Sigmoid,8.857362357,5.15450716,-57.75396729,1.0325,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.6398715086308426,4.340519428253174
4577,7602,SK-MEL-30,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-.55,-4.7,10.6,-4.2,7.22,-9.5,18.0,-.78","2.40,6.59,6.07,8.45,7.48,1.31,.042,15.6",8,Constant,,8.0,1.236397505,0.0465,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.0202555656433105
4578,7603,SK-MEL-31,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-1.4,-1.2,1.57,7.00,2.71,-18,-40","13.9,5.51,14.9,3.68,8.39,11.3,30.9,2.99",8,Sigmoid,2.632866383,8.0,-40.20570374,0.4061,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.217230796813965
4579,7604,SK-MEL-5,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-8.1,-4.6,-11,-39,-61,-61,-64","3.44,4.86,4.29,14.9,8.42,1.32,2.11,2.01",8,Sigmoid,0.212985426,0.369111031,-63.1432457,2.0478,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-0.9966577831830689,4.323884010314941
4580,7605,SK-MES-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,-2.5,-6.4,-12,-9.7,-16,-28,-59","18.6,15.1,21.5,9.85,12.7,5.08,12.0,4.59",8,Sigmoid,8.269816846,6.108966351,-58.44990921,1.0515,SKMES1_LUNG,SKMES1,ACH-000665,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.809757585549661,4.7896528244018555
4581,7606,SK-MM-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-1.8,-1.2,2.50,8.83,5.52,6.22,-42","0,7.94,1.28,5.06,16.0,2.90,5.61,9.55",8,Sigmoid,8.024418625,8.0,-41.41257477,0.3525,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.255259990692139
4582,7607,SK-N-AS,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,-1.2,2.04,6.99,10.5,12.8,.83,14.9",".19,6.77,5.36,1.58,6.17,5.81,9.00,1.57",8,Linear,,8.0,-9.558387756,0.07928,SKNAS_AUTONOMIC_GANGLIA,SKNAS,ACH-000260,Neuroblastoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.520054817199707
4583,7608,SK-N-BE(2),PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-4.1,5.49,22.1,3.73,17.0,4.92,28.7","5.05,19.3,16.8,13.9,11.0,6.97,19.1,4.40",8,Linear,,8.0,-11.24112129,0.0524,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.423372268676758
4584,7609,SK-N-DZ,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".34,-2.3,-8.6,-1.6,13.1,12.7,20.3,-1.5","4.80,1.73,3.31,1.12,2.08,20.4,10.1,6.47",8,Linear,,8.0,-6.891908169,0.1446,SKNDZ_AUTONOMIC_GANGLIA,SKNDZ,ACH-000366,Neuroblastoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.29535436630249
4585,7610,SK-N-FI,PLX4720,RAF,".0025,.025,.080,.25,.80,2.53,8","3.42,35.6,44.0,13.6,67.7,12.2,5.96","2.96,26.5,1.67,12.9,46.8,54.0,22.9",7,Constant,,8.0,21.72346115,0.2167,SKNFI_AUTONOMIC_GANGLIA,SKNFI,ACH-000341,Neuroblastoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.399686336517334
4586,7611,SK-N-SH,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-.018,-.80,-1.4,17.0,2.33,13.4,-80","6.45,10.5,3.26,6.11,10.7,6.64,2.13,5.25",8,Sigmoid,8.027166279,6.900910854,-79.97498322,0.8964,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.9316534107170342,4.400329113006592
4587,7612,SK-OV-3,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-3.6,-3.9,-5.0,14.8,14.7,-1.0,-28",".25,25.3,14.2,8.78,27.9,13.4,13.3,9.86",8,Constant,,8.0,-10.05093098,0.3349,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.443397045135498
4588,7613,SNG-M,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-.64,-5.7,3.43,-6.2,5.81,4.15,-29","2.43,4.33,10.5,9.52,22.8,5.82,7.61,11.5",8,Sigmoid,7.974878788,8.0,-28.91303253,0.2797,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.27373743057251
4589,7614,SNU-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,7.83,-13,8.46,5.08,16.8,-7.1,5.82","6.10,.21,2.52,6.76,6.63,7.27,14.8,1.97",8,Constant,,8.0,4.22454071,0.1584,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.269912242889404
4590,7615,SNU-182,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,6.79,3.80,.93,.040,9.85,-17,-11","2.92,10.6,.24,11.4,1.18,2.80,11.6,13.5",8,Constant,,8.0,-0.524483621,0.3584,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.357630252838135
4591,7616,SNU-387,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,.40,-4.5,-17,-2.3,-2.7,-15,-16","6.21,.45,18.6,.12,16.1,7.84,20.1,1.02",8,Constant,,8.0,-11.20980549,1.2764,SNU387_LIVER,SNU387,ACH-000478,Liver Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.33296537399292
4592,7617,SNU-398,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-14,-18,-13,-.60,12.7,-1.8,-6.4","7.63,15.5,.074,9.14,23.6,2.90,25.9,1.61",8,Constant,,8.0,-8.005005836,0.7115,SNU398_LIVER,SNU398,ACH-000221,Liver Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.284321308135986
4593,7618,SNU-423,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,1.12,4.24,1.43,4.81,8.23,-1.7,-6.6","3.12,7.12,1.15,.24,.91,5.22,16.2,14.1",8,Constant,,8.0,3.144881248,0.1018,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.345737934112549
4594,7619,SNU-449,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,10.1,-13,-1.1,6.01,8.73,-16,-22","4.09,5.23,7.68,1.84,11.6,5.32,10.2,19.8",8,Constant,,8.0,-5.364242554,0.3743,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.791535377502441
4595,7620,SNU-475,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.1,1.13,-31,-26,30.1,8.76,15.7,-27","8.58,23.4,17.3,10.6,.36,31.4,44.1,18.5",8,Constant,,8.0,-14.007411,0.6943,SNU475_LIVER,SNU475,ACH-000422,Liver Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.424132823944092
4596,7621,SNU-C2A,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","7.55,-3.5,.64,-6.5,13.0,12.0,4.68,-1.4","4.15,8.23,1.49,7.44,12.8,8.62,23.4,31.0",8,Constant,,8.0,3.24921751,0.05934,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.538198471069336
4597,7622,Sq-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","9.22,4.25,-7.9,-14,4.42,8.05,-3.5,-25","13.3,5.70,14.3,12.7,9.38,1.82,13.8,1.92",8,Sigmoid,9.080502413,8.0,-25.26546478,0.5213,SQ1_LUNG,SQ1,ACH-000553,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.607903957366943
4598,7623,SU.86.86,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","2.14,-4.6,4.11,-4.4,3.65,-4.0,-3.8,-15","3.13,4.74,10.0,1.95,2.39,2.37,4.06,8.86",8,Constant,,8.0,-2.50739193,0.2061,SU8686_PANCREAS,SU8686,ACH-000114,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.477114200592041
4599,7624,SU-DHL-10,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","20.0,12.4,40.4,9.40,15.0,45.9,80.9,35.6","51.6,20.3,34.0,1.35,12.3,53.8,49.4,62.2",8,Constant,,8.0,20.46619415,0.0,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4288411140441895
4600,7625,SU-DHL-4,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","1.00,-42,-.40,-7.1,-3.7,-12,-24,-56","11.7,27.2,19.2,9.65,8.92,11.5,27.7,9.66",8,Linear,,3.607176882,-55.39219284,1.988,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.2829254392552318,4.144461154937744
4601,7626,SU-DHL-6,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","6.06,19.9,-10,4.38,26.2,-27,6.44,-31","40.2,35.2,14.7,20.6,11.4,22.7,11.3,29.3",8,Constant,,8.0,-2.30645752,1.3646,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.157166004180908
4602,7627,SU-DHL-8,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,7.39,.48,-3.2,-16,-18,-25,-34","6.39,3.07,.51,1.58,5.33,1.02,10.7,3.74",8,Sigmoid,0.605098248,8.0,-33.03680801,1.6986,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.503385543823242
4603,7628,SUIT-2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,.89,-9.2,-4.9,.68,-.20,-4.4,-32","5.33,6.13,6.93,2.37,3.50,6.09,5.94,4.71",8,Constant,,8.0,-4.347601891,0.2664,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.261745929718018
4604,7629,SUP-M2,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","2.34,-10,4.00,1.58,25.1,1.70,20.1,-26","15.8,6.46,11.4,3.24,5.71,6.96,3.80,13.0",8,Sigmoid,7.452515602,8.0,-25.31637573,0.1102,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,3.9698102474212646
4605,7630,SUP-T1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-4.7,2.57,-8.5,2.92,-.30,7.30,-14","4.58,5.51,14.2,.55,21.9,15.7,17.0,9.86",8,Constant,,8.0,-5.529651642,0.3396,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.395246505737305
4606,7631,SW 1088,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-16,-13,-14,.73,2.00,-14,-51","8.18,22.4,5.15,2.74,3.69,2.71,1.64,12.8",8,Sigmoid,3.647395372,6.770390034,-51.0481987,0.4742,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.9125586973769295,4.497888565063477
4607,7632,SW 1271,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-1.4,-5.1,7.29,-8.6,-3.6,-15,-41","12.7,.28,28.8,4.49,4.25,23.8,15.0,9.86",8,Sigmoid,8.309041548,8.0,-40.07550812,0.5061,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4696784019470215
4608,7633,SW 1353,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".63,1.23,-5.0,-4.5,-4.7,1.47,3.90,-13","16.9,3.33,26.0,7.19,17.0,2.62,6.53,1.02",8,Constant,,8.0,-0.364839524,0.414,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.526976108551025
4609,7634,SW1417,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,-2.7,19.3,-25,-13,-48,-56,-72","6.32,2.77,37.1,3.20,13.1,25.1,13.9,.23",8,Sigmoid,8.309701413,2.278774738,-72.86354065,1.6968,SW1417_LARGE_INTESTINE,SW1417,ACH-000236,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,0.8236379029035383,4.850870132446289
4610,7635,SW 1573,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-3.2,-1.6,-1.7,12.6,16.0,-16,-35","10.8,4.16,8.01,16.0,5.67,1.26,2.02,9.59",8,Sigmoid,2.584011555,8.0,-35.10100555,0.4281,SW1573_LUNG,SW1573,ACH-000677,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.397968769073486
4611,7636,SW 1990,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,5.83,-5.6,-17,8.40,10.8,-19,-43","16.7,16.7,7.82,8.72,5.39,1.32,2.87,5.18",8,Sigmoid,2.676204681,8.0,-43.46043396,0.6876,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.698337554931641
4612,7637,SW403,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,6.45,19.3,16.7,61.7,51.6,58.3,19.0","13.3,31.0,11.9,17.3,13.1,22.6,32.0,20.3",8,Linear,,8.0,-2.441570997,0.1555,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.792559623718262
4613,7638,SW48,PLX4720,RAF,".0080,.025,.080,.25,.80,2.53,8","-9.6,6.16,-10,18.7,52.2,36.1,11.5","31.3,41.7,4.01,11.2,15.5,24.9,52.2",7,Constant,,8.0,15.3808651,0.0,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.2342705726623535
4614,7639,SW480,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8",".42,-7.7,-1.8,3.83,1.16,4.10,14.4,-2.3","16.2,4.24,6.30,11.0,.081,12.2,5.76,12.7",8,Constant,,8.0,1.158480525,0.08871,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.663057804107666
4615,7640,SW579,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,3.10,2.28,3.17,-34,5.37,.068,-26","5.27,2.64,3.42,3.16,57.7,6.67,14.1,1.00",8,Constant,,8.0,0.996848047,0.632,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.38781213760376
4616,7641,SW620,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-6.6,-4.1,13.7,19.4,51.5,42.8,29.6",".48,7.21,.18,.63,22.6,21.4,.78,23.3",8,Linear,,8.0,-16.26911163,0.09719,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.292212009429932
4617,7642,SW 780,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.6,9.30,-1.6,6.11,6.96,31.6,14.6,-5.9","3.62,11.1,2.66,8.79,7.43,13.3,1.08,1.42",8,Linear,,8.0,-6.945967197,0.1303,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.545821189880371
4618,7643,SW 900,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","2.11,-13,12.7,1.84,12.2,-2.9,-4.6,-7.7","4.16,2.64,14.1,6.68,29.1,14.1,14.9,3.87",8,Constant,,8.0,-1.64299202,0.01962,SW900_LUNG,SW900,ACH-000669,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.726410388946533
4619,7644,T24,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,8.43,-7.2,7.27,5.08,11.8,-23,-54","6.28,6.17,1.63,8.11,4.80,.73,8.70,1.51",8,Sigmoid,2.636778355,4.326249123,-54.21805954,0.9257,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.4647009132514184,4.350806713104248
4620,7645,T3M-10,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-7.1,-.33,-7.6,8.38,6.42,.32,-2.4","12.7,10.1,7.51,19.4,13.7,9.48,29.4,22.5",8,Constant,,8.0,-0.530736685,0.1352,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.5216522216796875
4621,7646,T-47D,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,-1.8,-11,-3.6,18.1,24.2,.31,-6.6","23.3,2.55,9.72,25.9,10.5,19.3,9.41,3.41",8,Constant,,8.0,-0.886463165,0.04939,T47D_BREAST,T47D,ACH-000147,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.782521724700928
4622,7647,T84,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,7.14,-35,67.0,-24,56.0,9.33,-23","67.9,2.18,8.21,19.6,19.1,87.3,28.5,10.7",8,Constant,,8.0,-5.916012764,0.5119,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.608058452606201
4623,7648,TCCSUP,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,-2.0,7.33,4.17,2.67,-.051,11.3,-24","2.99,.52,6.20,4.72,5.16,2.20,2.29,4.28",8,Sigmoid,8.12995573,8.0,-23.9948597,0.1503,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.365242004394531
4624,7649,TE-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-5.7,-9.9,-3.3,7.29,8.68,-6.7,-14","8.15,2.82,1.29,2.08,1.28,6.39,.55,1.00",8,Linear,,8.0,-15.25883198,0.3786,TE1_OESOPHAGUS,TE1,ACH-000647,Esophageal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.49167537689209
4625,7650,TE-15,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,13.8,-39,-6.7,13.4,6.92,-71,-52","3.67,26.4,7.27,9.13,16.1,16.0,28.4,11.1",8,Constant,,8.0,-11.54154587,1.5586,TE15_OESOPHAGUS,TE15,ACH-000353,Esophageal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.525900840759277
4626,7651,TE-5,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-1.6,2.75,-.94,4.15,.059,-6.0,-10","2.36,7.90,1.42,.87,.37,7.71,9.06,.094",8,Constant,,8.0,-0.94252044,0.06209,TE5_OESOPHAGUS,TE5,ACH-000408,Esophageal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.452305316925049
4627,7652,TE 617.T,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","4.10,-8.5,12.0,-4.7,8.78,24.4,36.5,12.0","19.4,2.77,1.03,2.44,8.98,1.93,3.02,11.2",8,Linear,,8.0,-2.194421291,0.03409,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,3.8776869773864746
4628,7653,TE-9,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,6.01,-3.8,7.14,3.98,4.17,-6.9,-17","4.61,.58,11.2,12.6,12.6,5.12,13.8,5.91",8,Constant,,8.0,-0.260449678,0.4148,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.560275554656982
4629,7654,TEN,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,15.9,-14,.28,-11,15.4,-11,-7.2",".45,26.4,19.0,26.1,21.6,5.04,13.4,.89",8,Constant,,8.0,-4.266846657,0.8197,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.559872150421143
4630,7655,Toledo,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.9,-17,-.72,7.80,-19,13.4,-19,1.40","1.93,9.43,22.9,16.0,12.9,18.0,5.31,10.3",8,Constant,,8.0,-5.354890347,0.0,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.308588981628418
4631,7656,TOV-112D,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","3.08,9.57,1.13,-1.0,2.58,3.76,.070,-11",".92,4.74,2.07,21.0,.12,7.65,2.14,8.58",8,Constant,,8.0,2.486178637,0.05898,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.27060604095459
4632,7657,TOV-21G,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.4,1.00,-5.3,6.25,6.40,8.30,-16,-66",".11,13.7,8.88,3.04,13.0,8.09,4.12,4.22",8,Sigmoid,3.139323235,3.959041595,-65.51107788,0.6667,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,1.3760019745098218,3.7978196144104004
4633,7658,TT2609-C02,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,10.0,-13,25.6,2.06,2.88,-19,-31","21.0,38.9,30.4,2.75,39.2,21.9,28.0,7.72",8,Constant,,8.0,-5.831558704,0.1878,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.235110759735107
4634,7659,TYK-nu,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","13.1,15.0,17.7,8.99,24.7,18.2,34.8,-15",".12,7.56,7.73,4.14,6.26,1.55,3.05,10.5",8,Sigmoid,8.105310151,8.0,-14.90351772,0.1161,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4562764167785645
4635,7660,U-118 MG,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,1.15,-10,13.8,-5.8,4.42,5.15,.19","3.41,2.78,17.9,3.77,.94,2.46,7.69,9.96",8,Constant,,8.0,0.731656611,0.09208,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.4310736656188965
4636,7661,U-2 OS,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-4.8,-14,-.14,-2.7,11.5,3.88,9.66","1.00,9.27,11.0,10.9,13.4,10.0,18.9,1.71",8,Linear,,8.0,-18.72562218,0.6723,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.3438310623168945
4637,7662,U-87 MG,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-4.2,5.33,-3.8,10.1,-7.6,5.74,-11","4.57,13.9,19.6,5.10,1.14,8.15,10.6,15.2",8,Constant,,8.0,-1.253293991,0.02147,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.463195323944092
4638,7663,U-937,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,-2.4,-2.2,6.09,2.23,8.15,.60,-19","7.16,7.18,4.45,7.69,15.5,17.0,3.64,27.5",8,Constant,,8.0,10.24884605,0.3454,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.102956295013428
4639,7664,UACC-257,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.3,-2.4,-9.8,-2.5,-26,-40,-67,-70","5.69,3.13,3.41,6.13,2.31,.63,1.57,2.32",8,Sigmoid,0.637085676,1.064142346,-71.95616913,2.0796,UACC257_SKIN,UACC257,ACH-000579,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,0.0621691658057799,4.169465065002441
4640,7665,UACC-62,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,.67,-31,-25,-54,-66,-74,-82","5.63,3.88,8.89,7.80,6.79,1.23,2.19,.082",8,Sigmoid,0.175636262,0.249700621,-80.01663971,3.0249,UACC62_SKIN,UACC62,ACH-000425,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-1.3874925947151207,4.197404384613037
4641,7666,UACC-812,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","1.11,10.3,8.61,7.36,-5.5,7.91,7.21,.41","24.4,14.7,25.7,5.76,17.5,5.91,33.9,15.7",8,Constant,,8.0,6.298837662,0.0,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.969303607940674
4642,7667,UM-UC-3,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,1.89,3.00,.34,4.49,1.52,-18,-13","1.93,5.84,10.8,7.07,4.73,6.75,.52,5.79",8,Constant,,8.0,-2.401624918,0.2678,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.051872730255127
4643,7668,VMRC-RCW,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.9,-8.2,-2.6,-5.3,.67,-12,2.14,-13","12.4,21.6,6.97,2.89,8.43,7.44,3.56,6.17",8,Constant,,8.0,-6.022433758,0.01988,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.247057914733887
4644,7669,VMRC-RCZ,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,-.79,-7.9,-11,1.89,-.82,-1.0,-17","6.28,8.41,15.1,18.2,7.98,22.3,16.2,13.7",8,Constant,,8.0,-4.912830353,0.4771,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.307309627532959
4645,7670,WM-115,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,7.23,5.58,12.9,1.14,-5.7,-39,-38","11.3,6.72,8.39,26.2,4.68,8.33,2.73,16.0",8,Sigmoid,1.070204616,8.0,-39.21532822,0.691,WM115_SKIN,WM115,ACH-000304,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.310873985290527
4646,7671,WM1799,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,-1.4,1.75,5.90,-28,-43,-58,-70","1.86,17.8,15.0,23.6,.54,1.44,3.88,4.01",8,Sigmoid,0.697920561,1.226397991,-69.3343811,1.9707,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,0.20408141044627173,4.1193037033081055
4647,7672,WM-266-4,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","5.84,2.31,-3.3,-.038,-7.8,-20,-68,-80","0,0,0,0,0,0,0,0",8,Sigmoid,1.277853489,1.578695059,-80.35575867,1.5993,WM2664_SKIN,WM2664,ACH-001239,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,0.4565985937603125,4.071823596954346
4648,7673,WM-793,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,7.36,-8.5,19.9,-19,-27,-42,-50","5.97,5.40,18.5,20.1,5.98,9.84,4.08,11.8",8,Sigmoid,0.734471619,8.0,-49.33164597,1.3967,WM793_SKIN,WM793,ACH-000827,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.611480236053467
4649,7674,WM-88,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,2.00,-6.3,-24,-57,-77,-85,-89","2.56,1.19,1.47,.95,2.63,1.89,.74,1.02",8,Sigmoid,0.168979511,0.204083994,-87.52676392,3.4382,WM88_SKIN,WM88,ACH-000899,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-1.5892236345835198,4.330152988433838
4650,7675,WM-983B,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,-12,-1.8,-17,-21,-56,-84,-87","3.85,14.6,3.54,7.39,41.4,20.9,4.24,5.02",8,Sigmoid,0.473212808,0.51123476,-88.41945648,3.138,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,-0.6709263813603848,4.217310905456543
4651,7676,YKG1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-10,-.029,-6.0,.99,-6.5,-1.5,-18","10.1,7.48,1.00,1.99,4.00,7.50,8.86,.96",8,Constant,,8.0,-6.392635822,0.241,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.365657329559326
4652,7677,ZR-75-1,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,36.7,-.47,64.5,-2.9,40.4,43.9,1.44","5.84,34.7,30.4,10.9,9.07,14.8,18.7,5.70",8,Constant,,8.0,16.70590782,0.5641,ZR751_BREAST,ZR751,ACH-000097,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.509915351867676
4653,7678,ZR-75-30,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-6.8,-4.1,7.63,17.2,12.0,-1.9,12.5","5.15,40.2,24.1,16.3,22.9,39.1,3.57,31.7",8,Constant,,8.0,-1.389397264,0.02117,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.870754718780518
4654,7679,SCC-25,PLX4720,RAF,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-7.8,-2.1,3.71,-.66,10.3,1.52,-33","10.8,9.24,.83,6.70,1.68,1.17,7.19,20.2",8,Sigmoid,7.549185753,8.0,-32.82247162,0.3717,SCC25_UPPER_AERODIGESTIVE_TRACT,SCC25,ACH-000188,Head and Neck Cancer,13,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,,RAF ,Raf kinase B Inhibitor,Kinase inhibitor,Preclinical,Plexxikon,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2.0794415416798357,4.172088146209717
4655,8046,A172,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,4.55,6.32,-2.9,-3.7,-12,-50,-95",".34,2.84,3.10,.21,10.9,2.84,.23,1.82",8,Sigmoid,3.027561903,2.530820608,-95.5039444,1.4006,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.928543601137161,1.4436335563659668
4656,8047,A-204,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","15.9,-16,21.9,.77,19.5,-25,-44,-88","4.48,6.62,19.6,20.5,10.7,.64,6.63,.82",8,Sigmoid,3.246451139,2.659318924,-87.07484436,1.2913,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.9780700463998239,0.9838470816612244
4657,8048,A2058,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.023,.40,-.31,-3.7,2.17,-12,-29,-66","4.48,3.15,3.47,2.01,3.14,3.95,6.62,1.40",8,Sigmoid,6.841276169,4.927721977,-66.41762543,0.8825,A2058_SKIN,A2058,ACH-000788,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.5948768076348494,1.1481870412826538
4658,8049,A-253,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-3.7,-6.7,3.87,3.80,5.18,4.26,-40","4.79,4.19,3.09,4.06,2.91,6.89,5.02,6.85",8,Sigmoid,8.005974884,8.0,-40.09928894,0.7365,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,0.994906485080719
4659,8050,A2780,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,2.20,.17,4.23,-6.3,-12,-81,-89","7.49,8.37,3.58,10.7,3.78,7.21,3.25,1.27",8,Sigmoid,1.3314949,1.494494081,-88.27892303,1.9146,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.40178774221209895,1.0042434930801392
4660,8051,A-375,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,-1.2,1.74,-1.7,-8.8,-38,-74,-81","7.29,.37,1.56,.67,5.02,5.47,3.50,1.91",8,Sigmoid,0.86318785,1.073880553,-81.6411438,1.8735,A375_SKIN,A375,ACH-000219,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.0712787729556135,0.8153315186500549
4661,8052,A549,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.02,4.32,6.09,5.20,8.46,-32,-68,-101",".37,7.19,2.38,3.41,3.30,8.81,1.06,4.19",8,Sigmoid,1.762624145,1.637758732,-100.6070633,1.3264,A549_LUNG,A549,ACH-000681,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.49332868032071836,1.4786980152130127
4662,8053,A-673,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.52,-2.6,16.9,-9.4,-3.9,-41,-60,-73","11.4,25.5,3.25,6.12,2.46,8.05,.25,3.46",8,Sigmoid,0.597751021,1.243872643,-71.14427948,1.734,A673_BONE,A673,ACH-000052,Bone Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.21822961206645763,1.3195478916168213
4663,8054,ACHN,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.43,-5.1,7.08,-2.2,6.00,3.17,-39,-65","1.40,2.99,2.23,5.82,.18,3.74,1.48,3.03",8,Sigmoid,2.297744036,2.960450411,-65.22975922,0.9626,ACHN_KIDNEY,ACHN,ACH-000046,Kidney Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.0853414226382945,1.5148433446884155
4664,8055,ALL-SIL,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.67,-4.7,-2.2,5.74,.42,-34,-94,-94","30.5,9.10,6.55,16.2,2.66,9.11,2.22,.71",8,Sigmoid,0.907129347,0.92615211,-93.97434235,2.8218,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.07671679216733643,1.122169017791748
4665,8056,AMO-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,-3.8,.32,-15,-32,-68,-93,-98","9.66,6.51,25.4,.49,18.1,2.00,4.56,.19",8,Sigmoid,0.435161233,0.385257065,-99.32347107,3.1165,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.9538444662089873,1.4807296991348267
4666,8057,AsPC-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.67,7.11,-2.7,-19,-10,-57,-63,-86","16.1,12.3,17.2,14.2,8.15,2.36,5.03,8.34",8,Sigmoid,0.7527784,1.224158168,-79.38336182,1.4991,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.2022533979638844,1.3645437955856323
4667,8058,AU565,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.7,8.25,-2.2,6.26,7.10,25.6,-.54,-.89","18.6,2.53,6.15,9.21,10.4,11.1,12.0,9.83",8,Constant,,8.0,4.194328308,0.1526,AU565_BREAST,AU565,ACH-000248,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.564767599105835
4668,8059,B-CPAP,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,.39,-3.5,-1.5,-.53,-17,-59,-67","1.27,3.74,4.45,2.15,3.90,4.62,7.36,5.66",8,Sigmoid,1.240136504,1.781927466,-67.03926849,1.6747,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.5776956245164956,1.2712610960006714
4669,8060,BDCM,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,.53,5.97,2.96,2.93,6.15,9.62,-18","32.7,10.8,20.1,14.9,1.42,26.7,5.96,7.71",8,Constant,,8.0,-2.333399773,0.175,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.232995629310608
4670,8061,BFTC-909,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.65,-1.2,-2.7,.76,4.50,-.80,2.75,-67",".54,10.5,8.33,7.68,.65,6.66,1.98,2.85",8,Sigmoid,8.006002526,7.229048729,-67.07100677,0.6489,BFTC909_KIDNEY,BFTC909,ACH-000792,Kidney Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.978107454761799,1.311497449874878
4671,8062,BL-41,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".17,.013,1.05,5.93,8.86,7.59,-23,-40","3.20,1.76,1.10,1.50,12.2,1.90,44.7,87.0",8,Constant,,8.0,2.049209356,0.4967,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2250072956085205
4672,8063,BL-70,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.1,1.81,6.98,-2.2,1.26,1.64,-16,-60",".25,12.6,.55,8.07,2.57,15.6,29.1,57.4",8,Sigmoid,2.033646345,8.0,-21.74225426,0.6416,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2726988792419434
4673,8064,BT-20,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,-1.4,.20,-12,3.52,-15,-19,-52","27.5,1.18,25.4,4.25,31.8,22.9,9.25,2.29",8,Sigmoid,8.243600053,7.626374722,-51.76485443,0.7985,BT20_BREAST,BT20,ACH-000536,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0316125976527686,1.5997010469436646
4674,8065,BT-474,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.2,16.2,-16,-4.0,8.77,-1.5,-1.9,-40","15.3,22.1,6.10,17.3,1.65,20.7,14.6,4.28",8,Sigmoid,9.143185,8.0,-40.45085144,0.3988,BT474_BREAST,BT474,ACH-000927,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,2.122596502304077
4675,8066,BT-549,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.46,27.6,1.71,8.04,-5.7,-3.9,-20,-71","14.4,15.4,1.00,4.78,4.90,6.28,.80,9.11",8,Sigmoid,8.607239045,5.395706654,-70.46554565,0.7964,BT549_BREAST,BT549,ACH-000288,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6856035732650865,1.6506946086883545
4676,8067,BxPC-3,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.15,-15,.84,-15,22.7,-20,-25,-75","11.3,11.4,.90,13.4,19.3,14.9,8.11,2.08",8,Sigmoid,8.289853851,5.210793972,-75.00107574,1.6433,BXPC3_PANCREAS,BXPC3,ACH-000535,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6507322380124767,1.381505012512207
4677,8068,C2BBe1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","14.2,3.34,-1.4,-1.5,1.05,-25,-63,-72","6.41,4.20,15.9,3.04,5.47,5.73,2.89,4.16",8,Sigmoid,1.021552205,1.563514233,-72.59511566,1.4705,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.44693600116821613,1.6087017059326172
4678,8069,C32,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.06,6.27,-.73,24.9,13.2,-19,-32,-47","28.1,0,10.8,9.86,32.5,9.94,4.50,3.76",8,Sigmoid,0.935053527,8.0,-44.25482559,0.6679,C32_SKIN,C32,ACH-000580,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2322604656219482
4679,8070,CAL-12T,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-5.9,-25,-16,-9.9,-62,-68,-96","38.5,.69,14.2,11.3,4.74,5.87,.89,2.51",8,Sigmoid,0.672173083,0.690349579,-82.33850098,2.8724,CAL12T_LUNG,CAL12T,ACH-000826,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.37055717345575223,1.497202754020691
4680,8071,CAL 27,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-2.1,-1.2,-3.4,9.69,.012,-22,-62","5.16,1.22,1.08,3.72,6.33,5.10,3.10,9.37",8,Sigmoid,2.874865532,3.846338987,-60.98190689,0.5994,CAL27_UPPER_AERODIGESTIVE_TRACT,CAL27,ACH-000832,Head and Neck Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.3471217834280795,1.3570506572723389
4681,8072,CAL-85-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","14.0,2.94,23.2,14.4,-13,-25,-35,-52","9.42,19.1,4.57,33.6,.078,28.1,2.85,24.5",8,Sigmoid,0.221374631,8.0,-37.3459816,0.9655,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.40269935131073
4682,8073,Calu-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-15,5.30,-2.3,-3.8,-12,-12,-61","6.71,3.18,2.80,3.91,22.6,19.9,9.45,2.47",8,Sigmoid,8.278137411,6.918637276,-60.62951279,0.8478,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.9342188248036931,1.771791934967041
4683,8074,Calu-3,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,12.1,-1.9,1.56,-20,-1.3,-13,-81","14.3,20.8,15.0,17.7,4.96,14.7,.59,7.34",8,Sigmoid,8.00846385,5.718297482,-80.89070129,1.1636,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.7436711180802422,1.6066021919250488
4684,8075,Calu-6,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,11.2,6.87,8.96,-23,-54,-73,-91","17.7,22.4,2.10,18.4,18.7,5.02,1.53,1.99",8,Sigmoid,0.625675917,0.77653265,-89.69820404,2.1373,CALU6_LUNG,CALU6,ACH-000264,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.2529165896276626,1.2444281578063965
4685,8076,CAMA-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.39,6.55,-2.9,7.91,-2.2,4.95,-17,-12","12.7,2.44,7.97,10.2,7.36,15.3,4.61,4.84",8,Constant,,8.0,-2.042665243,0.1146,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.5277698040008545
4686,8077,Capan-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","14.8,-10,3.06,-20,-21,-52,-84,-107","6.56,14.0,12.7,9.58,15.5,11.2,8.68,7.02",8,Sigmoid,8.170026395,0.671418905,-114.2922363,2.4551,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.3983620372514461,1.6110150814056396
4687,8078,CAS-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,1.91,-2.7,-3.9,.66,-8.0,-26,-88","9.90,15.5,4.00,1.06,10.3,9.62,17.8,1.35",8,Sigmoid,8.03157465,4.411480904,-87.73142242,1.0183,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.4842104389842659,1.624251365661621
4688,8079,CCK-81,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,1.29,-17,-9.4,.65,-12,-56,-54","18.8,38.7,7.99,7.60,22.1,.15,9.01,3.06",8,Sigmoid,1.515441775,2.169864178,-56.04158783,1.8427,CCK81_LARGE_INTESTINE,CCK81,ACH-000963,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.7746645748100732,1.5917325019836426
4689,8080,CHP-212,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-34,12.3,-17,5.79,-9.8,-20,-57,-89","11.2,33.1,10.1,12.0,12.4,11.3,12.9,.25",8,Sigmoid,2.31303668,2.156605005,-89.27960205,2.3225,CHP212_AUTONOMIC_GANGLIA,CHP212,ACH-000120,Neuroblastoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.7685352282458554,1.2345824241638184
4690,8081,CI-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,15.7,19.8,14.7,6.09,-15,-57,-40","5.91,75.2,50.4,14.4,35.3,14.6,5.76,13.0",8,Linear,,8.0,-55.42824554,1.1676,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,0.9992274641990662
4691,8082,COLO-320,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-5.4,-4.5,-14,-36,-77,-83,-91","8.04,.30,1.15,8.23,16.1,1.11,.99,.56",8,Sigmoid,0.297326595,0.329955041,-88.52603912,2.7318,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-1.1087988731969798,1.311504602432251
4692,8083,COLO-678,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,2.96,-11,2.84,-7.2,-15,-33,-75","4.35,1.81,4.37,5.85,8.19,13.1,.96,2.34",8,Sigmoid,8.436269384,4.441536427,-74.68886566,1.4769,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.4910003587024858,1.6257953643798828
4693,8084,COLO-679,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-14,16.6,-15,19.4,-19,.53,-50","24.2,5.73,13.0,20.3,16.6,2.04,21.4,5.78",8,Constant,,8.0,-11.89255142,0.853,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.3406715393066406
4694,8085,COLO 741,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.48,-7.8,-9.7,-15,-6.9,-1.9,-24,-48","17.0,1.63,13.8,21.3,6.82,17.8,4.27,18.3",8,Sigmoid,2.695671558,8.0,-47.42326355,1.3744,COLO741_SKIN,COLO741,ACH-000582,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.3988556861877441
4695,8086,COR-L105,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","35.0,-3.6,22.2,-2.3,10.2,9.51,-6.5,-11","11.1,11.4,26.9,18.7,9.14,14.3,10.7,8.53",8,Constant,,8.0,4.072333336,0.1953,CORL105_LUNG,CORL105,ACH-000161,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.712437391281128
4696,8087,COR-L23,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,4.52,1.92,-1.8,-3.9,-4.8,-25,-52","4.16,1.85,3.40,5.22,4.66,5.05,6.22,3.12",8,Sigmoid,8.0,7.618295193,-50.94036484,0.6334,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0305526167149672,1.3781261444091797
4697,8088,COV318,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,13.6,-13,14.9,-18,-11,-37,-64","29.7,10.7,5.22,6.53,1.27,4.14,3.80,2.92",8,Sigmoid,8.113463586,4.677239895,-64.63754272,1.4239,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.5427081699235232,1.7223663330078125
4698,8089,COV504,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,10.2,3.04,3.68,-.39,-30,-54,-88","4.05,10.1,7.47,16.6,5.58,7.23,.75,3.67",8,Sigmoid,2.317010164,2.071975231,-86.85720062,1.1179,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.7285023701752061,1.5150426626205444
4699,8090,Daoy,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,-7.0,3.45,1.11,-8.5,-12,-31,-47","2.01,22.6,11.5,15.0,28.9,20.4,7.66,10.8",8,Sigmoid,2.145682573,8.0,-46.84990311,0.7283,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.1315397024154663
4700,8091,DBTRG-05MG,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.30,-5.6,1.47,-3.5,-9.7,-30,-40,-67",".16,.62,4.70,.97,1.21,3.61,2.56,.96",8,Sigmoid,8.09011932,3.781657457,-66.31609344,1.4749,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.3301623942147625,1.317379117012024
4701,8092,Detroit 562,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.07,10.1,12.3,-2.4,-4.5,-6.8,-17,-36","2.57,11.0,23.4,.068,.40,9.66,9.53,12.3",8,Sigmoid,9.002188774,8.0,-35.11312485,0.5406,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2768893241882324
4702,8093,DK-MG,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.44,5.64,-.88,-8.2,8.56,5.05,-23,-31",".011,1.72,15.5,6.25,3.14,15.7,3.11,8.43",8,Sigmoid,2.023636818,8.0,-31.11401749,0.4276,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4145653247833252
4703,8094,DMS 114,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,2.38,-12,-4.3,-1.4,-41,-57,-78",".44,18.0,3.44,9.76,3.85,6.72,9.72,.039",8,Sigmoid,0.800305426,0.894316435,-74.09068298,1.8487,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.11169561229690896,2.007746696472168
4704,8095,DOHH-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","33.2,-7.9,3.24,-9.0,-10,-29,-43,-84","44.7,3.54,1.56,33.9,15.9,20.9,41.6,.0020",8,Linear,,0.768781009,-83.69490814,1.9472,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.2629491237643516,1.4931713342666626
4705,8096,DV-90,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-1.3,9.68,15.1,31.5,2.38,-7.0,-62","20.4,16.6,29.4,23.4,48.8,2.57,61.5,18.0",8,Linear,,1.319583046,-60.90460205,1.0057,DV90_LUNG,DV90,ACH-000925,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.2773158124570786,1.3634388446807861
4706,8097,EB1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.92,-18,5.02,-7.1,27.6,12.7,6.15,-32","15.4,.90,8.45,15.4,27.4,6.81,27.3,4.64",8,Linear,,8.0,-30.59740067,0.408,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.0577332973480225
4707,8098,EBC-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-54,.39,-1.3,9.61,-14,-9.4,-53,-59","11.6,6.95,13.1,4.90,12.2,4.71,2.24,6.43",8,Sigmoid,1.316774011,2.244243145,-59.69499588,1.6407,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.808368335177455,1.5574371814727783
4708,8099,EFE-184,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","12.7,-3.7,1.29,8.17,-3.7,-21,-10,-37","2.12,27.5,12.9,18.9,4.70,8.12,8.09,11.6",8,Sigmoid,8.328719529,8.0,-32.58059311,0.4804,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.5541740655899048
4709,8100,EFM-19,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,1.75,-5.6,.21,-12,-31,-31,-43","30.2,8.18,5.93,3.52,13.1,5.78,1.04,.28",8,Sigmoid,0.41806224,8.0,-37.91172028,1.2299,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.702622652053833
4710,8101,EFO-21,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","17.1,-6.6,19.5,-8.2,-11,-46,-56,-81","21.6,12.9,20.7,12.0,9.30,9.42,1.66,6.67",8,Sigmoid,1.216094255,1.474155068,-78.70523834,1.7014,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.38808499040474786,1.5091512203216553
4711,8102,EFO-27,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.49,7.15,6.77,12.3,-.75,-.46,-28,-41","2.82,.16,4.99,.075,5.20,1.54,11.0,.39",8,Sigmoid,1.757758141,8.0,-40.68094635,0.4506,EFO27_OVARY,EFO27,ACH-000936,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2052308320999146
4712,8103,EM-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".92,.32,2.40,-24,8.08,-3.2,-87,-86","13.7,2.79,5.37,4.96,1.38,13.7,.29,3.00",8,Sigmoid,1.259117365,1.351062655,-87.50790405,2.3065,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.30089143466065027,1.1140764951705933
4713,8104,EN,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-.61,-8.3,4.58,.99,-.38,-41,-30","1.00,3.38,4.75,8.99,2.62,2.38,5.87,2.02",8,Sigmoid,1.382069349,8.0,-35.06503296,0.698,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.3663790225982666
4714,8105,ES-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-8.7,-.22,-8.9,4.38,-4.9,-.086,-7.7","6.61,9.83,9.53,7.29,6.96,11.5,5.86,4.53",8,Constant,,8.0,-4.034076214,0.1766,ES2_OVARY,ES2,ACH-000906,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.49601149559021
4715,8106,ESS-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,2.90,-2.6,-1.7,13.0,-3.4,-46,-94","4.14,.88,.96,7.44,2.39,1.05,.021,3.61",8,Sigmoid,2.633247614,2.685304403,-93.53655243,1.9378,ESS1_ENDOMETRIUM,ESS1,ACH-000913,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.9877940932293428,1.1937146186828613
4716,8107,F-36P,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.79,-3.3,8.19,-16,-29,-70,-86,-87","11.7,14.0,9.87,7.61,7.52,2.18,3.46,8.26",8,Sigmoid,0.351839483,0.419441044,-89.04936218,3.0508,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.868832301687961,1.2635993957519531
4717,8108,FaDu,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.52,.20,4.53,-18,-2.4,-5.4,-28,-61","15.7,7.01,9.20,9.83,29.9,14.4,7.70,6.93",8,Sigmoid,8.237484832,5.832924843,-61.31760025,0.9511,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.763518562895074,1.2092549800872803
4718,8109,FU97,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-12,-3.2,12.6,-5.3,-4.4,-38,-93",".84,4.60,.50,11.3,10.5,10.1,6.94,1.90",8,Sigmoid,2.866034746,2.849743128,-93.3195343,1.3489,FU97_STOMACH,FU97,ACH-000633,Gastric Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.0472288596922434,1.1816470623016357
4719,8110,FU-OV-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.3,6.41,3.39,1.49,-17,-32,-51,-75","11.7,7.73,.33,10.4,13.6,13.6,12.4,12.6",8,Sigmoid,4.043495655,2.28670001,-74.11959076,1.5291,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.8271097345960263,1.294398307800293
4720,8111,G-361,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,5.28,4.75,-1.7,-3.1,-3.7,-16,-98","6.86,2.08,5.70,15.8,2.13,4.76,11.8,.43",8,Sigmoid,8.141192635,4.944403648,-97.50270081,1.2092,G361_SKIN,G361,ACH-000572,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.5982563608356435,1.1704168319702148
4721,8112,G-401,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.71,-7.2,3.98,-14,7.23,-33,-66,-93","7.57,4.02,4.92,11.0,15.0,3.72,6.82,.93",8,Sigmoid,1.61757946,1.472729087,-92.86927795,2.1525,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.3871172013527893,1.0531442165374756
4722,8113,G-402,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-1.6,3.45,-4.0,7.89,10.4,8.15,-52","22.3,.75,6.29,.047,12.5,11.4,7.01,22.7",8,Sigmoid,7.513617516,8.0,-49.96888351,0.6709,G402_SOFT_TISSUE,G402,ACH-000375,Kidney Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2017548084259033
4723,8114,GAMG,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.2,7.84,.64,-5.2,7.62,10.6,1.87,-25","8.29,4.05,4.31,14.0,6.60,6.97,13.9,5.63",8,Sigmoid,4.337661743,8.0,-24.66205215,0.1636,GAMG_CENTRAL_NERVOUS_SYSTEM,GAMG,ACH-000098,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.5604397058486938
4724,8115,GB-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.87,1.25,-3.3,-3.3,-10,-14,-61,-92","5.09,15.0,1.36,15.3,10.4,6.20,13.8,3.64",8,Sigmoid,2.057009935,2.040796757,-92.15433502,1.6221,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.7133402987614893,1.590665340423584
4725,8116,GCT,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,-23,4.28,-10,-8.6,-28,-64,-90","4.88,23.1,12.6,6.31,22.1,12.8,6.59,.10",8,Sigmoid,1.933865547,1.617829323,-90.35519409,2.0993,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.48108532666925147,1.4089926481246948
4726,8117,GI-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-1.9,-26,-7.7,-7.7,-7.0,-26,-88","13.4,4.42,8.57,2.30,15.8,9.22,4.08,11.3",8,Sigmoid,3.254235029,3.301204205,-87.81269836,1.8359,GI1_CENTRAL_NERVOUS_SYSTEM,GI1,ACH-000756,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.1942873125148126,1.1121671199798584
4727,8118,GMS-10,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,7.92,5.55,14.1,-2.5,-1.4,-21,-59","7.27,16.5,10.7,8.84,5.47,3.11,1.63,1.13",8,Sigmoid,7.680865765,6.281594753,-59.40642166,0.6572,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.8376238898029165,1.138896107673645
4728,8119,GRANTA-519,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-31,-3.6,-7.8,-3.5,-7.6,-21,-69,-57","9.97,5.27,3.11,13.3,3.85,30.9,3.21,1.45",8,Sigmoid,0.722523868,0.91481179,-63.21466064,2.4579,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.08903692885359675,1.3603639602661133
4729,8120,H4,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.68,-9.4,-6.8,-8.5,2.23,-7.1,-49,-95","5.23,12.4,3.57,.55,7.28,.17,5.45,1.59",8,Sigmoid,2.599748135,2.550216913,-95.17319489,1.8596,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.9361784194741731,1.5679059028625488
4730,8121,HARA,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,-8.6,4.13,-3.7,3.45,7.40,-26,-74","8.60,3.81,11.9,8.01,16.1,13.3,16.6,4.88",8,Sigmoid,2.87883091,3.312074423,-73.82379913,1.0078,HARA_LUNG,HARA,ACH-000843,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.1975747069831109,1.345459222793579
4731,8122,HCC1187,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.3,-4.4,8.05,.37,-16,5.87,-6.5,-33","7.40,3.40,5.45,3.24,46.8,.89,10.0,6.48",8,Constant,,8.0,-1.095068812,0.4494,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.740854263305664
4732,8123,HCC1395,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.94,26.1,-18,-10,19.3,16.6,-1.5,-33","19.0,5.62,13.6,7.42,18.5,2.32,1.10,39.5",8,Constant,,8.0,-1.494877219,0.4094,HCC1395_BREAST,HCC1395,ACH-000699,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.3990592956542969
4733,8124,HCC-15,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".85,7.66,-4.0,2.18,2.20,-12,-45,-59","3.99,5.76,10.7,1.98,2.00,8.00,3.53,9.39",8,Sigmoid,1.461821079,3.222835064,-58.33421326,1.3415,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.1702614268418587,1.6305601596832275
4734,8125,HCC1569,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.62,2.69,-.41,10.4,1.20,2.13,-.69,-5.0","6.42,5.63,1.84,10.9,11.2,.54,7.27,.35",8,Constant,,8.0,1.295406699,0.0,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.6851445436477661
4735,8126,HCC1806,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,-5.4,-11,-2.6,-1.7,-14,-48,-82","26.3,10.5,1.26,15.7,5.53,1.96,17.6,5.07",8,Sigmoid,2.44173193,2.626514673,-81.91441345,1.8193,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.9656577479182621,1.5186841487884521
4736,8127,HCC1954,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.79,-6.9,8.22,-1.6,6.69,.82,-3.5,-52","6.36,30.0,11.0,14.6,1.03,1.07,9.44,14.4",8,Sigmoid,6.896231651,7.747289658,-51.73308182,0.5027,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0473430606500265,1.7077059745788574
4737,8128,HCC2935,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".017,-3.6,5.05,-10,16.5,-11,-34,-82","17.6,19.7,.93,17.3,22.6,7.08,.71,4.06",8,Sigmoid,7.960268974,3.912908316,-81.71785736,0.9348,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.3642809123378785,1.5751185417175293
4738,8129,HCC4006,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-.28,6.42,-8.5,-3.3,-28,-34,-91","1.34,1.53,5.86,37.0,21.3,12.6,1.07,3.75",8,Sigmoid,8.48423747,3.425027609,-89.43846893,1.5185,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.2311095327035966,1.5501569509506226
4739,8130,HCC-44,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,-6.3,-2.0,3.29,2.55,-6.8,-6.6,-73","6.09,9.16,3.49,5.61,2.88,3.57,16.5,16.6",8,Sigmoid,6.030266762,5.976231575,-72.90222168,1.0325,HCC44_LUNG,HCC44,ACH-000667,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.787790197916402,1.4486134052276611
4740,8131,HCC-56,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.3,-13,.49,7.48,1.67,-2.7,-11,-67","17.6,8.85,2.96,1.25,15.5,2.29,3.28,14.9",8,Sigmoid,7.454293251,6.227405548,-66.76256561,0.8885,HCC56_LARGE_INTESTINE,HCC56,ACH-000467,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.8289598011182642,1.0198626518249512
4741,8132,HCC70,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.6,-1.2,11.0,-2.0,-4.8,-17,-25,-70","5.76,11.8,20.0,5.08,14.7,16.0,13.6,10.9",8,Linear,,6.094072261,-52.40468979,0.9657,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.8073165382221286,1.498353362083435
4742,8133,HCC-78,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,6.71,-1.2,-8.0,-7.8,-17,-43,-35","3.60,8.19,5.48,7.09,8.17,6.64,2.31,6.79",8,Sigmoid,0.878724694,8.0,-39.82443619,0.8875,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.6717302799224854
4743,8134,HCC827,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,24.1,-3.2,-34,2.88,-5.6,9.19,-96","12.2,2.39,43.6,14.7,30.6,27.1,7.24,1.50",8,Linear,,0.036157422,-93.96211243,1.5033,HCC827_LUNG,HCC827,ACH-000012,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-3.3198730402475047,1.5653407573699951
4744,8135,HCT 116,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","18.0,8.91,10.8,4.90,2.05,-10,-31,-71","14.8,5.79,3.36,17.4,3.82,11.0,5.55,2.41",8,Sigmoid,8.886339973,4.750010014,-70.48578644,1.092,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.5581467262548538,1.0776207447052002
4745,8136,HCT-15,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.25,.98,1.86,19.7,-12,-8.9,-17,-74","7.71,3.89,6.60,4.62,23.8,11.6,4.17,7.71",8,Sigmoid,8.56580063,5.418049335,-73.17756653,0.9206,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6897358493800287,1.4742488861083984
4746,8137,HD-MY-Z,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,-6.1,4.89,5.55,13.1,3.88,-40,-79","33.5,2.13,3.64,3.33,10.1,4.04,22.5,10.1",8,Sigmoid,2.491329908,2.796273947,-79.49278259,1.4183,HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HDMYZ,ACH-000190,Unknown,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.028287797755134,1.192789077758789
4747,8138,HDQ-P1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","21.2,19.2,27.9,13.0,2.83,3.72,-59,-82","36.2,18.8,11.2,11.4,11.6,15.2,16.4,14.6",8,Linear,,0.60489908,-83.29244232,1.7956,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.5026936447829725,1.472952961921692
4748,8139,HEC-151,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,-11,-6.0,-8.0,2.89,-38,-56,-80","4.97,8.12,25.8,.043,22.9,10.9,9.39,2.31",8,Sigmoid,1.719371915,1.77215457,-79.25601196,1.695,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.5721960774982896,1.0516862869262695
4749,8140,HEC-1-A,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.39,6.01,14.8,-4.5,-1.9,4.55,-26,-45","17.3,5.37,29.7,5.89,28.5,10.8,8.65,3.30",8,Sigmoid,2.337085724,8.0,-45.39464569,0.614,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.25724196434021
4750,8141,HEC-1-B,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","21.7,27.6,13.0,-10,.031,-34,-7.6,-61","1.64,36.0,11.8,32.6,11.8,7.25,10.6,6.21",8,Linear,,3.221070013,-59.09746933,1.0383,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.169713606530091,1.2644295692443848
4751,8142,HEC-251,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,5.94,-6.4,9.07,-2.4,12.0,-19,-69","16.7,10.6,30.3,8.33,40.2,9.49,9.36,2.62",8,Sigmoid,2.951519728,3.615829468,-69.08562469,0.8138,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.2853212810196133,1.5621795654296875
4752,8143,HEC-265,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-2.2,-2.6,3.93,-2.4,-1.9,-.12,-38","13.3,16.6,9.10,14.3,5.92,13.4,18.2,6.66",8,Sigmoid,7.212037086,8.0,-38.25193787,0.4049,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.306223750114441
4753,8144,HEC-59,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,7.54,2.34,16.5,-.81,7.30,-42,-79","3.16,8.95,6.14,4.28,15.5,11.4,.71,5.10",8,Sigmoid,2.417768717,2.747899294,-78.62499237,1.0285,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.010836726672573,1.2813770771026611
4754,8145,HEC-6,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.61,-14,11.4,25.4,18.9,-12,-19,-41","8.99,.47,19.5,1.23,56.0,26.5,33.8,10.2",8,Linear,,8.0,-39.87857819,1.1543,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.596696138381958
4755,8146,HEL 92.1.7,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-11,-5.8,-8.2,.80,.93,-11,-9.2","11.2,7.19,15.1,16.6,14.2,14.0,10.7,12.6",8,Constant,,8.0,-7.332537651,0.6456,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.101445198059082
4756,8147,Hep 3B2.1-7,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-8.3,-3.5,-11,-21,-39,-77,-96","3.69,4.98,6.07,11.7,13.9,2.33,9.59,.20",8,Sigmoid,1.341786504,1.113664031,-95.88372803,2.3426,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.10765550804701973,1.5881681442260742
4757,8148,Hep G2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.15,7.68,.31,-5.6,-35,-37,-62,-39","2.77,5.54,28.5,2.97,7.34,19.6,3.43,20.2",8,Sigmoid,0.183317095,0.550195515,-57.85987091,1.5851,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.5974815821061304,1.538651943206787
4758,8149,Hey-A8,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,1.94,-2.1,2.05,-4.0,-22,-37,-61","5.27,.30,6.80,1.81,8.52,9.51,.048,3.68",8,Sigmoid,2.578943014,4.445700169,-60.57483292,0.8663,HEYA8_OVARY,HEYA8,ACH-000542,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.4919373748963658,1.2813918590545654
4759,8150,HGC-27,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.1,1.97,-3.6,-2.7,-5.5,-19,-90,-91","3.43,2.63,3.37,.63,.31,5.05,.65,.48",8,Sigmoid,1.097139239,1.122888923,-91.14663696,2.0106,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.11590475991149035,1.207924723625183
4760,8151,HH,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","33.7,22.7,-11,.19,25.3,4.23,-27,-51","22.4,23.8,13.6,.62,5.74,5.63,.031,13.3",8,Linear,,7.147410516,-51.20155334,1.496,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.9667501255137132,1.2151896953582764
4761,8152,HLF,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.25,-5.7,5.37,-2.8,-3.7,-4.1,-20,-66",".35,1.60,6.00,4.85,5.32,1.47,.86,2.95",8,Sigmoid,4.830480576,5.347187996,-66.31703186,0.8174,HLF_LIVER,HLF,ACH-000393,Liver Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6765708145031921,1.2656266689300537
4762,8153,HMC-1-8,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.10,-4.1,-8.5,-2.4,2.18,-13,-38,-70","3.07,4.18,1.10,1.87,1.42,4.81,10.4,.70",8,Sigmoid,2.863578796,3.662677526,-69.44747925,1.1591,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.2981944444312907,1.2782745361328125
4763,8154,HMCB,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,4.19,3.87,-2.7,-3.0,-25,-63,-77","17.6,3.82,8.81,3.08,2.01,.17,5.35,4.74",8,Sigmoid,1.190208197,1.607622266,-76.70227814,1.707,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.4747562339573057,1.073033094406128
4764,8155,HOS,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","23.2,1.88,3.85,17.2,-7.3,-1.3,-5.5,-37","9.70,3.26,8.19,10.2,21.6,2.30,2.18,4.29",8,Sigmoid,8.783818064,8.0,-34.48837662,0.6085,HOS_BONE,HOS,ACH-000613,Bone Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2534904479980469
4765,8156,HPAC,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,-14,3.10,6.27,-3.8,-21,-63,-91","2.49,10.8,12.3,37.8,1.26,24.5,8.43,.71",8,Sigmoid,2.215720654,2.2234478,-91.37731171,1.966,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.7990590541920249,1.3997864723205566
4766,8157,HPAF-II,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,3.82,38.8,1.64,27.2,-12,-26,-47","2.59,2.85,2.11,54.3,1.32,.68,29.1,3.13",8,Linear,,8.0,-45.80817413,1.1629,HPAFII_PANCREAS,HPAFII,ACH-000094,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.7504035234451294
4767,8158,Hs 294T,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,.070,1.59,-7.2,3.99,-12,-33,-59","14.3,2.45,7.39,3.29,13.1,7.28,.23,.57",8,Sigmoid,8.102874436,5.729112625,-58.67863083,0.9395,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.7455606539869193,1.4736484289169312
4768,8159,Hs 578T,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","14.4,6.10,-10,6.14,3.37,-15,-23,-36","8.48,7.31,2.11,.33,11.5,5.22,1.20,12.8",8,Sigmoid,2.712449074,8.0,-35.76514435,0.7075,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.5620962381362915
4769,8160,Hs 683,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,-11,-5.7,-6.8,2.44,-14,-35,-86","5.02,13.4,4.03,3.64,10.1,.54,11.3,7.26",8,Sigmoid,4.6233687,3.532052755,-80.74957275,1.7276,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.261879218926884,1.2362622022628784
4770,8161,Hs 695T,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.3,-1.4,2.30,-3.8,-12,-18,-19,-48",".38,12.9,.031,1.40,5.55,1.25,4.79,8.09",8,Sigmoid,8.662956152,8.0,-46.1967926,0.9149,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.6279852390289307
4771,8162,Hs 729,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-11,-6.8,7.18,-6.2,-7.7,-11,-34","8.07,2.20,11.7,5.81,5.52,8.72,5.23,10.7",8,Sigmoid,7.270057201,8.0,-33.74967575,1.2524,HS729_SOFT_TISSUE,HS729,ACH-000133,Unknown,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4919204711914062
4772,8163,Hs 746T,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.54,2.18,3.07,4.78,3.79,5.60,-28,-51","7.16,6.37,.67,15.7,22.1,21.7,4.46,10.6",8,Sigmoid,2.349987745,5.439565659,-50.69814682,0.8022,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6936992155847133,1.627579689025879
4773,8164,Hs 766T,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.95,-13,-17,-3.8,-13,-27,-32,-62",".87,11.7,.096,9.19,10.0,19.7,4.85,10.3",8,Sigmoid,8.398859117,5.293654442,-61.31341934,1.623,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6665088281573115,1.2518341541290283
4774,8165,Hs 852.T,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-3.5,-3.0,-11,-19,-58,-76,-91","5.60,1.64,.48,9.61,2.17,3.29,2.29,1.11",8,Sigmoid,0.630113304,0.677948415,-88.48822784,2.5434,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.38868407800707766,1.4747827053070068
4775,8166,Hs 936.T,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.29,-4.3,.86,-6.3,5.98,3.62,-10.0,-36","10.0,9.22,5.80,4.27,2.23,.95,6.71,.14",8,Sigmoid,3.055045605,8.0,-36.27807617,0.2688,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,0.5631306767463684
4776,8167,Hs 939.T,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.44,-1.8,-3.2,-5.9,8.34,-1.4,2.19,-28","7.79,10.7,4.32,.25,11.3,40.8,19.4,30.1",8,Constant,,8.0,-4.264249802,0.2371,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.3413747549057007
4777,8168,Hs 944.T,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,-2.1,2.12,10.9,2.42,-11,-32,-56","7.47,6.61,1.98,7.74,19.0,3.01,2.53,5.13",8,Sigmoid,3.092316389,5.717155933,-56.04174805,0.8553,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.7434714672290927,1.2173700332641602
4778,8169,HSC-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.6,-1.9,-1.6,3.36,-3.8,-5.7,-9.3,-17","3.42,3.41,2.25,2.87,1.52,8.80,3.38,5.95",8,Constant,,8.0,-3.775567532,0.1918,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.390122890472412
4779,8170,HT,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","24.8,23.2,-3.0,-51,-6.1,-18,-59,-86","21.6,60.9,52.5,45.7,9.13,23.8,.52,10.9",8,Linear,,0.574935419,-85.80550385,2.4755,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.5534975592751729,1.4691519737243652
4780,8171,HT-1080,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,1.86,.18,3.36,6.35,3.77,-20,-50","5.41,2.42,3.19,4.59,.47,2.38,3.40,8.75",8,Sigmoid,2.67997098,8.0,-49.6790123,0.5672,HT1080_SOFT_TISSUE,HT1080,ACH-000054,Sarcoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,0.964896559715271
4781,8172,HT-1197,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.77,-.39,-1.2,-5.9,-17,-26,-30,-63","8.10,6.18,1.92,3.03,6.84,1.14,13.0,7.43",8,Sigmoid,9.197566447,4.983293056,-60.76349258,1.032,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6060909287278962,1.6734271049499512
4782,8173,HT-144,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,-17,2.02,-14,23.2,-17,-15,-56","10.8,3.93,14.5,5.11,2.61,7.31,15.9,9.33",8,Sigmoid,8.172978369,7.234825611,-55.30545044,1.1289,HT144_SKIN,HT144,ACH-000322,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.978906256268419,1.3291313648223877
4783,8174,HuCCT1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,2.91,-2.6,3.64,8.39,2.62,-9.4,-59","2.44,10.0,7.41,2.10,5.14,7.75,.44,7.42",8,Sigmoid,3.395175934,4.738058567,-59.03451157,0.7162,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.5556274667830323,1.3211981058120728
4784,8175,huH-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,-6.7,6.86,1.01,-8.1,-43,-60,-77","12.0,28.7,1.33,21.3,10.7,23.6,4.16,.13",8,Sigmoid,1.13311553,1.724883199,-76.69556427,1.3823,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.5451593374662108,1.3686434030532837
4785,8176,HUP-T3,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-3.3,10.5,-.98,16.6,-3.8,-2.9,-20","10.2,16.3,4.87,8.61,12.4,5.63,11.2,10.4",8,Constant,,8.0,-2.185546398,0.1825,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.762943148612976
4786,8177,HuT 78,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-24,21.0,-26,-.80,-3.3,-31,-25,-81","24.9,64.0,19.4,4.24,23.8,11.9,41.3,3.36",8,Constant,,8.0,-20.40480804,1.8444,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.372812032699585
4787,8178,IA-LM,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.90,-1.2,23.8,6.45,15.7,16.3,-7.2,-39","17.6,12.0,41.0,16.1,31.1,19.7,22.5,2.18",8,Linear,,8.0,-38.95386887,0.4315,IALM_LUNG,IALM,ACH-000672,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4333269596099854
4788,8179,IGR-37,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-17,5.56,-4.7,4.19,10.8,-30,-45","8.79,3.78,2.78,2.52,6.15,4.87,10.2,7.24",8,Sigmoid,2.281206369,8.0,-45.5406189,1.4119,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.1482350826263428
4789,8180,IGR-39,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.11,-2.7,27.1,-15,24.9,-14,-7.3,-66","12.3,10.1,2.90,10.8,21.0,6.16,7.61,5.63",8,Linear,,1.640936053,-63.35041428,0.8205,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.4952668430366645,1.324760913848877
4790,8181,IGROV1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,2.41,-4.5,5.54,-11,.60,-19,-32","2.45,1.70,6.03,1.05,6.92,3.28,6.45,4.59",8,Sigmoid,2.373689413,8.0,-31.71525574,0.568,IGROV1_OVARY,IGROV1,ACH-000966,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4040570259094238
4791,8182,IMR-32,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,18.4,-13,-20,-16,-30,-86,-84","2.14,40.6,4.20,2.78,17.7,5.85,7.77,.99",8,Sigmoid,1.051936746,1.046906471,-85.2155304,2.4557,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.0458395974301921,1.3457202911376953
4792,8183,IPC-298,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,2.61,8.99,5.98,-7.6,-12,-16,-36","1.13,.38,1.99,4.41,4.44,2.35,8.00,3.79",8,Sigmoid,8.039010309,8.0,-35.18463898,0.4449,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.3514561653137207
4793,8184,IST-MES2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,11.0,-10,6.78,17.5,-.016,-45,-73","3.52,14.1,6.17,5.08,5.08,12.6,3.06,3.91",8,Sigmoid,2.160493612,2.76738596,-73.1344986,1.1692,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.0179031778862266,1.417198657989502
4794,8185,J82,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.70,-3.0,-1.3,18.1,3.09,7.71,-11,-28","7.82,10.3,8.38,5.02,10.5,4.98,2.70,6.10",8,Sigmoid,2.536017656,8.0,-27.87685585,0.3088,J82_URINARY_TRACT,J82,ACH-000396,Bladder Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.59769606590271
4795,8186,JHH-4,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.97,-1.6,.49,-6.7,7.23,3.61,-12,-29","10.0,22.8,5.13,6.90,7.82,9.61,5.29,.64",8,Sigmoid,2.637005329,8.0,-29.48501587,0.4165,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.376084566116333
4796,8187,JHOS-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.15,6.18,5.53,9.06,3.90,20.3,-11,-85","8.68,11.9,38.5,12.5,18.9,36.6,2.37,14.9",8,Sigmoid,4.068669796,4.392546654,-84.10263062,0.7772,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.4799091623089933,1.6231496334075928
4797,8188,JHUEM-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-27,-4.8,-.0073,15.8,3.67,-3.0,-21,-94","8.17,5.81,7.52,7.14,10.0,5.32,12.6,3.23",8,Sigmoid,4.486836433,4.083443642,-93.64998627,1.377,JHUEM2_ENDOMETRIUM,JHUEM2,ACH-000909,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.4069406623250917,1.176020622253418
4798,8189,JM1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","17.4,1.29,-11,7.85,28.1,52.3,34.9,48.8","11.4,7.28,4.82,1.83,6.21,15.8,8.86,10.3",8,Linear,,8.0,-6.806184292,0.0,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.261333703994751
4799,8190,JMSU-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".78,-.81,-.18,-1.4,-25,-72,-89,-97","9.06,1.57,1.70,3.44,.71,1.68,2.43,.097",8,Sigmoid,0.438115776,0.465483159,-94.65274048,2.6435,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.764679361222366,1.607616662979126
4800,8191,JURKAT,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,11.6,.16,-.038,-11,-31,-59,-69","10.7,.56,1.31,18.3,1.70,.34,2.55,1.01",8,Sigmoid,0.882688642,1.693429708,-69.69205475,2.2342,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.5267558854759591,1.1388070583343506
4801,8192,JVM-3,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.90,-4.4,9.08,13.8,-8.2,-13,-76,-77","5.06,17.7,29.6,16.8,2.13,19.3,8.77,6.84",8,Sigmoid,1.118497014,1.300479174,-77.80857849,2.3725,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.26273279193751575,1.6474026441574097
4802,8193,K029AX,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".89,8.30,-4.5,-5.5,-6.1,-8.4,-24,-70","25.9,.52,19.4,10.1,7.05,20.7,15.1,5.67",8,Sigmoid,8.254008508,5.298291683,-69.06526947,0.8642,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6673844446382786,1.2628192901611328
4803,8194,KALS-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,14.3,-5.9,14.2,-10,3.61,-37,-68","3.85,15.4,7.66,5.60,.88,18.5,11.5,5.26",8,Sigmoid,2.467201948,3.022300959,-67.61029053,1.3825,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.106018448236663,1.1788557767868042
4804,8195,KARPAS-422,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.17,.38,4.93,.68,1.12,-18,-68,-97","1.75,1.94,7.62,8.58,6.20,3.36,26.7,.34",8,Sigmoid,3.823832512,2.468577623,-96.93519592,1.9474,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.9036421236345775,1.329944133758545
4805,8196,KASUMI-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.44,10.2,1.94,-8.2,-6.4,-8.8,-48,-45","4.46,9.71,.31,22.7,7.14,.35,6.47,2.58",8,Sigmoid,0.991944015,8.0,-46.79426956,1.0007,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2132527828216553
4806,8197,KCL-22,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-6.2,.19,4.36,-8.6,-13,-55,-80","1.30,19.5,9.37,5.58,8.99,2.59,4.60,2.85",8,Sigmoid,1.931789517,2.26606822,-79.86215973,2.1484,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.8180462680661447,1.2609169483184814
4807,8198,KG-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,-11,8.84,-5.8,15.3,-56,-71,-93","9.81,16.3,4.31,4.63,3.97,4.26,11.9,2.11",8,Sigmoid,0.689632952,0.753083825,-83.02766418,2.5558,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.28357873599686645,1.2970352172851562
4808,8199,KHM-1B,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,7.22,-7.3,-44,-74,-92,-95,-96","13.2,6.88,8.80,3.86,7.02,.85,.32,.89",8,Sigmoid,0.089789234,0.102221638,-95.67519379,4.532,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-2.2806119015089936,1.4931211471557617
4809,8200,KMBC-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.8,-4.8,-1.6,.79,5.16,5.16,-8.9,-30","3.22,.0077,3.68,1.55,1.59,.65,23.9,51.2",8,Constant,,8.0,0.292039007,0.3795,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.6056519746780396
4810,8201,KMM-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.3,1.66,5.24,-9.3,-31,-62,-77,-90","1.67,20.8,25.2,.96,3.32,4.02,3.89,2.18",8,Sigmoid,0.49919647,0.53859663,-87.61354065,2.7704,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.6187883555867087,1.5618693828582764
4811,8202,KMRC-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.47,-19,9.15,-11,6.62,-10,-6.3,-68","1.53,5.51,1.60,1.30,1.16,16.2,5.76,13.3",8,Sigmoid,7.999233246,6.742055893,-67.43247223,0.8743,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.9083649070474544,1.6111708879470825
4812,8203,KMRC-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.67,32.8,-2.9,-8.4,-17,-6.8,-47,-93",".19,12.2,.43,10.3,13.1,8.45,3.37,2.57",8,Sigmoid,8.614345598,2.807507753,-91.06212616,1.8094,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.0322971691582599,1.088578224182129
4813,8204,KMS-11,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.97,21.2,13.6,-4.2,-51,-75,-84,-88","11.7,19.8,4.81,2.11,8.90,6.01,2.12,1.56",8,Sigmoid,0.186281607,0.256441385,-85.27386475,3.1159,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-1.3608551590041664,1.3855881690979004
4814,8205,KMS-12-BM,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.94,33.4,-4.8,-14,6.17,-18,-62,-83",".38,32.5,17.9,22.5,13.2,4.87,1.67,6.51",8,Sigmoid,1.425675988,1.805486321,-82.87076569,1.8171,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.5908299854120199,1.4507100582122803
4815,8206,KMS-34,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.31,8.74,-2.1,-17,-46,-86,-93,-91","34.0,6.54,12.3,19.5,1.76,1.77,1.96,7.35",8,Sigmoid,0.24901256,0.274660707,-92.26631927,3.5637,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-1.29221873579171,1.407374382019043
4816,8207,KNS-60,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".68,-3.4,7.40,-7.8,10.8,-13,18.1,-78","14.0,9.12,16.3,.89,3.61,22.7,13.4,22.2",8,Sigmoid,8.094935064,7.04292202,-77.3468399,0.8137,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.952023143715609,1.4778196811676025
4817,8208,KNS-62,TAE684,ALK,".0080,.025,.080,.25,.80,2.53,8","-22,15.7,11.6,-.070,13.4,10.9,3.14","2.22,1.16,33.2,17.4,9.48,8.69,10.9",7,Linear,,8.0,-21.51775742,0.127,KNS62_LUNG,KNS62,ACH-000858,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.203169345855713
4818,8209,KNS-81,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,8.12,9.32,8.73,-2.3,-27,-45,-79","7.22,10.9,5.01,9.73,18.4,1.11,7.13,5.68",8,Sigmoid,2.669586897,2.613715172,-77.37509155,1.3852,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.9607726467556208,1.484128475189209
4819,8210,KO52,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.89,-8.7,5.16,-3.4,6.81,-3.1,-72,-67","16.0,1.26,.58,3.20,5.43,11.9,2.03,4.46",8,Sigmoid,1.296673179,1.549693108,-70.73873901,1.7366,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.4380569164888799,1.3432621955871582
4820,8211,KP-N-SI9s,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,1.63,4.19,-4.6,-8.8,-47,-82,-96","10.0,10.5,3.88,17.2,6.11,2.86,2.24,.14",8,Sigmoid,0.832707584,0.883854568,-95.24791718,2.6934,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.12346274571581249,1.4103082418441772
4821,8212,KU812,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,4.31,25.8,19.4,12.9,13.4,10.5,32.1","12.7,7.20,17.5,10.3,15.4,5.38,20.0,32.0",8,Constant,,8.0,11.65635395,0.0,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2133843898773193
4822,8213,KYM-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.43,-5.1,24.9,-14,6.84,-6.2,-19,-67","16.1,22.1,.75,12.6,8.18,9.94,12.6,25.5",8,Linear,,1.298575132,-66.35772705,1.0759,KYM1_SOFT_TISSUE,KYM1,ACH-000607,Rhabdoid,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.2612676110552,1.0024642944335938
4823,8214,KYSE-140,TAE684,ALK,".025,.080,.25,.80,2.53,8","-.064,12.5,28.7,4.80,-1.6,-84","10.1,10.3,14.8,7.17,16.9,4.45",6,Sigmoid,8.472711718,6.06253624,-83.55287933,0.808,KYSE140_OESOPHAGUS,KYSE140,ACH-000823,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.8021282339776938,1.391932487487793
4824,8215,KYSE-150,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.01,-5.1,5.52,3.35,4.53,3.93,-1.4,-42","14.5,.16,1.80,2.53,2.08,5.42,5.24,.20",8,Sigmoid,4.013441563,8.0,-41.85498428,0.4303,KYSE150_OESOPHAGUS,KYSE150,ACH-000855,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.5655145645141602
4825,8216,KYSE-180,TAE684,ALK,".0080,.025,.080,.25,.80,2.53,8","-18,5.14,-6.3,7.51,-10,-28,-74","18.8,18.7,12.9,9.27,3.12,31.9,2.38",7,Sigmoid,2.004482031,2.578639507,-73.44825745,1.0755,KYSE180_OESOPHAGUS,KYSE180,ACH-000693,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.9472619369817086,1.306937575340271
4826,8217,KYSE-30,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-38,.41,-3.8,5.52,1.84,-4.3,-36,-59","36.7,.34,6.10,3.18,6.67,4.41,7.56,5.10",8,Sigmoid,2.188568354,4.018353462,-58.78879166,1.2814,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.3908722321602762,1.6746474504470825
4827,8218,KYSE-510,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.65,6.56,-1.8,-1.9,21.1,-3.9,4.33,-44","8.79,13.6,6.16,7.63,17.8,.90,3.47,9.67",8,Sigmoid,8.518701289,8.0,-43.83617783,0.5215,KYSE510_OESOPHAGUS,KYSE510,ACH-000824,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.5144991874694824
4828,8219,KYSE-520,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.4,1.08,-16,.81,5.54,2.91,-27,-66","7.08,.88,7.20,3.31,12.2,3.17,4.93,4.40",8,Sigmoid,2.771141291,3.443650961,-66.18257141,1.0372,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.2365322344492766,1.6498007774353027
4829,8220,KYSE-70,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,6.03,-20,4.54,14.7,-7.7,-38,-82","11.5,4.37,4.35,7.40,6.09,2.71,7.56,1.44",8,Sigmoid,3.126843929,3.304603577,-81.80386353,1.3801,KYSE70_OESOPHAGUS,KYSE70,ACH-000784,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.1953165196647189,1.2546818256378174
4830,8221,L3.3,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.07,-.92,.68,.74,5.52,10.4,-22,-64","3.63,9.49,18.6,6.03,7.29,3.32,7.07,18.5",8,Sigmoid,2.65017724,8.0,-44.77345276,0.8375,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4434455633163452
4831,8222,L-363,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.18,9.35,-12,-33,-41,-86,-87,-96","6.06,1.25,9.57,5.30,16.4,3.42,2.10,2.06",8,Sigmoid,0.143580243,0.185580403,-95.24684143,3.8758,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-1.6842670514892493,1.3753302097320557
4832,8223,L-428,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.68,-.15,7.26,6.18,-2.9,-.15,-20,-40","0,13.0,2.19,.93,4.53,2.36,7.63,4.86",8,Sigmoid,2.995382071,8.0,-40.23371887,0.7929,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.490256667137146
4833,8224,LCLC-103H,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,-11,1.93,-12,7.26,-13,-10,-53","1.57,26.3,3.21,18.0,16.5,15.2,1.74,9.44",8,Sigmoid,7.561956882,7.560817242,-52.79426956,0.8001,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0229792851426227,1.3380377292633057
4834,8225,LN-229,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.3,-8.7,-1.2,-8.4,-7.8,-19,-47,-68","10.8,11.8,13.7,2.70,5.03,9.24,4.13,3.69",8,Sigmoid,1.994626403,2.833112717,-67.67616272,1.6332,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.0413760072083214,1.3199477195739746
4835,8226,LOU-NH91,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","16.3,-12,5.70,4.53,21.3,-12,-54,-97","21.5,8.75,13.9,15.0,6.27,1.08,1.25,2.71",8,Sigmoid,2.288414955,2.279930353,-96.23335266,1.7266,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.824144895569958,1.500786304473877
4836,8227,LOX IMVI,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.2,-.94,-2.0,1.68,1.58,-3.0,-19,-93","7.75,.63,.46,3.02,2.31,9.41,10.5,3.85",8,Sigmoid,5.078281403,4.300870419,-93.29390717,1.1578,LOXIMVI_SKIN,LOXIMVI,ACH-000750,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.4588174252379966,1.3362417221069336
4837,8228,LP-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","78.4,-3.8,16.6,12.7,-50,-62,-32,-85","75.6,5.68,22.0,40.4,5.31,.30,14.1,8.20",8,Linear,,1.468751704,-83.98506927,2.6661,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.3844128590798718,1.4066894054412842
4838,8229,LS123,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,15.4,7.84,5.00,1.04,-6.2,-22,-81","11.6,25.9,4.80,11.3,5.39,.27,10.2,6.12",8,Sigmoid,8.890914197,5.005696297,-80.6412735,1.0933,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6105765233705756,1.4089796543121338
4839,8230,LS411N,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-13,-7.8,2.31,11.9,-9.7,-48,-81","16.5,26.5,18.5,18.2,16.0,19.7,6.78,10.2",8,Sigmoid,2.34105587,2.61978507,-80.59518433,1.4321,LS411N_LARGE_INTESTINE,LS411N,ACH-000985,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.963092280056859,1.26555597782135
4840,8231,LS513,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","26.7,-1.3,21.3,-40,.18,-78,-81,-96","5.97,21.0,36.8,7.71,.82,13.6,5.43,.31",8,Sigmoid,0.044141453,0.156419605,-93.11910248,2.7267,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-1.8552131070643854,1.5561466217041016
4841,8232,LU99,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,6.71,2.54,12.1,-7.5,-15,-76,-87","12.2,4.66,5.21,7.50,7.20,20.7,2.26,6.75",8,Sigmoid,1.042403221,1.221941113,-88.17984772,1.7623,LU99_LUNG,LU99,ACH-000444,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.20044067055390485,1.1745681762695312
4842,8233,LUDLU-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.4,24.1,10.1,12.8,8.14,-29,-76,-81","22.4,20.9,14.6,5.64,1.79,11.6,6.21,10.5",8,Sigmoid,0.889362276,1.139623761,-80.89376831,1.7285,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.13069817372260198,1.5676674842834473
4843,8234,Malme-3M,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,1.20,.93,-6.4,-16,-29,-53,-37","4.48,8.22,4.58,6.08,12.7,7.61,30.1,4.48",8,Sigmoid,0.310532212,8.0,-36.43000412,1.2676,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.233031988143921
4844,8235,MCAS,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,.66,3.11,3.62,3.82,-1.4,-39,-77","3.84,5.59,6.38,2.20,4.32,4.66,15.5,5.60",8,Sigmoid,2.918482304,3.335100889,-74.64524841,1.0451,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.2045029304842303,1.4688011407852173
4845,8236,MCF7,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.40,5.19,16.3,-22,-36,-81,-118,-112","1.49,12.6,56.2,32.2,1.19,21.2,13.9,5.84",8,Sigmoid,0.361564428,0.323893487,-114.1820374,1.5781,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-1.1273405610650657,1.767874002456665
4846,8237,MDA-MB-157,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.91,9.98,33.3,9.35,-7.8,-6.8,-18,-68","3.31,15.7,8.29,19.3,12.7,7.35,30.0,15.7",8,Linear,,0.913886624,-67.6920929,1.1916,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.09004875898572715,1.3053756952285767
4847,8238,MDA-MB-175-VII,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,11.9,-22,5.37,-17,37.5,.63,12.3","7.66,17.5,1.04,1.07,4.14,28.5,7.46,21.7",8,Constant,,8.0,2.00455761,0.2732,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.8494441509246826
4848,8239,MDA-MB-415,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.44,1.28,-11,9.95,11.4,17.5,-7.8,-9.6","18.4,43.2,29.6,14.9,37.8,10.7,4.76,1.23",8,Constant,,8.0,-2.286197662,0.2655,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.7322614192962646
4849,8240,MDA-MB-436,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.46,-16,8.80,-23,6.00,-27,-43,-68","3.46,15.6,24.4,6.84,16.8,2.92,17.9,1.98",8,Sigmoid,3.293587685,3.299835205,-68.23232269,1.8553,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.1938725293467092,1.498834490776062
4850,8241,MDA-MB-453,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,17.6,4.22,10.5,-4.6,-11,-52,-69","15.5,9.67,32.7,4.23,31.7,13.4,24.8,5.19",8,Linear,,0.274789904,-70.05709839,1.0628,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-1.2917484587557233,1.633702039718628
4851,8242,MDA-MB-468,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.41,-12,13.3,-13,10.1,-8.5,-45,-83","7.63,7.15,1.36,11.2,8.73,.36,4.30,.57",8,Sigmoid,2.460805893,2.787567377,-82.9691925,1.4916,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.0251693076151964,1.5552597045898438
4852,8243,MEG-01,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.39,8.02,4.72,11.9,-.56,19.7,.37,-15","15.4,12.9,24.3,17.5,5.34,24.5,5.31,33.6",8,Constant,,8.0,3.181217909,0.1,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2780157327651978
4853,8244,MEL-HO,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,-5.0,4.38,-3.3,-11,-16,-15,-90","14.6,5.46,13.7,3.81,.66,4.56,17.9,.23",8,Sigmoid,9.081918095,5.398359776,-89.98838806,1.4747,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6860951622451315,1.0653541088104248
4854,8245,MES-SA,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-1.7,.40,2.48,12.1,-1.3,-1.6,-69","13.9,2.47,3.78,2.79,6.81,1.35,1.73,2.06",8,Sigmoid,6.351518154,6.507004261,-68.50524139,0.6457,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.872879175345889,1.3440606594085693
4855,8246,MeWo,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.9,40.9,-5.1,14.8,-1.1,-14,-34,-57","31.5,41.7,2.59,36.8,13.6,2.62,3.21,11.1",8,Sigmoid,8.550389528,6.019351482,-56.99772263,0.8891,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.7949795262752086,1.1975184679031372
4856,8247,MFE-296,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-28,-2.9,1.75,6.07,10.9,-6.0,-16,-59","4.89,13.6,4.07,9.29,2.56,.36,10.3,1.89",8,Sigmoid,8.120870245,6.642848015,-58.70088196,0.7959,MFE296_ENDOMETRIUM,MFE296,ACH-000879,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.8935407894510319,1.2625422477722168
4857,8248,MG-63,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.7,-1.0,-2.0,-2.1,-13,-44,-71,-95","4.72,7.39,.49,5.87,1.38,7.90,8.19,.68",8,Sigmoid,1.180657744,1.108850002,-95.22187805,2.2176,MG63_BONE,MG63,ACH-000359,Bone Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.10332344403557144,1.2811124324798584
4858,8249,Mino,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-34,-13,.69,7.84,-16,-25,-74,-92","8.91,.38,13.2,.27,24.6,20.2,8.04,6.79",8,Linear,,0.023940077,-93.35662842,1.8164,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-3.7322013624832135,1.5500625371932983
4859,8250,MJ,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.59,18.5,-9.9,11.2,-12,8.64,-15,-74","41.2,10.6,18.6,2.95,21.3,25.5,1.85,2.46",8,Sigmoid,8.222788573,5.734483719,-74.1186676,0.8332,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.7464977236868378,1.1135587692260742
4860,8251,MKN-45,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,2.69,15.9,14.7,13.8,-5.3,-35,-42",".024,13.8,.36,2.39,5.59,.96,6.94,4.28",8,Sigmoid,1.067558527,8.0,-41.29027176,0.5641,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.6154561042785645
4861,8252,MKN7,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,-12,-21,-17,-16,-19,-22,-73",".48,20.5,39.8,19.1,30.2,1.56,.49,13.3",8,Sigmoid,8.230589546,5.466119289,-72.78243256,2.3151,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6985689110877182,1.4945638179779053
4862,8253,MKN74,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,2.01,22.0,.77,-13,-25,-17,-29","6.06,16.3,.69,6.01,20.1,18.1,2.55,3.38",8,Sigmoid,0.189228281,8.0,-23.49207878,0.41,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2889525890350342
4863,8254,MOLP-8,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,4.66,-9.9,-19,-28,-52,-62,-82","4.24,26.0,11.0,22.0,21.2,14.7,10.7,10.5",8,Sigmoid,0.924863577,0.915599108,-80.15592194,2.9462,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.08817666512875219,1.437373161315918
4864,8255,MOLT-16,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","22.7,4.37,8.93,1.82,31.8,11.9,-23,-80","23.4,34.7,7.00,22.0,54.9,40.3,15.7,4.92",8,Linear,,0.773999958,-79.35383606,1.5482,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.25618345965597733,0.8658528327941895
4865,8256,MONO-MAC-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,16.0,-41,-36,-41,-64,-88,-94","10.8,2.12,24.6,10.2,.95,.021,1.30,.93",8,Sigmoid,0.487224549,0.315820903,-96.65407562,4.6298,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-1.1525799887241193,1.3194706439971924
4866,8257,MOR/CPR,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.3,-14,4.73,11.6,2.71,13.3,-5.0,-53","3.77,16.2,9.70,12.8,1.43,13.4,.55,33.5",8,Sigmoid,3.606700897,8.0,-46.6160202,0.5558,MORCPR_LUNG,MORCPR,ACH-000851,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4108326435089111
4867,8258,MSTO-211H,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,-4.3,-6.3,.36,1.91,4.17,-61,-97","19.8,3.80,2.69,6.94,9.21,2.38,10.9,.029",8,Sigmoid,2.293585539,2.312949419,-96.80767822,1.6265,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.8385235148735719,1.5028437376022339
4868,8259,NCI-H1048,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,2.94,8.81,7.03,-12,-23,-73,-92","10.4,18.0,5.35,44.2,5.64,5.13,.65,.90",8,Sigmoid,1.459519506,1.485293388,-92.27410126,1.9009,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.3956123204175074,1.4832472801208496
4869,8260,NCI-H1092,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,1.81,2.65,4.09,-7.5,11.3,-14,-11","14.3,5.18,8.34,4.35,21.2,9.46,12.1,10.8",8,Constant,,8.0,-0.224436194,0.0,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.9546947479248047
4870,8261,NCI-H1155,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-9.0,10.6,34.8,13.3,-.33,-66,-72","9.89,3.75,13.8,10.3,3.96,13.8,7.01,1.56",8,Linear,,0.314884716,-74.88671875,1.5621,NCIH1155_LUNG,NCIH1155,ACH-000980,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-1.1555486880962582,1.4649689197540283
4871,8262,NCI-H1184,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","31.6,11.0,38.6,116,15.3,82.3,41.3,-34","108,62.6,30.0,39.3,1.22,69.5,5.09,57.8",8,Constant,,8.0,36.94775009,0.3275,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.880744457244873
4872,8263,NCI-H1341,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-20,-1.9,-2.6,-7.0,-4.0,-45,-79,-94","6.95,56.1,9.15,17.1,.17,31.6,6.61,1.58",8,Sigmoid,1.437150359,1.399953008,-94.13153839,2.2016,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.33643867034358604,1.3523223400115967
4873,8264,NCI-H1373,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-4.8,-2.1,6.31,5.21,-14,-5.8,-23","17.3,1.55,3.05,20.3,11.5,1.67,15.8,14.4",8,Constant,,8.0,-4.988949299,0.2048,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.6575284004211426
4874,8265,NCI-H1568,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","16.4,3.35,-18,12.9,-1.6,-18,-38,-65","11.0,27.0,.59,1.36,14.1,11.8,2.85,1.89",8,Sigmoid,3.355745077,4.127527237,-64.49376678,1.6053,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.417678495700125,1.6593314409255981
4875,8266,NCI-H1648,TAE684,ALK,".0080,.025,.080,.25,.80,2.53,8","-19,-5.5,-11,27.6,-15,-23,-32","19.1,15.4,7.16,38.7,9.17,15.7,.42",7,Constant,,8.0,-13.97048855,1.1125,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4149099588394165
4876,8267,NCI-H1650,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.37,-13,4.62,-2.7,8.27,-4.1,-31,-50","4.62,3.40,11.4,16.7,11.1,1.32,14.8,40.5",8,Sigmoid,2.055968285,8.0,-48.24371719,0.8811,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.6230292320251465
4877,8268,NCI-H1651,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,3.51,11.3,-1.3,16.0,3.31,-16,-42","2.32,26.7,3.37,10.0,2.76,16.0,4.32,16.5",8,Sigmoid,2.711140394,8.0,-41.9928627,0.7857,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.7378299236297607
4878,8269,NCI-H1792,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-1.6,-2.1,-5.3,4.54,-8.1,-50,-88","4.65,1.90,3.65,2.71,4.51,8.84,4.13,1.37",8,Sigmoid,2.394216537,2.524142504,-87.9874115,1.6733,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.9259014026731397,1.5835307836532593
4879,8270,NCI-H1793,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-.73,7.19,14.6,23.2,21.2,2.67,-54","27.3,6.98,1.29,9.57,11.9,.10,10.1,9.22",8,Sigmoid,3.663915396,5.928136349,-54.24939728,0.3799,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.7797098885727252,1.5441906452178955
4880,8271,NCI-H1915,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.5,-9.8,6.66,8.31,18.7,-2.6,-26,-64","12.0,.010,18.6,25.1,20.7,1.76,.46,1.26",8,Sigmoid,2.879093409,3.614163637,-64.06777191,0.8856,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.2848604697836177,1.423445224761963
4881,8272,NCI-H1944,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.3,.23,-5.6,11.7,12.3,25.0,-14,-36","18.0,3.01,8.98,6.39,6.38,4.27,7.74,.31",8,Sigmoid,2.5858922,8.0,-36.11326981,0.1488,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.509887456893921
4882,8273,NCI-H1975,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.44,-11,1.24,1.43,2.23,-4.5,-41,-90",".21,.032,7.64,7.23,7.19,5.37,8.09,.55",8,Sigmoid,2.833262205,2.905841351,-90.20066833,1.3584,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.066722970058357,1.6011120080947876
4883,8274,NCI-H2009,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,-3.5,15.0,-9.7,14.4,-13,-32,-73","9.19,5.54,10.5,27.2,5.01,8.98,13.4,2.70",8,Sigmoid,3.648304701,3.951325178,-73.10800171,1.2731,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.3740510107507466,1.3624922037124634
4884,8275,NCI-H2023,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.71,-1.9,.77,-7.6,-13,-30,-39,-72","29.1,1.98,4.49,10.4,22.7,12.7,18.0,21.1",8,Sigmoid,8.862834454,3.460036039,-70.2881546,1.0811,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.2412790049113416,1.6064448356628418
4885,8276,NCI-H2030,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".94,6.38,2.66,5.36,-11,-8.1,-18,-58",".42,10.2,1.05,7.12,20.3,2.43,5.60,3.80",8,Sigmoid,8.585393498,6.806890011,-57.03086853,0.8499,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.917935336115789,1.5716314315795898
4886,8277,NCI-H2052,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","11.1,1.83,15.4,-5.0,6.72,-23,-28,-86","7.79,5.40,.92,1.53,6.44,5.31,11.1,3.01",8,Sigmoid,8.582444925,3.856219053,-84.5166626,1.5411,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.3496871834853883,1.6615322828292847
4887,8278,NCI-H2085,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-1.3,-8.3,-12,-11,-33,-63,-94","22.4,5.63,2.38,13.1,16.0,3.70,2.64,2.16",8,Sigmoid,6.785653114,1.596056938,-94.02947235,2.1719,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.46753617382986024,1.805114984512329
4888,8279,NCI-H2087,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,-1.3,-.35,-17,8.73,-12,-21,-58","3.02,8.72,2.72,4.64,5.99,6.06,9.22,9.21",8,Sigmoid,8.165424154,6.56292057,-58.02708054,1.1913,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.88143571272141,1.6712372303009033
4889,8280,NCI-H211,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.1,12.4,1.20,-6.6,3.87,-13,-38,-80","19.2,11.6,4.05,14.6,12.9,7.52,20.7,3.90",8,Sigmoid,1.974393487,2.398709774,-82.09334564,1.3403,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.8749309986316787,1.570062279701233
4890,8281,NCI-H2122,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.80,-3.7,4.49,.90,-17,-23,-88,-105","22.3,1.15,20.0,18.7,21.7,14.4,8.04,2.49",8,Sigmoid,1.375943661,1.284851313,-105.6432037,1.8716,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.25064300192466976,1.1427408456802368
4891,8282,NCI-H2170,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.0,2.23,4.39,5.74,-2.6,-20,-61,-73","30.6,9.88,14.2,.26,12.3,17.5,4.46,8.49",8,Sigmoid,1.171037793,1.748815775,-72.9992981,1.5386,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.5589388588706331,1.5970479249954224
4892,8283,NCI-H2172,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","25.2,-25,-22,-9.5,14.0,-15,-58,-58","5.31,22.5,24.5,10.5,15.3,13.6,28.1,8.39",8,Linear,,3.548501577,-65.60303497,0.4014,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.2665254233959342,1.708791971206665
4893,8284,NCI-H2228,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.42,-29,-53,-58,-62,-75,-83,-103","9.06,8.58,2.39,1.28,.20,.50,4.81,.85",8,Sigmoid,0.002542614,0.041489352,-93.72054291,4.0317,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-3.1823184629805845,1.4400887489318848
4894,8285,NCI-H2286,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.35,-1.7,-1.9,1.70,-19,-52,-90,-94","4.05,8.31,5.16,4.87,9.75,15.5,.89,.94",8,Sigmoid,0.650069654,0.680661559,-95.212883,3.3459,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.3846900728715181,1.3967119455337524
4895,8286,NCI-H23,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-21,-3.5,-1.9,4.82,-1.8,-18,-59,-51","3.32,3.93,3.65,10.4,13.5,.37,1.01,7.67",8,Sigmoid,0.960220695,1.43065083,-56.4356308,1.688,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.3581294666075753,1.465687870979309
4896,8287,NCI-H2444,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","16.6,-11,26.0,6.46,14.6,-16,11.2,-14","6.64,3.75,8.18,15.9,28.3,.74,5.00,4.42",8,Constant,,8.0,1.846100211,0.3241,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.541478157043457
4897,8288,NCI-H2452,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","29.6,-24,12.1,-4.6,6.60,-18,-14,-82","16.1,12.2,2.84,33.3,.51,12.0,2.84,6.41",8,Sigmoid,8.602288974,5.233737946,-81.38021088,1.2638,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.655125735219832,1.6291346549987793
4898,8289,NCI-H28,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.87,-11,2.97,-3.8,-.51,-19,-51,-85","24.8,6.49,26.0,6.47,22.2,7.82,22.3,.050",8,Sigmoid,2.503588915,2.413717031,-85.03094482,1.4364,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.8811678958376825,1.4109748601913452
4899,8290,NCI-H322,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,4.44,-3.4,7.30,5.05,6.41,-42,-50","9.14,7.96,.74,7.11,.93,9.43,8.42,4.03",8,Sigmoid,1.844024777,5.500570774,-50.19010162,0.573,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.7048518639448644,1.7198376655578613
4900,8291,NCI-H3255,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-3.0,-.24,-12,-19,-67,-97,-97","11.3,1.44,.42,2.93,4.91,1.41,.17,1.03",8,Sigmoid,0.578658044,0.556460023,-98.37501526,2.8646,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.5861599473248884,1.583414912223816
4901,8292,NCI-H358,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.61,3.37,9.03,.40,8.08,-28,-60,-68","8.61,9.25,7.57,4.99,1.35,3.91,.37,3.46",8,Sigmoid,0.842217028,1.331018448,-65.28378296,1.5223,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.28594439957236917,1.6673433780670166
4902,8293,NCI-H441,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".48,4.29,3.48,-4.2,-13,-22,-38,-64","2.13,3.85,7.21,1.22,9.62,12.7,6.71,3.56",8,Sigmoid,8.219367828,4.349505901,-64.15705109,1.205,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.4700622526722056,1.4867675304412842
4903,8294,NCI-H460,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,-4.2,8.31,8.16,-6.5,6.49,3.23,-74","16.3,6.44,10.4,11.0,5.30,8.33,6.17,8.43",8,Sigmoid,7.547400475,6.896989346,-74.28656006,0.8719,NCIH460_LUNG,NCIH460,ACH-000463,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.9310849897183684,1.405113935470581
4904,8295,NCI-H522,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.74,-5.0,-15,-2.1,-12,-14,-33,-41","3.01,12.4,13.1,9.42,5.42,27.9,10.3,4.88",8,Sigmoid,8.901842394,8.0,-41.53252411,1.397,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.6733460426330566
4905,8296,NCI-H647,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,.53,17.5,.10,28.1,11.0,-12,-18","7.03,1.72,9.27,6.89,5.38,9.23,24.2,.087",8,Sigmoid,2.028427601,8.0,-18.17402077,0.1524,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.3555893898010254
4906,8297,NCI-H650,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.44,-5.6,7.40,4.21,7.78,-13,-25,-45","10.1,1.20,6.86,4.66,16.3,5.91,10.6,.84",8,Sigmoid,2.504458904,8.0,-45.01779938,0.5029,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4306178092956543
4907,8298,NCI-H661,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".59,.67,2.86,-2.2,-3.1,-14,-24,-47","8.37,9.30,3.61,8.03,7.18,27.2,31.4,67.9",8,Constant,,8.0,0.910979748,0.8723,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4462263584136963
4908,8299,NCI-H727,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,-2.4,8.51,3.80,-7.4,-31,-33,-69","11.3,7.95,4.80,12.5,16.9,35.8,34.6,46.0",8,Constant,,8.0,2.117031574,1.3735,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.7364109754562378
4909,8300,NCI-H747,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.41,14.2,-7.1,-.029,2.04,-28,-37,-85","10.2,24.4,26.8,9.26,17.4,.065,2.62,1.37",8,Sigmoid,8.885254154,3.33858633,-83.94674683,1.389,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.2055474629001264,1.5690116882324219
4910,8301,NCI-H810,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".22,-3.2,1.29,-8.3,-5.7,-12,-45,-40","12.0,3.55,4.48,8.04,12.2,11.9,2.28,2.10",8,Sigmoid,1.508470893,3.186504126,-51.0745163,1.318,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.1589244306089697,1.7492592334747314
4911,8302,NCI-N87,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,-13,-14,4.76,9.10,-12,-25,-65","18.8,21.1,5.00,45.0,28.1,30.2,4.96,.0067",8,Sigmoid,3.153451204,3.872960567,-64.74781799,1.8145,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.3540192189677442,1.3796647787094116
4912,8303,NCO2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,5.50,-1.4,-26,-21,-33,-51,-96","5.84,2.98,1.62,16.6,38.1,18.6,12.1,.93",8,Linear,,0.066367372,-96.12483215,2.6798,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-2.7125497288113576,1.0979489088058472
4913,8304,NIH:OVCAR-3,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.05,-18,27.9,-4.8,-11,-31,-48,-78","9.61,1.28,7.78,18.9,.44,10.4,4.10,9.78",8,Sigmoid,3.389889717,2.449764729,-76.39696503,2.0012,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.8959919909659662,1.3891277313232422
4914,8305,NUGC-3,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.30,-13,-.34,3.75,20.0,7.13,-38,-70",".97,5.23,20.5,.29,5.63,15.1,26.0,14.6",8,Sigmoid,2.415089369,2.938385487,-69.83745575,1.003,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.0778602764286294,1.372200608253479
4915,8306,NUGC-4,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,4.83,2.87,-1.5,13.6,10.0,-12,-33","8.60,6.75,8.47,2.42,13.8,13.5,3.35,14.4",8,Sigmoid,2.74168396,8.0,-32.83828354,0.3712,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.8266397714614868
4916,8307,OCI-AML2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.2,-.97,2.37,2.23,-5.5,-38,-88,-97","3.66,1.06,2.81,1.44,11.9,12.6,3.22,.10",8,Sigmoid,0.980189264,0.998434305,-97.41558075,2.1811,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.001566921981302781,0.8878366947174072
4917,8308,OCI-AML5,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,-6.2,-.17,-.28,-21,-49,-88,-92","6.26,5.70,5.31,4.97,8.84,6.87,1.09,.95",8,Sigmoid,0.74822396,0.761869073,-93.80576324,2.9182,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.2719805582682479,0.9005734324455261
4918,8309,OCUM-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,6.79,-3.4,13.5,-15,-5.7,-41,-60","17.2,8.81,2.91,8.27,19.7,14.2,23.3,13.4",8,Sigmoid,1.94652915,3.463120222,-60.21934509,1.467,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.242169980959767,1.4076992273330688
4919,8310,OE21,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.32,8.59,-4.1,12.4,-18,5.45,-60,-90","5.31,6.39,9.01,14.2,12.6,.93,2.40,1.45",8,Sigmoid,2.19575882,2.314193249,-90.52220917,1.5289,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.8390611382490349,1.2789007425308228
4920,8311,OE33,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,5.56,-26,3.02,-19,2.33,-47,-81","7.01,12.3,.093,6.20,25.8,17.7,7.32,4.44",8,Sigmoid,2.444816351,2.604136705,-81.45487976,1.8779,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.957101221048224,1.6410095691680908
4921,8312,ONCO-DG-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.8,17.5,-2.8,1.11,-5.4,4.26,-20,-60","15.6,9.91,12.5,3.41,14.3,12.2,15.3,1.22",8,Sigmoid,2.846934557,3.90438199,-60.35761261,0.8336,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.3620995095634385,1.4290626049041748
4922,8313,ONS-76,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,2.36,6.12,11.3,-1.1,-.79,-7.7,-33","4.28,.28,.78,2.01,2.72,2.37,1.65,4.07",8,Sigmoid,8.770898085,8.0,-33.05195618,0.3495,ONS76_CENTRAL_NERVOUS_SYSTEM,ONS76,ACH-000776,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4660460948944092
4923,8314,OPM-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,7.61,-17,-10,16.1,-1.2,-41,-49","15.9,15.3,26.3,16.7,13.4,2.77,12.0,.38",8,Sigmoid,1.588359594,8.0,-49.44578934,0.9299,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.5048723220825195
4924,8315,OV-90,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.12,-.40,-9.1,-50,-15,-41,-49,-80","10.6,1.35,3.12,52.1,13.6,13.5,9.17,.024",8,Sigmoid,8.789718202,1.618599892,-74.83753204,2.2049,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.48156151135513253,1.4002704620361328
4925,8316,OVCAR-4,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.3,-2.9,-3.1,-1.8,.30,-24,-32,-77","4.70,12.0,1.51,4.68,2.51,14.3,5.30,3.90",8,Sigmoid,5.487578869,4.098715305,-76.87184143,1.1837,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.4106735843650482,1.5168237686157227
4926,8317,OVCAR-8,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.30,1.00,16.2,5.60,1.29,-5.0,-15,-58","4.92,5.08,23.5,15.6,5.23,9.58,2.48,9.08",8,Sigmoid,9.081501237,6.886720181,-57.63171005,0.7201,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.9295949457095511,1.6190242767333984
4927,8318,OVMANA,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".032,4.11,.26,2.44,.56,-.28,-34,-63","1.37,14.1,3.97,8.89,4.63,8.61,6.14,.60",8,Sigmoid,2.433033228,3.367275715,-63.46606445,1.112,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.2141040242632317,1.003098487854004
4928,8319,OVSAHO,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","11.7,13.9,-4.7,3.07,-5.4,-15,-28,-48","2.36,24.5,13.9,7.68,18.8,13.8,6.58,.16",8,Sigmoid,8.853688062,8.0,-47.45096207,0.666,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.7533890008926392
4929,8320,OVTOKO,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.78,-3.8,2.23,-.52,-6.1,-9.4,-20,-52","3.21,2.85,.27,6.72,7.21,2.33,.87,3.84",8,Sigmoid,8.89590595,7.678687096,-51.65007019,0.7926,OVTOKO_OVARY,OVTOKO,ACH-000663,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0384485815041193,1.3484435081481934
4930,8321,P12-ICHIKAWA,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.0,-1.3,-.99,-4.5,-4.1,-8.0,-77,-97","3.67,14.6,6.24,1.95,8.57,5.71,.62,.024",8,Sigmoid,1.783993244,1.778208494,-96.88304138,2.3245,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.5756063934340171,0.9911002516746521
4931,8322,P31/FUJ,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.60,-6.6,10.2,-8.4,3.95,-3.2,-47,-79","4.95,3.65,19.6,3.46,13.5,4.35,2.85,7.86",8,Sigmoid,2.37947154,2.609502792,-79.30410767,1.5481,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.9591597020375279,1.4440326690673828
4932,8323,P3HR-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.92,-4.5,5.44,-18,28.8,8.65,4.95,8.80","1.26,4.37,12.8,.82,9.52,10.3,21.7,9.19",8,Constant,,8.0,0.859539092,0.04795,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.670898675918579
4933,8324,Panc 02.03,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","14.9,10.3,.88,15.7,-2.3,-10,-35,-78","3.55,2.30,2.56,10.3,1.83,15.3,1.69,2.62",8,Sigmoid,8.504512717,4.108170509,-78.42403412,1.1405,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.4129777977774791,1.394698143005371
4934,8325,Panc 03.27,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".14,.83,8.24,17.7,3.45,8.87,-27,-76","2.94,7.13,6.21,5.30,3.44,13.7,4.35,1.71",8,Sigmoid,2.80417037,3.227095604,-75.90705109,0.9404,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.1715825389092522,1.365337610244751
4935,8326,Panc 04.03,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","30.3,.15,13.1,-2.5,1.42,-60,-65,-79","14.7,39.0,9.02,2.48,33.6,8.97,6.09,4.86",8,Sigmoid,0.229738995,0.686774373,-77.64710999,1.5515,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.375749464283409,1.7538470029830933
4936,8327,Panc 10.05,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.23,10.2,1.48,7.97,4.39,-6.6,-28,-58","11.1,20.3,4.86,.77,27.3,5.80,10.7,3.74",8,Sigmoid,4.429858685,5.897616863,-57.6337471,0.773,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.774548347787977,1.6162834167480469
4937,8328,PA-TU-8902,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.41,2.06,-2.7,-1.4,.011,-23,-45,-82","3.26,6.35,1.03,5.39,.58,2.88,1.20,5.42",8,Sigmoid,3.826987743,2.869775534,-81.20188904,1.4907,PATU8902_PANCREAS,PATU8902,ACH-000599,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.0542338155630524,1.3555151224136353
4938,8329,PC-3,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-.77,.30,-10,1.11,-12,-32,-52","2.05,3.50,11.1,9.92,3.36,2.77,4.39,1.22",8,Sigmoid,2.418330908,6.503806591,-52.13366699,0.9641,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.8723876348722388,1.672692060470581
4939,8330,Pfeiffer,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.94,1.17,12.1,21.1,42.4,6.81,-60,-85","2.58,3.89,35.3,31.5,2.24,11.1,8.46,.45",8,Sigmoid,2.111199141,2.288246155,-85.53067017,1.406,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.8277856529579487,0.8824694752693176
4940,8331,PK-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.4,1.05,.36,.29,.74,-4.0,-23,-49",".94,7.99,.84,7.13,3.79,6.97,18.3,.13",8,Sigmoid,2.997105837,8.0,-48.61893463,0.8173,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.5617856979370117
4941,8332,PK-45H,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.8,4.81,-1.3,6.12,-17,-10.0,-45,-75","1.37,22.4,12.5,7.93,13.8,22.4,6.50,.18",8,Sigmoid,3.232883692,2.887463808,-74.49659729,1.4209,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.0603785417433864,1.6472305059432983
4942,8333,PK-59,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.42,-3.4,.57,-1.8,5.25,-4.7,-47,-92","1.43,1.32,5.04,.52,2.14,6.43,4.27,1.51",8,Sigmoid,2.566957951,2.641932249,-91.92698669,1.2743,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.9715105619408934,1.439136028289795
4943,8334,PLC/PRF/5,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".61,3.20,-8.4,-3.1,5.30,7.14,-9.9,-25","8.26,6.24,5.14,6.96,15.5,.079,4.42,1.16",8,Sigmoid,2.720446825,8.0,-24.7558136,0.5653,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.0885299444198608
4944,8335,PSN1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-17,-1.9,-11,1.53,-5.1,-3.3,-5.3,-69","2.21,11.0,.82,1.06,8.11,.56,6.38,35.2",8,Sigmoid,7.486505032,7.245391846,-61.82649231,0.8693,PSN1_PANCREAS,PSN1,ACH-000320,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.9803656593342582,1.308004379272461
4945,8336,QGP-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,5.01,-11,23.7,-1.1,-31,-48,-59","0,0,0,0,0,0,0,0",8,Sigmoid,0.747789085,2.061149836,-56.31702423,1.2875,QGP1_PANCREAS,QGP1,ACH-000347,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.7232639998965209,1.806566834449768
4946,8337,Raji,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","27.0,3.94,36.7,4.80,6.75,-21,27.1,15.5","62.1,6.20,20.0,1.01,10.2,11.6,32.9,47.5",8,Constant,,8.0,5.335071087,0.1373,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2802850008010864
4947,8338,RD,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".17,-3.2,-3.8,-5.8,-.33,-20,-58,-72","28.2,4.58,18.5,1.67,22.3,3.38,4.44,.40",8,Sigmoid,1.458861709,1.981057048,-71.91709137,1.4087,RD_SOFT_TISSUE,RD,ACH-000169,Sarcoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.683630564878753,1.58650803565979
4948,8339,Reh,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.56,.078,5.20,.40,4.03,-5.1,-32,-90",".82,1.31,18.4,14.9,27.0,11.3,10.6,.99",8,Sigmoid,4.85379982,3.686215639,-90.3245697,1.1366,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.3046003597068208,0.7950876355171204
4949,8340,RERF-GC-1B,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.97,6.80,9.08,-7.8,-4.8,-9.5,-27,-63","8.40,2.38,10.0,6.09,17.5,19.9,3.33,13.0",8,Sigmoid,9.039947709,5.736598015,-63.11249161,0.9959,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.7468663543134815,1.7009716033935547
4950,8341,RERF-LC-AI,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.14,1.09,-3.9,-.22,-4.7,-9.8,-22,-57","2.21,7.92,9.47,4.80,6.69,1.49,5.43,2.87",8,Sigmoid,8.786142691,6.855476379,-56.09109116,0.873,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.9250478042539725,1.5106782913208008
4951,8342,RERF-LC-MS,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,11.5,12.8,12.6,8.15,5.75,-15,-25","3.58,3.46,5.87,7.79,15.5,2.69,4.03,8.95",8,Sigmoid,1.703602433,8.0,-25.17816544,0.07675,RERFLCMS_LUNG,RERFLCMS,ACH-000062,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2193328142166138
4952,8343,RKO,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-12,-9.7,-3.8,-8.6,-16,-42,-69","3.42,2.85,8.15,9.63,1.10,10.3,4.01,2.03",8,Sigmoid,2.510347128,3.145311832,-68.98265839,1.6675,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.1459130369065182,1.394255518913269
4953,8344,RL95-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-4.0,-8.1,-5.2,-11,-13,-41,-50","8.55,12.3,13.1,19.0,7.20,14.7,31.5,9.86",8,Sigmoid,1.076512933,1.342188239,-62.10081482,1.0425,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.29430129622409984,1.5599541664123535
4954,8345,RPMI-7951,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.2,5.47,2.74,-5.4,-5.1,-2.7,-24,-63","4.33,10.0,30.0,20.8,11.9,17.1,10.9,3.07",8,Sigmoid,2.855042219,3.649759531,-63.44491577,1.0404,RPMI7951_SKIN,RPMI7951,ACH-000348,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.294661283506283,1.5279357433319092
4955,8346,RPMI-8402,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.35,-.30,-1.3,-.37,-20,-25,-86,-80","1.00,8.35,4.36,17.3,7.40,2.16,1.17,2.69",8,Sigmoid,0.940792143,1.023247361,-83.30306244,2.4255,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.02298125734966863,0.8743204474449158
4956,8347,RT-112,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,-6.2,1.44,-6.5,-19,-69,-89,-98","10.5,19.8,15.9,7.02,8.16,5.86,.15,.14",8,Sigmoid,0.570986688,0.549882889,-94.88999176,2.9431,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.5980499525191468,1.4659392833709717
4957,8348,RT4,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.13,-4.5,1.31,-30,9.62,-36,-50,-89","8.10,15.6,10.7,16.7,12.3,18.1,29.3,10.8",8,Linear,,0.32397661,-87.39542389,2.2436,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-1.1270839571537539,1.4631528854370117
4958,8349,RVH-421,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,-11,-1.7,1.28,3.46,2.09,-5.2,-13","3.16,6.19,5.11,7.68,10.2,6.56,11.4,3.35",8,Constant,,8.0,-3.585280418,0.3535,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.2909561395645142
4959,8350,SBC-5,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,-1.9,5.91,.50,4.57,4.97,-67,-63","2.41,6.67,5.61,3.52,3.24,2.88,5.95,5.85",8,Sigmoid,1.47885406,1.863162994,-66.51837921,0.6623,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.6222755778621984,1.2178844213485718
4960,8351,SCaBER,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.66,-7.8,-2.9,7.34,-16,-37,-55,-77","4.08,22.9,6.36,3.53,5.13,3.31,12.2,1.95",8,Sigmoid,0.864010334,1.347083688,-76.93347931,1.2242,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.2979420246742361,1.6209733486175537
4961,8352,SCC-9,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,-12,14.5,-12,5.54,-1.5,-4.9,-27",".50,2.08,9.73,9.33,10.2,7.54,15.8,.75",8,Constant,,8.0,-8.297755241,0.4782,SCC9_UPPER_AERODIGESTIVE_TRACT,SCC9,ACH-000181,Head and Neck Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.1643927097320557
4962,8353,SF126,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.7,-2.5,-2.5,-10,1.70,-9.4,-41,-97","4.82,1.70,3.00,7.87,6.77,3.58,11.9,.024",8,Sigmoid,3.614470243,3.022811651,-96.93955994,1.3627,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.1061874085304284,1.4016697406768799
4963,8354,SF-295,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".21,-13,3.16,-13,7.13,-9.9,-20,-81","3.02,9.58,4.73,2.63,3.61,14.6,6.07,5.25",8,Sigmoid,6.436020851,4.876365185,-81.32813263,1.0372,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.5844001031952208,1.2471234798431396
4964,8355,SH-10-TC,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.7,-9.2,-4.7,-14,6.12,-12,-16,-48","3.73,13.1,4.12,7.47,8.01,16.7,13.1,7.50",8,Sigmoid,4.939777851,8.0,-47.7334938,0.6445,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4710928201675415
4965,8356,SHP-77,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.27,-17,9.44,6.39,3.02,14.9,18.2,-34","4.81,5.23,24.1,5.06,17.0,6.35,37.7,13.7",8,Linear,,8.0,-33.90289688,0.5531,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.5313299894332886
4966,8357,SIG-M5,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,22.3,12.0,12.6,-28,-71,-91,-98","2.13,1.03,40.8,25.3,24.6,15.1,8.19,.50",8,Linear,,0.119100617,-98.09027863,3.3125,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-2.1277866221137303,0.796876072883606
4967,8358,SIMA,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","6.31,-7.8,25.4,-26,-10,-56,-63,-69","9.51,3.09,14.1,11.9,16.9,15.9,3.99,1.34",8,Sigmoid,0.408506453,0.837575078,-69.30187988,2.6995,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.1772443739276876,1.3235185146331787
4968,8359,SJSA-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","17.9,-6.2,11.6,-20,15.0,-22,-34,-46","11.9,4.38,19.6,8.34,11.1,19.0,8.30,1.78",8,Linear,,8.0,-46.88439178,1.2566,SJSA1_BONE,SJSA1,ACH-000748,Bone Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.248610019683838
4969,8360,SK-BR-3,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,2.51,6.52,1.92,-1.9,12.7,28.6,15.7","21.3,6.08,27.1,14.5,9.96,8.84,14.8,9.93",8,Constant,,8.0,7.934308052,0.0109,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.6784820556640625
4970,8361,SK-CO-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.02,-6.2,15.9,-21,-22,-48,-62,-67","31.7,.025,39.5,9.40,11.2,6.85,3.15,2.39",8,Sigmoid,0.457819819,0.910102069,-67.15113068,2.2025,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.09419852202485912,1.4431349039077759
4971,8362,SK-ES-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,-3.8,-5.3,-11,-19,-57,-76,-89","9.55,11.3,.80,1.66,.61,4.49,4.65,.90",8,Sigmoid,0.66368866,0.707679987,-88.04553223,2.3471,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.3457632832320053,1.5075136423110962
4972,8363,SK-HEP-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","23.5,-3.0,35.6,-2.0,26.4,-13,-.91,-58",".62,8.18,4.52,9.10,15.1,2.57,3.34,.57",8,Linear,,4.221798744,-56.0965271,0.4886,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.4402612798863543,1.5408103466033936
4973,8364,SK-MEL-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,2.92,-14,-4.1,6.08,37.0,12.6,-.22","8.56,15.9,6.02,1.00,20.8,6.40,18.4,0",8,Linear,,8.0,-12.4382391,0.8386,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.3770694732666016
4974,8365,SK-MEL-24,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.42,14.2,-.099,.46,-12,-17,-26,-81","6.01,12.2,5.34,13.7,1.17,1.19,4.10,23.5",8,Sigmoid,8.768262933,4.193741798,-78.76766968,1.0744,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.433593365968431,1.4033641815185547
4975,8366,SK-MEL-30,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,-6.0,-4.0,.52,-5.7,1.78,-8.4,-21","7.22,1.90,.40,.29,5.58,5.62,8.62,1.60",8,Constant,,8.0,-3.996038914,0.267,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.0085222721099854
4976,8367,SK-MEL-31,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-8.7,-5.4,4.19,-1.2,-5.1,-15,-61","12.6,13.0,7.49,8.97,4.75,2.17,8.04,5.36",8,Sigmoid,5.580551147,6.208492756,-61.15146255,1.0295,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.8259181540866103,1.3252160549163818
4977,8368,SK-MEL-5,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","10.6,-4.3,8.30,-5.0,1.29,-21,-30,-85","27.9,4.20,16.5,19.4,35.6,8.91,14.8,10.6",8,Sigmoid,8.393246969,3.842323303,-83.38514709,0.8215,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.3460772104676153,1.4581794738769531
4978,8369,SK-MES-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.54,2.12,-8.8,-14,15.5,-26,-59,-97","9.61,10.7,8.44,2.51,4.84,4.53,7.13,1.19",8,Sigmoid,7.391059399,1.970706701,-97.724823,2.4285,SKMES1_LUNG,SKMES1,ACH-000665,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.6783922098932278,1.8320491313934326
4979,8370,SK-MM-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,-.31,-3.0,.44,-5.7,-13,-23,-61","9.14,1.14,3.89,5.05,3.75,5.12,15.1,1.67",8,Sigmoid,4.481600761,5.6049757,-60.56400299,0.92,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.7236547210999171,1.2254712581634521
4980,8371,SK-N-AS,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.7,5.55,-.18,.18,-3.7,-15,-44,-80","8.87,2.28,7.83,4.69,6.80,1.62,4.92,4.47",8,Sigmoid,3.562440395,3.056384087,-79.54540253,1.356,SKNAS_AUTONOMIC_GANGLIA,SKNAS,ACH-000260,Neuroblastoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.117232546325686,1.4257771968841553
4981,8372,SK-N-BE(2),TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-5.7,9.55,-13,-19,-40,-86,-68","14.5,2.81,20.0,26.8,21.2,9.44,1.41,6.56",8,Sigmoid,0.81881994,0.893670976,-77.48857117,2.2338,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.1124176073446007,1.4473495483398438
4982,8373,SK-N-DZ,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.67,-3.3,7.05,-.24,7.86,-16,-58,-84","16.1,14.3,.095,13.9,13.0,13.4,10.4,5.05",8,Sigmoid,1.750694752,2.069112539,-83.73816681,1.5215,SKNDZ_AUTONOMIC_GANGLIA,SKNDZ,ACH-000366,Neuroblastoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.7271197902276143,1.2850180864334106
4983,8374,SK-N-FI,TAE684,ALK,".0025,.025,.080,.25,.80,2.53,8","-7.5,-31,-4.4,-47,-44,-83,-53","53.1,11.5,8.41,7.66,27.6,2.66,1.75",7,Linear,,3.705838287,-73.41200256,2.8196,SKNFI_AUTONOMIC_GANGLIA,SKNFI,ACH-000341,Neuroblastoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.3099094914550966,1.5908887386322021
4984,8375,SK-N-SH,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,-8.7,-6.0,-29,-35,-71,-93,-97","7.21,11.8,3.23,17.4,6.74,2.41,2.20,.28",8,Sigmoid,0.405084074,0.383350194,-98.33365631,3.3946,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.9588063629124081,1.3936996459960938
4985,8376,SK-OV-3,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,-18,4.68,-4.5,6.18,-4.8,-13,-52","3.56,19.5,16.0,4.85,18.0,5.51,5.39,2.88",8,Constant,,8.0,-6.309521198,0.7187,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.3251917362213135
4986,8377,SNG-M,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".31,-3.4,1.78,1.66,2.77,-1.5,-3.4,-61",".40,7.59,3.05,.049,2.83,6.21,8.26,18.2",8,Sigmoid,5.566115379,7.080456257,-55.92731094,0.5714,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.9573383487083584,1.3336647748947144
4987,8378,SNU-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.15,7.63,-14,8.48,-1.6,-11,-50,-79","2.43,7.83,5.19,4.70,5.30,3.23,7.88,6.80",8,Sigmoid,2.045048475,2.542354822,-78.65575409,1.4561,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.9330907468186408,1.2460535764694214
4988,8379,SNU-182,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,-9.1,-13,-1.6,-14,2.92,-37,-46","2.37,8.54,4.82,2.58,4.56,31.1,2.88,19.4",8,Sigmoid,2.052229166,8.0,-45.35533524,1.0013,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4771815538406372
4989,8380,SNU-387,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","16.3,-5.9,1.58,-1.2,14.9,-6.1,-6.5,-22","12.3,.78,20.6,11.8,13.8,5.21,20.4,1.36",8,Sigmoid,8.549709406,8.0,-22.40690804,0.8824,SNU387_LIVER,SNU387,ACH-000478,Liver Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4340934753417969
4990,8381,SNU-398,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-29,11.7,13.9,-11,7.37,-35,-45,-87","3.97,10.6,26.9,18.0,3.18,8.39,3.00,2.83",8,Linear,,0.046819357,-85.31328583,1.9352,SNU398_LIVER,SNU398,ACH-000221,Liver Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-3.0614585504609217,1.478515386581421
4991,8382,SNU-423,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,4.07,-3.7,-7.4,-4.4,3.21,-2.4,-20","9.96,4.15,11.3,5.80,13.1,.45,5.84,9.91",8,Constant,,8.0,-1.111985445,0.2347,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.3967680931091309
4992,8383,SNU-449,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.30,5.78,-11,-8.8,13.3,1.03,-8.7,-36","2.13,9.95,7.98,4.22,1.33,6.48,3.42,4.71",8,Sigmoid,3.134450674,8.0,-35.78478241,0.3874,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.8666527271270752
4993,8384,SNU-475,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.48,-7.2,7.23,-17,49.7,-14,24.5,-67","61.2,39.2,20.2,30.7,14.3,5.95,18.2,15.0",8,Constant,,8.0,-1.552358031,0.914,SNU475_LIVER,SNU475,ACH-000422,Liver Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.5579071044921875
4994,8385,SNU-C2A,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.71,.48,-6.6,-16,7.89,-17,-47,-52",".26,4.78,26.6,14.9,8.04,18.2,12.5,2.53",8,Sigmoid,0.968007445,3.785260916,-50.35179901,1.3696,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.331114818727561,1.4187109470367432
4995,8386,Sq-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.40,5.20,-9.1,-15,7.42,-8.9,-7.5,-58",".57,8.49,1.33,2.98,2.15,14.1,7.24,18.6",8,Sigmoid,8.877389082,7.319000244,-58.23073196,0.7909,SQ1_LUNG,SQ1,ACH-000553,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.9904737399569772,1.5824882984161377
4996,8387,SU.86.86,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-4.3,-7.7,2.87,4.58,.71,-4.9,-14","1.89,6.30,8.32,7.19,4.10,2.16,2.77,7.44",8,Constant,,8.0,-2.620782852,0.2885,SU8686_PANCREAS,SU8686,ACH-000114,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.3855042457580566
4997,8388,SU-DHL-10,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,26.9,24.0,53.3,6.71,21.3,-28,-97","17.3,39.1,1.89,54.2,2.15,3.00,39.3,.79",8,Linear,,0.100763131,-98.41992188,1.2132,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-2.2949827541416843,1.5016765594482422
4998,8389,SU-DHL-4,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-3.1,-5.4,-1.9,-7.1,-21,-35,-86","7.13,12.3,2.47,5.38,1.85,9.20,2.21,.45",8,Sigmoid,8.554376365,3.902643204,-85.44911194,2.3917,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.361654068185822,1.093685507774353
4999,8390,SU-DHL-6,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","20.5,8.53,107,71.7,63.8,34.5,-22,-96","0,0,0,0,0,0,0,0",8,Linear,,0.292797252,-96.42205811,1.2094,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-1.2282748821849239,1.052861213684082
5000,8391,SU-DHL-8,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","16.0,5.48,-.94,8.44,-.60,10.4,-65,-82","6.14,21.5,12.6,6.64,2.48,15.4,.45,19.6",8,Sigmoid,1.919525266,2.145337343,-82.44967651,1.7707,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.7632968094783041,1.4225635528564453
5001,8392,SUIT-2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.97,-5.4,-2.3,-8.3,11.8,-21,-20,-78","3.58,6.86,1.98,3.25,.85,18.8,9.60,4.38",8,Sigmoid,9.370333466,4.501640797,-76.69540405,0.9789,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.5044419518735446,1.1080702543258667
5002,8393,SUP-M2,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.6,.40,17.7,-31,-95,-97,-97,-97","8.74,19.0,18.3,10.0,2.68,.20,.18,.30",8,Sigmoid,0.09077923,0.093504936,-96.59415436,4.0199,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-2.369741052637065,0.9941349625587463
5003,8394,SUP-T1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,-9.9,-6.3,1.28,.55,8.23,-5.8,-9.4",".98,3.61,.30,8.58,4.66,12.1,12.8,3.09",8,Constant,,8.0,-3.738618851,0.6526,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4147523641586304
5004,8395,SW 1088,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,2.45,-16,4.49,-3.8,-7.7,-49,-35","2.92,4.25,12.7,9.24,19.7,20.8,4.78,12.3",8,Sigmoid,1.184045434,8.0,-42.54684448,0.5267,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.5650428533554077
5005,8396,SW 1271,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.1,5.13,2.70,9.42,13.3,-10,-31,-43","8.71,5.34,24.7,2.34,7.74,2.12,1.08,6.70",8,Sigmoid,1.278945923,8.0,-42.16709518,0.818,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.376680850982666
5006,8397,SW 1353,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,1.39,-5.9,1.43,-8.4,-16,-28,-92","2.87,13.7,2.16,4.75,2.89,9.15,9.57,6.88",8,Sigmoid,8.759789663,4.319674969,-91.43768311,1.8519,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.463180160768042,1.4895358085632324
5007,8398,SW1417,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,-7.5,4.36,6.43,22.9,-3.7,-46,-87","27.1,37.0,5.18,20.2,26.1,23.4,20.1,3.28",8,Linear,,0.192437288,-87.38665009,1.3905,SW1417_LARGE_INTESTINE,SW1417,ACH-000236,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-1.6479849549544066,1.7830345630645752
5008,8399,SW 1573,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.9,-1.4,1.00,-6.6,-1.2,-24,-42,-80","6.14,15.8,.90,14.1,7.16,9.48,14.2,3.32",8,Sigmoid,4.43158102,3.088858128,-79.25131226,1.4503,SW1573_LUNG,SW1573,ACH-000677,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.127801484749634,1.3431628942489624
5009,8400,SW 1990,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.98,7.25,.60,6.57,-19,-15,-69,-78","10.8,3.70,3.90,.86,10.4,9.38,2.67,3.05",8,Sigmoid,1.222394228,1.548194051,-78.11022186,1.7119,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.43708912325428817,1.5679210424423218
5010,8401,SW403,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.96,-16,-3.1,-9.5,-1.3,-44,-71,-86","13.8,16.8,21.8,3.12,5.46,1.05,8.03,1.63",8,Sigmoid,0.818802238,0.927091599,-82.72109222,2.2255,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.07570290600016075,1.709500789642334
5011,8402,SW48,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","8.37,15.0,-20,-30,-25,-65,-93,-93","5.18,38.3,29.0,10.4,18.7,2.34,.77,2.45",8,Sigmoid,0.391217083,0.33778125,-97.76251221,3.1949,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-1.0853567823656607,1.1261236667633057
5012,8403,SW480,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.5,8.07,10.1,2.49,-12,-21,-43,-62","2.71,.64,8.59,10.3,24.2,7.38,.81,.54",8,Sigmoid,1.501548529,3.404621601,-61.38656616,0.995,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.22513380302956,1.7103121280670166
5013,8404,SW579,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","5.67,-8.8,8.84,-12,13.8,-14,-14,-98","6.53,2.77,5.26,9.50,15.7,8.60,14.6,.095",8,Sigmoid,8.984827519,5.123246193,-97.70323944,1.35,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6337882602146512,1.5914413928985596
5014,8405,SW620,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","7.12,-.59,19.9,-7.9,-2.8,-48,-69,-90","23.8,8.42,16.7,9.57,6.53,2.01,9.77,1.41",8,Sigmoid,0.813027978,0.981493473,-86.52507782,1.9704,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.018679915313204027,1.2311712503433228
5015,8406,SW 780,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.6,-14,-6.6,-7.9,-9.7,-15,-62,-79","22.2,17.0,8.77,5.86,2.25,19.3,15.8,11.3",8,Sigmoid,1.743029237,1.951426506,-78.83125305,1.36,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.6685606466680297,1.5533148050308228
5016,8407,SW 900,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".35,-11,13.8,-3.6,17.4,-3.9,3.94,-12","15.1,.36,12.3,57.0,18.4,3.73,3.68,15.7",8,Constant,,8.0,0.053337883,0.4458,SW900_LUNG,SW900,ACH-000669,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.6625480651855469
5017,8408,T24,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,-2.2,-.34,-4.4,-1.6,-21,-33,-74","7.23,6.32,.14,1.84,5.49,2.50,5.24,1.02",8,Sigmoid,8.55144663,4.323724747,-74.24494171,1.8013,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.4641172407202399,1.401645302772522
5018,8409,T3M-10,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".78,-12,14.5,7.44,9.36,-.48,-.012,-9.2","5.23,13.3,12.8,1.90,2.23,10.6,2.23,12.9",8,Constant,,8.0,2.8706007,0.07138,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.463783621788025
5019,8410,T-47D,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","20.7,-3.7,.73,-8.0,14.2,-8.1,-.27,-31","4.64,20.7,4.74,4.55,6.71,6.87,5.60,16.7",8,Sigmoid,9.464862726,8.0,-30.49042702,0.3381,T47D_BREAST,T47D,ACH-000147,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.978212833404541
5020,8411,T84,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-33,-36,-5.0,-1.7,38.7,-48,-68,-47","6.25,17.0,15.6,13.5,34.9,3.77,12.7,5.22",8,Linear,,8.0,-80.03879547,2.3855,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.6224696636199951
5021,8412,TCCSUP,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.5,-4.3,7.52,4.28,.16,-2.0,-23,-84","3.28,3.38,3.99,4.57,7.10,.55,12.6,1.21",8,Sigmoid,4.383178711,4.234785557,-83.73477936,0.9076,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.4433326909305964,1.3419744968414307
5022,8413,TE-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-3.6,.18,9.54,7.59,-13,-25,-84","2.40,9.47,2.90,.31,3.30,.69,4.49,5.01",8,Sigmoid,8.138754206,4.546535969,-83.97624207,1.3627,TE1_OESOPHAGUS,TE1,ACH-000647,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.514365617512923,1.481052279472351
5023,8414,TE-11,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-56,-18,-.070,-10,12.5,-20,-45,-83","1.48,8.44,3.26,8.53,3.21,10.9,7.53,6.10",8,Sigmoid,2.986466169,2.809319735,-83.15868378,1.9404,TE11_OESOPHAGUS,TE11,ACH-000488,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.0329423668492086,1.4290826320648193
5024,8415,TE-15,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.3,22.2,-6.2,-19,44.2,20.0,-4.2,-51","1.85,21.2,20.0,3.01,28.4,14.2,14.3,9.36",8,Linear,,7.962886668,-50.02357101,0.8225,TE15_OESOPHAGUS,TE15,ACH-000353,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0747915808495265,1.4885802268981934
5025,8416,TE-5,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.1,-2.0,1.35,.87,.18,-3.6,-1.9,-19","1.09,.49,7.19,5.61,5.58,1.57,3.49,.50",8,Constant,,8.0,-2.732578039,0.2672,TE5_OESOPHAGUS,TE5,ACH-000408,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4010696411132812
5026,8417,TE 617.T,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.10,11.6,16.1,5.10,10.9,-35,-85,-97","4.46,18.4,21.5,2.46,2.53,33.6,3.57,.49",8,Sigmoid,1.346003532,1.415370941,-96.83300018,2.1155,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.347391645856733,0.8843639492988586
5027,8418,TE-9,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-.51,-7.8,-4.7,-1.6,-6.7,-5.1,-53,-80","7.58,1.22,4.54,14.5,2.06,5.58,.89,4.88",8,Sigmoid,2.282842875,2.445929289,-80.5043335,1.8908,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.8944251280163682,1.6077340841293335
5028,8419,TEN,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","13.9,5.90,-11,4.14,-31,-19,-42,-63","36.8,3.28,15.0,14.3,4.81,14.9,8.03,7.55",8,Sigmoid,8.739326506,4.035426617,-61.25209808,1.8601,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.3951120252531808,1.5528779029846191
5029,8420,Toledo,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","27.1,10.3,24.2,9.57,14.3,39.6,-6.1,-14","6.52,9.51,1.81,26.0,8.79,7.23,5.84,12.9",8,Constant,,8.0,18.38907051,0.0,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.1947996616363525
5030,8421,TOV-112D,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","3.77,-1.1,-7.9,-7.3,-5.1,-27,-52,-73",".099,7.88,4.48,28.0,6.41,.88,9.24,7.21",8,Sigmoid,1.49516201,2.203894615,-72.14957428,1.4665,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.7902260748117252,1.3063796758651733
5031,8422,TOV-21G,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,6.10,-4.0,5.22,-1.2,-5.0,-57,-82","1.13,5.84,.13,2.17,8.56,5.24,22.9,1.81",8,Sigmoid,2.150446415,2.459191084,-82.03795624,1.3244,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.8998324682263311,0.7205687165260315
5032,8423,TT2609-C02,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,-17,-12,-16,-18,-39,-58,-82","8.82,5.46,23.5,13.5,16.2,3.18,.97,.98",8,Sigmoid,5.117928505,1.675446153,-82.47768402,2.1649,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.5160794898095029,1.3110783100128174
5033,8424,TYK-nu,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.2,1.74,-10,8.67,-7.3,-8.1,-49,-71","11.4,5.47,1.36,.98,2.57,8.23,5.18,7.50",8,Sigmoid,1.960717797,2.630714178,-70.89117432,1.0603,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.9672553598968325,1.4568661451339722
5034,8425,U-118 MG,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.95,-4.1,-2.0,-5.1,-.52,-19,-23,-74","6.55,14.5,13.1,9.08,15.6,18.2,8.13,9.27",8,Sigmoid,8.35836576,5.086780071,-73.78694916,1.1033,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6266450313695662,1.4741737842559814
5035,8426,U-2 OS,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-.082,-11,-1.5,-7.3,5.33,-19,-61","2.87,9.02,.58,4.43,5.47,4.96,14.0,6.40",8,Sigmoid,3.161715031,4.141691208,-61.12265015,1.324,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.4211042087698642,1.4951462745666504
5036,8427,U-87 MG,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.12,11.4,-2.5,-3.1,-11,-9.7,.92,-26","8.04,3.16,14.6,2.05,7.56,4.07,4.29,4.19",8,Sigmoid,8.254788848,8.0,-21.23158073,0.5188,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.5301244258880615
5037,8428,U-937,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8",".27,4.79,8.64,-5.4,-2.0,-5.4,-32,-35","5.69,9.02,13.6,6.54,6.76,11.8,46.0,58.5",8,Sigmoid,1.524176836,1.888259768,-74.21713257,0.5798,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.6356556472418637,0.8972663283348083
5038,8429,UACC-257,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.3,-2.4,6.66,3.95,4.43,-8.4,-17,-25","9.86,2.46,10.9,10.5,5.53,8.08,5.12,1.68",8,Sigmoid,1.500853896,8.0,-24.7109108,0.4377,UACC257_SKIN,UACC257,ACH-000579,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.427363395690918
5039,8430,UACC-62,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,.14,-18,-22,6.72,3.60,-18,-54","4.13,2.74,3.81,3.83,1.12,2.54,4.48,1.66",8,Sigmoid,3.268721819,5.010543346,-54.48609924,1.354,UACC62_SKIN,UACC62,ACH-000425,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6115443615116576,1.3506379127502441
5040,8431,UACC-812,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","1.75,9.60,.46,.71,14.2,-8.3,-40,-48","30.5,10.2,16.5,22.2,8.33,18.2,12.0,23.1",8,Sigmoid,1.384894013,2.535139799,-62.88145828,0.6884,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,0.9302487830570939,2.0485167503356934
5041,8432,UM-UC-3,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,5.25,-7.6,5.68,-5.0,7.42,-3.5,-20","12.2,1.73,9.62,9.66,.057,10.6,3.66,2.34",8,Constant,,8.0,-1.268966913,0.2892,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.1490437984466553
5042,8433,VMRC-RCW,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,-9.8,9.47,7.03,15.9,-1.5,-28,-96","10.8,4.97,24.0,6.40,5.97,2.33,10.5,.41",8,Sigmoid,3.970807314,3.615829468,-96.05432892,1.284,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.2853212810196133,1.265154480934143
5043,8434,VMRC-RCZ,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","2.72,-8.0,-.90,-4.5,12.6,-1.0,-37,-69","25.0,7.55,24.5,17.3,31.6,5.81,3.96,17.6",8,Sigmoid,2.475645542,2.984285355,-69.02798462,1.457,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.0933603061206216,1.3300100564956665
5044,8435,WM-115,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-15,-2.0,-5.3,-12,7.02,-12,2.94,-12","14.1,3.59,22.0,5.73,9.82,.87,2.97,25.3",8,Constant,,8.0,-4.914944172,0.07927,WM115_SKIN,WM115,ACH-000304,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.3062773942947388
5045,8436,WM1799,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","4.67,.74,6.37,-3.0,-2.5,-21,-39,-46","2.89,5.85,7.06,17.6,4.18,5.87,4.22,6.21",8,Sigmoid,0.831913769,8.0,-45.6775856,1.0123,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.1065819263458252
5046,8437,WM-266-4,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.7,-.89,-4.1,-.82,6.85,4.56,-5.1,-36","5.50,2.01,.97,1.15,2.57,5.07,5.54,20.8",8,Sigmoid,3.546302795,8.0,-31.24645233,0.4785,WM2664_SKIN,WM2664,ACH-001239,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.1001794338226318
5047,8438,WM-793,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.8,1.47,22.9,-.46,2.77,-11,-19,-63","4.86,1.88,9.01,3.41,11.9,3.64,11.3,7.75",8,Sigmoid,8.867720032,6.179851532,-62.65832901,0.9968,WM793_SKIN,WM793,ACH-000827,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.8212942472327995,1.7148499488830566
5048,8439,WM-88,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,4.18,-1.7,4.83,-7.6,-14,-30,-29","2.15,8.37,3.66,6.92,12.9,.65,7.33,3.21",8,Sigmoid,0.858956993,8.0,-29.94994354,0.6657,WM88_SKIN,WM88,ACH-000899,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.4472770690917969
5049,8440,WM-983B,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,22.4,1.80,-15,-43,-49,-69,-64","1.79,9.02,4.51,18.0,8.51,2.09,6.01,10.1",8,Sigmoid,0.156724989,0.441951066,-64.71271515,3.2014,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,-0.8165561134405283,1.1250420808792114
5050,8441,YKG1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-19,-6.6,4.37,2.52,6.35,-14,-22,-58","22.4,6.70,3.49,1.63,5.30,9.18,5.44,.21",8,Sigmoid,8.01757528,6.361808777,-57.8971138,0.7847,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.850312735817701,1.2806861400604248
5051,8442,ZR-75-1,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","9.70,-27,17.1,-5.6,-21,-3.6,-42,-7.2","23.0,5.83,27.5,17.8,14.1,8.49,1.43,22.9",8,Constant,,8.0,-10.63423061,0.6762,ZR751_BREAST,ZR751,ACH-000097,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.5540813207626343
5052,8443,ZR-75-30,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-22,-3.5,-15,-14,2.31,6.72,15.4,-25","20.7,3.53,4.95,5.34,10.1,24.9,15.7,8.60",8,Linear,,8.0,-24.40401649,0.3207,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2.0794415416798357,1.848588228225708
5053,8444,SCC-25,TAE684,ALK,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.0,-11,2.09,-6.2,-1.7,-8.4,-24,-69","17.6,18.2,15.7,2.42,7.23,8.99,7.55,5.27",8,Sigmoid,5.953351974,5.110826015,-69.36701202,0.9235,SCC25_UPPER_AERODIGESTIVE_TRACT,SCC25,ACH-000188,Head and Neck Cancer,4,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,,ALK,ALK Inhibitor,Kinase inhibitor,Preclinical,Novartis,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,1.6313610379232186,1.1506872177124023
5054,8844,A172,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.17,5.13,11.5,.19,3.16,-2.8,-5.5,-15",".49,.11,10.5,.47,1.48,4.82,2.49,2.82",8,Constant,,8.0,1.337891936,0.08293,A172_CENTRAL_NERVOUS_SYSTEM,A172,ACH-000558,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8041744232177734
5055,8845,A-204,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.00,-5.8,6.01,-9.6,6.24,-29,8.67,-35","10.9,11.2,11.1,0,10.9,6.83,15.3,3.88",8,Constant,,8.0,-1.361821532,0.3697,A204_SOFT_TISSUE,A204,ACH-000201,Rhabdoid,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.5850234031677246
5056,8846,A2058,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.21,-.19,.71,-.79,-.89,-5.4,-6.0,-4.3","5.06,2.22,8.33,8.23,2.49,4.08,.13,5.73",8,Constant,,8.0,-2.110151529,0.0,A2058_SKIN,A2058,ACH-000788,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.60613751411438
5057,8847,A-253,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,1.72,3.94,-6.3,-11,-13,-31,-37","5.51,3.95,7.68,.60,12.2,7.89,1.88,1.43",8,Sigmoid,1.207963228,8.0,-37.42863083,0.8588,A253_SALIVARY_GLAND,A253,ACH-000740,Head and Neck Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.61609148979187
5058,8848,A2780,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.2,10.9,8.56,5.21,7.65,-.12,-2.0,-34","7.82,7.10,4.47,1.60,4.58,7.87,5.97,14.0",8,Sigmoid,8.98629013,8.0,-47.8158989,0.2241,A2780_OVARY,A2780,ACH-000657,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.634838104248047
5059,8849,A-375,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".27,-.80,2.46,-2.6,1.89,-2.6,-8.3,-34","3.49,10.5,3.84,5.23,3.09,3.44,2.59,6.22",8,Sigmoid,8.040614408,8.0,-33.58548355,0.2889,A375_SKIN,A375,ACH-000219,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.490562677383423
5060,8850,A549,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.6,-1.1,4.70,-.63,3.12,-11,-25,-43",".61,1.43,5.41,.84,3.71,0,4.15,6.68",8,Sigmoid,2.394717693,8.0,-43.08367538,0.4884,A549_LUNG,A549,ACH-000681,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8330867290496826
5061,8851,A-673,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","23.8,2.46,1.14,1.23,-4.2,.16,-2.9,-15","3.78,16.0,3.31,.91,7.52,16.4,5.57,9.57",8,Sigmoid,0.002542614,8.0,-5.125430584,0.1029,A673_BONE,A673,ACH-000052,Bone Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.885532855987549
5062,8852,ACHN,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.51,-5.8,6.05,-.65,-21,-31,-45,-53","5.27,1.40,3.36,1.36,1.84,3.65,2.34,3.19",8,Sigmoid,0.513201594,4.997091293,-51.79050446,1.2474,ACHN_KIDNEY,ACHN,ACH-000046,Kidney Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.6088560017569187,2.8588790893554688
5063,8853,ALL-SIL,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","20.7,7.08,17.9,7.53,6.06,-9.6,-23,-55","11.7,10.7,9.35,1.66,13.0,9.27,3.48,4.31",8,Sigmoid,8.806416587,6.930338383,-54.63547134,1.0818,ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,ALLSIL,ACH-000105,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.9359086407254575,2.8143703937530518
5064,8854,AMO-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.67,5.14,-7.0,-4.8,15.2,5.43,-13,-30","5.08,3.10,2.15,6.80,1.77,2.64,7.09,7.85",8,Sigmoid,2.553803444,8.0,-30.04038048,1.0362,AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,AMO1,ACH-000838,Myeloma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9403982162475586
5065,8855,AsPC-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.7,.56,18.9,18.9,7.72,-9.0,-18,-29","26.8,17.3,18.1,5.28,24.2,7.84,13.1,9.72",8,Sigmoid,3.7248404,8.0,-22.35022354,0.2484,ASPC1_PANCREAS,ASPC1,ACH-000222,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9789228439331055
5066,8856,AU565,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".21,7.26,-4.0,14.6,-.22,18.1,-9.7,-44","8.54,14.8,11.3,16.0,11.9,.66,11.1,.16",8,Sigmoid,2.978539467,8.0,-43.89791107,0.491,AU565_BREAST,AU565,ACH-000248,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.969719886779785
5067,8857,B-CPAP,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.75,6.74,9.51,13.3,3.37,1.15,-6.4,-23","9.23,4.87,.24,1.15,4.89,7.16,8.95,3.12",8,Sigmoid,7.366518974,8.0,-22.38445663,0.3177,BCPAP_THYROID,BCPAP,ACH-000456,Thyroid Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8125767707824707
5068,8858,BDCM,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","17.6,12.7,16.1,-.63,-.29,30.6,-8.3,-6.6","6.49,6.20,7.25,2.97,1.68,37.6,7.49,.087",8,Constant,,8.0,3.431539059,0.0,BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BDCM,ACH-000080,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.885608673095703
5069,8859,BFTC-909,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.54,2.52,1.16,1.86,-.56,-3.8,-10,-9.8",".78,.57,6.15,.65,1.32,1.09,2.61,5.04",8,Constant,,8.0,-0.557689965,0.04175,BFTC909_KIDNEY,BFTC909,ACH-000792,Kidney Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7566518783569336
5070,8860,BL-41,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.74,-4.2,5.78,-4.2,3.73,.31,-1.7,-9.7","1.51,4.34,2.96,.74,.80,3.32,1.04,2.40",8,Constant,,8.0,-1.137335658,0.01175,BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL41,ACH-000245,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8690357208251953
5071,8861,BL-70,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.3,12.9,4.53,.71,7.29,-2.4,17.1,-21","5.04,21.4,.67,12.0,7.98,4.85,9.47,7.82",8,Constant,,8.0,4.527453423,0.3595,BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,BL70,ACH-000402,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.873112201690674
5072,8862,BT-20,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,2.38,-13,11.3,-35,5.03,-43,-43","20.1,.75,11.3,31.7,6.55,2.03,10.3,13.7",8,Constant,,8.0,-15.24391079,1.3084,BT20_BREAST,BT20,ACH-000536,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.096060276031494
5073,8863,BT-474,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","18.0,11.3,-.93,16.6,31.2,-.70,-23,-30","27.3,14.1,4.47,22.1,15.6,2.27,8.09,6.06",8,Sigmoid,0.981348634,8.0,-27.10237503,0.3156,BT474_BREAST,BT474,ACH-000927,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.4481372833251953
5074,8864,BT-549,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.6,5.54,17.1,1.92,2.82,-9.5,-1.7,-23","9.45,13.8,4.79,2.70,31.6,20.6,17.9,3.84",8,Constant,,8.0,3.977365732,0.2467,BT549_BREAST,BT549,ACH-000288,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.985598564147949
5075,8865,BxPC-3,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","19.3,15.3,-4.3,19.5,-8.4,-13,-41,-45","7.81,4.19,14.7,6.31,9.21,13.8,17.9,8.65",8,Sigmoid,1.015475988,8.0,-46.18301773,0.7307,BXPC3_PANCREAS,BXPC3,ACH-000535,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.892348527908325
5076,8866,C2BBe1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.8,-3.1,14.9,-2.9,-8.8,-32,-45,-49","9.11,3.15,5.24,6.04,12.2,1.67,13.8,13.0",8,Sigmoid,0.560010612,8.0,-48.82560349,1.128,C2BBE1_LARGE_INTESTINE,C2BBE1,ACH-000009,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9680864810943604
5077,8867,C32,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,-5.1,7.83,22.0,7.50,4.01,-25,-11","17.3,4.13,21.3,4.79,19.8,27.7,25.5,6.11",8,Constant,,8.0,-6.059148312,0.286,C32_SKIN,C32,ACH-000580,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.6627273559570312
5078,8868,CAL-12T,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.72,6.61,3.79,.45,-13,-63,-79,-83","5.48,6.48,.40,5.63,4.43,8.91,7.30,.62",8,Sigmoid,0.476265877,0.595180452,-82.32112885,1.7747,CAL12T_LUNG,CAL12T,ACH-000826,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-0.518890638744525,2.8976263999938965
5079,8869,CAL 27,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.53,-2.5,-1.7,-3.2,-51,-51,-78,-79","2.44,1.20,1.16,6.14,2.67,3.06,.42,1.76",8,Sigmoid,0.208415255,0.247576982,-78.48035431,2.316,CAL27_UPPER_AERODIGESTIVE_TRACT,CAL27,ACH-000832,Head and Neck Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-1.3960337069519637,2.8642385005950928
5080,8870,CAL-85-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.46,-19,1.87,-10,-36,-44,-62,-73","3.40,10.5,12.9,20.8,4.25,12.6,3.78,1.36",8,Sigmoid,0.578028142,0.870514452,-73.22431183,2.0234,CAL851_BREAST,CAL851,ACH-000857,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-0.1386709179588036,2.945981979370117
5081,8871,Calu-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.56,5.00,5.96,12.0,8.96,-4.4,-.99,-13","1.69,3.96,1.60,8.28,5.41,4.15,5.20,4.41",8,Constant,,8.0,5.121509552,0.04256,CALU1_LUNG,CALU1,ACH-000511,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.194798469543457
5082,8872,Calu-3,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.7,12.3,15.4,20.7,1.12,-21,-43,-69","10.4,.36,4.78,32.6,5.22,12.5,9.50,6.57",8,Sigmoid,2.173266649,3.225658417,-68.47550964,1.1767,CALU3_LUNG,CALU3,ACH-000392,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.1711370897199334,3.119418144226074
5083,8873,Calu-6,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.5,-2.8,18.9,16.3,15.8,-4.6,3.92,-53","11.8,8.28,9.89,6.67,8.08,7.41,6.10,3.58",8,Sigmoid,8.704103248,7.807984352,-51.7345047,0.4963,CALU6_LUNG,CALU6,ACH-000264,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0551468450104227,2.7563209533691406
5084,8874,CAMA-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".68,12.1,3.84,10.5,1.32,5.73,-8.9,-6.7","4.04,21.4,20.9,5.74,1.16,7.25,32.6,12.1",8,Constant,,8.0,1.737449884,0.003827,CAMA1_BREAST,CAMA1,ACH-000783,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.975785732269287
5085,8875,Capan-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.21,16.8,-8.3,-11,4.99,-12,-11,-29","2.91,28.0,10.2,10.5,19.2,5.71,19.0,12.9",8,Constant,,8.0,-9.353793144,0.399,CAPAN2_PANCREAS,CAPAN2,ACH-000107,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.1292662620544434
5086,8876,CAS-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.83,5.11,5.64,9.20,-8.5,12.7,9.07,-14","1.08,7.63,3.08,7.52,11.2,18.2,18.0,25.7",8,Constant,,8.0,3.509302139,0.08698,CAS1_CENTRAL_NERVOUS_SYSTEM,CAS1,ACH-000464,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.985121250152588
5087,8877,CCK-81,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.45,22.4,-8.6,5.08,-.85,-45,-66,-69","3.31,27.1,23.5,1.02,25.4,22.7,12.2,.016",8,Sigmoid,0.38376525,0.684667587,-68.34850311,1.8156,CCK81_LARGE_INTESTINE,CCK81,ACH-000963,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-0.37882183295622024,2.9769177436828613
5088,8878,CHP-212,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.36,21.6,9.58,14.9,-8.3,13.2,-1.3,-29","14.0,.71,30.5,27.4,10.3,13.6,9.14,1.63",8,Linear,,8.0,-29.56256676,0.4165,CHP212_AUTONOMIC_GANGLIA,CHP212,ACH-000120,Neuroblastoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7769408226013184
5089,8879,CI-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.93,-8.6,28.8,-7.1,24.4,36.6,-22,9.79","27.3,14.0,37.6,6.97,34.3,1.62,10.9,12.8",8,Constant,,8.0,1.376956463,0.4621,CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,CI1,ACH-000687,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.6308205127716064
5090,8880,COLO-320,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.04,1.93,10.00,-3.0,6.72,-.61,-24,-44","1.40,3.96,.44,11.2,4.17,7.16,1.12,6.41",8,Sigmoid,2.291812897,8.0,-44.01358032,0.6266,COLO320_LARGE_INTESTINE,COLO320,ACH-000202,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.748685836791992
5091,8881,COLO-678,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","21.3,4.46,28.5,12.5,-17,-33,-33,-45","4.34,15.5,18.0,14.6,10.8,7.41,1.55,15.3",8,Sigmoid,0.189377457,8.0,-35.84820938,1.1618,COLO678_LARGE_INTESTINE,COLO678,ACH-000350,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.1669363975524902
5092,8882,COLO-679,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","25.6,-26,29.9,-5.3,24.3,-1.3,7.03,-43","7.11,25.6,10.1,10.6,9.28,5.50,.88,.84",8,Constant,,8.0,4.391588211,0.4867,COLO679_SKIN,COLO679,ACH-000805,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.746382713317871
5093,8883,COLO 741,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","21.5,5.81,-13,-4.5,-8.8,-5.5,-32,-54","29.5,.62,13.5,19.2,4.34,9.01,12.6,15.4",8,Sigmoid,8.618299106,7.229937077,-52.20883942,0.9611,COLO741_SKIN,COLO741,ACH-000582,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.9782303330899247,2.7559690475463867
5094,8884,COR-L105,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.16,8.47,-3.6,-6.6,-20,-17,-62,-60","6.95,9.59,7.43,3.97,1.87,17.6,1.85,5.49",8,Sigmoid,0.53757745,1.692961574,-62.86543274,1.1257,CORL105_LUNG,CORL105,ACH-000161,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.5264794059058218,3.039735794067383
5095,8885,COR-L23,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".39,5.19,9.55,3.96,.39,-1.3,-2.2,-9.7","3.53,8.28,3.59,3.54,.67,2.81,2.10,6.25",8,Constant,,8.0,0.138689622,0.03604,CORL23_LUNG,CORL23,ACH-000662,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.965214729309082
5096,8886,COV318,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.70,15.9,4.35,6.46,19.0,2.97,2.86,-1.5",".089,10.7,6.86,1.43,1.25,4.58,16.6,10.0",8,Constant,,8.0,5.764453411,0.05132,COV318_OVARY,COV318,ACH-000256,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.1256325244903564
5097,8887,COV504,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.7,12.8,7.84,-7.9,-12,.30,-23,-36","22.4,5.73,12.9,1.85,3.61,8.66,8.73,5.12",8,Sigmoid,8.989180119,8.0,-36.2047348,0.258,COV504_OVARY,COV504,ACH-001048,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9992215633392334
5098,8888,Daoy,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,.86,-5.5,-6.2,5.25,-6.4,-7.3,-24","26.3,.65,6.88,10.5,14.6,5.99,13.6,.23",8,Constant,,8.0,-3.453150511,0.2287,DAOY_CENTRAL_NERVOUS_SYSTEM,DAOY,ACH-000211,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.623278856277466
5099,8889,DBTRG-05MG,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.33,9.53,-4.0,8.86,-4.6,9.97,-8.8,-23",".092,2.03,3.57,.47,1.38,3.87,8.70,6.36",8,Sigmoid,2.569366217,8.0,-22.91773987,0.3955,DBTRG05MG_CENTRAL_NERVOUS_SYSTEM,DBTRG05MG,ACH-000863,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8668019771575928
5100,8890,Detroit 562,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.5,13.4,-8.3,18.9,-.50,-16,-41,-45","7.93,4.32,7.95,20.4,.089,.59,6.12,.71",8,Sigmoid,0.959799469,8.0,-45.0917244,0.8498,DETROIT562_UPPER_AERODIGESTIVE_TRACT,DETROIT562,ACH-000207,Head and Neck Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8447811603546143
5101,8891,DK-MG,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.025,6.63,5.54,8.96,.55,-4.3,-5.7,-28","24.0,.11,12.9,8.52,13.4,1.63,4.00,2.17",8,Sigmoid,9.235823084,8.0,-27.54204559,0.1756,DKMG_CENTRAL_NERVOUS_SYSTEM,DKMG,ACH-000244,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9082083702087402
5102,8892,DMS 114,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.93,15.3,-11,21.1,-9.7,27.1,.79,-10","3.66,14.1,15.0,19.1,12.2,34.1,11.0,17.3",8,Constant,,8.0,1.516382217,0.4546,DMS114_LUNG,DMS114,ACH-000530,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.350534439086914
5103,8893,DOHH-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","20.0,23.9,-7.0,26.1,14.9,5.92,.26,-4.3","28.1,43.5,52.6,17.6,9.39,18.3,41.7,13.1",8,Constant,,8.0,11.54635715,0.9251,DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,DOHH2,ACH-000056,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.035736560821533
5104,8894,DV-90,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","44.0,14.8,-3.1,-2.9,-13,-35,-26,-44","48.2,27.3,20.3,18.0,20.0,7.71,34.0,1.35",8,Linear,,8.0,-42.60942459,1.4945,DV90_LUNG,DV90,ACH-000925,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8420681953430176
5105,8895,EB1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.5,8.63,43.1,-12,12.4,-1.7,2.95,-17","9.56,7.66,33.2,13.1,12.9,1.16,20.4,1.56",8,Constant,,8.0,3.653625965,0.3605,EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EB1,ACH-000877,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7489020824432373
5106,8896,EBC-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,-5.6,1.91,4.65,-5.9,-3.3,-18,-20","13.8,18.9,12.1,14.0,5.27,5.91,27.2,20.2",8,Constant,,8.0,-5.432577133,0.2728,EBC1_LUNG,EBC1,ACH-000563,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9391791820526123
5107,8897,EFE-184,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.86,-5.3,4.72,-5.4,-4.5,-26,-23,-32","6.15,6.31,.81,.69,2.07,2.40,7.07,1.32",8,Sigmoid,0.456324488,8.0,-30.59578133,0.5729,EFE184_ENDOMETRIUM,EFE184,ACH-000435,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9991750717163086
5108,8898,EFM-19,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.50,-7.5,4.72,.77,-1.6,2.34,10.2,-15","5.69,.80,.71,3.37,2.53,9.11,12.4,20.8",8,Constant,,8.0,1.025663733,0.09867,EFM19_BREAST,EFM19,ACH-000330,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0974879264831543
5109,8899,EFO-21,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.64,-4.6,22.6,15.9,6.29,.53,-12,-36","4.69,.75,9.54,10.9,6.63,21.2,2.82,15.0",8,Sigmoid,4.168848515,8.0,-35.66239166,0.463,EFO21_OVARY,EFO21,ACH-000308,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9720282554626465
5110,8900,EFO-27,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.02,1.70,9.49,-.0086,-16,-29,-41,-50","7.30,4.83,1.65,.37,4.12,6.39,5.61,7.48",8,Sigmoid,0.498583347,8.0,-48.38506699,0.8427,EFO27_OVARY,EFO27,ACH-000936,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.6941487789154053
5111,8901,EM-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","22.5,16.8,19.7,2.50,.098,-8.1,-17,-39","2.16,4.60,4.51,10.0,4.67,2.11,7.79,.54",8,Sigmoid,8.849429867,8.0,-37.23640442,0.8905,EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,EM2,ACH-000295,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.97160005569458
5112,8902,EN,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.2,2.29,-2.1,1.85,-.91,-5.3,2.02,-2.5","15.3,3.98,2.51,8.60,.56,3.04,.40,7.96",8,Constant,,8.0,-0.486901253,0.0,EN_ENDOMETRIUM,EN,ACH-000978,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8604164123535156
5113,8903,ES-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.04,-1.0,4.40,4.65,-.63,1.94,-6.9,-15","4.47,2.91,6.73,3.31,10.2,.78,9.21,.78",8,Constant,,8.0,0.407657593,0.09704,ES2_OVARY,ES2,ACH-000906,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.812028408050537
5114,8904,ESS-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.8,14.3,8.99,6.07,-1.2,.16,-25,-45","4.53,4.17,7.27,5.07,.83,7.58,4.80,2.12",8,Sigmoid,8.243766737,8.0,-45.11304474,0.6877,ESS1_ENDOMETRIUM,ESS1,ACH-000913,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7153594493865967
5115,8905,F-36P,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,3.08,10.8,35.2,-8.3,12.5,5.14,-42","1.85,2.75,.60,1.00,10.5,28.5,14.0,12.0",8,Sigmoid,6.356070042,8.0,-42.0100975,0.6618,F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,F36P,ACH-000487,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8688530921936035
5116,8906,FaDu,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.031,12.4,4.26,.53,-13,-36,-56,-69","4.49,9.29,3.24,12.1,10.1,5.75,.77,.88",8,Sigmoid,0.767408073,1.640679717,-68.01077271,1.5452,FADU_UPPER_AERODIGESTIVE_TRACT,FADU,ACH-000846,Head and Neck Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.49511061755599456,2.8380374908447266
5117,8907,FU97,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.91,8.25,10.4,-.38,9.77,-13,-14,-32","5.37,2.24,12.2,12.5,3.39,6.72,13.5,2.47",8,Sigmoid,0.985450149,8.0,-30.33570099,0.3636,FU97_STOMACH,FU97,ACH-000633,Gastric Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.650059700012207
5118,8908,FU-OV-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".11,2.83,-5.2,-12,-15,-15,-16,-39","10.7,10.8,16.9,6.00,11.1,8.25,8.19,4.90",8,Sigmoid,8.502243047,8.0,-35.64892197,0.8677,FUOV1_OVARY,FUOV1,ACH-000574,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.736131191253662
5119,8909,G-361,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.44,3.39,2.28,-2.0,-6.5,.41,-29,-52","22.2,2.80,8.32,16.7,5.25,14.8,.72,2.11",8,Sigmoid,2.433682442,4.410532475,-52.41119385,0.996,G361_SKIN,G361,ACH-000572,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.4839954248003355,2.611023426055908
5120,8910,G-401,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","17.7,-2.0,15.0,-1.7,16.5,5.94,-4.0,-25","6.70,1.51,2.85,17.4,5.77,6.91,.62,13.1",8,Sigmoid,3.924662113,8.0,-24.77778625,0.3828,G401_SOFT_TISSUE,G401,ACH-000096,Rhabdoid,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.557624101638794
5121,8911,G-402,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","19.9,1.33,29.1,24.1,3.64,10.3,3.39,-11","8.76,5.26,18.1,4.25,1.61,23.9,3.46,5.57",8,Constant,,8.0,5.267155647,0.0,G402_SOFT_TISSUE,G402,ACH-000375,Kidney Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7096142768859863
5122,8912,GAMG,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.26,9.42,-7.7,-12,-.026,1.30,-12,1.68","14.0,4.50,6.07,4.27,3.22,13.5,16.1,16.4",8,Constant,,8.0,-1.541104436,0.1358,GAMG_CENTRAL_NERVOUS_SYSTEM,GAMG,ACH-000098,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.944652557373047
5123,8913,GB-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.88,6.32,5.81,11.9,2.65,8.62,-21,-33","33.4,16.4,12.3,25.1,1.47,6.23,9.26,13.1",8,Sigmoid,2.154639244,8.0,-33.52809525,0.4303,GB1_CENTRAL_NERVOUS_SYSTEM,GB1,ACH-000738,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8926467895507812
5124,8914,GCT,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.89,-6.2,11.1,1.16,12.7,-5.7,-4.6,-41","6.35,4.44,12.5,11.5,5.13,13.0,.31,5.69",8,Sigmoid,8.169985783,8.0,-41.26877975,0.6055,GCT_SOFT_TISSUE,GCT,ACH-000835,Sarcoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7899117469787598
5125,8915,GI-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.9,8.05,7.97,1.40,3.68,10.8,-14,-7.9","4.74,9.10,3.96,13.0,16.6,1.46,10.5,4.70",8,Constant,,8.0,7.054241657,0.1787,GI1_CENTRAL_NERVOUS_SYSTEM,GI1,ACH-000756,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.6508169174194336
5126,8916,GMS-10,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.01,.32,1.02,-7.7,5.90,-2.6,-4.6,-18","4.73,6.61,6.67,2.50,7.30,.017,6.55,22.2",8,Constant,,8.0,-2.606539726,0.1201,GMS10_CENTRAL_NERVOUS_SYSTEM,GMS10,ACH-000102,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.728609085083008
5127,8917,GRANTA-519,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.5,9.71,5.90,3.85,-5.6,-2.7,-21,-4.5","9.86,21.2,12.9,8.32,13.5,15.0,2.33,19.4",8,Constant,,8.0,0.846624851,0.3789,GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,GRANTA519,ACH-000073,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.910205841064453
5128,8918,H4,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".66,4.10,-4.7,4.30,.18,1.22,-10,-22","5.53,7.70,2.77,15.7,4.77,8.84,1.19,4.01",8,Sigmoid,2.658244133,8.0,-22.44680595,0.2662,H4_CENTRAL_NERVOUS_SYSTEM,H4,ACH-000389,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.948897361755371
5129,8919,HARA,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.60,-.54,-1.5,.12,-6.1,-14,-42,-44","13.4,10.6,8.83,1.36,18.6,14.6,.92,.43",8,Sigmoid,1.001384735,8.0,-44.40664673,0.8434,HARA_LUNG,HARA,ACH-000843,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.753936767578125
5130,8920,HCC1187,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".52,-14,5.03,-.67,-6.1,-3.7,-29,-7.6","11.1,.69,.32,1.85,11.3,4.53,6.53,3.61",8,Constant,,8.0,-5.974428654,0.1981,HCC1187_BREAST,HCC1187,ACH-000111,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.097700595855713
5131,8921,HCC1395,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","24.3,-5.7,19.2,-6.0,8.18,9.41,-13,-33","11.7,9.23,18.9,4.54,12.1,9.77,7.60,7.45",8,Sigmoid,8.338648497,8.0,-33.78575516,0.5515,HCC1395_BREAST,HCC1395,ACH-000699,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8500876426696777
5132,8922,HCC-15,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.0,.70,1.30,-7.1,-1.1,-7.3,1.14,-7.0","20.6,6.42,20.1,17.3,18.1,4.82,7.12,3.08",8,Constant,,8.0,-3.865206242,0.3449,HCC15_LUNG,HCC15,ACH-000878,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.984907627105713
5133,8923,HCC1569,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","20.0,-9.6,-11,-5.3,8.90,4.94,4.78,-20","8.08,10.2,10.8,21.1,9.70,7.37,13.1,4.82",8,Linear,,8.0,-19.11942291,0.1893,HCC1569_BREAST,HCC1569,ACH-000930,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.059030532836914
5134,8924,HCC1806,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-18,20.7,-26,11.0,-33,-15,-58,-68","6.56,16.3,13.8,17.2,3.37,2.06,2.97,5.03",8,Sigmoid,1.954791307,2.15597558,-68.43061829,2.1,HCC1806_BREAST,HCC1806,ACH-000624,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.7682433264519928,2.989394426345825
5135,8925,HCC1954,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.60,16.0,-12,-.76,-.066,-10,-40,-52","7.83,4.65,3.92,8.47,6.83,3.75,1.80,4.52",8,Sigmoid,1.433703661,5.570298195,-52.21885681,0.8402,HCC1954_BREAST,HCC1954,ACH-000859,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.7174485884128399,3.1050925254821777
5136,8926,HCC2935,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.32,.99,5.78,-23,-43,-71,-80,-78","7.96,4.86,.71,13.3,11.8,2.12,1.84,.33",8,Sigmoid,0.183143467,0.280773968,-79.92745972,2.6857,HCC2935_LUNG,HCC2935,ACH-000150,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-1.2702053176807058,3.028646945953369
5137,8927,HCC4006,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.89,-6.3,-12,-27,-78,-92,-92,-95","3.62,26.7,8.52,7.92,3.29,.65,.60,1.05",8,Sigmoid,0.110252991,0.124252401,-94.32579803,3.7373,HCC4006_LUNG,HCC4006,ACH-000066,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-2.085440290248442,3.0310850143432617
5138,8928,HCC-44,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.1,5.27,19.0,-1.4,12.8,.32,2.21,-20","7.81,13.0,2.69,3.24,1.17,3.74,2.74,4.14",8,Sigmoid,8.705939726,8.0,-19.15372086,0.1511,HCC44_LUNG,HCC44,ACH-000667,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9364473819732666
5139,8929,HCC-56,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.54,11.2,22.6,12.9,4.54,-10.0,-18,-22","17.0,8.95,4.16,6.78,5.19,15.9,2.89,3.11",8,Sigmoid,0.460833997,8.0,-20.96335983,0.2732,HCC56_LARGE_INTESTINE,HCC56,ACH-000467,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7624456882476807
5140,8930,HCC70,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.37,11.3,7.50,5.82,-14,-17,-15,-26","10.1,6.85,14.6,12.0,14.3,8.28,16.3,13.4",8,Constant,,8.0,5.798483372,0.3408,HCC70_BREAST,HCC70,ACH-000668,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0412204265594482
5141,8931,HCC-78,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.1,-2.1,4.36,1.24,8.46,5.18,-1.7,-7.2","7.48,1.00,3.61,11.2,14.7,8.79,.050,.11",8,Constant,,8.0,-1.001159549,0.02019,HCC78_LUNG,HCC78,ACH-000562,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0695931911468506
5142,8932,HCC827,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.85,1.47,-33,-72,-83,-80,-86,-90","26.3,14.2,14.2,5.34,.98,6.57,9.09,.13",8,Sigmoid,0.029334972,0.038917925,-85.47996521,4.4132,HCC827_LUNG,HCC827,ACH-000012,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-3.246300337576865,2.916255474090576
5143,8933,HCT 116,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,-9.3,6.71,2.20,1.40,3.01,-13,-16",".78,5.23,2.76,3.43,9.70,1.79,3.46,4.14",8,Constant,,8.0,-1.00238061,0.2184,HCT116_LARGE_INTESTINE,HCT116,ACH-000971,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.73160982131958
5144,8934,HCT-15,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.2,2.26,3.32,.85,19.2,2.57,-9.8,-50","7.95,19.2,10.7,9.69,25.4,13.9,2.90,3.13",8,Sigmoid,8.169568807,8.0,-49.49138641,0.4596,HCT15_LARGE_INTESTINE,HCT15,ACH-000997,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.906175136566162
5145,8935,HD-MY-Z,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.61,-3.8,5.37,2.66,-.23,-1.3,-23,-71","9.09,2.15,8.10,4.19,12.0,2.57,7.91,1.24",8,Sigmoid,3.82346797,4.557374477,-70.69909668,0.8709,HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HDMYZ,ACH-000190,Unknown,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.516746685117886,2.6942825317382812
5146,8936,HDQ-P1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,4.91,9.39,13.8,-43,-23,-46,-53","14.1,23.1,21.1,15.7,10.2,6.23,11.9,4.70",8,Sigmoid,0.154859424,8.0,-42.78325272,1.6374,HDQP1_BREAST,HDQP1,ACH-000643,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.999537944793701
5147,8937,HEC-151,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,-2.1,-7.7,-13,-51,-29,-48,-50","8.82,8.83,17.5,20.7,14.3,13.9,2.74,.21",8,Sigmoid,0.105709143,8.0,-46.57953262,2.2608,HEC151_ENDOMETRIUM,HEC151,ACH-000972,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.544552803039551
5148,8938,HEC-1-A,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","30.6,17.5,12.1,20.6,11.6,8.52,11.5,-8.5","2.02,21.3,13.7,39.2,27.3,4.09,0,2.81",8,Constant,,8.0,11.24893761,0.1217,HEC1A_ENDOMETRIUM,HEC1A,ACH-000954,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.789677143096924
5149,8939,HEC-1-B,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".45,15.1,-8.1,19.7,-4.7,-6.3,-21,-40","12.6,13.8,19.8,13.3,3.87,3.33,20.8,5.45",8,Sigmoid,7.174179077,8.0,-39.54808044,1.0704,HEC1B_ENDOMETRIUM,HEC1B,ACH-000941,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7676587104797363
5150,8940,HEC-251,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.70,16.7,-13,9.48,-4.8,-.33,-31,-33","9.50,2.38,6.37,5.99,3.88,23.8,11.6,4.72",8,Sigmoid,0.438649237,8.0,-33.53871918,0.7614,HEC251_ENDOMETRIUM,HEC251,ACH-000996,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.994993209838867
5151,8941,HEC-265,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.08,20.0,7.15,15.4,8.03,12.9,10.1,-1.1","2.48,.13,3.36,.21,16.0,6.18,17.2,7.05",8,Constant,,8.0,9.098386765,0.0,HEC265_ENDOMETRIUM,HEC265,ACH-000946,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7155895233154297
5152,8942,HEC-59,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.1,8.04,.029,10.1,-5.7,2.47,-8.9,-15","9.72,.62,3.30,16.2,4.28,1.86,11.1,3.70",8,Constant,,8.0,-1.051799655,0.05487,HEC59_ENDOMETRIUM,HEC59,ACH-000994,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7696776390075684
5153,8943,HEC-6,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","26.3,9.29,36.4,13.0,-9.6,-22,32.7,-22","21.9,52.4,37.5,14.5,21.8,6.35,50.6,5.27",8,Constant,,8.0,4.139275074,0.7348,HEC6_ENDOMETRIUM,HEC6,ACH-000984,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9504165649414062
5154,8944,HEL 92.1.7,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.81,3.87,-2.3,-2.9,-.31,1.81,-7.2,-11","1.71,5.52,1.74,7.72,3.97,7.14,1.84,1.82",8,Constant,,8.0,-2.070747852,0.4473,HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HEL9217,ACH-000005,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7410006523132324
5155,8945,Hep 3B2.1-7,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.3,37.2,-3.2,35.5,-23,24.5,-10,19.0","2.99,18.4,9.18,3.13,13.9,23.2,7.78,23.0",8,Constant,,8.0,3.308411837,0.4963,HEP3B217_LIVER,HEP3B217,ACH-000625,Liver Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.971600294113159
5156,8946,Hep G2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.40,9.43,9.76,1.23,-7.4,-1.7,-6.7,-22","6.90,.80,13.4,11.1,21.7,1.68,3.34,14.2",8,Sigmoid,8.269482414,8.0,-17.8189888,0.1433,HEPG2_LIVER,HEPG2,ACH-000739,Liver Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8945958614349365
5157,8947,Hey-A8,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.24,6.29,1.96,-1.2,-3.3,-3.7,-1.1,-32","5.37,2.30,5.01,1.14,3.16,5.99,3.29,2.36",8,Sigmoid,8.726591628,8.0,-31.88303947,0.2561,HEYA8_OVARY,HEYA8,ACH-000542,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.740419387817383
5158,8948,HGC-27,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.24,2.38,4.45,3.73,4.02,-1.7,-3.1,-30",".97,.82,2.70,.069,1.15,1.64,1.15,5.74",8,Sigmoid,8.572992371,8.0,-29.61772537,0.2264,HGC27_STOMACH,HGC27,ACH-000847,Gastric Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.6681180000305176
5159,8949,HH,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.8,-9.1,4.73,6.82,-13,14.2,10.1,30.4","3.41,10.9,5.54,1.69,10.2,1.53,1.73,14.6",8,Linear,,8.0,-7.221300602,0.4083,HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HH,ACH-000061,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7404122352600098
5160,8950,HLF,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.61,12.5,-6.3,6.30,.81,-2.8,-3.2,-27","4.91,5.47,1.57,2.12,7.63,1.70,3.61,11.5",8,Sigmoid,8.315647428,8.0,-26.77819061,0.5841,HLF_LIVER,HLF,ACH-000393,Liver Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7074925899505615
5161,8951,HMC-1-8,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.26,.66,-1.4,1.38,.0037,-2.4,-7.2,-7.6","14.5,3.68,7.69,1.87,9.28,1.06,10.2,8.26",8,Constant,,8.0,-1.763302565,0.3479,HMC18_BREAST,HMC18,ACH-000721,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.716639280319214
5162,8952,HMCB,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.24,3.09,.41,3.32,-11,-6.6,-41,-64","5.15,9.69,6.15,7.85,9.65,.36,11.3,5.11",8,Sigmoid,2.144095898,3.607230186,-64.24649811,1.0646,HMCB_SKIN,HMCB,ACH-000931,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.2829402163531967,2.613370656967163
5163,8953,HOS,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.3,-17,-12,3.10,5.07,10.1,5.65,-2.3","7.79,11.4,.25,12.8,6.29,13.7,6.92,10.2",8,Constant,,8.0,0.995820701,0.2068,HOS_BONE,HOS,ACH-000613,Bone Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.768746852874756
5164,8954,HPAC,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,13.7,37.0,16.2,-18,14.4,-33,-30","3.97,11.2,44.7,.80,10.8,4.69,1.95,21.1",8,Linear,,8.0,-32.80316544,0.7557,HPAC_PANCREAS,HPAC,ACH-000270,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0061521530151367
5165,8955,HPAF-II,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","30.9,14.4,36.5,-12,26.0,18.5,-27,-37","9.51,32.1,7.75,7.83,8.33,.025,12.7,11.0",8,Sigmoid,1.347590685,8.0,-37.12796783,0.965,HPAFII_PANCREAS,HPAFII,ACH-000094,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.2964162826538086
5166,8956,Hs 294T,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,-3.0,3.39,8.45,-14,.98,-7.8,-27","1.99,4.87,2.84,3.96,7.68,2.85,1.25,8.24",8,Sigmoid,3.169720173,8.0,-27.09840012,0.6342,HS294T_SKIN,HS294T,ACH-000014,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9082553386688232
5167,8957,Hs 578T,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.67,5.83,1.42,-2.5,11.9,1.85,-2.5,-13","2.50,5.67,.30,.27,6.02,7.73,1.06,8.57",8,Constant,,8.0,1.417373419,0.05836,HS578T_BREAST,HS578T,ACH-000148,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9056591987609863
5168,8958,Hs 683,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.59,6.15,-3.8,1.89,-2.5,.30,-9.2,-.93","4.13,2.47,8.74,11.3,6.53,6.20,3.59,.29",8,Constant,,8.0,-1.077103496,0.07119,HS683_CENTRAL_NERVOUS_SYSTEM,HS683,ACH-000067,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7070865631103516
5169,8959,Hs 695T,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.14,7.20,4.01,10.7,2.23,16.3,.33,-8.5","8.53,19.4,14.4,2.42,16.0,1.91,9.62,8.06",8,Constant,,8.0,7.92060709,0.0222,HS695T_SKIN,HS695T,ACH-000799,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9877333641052246
5170,8960,Hs 729,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","16.2,4.53,16.8,.090,5.63,1.86,-1.6,-15","2.33,5.29,1.50,.19,1.97,7.34,9.30,11.4",8,Sigmoid,8.404402608,8.0,-13.1375761,0.1266,HS729_SOFT_TISSUE,HS729,ACH-000133,Unknown,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.866090774536133
5171,8961,Hs 746T,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.4,9.70,6.02,16.5,-.78,1.18,-3.6,-34","5.19,2.36,15.5,20.9,8.54,18.9,1.93,4.77",8,Sigmoid,9.307457919,8.0,-32.81226349,0.3248,HS746T_STOMACH,HS746T,ACH-000616,Gastric Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.952040433883667
5172,8962,Hs 766T,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.4,-1.3,-5.3,-5.0,-4.8,-13,-24,-31","4.03,4.60,5.33,12.7,5.64,19.6,8.39,6.07",8,Sigmoid,2.112795353,8.0,-31.36722374,0.6797,HS766T_PANCREAS,HS766T,ACH-000178,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.81900954246521
5173,8963,Hs 852.T,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".31,3.65,-4.8,-2.3,-6.6,-6.4,-15,-21","4.07,2.98,7.19,4.87,8.68,4.22,3.93,4.00",8,Sigmoid,8.739866186,8.0,-20.69029617,0.2035,HS852T_SKIN,HS852T,ACH-000274,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8736462593078613
5174,8964,Hs 936.T,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.52,.40,4.02,1.16,-1.5,-5.8,1.01,-5.6","8.77,10.4,.88,3.74,11.0,3.84,5.11,.21",8,Constant,,8.0,0.169800982,0.0,HS936T_SKIN,HS936T,ACH-000801,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.152082681655884
5175,8965,Hs 939.T,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.46,9.34,11.4,18.9,5.98,-2.7,-16,2.10","11.1,25.6,20.6,10.8,14.5,18.6,13.6,7.15",8,Constant,,8.0,4.455478668,0.1288,HS939T_SKIN,HS939T,ACH-000814,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8132691383361816
5176,8966,Hs 944.T,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.51,7.32,.59,8.09,2.28,-1.3,-2.2,-41","2.97,1.07,6.82,6.42,7.44,8.13,7.39,.99",8,Sigmoid,8.070107721,8.0,-40.83175659,0.3722,HS944T_SKIN,HS944T,ACH-000632,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.636337995529175
5177,8967,HSC-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.06,3.06,8.17,7.50,9.21,-13,-22,-34","6.41,3.48,4.62,4.15,2.61,6.45,5.76,3.46",8,Sigmoid,1.017567992,8.0,-31.69483566,0.6125,HSC2_UPPER_AERODIGESTIVE_TRACT,HSC2,ACH-000472,Head and Neck Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8204689025878906
5178,8968,HT,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","35.0,-17,28.6,-16,-2.7,1.73,7.05,35.3","14.3,43.4,23.6,26.9,19.3,30.8,13.3,86.1",8,Constant,,8.0,11.23945427,0.6185,HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HT,ACH-000914,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9689431190490723
5179,8969,HT-1080,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.51,-1.4,3.35,-.069,1.74,1.99,-2.6,-16","1.67,1.63,2.82,2.25,1.17,1.91,.56,1.14",8,Constant,,8.0,0.837718129,0.02918,HT1080_SOFT_TISSUE,HT1080,ACH-000054,Sarcoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.482574462890625
5180,8970,HT-1197,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.1,29.0,26.2,4.09,-17,-1.4,-15,-13","1.56,9.59,20.7,11.9,49.5,12.3,1.25,.090",8,Sigmoid,0.079169571,8.0,-9.233660698,0.2642,HT1197_URINARY_TRACT,HT1197,ACH-000547,Bladder Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.973564624786377
5181,8971,HT-144,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.0,7.80,-9.6,1.00,-6.8,.40,-17,-44","16.1,8.27,1.84,6.98,.26,13.9,9.09,1.53",8,Sigmoid,9.204066346,8.0,-44.16248322,0.5338,HT144_SKIN,HT144,ACH-000322,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.748180866241455
5182,8972,HuCCT1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.53,1.90,4.77,2.89,-6.1,-8.9,-21,-41",".22,4.43,1.38,4.73,6.63,2.41,5.95,2.09",8,Sigmoid,8.800328501,8.0,-41.22437286,0.4576,HUCCT1_BILIARY_TRACT,HUCCT1,ACH-000976,Bile Duct Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.890322208404541
5183,8973,huH-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.18,25.0,19.6,2.37,-5.4,2.44,-14,-29","14.2,5.03,13.7,13.4,9.03,2.38,2.96,14.7",8,Sigmoid,8.384017464,8.0,-27.84748268,0.4804,HUH1_LIVER,HUH1,ACH-000475,Liver Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7495927810668945
5184,8974,HUP-T3,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.54,-1.4,-7.3,3.18,-4.1,-3.6,-12,-26","5.04,6.45,5.58,37.0,4.84,4.02,17.3,1.04",8,Constant,,8.0,-4.782395363,0.2869,HUPT3_PANCREAS,HUPT3,ACH-000118,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.187619686126709
5185,8975,HuT 78,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","48.3,16.4,-3.5,35.5,22.9,-25,-5.0,-13","22.8,29.7,25.5,1.03,21.3,18.7,63.4,99.0",8,Constant,,8.0,23.24990654,0.7256,HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,HUT78,ACH-000509,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.926027774810791
5186,8976,IA-LM,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.08,12.6,8.80,-7.3,8.16,14.1,-8.5,-22","13.1,4.83,29.3,34.6,8.57,4.16,40.7,30.5",8,Constant,,8.0,10.36487675,0.3108,IALM_LUNG,IALM,ACH-000672,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.830138921737671
5187,8977,IGR-37,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.67,.49,8.24,8.19,11.2,-10,-8.2,-18","6.49,12.0,31.0,7.38,16.4,20.1,1.70,3.97",8,Constant,,8.0,-0.22112982,0.3618,IGR37_SKIN,IGR37,ACH-000650,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.650102138519287
5188,8978,IGR-39,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","17.4,-6.9,27.6,-.15,22.4,-19,8.13,-21","4.36,17.6,6.24,15.4,4.06,25.1,14.4,3.08",8,Constant,,8.0,7.474345207,0.4376,IGR39_SKIN,IGR39,ACH-000550,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.779796600341797
5189,8979,IGROV1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,6.05,4.65,7.74,-15,-24,-42,-46","7.87,.87,.86,0,5.34,7.58,.22,9.72",8,Sigmoid,0.499017566,8.0,-47.74693298,1.1493,IGROV1_OVARY,IGROV1,ACH-000966,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.847388744354248
5190,8980,IMR-32,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.6,9.38,-1.2,11.6,-6.4,13.7,18.6,8.38","2.43,1.71,20.1,12.8,26.6,19.6,27.0,4.81",8,Constant,,8.0,6.709219933,0.0,IMR32_AUTONOMIC_GANGLIA,IMR32,ACH-000310,Neuroblastoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9230895042419434
5191,8981,IPC-298,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.2,3.69,-.77,1.66,6.46,-5.5,-11,-58","1.86,6.26,2.37,2.97,1.96,9.05,7.87,1.18",8,Sigmoid,8.472662667,6.998702526,-57.99394989,0.5104,IPC298_SKIN,IPC298,ACH-000915,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.9457247784466722,2.8073606491088867
5192,8982,IST-MES2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.09,13.7,13.7,8.98,1.32,5.47,-3.0,-32","15.8,16.4,23.3,6.84,10.7,20.2,19.2,12.7",8,Sigmoid,8.323075691,8.0,-31.40408134,0.3595,ISTMES2_PLEURA,ISTMES2,ACH-000331,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8180832862854004
5193,8983,J82,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.49,3.54,-.17,5.72,-7.6,-4.7,-13,-16","7.17,9.83,3.57,2.66,10.4,10.4,.52,2.65",8,Constant,,8.0,-1.915980697,0.3626,J82_URINARY_TRACT,J82,ACH-000396,Bladder Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9670300483703613
5194,8984,JHH-4,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.59,14.6,13.2,1.84,-7.0,-5.9,-16,-27","9.22,11.6,1.33,1.29,11.5,4.35,.81,9.48",8,Sigmoid,8.008284116,8.0,-25.6199913,0.4773,JHH4_LIVER,JHH4,ACH-000476,Liver Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.794069528579712
5195,8985,JHOS-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.9,25.3,1.34,22.8,16.0,-2.6,10.1,-27",".23,38.9,10.0,2.66,18.3,1.59,38.3,.54",8,Constant,,8.0,5.917158604,0.1802,JHOS2_OVARY,JHOS2,ACH-000132,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0303797721862793
5196,8986,JHUEM-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.9,14.3,15.3,14.7,-12,-2.9,-6.1,-17","3.63,11.9,2.03,16.2,.90,5.84,12.5,9.59",8,Sigmoid,0.134762362,8.0,-9.778969765,0.1292,JHUEM2_ENDOMETRIUM,JHUEM2,ACH-000909,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7212438583374023
5197,8987,JM1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.8,11.9,-17,9.85,-24,11.5,-18,6.45","1.81,5.50,14.1,7.51,12.9,7.98,15.8,14.0",8,Constant,,8.0,-4.98126936,0.7337,JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JM1,ACH-000151,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9128153324127197
5198,8988,JMSU-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.98,2.00,9.44,11.3,4.09,-1.2,-44,-69","3.30,3.99,1.63,.65,6.88,.37,22.6,.43",8,Sigmoid,2.078505993,3.054365873,-69.34886932,1.0426,JMSU1_URINARY_TRACT,JMSU1,ACH-000753,Bladder Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.1165720008651145,3.041217803955078
5199,8989,JURKAT,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.7,20.5,7.10,19.8,-1.8,2.07,-25,-60","10.3,.66,14.2,4.30,.42,2.51,9.14,.88",8,Sigmoid,8.332445858,6.090600491,-60.61600876,1.1054,JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JURKAT,ACH-000995,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.8067466796523313,2.8945491313934326
5200,8990,JVM-3,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.12,12.0,43.8,28.5,1.61,-12,-35,-71","30.6,5.46,25.0,29.5,27.0,7.38,13.4,.088",8,Sigmoid,5.03568697,3.97213912,-70.54724884,1.8084,JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,JVM3,ACH-000346,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.3793047707457926,3.043138027191162
5201,8991,K029AX,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.6,21.7,-9.2,33.5,14.8,16.2,11.1,5.49","9.48,29.2,.24,18.3,11.4,2.31,18.6,4.63",8,Constant,,8.0,11.61962223,0.03277,K029AX_SKIN,K029AX,ACH-000404,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.6983487606048584
5202,8992,KALS-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,3.70,.31,8.18,-12,-10,-7.7,.39","9.69,10.4,5.24,3.27,13.9,13.2,7.54,17.9",8,Constant,,8.0,-2.92738843,0.3822,KALS1_CENTRAL_NERVOUS_SYSTEM,KALS1,ACH-000231,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.769026756286621
5203,8993,KARPAS-422,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","16.8,23.5,-.052,9.02,21.6,15.6,-4.8,19.1","14.6,2.65,12.7,26.6,5.18,16.1,32.3,2.79",8,Constant,,8.0,17.68476868,0.01967,KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KARPAS422,ACH-000315,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9462223052978516
5204,8994,KASUMI-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.39,.56,5.65,2.98,3.71,-10,-18,-17","14.0,5.50,6.07,9.28,19.6,2.92,9.65,1.60",8,Sigmoid,0.700849533,8.0,-17.38387871,1.0277,KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KASUMI2,ACH-000728,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.851311445236206
5205,8995,KCL-22,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".91,8.95,7.08,26.0,15.8,6.52,-21,-24","11.9,2.16,5.21,.45,3.94,14.1,1.64,15.5",8,Sigmoid,1.342782497,8.0,-24.29757309,0.6935,KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KCL22,ACH-000983,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8311290740966797
5206,8996,KG-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.53,8.51,40.7,18.1,-16,-10,-4.8,-49","38.8,8.90,42.6,30.9,15.7,14.3,.98,3.70",8,Linear,,8.0,-48.95952988,0.9725,KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KG1,ACH-000386,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9534332752227783
5207,8997,KHM-1B,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.6,12.0,33.5,8.46,2.68,-11,-13,-25","4.01,6.70,4.85,3.54,7.30,20.0,6.86,4.30",8,Sigmoid,4.960442543,8.0,-25.07034492,1.043,KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KHM1B,ACH-000564,Myeloma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.960977554321289
5208,8998,KMBC-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".64,-.83,6.95,5.91,2.09,.22,-1.6,-22","2.68,1.28,3.72,3.40,6.56,1.25,3.02,2.14",8,Sigmoid,8.161505439,8.0,-21.87475586,0.1784,KMBC2_URINARY_TRACT,KMBC2,ACH-000862,Bladder Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.074929714202881
5209,8999,KMM-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","19.2,4.52,2.19,10.6,4.68,10.1,6.02,-20","29.1,6.68,1.76,9.13,5.78,1.81,12.3,9.31",8,Sigmoid,6.723270893,8.0,-20.31590271,0.2421,KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMM1,ACH-000889,Myeloma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.997579574584961
5210,9000,KMRC-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.9,-18,7.79,-18,-20,-18,-25,-42","6.38,12.8,8.51,30.2,5.09,6.46,2.99,14.7",8,Sigmoid,8.608978342,8.0,-38.10947037,0.8457,KMRC1_KIDNEY,KMRC1,ACH-000684,Kidney Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9147064685821533
5211,9001,KMRC-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,18.2,20.9,-1.6,-.25,-12,-13,-33","17.2,39.6,33.7,20.7,16.1,17.7,9.19,6.79",8,Linear,,8.0,-32.69772339,0.505,KMRC2_KIDNEY,KMRC2,ACH-000709,Kidney Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.568429470062256
5212,9002,KMS-11,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","28.1,1.87,28.6,30.0,5.55,3.48,5.39,-.45","46.7,7.36,7.48,6.74,4.62,11.9,1.23,30.6",8,Constant,,8.0,7.707417011,0.2748,KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS11,ACH-000714,Myeloma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8896267414093018
5213,9003,KMS-12-BM,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,18.9,7.80,17.3,10.1,-40,5.03,-9.9","50.3,9.63,44.5,21.0,12.4,17.7,15.5,8.46",8,Constant,,8.0,2.539219856,1.0481,KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS12BM,ACH-000380,Myeloma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.931525945663452
5214,9004,KMS-34,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,-5.6,9.70,12.8,43.4,10.7,11.9,-19","0,0,0,0,0,0,0,0",8,Linear,,8.0,-17.27235603,0.2969,KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KMS34,ACH-000541,Myeloma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.992013931274414
5215,9005,KNS-60,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.39,-1.6,9.47,.79,-7.2,-.97,3.31,-23","14.3,13.2,2.57,1.67,.65,8.35,8.63,4.30",8,Linear,,8.0,-23.23505783,0.161,KNS60_CENTRAL_NERVOUS_SYSTEM,KNS60,ACH-000445,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9173693656921387
5216,9006,KNS-62,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.28,20.5,-2.4,5.25,-7.9,-21,-1.6,23.1","14.6,2.50,33.5,8.66,1.92,2.23,.74,34.6",8,Constant,,8.0,-0.806124747,0.1777,KNS62_LUNG,KNS62,ACH-000858,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7688374519348145
5217,9007,KNS-81,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.46,2.19,-.31,4.18,-16,-.47,2.14,-19","19.3,5.61,11.7,8.81,18.8,1.04,8.39,4.34",8,Constant,,8.0,-1.618371606,0.5309,KNS81_CENTRAL_NERVOUS_SYSTEM,KNS81,ACH-000479,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.938051700592041
5218,9008,KO52,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,17.2,35.2,13.4,-8.6,-.59,-22,-46","13.2,8.84,1.55,6.87,8.59,12.5,5.69,.22",8,Sigmoid,8.034002126,8.0,-45.95769119,0.6706,KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KO52,ACH-000498,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.050894021987915
5219,9009,KP-N-SI9s,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.64,11.5,4.05,14.2,-11,-15,-9.9,-24","6.84,11.6,36.0,7.08,3.34,7.93,20.5,11.0",8,Constant,,8.0,-4.926137447,0.8298,KPNSI9S_AUTONOMIC_GANGLIA,KPNSI9S,ACH-000446,Neuroblastoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8261702060699463
5220,9010,KU812,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.46,11.4,11.8,2.54,.045,11.6,-1.1,-65","10.4,25.8,2.62,5.84,.77,1.78,12.9,8.93",8,Sigmoid,3.984972715,5.065102577,-64.64276886,0.5995,KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,KU812,ACH-000074,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.622374389617984,2.840841293334961
5221,9011,KYM-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","17.2,-18,17.2,5.80,.17,-26,8.90,-5.0","10.6,17.9,1.87,2.10,13.5,12.7,5.53,26.8",8,Constant,,8.0,6.208180428,0.2845,KYM1_SOFT_TISSUE,KYM1,ACH-000607,Rhabdoid,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.508694887161255
5222,9012,KYSE-140,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.52,4.54,10.7,-3.9,-22,-57,-79,-83","11.4,4.22,12.3,20.2,1.16,10.1,2.34,.044",8,Sigmoid,0.435505867,0.617637634,-83.31472778,2.1105,KYSE140_OESOPHAGUS,KYSE140,ACH-000823,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-0.4818533462472569,2.806006908416748
5223,9013,KYSE-150,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,7.69,9.94,.34,-4.7,.86,-32,-52","1.30,4.43,7.95,6.34,2.74,12.5,6.97,8.76",8,Sigmoid,2.182477951,5.205513954,-51.88621902,0.7703,KYSE150_OESOPHAGUS,KYSE150,ACH-000855,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.6497184395553384,2.978440284729004
5224,9014,KYSE-180,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,10.7,2.91,3.51,-21,-25,-63,-73","2.66,4.31,1.87,13.8,3.24,7.17,1.80,1.00",8,Sigmoid,1.048347831,1.630503893,-74.50653839,1.55,KYSE180_OESOPHAGUS,KYSE180,ACH-000693,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.4888891038555486,2.7958128452301025
5225,9015,KYSE-30,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,1.91,-9.1,3.35,-18,-15,-24,-27","7.47,8.11,4.42,7.58,2.33,5.47,5.54,9.43",8,Sigmoid,0.196845695,8.0,-21.82675362,0.9731,KYSE30_OESOPHAGUS,KYSE30,ACH-000777,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0396506786346436
5226,9016,KYSE-510,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","19.0,6.50,18.6,-5.2,-.54,4.76,4.79,-21","14.6,3.42,16.3,4.70,1.86,8.95,8.67,12.7",8,Constant,,8.0,2.456861496,0.3023,KYSE510_OESOPHAGUS,KYSE510,ACH-000824,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8885393142700195
5227,9017,KYSE-520,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.1,11.1,6.35,2.83,-14,-36,-55,-52","12.8,6.72,3.82,8.31,5.19,.74,2.57,3.89",8,Sigmoid,0.399792582,2.151475906,-55.1304245,1.2624,KYSE520_OESOPHAGUS,KYSE520,ACH-000637,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.766154074535229,3.0390751361846924
5228,9018,KYSE-70,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.56,10.7,12.8,.43,-9.6,-28,-46,-74","9.94,8.95,5.65,11.9,5.56,7.72,.96,1.62",8,Sigmoid,3.321890354,2.744313717,-72.84970093,1.3994,KYSE70_OESOPHAGUS,KYSE70,ACH-000784,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.0095310316814203,2.7455267906188965
5229,9019,L3.3,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.0,-6.5,8.31,2.77,-3.2,-18,-38,-62","7.83,23.9,12.6,10.8,12.8,3.02,4.56,1.33",8,Sigmoid,8.0,4.269798279,-62.18257904,1.0717,L33_PANCREAS,L33,ACH-000685,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.45156658467263,2.9328250885009766
5230,9020,L-363,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.64,14.9,5.71,5.42,20.8,24.9,-7.1,-27","20.8,30.4,10.8,25.2,9.65,.71,10.8,22.0",8,Linear,,8.0,-27.55168533,1.0643,L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L363,ACH-000183,Myeloma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9194931983947754
5231,9021,L-428,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.40,2.65,25.9,31.3,-.12,6.24,11.2,-34","6.32,5.18,13.4,12.3,.61,21.2,4.07,11.4",8,Sigmoid,8.154958944,8.0,-34.42297363,0.3904,L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,L428,ACH-000754,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9577319622039795
5232,9022,LCLC-103H,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.09,-3.8,1.02,3.71,1.54,4.05,-5.1,-15","4.09,11.2,11.3,15.6,.85,23.1,11.4,7.10",8,Constant,,8.0,-0.330886483,0.26,LCLC103H_LUNG,LCLC103H,ACH-000627,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7373437881469727
5233,9023,LN-229,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.25,6.63,-5.0,-.97,-9.1,-11,-22,-34","4.18,8.18,1.89,5.29,2.72,3.05,8.29,5.57",8,Sigmoid,8.855284236,8.0,-33.85599136,0.4374,LN229_CENTRAL_NERVOUS_SYSTEM,LN229,ACH-000595,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.804966926574707
5234,9024,LOU-NH91,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.4,2.82,-14,-12,-17,-13,-24,-41","9.07,0,18.6,0,16.4,0,1.89,3.28",8,Sigmoid,8.403948086,8.0,-41.24061584,1.0477,LOUNH91_LUNG,LOUNH91,ACH-000176,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8380813598632812
5235,9025,LOX IMVI,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.55,-.55,5.97,2.96,-.58,.12,-10,-9.6","3.94,.61,1.39,.42,3.71,2.81,3.20,4.14",8,Constant,,8.0,0.875269353,0.09979,LOXIMVI_SKIN,LOXIMVI,ACH-000750,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.6588540077209473
5236,9026,LP-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.8,13.0,44.7,42.5,18.7,8.53,54.8,21.0","35.3,7.54,38.2,44.1,62.7,2.57,12.0,30.4",8,Constant,,8.0,18.66890526,0.0,LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,LP1,ACH-000204,Myeloma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.007711887359619
5237,9027,LS123,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.60,14.6,1.01,.91,-2.6,-9.9,-32,-18","1.50,10.5,9.50,8.02,19.9,11.0,2.29,5.54",8,Sigmoid,0.816784859,8.0,-25.41209602,0.4793,LS123_LARGE_INTESTINE,LS123,ACH-000501,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.989016532897949
5238,9028,LS411N,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.0,3.82,4.07,13.2,-22,6.52,2.12,-32","7.34,2.05,37.1,7.34,9.35,.29,1.49,17.1",8,Constant,,8.0,1.787877083,0.3804,LS411N_LARGE_INTESTINE,LS411N,ACH-000985,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8337490558624268
5239,9029,LS513,Erlotinib,EGFR,".0080,.025,.080,.25,.80,2.53,8","-15,-9.0,-6.1,-9.4,-22,-1.2,-41",".053,29.7,8.97,3.00,22.9,32.1,7.18",7,Constant,,8.0,-13.333004,1.5967,LS513_LARGE_INTESTINE,LS513,ACH-000007,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.1068267822265625
5240,9030,LU99,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.44,-7.0,14.0,1.78,1.30,-15,-23,-66","1.09,3.10,6.85,1.06,3.06,7.38,10.4,3.03",8,Sigmoid,8.740283209,5.644115925,-65.39385986,0.8666,LU99_LUNG,LU99,ACH-000444,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.7306135732906198,2.6232423782348633
5241,9031,LUDLU-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.0,5.44,2.74,-13,-10,-48,-52,-64","18.7,48.1,13.4,9.06,14.2,3.47,9.53,3.34",8,Sigmoid,0.336647272,1.652492166,-63.64346695,1.5519,LUDLU1_LUNG,LUDLU1,ACH-000390,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.5022845520365519,3.0400733947753906
5242,9032,Malme-3M,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.46,7.26,-.56,5.60,13.0,-3.1,-9.0,-27","15.2,7.89,2.59,8.50,0,5.74,1.55,1.27",8,Sigmoid,7.80415535,8.0,-26.98543549,0.2374,MALME3M_SKIN,MALME3M,ACH-000477,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.788905143737793
5243,9033,MCAS,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,7.03,-.40,4.40,-2.7,.84,-13,-14","4.63,6.29,4.35,8.33,4.96,6.62,1.32,7.68",8,Constant,,8.0,-2.618792534,0.05463,MCAS_OVARY,MCAS,ACH-000796,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9447989463806152
5244,9034,MCF7,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-30,56.0,37.2,35.4,-12,24.5,-23,-31","9.30,13.8,5.39,27.2,12.6,24.6,42.4,35.3",8,Linear,,8.0,-34.25540924,0.3573,MCF7_BREAST,MCF7,ACH-000019,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.105771541595459
5245,9035,MDA-MB-157,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.79,4.47,18.0,-4.8,11.2,2.59,4.94,-22","8.71,12.2,3.89,17.8,1.21,19.4,1.56,11.6",8,Constant,,8.0,6.50525856,0.2684,MDAMB157_BREAST,MDAMB157,ACH-000621,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7418081760406494
5246,9036,MDA-MB-175-VII,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.5,22.1,6.58,6.44,-11,-12,-57,-77",".067,7.96,5.65,29.2,9.41,5.72,19.4,11.2",8,Sigmoid,1.857569337,2.391020775,-77.70800018,1.1964,MDAMB175VII_BREAST,MDAMB175VII,ACH-000759,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.8717203772715642,3.2086753845214844
5247,9037,MDA-MB-415,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.33,3.86,-5.5,27.4,3.94,8.22,-5.1,-12","6.85,13.0,17.4,9.37,6.24,1.98,11.9,5.74",8,Constant,,8.0,4.483168602,0.03477,MDAMB415_BREAST,MDAMB415,ACH-000876,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0257503986358643
5248,9038,MDA-MB-436,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,1.97,-17,8.78,-5.0,-8.0,-17,-16","4.55,8.69,5.73,3.66,3.12,5.38,3.71,4.50",8,Constant,,8.0,-8.276685715,0.4275,MDAMB436_BREAST,MDAMB436,ACH-000573,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.925196647644043
5249,9039,MDA-MB-453,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.89,-6.6,16.6,-7.3,-.57,-1.2,-7.7,-25","14.0,7.32,1.33,12.4,1.57,20.9,3.66,6.15",8,Constant,,8.0,-3.528245211,0.1473,MDAMB453_BREAST,MDAMB453,ACH-000910,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.100175619125366
5250,9040,MDA-MB-468,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","17.5,-10.0,16.9,-30,-3.1,-52,-37,-73","18.7,26.0,15.1,5.46,.37,3.55,2.78,6.82",8,Linear,,1.153329258,-70.51806641,1.8648,MDAMB468_BREAST,MDAMB468,ACH-000849,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.14265276686926878,2.994922637939453
5251,9041,MEG-01,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.12,3.50,10.9,-9.4,-2.7,-.80,7.36,-32","2.35,.70,14.4,7.97,27.4,11.8,23.6,5.96",8,Sigmoid,8.772012469,8.0,-31.88332748,0.3546,MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MEG01,ACH-000072,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.757293224334717
5252,9042,MEL-HO,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.7,7.15,14.7,.76,15.1,10.1,4.98,-50","26.8,16.3,13.4,0,16.2,7.28,14.5,60.3",8,Sigmoid,8.067915748,8.0,-10.18223858,0.49,MELHO_SKIN,MELHO,ACH-000450,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.5744454860687256
5253,9043,MES-SA,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.59,9.07,-.96,3.03,-3.6,-4.3,2.52,-6.6","1.43,7.12,4.56,2.18,2.45,2.92,12.4,8.80",8,Constant,,8.0,0.423126101,0.0,MESSA_SOFT_TISSUE,MESSA,ACH-000449,Sarcoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.773655414581299
5254,9044,MeWo,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.7,2.11,-9.1,22.3,16.7,25.4,40.2,4.69","3.19,.14,11.0,2.08,22.5,10.6,7.14,31.9",8,Constant,,8.0,15.62043762,0.002914,MEWO_SKIN,MEWO,ACH-000987,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.626918077468872
5255,9045,MFE-296,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,4.35,3.64,2.82,-11,-11,-32,-47","13.1,1.57,7.30,5.69,3.64,1.65,.89,2.04",8,Sigmoid,3.721626043,8.0,-46.88686371,0.6176,MFE296_ENDOMETRIUM,MFE296,ACH-000879,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.732987403869629
5256,9046,MG-63,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.9,2.12,4.69,4.11,-.58,6.07,5.52,-18","1.52,9.21,4.75,6.85,.56,.22,4.06,.67",8,Sigmoid,6.081908703,8.0,-18.36063004,0.1603,MG63_BONE,MG63,ACH-000359,Bone Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.762698173522949
5257,9047,Mino,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","17.3,18.2,28.1,6.84,20.1,1.39,-42,-87","13.3,.22,33.5,19.9,18.7,31.1,2.89,.13",8,Sigmoid,2.392301083,2.840651989,-87.00595093,1.1327,MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MINO,ACH-000220,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.0440335994166794,3.034724712371826
5258,9048,MJ,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.45,30.8,29.7,34.0,2.20,26.4,5.10,25.2","5.05,15.1,25.2,10.5,12.6,11.1,16.2,19.1",8,Constant,,8.0,17.44677544,0.007088,MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MJ,ACH-000077,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.745710849761963
5259,9049,MKN-45,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.0,-5.9,9.36,6.76,5.70,.90,-10,-18","22.4,13.3,1.23,18.9,14.0,3.95,15.2,13.8",8,Constant,,8.0,-0.816318393,0.18,MKN45_STOMACH,MKN45,ACH-000356,Gastric Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0556890964508057
5260,9050,MKN7,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","27.1,7.57,14.3,1.46,6.94,-7.7,8.47,-29","26.0,11.7,41.1,6.71,29.0,10.2,14.5,3.35",8,Constant,,8.0,-0.601129472,0.3438,MKN7_STOMACH,MKN7,ACH-000678,Gastric Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.964968204498291
5261,9051,MKN74,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.1,.035,-2.7,14.9,-4.6,-5.5,-7.3,-30","13.2,4.87,9.91,4.75,20.8,6.17,4.63,6.17",8,Sigmoid,8.617574259,8.0,-29.19649696,0.3761,MKN74_STOMACH,MKN74,ACH-000758,Gastric Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.861786365509033
5262,9052,MOLP-8,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","56.1,32.7,48.1,33.5,43.6,5.74,20.7,-25","78.3,26.4,2.27,3.95,84.7,25.1,49.7,2.88",8,Constant,,8.0,26.67569542,0.3782,MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLP8,ACH-000745,Myeloma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9518356323242188
5263,9053,MOLT-16,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","24.7,14.7,-15,-2.2,9.28,.50,-22,-19","27.9,35.4,11.6,23.2,3.22,26.2,.70,5.27",8,Constant,,8.0,-8.178717613,1.5452,MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MOLT16,ACH-000918,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.6596648693084717
5264,9054,MONO-MAC-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.34,34.7,-14,19.4,16.0,-5.8,-47,-78","9.49,19.6,3.02,12.1,6.72,1.56,6.14,1.31",8,Sigmoid,1.854851007,2.667337894,-78.23864746,2.0672,MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,MONOMAC1,ACH-001129,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.9810809315880162,3.0088632106781006
5265,9055,MOR/CPR,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.61,-13,2.33,2.81,-12,-7.1,-4.8,-17","2.42,21.5,.53,12.7,6.18,4.69,18.2,5.87",8,Constant,,8.0,-4.80092001,0.2041,MORCPR_LUNG,MORCPR,ACH-000851,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.850381851196289
5266,9056,MSTO-211H,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.13,-2.0,2.25,-14,2.13,-4.2,-18,-21","16.1,4.58,19.7,1.49,5.04,3.31,5.71,9.83",8,Constant,,8.0,-8.648255348,0.3184,MSTO211H_PLEURA,MSTO211H,ACH-000335,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8223586082458496
5267,9057,NCI-H1048,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".10,13.9,11.3,4.56,-6.3,13.1,-8.0,-27","34.7,6.31,37.0,28.9,6.00,10.3,9.26,32.5",8,Constant,,8.0,-2.104015589,0.662,NCIH1048_LUNG,NCIH1048,ACH-000866,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0103487968444824
5268,9058,NCI-H1092,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.7,16.3,33.6,23.7,-17,14.4,7.76,19.8","1.20,1.81,45.9,17.0,2.58,16.5,9.91,38.5",8,Constant,,8.0,14.14727783,0.06946,NCIH1092_LUNG,NCIH1092,ACH-000514,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.3067965507507324
5269,9059,NCI-H1155,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.32,2.31,8.93,15.9,5.92,13.7,-29,-36",".61,36.4,29.8,18.9,9.26,7.39,14.3,9.61",8,Sigmoid,1.82881856,8.0,-35.96055984,0.6025,NCIH1155_LUNG,NCIH1155,ACH-000980,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.897247314453125
5270,9060,NCI-H1184,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","60.9,38.1,38.8,45.4,105,82.8,-47,-9.3","13.1,53.4,45.9,26.0,50.7,67.6,16.6,30.3",8,Constant,,8.0,44.99138641,0.67,NCIH1184_LUNG,NCIH1184,ACH-000523,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.2658867835998535
5271,9061,NCI-H1341,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","24.7,26.9,.62,19.3,-5.8,-21,-26,-38","34.4,23.7,28.8,25.4,22.2,.90,13.0,35.9",8,Linear,,8.0,-37.31576538,1.1779,NCIH1341_LUNG,NCIH1341,ACH-000129,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.825389862060547
5272,9062,NCI-H1373,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.2,13.7,-11,-8.9,-4.3,4.93,-23,-22","2.99,12.0,5.45,11.6,11.0,5.20,13.2,4.38",8,Constant,,8.0,-5.396407127,0.2836,NCIH1373_LUNG,NCIH1373,ACH-000845,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.1175715923309326
5273,9063,NCI-H1568,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.26,6.12,-16,-8.0,-24,-19,-48,-53","11.4,3.32,2.58,1.21,1.89,5.74,7.03,2.27",8,Sigmoid,8.474329607,5.748595715,-54.209095,1.6905,NCIH1568_LUNG,NCIH1568,ACH-000869,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.748955601503588,2.9910337924957275
5274,9064,NCI-H1648,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.7,5.63,34.4,25.7,5.21,-18,-28,-33","2.75,11.7,9.40,14.1,.77,2.08,11.3,19.7",8,Sigmoid,0.522349596,8.0,-30.90703392,0.6008,NCIH1648_LUNG,NCIH1648,ACH-000766,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9397640228271484
5275,9065,NCI-H1650,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.1,11.0,-9.8,-21,-30,-33,-41,-42","18.5,17.7,12.2,4.81,3.99,11.7,2.09,3.07",8,Sigmoid,0.064510889,8.0,-42.25717163,1.3557,NCIH1650_LUNG,NCIH1650,ACH-000035,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.069700241088867
5276,9066,NCI-H1651,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.17,.33,13.0,-3.7,5.93,-7.9,-9.8,-36","1.47,9.70,11.0,5.43,14.2,15.6,4.22,5.33",8,Sigmoid,9.119662689,8.0,-35.42674255,0.2825,NCIH1651_LUNG,NCIH1651,ACH-000893,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.058488368988037
5277,9067,NCI-H1792,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".41,3.57,5.06,5.28,-2.4,-2.5,-12,-20","3.92,2.39,2.86,15.3,7.28,1.06,4.91,.99",8,Sigmoid,2.615903139,8.0,-20.43450165,0.2512,NCIH1792_LUNG,NCIH1792,ACH-000496,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0006847381591797
5278,9068,NCI-H1793,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.02,13.4,-7.0,-5.7,-7.7,-38,-33,-37","21.5,2.87,11.5,2.58,.44,3.92,14.6,7.47",8,Sigmoid,0.330665171,8.0,-36.8098259,0.4024,NCIH1793_LUNG,NCIH1793,ACH-000888,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0049476623535156
5279,9069,NCI-H1915,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.09,22.2,-7.1,-3.3,-11,-3.7,-9.8,-38","11.7,8.11,6.24,9.68,8.05,1.34,5.18,13.0",8,Sigmoid,8.861013452,8.0,-33.73491287,0.4244,NCIH1915_LUNG,NCIH1915,ACH-000434,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.866760492324829
5280,9070,NCI-H1944,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.9,6.25,5.57,14.0,-16,-8.8,-35,-46","3.09,12.5,6.33,16.2,13.1,3.95,6.78,6.54",8,Sigmoid,1.561166406,8.0,-46.7185936,0.3705,NCIH1944_LUNG,NCIH1944,ACH-000414,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.851313352584839
5281,9071,NCI-H1975,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.4,-5.3,10.6,-12,8.38,-17,-6.3,-46","3.67,6.11,.48,6.49,1.17,1.11,6.09,6.10",8,Sigmoid,8.819179207,8.0,-44.45196533,0.4621,NCIH1975_LUNG,NCIH1975,ACH-000587,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.009584426879883
5282,9072,NCI-H2009,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".037,-1.3,-5.9,1.21,3.47,-15,-26,-30",".86,8.97,13.0,8.75,1.34,2.88,27.0,4.86",8,Sigmoid,0.833611012,8.0,-33.84302521,0.6598,NCIH2009_LUNG,NCIH2009,ACH-000886,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9213781356811523
5283,9073,NCI-H2023,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.4,19.4,11.3,19.3,10.3,2.84,-2.9,-22","29.4,3.09,2.30,16.5,19.0,13.6,8.07,15.3",8,Sigmoid,8.328229462,8.0,-21.09889412,0.1764,NCIH2023_LUNG,NCIH2023,ACH-000781,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.972341537475586
5284,9074,NCI-H2030,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.14,6.35,.034,-5.7,-17,-21,-37,-55",".64,9.56,3.98,3.16,.32,2.27,11.8,4.68",8,Sigmoid,8.493114644,6.153043747,-54.41020203,1.2982,NCIH2030_LUNG,NCIH2030,ACH-000521,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.8169468775981847,2.933368444442749
5285,9075,NCI-H2052,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.6,-5.6,5.81,-11,5.06,-24,-13,-37","18.1,28.0,9.60,18.6,12.9,8.75,12.0,4.94",8,Constant,,8.0,-4.099585056,0.9973,NCIH2052_PLEURA,NCIH2052,ACH-000153,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.1438374519348145
5286,9076,NCI-H2085,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-4.2,15.7,10.3,8.90,-.76,1.32,-28,-19","13.1,5.59,42.7,18.6,26.6,16.6,16.1,1.68",8,Constant,,8.0,-6.610373497,0.4553,NCIH2085_LUNG,NCIH2085,ACH-000451,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.077040672302246
5287,9077,NCI-H2087,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,2.33,-.16,6.84,-13,-7.8,-21,-33","2.60,6.55,10.3,3.67,6.09,3.06,5.20,1.82",8,Sigmoid,3.592051744,8.0,-32.86921692,0.4709,NCIH2087_LUNG,NCIH2087,ACH-000841,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0794713497161865
5288,9078,NCI-H211,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.7,10.5,7.26,11.9,6.35,18.2,-9.8,9.14","3.45,15.6,2.47,3.12,2.93,17.2,.94,7.54",8,Constant,,8.0,2.23273325,0.1121,NCIH211_LUNG,NCIH211,ACH-000639,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0830891132354736
5289,9079,NCI-H2122,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","24.1,6.98,16.1,5.16,21.8,-22,-22,-66","19.7,14.1,26.1,.52,11.2,6.94,21.1,9.87",8,Sigmoid,8.359945088,5.234381199,-64.62232208,0.8959,NCIH2122_LUNG,NCIH2122,ACH-000311,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.6552486327512606,2.6965672969818115
5290,9080,NCI-H2170,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.61,-.16,27.6,12.1,-14,-28,-60,-84","11.0,8.38,15.7,9.31,7.45,29.0,10.8,8.37",8,Sigmoid,1.180775642,1.564355135,-82.49170685,2.0307,NCIH2170_LUNG,NCIH2170,ACH-000481,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.4474736847613111,3.017421007156372
5291,9081,NCI-H2172,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","32.7,-21,18.1,-39,12.0,-33,13.4,-36","60.6,29.2,54.4,11.1,66.9,19.3,22.7,9.33",8,Constant,,8.0,-19.36130714,0.198,NCIH2172_LUNG,NCIH2172,ACH-000924,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0079574584960938
5292,9082,NCI-H2228,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.14,-.055,10.7,.73,-4.5,-23,-26,-46","7.14,20.2,11.5,12.2,7.03,11.7,.63,12.2",8,Sigmoid,2.568438292,8.0,-44.19145966,0.8593,NCIH2228_LUNG,NCIH2228,ACH-000447,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.853627920150757
5293,9083,NCI-H2286,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,7.34,10.6,7.72,-7.0,-9.6,-27,-59","3.45,18.5,7.43,1.69,7.45,3.50,2.27,3.88",8,Sigmoid,8.12688574,6.048270702,-58.48260498,1.2231,NCIH2286_LUNG,NCIH2286,ACH-000912,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.7997723968041524,2.8254177570343018
5294,9084,NCI-H23,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.09,15.0,8.97,11.3,7.07,-4.1,-3.2,-3.7",".72,9.28,11.9,8.86,2.28,2.57,3.73,10.1",8,Constant,,8.0,5.463197708,0.0,NCIH23_LUNG,NCIH23,ACH-000900,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8965439796447754
5295,9085,NCI-H2444,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.97,11.9,4.97,-4.0,-4.9,-2.2,-20,-34","13.7,14.4,9.46,2.15,3.73,14.3,1.87,15.9",8,Sigmoid,9.085799512,8.0,-33.21539307,0.4111,NCIH2444_LUNG,NCIH2444,ACH-000186,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9236321449279785
5296,9086,NCI-H2452,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.9,-12,5.98,1.37,-.91,-36,3.01,-46","15.6,2.91,4.79,3.61,2.67,9.66,4.35,5.71",8,Constant,,8.0,-0.467184961,0.7658,NCIH2452_PLEURA,NCIH2452,ACH-000092,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9457755088806152
5297,9087,NCI-H28,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".34,6.85,-16,-11,-40,-43,-58,-52","4.12,.58,3.21,20.7,2.34,6.60,3.83,3.58",8,Sigmoid,0.068333998,1.191120028,-54.15839386,1.7382,NCIH28_PLEURA,NCIH28,ACH-000648,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.17489406447244504,2.8159220218658447
5298,9088,NCI-H322,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.24,2.04,.46,-6.7,-22,-66,-76,-86","5.78,3.09,4.89,6.13,2.34,9.81,.23,6.07",8,Sigmoid,0.483234793,0.644645035,-84.20258331,1.9746,NCIH322_LUNG,NCIH322,ACH-000837,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-0.4390554470086689,3.033669948577881
5299,9089,NCI-H3255,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,-6.0,-18,-52,-85,-90,-94,-96","12.7,7.57,7.33,2.95,1.35,4.98,2.39,1.80",8,Sigmoid,0.074169464,0.075178206,-94.33956909,4.0635,NCIH3255_LUNG,NCIH3255,ACH-000109,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-2.587893903860274,2.968289375305176
5300,9090,NCI-H358,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.49,.68,-1.8,-1.1,-11,-31,-53,-68","5.58,13.1,12.5,9.16,7.30,2.12,2.17,3.53",8,Sigmoid,1.096916676,2.132719517,-67.59581757,1.6179,NCIH358_LUNG,NCIH358,ACH-000860,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.7573979338900824,3.140327215194702
5301,9091,NCI-H441,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.5,1.35,20.6,9.63,13.5,-.46,-10,-29","17.7,.43,7.34,5.11,8.21,1.76,6.97,1.92",8,Sigmoid,3.365048885,8.0,-28.69470215,0.3066,NCIH441_LUNG,NCIH441,ACH-000638,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.860123872756958
5302,9092,NCI-H460,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".052,.18,8.84,.73,7.74,-5.0,-2.6,-6.4","3.51,1.25,4.97,7.09,2.83,10.8,3.32,3.01",8,Constant,,8.0,0.288564861,0.06994,NCIH460_LUNG,NCIH460,ACH-000463,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.773738384246826
5303,9093,NCI-H522,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","21.2,12.8,7.18,-.93,1.61,.13,-12,-31","24.5,13.6,9.48,15.9,31.0,3.92,1.32,13.1",8,Sigmoid,9.156580894,8.0,-27.68039894,0.4055,NCIH522_LUNG,NCIH522,ACH-000343,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0854387283325195
5304,9094,NCI-H647,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.9,7.90,8.02,-7.0,-2.8,-8.3,11.4,-19","6.92,14.6,32.1,10.5,21.7,9.16,9.64,7.22",8,Constant,,8.0,-0.878604352,0.2912,NCIH647_LUNG,NCIH647,ACH-000378,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8678765296936035
5305,9095,NCI-H650,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".65,.079,7.39,12.4,12.5,9.57,4.29,-15","5.72,3.26,6.15,3.05,2.44,6.26,1.58,5.09",8,Sigmoid,3.635783911,8.0,-14.86487103,0.04207,NCIH650_LUNG,NCIH650,ACH-000945,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8207826614379883
5306,9096,NCI-H661,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.0,-9.0,7.30,-4.4,-3.3,-2.2,1.44,-9.2","7.91,1.30,3.39,3.41,9.01,12.5,8.75,4.08",8,Constant,,8.0,-6.693270206,0.09786,NCIH661_LUNG,NCIH661,ACH-000853,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8279614448547363
5307,9097,NCI-H727,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-14,5.71,4.28,-8.0,.43,13.9,-4.4,-9.3","8.56,18.3,29.8,37.1,15.3,24.3,17.1,5.77",8,Constant,,8.0,-3.71881938,0.3191,NCIH727_LUNG,NCIH727,ACH-000775,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.187652111053467
5308,9098,NCI-H747,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.7,.68,5.81,-4.5,7.66,-26,-16,-40","27.1,.93,23.0,3.16,7.77,6.38,.24,10.6",8,Sigmoid,0.52594614,8.0,-27.36982727,0.8585,NCIH747_LARGE_INTESTINE,NCIH747,ACH-000403,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.090721607208252
5309,9099,NCI-H810,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.21,4.30,-14,10.2,-11,6.57,.20,2.49","15.9,10.8,1.62,2.07,2.20,21.9,11.5,9.41",8,Constant,,8.0,5.218783855,0.1621,NCIH810_LUNG,NCIH810,ACH-000789,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.089339256286621
5310,9100,NCI-N87,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.0,7.82,-3.1,-10,3.32,26.1,-34,-62","2.08,2.92,43.5,6.70,4.97,18.9,10.9,6.40",8,Sigmoid,2.399151325,3.197930098,-62.45911407,0.9619,NCIN87_STOMACH,NCIN87,ACH-000427,Gastric Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.1625037561365994,2.994410514831543
5311,9101,NCO2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","21.9,4.25,-2.3,-15,-16,7.92,-48,-55","19.6,2.50,10.9,22.8,20.0,2.36,8.48,10.9",8,Sigmoid,1.805310369,2.788766623,-56.00983429,1.5548,NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,NCO2,ACH-000076,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.0255994274819364,2.8063411712646484
5312,9102,NIH:OVCAR-3,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.91,27.2,-3.8,16.1,-14,-28,-39,-44","7.41,36.6,.086,15.2,20.1,26.2,24.0,3.67",8,Linear,,8.0,-44.66892624,1.1932,NIHOVCAR3_OVARY,NIHOVCAR3,ACH-000001,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.843409538269043
5313,9103,NUGC-3,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.57,-5.4,-11,6.83,-18,-53,-57,-68","7.97,7.40,23.3,23.9,7.75,8.83,7.50,7.32",8,Sigmoid,0.398794264,0.738386512,-64.20761871,1.82,NUGC3_STOMACH,NUGC3,ACH-000911,Gastric Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-0.3032878624825397,2.8617115020751953
5314,9104,NUGC-4,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.1,20.0,-4.9,-13,-48,-68,-78,-77","4.43,14.4,7.33,12.7,9.85,2.81,1.41,1.70",8,Sigmoid,0.121240623,0.258506,-79.0364151,2.6443,NUGC4_STOMACH,NUGC4,ACH-000674,Gastric Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-1.3528363744712988,3.2712669372558594
5315,9105,OCI-AML2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.4,.25,1.78,5.63,-1.3,-6.6,-8.4,-9.4","7.05,.24,6.59,2.73,2.14,3.20,7.64,2.02",8,Constant,,8.0,-2.656908035,0.02743,OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML2,ACH-000113,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7004518508911133
5316,9106,OCI-AML5,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.56,6.81,14.0,8.27,8.29,-3.4,-15,-23","4.30,6.09,5.09,7.01,9.94,3.90,20.9,15.4",8,Sigmoid,0.912682712,8.0,-22.39680672,1.2901,OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OCIAML5,ACH-000065,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.649745464324951
5317,9107,OCUM-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.95,-4.3,15.4,7.45,1.33,-3.5,4.28,3.04","7.97,9.48,20.9,4.38,2.82,9.43,1.13,28.0",8,Constant,,8.0,2.981343269,0.01577,OCUM1_STOMACH,OCUM1,ACH-000247,Gastric Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.936490297317505
5318,9108,OE21,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.67,-1.9,-14,-29,-21,-66,-75,-78","16.2,17.2,.43,3.85,13.1,2.93,1.47,5.73",8,Sigmoid,0.186184317,0.270831227,-78.42411804,2.3549,OE21_OESOPHAGUS,OE21,ACH-000544,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-1.3062594307073663,2.7531394958496094
5319,9109,OE33,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.2,9.84,5.86,-2.4,5.68,-16,-28,-56","12.6,6.07,5.82,7.58,2.27,1.08,9.80,.21",8,Sigmoid,8.63796029,6.558083057,-55.61484909,0.842,OE33_OESOPHAGUS,OE33,ACH-000383,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.8806983433315823,3.121438980102539
5320,9110,ONCO-DG-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.61,-3.7,8.36,-4.2,-7.2,-34,-26,-51","3.61,8.18,5.71,3.30,3.12,17.9,4.22,1.86",8,Sigmoid,8.295159059,7.971845627,-50.06347656,1.0886,ONCODG1_OVARY,ONCODG1,ACH-000013,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0759160377626547,2.9555020332336426
5321,9111,ONS-76,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.69,3.68,1.08,8.57,-7.7,-.061,-9.5,-.90","0,0,0,0,0,0,0,0",8,Constant,,8.0,0.510847032,0.06366,ONS76_CENTRAL_NERVOUS_SYSTEM,ONS76,ACH-000776,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9904069900512695
5322,9112,OPM-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","25.1,22.4,-21,18.0,-2.8,-3.1,-38,-17","27.8,.45,22.0,39.8,13.3,10.3,16.1,5.19",8,Constant,,8.0,-7.509171009,0.8885,OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,OPM2,ACH-000024,Myeloma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.967216730117798
5323,9113,OV-90,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.57,21.2,-7.3,19.4,13.8,8.75,13.7,7.17","17.8,3.50,7.13,0,19.0,0,0,1.41",8,Constant,,8.0,8.749404907,0.0,OV90_OVARY,OV90,ACH-000291,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7828097343444824
5324,9114,OVCAR-4,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,-5.7,-3.0,-11,-.46,-23,2.74,-27","6.75,7.95,4.14,.11,18.2,7.19,7.94,.22",8,Constant,,8.0,-10.78780365,0.3913,OVCAR4_OVARY,OVCAR4,ACH-000617,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9792590141296387
5325,9115,OVCAR-8,Erlotinib,EGFR,".0080,.025,.080,.25,.80,2.53,8","-6.2,15.5,-11,10.6,-1.8,.80,-41","1.28,8.99,2.61,18.0,10.1,26.9,2.29",7,Sigmoid,8.05631073,8.0,-40.58952713,0.532,OVCAR8_OVARY,OVCAR8,ACH-000696,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.987973213195801
5326,9116,OVMANA,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.43,12.2,8.01,15.0,3.44,6.05,-9.7,-13","12.9,3.08,5.61,14.5,11.8,6.81,11.3,8.25",8,Sigmoid,1.4950701,8.0,-12.85731602,0.03859,OVMANA_OVARY,OVMANA,ACH-000646,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.658750534057617
5327,9117,OVSAHO,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.3,10.6,13.3,10.7,-3.0,2.86,-7.9,-23","14.8,23.1,9.59,12.5,17.6,2.06,11.4,5.86",8,Sigmoid,6.135296345,8.0,-22.47266769,0.1429,OVSAHO_OVARY,OVSAHO,ACH-000409,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.137988567352295
5328,9118,OVTOKO,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.51,-2.4,12.1,-.50,-7.9,-23,-21,-46",".69,6.68,.39,8.93,9.07,3.91,4.50,1.72",8,Sigmoid,8.226384622,8.0,-44.21923828,0.8693,OVTOKO_OVARY,OVTOKO,ACH-000663,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7822039127349854
5329,9119,P12-ICHIKAWA,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.38,3.02,30.7,12.7,3.89,-10,-8.8,-38","10.4,10.8,7.70,4.77,17.8,6.81,13.7,5.21",8,Sigmoid,8.210423533,8.0,-36.84268188,0.7472,P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P12ICHIKAWA,ACH-000372,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.711595296859741
5330,9120,P31/FUJ,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.36,-5.6,.72,-9.5,19.0,-3.7,11.9,-28","8.28,26.0,8.82,.39,19.5,9.51,15.9,9.36",8,Constant,,8.0,1.996513724,0.8033,P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P31FUJ,ACH-000770,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.982055902481079
5331,9121,P3HR-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.0,17.2,16.5,1.29,6.52,3.85,6.77,1.25","13.7,6.66,8.07,14.5,2.45,3.42,6.44,2.78",8,Constant,,8.0,7.142673492,0.0,P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,P3HR1,ACH-000707,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.058745861053467
5332,9122,Panc 02.03,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.22,11.3,.15,3.26,-6.9,-14,-53,-44","1.08,1.53,8.56,2.42,4.72,5.55,1.78,9.55",8,Sigmoid,0.91822058,4.219331264,-50.0255127,1.0194,PANC0203_PANCREAS,PANC0203,ACH-000042,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.4396766472440556,2.9309380054473877
5333,9123,Panc 03.27,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.32,5.21,2.25,10.6,-3.4,-19,-10,-35","26.5,9.91,4.33,11.0,1.75,3.47,2.50,15.9",8,Sigmoid,8.118757178,8.0,-30.58411598,0.4879,PANC0327_PANCREAS,PANC0327,ACH-000139,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.031649589538574
5334,9124,Panc 04.03,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,-13,-8.6,8.73,-7.3,-15,-32,-50","9.00,11.8,13.6,3.52,19.1,10.8,8.02,12.6",8,Sigmoid,2.259186983,8.0,-49.48947144,0.494,PANC0403_PANCREAS,PANC0403,ACH-000235,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.240424633026123
5335,9125,Panc 10.05,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,7.89,27.2,-17,1.73,-7.0,-20,-24","3.81,13.0,31.5,29.2,3.25,10.8,19.2,16.0",8,Constant,,8.0,-0.612631142,0.5347,PANC1005_PANCREAS,PANC1005,ACH-000060,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.116103172302246
5336,9126,PA-TU-8902,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.68,3.27,5.94,3.63,-1.6,1.46,-1.5,-19","3.53,4.51,2.28,5.03,.16,.76,1.71,3.43",8,Sigmoid,8.633975803,8.0,-19.22405052,0.0789,PATU8902_PANCREAS,PATU8902,ACH-000599,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8227005004882812
5337,9127,PC-3,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.25,.23,5.55,-4.1,-1.9,-9.8,-11,-27","14.3,9.66,2.30,9.42,21.6,11.8,8.06,10.6",8,Sigmoid,8.28279928,8.0,-24.98353767,0.5852,PC3_PROSTATE,PC3,ACH-000090,Prostate Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0952231884002686
5338,9128,Pfeiffer,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.5,21.8,-9.9,-8.2,-24,-1.1,-36,-50","5.74,19.9,26.0,4.23,7.03,6.19,20.4,5.66",8,Linear,,6.251271889,-51.41848755,1.171,PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,PFEIFFER,ACH-000140,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.8327849452845382,2.51649808883667
5339,9129,PK-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.72,2.19,-3.8,-5.5,-3.0,-12,-25,-46","3.93,.55,7.25,2.09,6.41,1.25,3.85,1.23",8,Sigmoid,8.950259785,8.0,-45.75131989,0.5614,PK1_PANCREAS,PK1,ACH-000307,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0507779121398926
5340,9130,PK-45H,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.55,9.50,8.39,10.5,-7.1,-2.4,-18,-16","2.12,1.74,8.67,12.3,1.86,9.90,7.47,6.71",8,Sigmoid,0.253063887,8.0,-16.27216721,0.3102,PK45H_PANCREAS,PK45H,ACH-000468,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0161311626434326
5341,9131,PK-59,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.70,4.51,7.27,2.48,-.52,-1.1,-15,-24","3.11,4.01,4.02,.96,1.64,7.17,2.82,4.41",8,Sigmoid,2.529034138,8.0,-23.95049858,0.2714,PK59_PANCREAS,PK59,ACH-000205,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.068340301513672
5342,9132,PLC/PRF/5,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.4,9.10,6.13,1.02,-6.3,-15,-27,-29","8.54,1.53,1.75,3.47,17.3,5.38,.28,10.3",8,Sigmoid,0.706856847,8.0,-32.87755585,0.3737,PLCPRF5_LIVER,PLCPRF5,ACH-001318,Liver Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.5822713375091553
5343,9133,PSN1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.5,-.65,.56,10.2,-4.3,.71,-16,-17","6.11,2.00,3.88,10.1,4.72,18.7,7.71,9.91",8,Constant,,8.0,-2.002505302,0.2199,PSN1_PANCREAS,PSN1,ACH-000320,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8310604095458984
5344,9134,QGP-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","9.12,-12,-8.2,25.2,.54,.83,-30,-24","5.95,4.89,13.1,4.90,9.27,21.7,6.25,2.91",8,Sigmoid,1.22161305,8.0,-27.55322647,0.7446,QGP1_PANCREAS,QGP1,ACH-000347,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.1946144104003906
5345,9135,Raji,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","15.5,-12,38.7,-11,27.1,-4.1,48.7,-15","16.2,2.02,7.12,5.28,7.90,17.1,.051,8.92",8,Constant,,8.0,5.978127956,0.218,RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RAJI,ACH-000654,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.858980655670166
5346,9136,RD,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.2,-4.5,4.36,5.25,-.79,-3.5,1.02,-6.8","10.5,7.39,7.88,5.57,11.3,.21,2.77,10.7",8,Constant,,8.0,0.354377031,0.1262,RD_SOFT_TISSUE,RD,ACH-000169,Sarcoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.010586738586426
5347,9137,Reh,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.7,-1.2,11.1,1.46,21.4,-5.7,4.06,-21","13.1,6.32,3.22,10.6,3.53,4.54,13.3,9.81",8,Constant,,8.0,4.517585754,0.1718,REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,REH,ACH-000960,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.6797990798950195
5348,9138,RERF-GC-1B,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.74,-12,18.7,17.2,-7.5,-17,-21,-32","4.53,8.23,14.9,5.03,18.9,3.11,.76,7.34",8,Sigmoid,0.505811334,8.0,-27.13772392,0.4351,RERFGC1B_STOMACH,RERFGC1B,ACH-000144,Gastric Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0475950241088867
5349,9139,RERF-LC-AI,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.9,1.68,-6.0,-1.3,-1.1,-2.5,-11,-27","2.31,2.84,6.22,3.84,6.82,4.58,4.34,5.00",8,Sigmoid,3.556686878,8.0,-26.91756821,0.2999,RERFLCAI_LUNG,RERFLCAI,ACH-000261,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8836560249328613
5350,9140,RERF-LC-MS,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.15,15.3,8.65,10.1,5.60,-3.2,10.2,12.6","11.5,19.8,10.2,7.38,4.31,4.55,13.9,3.42",8,Constant,,8.0,6.808954716,0.0,RERFLCMS_LUNG,RERFLCMS,ACH-000062,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.664777994155884
5351,9141,RKO,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.65,2.17,9.15,9.90,15.2,9.00,8.04,-14","1.46,2.69,2.32,4.28,1.26,10.0,.85,4.63",8,Sigmoid,5.934838295,8.0,-14.04634285,0.06025,RKO_LARGE_INTESTINE,RKO,ACH-000943,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7906768321990967
5352,9142,RL95-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","22.2,1.20,3.71,-16,-26,-32,-46,-68","8.94,10.5,2.94,5.13,5.45,10.4,5.20,6.38",8,Sigmoid,8.115574905,3.060330629,-63.50956726,1.5385,RL952_ENDOMETRIUM,RL952,ACH-000965,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.1185229588202603,2.9543089866638184
5353,9143,RPMI-7951,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.7,2.01,-3.6,20.2,-8.3,11.1,-14,2.23","8.61,7.01,1.69,11.1,10.5,10.4,2.15,6.27",8,Constant,,8.0,-1.604552865,0.172,RPMI7951_SKIN,RPMI7951,ACH-000348,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9647159576416016
5354,9144,RPMI-8402,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.0,.15,16.3,24.1,3.76,.82,-1.6,-38","21.0,2.32,8.43,1.60,28.6,9.97,3.09,1.46",8,Sigmoid,8.316598655,8.0,-37.57675171,0.6156,RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,RPMI8402,ACH-000636,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.68845796585083
5355,9145,RT-112,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-11,-5.3,-2.4,-.42,1.46,-7.3,-24,-18","9.98,0,10.7,6.76,.79,10.4,0,.34",8,Constant,,8.0,-5.126831532,0.3784,RT112_URINARY_TRACT,RT112,ACH-000473,Bladder Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8403444290161133
5356,9146,RT4,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.67,7.56,2.72,2.52,-43,-13,-36,-52","28.5,.59,9.68,2.67,13.1,41.6,36.1,8.28",8,Sigmoid,0.168995082,8.0,-49.82910156,1.6683,RT4_URINARY_TRACT,RT4,ACH-000242,Bladder Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9762542247772217
5357,9147,RVH-421,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.85,3.36,5.24,-3.0,-4.0,1.82,-2.5,-3.9","8.21,.75,.74,.042,4.27,17.6,9.00,4.62",8,Constant,,8.0,0.272412479,0.05907,RVH421_SKIN,RVH421,ACH-000614,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.787132740020752
5358,9148,SBC-5,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".84,3.51,2.90,5.14,-3.8,1.16,.77,-12","4.15,12.4,5.69,6.65,5.53,7.36,8.40,.90",8,Constant,,8.0,-0.491069943,0.1555,SBC5_LUNG,SBC5,ACH-000670,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.651118040084839
5359,9149,SCaBER,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-16,4.62,-1.5,-4.3,-21,-52,-67,-71","6.95,3.69,2.14,1.00,11.5,1.36,.074,.058",8,Sigmoid,0.403848857,0.734280467,-71.03683472,2.0435,SCABER_URINARY_TRACT,SCABER,ACH-000839,Bladder Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-0.3088642157227225,3.0340466499328613
5360,9150,SCC-9,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.9,-16,19.1,4.60,-22,-27,-66,-74","13.4,9.91,10.9,23.6,18.0,14.3,.45,3.50",8,Sigmoid,0.934977889,1.494333386,-76.13653564,2.1038,SCC9_UPPER_AERODIGESTIVE_TRACT,SCC9,ACH-000181,Head and Neck Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.4016802117494483,2.7345333099365234
5361,9151,SF126,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.19,6.99,2.11,-.091,7.69,5.53,.099,-8.6","2.85,5.83,1.37,4.51,4.84,1.67,6.09,3.49",8,Constant,,8.0,3.058148623,0.07066,SF126_CENTRAL_NERVOUS_SYSTEM,SF126,ACH-000609,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.833620071411133
5362,9152,SF-295,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.34,-17,6.57,-15,4.62,-11,-.70,-14","2.01,10.6,9.09,7.16,8.05,5.28,.87,15.3",8,Constant,,8.0,-2.515156269,0.1438,SF295_CENTRAL_NERVOUS_SYSTEM,SF295,ACH-000376,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7643511295318604
5363,9153,SH-10-TC,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.1,-2.0,-5.0,1.25,-4.5,5.73,-9.8,-22","11.4,5.10,7.63,11.3,16.1,3.43,6.83,5.75",8,Constant,,8.0,-5.32046175,0.1529,SH10TC_STOMACH,SH10TC,ACH-000764,Gastric Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.827714204788208
5364,9154,SHP-77,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-10,25.5,-3.1,.032,.57,25.2,-7.3,-2.7","8.66,1.92,9.39,11.0,24.5,9.52,12.4,23.7",8,Constant,,8.0,2.088600636,0.2221,SHP77_LUNG,SHP77,ACH-000790,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.934903860092163
5365,9155,SIG-M5,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","23.8,45.4,13.0,29.4,-24,-11,-43,-52","37.3,11.7,14.4,1.51,7.19,13.0,21.0,1.66",8,Linear,,5.476659923,-53.75166321,1.9143,SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SIGM5,ACH-000112,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.7004954120352085,2.5926411151885986
5366,9156,SIMA,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","24.9,31.0,41.4,55.9,.46,3.66,41.5,-11","1.47,5.85,.79,1.29,22.8,33.0,17.1,54.2",8,Constant,,8.0,26.48429298,0.1907,SIMA_AUTONOMIC_GANGLIA,SIMA,ACH-000099,Neuroblastoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7287988662719727
5367,9157,SJSA-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.0,-8.2,7.98,-5.7,-.79,-8.6,-5.8,-21","22.1,16.7,22.5,.90,.0096,15.6,10.7,11.4",8,Constant,,8.0,-3.405080318,0.4775,SJSA1_BONE,SJSA1,ACH-000748,Bone Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7885217666625977
5368,9158,SK-BR-3,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.68,10.1,-.24,4.15,-6.8,14.3,-28,-32","2.02,10.3,2.95,16.8,15.1,30.1,10.5,1.92",8,Sigmoid,1.055330515,8.0,-32.13349915,0.6481,SKBR3_BREAST,SKBR3,ACH-000017,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.057321548461914
5369,9159,SK-CO-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".85,-14,-3.1,-3.9,-7.0,-23,-29,-42","4.99,14.3,21.7,20.4,1.60,20.0,7.74,2.30",8,Sigmoid,2.241742849,8.0,-41.66202164,0.7601,SKCO1_LARGE_INTESTINE,SKCO1,ACH-000400,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9362311363220215
5370,9160,SK-ES-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.6,24.2,-16,10.6,-8.0,4.45,-25,-46","1.63,1.59,14.4,1.49,18.2,5.43,4.66,1.93",8,Sigmoid,2.406007528,8.0,-45.60988235,0.8541,SKES1_BONE,SKES1,ACH-000087,Bone Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0327439308166504
5371,9161,SK-HEP-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","23.5,13.3,10.8,-.67,6.77,1.69,5.19,-52","4.58,1.60,5.79,.21,.94,.46,4.12,2.39",8,Sigmoid,8.758600302,7.896037102,-51.57125473,0.3647,SKHEP1_LIVER,SKHEP1,ACH-000361,Liver Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.066361000954994,2.9839587211608887
5372,9162,SK-MEL-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.2,12.6,-4.6,25.1,2.74,4.44,14.4,36.9","12.5,10.6,9.41,19.9,2.92,18.1,.98,5.96",8,Constant,,8.0,8.684378624,0.09419,SKMEL2_SKIN,SKMEL2,ACH-001190,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8399581909179688
5373,9163,SK-MEL-24,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.76,-.57,-1.2,23.0,2.79,-1.1,-5.0,-14","13.7,4.85,30.7,3.05,5.17,19.5,22.6,7.04",8,Constant,,8.0,1.146056056,0.1272,SKMEL24_SKIN,SKMEL24,ACH-000822,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8401546478271484
5374,9164,SK-MEL-30,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.66,-2.5,2.32,-.14,1.66,-1.2,-1.2,-5.0","11.8,8.47,.83,17.2,2.82,11.1,1.85,9.83",8,Constant,,8.0,0.816992998,0.0,SKMEL30_SKIN,SKMEL30,ACH-000810,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.5667502880096436
5375,9165,SK-MEL-31,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.3,3.18,-.067,2.96,4.73,11.5,-9.1,-15","23.0,8.62,1.11,7.89,8.74,20.0,5.94,1.73",8,Constant,,8.0,-1.477268934,0.1344,SKMEL31_SKIN,SKMEL31,ACH-000640,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.754948616027832
5376,9166,SK-MEL-5,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.11,5.23,-8.6,2.96,1.28,.40,-13,-49","13.6,19.2,13.3,22.6,14.8,13.6,15.8,0",8,Sigmoid,4.322117329,8.0,-49.48643112,0.4067,SKMEL5_SKIN,SKMEL5,ACH-000730,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8468940258026123
5377,9167,SK-MES-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","18.0,17.2,3.24,-14,-21,-42,-74,-90","11.4,8.40,18.9,17.9,5.17,13.4,2.34,.077",8,Sigmoid,1.085312366,0.96515131,-91.42735291,2.3791,SKMES1_LUNG,SKMES1,ACH-000665,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-0.03547039200720019,3.190516471862793
5378,9168,SK-MM-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.06,9.86,-.70,-12,-11,-28,-44,-59",".69,3.39,4.35,7.50,8.33,10.4,3.67,5.65",8,Sigmoid,1.351873875,3.537265301,-57.95610809,1.4542,SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SKMM2,ACH-000363,Myeloma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.2633539147612953,2.850856304168701
5379,9169,SK-N-AS,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,.90,3.39,7.50,-6.6,2.42,-4.8,-8.5","4.60,2.67,9.15,.11,3.32,1.49,9.46,1.15",8,Constant,,8.0,-0.587903082,0.03266,SKNAS_AUTONOMIC_GANGLIA,SKNAS,ACH-000260,Neuroblastoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9057350158691406
5380,9170,SK-N-BE(2),Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.99,6.88,-1.1,12.7,13.7,18.1,13.4,-24","15.8,.93,18.1,40.8,.13,39.2,6.44,1.41",8,Constant,,8.0,8.321310997,0.2446,SKNBE2_AUTONOMIC_GANGLIA,SKNBE2,ACH-000312,Neuroblastoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8622214794158936
5381,9171,SK-N-DZ,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","18.0,-2.8,29.5,9.32,-5.3,20.3,.45,-7.3","4.38,5.86,14.6,4.35,11.0,6.97,2.84,8.61",8,Constant,,8.0,4.384623051,0.04943,SKNDZ_AUTONOMIC_GANGLIA,SKNDZ,ACH-000366,Neuroblastoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.730496406555176
5382,9172,SK-N-FI,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-13,24.1,12.9,4.91,-26,.32,14.9,-1.9","54.3,23.2,9.36,38.4,15.0,35.1,23.9,6.77",8,Constant,,8.0,4.615112305,0.4157,SKNFI_AUTONOMIC_GANGLIA,SKNFI,ACH-000341,Neuroblastoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8941116333007812
5383,9173,SK-N-SH,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.8,-3.2,10.6,8.76,21.9,9.41,-8.4,-28","17.8,16.8,5.66,29.7,4.75,8.89,6.85,13.5",8,Sigmoid,2.566256523,8.0,-28.01514816,0.5904,SKNSH_AUTONOMIC_GANGLIA,SKNSH,ACH-000149,Neuroblastoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.830784559249878
5384,9174,SK-OV-3,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","12.7,-11,17.9,-15,-4.1,-10.0,-19,-38","24.7,1.86,9.82,15.5,3.98,8.25,13.6,10.2",8,Linear,,8.0,-43.6240654,0.6147,SKOV3_OVARY,SKOV3,ACH-000811,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.843329429626465
5385,9175,SNG-M,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.41,-4.1,5.08,.35,2.99,-21,-14,-38","1.02,11.4,.95,3.35,1.29,4.30,.28,10.3",8,Sigmoid,8.721974131,8.0,-37.49861145,0.7714,SNGM_ENDOMETRIUM,SNGM,ACH-000974,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7613847255706787
5386,9176,SNU-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.5,11.3,-18,5.28,-15,-4.4,-23,-21","17.7,1.75,1.23,.085,15.8,1.55,1.37,8.26",8,Constant,,8.0,-10.2054224,0.3576,SNU1_STOMACH,SNU1,ACH-000932,Gastric Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.760535717010498
5387,9177,SNU-182,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-6.6,7.65,-4.0,-9.8,-14,-32,-20,-23",".080,11.7,4.92,.76,11.4,4.93,4.48,.40",8,Constant,,8.0,-9.773207664,0.9051,SNU182_LIVER,SNU182,ACH-000483,Liver Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.810281276702881
5388,9178,SNU-387,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-9.6,-.79,-11,-14,7.09,5.09,-2.2,14.4","1.75,18.9,5.47,4.44,21.5,7.58,8.15,13.2",8,Constant,,8.0,-7.356926441,0.8118,SNU387_LIVER,SNU387,ACH-000478,Liver Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8154420852661133
5389,9179,SNU-398,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.99,13.3,.50,15.0,10.3,24.4,8.36,16.9","7.24,5.53,11.7,13.0,17.9,2.08,3.52,24.5",8,Constant,,8.0,10.15572929,0.01824,SNU398_LIVER,SNU398,ACH-000221,Liver Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.807774066925049
5390,9180,SNU-423,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.0,-9.7,4.56,-3.0,1.62,-8.9,-5.7,-13","2.49,1.71,.95,3.58,7.88,1.85,6.43,9.46",8,Constant,,8.0,-4.529827595,0.0,SNU423_LIVER,SNU423,ACH-000493,Liver Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.836134433746338
5391,9181,SNU-449,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.40,-3.0,-2.8,5.48,-6.1,-7.7,-19,-21","4.31,6.96,.62,.46,2.96,4.77,2.13,.84",8,Sigmoid,1.045074344,8.0,-21.6228199,0.3379,SNU449_LIVER,SNU449,ACH-000420,Liver Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.2057571411132812
5392,9182,SNU-475,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","87.5,-16,2.36,62.1,11.6,13.9,-34,-25","2.76,26.0,28.2,75.2,61.7,27.8,29.3,46.8",8,Linear,,8.0,-29.83067894,0.6863,SNU475_LIVER,SNU475,ACH-000422,Liver Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9098262786865234
5393,9183,SNU-C2A,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.54,4.32,-2.6,20.2,-16,-25,-23,-14","5.85,9.04,10.2,17.6,2.24,0,5.92,2.43",8,Sigmoid,0.186988384,8.0,-19.92651176,0.4618,SNUC2A_LARGE_INTESTINE,SNUC2A,ACH-000967,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9082908630371094
5394,9184,Sq-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","14.0,11.9,11.1,10.3,7.70,-6.6,-16,-66","3.68,14.1,9.21,7.98,2.33,9.51,1.04,1.84",8,Sigmoid,8.595465466,5.999964714,-64.72824097,0.9531,SQ1_LUNG,SQ1,ACH-000553,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.7917535882107618,3.0215463638305664
5395,9185,SU.86.86,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.40,1.29,1.45,.38,-6.7,-11,-9.9,-23",".76,3.94,3.54,.029,.31,4.44,4.24,4.90",8,Sigmoid,8.917250367,8.0,-22.21760368,0.1866,SU8686_PANCREAS,SU8686,ACH-000114,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9335999488830566
5396,9186,SU-DHL-10,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".51,-24,.64,-1.4,10.1,-7.4,13.9,15.7","4.81,3.29,17.2,22.5,7.56,8.98,38.2,12.5",8,Constant,,8.0,1.157077074,0.06596,SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL10,ACH-000271,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.963552236557007
5397,9187,SU-DHL-4,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.42,7.68,12.9,13.0,6.33,-2.1,-25,-28","7.75,1.03,1.73,7.28,9.06,4.90,3.83,2.38",8,Sigmoid,1.091618776,8.0,-28.29516602,1.0076,SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL4,ACH-000365,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.707381010055542
5398,9188,SU-DHL-6,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","51.9,29.4,10.3,31.8,5.75,-.47,33.9,-2.9","5.83,7.02,3.82,29.3,29.6,12.9,25.2,25.3",8,Constant,,8.0,15.47608948,0.3886,SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL6,ACH-000611,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.689484119415283
5399,9189,SU-DHL-8,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","32.0,-4.6,24.6,7.30,30.3,-7.1,11.8,-18","7.26,3.15,23.7,21.5,21.4,2.63,6.58,4.37",8,Constant,,8.0,8.100821495,0.689,SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUDHL8,ACH-000656,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0137364864349365
5400,9190,SUIT-2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.99,-9.7,2.52,-.97,-7.7,-29,-21,-62","13.6,3.08,12.8,2.50,6.49,.90,10.5,6.80",8,Sigmoid,6.745168209,8.0,-49.72615051,0.9399,SUIT2_PANCREAS,SUIT2,ACH-000652,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7254300117492676
5401,9191,SUP-M2,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-12,-1.7,10.2,12.3,-4.1,-10,17.8,16.2","3.61,14.4,13.5,3.85,1.65,25.5,28.5,13.8",8,Constant,,8.0,3.878909588,0.0,SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPM2,ACH-000226,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.567422389984131
5402,9192,SUP-T1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-7.2,9.86,-5.5,11.2,-15,13.2,-23,17.2","8.49,10.6,4.26,5.56,2.28,15.8,12.1,5.82",8,Constant,,8.0,0.561099648,0.3717,SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,SUPT1,ACH-000953,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9972448348999023
5403,9193,SW 1088,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","3.71,.88,-13,8.85,-.68,-8.1,-14,-26","3.48,24.9,36.4,31.5,28.3,22.0,16.1,24.2",8,Constant,,8.0,-6.956596851,0.1109,SW1088_CENTRAL_NERVOUS_SYSTEM,SW1088,ACH-000437,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.979233980178833
5404,9194,SW 1271,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.4,16.1,22.4,16.7,-5.7,1.53,-9.3,-6.3","15.5,15.1,24.7,3.53,12.1,2.14,.23,9.80",8,Sigmoid,0.133498222,8.0,-4.977474213,0.08464,SW1271_LUNG,SW1271,ACH-000890,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.891111373901367
5405,9195,SW 1353,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.8,15.0,14.0,13.6,1.89,-12,10.2,-13","20.2,14.7,12.6,12.2,7.57,5.09,15.6,5.58",8,Constant,,8.0,5.343530655,0.1981,SW1353_BONE,SW1353,ACH-000418,Bone Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9201695919036865
5406,9196,SW1417,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.19,-5.3,21.0,12.0,3.01,-4.7,3.50,-32","16.9,3.52,10.4,23.3,27.4,18.7,31.3,1.53",8,Constant,,8.0,-3.026026487,0.3159,SW1417_LARGE_INTESTINE,SW1417,ACH-000236,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.184774875640869
5407,9197,SW 1573,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.46,8.74,-1.3,6.30,-9.1,-9.1,-20,-29","12.6,5.74,17.7,2.96,5.54,8.90,8.30,5.67",8,Sigmoid,1.578596115,8.0,-28.80326843,0.3446,SW1573_LUNG,SW1573,ACH-000677,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8530616760253906
5408,9198,SW 1990,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.86,9.37,10.4,6.93,-5.3,-13,-8.6,-38","4.90,15.4,7.03,8.33,2.34,19.8,9.17,10.4",8,Sigmoid,8.541175532,8.0,-36.1482811,0.5871,SW1990_PANCREAS,SW1990,ACH-000155,Pancreatic Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.070368766784668
5409,9199,SW403,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.0,2.22,12.1,5.83,-7.2,-20,-37,-46","14.7,35.8,1.22,.34,18.1,5.53,12.5,2.96",8,Sigmoid,0.816393495,8.0,-45.99539566,1.0355,SW403_LARGE_INTESTINE,SW403,ACH-000820,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.1744003295898438
5410,9200,SW48,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-5.1,-9.5,-26,-42,-41,-32,-51,-62","17.9,2.01,12.3,1.45,12.1,16.4,10.1,3.57",8,Sigmoid,0.002542614,1.215090156,-57.65122223,2.558,SW48_LARGE_INTESTINE,SW48,ACH-000958,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.19481827650878059,2.6810193061828613
5411,9201,SW480,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".33,5.66,18.0,3.61,13.0,-5.4,-7.0,-5.9","9.13,5.14,7.35,.93,14.1,2.24,12.1,1.18",8,Constant,,8.0,2.607806444,0.2869,SW480_LARGE_INTESTINE,SW480,ACH-000842,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.0518736839294434
5412,9202,SW579,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.59,-4.3,9.88,-9.5,4.66,-2.1,1.03,-42","4.55,1.11,3.85,3.08,5.55,2.26,3.82,47.0",8,Constant,,8.0,-1.038875818,0.3561,SW579_THYROID,SW579,ACH-000163,Thyroid Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.915308952331543
5413,9203,SW620,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.77,-8.0,7.31,13.0,9.54,4.24,8.06,-10","10.7,5.97,5.53,3.93,8.55,13.8,15.0,.74",8,Constant,,8.0,3.735089302,0.0,SW620_LARGE_INTESTINE,SW620,ACH-000651,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7670207023620605
5414,9204,SW 780,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.9,-2.2,-3.7,.71,-18,-15,-32,-33","13.5,.37,.26,1.91,5.48,.10,12.0,4.25",8,Sigmoid,1.767854452,8.0,-32.52693558,0.9057,SW780_URINARY_TRACT,SW780,ACH-000384,Bladder Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.956389904022217
5415,9205,SW 900,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.42,-14,13.4,-.20,-12,-5.5,.92,-13","21.0,7.02,17.3,17.9,7.36,6.09,27.7,6.85",8,Constant,,8.0,-8.991792679,0.1385,SW900_LUNG,SW900,ACH-000669,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.1243433952331543
5416,9206,T24,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.8,10.0,1.71,16.4,-8.1,-4.3,-24,-50","2.23,3.38,2.84,7.24,12.2,1.32,3.84,6.95",8,Sigmoid,3.92647624,7.82816124,-50.43416977,0.8934,T24_URINARY_TRACT,T24,ACH-000018,Bladder Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.057727647175555,2.8269846439361572
5417,9207,T3M-10,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,6.33,13.8,14.3,-9.5,-6.0,-13,-37","13.9,16.7,18.0,19.2,12.3,8.38,11.4,6.73",8,Sigmoid,8.610752295,8.0,-36.85489273,0.3811,T3M10_LUNG,T3M10,ACH-000813,Lung Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9186744689941406
5418,9208,T-47D,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.4,.57,-2.8,-6.7,-4.2,-11,-10.0,-12","5.02,23.8,26.3,1.14,19.6,12.9,15.3,17.3",8,Constant,,8.0,-6.683815479,0.1791,T47D_BREAST,T47D,ACH-000147,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.266414165496826
5419,9209,T84,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","44.1,-10,30.6,-.61,25.4,10.5,-27,-38","69.9,21.5,34.8,81.4,50.5,18.9,35.4,19.4",8,Constant,,8.0,-2.324239969,1.0015,T84_LARGE_INTESTINE,T84,ACH-000381,Colon/Colorectal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.058781147003174
5420,9210,TCCSUP,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.27,-5.9,15.5,.35,6.39,.12,2.79,-16","5.53,.0070,5.27,1.97,3.88,5.16,1.71,7.99",8,Constant,,8.0,1.657687187,0.06454,TCCSUP_URINARY_TRACT,TCCSUP,ACH-000720,Bladder Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8026421070098877
5421,9211,TE-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.64,11.6,-.14,6.61,-9.3,-13,-26,-51","8.38,4.02,2.62,1.57,6.40,.12,10.3,1.72",8,Sigmoid,8.792121557,7.821309566,-50.54677963,0.8417,TE1_OESOPHAGUS,TE1,ACH-000647,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.056852004219607,2.892812728881836
5422,9212,TE-11,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","8.48,2.91,13.5,-4.3,-11,-45,-74,-92","5.64,3.22,5.22,2.23,.70,3.13,4.95,1.01",8,Sigmoid,0.870171726,0.987239659,-91.84072113,2.0088,TE11_OESOPHAGUS,TE11,ACH-000488,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-0.012842453420755868,2.888033628463745
5423,9213,TE-15,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","27.5,21.7,16.2,11.6,-8.1,-47,-72,-79","8.28,29.9,34.4,16.6,17.1,5.79,2.43,1.53",8,Sigmoid,0.412335545,0.877725303,-79.58098602,1.677,TE15_OESOPHAGUS,TE15,ACH-000353,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-0.13042160104262734,2.945918083190918
5424,9214,TE-5,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","4.60,8.55,8.76,9.92,1.44,5.70,-12,-15","5.08,3.61,1.28,3.55,7.63,6.59,4.44,8.50",8,Sigmoid,1.534486651,8.0,-14.77249432,0.23,TE5_OESOPHAGUS,TE5,ACH-000408,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.889479160308838
5425,9215,TE 617.T,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.00,21.3,-1.5,11.9,.86,-23,-70,-88","7.93,21.7,3.87,22.6,26.0,4.65,2.36,1.15",8,Sigmoid,1.359577656,1.51734972,-88.6974411,1.7201,TE617T_SOFT_TISSUE,TE617T,ACH-000051,Sarcoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,0.4169652077461104,2.4591264724731445
5426,9216,TE-9,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8",".18,13.1,-6.1,6.61,-7.4,2.33,-35,-45","1.99,16.8,8.36,12.4,2.42,20.8,.31,12.8",8,Sigmoid,1.980753779,8.0,-45.5231514,0.9259,TE9_OESOPHAGUS,TE9,ACH-000694,Esophageal Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9929752349853516
5427,9217,TEN,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.25,14.3,4.08,9.07,-4.0,4.08,-13,14.2","13.4,15.7,15.5,29.8,8.45,.32,15.1,4.28",8,Constant,,8.0,3.83914876,0.08303,TEN_ENDOMETRIUM,TEN,ACH-000397,Endometrial/Uterine Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9581899642944336
5428,9218,Toledo,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-2.4,14.1,-5.6,.54,3.10,-11,10.0,-3.8","2.19,24.3,15.3,4.00,44.3,20.2,10.1,32.4",8,Constant,,8.0,0.675030708,0.01286,TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,TOLEDO,ACH-000285,Lymphoma,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8701353073120117
5429,9219,TOV-112D,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.5,1.69,-12,-17,-2.1,-13,-13,-47","9.04,7.23,15.7,7.13,3.82,9.99,16.5,3.52",8,Sigmoid,8.39237468,8.0,-46.47077942,0.8777,TOV112D_OVARY,TOV112D,ACH-000048,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.768254280090332
5430,9220,TOV-21G,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","11.0,1.04,16.7,2.26,-4.4,-1.4,-19,-57","2.41,2.46,6.73,2.72,2.55,3.55,2.99,10.2",8,Sigmoid,8.539506363,6.919062614,-56.10400009,0.8857,TOV21G_OVARY,TOV21G,ACH-000885,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,1.9342803000493647,2.4099812507629395
5431,9221,TT2609-C02,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","30.1,18.2,1.56,28.8,-5.0,5.53,-31,-47","36.4,1.63,14.5,16.0,11.2,21.1,21.8,13.8",8,Sigmoid,2.478951454,8.0,-48.0713501,0.8222,TT2609C02_THYROID,TT2609C02,ACH-000716,Thyroid Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.787541389465332
5432,9222,TYK-nu,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","20.3,-1.9,15.1,-6.4,13.9,-.18,28.6,-14","12.9,1.56,12.7,11.0,7.84,12.3,17.4,5.13",8,Constant,,8.0,7.284276962,0.2076,TYKNU_OVARY,TYKNU,ACH-000430,Ovarian Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.907040596008301
5433,9223,U-118 MG,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-3.4,-7.6,-.63,-.024,10.3,-8.3,.32,-6.5","11.3,15.4,1.85,1.75,.18,10.7,11.2,12.5",8,Constant,,8.0,-0.298017919,0.05681,U118MG_CENTRAL_NERVOUS_SYSTEM,U118MG,ACH-000040,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8980870246887207
5434,9224,U-2 OS,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","2.79,5.16,2.32,2.76,-8.9,-10,-5.4,-28","1.18,15.3,5.45,6.35,5.14,.31,6.00,17.9",8,Sigmoid,8.832890524,8.0,-25.13688087,0.4888,U2OS_BONE,U2OS,ACH-000364,Bone Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8522515296936035
5435,9225,U-87 MG,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","7.54,4.25,16.3,-2.3,10.2,16.7,8.94,15.4","12.2,5.84,7.91,21.8,6.70,2.95,16.1,9.94",8,Constant,,8.0,11.64905548,0.07387,U87MG_CENTRAL_NERVOUS_SYSTEM,U87MG,ACH-000075,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9154772758483887
5436,9226,U-937,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.6,3.38,16.2,18.5,5.05,-9.5,-15,-21","4.88,6.03,4.61,12.1,10.7,9.62,1.64,16.6",8,Sigmoid,2.030527592,8.0,-31.24400902,0.5495,U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE,U937,ACH-000406,Leukemia,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.641989231109619
5437,9227,UACC-257,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","5.15,5.38,5.97,8.88,4.36,12.4,-3.6,-2.1","2.34,7.66,.52,6.22,.72,4.02,1.72,2.50",8,Constant,,8.0,4.788830757,0.0,UACC257_SKIN,UACC257,ACH-000579,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7407524585723877
5438,9228,UACC-62,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.8,1.57,-.13,-3.2,-7.8,-16,-24,-51","10.3,6.66,7.20,3.85,9.92,12.1,4.80,6.57",8,Sigmoid,8.614220499,8.0,-48.51916504,0.6873,UACC62_SKIN,UACC62,ACH-000425,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7584903240203857
5439,9229,UACC-812,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","10.7,14.4,-15,12.7,9.02,14.9,-13,-43","17.1,35.3,24.8,26.3,30.8,25.5,51.0,42.1",8,Linear,,0.912124534,-71.85778046,0.4433,UACC812_BREAST,UACC812,ACH-000568,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,-0.09197874779137165,3.409005641937256
5440,9230,UM-UC-3,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.80,7.97,5.99,4.26,8.03,3.29,4.63,2.22","14.3,1.50,3.14,.31,3.59,2.20,2.17,.72",8,Constant,,8.0,4.613566399,0.0,UMUC3_URINARY_TRACT,UMUC3,ACH-000522,Bladder Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.6160573959350586
5441,9231,VMRC-RCW,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-8.3,-6.0,11.8,-.80,21.7,2.57,.021,-26","15.8,1.05,1.64,4.76,6.68,11.6,17.1,16.8",8,Sigmoid,4.227674007,8.0,-26.24533272,0.194,VMRCRCW_KIDNEY,VMRCRCW,ACH-000484,Kidney Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7273831367492676
5442,9232,VMRC-RCZ,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.09,8.22,11.8,-5.1,11.3,1.30,-15,-24","3.08,15.8,25.2,8.47,11.0,9.54,.40,8.20",8,Sigmoid,2.178513288,8.0,-23.6163578,0.9017,VMRCRCZ_KIDNEY,VMRCRCZ,ACH-000171,Kidney Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7753520011901855
5443,9233,WM-115,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","13.5,2.34,10.1,5.14,11.9,-2.7,2.68,-26","10.3,20.1,2.86,5.23,3.62,21.2,23.6,6.39",8,Sigmoid,2.255732775,8.0,-26.29893875,0.1035,WM115_SKIN,WM115,ACH-000304,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7937541007995605
5444,9234,WM1799,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","6.35,8.58,28.7,11.9,1.05,-8.2,-8.8,-42","6.96,10.3,15.1,5.25,4.21,15.5,11.9,.88",8,Sigmoid,8.494191199,8.0,-40.77984238,0.6819,WM1799_SKIN,WM1799,ACH-000661,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.677272319793701
5445,9235,WM-266-4,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-1.6,9.92,-4.9,6.90,-2.8,8.43,-12,-1.3","7.77,3.55,1.71,4.37,10.9,5.51,12.5,13.1",8,Constant,,8.0,3.805812597,0.08816,WM2664_SKIN,WM2664,ACH-001239,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.6245598793029785
5446,9236,WM-793,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-.050,3.17,.15,2.59,-4.0,10.3,-12,-17","14.0,16.4,4.83,11.5,1.51,17.5,6.24,17.9",8,Constant,,8.0,-4.040697575,0.07185,WM793_SKIN,WM793,ACH-000827,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.073639392852783
5447,9237,WM-88,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.99,-1.1,6.73,13.1,-4.1,-4.3,2.53,-14","3.25,3.41,7.44,11.5,.45,6.40,1.28,5.15",8,Constant,,8.0,0.592600942,0.242,WM88_SKIN,WM88,ACH-000899,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.8364007472991943
5448,9238,WM-983B,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","17.2,15.1,4.57,26.9,-3.3,-2.0,-2.8,-3.1","24.1,24.5,18.1,21.7,5.15,8.95,9.30,48.2",8,Constant,,8.0,2.241383076,0.981,WM983B_SKIN,WM983B,ACH-000765,Skin Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.7007341384887695
5449,9239,YKG1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","1.31,-4.4,-2.9,-1.3,-.39,-5.0,-9.3,-16","1.72,3.30,6.16,2.33,4.65,4.73,3.47,2.82",8,Constant,,8.0,-3.171900034,0.07841,YKG1_CENTRAL_NERVOUS_SYSTEM,YKG1,ACH-000570,Brain Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.839571952819824
5450,9240,ZR-75-1,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","39.3,-25,31.8,25.5,10.6,-37,-22,-37","38.8,7.84,7.22,3.57,.86,23.7,18.6,8.01",8,Linear,,8.0,-34.83546066,1.1717,ZR751_BREAST,ZR751,ACH-000097,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,2.9788451194763184
5451,9241,ZR-75-30,Erlotinib,EGFR,".0025,.0080,.025,.080,.25,.80,2.53,8","-23,9.04,8.59,26.0,17.9,12.1,-11,-22","15.7,1.31,1.58,22.9,26.8,23.5,32.8,19.9",8,Linear,,8.0,-22.0538826,0.03998,ZR7530_BREAST,ZR7530,ACH-000828,Breast Cancer,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Tarceva,EGFR,EGFR  Inhibitor,Kinase inhibitor,Launched-2004,Genentech,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2.0794415416798357,3.265672445297241
